data_2k3d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k3d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.375 0.607 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -63.56 -40.84 98.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.245 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -62.71 -40.66 97.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.588 -0.695 . . . . 0.0 109.477 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.06 -41.14 97.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.759 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.0 -41.18 97.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 109.437 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -64.1 -42.05 97.04 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.01 -43.27 93.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.606 -0.683 . . . . 0.0 109.859 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.31 -44.3 92.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.431 -0.793 . . . . 0.0 109.801 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.5 t -64.5 -45.26 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 110.072 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.8 m -62.44 -48.04 81.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.267 -0.896 . . . . 0.0 109.538 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 tp -64.08 -41.92 97.15 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.775 0.798 . . . . 0.0 109.656 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.604 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 78.5 t80 -63.96 -40.57 96.72 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.922 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.08 -46.13 90.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.855 . . . . 0.0 110.472 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -68.89 -29.2 67.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 110.308 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -68.48 -39.74 81.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.269 -0.894 . . . . 0.0 109.897 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.604 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 71.6 m-80 -94.63 -3.69 49.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 108.65 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.6 mt -138.38 93.98 11.04 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.92 -16.53 36.92 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.071 1.848 . . . . 0.0 111.057 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -90.12 5.54 46.38 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -58.11 133.81 55.9 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.55 -0.719 . . . . 0.0 110.164 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -110.19 -58.08 2.12 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 t -153.45 160.5 42.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 109.97 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.3 134.69 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -123.49 125.83 45.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.01 144.61 26.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.608 -0.682 . . . . 0.0 109.338 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.1 t -161.91 61.06 0.25 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.183 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -161.53 -83.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 40' ' ' GLU . 4.1 tm-20 56.13 75.13 0.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.794 . . . . 0.0 109.375 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -120.3 150.58 40.5 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.622 0.725 . . . . 0.0 109.614 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -92.23 120.31 32.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.376 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -103.49 156.01 36.07 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.28 -37.97 25.29 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.399 2.066 . . . . 0.0 112.06 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.72 -37.73 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.119 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.11 -98.44 0.13 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 pt -123.35 157.81 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.526 -0.985 . . . . 0.0 110.275 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.0 p -139.98 123.78 17.42 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.405 HD12 HG21 ' A' ' 49' ' ' ILE . 96.8 mt -118.58 133.06 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.681 -0.637 . . . . 0.0 109.427 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 50.1 t0 -131.18 147.1 52.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.613 -0.68 . . . . 0.0 109.449 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -172.43 -170.61 36.44 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -141.42 165.59 27.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.356 -1.085 . . . . 0.0 110.156 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.4 pt -121.75 162.84 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.531 0.682 . . . . 0.0 110.872 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 57.76 33.18 22.91 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.347 0.594 . . . . 0.0 110.126 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 48.31 26.73 1.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.4 -0.812 . . . . 0.0 110.246 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -108.57 108.59 19.55 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.375 -0.828 . . . . 0.0 109.644 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.15 -32.47 68.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.652 -0.655 . . . . 0.0 109.65 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -62.58 -39.73 94.65 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.45 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.8 mt -81.89 80.31 8.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.163 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.8 m -104.86 153.41 21.4 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.747 0.784 . . . . 0.0 110.417 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -139.61 150.98 45.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.779 -0.575 . . . . 0.0 109.635 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.2 m -133.67 136.23 44.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.544 -0.723 . . . . 0.0 109.917 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.26 155.21 40.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.232 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.44 -130.35 3.91 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' ASP . 54.9 mtpt -59.23 128.57 37.82 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.487 -1.008 . . . . 0.0 110.716 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 67' ' ' VAL . 43.2 t0 44.93 -173.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.505 0.669 . . . . 0.0 110.278 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.527 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 2.3 t -94.69 21.28 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.097 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -63.4 -41.84 98.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.219 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.413 HG22 HD11 ' A' ' 69' ' ' ILE . 96.9 mt -118.37 126.06 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -136.13 135.44 39.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.537 -0.727 . . . . 0.0 109.183 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 t -134.48 144.54 48.13 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.74 . . . . 0.0 109.413 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.1 p -152.71 164.08 38.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 110.516 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.1 p -68.06 167.44 13.95 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.611 0.72 . . . . 0.0 110.67 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -66.46 -36.61 83.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.313 -0.867 . . . . 0.0 109.447 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.83 -32.22 73.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.552 -0.717 . . . . 0.0 109.478 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.4 tp -90.52 -17.94 26.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 109.16 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -73.2 -42.27 62.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.67 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -63.77 -21.31 66.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.642 -0.661 . . . . 0.0 109.745 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 86.1 mmm -64.51 -35.36 80.7 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.341 -0.849 . . . . 0.0 109.15 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -64.31 132.79 51.23 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.32 -0.862 . . . . 0.0 109.86 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -113.21 -16.99 12.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -119.08 153.62 53.04 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.742 -0.598 . . . . 0.0 109.853 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.31 157.34 58.36 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 123.022 2.481 . . . . 0.0 113.012 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -67.4 141.65 56.98 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.726 0.774 . . . . 0.0 110.845 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -141.27 150.54 42.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.647 -0.658 . . . . 0.0 109.308 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.65 158.72 51.16 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -60.41 -44.08 96.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.715 -0.873 . . . . 0.0 109.58 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -66.26 -34.58 78.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 109.663 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -62.65 -49.5 74.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 109.689 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 pt -66.95 -37.46 79.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.472 -0.767 . . . . 0.0 109.427 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.3 tp -62.51 -44.23 96.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.899 . . . . 0.0 109.461 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.394 -0.817 . . . . 0.0 109.525 -179.472 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.0 t80 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.385 0.612 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -64.39 -36.56 84.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 109.658 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -63.23 -41.35 99.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.499 -0.751 . . . . 0.0 110.026 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 54.8 mp0 -67.62 -40.41 84.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.606 -0.683 . . . . 0.0 109.91 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 56.2 tp60 -67.75 -36.72 81.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.402 -0.811 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.72 -42.69 99.3 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.623 0.725 . . . . 0.0 109.372 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.62 -39.88 91.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.737 -0.602 . . . . 0.0 109.94 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.74 -42.37 97.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.377 -0.827 . . . . 0.0 109.962 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.38 -42.3 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.1 m -60.51 -45.28 94.38 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.729 0.776 . . . . 0.0 109.078 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -63.83 -41.91 97.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.444 -0.785 . . . . 0.0 108.998 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.525 ' CE2' ' OD1' ' A' ' 28' ' ' ASN . 75.6 t80 -61.36 -47.36 86.21 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.63 -39.83 94.39 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.57 0.7 . . . . 0.0 109.571 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -58.52 -47.82 82.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.624 -0.673 . . . . 0.0 110.272 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -74.29 -42.75 59.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.28 -0.887 . . . . 0.0 110.072 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.525 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 28.2 m120 -65.28 -39.81 93.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.761 . . . . 0.0 109.499 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.1 mt -105.18 109.32 63.08 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.709 -0.62 . . . . 0.0 109.607 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.94 -16.67 29.14 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.258 1.972 . . . . 0.0 111.15 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -97.33 13.64 28.89 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -58.16 129.54 42.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.485 -0.759 . . . . 0.0 110.036 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.83 -53.64 1.54 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -146.19 158.17 43.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.358 -0.839 . . . . 0.0 110.044 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.2 138.38 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.185 0.516 . . . . 0.0 109.874 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -130.51 124.06 31.07 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.516 0.674 . . . . 0.0 109.589 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -101.32 117.73 35.55 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.452 0.644 . . . . 0.0 109.583 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 t -154.76 30.04 0.42 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.601 -0.687 . . . . 0.0 109.237 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -147.51 16.16 1.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.487 -0.758 . . . . 0.0 109.006 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.75 141.11 45.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.592 0.711 . . . . 0.0 110.685 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -146.3 155.41 42.62 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.472 0.653 . . . . 0.0 109.751 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -75.76 140.82 42.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.637 -0.664 . . . . 0.0 109.789 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -112.01 140.32 23.33 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.22 -36.62 29.75 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.253 1.969 . . . . 0.0 111.422 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.3 tt -86.5 -6.4 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.395 -0.815 . . . . 0.0 109.217 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.92 -114.88 0.63 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 pt -127.21 157.09 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.786 -0.832 . . . . 0.0 110.289 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -128.23 131.48 48.8 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.54 0.686 . . . . 0.0 109.396 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 49' ' ' ILE . 36.1 mm -98.82 119.21 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.432 0.634 . . . . 0.0 109.457 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -123.58 141.93 51.53 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.45 0.643 . . . . 0.0 109.601 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.29 -168.27 38.01 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -145.9 164.93 30.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.88 -0.777 . . . . 0.0 109.955 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -122.75 164.82 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 121.844 0.831 . . . . 0.0 110.7 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 57.98 32.43 21.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.774 0.797 . . . . 0.0 109.783 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 46.56 30.52 1.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.852 -0.53 . . . . 0.0 110.164 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -112.82 111.62 22.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.553 -0.717 . . . . 0.0 109.569 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.04 -32.52 69.82 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.449 0.642 . . . . 0.0 109.493 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.82 -39.01 92.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.806 . . . . 0.0 109.424 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.35 76.13 9.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.456 -0.777 . . . . 0.0 109.442 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.1 m -100.34 159.65 14.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.459 0.647 . . . . 0.0 110.452 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -146.62 150.24 35.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.429 0.633 . . . . 0.0 109.812 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 52.3 m -131.29 135.59 47.43 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.23 145.94 51.01 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.591 0.71 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -93.99 111.59 4.17 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.578 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 13.0 ptmt 26.93 -107.3 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.527 0.679 . . . . 0.0 111.123 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.37 42.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.714 0.769 . . . . 0.0 109.666 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.52 ' H ' ' C ' ' A' ' 65' ' ' LYS . 2.3 t 51.13 37.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.939 0.876 . . . . 0.0 109.921 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -63.64 -41.96 98.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.655 -0.653 . . . . 0.0 109.362 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 tp -135.09 131.31 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.617 -0.677 . . . . 0.0 109.279 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -124.21 133.43 53.53 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.525 0.679 . . . . 0.0 110.168 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -128.76 152.32 48.58 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.0 m -130.21 152.44 49.63 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.803 0.811 . . . . 0.0 110.161 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 77' ' ' ASP . 17.0 p -78.58 172.3 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.811 0.815 . . . . 0.0 110.65 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -58.64 -44.11 89.97 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.55 0.691 . . . . 0.0 109.9 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.05 -36.81 75.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.447 -0.783 . . . . 0.0 109.567 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.7 tp -81.37 -15.99 53.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.752 0.787 . . . . 0.0 109.43 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' SER . 65.2 t0 -61.12 -47.29 86.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.22 -0.925 . . . . 0.0 110.589 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -59.98 -44.0 94.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.445 -0.784 . . . . 0.0 110.595 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 94.5 mtp -66.51 -38.99 88.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.66 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -75.17 108.31 7.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.48 -0.763 . . . . 0.0 109.983 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -145.24 7.47 1.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -122.52 83.23 47.49 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.5 118.71 2.23 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.776 2.318 . . . . 0.0 113.128 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -80.97 166.0 21.23 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.972 0.891 . . . . 0.0 110.594 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -87.74 -5.91 58.44 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.867 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.65 165.79 14.39 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.715 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.71 -22.23 66.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.907 -0.761 . . . . 0.0 109.154 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -81.3 -26.82 35.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.552 -0.718 . . . . 0.0 109.937 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -72.48 -40.86 66.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.428 -0.795 . . . . 0.0 110.184 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.5 pt -60.44 -23.93 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.453 -0.779 . . . . 0.0 110.356 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.2 mt -65.55 -33.58 76.25 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.242 -0.911 . . . . 0.0 109.896 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.454 0.645 . . . . 0.0 110.024 -179.325 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.8 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.252 0.548 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -85.56 -27.25 25.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.795 -0.566 . . . . 0.0 109.519 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -62.69 -44.83 95.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.789 -0.569 . . . . 0.0 109.947 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -65.79 -37.12 85.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.851 -0.531 . . . . 0.0 109.755 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.98 -43.08 99.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.8 -0.563 . . . . 0.0 110.033 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -64.78 -39.96 94.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.781 -0.574 . . . . 0.0 110.362 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.19 -39.48 94.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.712 -0.617 . . . . 0.0 109.561 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.33 -42.25 98.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.81 -0.556 . . . . 0.0 109.68 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.18 -43.3 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -61.88 -43.48 98.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.157 0.503 . . . . 0.0 109.782 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 tp -62.26 -41.26 98.3 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.324 0.583 . . . . 0.0 109.595 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.533 ' CD1' ' OD1' ' A' ' 28' ' ' ASN . 74.6 t80 -60.14 -46.28 90.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 29' ' ' ILE . 69.4 mt -63.77 -41.28 98.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.819 -0.551 . . . . 0.0 110.611 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -61.73 -40.51 95.33 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.869 -0.519 . . . . 0.0 110.148 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -86.72 -25.1 24.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.995 -0.441 . . . . 0.0 110.431 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' OD1' ' CD1' ' A' ' 24' ' ' TYR . 25.6 m120 -97.33 -11.41 24.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.427 -0.795 . . . . 0.0 109.228 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 25' ' ' LEU . 11.1 mt -148.16 88.67 5.39 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.31 -30.84 64.39 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.816 2.344 . . . . 0.0 112.051 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -78.94 6.17 9.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.54 130.67 47.08 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.782 0.801 . . . . 0.0 109.994 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -107.77 -56.06 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -161.46 165.95 27.96 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.503 0.668 . . . . 0.0 109.93 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.59 137.22 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.741 0.782 . . . . 0.0 109.804 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.9 m -119.08 122.84 43.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.525 0.678 . . . . 0.0 109.549 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' ' CG2' ' A' ' 49' ' ' ILE . 72.9 m-85 -106.4 119.77 40.13 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.717 0.77 . . . . 0.0 109.743 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -33.91 0.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' GLU . 8.9 m120 -69.51 -73.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.762 -0.586 . . . . 0.0 109.757 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 39' ' ' ASN . 81.7 tt0 55.5 151.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.924 0.869 . . . . 0.0 111.233 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -160.97 144.92 13.45 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.798 0.809 . . . . 0.0 109.806 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -92.83 140.54 29.4 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.532 0.682 . . . . 0.0 109.917 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -131.1 149.73 74.56 Favored Pre-proline 0 N--CA 1.486 1.352 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.77 -35.16 38.24 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.638 2.225 . . . . 0.0 112.021 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.8 pt -72.7 -4.94 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.53 -118.44 1.42 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 pt -126.55 154.73 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.797 -0.825 . . . . 0.0 110.103 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.2 p -135.87 131.46 35.33 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.759 0.79 . . . . 0.0 109.678 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.482 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 96.8 mt -94.48 127.64 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.538 0.685 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 65.9 t0 -127.58 137.13 52.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.615 0.721 . . . . 0.0 109.786 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -177.08 -151.66 9.25 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -146.09 160.69 41.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.816 -0.814 . . . . 0.0 110.26 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.0 pt -120.31 163.7 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.804 0.812 . . . . 0.0 110.95 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 58.09 33.54 23.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.837 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 45.92 29.26 0.71 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.436 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -111.74 109.57 19.48 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.773 0.797 . . . . 0.0 109.433 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -58.15 -34.21 70.04 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.846 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -62.26 -39.4 92.78 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.2 mt -81.69 86.8 6.36 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.562 0.696 . . . . 0.0 110.041 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.5 p -80.3 163.87 23.62 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.872 0.844 . . . . 0.0 110.846 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -149.66 131.03 14.69 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.585 0.707 . . . . 0.0 109.672 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.4 m -137.45 132.47 33.42 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.783 0.801 . . . . 0.0 110.058 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.41 142.62 37.48 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.789 0.804 . . . . 0.0 109.736 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -99.28 129.11 9.79 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' GLY . 17.9 tptm 35.36 -122.43 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.08 0.467 . . . . 0.0 110.649 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 68' ' ' LYS . 67.2 t0 -83.36 72.26 10.22 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.377 0.608 . . . . 0.0 109.745 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 66' ' ' ASP . 2.1 t 40.87 28.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.507 0.67 . . . . 0.0 109.345 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ASP . 49.1 mtpt -63.05 -41.94 99.6 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.69 126.17 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.639 0.733 . . . . 0.0 109.82 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -92.71 123.55 36.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.877 0.846 . . . . 0.0 109.718 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -141.29 119.75 12.34 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.809 0.814 . . . . 0.0 109.437 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 p -153.36 165.16 36.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.947 0.88 . . . . 0.0 110.489 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.2 p -75.19 164.35 26.57 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.838 0.828 . . . . 0.0 110.433 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.65 -36.99 83.87 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.6 -34.69 76.07 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 tp -91.97 -21.28 20.63 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -65.76 -35.43 80.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 109.754 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -75.03 -12.26 60.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.624 -0.672 . . . . 0.0 110.133 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.2 mtp -77.11 -5.18 47.96 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -89.7 120.62 31.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.764 0.792 . . . . 0.0 109.031 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.419 ' CD ' ' N ' ' A' ' 81' ' ' GLN . 23.7 mp0 -97.47 -11.99 23.17 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -133.03 149.95 74.23 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.692 -0.63 . . . . 0.0 109.702 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.62 149.57 10.04 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.503 2.135 . . . . 0.0 112.393 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -64.55 136.8 57.4 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.654 0.74 . . . . 0.0 110.285 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -128.65 143.89 51.04 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.053 0.93 . . . . 0.0 110.355 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.21 160.24 52.7 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -60.25 -45.33 93.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.234 -0.568 . . . . 0.0 109.938 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.68 -36.97 86.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.577 -0.702 . . . . 0.0 109.695 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -62.22 -48.4 80.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.824 -0.547 . . . . 0.0 110.0 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.9 pt -69.59 -32.49 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.767 -0.583 . . . . 0.0 109.518 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.24 -44.23 92.46 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.863 -0.523 . . . . 0.0 109.733 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.323 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -62.35 -43.81 97.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.85 -0.531 . . . . 0.0 110.37 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -62.52 -42.16 99.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.444 -0.785 . . . . 0.0 110.163 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.81 -39.15 87.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.797 -0.565 . . . . 0.0 110.272 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.405 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 20.1 mm100 -66.0 -39.71 90.51 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.716 . . . . 0.0 109.751 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.98 -43.16 99.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.604 -0.685 . . . . 0.0 109.923 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.59 -43.38 80.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.774 -0.579 . . . . 0.0 110.06 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -65.47 -42.52 92.16 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.0 109.915 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.56 -43.76 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.845 -0.535 . . . . 0.0 109.913 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -61.09 -48.53 81.28 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.93 -40.81 91.74 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.495 ' HH ' ' H ' ' A' ' 84' ' ' ARG . 36.6 t80 -61.07 -48.77 80.2 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.13 -41.87 94.41 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.315 0.579 . . . . 0.0 109.834 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.1 -44.0 91.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.884 -0.51 . . . . 0.0 110.68 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -68.86 -37.06 78.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.373 -0.83 . . . . 0.0 110.318 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.443 HD22 ' CG ' ' A' ' 84' ' ' ARG . 1.3 m-20 -87.2 -5.15 59.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -138.2 94.54 10.97 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.06 -18.51 27.4 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.321 2.014 . . . . 0.0 111.278 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.98 7.44 44.05 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CG ' ' N ' ' A' ' 33' ' ' ASN . 61.1 t80 -54.82 158.19 2.8 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.704 0.764 . . . . 0.0 110.143 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.451 ' N ' ' CG ' ' A' ' 32' ' ' PHE . 65.4 t30 -145.31 -52.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -149.8 151.35 33.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.818 . . . . 0.0 110.095 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.2 137.15 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.534 0.683 . . . . 0.0 109.834 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.4 m -116.96 112.23 20.71 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.621 0.724 . . . . 0.0 109.117 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -80.6 145.63 31.63 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.485 0.659 . . . . 0.0 110.303 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 50' ' ' ASP . 25.3 p -155.45 106.45 2.54 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.712 0.767 . . . . 0.0 109.655 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 38' ' ' THR . 9.3 m120 -49.99 -105.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.383 0.611 . . . . 0.0 109.989 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 41' ' ' GLU . 81.6 tt0 55.83 113.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.48 0.657 . . . . 0.0 110.336 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 42' ' ' PHE . 5.5 tm-20 79.23 141.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.466 0.65 . . . . 0.0 110.395 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.502 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 96.9 m-85 -135.06 151.92 51.21 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.835 0.826 . . . . 0.0 110.372 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.51 157.08 89.61 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -37.48 -66.74 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.904 2.403 . . . . 0.0 112.598 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 45' ' ' ILE . 27.9 mm -108.01 -26.71 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.72 -160.63 34.18 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.5 pt -120.44 146.27 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.694 0.759 . . . . 0.0 109.818 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.405 ' H ' ' HA ' ' A' ' 42' ' ' PHE . 10.1 t -111.47 128.46 56.01 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.551 0.691 . . . . 0.0 109.532 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -115.27 127.3 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.672 0.748 . . . . 0.0 109.767 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 59.4 t0 -113.89 154.14 28.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.846 0.831 . . . . 0.0 109.667 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -179.58 -175.23 46.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.1 p90 -149.91 166.22 30.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.874 -0.78 . . . . 0.0 110.436 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 pt -118.83 158.86 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 CA-C-O 121.89 0.852 . . . . 0.0 110.849 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 66.0 m-80 56.75 36.87 28.31 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.194 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 25.1 p30 45.04 23.28 0.09 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.084 0.469 . . . . 0.0 110.535 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -105.67 113.97 27.85 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.66 0.743 . . . . 0.0 109.836 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.23 -30.64 69.54 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -62.17 -38.7 90.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.549 -0.72 . . . . 0.0 109.381 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.4 mt -83.56 63.45 7.38 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.6 p -89.49 160.86 16.53 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.121 0.962 . . . . 0.0 110.961 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -151.9 150.91 30.59 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.468 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.7 m -134.86 134.1 40.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.598 0.713 . . . . 0.0 110.069 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.33 135.85 54.39 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.844 0.83 . . . . 0.0 109.564 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -100.22 89.06 0.81 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.405 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 65.6 tttm 57.89 -72.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 122.286 -0.538 . . . . 0.0 110.259 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 64' ' ' GLY . 98.1 m-20 -89.46 129.91 35.88 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.864 0.84 . . . . 0.0 110.21 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.2 t -62.6 -0.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 66' ' ' ASP . 66.0 tttm -62.92 -41.59 99.51 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.65 111.13 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.808 0.813 . . . . 0.0 108.897 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -140.8 126.93 19.58 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.733 0.778 . . . . 0.0 110.333 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 p -84.01 168.32 16.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.493 0.663 . . . . 0.0 109.535 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.6 p -152.75 155.91 38.1 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.855 0.836 . . . . 0.0 110.704 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.2 p -75.7 166.03 24.16 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.738 0.78 . . . . 0.0 110.46 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.92 -44.15 97.37 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.027 0.442 . . . . 0.0 109.813 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.5 mp0 -69.24 -39.14 78.67 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.47 0.653 . . . . 0.0 109.844 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.44 -34.9 77.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.749 -0.594 . . . . 0.0 109.513 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -61.93 -33.33 74.05 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -73.26 -38.25 66.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.532 -0.73 . . . . 0.0 109.863 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.4 mmm -66.22 -65.29 0.7 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.602 -0.687 . . . . 0.0 110.55 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -60.04 149.27 32.77 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.764 0.792 . . . . 0.0 110.38 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -80.39 -105.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.34 0.591 . . . . 0.0 110.503 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -104.44 147.3 34.16 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.773 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.6 145.89 53.51 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.36 2.04 . . . . 0.0 112.073 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.495 ' H ' ' HH ' ' A' ' 24' ' ' TYR . 74.4 mmt-85 -86.55 165.99 15.79 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.881 0.848 . . . . 0.0 110.671 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.66 -6.06 58.42 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.02 176.72 25.01 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -63.39 -37.14 86.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.922 -0.752 . . . . 0.0 109.25 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.69 -20.67 62.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.566 -0.709 . . . . 0.0 109.207 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -72.32 -48.67 40.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.634 -0.666 . . . . 0.0 109.741 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.3 pt -61.84 -41.18 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.623 -0.673 . . . . 0.0 109.869 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.0 mt -65.41 -40.28 93.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.577 -0.702 . . . . 0.0 109.721 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.795 -0.566 . . . . 0.0 109.813 -179.286 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.6 t80 . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.119 0.485 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -63.04 -43.48 98.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.528 -0.732 . . . . 0.0 109.62 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -64.3 -42.25 96.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.695 -0.628 . . . . 0.0 110.08 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.74 -37.91 85.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.458 -0.776 . . . . 0.0 110.195 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.554 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 48.9 tp60 -62.93 -42.59 99.85 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -63.71 -40.38 96.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.472 -0.768 . . . . 0.0 109.369 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -63.4 -41.51 98.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.537 -0.727 . . . . 0.0 110.085 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -61.38 -42.05 98.09 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.508 -0.745 . . . . 0.0 109.847 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.01 -40.89 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.433 -0.792 . . . . 0.0 109.267 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 m -59.69 -43.46 94.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.642 -0.661 . . . . 0.0 109.247 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.24 -41.43 98.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.509 -0.744 . . . . 0.0 109.831 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.524 ' OH ' ' CE1' ' A' ' 70' ' ' PHE . 90.1 t80 -60.28 -49.11 78.92 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.3 mt -68.18 -41.2 81.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.634 -0.666 . . . . 0.0 110.641 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -65.05 -43.33 92.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.405 -0.809 . . . . 0.0 110.442 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -80.28 -15.94 55.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.386 -0.821 . . . . 0.0 110.456 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.506 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 8.3 m120 -104.2 -10.24 18.06 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.258 -0.901 . . . . 0.0 108.88 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 mt -144.11 88.11 7.63 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 32' ' ' PHE . 53.2 Cg_exo -53.63 -30.89 57.51 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.51 2.14 . . . . 0.0 111.271 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -72.66 13.09 0.4 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.516 ' H ' ' C ' ' A' ' 30' ' ' PRO . 29.1 t80 -61.22 130.38 45.95 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.689 0.757 . . . . 0.0 110.236 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -118.96 -61.52 1.63 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 t -146.12 164.54 31.85 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.515 0.674 . . . . 0.0 109.935 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.5 138.16 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.544 0.688 . . . . 0.0 109.624 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.2 m -126.76 115.24 19.07 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.66 0.743 . . . . 0.0 109.551 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -94.08 126.61 39.41 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.759 0.79 . . . . 0.0 109.563 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.34 86.1 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -177.43 -64.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 41.38 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.592 -0.693 . . . . 0.0 110.053 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -122.4 147.34 46.42 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.996 0.903 . . . . 0.0 110.034 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 42' ' ' PHE . 53.0 p90 -88.81 120.24 30.03 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.503 0.668 . . . . 0.0 109.736 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -107.41 154.74 40.48 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -46.38 -40.76 22.77 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.504 2.136 . . . . 0.0 111.907 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.4 tt -70.02 -38.93 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.76 . . . . 0.0 109.615 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.25 -107.66 0.25 Allowed Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -121.23 143.81 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.626 -0.926 . . . . 0.0 110.17 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.0 t -119.26 134.91 54.95 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.653 0.739 . . . . 0.0 110.09 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.16 129.42 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.681 0.753 . . . . 0.0 109.359 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.5 t0 -133.49 142.4 48.23 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.831 0.824 . . . . 0.0 109.687 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -173.5 -165.16 29.89 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -142.39 165.09 28.38 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.678 -0.895 . . . . 0.0 110.274 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.5 pt -122.42 167.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.934 0.873 . . . . 0.0 110.725 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' ASP . 69.1 m-80 57.31 34.25 24.46 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.662 0.744 . . . . 0.0 109.441 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 44.56 24.44 0.1 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 54' ' ' ASN . 99.5 m-20 -108.17 111.1 22.93 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.668 0.747 . . . . 0.0 109.293 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HZ2' ' CB ' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -59.22 -31.58 69.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.727 -0.608 . . . . 0.0 110.102 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -61.96 -38.77 89.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.45 -0.781 . . . . 0.0 109.495 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -82.74 75.26 9.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.474 -0.766 . . . . 0.0 109.534 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 m -95.85 156.13 16.46 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.922 0.867 . . . . 0.0 110.397 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -147.12 157.03 43.47 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.628 0.728 . . . . 0.0 109.923 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.1 m -141.29 138.87 33.49 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.692 -0.63 . . . . 0.0 109.873 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.94 144.62 31.16 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.649 0.737 . . . . 0.0 109.528 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -98.24 128.7 9.65 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.554 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 15.1 ptmt 24.76 -114.18 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.461 0.648 . . . . 0.0 111.238 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 68' ' ' LYS . 67.2 t0 -71.54 66.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.158 0.98 . . . . 0.0 109.955 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 50.43 12.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.545 0.688 . . . . 0.0 109.455 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 66' ' ' ASP . 68.7 mmtt -61.43 115.57 3.99 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 122.051 0.929 . . . . 0.0 109.82 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.6 mt 55.16 115.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.87 0.843 . . . . 0.0 109.883 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.524 ' CE1' ' OH ' ' A' ' 24' ' ' TYR . 47.2 p90 -139.26 153.9 47.88 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.877 0.846 . . . . 0.0 110.203 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 p -141.74 160.86 39.32 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.621 0.724 . . . . 0.0 109.47 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.2 m -145.68 155.21 42.85 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.977 0.894 . . . . 0.0 110.414 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -65.88 163.03 17.78 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.943 0.878 . . . . 0.0 110.371 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.1 mp0 -58.5 -48.9 79.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.545 -0.722 . . . . 0.0 109.743 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mp0 -64.54 -42.04 95.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.622 -0.674 . . . . 0.0 110.066 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.17 -38.76 85.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.595 -0.691 . . . . 0.0 110.034 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -63.32 -33.67 76.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.411 -0.806 . . . . 0.0 109.402 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.01 -12.32 60.88 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.38 -0.825 . . . . 0.0 109.973 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.7 mtp -85.09 -8.21 58.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.26 -0.9 . . . . 0.0 109.38 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -63.64 135.91 57.11 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.591 0.71 . . . . 0.0 110.006 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -111.9 -25.04 9.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -120.13 153.7 55.54 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.75 179.63 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.982 2.455 . . . . 0.0 113.094 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.46 ' NH1' ' CZ ' ' A' ' 70' ' ' PHE . 95.5 mtt-85 -63.86 126.72 28.54 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.067 0.937 . . . . 0.0 110.597 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -136.88 147.51 46.52 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.734 0.778 . . . . 0.0 109.911 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.88 164.44 44.67 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -61.5 -44.0 97.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.804 -0.821 . . . . 0.0 109.133 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -70.13 -31.11 68.49 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.476 -0.765 . . . . 0.0 109.803 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.86 -45.51 77.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.415 HD12 HG22 ' A' ' 90' ' ' ILE . 28.8 pt -66.16 -35.91 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.43 -0.794 . . . . 0.0 109.57 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.36 -42.41 98.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 92' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.524 ' CZ ' ' NE2' ' A' ' 17' ' ' GLN . 91.3 t80 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.645 0.736 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -65.31 -36.64 84.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.512 -0.742 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.53 -41.33 98.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.148 -0.97 . . . . 0.0 109.838 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.62 -39.97 88.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.58 -0.7 . . . . 0.0 110.445 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.524 ' NE2' ' CZ ' ' A' ' 13' ' ' PHE . 96.6 mm-40 -64.78 -40.72 95.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 109.897 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.04 -40.99 97.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.71 -41.83 98.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.861 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -64.1 -42.43 96.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.745 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.9 -43.08 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.444 -0.785 . . . . 0.0 109.619 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.8 m -61.29 -44.65 96.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.497 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.88 -42.81 99.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.367 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.507 ' CE1' ' OD1' ' A' ' 28' ' ' ASN . 58.7 t80 -61.05 -47.85 84.46 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.492 0.663 . . . . 0.0 109.712 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.01 -39.6 93.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -0.791 . . . . 0.0 109.703 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -59.75 -45.51 92.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.877 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.419 ' O ' ' OE1' ' A' ' 82' ' ' GLU . 32.9 m-70 -74.47 -32.78 62.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.826 . . . . 0.0 109.757 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.507 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 32.1 m120 -87.19 -2.9 58.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.379 -0.826 . . . . 0.0 109.608 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.4 mt -146.76 89.85 5.63 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.229 -0.919 . . . . 0.0 109.034 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -55.38 -30.19 71.77 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.454 2.103 . . . . 0.0 111.34 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -84.98 16.15 3.59 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 21.8 t80 -57.57 128.99 39.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.493 -0.755 . . . . 0.0 110.463 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.456 ' ND2' ' OD1' ' A' ' 54' ' ' ASN . 99.9 m-20 -113.8 -64.96 1.24 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.562 0.696 . . . . 0.0 109.331 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -150.82 158.73 44.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.752 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.13 135.53 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.586 -0.696 . . . . 0.0 109.425 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -124.64 123.8 40.83 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.661 0.743 . . . . 0.0 109.368 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -96.31 137.54 35.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.647 -0.658 . . . . 0.0 109.241 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.6 p -147.12 -35.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 108.805 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -103.41 145.45 29.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.28 -0.887 . . . . 0.0 110.356 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -169.05 143.94 3.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.377 -0.827 . . . . 0.0 109.623 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -139.07 151.8 47.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.443 -0.786 . . . . 0.0 109.321 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -90.59 118.84 30.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.233 -0.917 . . . . 0.0 109.903 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.5 OUTLIER -90.43 158.07 43.77 Favored Pre-proline 0 C--N 1.306 -1.326 0 O-C-N 121.5 -0.75 . . . . 0.0 109.975 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.23 -27.12 41.48 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 123.099 2.532 . . . . 0.0 110.417 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -102.56 -8.23 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 171.06 -144.42 8.26 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.404 ' HA ' ' H ' ' A' ' 43' ' ' ASN . 42.0 pt -124.82 152.31 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.558 -0.966 . . . . 0.0 109.485 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.4 m -117.43 127.45 54.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.435 HD12 HG21 ' A' ' 49' ' ' ILE . 96.7 mt -111.74 130.36 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.619 0.723 . . . . 0.0 109.36 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -130.06 125.84 36.2 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.588 0.709 . . . . 0.0 109.225 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.31 -161.46 10.36 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -144.15 160.88 40.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.983 . . . . 0.0 109.874 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.6 pt -119.76 167.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-O 121.601 0.715 . . . . 0.0 110.728 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.456 ' OD1' ' ND2' ' A' ' 33' ' ' ASN . 66.4 m-80 59.11 32.92 22.56 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.629 0.728 . . . . 0.0 109.55 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 46.87 32.23 1.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.51 -0.744 . . . . 0.0 109.564 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -126.99 103.93 7.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.604 -0.685 . . . . 0.0 109.321 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -56.12 -17.13 6.32 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.416 0.627 . . . . 0.0 109.543 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -63.9 -38.32 90.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.35 -0.844 . . . . 0.0 108.889 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.5 mt -88.24 73.91 8.82 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.2 m -87.92 154.75 20.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.821 0.82 . . . . 0.0 110.771 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -147.62 158.82 44.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.722 -0.612 . . . . 0.0 109.587 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.2 m -134.11 136.53 43.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.771 . . . . 0.0 109.706 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.49 141.07 48.62 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 67' ' ' VAL . . . -97.93 115.71 5.34 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 64' ' ' GLY . 88.6 tttt 26.06 -95.17 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.389 0.614 . . . . 0.0 111.795 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -85.71 45.31 1.19 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.356 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 64' ' ' GLY . 2.1 t 51.93 35.3 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.164 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -62.83 -41.32 99.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.825 . . . . 0.0 109.008 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.0 tp -127.57 136.32 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -126.46 129.78 49.37 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.645 0.736 . . . . 0.0 109.835 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 t -137.3 149.06 46.81 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.2 p -138.89 157.04 46.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 0.0 110.357 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.0 p -76.02 171.12 15.0 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.866 0.841 . . . . 0.0 110.758 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -59.37 -41.01 88.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.681 -0.637 . . . . 0.0 109.947 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.45 -48.79 59.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.958 . . . . 0.0 109.886 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.69 -22.06 66.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.34 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -62.41 -36.18 81.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.559 -0.713 . . . . 0.0 110.077 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -62.68 -45.06 94.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 0.0 110.53 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 98.6 mtp -68.74 -38.03 79.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.09 -1.006 . . . . 0.0 109.482 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.512 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 72.4 t80 -75.68 119.39 19.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 110.03 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.401 ' NE2' ' O ' ' A' ' 80' ' ' PHE . 99.6 mm-40 -142.93 2.19 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.512 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 47.9 mt-10 -102.66 130.12 24.54 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.471 -0.768 . . . . 0.0 109.561 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -47.41 140.78 15.2 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.473 2.115 . . . . 0.0 113.151 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -76.97 140.07 40.32 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.6 0.714 . . . . 0.0 110.256 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -137.66 147.96 45.34 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.732 0.777 . . . . 0.0 109.698 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.47 161.15 12.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -62.46 -42.48 99.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.795 -0.827 . . . . 0.0 109.194 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 34.5 p-10 -68.54 -31.18 70.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.442 -0.786 . . . . 0.0 109.757 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 80.1 mm-40 -64.58 -48.6 74.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.451 -0.781 . . . . 0.0 109.848 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 91' ' ' LEU . 25.9 pt -68.18 -37.69 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.442 -0.786 . . . . 0.0 109.196 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.406 ' N ' HG13 ' A' ' 90' ' ' ILE . 57.9 tp -63.47 -41.94 98.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.226 -179.963 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.403 ' O ' ' OE1' ' A' ' 17' ' ' GLN . 79.2 t80 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.25 0.547 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -64.27 -40.1 95.3 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.351 0.596 . . . . 0.0 109.86 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -62.59 -40.72 97.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.676 -0.64 . . . . 0.0 109.931 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.6 -38.75 87.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.518 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 1.5 mp0 -64.09 -40.49 96.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.524 -0.735 . . . . 0.0 109.557 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -64.66 -40.21 95.03 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.249 0.547 . . . . 0.0 109.956 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -65.62 -41.01 93.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.705 -0.622 . . . . 0.0 110.052 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.517 ' NZ ' ' CE2' ' A' ' 87' ' ' TYR . 68.2 mttm -63.08 -44.29 96.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.605 -0.684 . . . . 0.0 110.101 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.48 -44.12 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.653 -0.654 . . . . 0.0 109.984 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.1 m -63.58 -43.8 95.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.574 -0.704 . . . . 0.0 109.841 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.7 -43.16 99.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.724 -0.61 . . . . 0.0 110.317 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.482 ' CE1' ' OD1' ' A' ' 28' ' ' ASN . 66.8 t80 -62.35 -47.83 82.5 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.335 0.588 . . . . 0.0 109.803 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.46 -41.45 96.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.616 -0.678 . . . . 0.0 109.895 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.17 -43.98 92.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.769 -0.582 . . . . 0.0 109.931 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -68.66 -37.88 79.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.751 -0.593 . . . . 0.0 110.236 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.482 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 9.3 m120 -90.79 -0.71 57.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.4 -0.812 . . . . 0.0 109.322 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.4 mt -143.81 83.6 10.37 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 109.035 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -54.88 -26.64 49.51 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.664 2.243 . . . . 0.0 111.284 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -78.38 0.36 25.96 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -59.0 129.14 40.75 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.723 0.773 . . . . 0.0 110.128 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -123.84 -57.82 1.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -147.49 155.58 42.03 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.73 0.776 . . . . 0.0 110.151 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.39 140.43 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.434 0.635 . . . . 0.0 109.41 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.9 m -128.67 125.9 39.02 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.898 0.856 . . . . 0.0 110.133 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -93.76 134.58 35.95 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 t -172.9 55.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.662 -0.649 . . . . 0.0 109.447 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' GLU . 24.3 t-20 -173.31 133.68 0.51 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.556 -0.715 . . . . 0.0 110.417 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' ASN . 96.9 mt-10 58.21 140.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.755 0.788 . . . . 0.0 110.683 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -144.54 -90.34 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.652 -0.655 . . . . 0.0 109.476 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -75.19 147.36 40.46 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.853 0.835 . . . . 0.0 110.243 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -173.96 168.1 2.26 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 46' ' ' GLY . 52.3 Cg_exo -50.91 -39.43 58.88 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.436 2.091 . . . . 0.0 111.814 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.5 pt -76.51 28.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.518 0.675 . . . . 0.0 109.195 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 81.82 -99.42 2.0 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.9 pt -119.85 144.14 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.859 0.838 . . . . 0.0 109.948 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.7 m -119.66 122.44 41.51 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.695 0.759 . . . . 0.0 109.831 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.02 125.89 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.929 0.871 . . . . 0.0 109.382 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.6 t0 -142.9 139.85 30.95 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.01 0.91 . . . . 0.0 109.832 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -167.22 -162.62 19.37 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -140.46 161.72 37.05 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.908 -0.76 . . . . 0.0 110.628 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 pt -118.73 156.6 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 121.959 0.885 . . . . 0.0 110.689 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 56.3 33.89 23.09 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.048 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 47.95 32.68 2.94 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.17 0.51 . . . . 0.0 110.0 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -111.79 109.65 19.6 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.72 0.771 . . . . 0.0 109.317 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -57.28 -34.51 68.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.905 -0.497 . . . . 0.0 109.98 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.57 -39.25 93.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.599 -0.688 . . . . 0.0 109.742 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.8 76.95 9.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.511 -0.743 . . . . 0.0 109.583 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.8 p -112.5 156.59 22.35 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.817 0.818 . . . . 0.0 110.478 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.404 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 32.1 p90 -150.49 158.45 44.17 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.461 0.648 . . . . 0.0 109.595 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.9 m -136.08 132.15 35.78 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.683 0.754 . . . . 0.0 110.135 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.07 140.95 42.37 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.832 0.825 . . . . 0.0 109.617 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 65' ' ' LYS . . . -109.08 140.2 15.55 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 64' ' ' GLY . 53.6 mtpt 40.46 100.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.298 0.57 . . . . 0.0 110.598 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.504 ' OD1' ' NE2' ' A' ' 17' ' ' GLN . 99.0 m-20 57.93 -88.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.404 0.621 . . . . 0.0 109.712 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.79 13.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 69' ' ' ILE . 68.5 mttm -70.51 131.45 44.04 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.872 0.844 . . . . 0.0 109.859 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.4 mt 52.59 103.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.645 0.736 . . . . 0.0 109.41 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -138.25 153.86 49.09 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.891 0.853 . . . . 0.0 110.29 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.1 t -136.87 151.02 48.62 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.76 0.79 . . . . 0.0 109.614 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.446 ' HG ' ' N ' ' A' ' 73' ' ' SER . 38.2 t -134.66 150.18 50.61 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.822 0.82 . . . . 0.0 110.101 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.446 ' N ' ' HG ' ' A' ' 72' ' ' SER . 23.0 p -75.89 166.8 22.98 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.883 0.849 . . . . 0.0 110.221 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.66 -45.39 92.19 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.215 0.531 . . . . 0.0 109.639 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.5 mp0 -65.28 -45.71 83.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.644 -0.66 . . . . 0.0 109.657 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.6 tp -69.0 -28.94 67.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.83 -36.4 83.38 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 109.407 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -75.68 -7.54 54.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.449 -0.782 . . . . 0.0 109.914 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 77.0 mtp -82.42 -8.79 59.62 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -69.1 138.5 54.35 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.62 0.724 . . . . 0.0 109.464 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -128.04 -45.45 1.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.49 154.96 39.58 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.626 -0.671 . . . . 0.0 109.581 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -53.31 145.55 44.39 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.363 2.042 . . . . 0.0 112.649 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -77.36 138.01 39.07 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.781 0.8 . . . . 0.0 109.969 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.86 150.47 47.17 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.858 0.837 . . . . 0.0 110.116 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.1 163.4 25.68 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.517 ' CE2' ' NZ ' ' A' ' 20' ' ' LYS . 78.5 t80 -60.57 -44.7 95.9 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.6 0.714 . . . . 0.0 109.681 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 36.6 p-10 -68.43 -32.87 73.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.572 -0.705 . . . . 0.0 109.902 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 79.8 mm-40 -66.78 -45.34 78.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.664 -0.647 . . . . 0.0 110.447 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.6 pt -65.92 -35.52 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.512 -0.742 . . . . 0.0 109.631 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 34.3 mt -63.02 -42.13 99.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.553 -0.717 . . . . 0.0 109.748 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.831 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.185 0.517 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -62.86 -42.2 99.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.643 -0.661 . . . . 0.0 109.931 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.21 -40.45 97.51 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.368 0.604 . . . . 0.0 109.696 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.41 -39.23 85.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.674 -0.641 . . . . 0.0 109.587 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.38 -39.71 95.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.383 -0.823 . . . . 0.0 108.946 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -62.66 -42.12 99.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.825 -0.547 . . . . 0.0 110.017 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -66.88 -39.74 87.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.628 -0.67 . . . . 0.0 109.546 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.8 -43.54 96.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.752 -0.592 . . . . 0.0 109.541 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.4 t -65.39 -42.83 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.841 -0.537 . . . . 0.0 109.577 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -59.74 -45.25 92.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.708 . . . . 0.0 109.263 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.94 -42.3 97.37 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.422 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 64.9 t80 -61.9 -46.92 87.27 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.46 ' CD2' ' CE2' ' A' ' 61' ' ' PHE . 92.6 mt -64.73 -39.3 93.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.564 -0.71 . . . . 0.0 109.883 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -60.72 -44.41 96.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.66 -0.65 . . . . 0.0 109.628 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.476 ' HD1' ' NH2' ' A' ' 84' ' ' ARG . 13.4 m170 -69.06 -41.98 76.87 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.658 -0.651 . . . . 0.0 110.186 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.422 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 44.2 m-80 -65.02 -41.36 95.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.432 -0.792 . . . . 0.0 109.338 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.7 mt -114.36 115.28 44.94 Favored Pre-proline 0 N--CA 1.485 1.307 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.5 -17.61 23.5 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.286 1.991 . . . . 0.0 110.652 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -95.87 8.87 42.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 34.9 t80 -51.65 126.85 18.8 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.82 0.819 . . . . 0.0 109.888 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -113.35 -65.88 1.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -147.17 160.56 42.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.591 -0.693 . . . . 0.0 110.319 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.9 p -140.16 139.73 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.4 0.619 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -129.21 125.66 37.44 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.558 0.694 . . . . 0.0 109.318 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 49' ' ' ILE . 59.2 m-85 -91.4 142.88 27.2 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.653 0.74 . . . . 0.0 109.732 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.461 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -173.28 123.12 0.39 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.721 -0.612 . . . . 0.0 109.647 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 38' ' ' THR . 1.1 m120 82.22 157.22 0.13 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.911 0.862 . . . . 0.0 110.983 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 69.53 101.38 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.58 0.705 . . . . 0.0 109.733 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -144.12 -22.08 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -115.85 133.69 55.77 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.77 0.795 . . . . 0.0 110.108 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -170.57 154.98 4.77 Favored Pre-proline 0 N--CA 1.487 1.404 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 46' ' ' GLY . 71.4 Cg_exo -44.85 -36.55 11.01 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.37 2.047 . . . . 0.0 112.034 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 mt -78.93 34.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.811 0.815 . . . . 0.0 109.028 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 80.33 -106.42 2.49 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 pt -118.31 149.65 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.652 0.739 . . . . 0.0 109.675 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.9 m -127.96 155.25 44.55 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.799 0.809 . . . . 0.0 110.457 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 96.7 mt -122.92 125.51 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.555 0.693 . . . . 0.0 109.395 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -128.69 130.54 47.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.67 0.748 . . . . 0.0 109.598 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.01 -163.14 13.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -143.11 162.5 35.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.748 -0.854 . . . . 0.0 109.685 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 pt -122.54 162.43 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.805 0.812 . . . . 0.0 110.438 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.83 30.65 19.36 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.432 0.634 . . . . 0.0 109.736 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 48.89 33.02 4.1 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.39 0.614 . . . . 0.0 109.624 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -112.9 111.17 21.73 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.416 0.627 . . . . 0.0 109.501 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -59.09 -33.02 70.34 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -62.47 -39.29 92.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.9 mt -84.52 83.03 8.15 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.408 0.623 . . . . 0.0 109.764 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.2 p -95.9 148.32 22.74 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.433 0.635 . . . . 0.0 110.069 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.46 ' CE2' ' CD2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -131.75 136.9 47.95 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.48 0.657 . . . . 0.0 109.985 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.8 m -128.42 129.73 46.6 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.731 0.777 . . . . 0.0 110.061 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.29 149.22 40.97 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.674 0.75 . . . . 0.0 109.376 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -90.8 135.61 12.94 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 39.84 -109.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.402 0.62 . . . . 0.0 110.579 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' CG ' ' H ' ' A' ' 67' ' ' VAL . 20.1 p-10 -82.15 -67.15 0.81 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.682 -0.636 . . . . 0.0 109.682 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.569 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 2.7 t -146.19 11.83 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.732 . . . . 0.0 109.032 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 69' ' ' ILE . 88.8 tttt -65.77 117.93 8.9 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.291 -0.881 . . . . 0.0 110.414 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.0 mt 56.94 125.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.793 0.806 . . . . 0.0 110.016 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -139.07 129.83 26.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.419 -0.801 . . . . 0.0 110.387 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.7 m -126.83 154.57 44.15 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.582 0.706 . . . . 0.0 109.412 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.9 p -153.11 163.97 38.89 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.751 0.786 . . . . 0.0 110.46 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -67.98 163.87 21.24 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.817 0.817 . . . . 0.0 110.158 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -57.8 -48.82 78.61 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.759 -0.588 . . . . 0.0 109.584 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.25 -40.73 98.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.773 -0.579 . . . . 0.0 109.674 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 tp -76.42 -22.58 54.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.525 -0.734 . . . . 0.0 110.252 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -72.06 -36.66 69.64 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.443 -0.785 . . . . 0.0 109.402 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -79.1 -8.01 58.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.586 -0.696 . . . . 0.0 110.334 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.4 mmm -63.89 -42.31 97.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.352 -0.842 . . . . 0.0 109.691 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.497 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 31.0 p90 -102.33 125.66 49.11 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.756 0.789 . . . . 0.0 109.72 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -97.68 -6.72 32.48 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -133.66 83.97 46.43 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.485 -0.759 . . . . 0.0 109.445 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.81 138.13 76.26 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 123.04 2.494 . . . . 0.0 112.97 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.476 ' NH2' ' HD1' ' A' ' 27' ' ' HIS . 21.0 mmm180 -99.04 162.97 12.77 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.606 0.717 . . . . 0.0 110.358 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -91.04 -131.64 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.31 0.576 . . . . 0.0 111.281 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.42 170.27 50.36 Favored Glycine 0 N--CA 1.498 2.803 0 CA-C-O 122.061 0.812 . . . . 0.0 111.971 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -61.76 -43.12 99.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.945 -0.738 . . . . 0.0 110.436 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.56 -38.76 92.35 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.447 -0.783 . . . . 0.0 109.635 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -60.84 -50.04 75.04 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.811 -0.556 . . . . 0.0 109.91 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.7 pt -69.24 -30.06 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.331 -0.856 . . . . 0.0 109.398 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.5 tp -64.24 -42.52 96.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.557 0.694 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -61.79 -33.32 73.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.495 -0.753 . . . . 0.0 109.632 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.71 -40.75 98.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.497 -0.752 . . . . 0.0 109.576 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.71 -39.61 88.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.483 -0.761 . . . . 0.0 109.628 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.45 -39.03 93.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.433 -0.792 . . . . 0.0 109.578 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -63.42 -41.47 98.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.588 0.709 . . . . 0.0 109.49 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -65.81 -42.4 90.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.626 -0.671 . . . . 0.0 109.975 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -63.66 -44.57 93.4 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.793 0.806 . . . . 0.0 110.036 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.21 -41.33 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.579 -0.701 . . . . 0.0 109.848 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -55.78 -46.22 77.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.478 -0.764 . . . . 0.0 110.029 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.6 tp -64.29 -42.4 96.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.551 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.621 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 89.1 t80 -59.96 -44.18 94.6 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.728 0.775 . . . . 0.0 109.317 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.85 -43.05 99.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.586 -0.696 . . . . 0.0 110.349 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.41 -43.44 97.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 0.0 110.537 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.419 ' CG ' ' CD1' ' A' ' 90' ' ' ILE . 33.8 m-70 -75.34 -32.11 60.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 110.992 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.621 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 29.3 m-80 -89.25 -6.94 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.102 -0.998 . . . . 0.0 109.47 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.3 mt -137.41 105.51 8.5 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.585 -0.697 . . . . 0.0 109.15 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.99 -16.49 32.38 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.436 2.09 . . . . 0.0 111.782 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -95.96 11.42 34.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.519 -0.738 . . . . 0.0 109.419 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -56.67 132.68 52.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.3 -0.875 . . . . 0.0 109.818 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -133.46 -48.69 0.83 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -148.31 154.71 40.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.293 -0.879 . . . . 0.0 110.219 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.89 137.13 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.307 0.575 . . . . 0.0 109.557 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -128.41 121.86 30.03 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.588 0.708 . . . . 0.0 109.162 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -97.39 122.83 40.89 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.6 p -106.37 -22.39 12.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.709 -0.619 . . . . 0.0 109.68 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -110.49 145.76 37.14 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.296 -0.878 . . . . 0.0 110.561 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -166.02 80.49 0.28 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -153.5 -161.91 1.36 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.429 -0.795 . . . . 0.0 109.777 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 42' ' ' PHE . 54.3 p90 -102.47 127.34 49.55 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.596 0.712 . . . . 0.0 109.953 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -96.97 164.63 17.49 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.719 -0.613 . . . . 0.0 109.457 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.3 -39.96 62.02 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.36 2.04 . . . . 0.0 111.584 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 45' ' ' ILE . 97.0 mt -81.73 -4.08 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.557 -0.714 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 137.92 -104.7 0.46 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.4 pt -127.37 133.78 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.876 . . . . 0.0 109.879 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.7 m -138.77 149.08 44.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.587 -0.695 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 49' ' ' ILE . 96.7 mt -125.58 133.74 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 33.0 t0 -127.73 147.27 50.4 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.588 0.708 . . . . 0.0 109.9 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -175.76 -165.57 31.91 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -144.11 164.53 30.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.768 -0.842 . . . . 0.0 109.77 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.1 pt -124.6 164.67 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.862 0.839 . . . . 0.0 111.344 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 58.43 32.38 22.03 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.643 0.735 . . . . 0.0 110.191 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.0 m120 48.89 29.84 2.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.639 -0.663 . . . . 0.0 109.838 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.49 111.74 22.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.448 -0.783 . . . . 0.0 109.988 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -58.88 -32.26 69.33 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.56 0.695 . . . . 0.0 109.441 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.57 -39.38 93.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.461 -0.774 . . . . 0.0 109.621 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.1 mt -82.03 78.94 8.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.533 -0.73 . . . . 0.0 109.81 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.6 t -104.39 155.16 19.02 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.656 0.741 . . . . 0.0 110.011 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -150.2 158.37 44.09 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.56 0.695 . . . . 0.0 109.825 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.7 m -134.17 138.7 45.34 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.87 135.29 48.2 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.589 0.709 . . . . 0.0 109.596 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.5 137.95 14.62 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 67' ' ' VAL . 29.3 mmtp 40.37 -161.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.489 0.661 . . . . 0.0 111.12 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 68' ' ' LYS . 93.8 m-20 -59.2 77.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.935 0.874 . . . . 0.0 109.782 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 65' ' ' LYS . 2.0 t 41.68 24.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.659 0.742 . . . . 0.0 109.853 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 66' ' ' ASP . 28.6 tptp -64.06 -44.23 93.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.2 mt -121.13 128.46 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -132.74 129.84 39.2 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.492 0.663 . . . . 0.0 109.628 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.5 m -130.48 152.29 50.04 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 p -143.0 155.46 44.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.742 0.782 . . . . 0.0 110.509 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 77' ' ' ASP . 18.6 p -74.73 168.78 19.17 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.772 0.796 . . . . 0.0 110.719 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -59.93 -43.07 95.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.753 -0.592 . . . . 0.0 110.167 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -65.94 -36.18 82.64 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.71 0.767 . . . . 0.0 109.558 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.5 tp -85.01 -21.02 29.63 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.926 0.87 . . . . 0.0 109.035 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 73' ' ' SER . 29.9 t70 -66.86 -44.54 80.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.538 -0.726 . . . . 0.0 110.084 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -71.68 -18.4 62.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 110.033 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.75 -62.37 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.44 -0.788 . . . . 0.0 109.966 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.439 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -71.72 138.62 48.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.602 -0.686 . . . . 0.0 110.519 -178.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -137.52 40.26 2.42 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -115.39 150.83 45.2 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.333 -0.855 . . . . 0.0 109.412 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.46 156.22 66.4 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.695 2.264 . . . . 0.0 112.465 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -69.93 132.74 46.44 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.808 0.813 . . . . 0.0 110.033 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -155.21 145.68 22.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.591 0.71 . . . . 0.0 109.47 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.39 168.14 51.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -62.45 -45.24 93.97 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.676 0.75 . . . . 0.0 109.7 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 47.7 p-10 -64.96 -33.39 75.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 109.687 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.551 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 14.4 tm-20 -62.98 -51.87 65.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.627 -0.671 . . . . 0.0 109.953 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.419 ' CD1' ' CG ' ' A' ' 27' ' ' HIS . 9.9 tt -67.82 -29.6 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.92 -44.04 97.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.505 -0.747 . . . . 0.0 109.703 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.959 0.885 . . . . 0.0 108.941 179.918 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.471 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 91.3 m-85 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.365 0.602 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -58.67 -34.96 71.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.435 -0.79 . . . . 0.0 109.48 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -62.37 -40.34 96.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.53 -39.26 91.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.572 -0.705 . . . . 0.0 109.831 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -65.73 -39.83 91.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.582 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.85 -40.42 96.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.423 -0.798 . . . . 0.0 109.893 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.68 -41.95 98.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -0.839 . . . . 0.0 109.809 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.1 -41.97 97.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.389 -0.82 . . . . 0.0 110.159 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.03 -42.87 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.724 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.9 m -60.96 -44.49 97.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.872 . . . . 0.0 109.93 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.56 -42.94 99.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.663 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 57.2 t80 -61.0 -42.79 99.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.56 -0.712 . . . . 0.0 109.763 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' ILE . 86.3 mt -62.77 -41.93 99.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.9 -40.28 94.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.327 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -65.85 -40.32 91.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.408 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.577 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 99.3 m-20 -93.73 -4.75 49.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.56 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 25' ' ' LEU . 8.7 mt -143.45 91.23 6.93 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -71.16 -16.67 31.76 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.447 2.098 . . . . 0.0 111.812 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -92.46 4.22 53.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.536 -0.728 . . . . 0.0 109.183 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -50.08 137.84 16.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.063 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -111.59 -63.35 1.43 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.749 -0.594 . . . . 0.0 109.891 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.523 ' HG1' ' N ' ' A' ' 35' ' ' VAL . 4.4 t -149.52 156.77 42.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.054 -1.029 . . . . 0.0 110.02 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.523 ' N ' ' HG1' ' A' ' 34' ' ' THR . 7.2 p -127.23 133.46 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.668 -0.645 . . . . 0.0 109.337 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.8 m -118.83 119.96 35.93 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -93.39 121.96 35.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.597 -0.69 . . . . 0.0 109.547 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.0 p -109.03 0.22 19.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.6 t30 59.01 -96.2 0.06 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.798 -0.564 . . . . 0.0 109.677 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 10.0 tm-20 60.14 -88.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.393 0.616 . . . . 0.0 110.845 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 40' ' ' GLU . 78.1 tt0 -57.36 148.89 21.77 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.466 -0.772 . . . . 0.0 110.362 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -151.68 96.75 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.263 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 46' ' ' GLY . 36.1 m-20 -44.27 108.61 0.74 Allowed Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.564 -0.71 . . . . 0.0 109.835 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.05 -33.45 43.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.223 1.949 . . . . 0.0 111.664 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -85.88 -5.26 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 43' ' ' ASN . . . -166.69 -127.93 0.94 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 pt -135.29 149.46 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.432 -1.04 . . . . 0.0 109.749 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.6 t -142.79 141.67 31.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.134 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -124.87 122.09 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.567 0.699 . . . . 0.0 109.707 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 54.7 t0 -104.5 154.71 19.55 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.46 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -175.42 -170.31 38.18 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.609 -1.281 . . . . 0.0 109.936 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -145.25 162.82 36.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.484 -1.009 . . . . 0.0 109.675 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.37 162.81 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.457 0.646 . . . . 0.0 110.747 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 56.97 32.85 22.35 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.45 0.643 . . . . 0.0 109.85 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 47.97 29.62 1.76 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -111.68 108.37 17.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.491 -0.756 . . . . 0.0 109.525 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -58.59 -33.99 70.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.663 . . . . 0.0 109.599 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -62.48 -38.53 90.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.432 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.2 mt -82.76 82.63 8.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.191 -0.943 . . . . 0.0 109.095 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 m -100.6 160.83 14.03 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.598 0.713 . . . . 0.0 110.524 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -146.26 153.77 40.96 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.5 m -133.13 133.27 42.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.682 -0.636 . . . . 0.0 109.741 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.21 139.54 52.86 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -112.16 130.83 9.83 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' VAL . 45.8 tttt 43.57 -144.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.623 0.725 . . . . 0.0 110.869 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.2 62.31 0.13 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.533 0.682 . . . . 0.0 109.185 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LYS . 1.9 t 51.8 19.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.477 0.656 . . . . 0.0 109.639 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -64.09 -42.67 96.85 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.395 -0.815 . . . . 0.0 109.53 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 64' ' ' GLY . 96.7 mt -131.96 118.55 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.584 -0.698 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -139.73 152.08 46.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.7 t -139.83 148.28 41.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.438 -0.789 . . . . 0.0 109.555 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.0 t -131.81 147.44 52.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.451 -0.781 . . . . 0.0 109.639 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -76.61 170.04 17.16 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.788 0.804 . . . . 0.0 110.789 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -61.99 -42.98 99.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.571 -0.705 . . . . 0.0 109.664 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.57 -40.95 96.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.239 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.8 tp -79.55 -26.62 41.37 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.382 -0.824 . . . . 0.0 109.347 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -62.15 -38.25 88.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 110.247 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -59.11 -28.46 66.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.398 -0.814 . . . . 0.0 109.804 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 97.7 mmm -64.9 -35.29 80.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.658 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -63.9 135.95 56.97 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.301 -0.874 . . . . 0.0 109.841 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -112.39 -22.91 10.62 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -113.68 166.15 11.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.672 -0.643 . . . . 0.0 109.477 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.1 146.64 87.09 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.526 2.151 . . . . 0.0 112.677 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -67.59 124.04 22.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 109.428 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.479 ' O ' ' CE1' ' A' ' 24' ' ' TYR . 68.8 mmtt -134.97 154.95 51.53 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.771 0.796 . . . . 0.0 109.997 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.64 166.34 52.11 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -60.73 -42.29 96.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 122.014 -0.698 . . . . 0.0 109.507 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 9.5 p-10 -64.61 -34.74 78.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.429 -0.794 . . . . 0.0 110.45 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 50.3 mp0 -64.77 -47.51 77.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.262 -0.899 . . . . 0.0 110.053 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.418 HD11 HG21 ' A' ' 90' ' ' ILE . 35.2 pt -69.93 -35.45 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 110.083 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.27 -42.99 99.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.986 -1.071 . . . . 0.0 109.395 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.487 1.389 0 O-C-N 121.346 -0.846 . . . . 0.0 109.547 -179.805 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -59.64 -37.97 80.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.883 -0.511 . . . . 0.0 109.848 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.51 -40.85 98.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.748 -0.595 . . . . 0.0 109.488 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.61 -39.37 88.33 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 99.3 mm-40 -64.5 -40.42 95.62 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.15 -42.08 99.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.055 -0.403 . . . . 0.0 110.372 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.42 -46.44 79.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.889 -0.507 . . . . 0.0 109.857 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -65.67 -43.23 89.98 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.035 0.445 . . . . 0.0 110.199 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.41 -43.85 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.6 m -62.37 -45.55 92.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -63.38 -43.92 96.2 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.812 -0.555 . . . . 0.0 109.72 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.602 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 71.7 t80 -62.21 -47.09 86.01 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.06 -40.56 96.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.936 -0.477 . . . . 0.0 109.929 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -59.66 -46.06 90.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 122.042 -0.411 . . . . 0.0 110.281 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -72.29 -34.02 67.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 110.528 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.602 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 73.3 m-80 -86.58 -2.35 58.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.21 -0.932 . . . . 0.0 109.231 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 53.2 mt -136.56 104.86 9.17 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.613 . . . . 0.0 109.472 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.03 -16.99 25.34 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.779 2.319 . . . . 0.0 111.298 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -94.01 8.03 42.93 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -56.5 133.55 53.43 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.927 0.87 . . . . 0.0 110.48 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -135.9 -51.08 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -148.64 156.09 41.94 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.663 0.744 . . . . 0.0 110.207 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 p -139.82 140.83 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.539 0.685 . . . . 0.0 109.601 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.0 m -126.09 118.52 25.46 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.723 0.773 . . . . 0.0 109.486 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -95.67 126.49 40.98 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.556 0.694 . . . . 0.0 109.742 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.7 p -97.34 -17.2 19.89 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.5 m120 59.82 33.57 21.7 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.379 0.609 . . . . 0.0 109.557 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -92.74 179.74 5.39 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.684 0.754 . . . . 0.0 110.452 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 59.1 150.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.692 0.758 . . . . 0.0 110.362 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -155.33 114.85 3.66 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.826 0.822 . . . . 0.0 109.594 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.432 ' N ' ' ND2' ' A' ' 43' ' ' ASN . 2.6 m120 -91.92 146.71 33.42 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.29 -21.43 41.46 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.395 2.063 . . . . 0.0 111.62 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -76.61 -4.3 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.815 -0.553 . . . . 0.0 109.815 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.06 -123.51 1.19 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 pt -129.37 140.75 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.848 -0.795 . . . . 0.0 110.005 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.2 t -115.96 130.0 56.63 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.599 0.714 . . . . 0.0 109.926 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.9 127.23 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.749 0.785 . . . . 0.0 109.284 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -114.09 149.44 35.54 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.831 0.825 . . . . 0.0 110.0 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.02 179.88 45.09 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -143.23 166.02 25.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.76 -0.847 . . . . 0.0 110.609 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.6 pt -120.48 162.29 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.747 0.785 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 57.52 33.6 23.48 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 44.59 29.23 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.015 0.436 . . . . 0.0 109.864 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -109.13 112.4 24.55 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.66 0.743 . . . . 0.0 109.811 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -57.99 -34.11 69.63 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.963 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.08 -38.72 92.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.723 -0.611 . . . . 0.0 109.354 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.6 mt -82.46 75.84 9.36 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.1 m -102.49 160.39 14.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.964 0.888 . . . . 0.0 110.72 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.2 154.95 40.79 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.631 0.729 . . . . 0.0 109.716 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 96.9 m -134.66 133.85 40.53 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.66 0.743 . . . . 0.0 110.643 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.98 138.09 50.65 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.773 0.797 . . . . 0.0 109.376 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.66 133.77 11.81 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.433 ' O ' ' OE1' ' A' ' 17' ' ' GLN . 71.3 tttt 37.9 -133.75 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.212 0.529 . . . . 0.0 110.894 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -73.84 62.1 0.81 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 45.39 24.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -64.09 -42.36 96.97 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.74 127.41 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.694 0.759 . . . . 0.0 109.013 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.56 ' CZ ' ' NE ' ' A' ' 84' ' ' ARG . 28.3 p90 -139.95 153.44 46.91 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.971 0.891 . . . . 0.0 110.621 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 t -140.84 152.41 45.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.688 0.756 . . . . 0.0 109.423 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 p -138.47 153.9 48.82 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.896 0.855 . . . . 0.0 110.144 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.0 p -82.64 168.89 16.85 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.817 0.818 . . . . 0.0 110.546 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -65.44 -29.6 70.3 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -73.93 -50.4 20.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.756 -0.59 . . . . 0.0 109.583 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.27 -19.97 65.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.68 . . . . 0.0 109.484 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -64.0 -33.38 75.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.878 -0.514 . . . . 0.0 110.01 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.514 ' CG ' ' N ' ' A' ' 79' ' ' MET . 17.7 pttp -64.05 -43.83 94.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.617 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.514 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 59.8 mmm -68.41 -38.33 81.17 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.527 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 73.8 t80 -66.27 124.43 22.64 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.551 0.691 . . . . 0.0 109.138 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -142.97 -1.2 1.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.527 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 6.2 tp10 -102.43 113.4 65.89 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -48.87 149.01 8.28 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.407 2.071 . . . . 0.0 112.805 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.56 ' NE ' ' CZ ' ' A' ' 70' ' ' PHE . 15.9 mmm180 -67.77 143.6 55.78 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.735 0.779 . . . . 0.0 110.064 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -140.4 -76.64 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 159.32 160.89 10.73 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -62.71 -44.8 95.29 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.407 0.622 . . . . 0.0 109.632 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.96 -34.74 78.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.684 -0.635 . . . . 0.0 110.095 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 47.8 mp0 -65.66 -44.58 85.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.346 -0.846 . . . . 0.0 110.891 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.2 pt -66.2 -38.75 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.595 -0.691 . . . . 0.0 110.3 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 31.1 mt -63.64 -40.47 96.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.665 -0.647 . . . . 0.0 109.556 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.828 -0.545 . . . . 0.0 109.614 -179.907 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.4 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -65.79 -38.71 89.74 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.544 -0.722 . . . . 0.0 109.522 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -61.67 -41.44 97.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.769 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -64.53 -44.07 92.01 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.331 -0.856 . . . . 0.0 108.956 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -65.16 -39.06 92.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.574 -0.704 . . . . 0.0 109.363 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -63.76 -40.35 96.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.599 -0.688 . . . . 0.0 109.773 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -65.6 -38.35 89.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.444 -0.785 . . . . 0.0 109.597 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.29 -41.39 98.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.334 -0.853 . . . . 0.0 109.78 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.22 -43.67 97.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.0 m -61.43 -44.31 97.35 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.526 -0.734 . . . . 0.0 109.095 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.53 -42.54 99.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.502 -0.749 . . . . 0.0 109.101 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.55 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 62.8 t80 -61.01 -47.28 87.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.434 -0.791 . . . . 0.0 109.402 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' ILE . 86.2 mt -63.51 -41.97 98.5 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.419 -0.801 . . . . 0.0 109.696 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -61.86 -42.24 98.82 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.469 -0.77 . . . . 0.0 110.046 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -69.21 -39.17 78.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -0.836 . . . . 0.0 109.914 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.55 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 69.6 m-80 -86.26 -13.06 47.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.141 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 25' ' ' LEU . 11.1 mt -137.25 81.38 31.78 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.24 -28.24 70.37 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.481 2.121 . . . . 0.0 110.823 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.71 12.69 5.54 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -54.1 134.34 43.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.604 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -110.32 -63.17 1.42 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 t -150.42 157.95 43.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 0.0 109.95 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.13 133.19 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.599 -0.688 . . . . 0.0 109.318 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.5 m -121.02 120.22 34.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.62 -0.675 . . . . 0.0 109.242 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -94.26 140.62 29.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.593 -0.692 . . . . 0.0 109.402 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.0 p -116.41 -32.14 5.36 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -138.66 139.35 38.45 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.383 -0.823 . . . . 0.0 110.103 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -138.14 58.72 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -175.21 -170.17 0.42 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.629 -0.669 . . . . 0.0 109.791 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 t80 63.24 92.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.513 0.673 . . . . 0.0 109.94 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -171.37 119.99 0.47 Allowed Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.432 -0.793 . . . . 0.0 109.139 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.95 -42.97 25.11 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.283 1.989 . . . . 0.0 112.479 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 tp -70.5 -37.53 70.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.423 -0.798 . . . . 0.0 109.816 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.15 -87.91 0.07 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.9 pt -135.19 151.83 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.485 -1.009 . . . . 0.0 110.008 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.1 t -116.41 131.8 56.85 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.691 -0.631 . . . . 0.0 109.567 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.6 mt -106.83 116.49 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -119.73 139.32 52.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.44 36.48 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -145.42 166.13 26.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -1.073 . . . . 0.0 110.077 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.9 pt -120.84 162.85 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 121.576 0.703 . . . . 0.0 110.584 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 56.59 32.75 21.5 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.524 0.678 . . . . 0.0 109.547 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 m120 44.7 30.94 0.58 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.482 -0.761 . . . . 0.0 109.734 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -109.11 112.35 24.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.558 -0.714 . . . . 0.0 109.268 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -58.61 -33.35 69.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.669 -0.644 . . . . 0.0 109.807 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -62.86 -38.33 90.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.789 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.7 mt -83.76 79.92 9.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -0.89 . . . . 0.0 109.575 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.3 t -104.45 158.12 16.69 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.492 0.663 . . . . 0.0 110.063 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -144.56 145.87 32.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.479 -0.763 . . . . 0.0 109.513 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 52.1 m -130.24 131.3 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.05 138.17 48.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.632 -0.667 . . . . 0.0 109.277 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -96.53 99.51 2.33 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.7 tttp 43.86 -83.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.984 -0.715 . . . . 0.0 110.915 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 64' ' ' GLY . 99.2 m-20 -73.86 125.37 28.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.89 -1.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.531 -0.731 . . . . 0.0 109.453 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' A' ' 66' ' ' ASP . 54.6 mtpt -62.89 -41.22 99.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 69' ' ' ILE . 96.6 mt -116.2 116.21 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.473 -0.767 . . . . 0.0 109.346 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.532 ' CZ ' ' OH ' ' A' ' 24' ' ' TYR . 54.6 p90 -141.09 157.27 45.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.724 . . . . 0.0 110.021 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.3 t -120.4 137.27 54.4 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.2 t -137.56 146.46 44.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.443 -0.786 . . . . 0.0 109.958 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.8 m -80.68 172.83 13.25 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.675 0.75 . . . . 0.0 110.275 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -66.0 -35.57 80.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.638 -0.663 . . . . 0.0 109.959 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -65.1 -33.3 75.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.495 -0.753 . . . . 0.0 109.772 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.5 tp -91.3 -24.44 19.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 109.019 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -65.11 -38.03 89.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.818 . . . . 0.0 109.858 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.05 -12.8 61.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 110.283 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.7 mmm -79.37 -9.49 59.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.808 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.38 128.96 37.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.958 . . . . 0.0 109.828 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -109.4 -43.99 4.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.617 -0.677 . . . . 0.0 109.573 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -96.5 165.44 16.11 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.419 -0.8 . . . . 0.0 110.175 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.55 146.91 89.21 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.297 1.998 . . . . 0.0 112.006 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.42 124.1 20.92 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.462 -0.774 . . . . 0.0 110.462 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -138.43 140.91 39.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.718 -0.613 . . . . 0.0 109.429 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.8 174.14 49.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -60.9 -43.97 97.77 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.67 0.748 . . . . 0.0 109.767 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 48.4 p-10 -69.76 -32.98 71.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.124 -0.985 . . . . 0.0 110.166 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 78.5 mm-40 -66.25 -44.21 84.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.1 pt -65.57 -38.46 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.007 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.5 -42.18 99.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.97 -1.081 . . . . 0.0 109.488 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.13 179.577 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.9 t80 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.87 0.843 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CD1' ' OE2' ' A' ' 40' ' ' GLU . 85.0 m-85 -68.91 -35.23 76.58 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.484 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -62.54 -44.96 95.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.103 -0.998 . . . . 0.0 110.291 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -69.18 -36.03 76.91 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.155 -0.965 . . . . 0.0 109.758 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -63.16 -42.27 99.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -0.938 . . . . 0.0 109.599 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.83 -40.86 95.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 0.0 109.232 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.04 -43.95 98.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.562 -0.711 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.67 -43.32 97.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.412 -0.805 . . . . 0.0 109.942 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.3 -42.79 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 m -60.99 -46.12 92.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.392 -0.818 . . . . 0.0 109.383 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 tp -63.98 -42.01 97.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.526 ' CE2' ' OD1' ' A' ' 28' ' ' ASN . 77.4 t80 -61.42 -46.87 88.31 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.689 0.757 . . . . 0.0 109.87 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.15 -39.24 89.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.348 -0.845 . . . . 0.0 110.237 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -60.31 -45.67 92.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.289 -0.882 . . . . 0.0 110.521 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -69.51 -38.67 77.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.203 -0.935 . . . . 0.0 110.37 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.526 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 25.2 m120 -64.17 -40.53 96.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.945 . . . . 0.0 109.81 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.4 mt -115.54 119.11 38.47 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.695 . . . . 0.0 109.908 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.61 -19.42 28.07 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.597 2.198 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -95.72 8.44 43.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 108.926 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -49.28 120.92 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.876 0.846 . . . . 0.0 110.032 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -102.27 -68.71 0.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.701 0.762 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.68 ' HG1' ' N ' ' A' ' 35' ' ' VAL . 2.8 t -148.06 163.92 35.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.193 -0.942 . . . . 0.0 109.711 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.68 ' N ' ' HG1' ' A' ' 34' ' ' THR . 3.8 p -133.25 137.08 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.585 -0.697 . . . . 0.0 109.493 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.9 m -125.21 123.51 39.73 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.681 0.753 . . . . 0.0 109.368 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -88.42 132.35 34.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.562 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -107.15 -53.94 2.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.48 -0.763 . . . . 0.0 109.756 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -100.65 142.43 32.13 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.073 -1.017 . . . . 0.0 110.427 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.427 ' OE2' ' CD1' ' A' ' 14' ' ' PHE . 76.5 tt0 -162.47 106.84 1.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.531 -0.731 . . . . 0.0 109.09 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -170.03 177.77 4.18 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.465 -0.772 . . . . 0.0 110.043 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -61.68 -178.37 0.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.988 0.899 . . . . 0.0 110.61 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -175.45 167.75 1.73 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.13 -40.54 76.65 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.295 1.997 . . . . 0.0 111.528 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.9 -4.09 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.752 . . . . 0.0 109.453 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 134.4 -94.31 0.26 Allowed Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.5 pt -126.9 149.14 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.626 -0.926 . . . . 0.0 110.04 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 t -127.28 130.89 50.39 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.666 0.746 . . . . 0.0 108.997 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -128.04 132.01 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 40.3 t0 -135.42 146.06 47.89 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.593 -0.692 . . . . 0.0 109.807 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -167.89 -164.9 24.38 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -144.28 161.5 38.76 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.492 -1.004 . . . . 0.0 110.028 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -121.05 159.63 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 122.09 0.948 . . . . 0.0 111.308 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.1 m-20 57.39 32.93 22.56 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.825 0.821 . . . . 0.0 109.902 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 49.42 30.86 3.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 0.0 109.536 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -112.6 108.15 17.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.401 -0.812 . . . . 0.0 109.528 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -59.7 -31.44 69.59 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.568 0.699 . . . . 0.0 109.518 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -62.76 -39.07 93.0 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.178 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.6 mt -83.09 77.52 9.73 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.226 -0.921 . . . . 0.0 109.684 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.4 p -104.08 161.74 13.75 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.803 0.811 . . . . 0.0 110.596 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -149.75 156.09 41.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.537 -0.727 . . . . 0.0 109.688 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.3 m -137.29 140.05 41.32 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.658 -0.652 . . . . 0.0 109.894 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.87 150.43 46.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.365 -0.835 . . . . 0.0 109.394 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 65' ' ' LYS . . . -126.86 94.64 0.42 Allowed Glycine 0 N--CA 1.503 3.15 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' GLY . 88.6 tttt 52.84 115.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.945 0.879 . . . . 0.0 111.133 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 68' ' ' LYS . 65.6 t0 60.05 139.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.84 0.828 . . . . 0.0 110.591 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.566 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 26.3 t -58.48 0.63 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.558 0.694 . . . . 0.0 109.354 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.59 ' H ' ' C ' ' A' ' 66' ' ' ASP . 63.3 tttp -55.79 -40.05 72.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 108.788 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.45 119.03 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.483 -0.761 . . . . 0.0 109.084 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -138.63 125.91 21.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.413 -0.804 . . . . 0.0 109.365 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.8 m -107.71 150.57 26.78 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.609 0.719 . . . . 0.0 109.338 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.2 m -151.51 152.52 33.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.93 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.3 p -80.95 172.62 13.51 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.91 0.862 . . . . 0.0 110.874 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -58.77 -45.67 89.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.679 -0.638 . . . . 0.0 110.074 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.59 -48.96 78.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.15 -0.969 . . . . 0.0 110.22 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.59 -36.2 83.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.091 -1.006 . . . . 0.0 109.108 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.77 -41.45 97.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.343 -0.848 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -66.1 -35.06 79.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.153 -0.967 . . . . 0.0 109.714 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.5 mmm -62.26 -38.53 89.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.203 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -55.97 140.7 42.26 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.949 0.88 . . . . 0.0 110.104 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -106.45 -16.8 14.45 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -133.21 154.97 81.37 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.364 -0.835 . . . . 0.0 109.589 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.87 162.95 29.96 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 123.041 2.494 . . . . 0.0 112.69 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -63.77 135.76 56.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.921 0.867 . . . . 0.0 110.355 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -138.85 151.18 46.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.701 0.762 . . . . 0.0 109.641 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.98 152.81 45.97 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.07 -42.88 95.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.778 -0.836 . . . . 0.0 109.518 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.86 -37.97 88.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.777 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -60.7 -48.1 83.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.379 -0.825 . . . . 0.0 110.382 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.444 HG21 HD11 ' A' ' 90' ' ' ILE . 34.8 pt -71.01 -31.58 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.937 -1.102 . . . . 0.0 109.946 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.04 -43.29 95.99 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 109.452 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.855 0.836 . . . . 0.0 109.32 -179.799 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.517 ' CE2' ' NE2' ' A' ' 17' ' ' GLN . 69.0 t80 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.643 0.735 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -65.3 -37.95 88.71 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.467 0.651 . . . . 0.0 109.465 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.47 -40.96 96.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.508 -0.745 . . . . 0.0 109.293 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.54 -49.52 76.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.455 -0.778 . . . . 0.0 109.423 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.517 ' NE2' ' CE2' ' A' ' 13' ' ' PHE . 97.8 mt-30 -68.18 -33.61 74.76 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.552 0.692 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.09 -44.83 95.8 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.494 0.664 . . . . 0.0 109.794 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.03 -39.53 87.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.668 -0.645 . . . . 0.0 110.133 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -63.47 -42.43 98.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.543 -0.723 . . . . 0.0 110.596 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.94 -42.01 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.812 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.5 m -60.5 -46.62 89.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.416 -0.803 . . . . 0.0 109.861 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.73 -40.97 96.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.763 . . . . 0.0 109.665 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.558 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 80.0 t80 -60.08 -44.71 94.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.491 -0.756 . . . . 0.0 109.849 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.45 -42.19 98.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.478 -0.764 . . . . 0.0 110.434 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -40.45 96.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.495 -0.753 . . . . 0.0 110.334 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -67.56 -35.22 78.63 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.495 -0.753 . . . . 0.0 110.585 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.558 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 71.4 m-80 -95.04 -1.3 52.53 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.112 -0.992 . . . . 0.0 109.515 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.1 mt -140.91 84.44 13.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 109.484 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.4 -28.94 75.3 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.709 2.273 . . . . 0.0 111.17 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -88.59 15.8 7.55 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.535 0.683 . . . . 0.0 109.164 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -49.85 130.5 21.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.458 -0.776 . . . . 0.0 109.912 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -115.85 -68.6 0.91 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 t -143.28 161.07 39.27 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.598 0.713 . . . . 0.0 110.058 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.61 139.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.9 m -123.45 125.79 45.57 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -90.88 136.88 32.78 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.615 0.722 . . . . 0.0 110.095 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 39' ' ' ASN . 14.4 p -117.02 -33.48 4.71 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' ' 38' ' ' THR . 9.0 p30 38.24 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.0 0.905 . . . . 0.0 110.838 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -157.9 36.08 0.26 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 109.394 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -144.58 121.33 11.21 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.221 -0.924 . . . . 0.0 109.871 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -109.97 121.7 45.86 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.538 0.685 . . . . 0.0 109.288 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.434 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 2.0 m-20 -106.46 137.39 19.42 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -49.4 -31.36 23.05 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.569 2.179 . . . . 0.0 112.007 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.0 pt -80.08 -10.14 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.513 -0.742 . . . . 0.0 109.588 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 43' ' ' ASN . . . 154.52 -176.78 32.19 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.636 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.417 ' H ' ' HE2' ' A' ' 65' ' ' LYS . 34.0 pt -83.84 140.09 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.67 -0.9 . . . . 0.0 110.424 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.434 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 72.2 m -111.15 126.46 54.87 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.607 0.718 . . . . 0.0 109.525 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.56 126.15 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.625 -0.672 . . . . 0.0 109.516 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -115.48 149.09 38.65 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.839 0.828 . . . . 0.0 110.109 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.85 -177.83 46.12 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -142.67 163.07 33.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.761 -0.846 . . . . 0.0 109.959 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 pt -121.94 162.78 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 121.914 0.864 . . . . 0.0 110.825 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.5 m120 59.59 31.31 20.86 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.529 0.68 . . . . 0.0 110.298 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 48.32 30.71 2.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.587 -0.696 . . . . 0.0 109.573 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -113.67 109.74 19.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.761 0.791 . . . . 0.0 109.513 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.53 -32.69 70.55 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.345 0.593 . . . . 0.0 109.588 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.76 -38.63 91.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.333 -0.854 . . . . 0.0 109.075 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.5 mt -83.2 75.82 9.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.559 -0.713 . . . . 0.0 109.506 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 t -99.76 162.99 12.66 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.723 0.773 . . . . 0.0 110.427 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -149.08 155.23 40.42 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.626 0.727 . . . . 0.0 109.793 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.1 m -132.74 136.1 46.15 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.451 0.643 . . . . 0.0 110.11 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.77 136.96 47.97 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.724 0.773 . . . . 0.0 109.287 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -102.43 136.3 12.74 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' GLY . 60.9 mmtt 33.59 -121.72 0.09 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.434 0.635 . . . . 0.0 111.421 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 68' ' ' LYS . 99.2 m-20 -85.67 76.3 9.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 66' ' ' ASP . 2.1 t 38.26 28.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.778 0.799 . . . . 0.0 110.003 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 66' ' ' ASP . 18.3 mmmt -62.62 -42.83 99.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.51 -0.744 . . . . 0.0 109.346 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 69' ' ' ILE . 97.2 mt -129.32 125.92 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.603 -0.686 . . . . 0.0 109.293 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -123.5 131.7 53.71 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.529 0.681 . . . . 0.0 109.573 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.6 m -127.49 150.63 49.59 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 p -136.93 155.2 50.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.911 0.862 . . . . 0.0 110.396 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -81.69 174.42 11.39 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.535 0.683 . . . . 0.0 110.066 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.2 -41.58 99.19 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.463 0.649 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.3 mp0 -70.57 -44.32 67.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -0.859 . . . . 0.0 109.549 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.62 -37.48 86.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.708 -0.62 . . . . 0.0 109.596 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -54.86 -33.0 61.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.742 . . . . 0.0 109.518 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.75 -40.84 97.71 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.352 -0.843 . . . . 0.0 110.057 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.2 mmm -65.93 -37.82 87.04 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.154 -0.966 . . . . 0.0 109.068 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -64.98 133.57 52.01 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.66 0.743 . . . . 0.0 109.988 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -116.5 -22.28 8.8 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' A' ' 82' ' ' GLU . 1.7 pm0 -114.82 153.35 46.94 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.692 -0.63 . . . . 0.0 109.495 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.88 173.5 8.1 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.679 2.253 . . . . 0.0 112.735 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.35 139.74 58.8 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.931 0.872 . . . . 0.0 110.181 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -139.67 145.51 38.52 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.763 0.792 . . . . 0.0 109.848 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -74.42 154.8 47.96 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -61.99 -43.37 98.97 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.66 0.743 . . . . 0.0 110.002 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.36 -36.23 83.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.433 -0.792 . . . . 0.0 109.787 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.557 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 41.5 mp0 -62.89 -51.67 66.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.41 -0.806 . . . . 0.0 110.452 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 pt -64.62 -37.37 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.23 -43.69 97.34 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.55 0.69 . . . . 0.0 110.077 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--N 1.3 -1.552 0 CA-C-O 121.711 0.767 . . . . 0.0 108.97 -179.557 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.437 ' CZ ' ' CZ ' ' A' ' 14' ' ' PHE . 50.8 p90 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.437 ' CZ ' ' CZ ' ' A' ' 13' ' ' PHE . 86.5 m-85 -59.91 -29.33 68.28 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.487 0.661 . . . . 0.0 109.321 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -61.81 -37.82 85.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.479 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.56 -46.43 86.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.647 -0.658 . . . . 0.0 109.957 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.617 HE22 ' CG2' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -67.24 -37.12 83.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.5 -0.75 . . . . 0.0 109.218 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.51 -42.02 99.22 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.479 0.657 . . . . 0.0 109.453 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -65.0 -40.55 95.11 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -64.01 -40.67 96.87 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.313 0.578 . . . . 0.0 110.047 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.617 ' CG2' HE22 ' A' ' 17' ' ' GLN . 69.1 t -64.68 -41.57 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.543 -0.723 . . . . 0.0 109.412 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 m -59.73 -46.18 89.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.633 -0.667 . . . . 0.0 109.691 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.67 -40.14 96.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.692 -0.63 . . . . 0.0 109.732 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.644 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 59.0 t80 -58.84 -48.18 82.24 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.97 -40.56 96.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.601 -0.687 . . . . 0.0 110.068 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -49.81 -61.77 1.94 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.759 -0.588 . . . . 0.0 111.259 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.634 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 20.9 p80 -71.47 -36.01 71.03 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.269 0.557 . . . . 0.0 110.523 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.644 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 33.4 m-80 -64.52 -41.13 96.58 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.9 mt -127.12 114.1 21.74 Favored Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 120.56 -0.456 . . . . 0.0 109.921 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.91 -15.74 26.24 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.633 2.222 . . . . 0.0 111.087 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.81 4.56 52.57 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -55.98 129.01 37.99 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.872 0.844 . . . . 0.0 110.201 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -118.16 -59.64 1.88 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.432 ' HG1' ' N ' ' A' ' 35' ' ' VAL . 4.1 t -146.5 167.29 24.05 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.868 0.842 . . . . 0.0 110.171 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.432 ' N ' ' HG1' ' A' ' 34' ' ' THR . 2.7 p -132.52 134.41 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.61 0.719 . . . . 0.0 109.573 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.0 m -115.64 105.8 13.17 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.737 0.779 . . . . 0.0 109.19 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -80.76 140.22 35.64 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.514 0.674 . . . . 0.0 109.76 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.1 p -120.09 -34.16 3.76 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 53.63 81.94 0.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.518 -0.739 . . . . 0.0 109.843 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -144.36 28.83 1.32 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.435 ' OE1' ' OD2' ' A' ' 50' ' ' ASP . 82.7 tt0 -160.3 135.86 8.2 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.882 0.848 . . . . 0.0 109.987 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -123.83 144.54 49.67 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.707 0.765 . . . . 0.0 109.915 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -98.59 149.91 36.2 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.694 -0.629 . . . . 0.0 109.653 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.47 -20.97 41.01 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.889 2.392 . . . . 0.0 111.495 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.3 pt -98.63 -5.18 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.02 -168.93 40.63 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.688 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 pt -81.55 157.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.865 0.841 . . . . 0.0 109.922 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.6 t -138.67 141.96 39.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.595 0.712 . . . . 0.0 109.809 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.9 mt -112.78 127.88 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.876 0.846 . . . . 0.0 109.968 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.435 ' OD2' ' OE1' ' A' ' 41' ' ' GLU . 24.8 m-20 -117.46 151.11 37.74 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.839 0.828 . . . . 0.0 110.021 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.84 -156.76 28.9 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -150.28 166.77 28.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.456 -1.026 . . . . 0.0 110.645 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.1 pt -121.76 167.8 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.732 0.777 . . . . 0.0 110.354 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 57.99 33.7 23.48 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.459 0.647 . . . . 0.0 109.978 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 42.19 34.52 0.49 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.958 -0.464 . . . . 0.0 109.935 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -115.18 107.67 15.6 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.706 0.765 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -58.6 -36.66 74.36 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.916 -0.49 . . . . 0.0 110.252 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -62.5 -37.03 84.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.245 -0.909 . . . . 0.0 109.804 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.9 mt -82.34 83.55 7.42 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.338 -0.851 . . . . 0.0 109.705 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 t -79.9 145.33 32.73 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.062 0.934 . . . . 0.0 110.668 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -140.29 130.37 24.88 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.756 0.789 . . . . 0.0 109.674 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.8 m -134.69 136.5 42.81 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.838 0.828 . . . . 0.0 110.11 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -134.22 144.07 48.21 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.943 0.878 . . . . 0.0 110.0 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.09 175.84 38.47 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -53.75 133.71 42.15 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.611 0.72 . . . . 0.0 110.943 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 68' ' ' LYS . 93.3 m-20 57.57 34.14 24.17 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.177 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' ILE . 39.6 t 59.46 -78.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' ASP . 67.9 mttm 39.45 -89.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.524 0.678 . . . . 0.0 109.99 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' VAL . 96.9 mt -109.04 136.43 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.777 0.799 . . . . 0.0 109.304 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.527 ' CZ ' ' OH ' ' A' ' 24' ' ' TYR . 53.0 p90 -139.75 167.27 22.49 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.014 0.912 . . . . 0.0 109.868 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.3 t -133.67 150.86 51.55 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.975 0.893 . . . . 0.0 109.688 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.9 p -151.33 160.74 43.63 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.715 0.769 . . . . 0.0 110.156 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 p -75.72 164.98 25.72 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.951 0.882 . . . . 0.0 110.737 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -61.05 -43.18 99.27 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -66.0 -34.0 77.09 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.4 tp -81.99 -26.16 34.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.404 -0.81 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -66.5 -43.82 84.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.531 -0.73 . . . . 0.0 109.998 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -71.75 -9.87 58.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.558 -0.714 . . . . 0.0 110.713 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.9 mtp -82.27 -8.89 59.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.217 -0.927 . . . . 0.0 109.362 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -68.06 135.92 52.99 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -0.855 . . . . 0.0 109.604 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -92.12 -74.21 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.305 0.574 . . . . 0.0 109.816 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.03 155.54 49.62 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.471 -0.768 . . . . 0.0 109.754 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.02 165.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.598 2.199 . . . . 0.0 112.724 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.25 136.25 53.24 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.787 0.803 . . . . 0.0 110.281 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.94 140.36 45.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.817 0.818 . . . . 0.0 109.905 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.5 165.92 53.24 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -62.25 -42.86 99.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.987 -0.714 . . . . 0.0 109.402 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -63.89 -37.71 88.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.64 -0.663 . . . . 0.0 110.324 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -65.21 -44.38 88.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.416 -0.802 . . . . 0.0 110.416 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.4 pt -72.66 -32.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.278 -0.889 . . . . 0.0 110.392 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.82 -40.39 96.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.105 -0.997 . . . . 0.0 109.342 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.234 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CZ ' ' CE2' ' A' ' 14' ' ' PHE . 22.4 p90 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.399 0.618 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.53 ' CE2' ' CZ ' ' A' ' 13' ' ' PHE . 90.2 m-85 -64.87 -37.52 87.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.175 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.88 -41.0 99.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -0.813 . . . . 0.0 109.466 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.67 -40.19 92.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.587 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.18 -41.5 94.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.77 -40.73 97.39 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.384 -0.822 . . . . 0.0 109.351 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.15 -43.3 99.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 0.0 109.618 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -63.53 -42.64 98.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.332 -0.855 . . . . 0.0 109.879 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.47 -42.94 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 0.0 109.417 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.526 ' CG2' ' NZ ' ' A' ' 26' ' ' LYS . 76.1 m -60.73 -44.33 96.76 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.38 -0.825 . . . . 0.0 109.688 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 tp -63.71 -42.14 98.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.246 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.616 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 75.0 t80 -60.82 -44.58 96.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.577 -0.702 . . . . 0.0 110.232 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 29' ' ' ILE . 88.9 mt -63.64 -41.81 98.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 110.305 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.526 ' NZ ' ' CG2' ' A' ' 22' ' ' THR . 62.2 mttp -61.12 -40.75 94.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.91 -1.119 . . . . 0.0 110.444 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -66.84 -38.84 87.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.969 -1.082 . . . . 0.0 110.178 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.616 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 97.5 m-20 -92.5 -7.29 47.78 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.086 -1.009 . . . . 0.0 109.358 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 25' ' ' LEU . 12.3 mt -142.15 81.83 13.84 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.576 -0.702 . . . . 0.0 109.427 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.73 -27.73 78.96 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.711 2.274 . . . . 0.0 111.093 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -82.81 10.07 8.49 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 22.7 t80 -56.08 130.39 43.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -100.52 -68.76 0.8 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.448 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.607 ' HG1' ' H ' ' A' ' 35' ' ' VAL . 3.6 t -152.33 168.22 26.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.722 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.607 ' H ' ' HG1' ' A' ' 34' ' ' THR . 3.5 p -129.03 138.22 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.4 m -125.12 124.67 42.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.606 -0.684 . . . . 0.0 109.27 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -104.43 118.47 36.7 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 t -141.26 18.64 2.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -151.09 106.67 3.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.113 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -130.82 140.6 50.28 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.323 -0.86 . . . . 0.0 109.473 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -135.82 156.35 48.93 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.453 -0.779 . . . . 0.0 109.577 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.49 ' CD2' ' O ' ' A' ' 42' ' ' PHE . 48.9 p90 -97.69 123.35 41.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.931 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.515 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 1.3 m-80 -96.05 153.97 39.01 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.466 -0.771 . . . . 0.0 109.145 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.64 -22.6 50.39 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.667 2.245 . . . . 0.0 111.299 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.4 pt -102.13 -3.84 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.49 -133.88 3.2 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.9 pt -127.79 159.61 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.312 -1.111 . . . . 0.0 110.749 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.515 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 3.6 p -126.14 137.13 53.56 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 49' ' ' ILE . 96.6 mt -124.88 130.66 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.536 -0.728 . . . . 0.0 109.344 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -130.6 137.51 49.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.621 -0.674 . . . . 0.0 109.382 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.75 -160.78 14.48 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -147.69 167.39 24.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.26 -1.141 . . . . 0.0 109.946 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.8 pt -121.2 160.44 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 121.953 0.882 . . . . 0.0 110.784 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 58.6 33.38 23.04 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.563 0.697 . . . . 0.0 109.873 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.8 m120 46.41 29.49 0.89 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.306 -0.871 . . . . 0.0 110.08 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -109.24 111.76 23.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 0.0 109.504 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -58.7 -34.29 71.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.529 -0.732 . . . . 0.0 109.495 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -61.76 -39.11 90.48 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.321 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.79 73.89 8.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.074 -1.016 . . . . 0.0 109.083 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -100.56 156.5 17.26 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.6 0.714 . . . . 0.0 110.109 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.0 154.52 37.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.567 -0.708 . . . . 0.0 109.614 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 93.2 m -131.59 132.66 44.27 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.95 144.59 45.51 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.408 -0.807 . . . . 0.0 109.662 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.89 179.37 36.78 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -51.67 132.46 30.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.645 -0.915 . . . . 0.0 110.836 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 t0 56.01 38.09 29.56 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.672 0.749 . . . . 0.0 109.698 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 69' ' ' ILE . 36.1 t 58.56 -103.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.562 -0.711 . . . . 0.0 110.315 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 62.09 -69.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.616 -0.678 . . . . 0.0 109.53 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 67' ' ' VAL . 87.6 mt -105.73 121.84 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 108.752 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -128.39 133.97 48.72 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.5 t -132.01 141.78 49.37 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.0 p -139.45 156.15 47.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.475 -0.766 . . . . 0.0 109.968 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.9 p -68.93 170.05 10.46 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.647 0.737 . . . . 0.0 110.805 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.62 -46.52 88.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.494 -0.754 . . . . 0.0 110.263 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 57.8 mp0 -65.36 -45.7 83.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 0.0 109.618 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.58 -38.74 90.39 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.314 -0.866 . . . . 0.0 109.678 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 84' ' ' ARG . 32.1 t70 -61.5 -36.02 79.31 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.128 -0.983 . . . . 0.0 109.59 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -68.86 -13.93 62.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.992 . . . . 0.0 110.207 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.2 mtp -82.2 -9.34 59.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.78 -1.2 . . . . 0.0 109.418 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -72.88 137.08 45.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.154 -0.966 . . . . 0.0 109.721 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -114.68 -11.39 12.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -127.1 153.43 76.65 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.71 -0.619 . . . . 0.0 109.917 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.86 152.13 59.8 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 122.323 2.015 . . . . 0.0 112.859 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.519 ' NH2' ' OD1' ' A' ' 77' ' ' ASP . 26.2 mmt85 -66.29 138.74 57.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 109.864 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -145.9 166.27 26.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.533 -0.729 . . . . 0.0 109.905 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.408 ' H ' ' CD ' ' A' ' 89' ' ' GLU . . . -82.31 167.8 47.56 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -62.01 -45.51 93.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.516 -0.99 . . . . 0.0 109.63 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -70.72 -29.14 65.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.839 -1.163 . . . . 0.0 109.005 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 86' ' ' GLY . 94.9 mt-10 -65.44 -45.33 84.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.395 -0.815 . . . . 0.0 109.936 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.6 pt -68.08 -33.42 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 109.749 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.4 mt -65.04 -41.23 95.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.384 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.11 -0.994 . . . . 0.0 109.653 -179.062 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 77.0 t80 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.771 0.796 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -59.88 -43.09 94.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.631 . . . . 0.0 109.555 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -62.95 -41.6 99.55 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.688 0.756 . . . . 0.0 109.007 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.99 -38.53 88.75 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.547 0.689 . . . . 0.0 109.398 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 67.4 tp60 -61.98 -43.56 98.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.679 . . . . 0.0 110.148 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.16 -40.21 96.9 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.658 0.742 . . . . 0.0 109.273 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.67 -44.34 94.04 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.546 0.689 . . . . 0.0 109.56 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -63.73 -42.94 97.81 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.427 0.632 . . . . 0.0 110.269 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.38 -44.69 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.641 0.734 . . . . 0.0 109.707 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.9 m -62.16 -42.4 99.22 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.55 0.691 . . . . 0.0 109.875 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.8 -44.36 96.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.489 -0.757 . . . . 0.0 109.597 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -62.46 -45.88 91.04 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.598 0.714 . . . . 0.0 110.186 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.33 -39.46 93.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.482 -0.761 . . . . 0.0 110.069 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -60.55 -42.0 95.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.521 -0.737 . . . . 0.0 109.804 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -66.51 -39.08 88.48 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.519 0.676 . . . . 0.0 110.0 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -87.97 -2.98 58.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.462 -0.774 . . . . 0.0 109.435 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.3 mt -142.53 83.1 12.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.67 . . . . 0.0 109.215 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.63 -32.06 73.38 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.597 2.198 . . . . 0.0 111.159 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -83.87 16.05 3.0 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.587 0.708 . . . . 0.0 109.445 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.73 129.19 40.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.497 -0.752 . . . . 0.0 109.883 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -108.98 -58.4 2.02 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -153.91 164.32 38.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.246 -0.908 . . . . 0.0 110.447 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.09 135.84 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 100.0 m -128.82 125.36 37.58 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.701 0.762 . . . . 0.0 110.01 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -99.16 147.42 25.13 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 p -142.17 -76.21 0.28 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.489 0.661 . . . . 0.0 109.595 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -78.18 128.48 33.82 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.662 0.744 . . . . 0.0 110.571 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.97 69.6 1.36 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -81.24 162.76 23.41 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.87 0.843 . . . . 0.0 110.213 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -99.4 119.88 38.69 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.777 0.799 . . . . 0.0 110.168 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.679 ' ND2' ' H ' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -95.15 152.25 39.33 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.36 -38.89 27.44 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.671 2.247 . . . . 0.0 112.077 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.9 -41.17 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.58 -0.7 . . . . 0.0 109.961 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' A' ' 43' ' ' ASN . . . -179.41 -135.1 2.32 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.418 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.523 ' C ' HD22 ' A' ' 43' ' ' ASN . 15.8 pt -103.74 139.26 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.758 -0.848 . . . . 0.0 109.801 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.513 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 50.7 m -116.54 124.96 51.17 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.579 0.705 . . . . 0.0 109.591 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.15 125.48 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 61' ' ' PHE . 38.8 t70 -124.25 153.67 41.33 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.861 0.839 . . . . 0.0 109.932 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 178.54 -167.49 38.0 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.469 ' CE2' ' NZ ' ' A' ' 57' ' ' LYS . 19.7 p90 -142.17 163.73 32.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.831 -0.805 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -120.78 161.53 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.674 0.749 . . . . 0.0 110.027 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 58.89 32.16 21.98 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.623 0.725 . . . . 0.0 109.844 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 45.82 32.11 1.2 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.653 . . . . 0.0 109.595 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -115.57 109.51 17.89 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.416 0.627 . . . . 0.0 109.541 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' NZ ' ' CE2' ' A' ' 52' ' ' TYR . 69.6 mmtt -57.85 -33.36 68.57 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.408 0.623 . . . . 0.0 110.032 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -60.5 -39.26 87.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 109.0 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.44 68.77 9.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.445 -0.785 . . . . 0.0 109.373 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.6 p -91.93 161.39 14.84 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.615 0.722 . . . . 0.0 109.855 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.408 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 49.2 p90 -155.07 160.9 41.35 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.63 0.728 . . . . 0.0 109.725 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.6 m -140.68 144.57 35.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.611 -0.681 . . . . 0.0 109.7 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.47 140.69 26.42 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -105.13 147.84 16.38 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.538 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 63.8 mmtt 35.22 -122.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.439 0.637 . . . . 0.0 111.232 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 68' ' ' LYS . 97.7 m-20 -88.21 86.84 7.15 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.774 0.797 . . . . 0.0 109.921 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.497 ' H ' HE22 ' A' ' 17' ' ' GLN . 2.0 t 45.67 14.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.661 0.743 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 66' ' ' ASP . 25.5 tptt -78.44 136.46 37.63 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.878 0.847 . . . . 0.0 110.05 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 68' ' ' LYS . 9.4 mm 49.15 99.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.59 0.709 . . . . 0.0 109.513 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -135.79 153.97 51.36 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.687 0.756 . . . . 0.0 110.083 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 p -136.53 157.25 47.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 m -133.95 153.08 52.01 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.935 0.874 . . . . 0.0 110.135 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.2 p -65.13 168.55 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.765 0.793 . . . . 0.0 110.744 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.17 -51.81 68.17 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.467 0.651 . . . . 0.0 109.82 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.95 -43.36 92.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.526 -0.734 . . . . 0.0 109.715 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.8 -39.1 93.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -61.02 -38.03 84.67 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.631 0.729 . . . . 0.0 109.371 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.97 -36.64 82.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.334 -0.854 . . . . 0.0 109.509 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 81' ' ' GLN . 79.1 mtp -63.32 -41.34 98.91 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.467 -0.771 . . . . 0.0 109.943 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -43.44 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.922 0.868 . . . . 0.0 110.238 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' MET . 57.7 tt0 -67.79 -36.34 80.28 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.194 -0.603 . . . . 0.0 109.642 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -105.89 152.66 40.29 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.499 -0.75 . . . . 0.0 109.921 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.54 167.62 20.34 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.81 2.34 . . . . 0.0 112.844 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -63.78 140.22 58.85 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.777 0.798 . . . . 0.0 110.212 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -144.52 -111.34 0.1 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.685 -0.634 . . . . 0.0 109.843 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -176.94 161.06 28.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.452 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.88 -44.39 97.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.385 0.612 . . . . 0.0 110.059 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -58.76 -39.79 82.01 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.534 0.683 . . . . 0.0 110.121 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -57.96 -56.36 22.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 109.667 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.403 HG21 HD12 ' A' ' 90' ' ' ILE . 38.8 pt -65.64 -26.14 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.436 -0.79 . . . . 0.0 110.029 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.61 -35.85 81.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.503 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.257 -0.902 . . . . 0.0 109.322 -179.111 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.606 0.717 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -67.9 -33.95 75.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.445 -0.785 . . . . 0.0 109.842 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.415 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 90.9 m-20 -61.62 -46.76 88.45 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.462 -0.774 . . . . 0.0 110.062 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.31 -36.07 71.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 109.588 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.451 HE22 ' H ' ' A' ' 67' ' ' VAL . 68.4 tp60 -66.27 -41.13 90.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.578 -0.701 . . . . 0.0 109.521 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -64.85 -40.93 95.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.557 -0.714 . . . . 0.0 109.58 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -61.35 -42.37 98.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.575 -0.703 . . . . 0.0 109.583 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.3 -42.51 96.34 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.599 0.714 . . . . 0.0 109.175 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.4 t -65.43 -43.61 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.476 0.655 . . . . 0.0 109.659 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -61.74 -45.1 95.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.694 -0.629 . . . . 0.0 110.103 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 tp -63.31 -41.01 98.89 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.949 0.881 . . . . 0.0 109.976 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.623 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 62.9 t80 -66.43 -39.26 88.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.499 -0.75 . . . . 0.0 109.52 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.0 mt -61.82 -47.31 85.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.588 -0.695 . . . . 0.0 111.017 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.97 -34.56 78.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.503 -0.748 . . . . 0.0 110.314 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -72.46 -35.92 68.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 110.277 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.623 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 69.9 m-80 -94.72 -1.28 53.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.292 -0.88 . . . . 0.0 109.483 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 mt -140.93 86.79 11.41 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.389 -0.82 . . . . 0.0 109.346 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -55.98 -31.92 83.96 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.678 2.252 . . . . 0.0 111.303 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -82.25 13.46 3.5 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 25.1 t80 -57.2 130.68 47.24 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.758 0.79 . . . . 0.0 109.826 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -116.42 -66.82 1.04 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.524 ' HG1' ' H ' ' A' ' 35' ' ' VAL . 3.0 t -141.06 165.31 27.9 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.507 -0.746 . . . . 0.0 109.935 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.524 ' H ' ' HG1' ' A' ' 34' ' ' THR . 3.0 p -133.68 138.84 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.42 0.629 . . . . 0.0 109.357 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.8 m -124.91 115.75 21.11 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.689 0.757 . . . . 0.0 109.494 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -86.85 135.47 33.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -111.53 -35.79 5.7 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.74 32.38 19.32 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.507 0.67 . . . . 0.0 109.363 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.33 16.7 14.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.467 -0.771 . . . . 0.0 109.561 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -134.68 148.39 50.32 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.298 -0.876 . . . . 0.0 109.929 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 42' ' ' PHE . 35.1 p90 -161.18 125.08 3.38 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.512 0.672 . . . . 0.0 109.313 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 4.3 p30 -91.02 150.99 42.76 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.527 -0.733 . . . . 0.0 109.847 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -65.06 -24.36 59.81 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.599 2.199 . . . . 0.0 111.766 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tp -70.39 -26.89 29.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.616 0.722 . . . . 0.0 109.382 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.38 -119.93 0.63 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.4 pt -126.2 158.98 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.691 -0.888 . . . . 0.0 110.533 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.4 m -141.67 139.75 33.05 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.2 127.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.55 0.691 . . . . 0.0 109.49 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.5 t0 -119.89 142.92 48.25 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.555 0.693 . . . . 0.0 109.571 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -173.09 -176.15 41.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -143.1 164.03 31.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.597 -0.943 . . . . 0.0 110.341 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 pt -119.03 164.47 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.793 0.806 . . . . 0.0 110.282 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' ASP . 68.7 m-80 58.11 34.35 24.1 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.543 0.687 . . . . 0.0 109.734 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 45.25 20.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.49 0.662 . . . . 0.0 109.657 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' ASN . 99.8 m-20 -102.14 109.65 21.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.494 -0.754 . . . . 0.0 109.232 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -57.37 -33.13 67.48 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.26 0.552 . . . . 0.0 109.933 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -61.99 -39.37 91.98 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.3 mt -81.24 71.28 8.22 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.293 -0.88 . . . . 0.0 109.59 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 p -90.67 161.69 15.26 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.676 0.75 . . . . 0.0 110.497 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -149.24 152.66 36.35 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.455 0.645 . . . . 0.0 109.665 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.8 m -131.06 135.21 47.35 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.583 0.706 . . . . 0.0 110.167 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.22 146.38 40.42 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.646 0.736 . . . . 0.0 109.309 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.09 -155.74 16.9 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.31 134.26 55.51 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.944 0.878 . . . . 0.0 110.571 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 50.93 29.88 4.81 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.474 0.654 . . . . 0.0 109.463 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.451 ' H ' HE22 ' A' ' 17' ' ' GLN . 2.0 t 48.49 30.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.659 0.743 . . . . 0.0 109.454 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' NH2' ' A' ' 84' ' ' ARG . 28.2 tptp -62.16 -45.19 94.51 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.622 -0.674 . . . . 0.0 109.237 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.18 128.26 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -134.5 138.49 44.73 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.664 0.745 . . . . 0.0 109.877 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 t -132.85 146.17 51.59 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.514 0.673 . . . . 0.0 109.25 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.1 t -135.01 147.12 49.6 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.817 0.818 . . . . 0.0 110.172 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.1 p -77.8 173.77 11.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.645 0.736 . . . . 0.0 110.284 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.39 -48.59 80.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.361 0.6 . . . . 0.0 110.16 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.457 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 59.5 mp0 -67.41 -45.01 77.4 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.441 -0.787 . . . . 0.0 109.819 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.16 -40.28 95.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.423 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -58.7 -41.26 85.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.595 -0.69 . . . . 0.0 109.191 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -65.21 -36.52 84.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.41 -0.807 . . . . 0.0 109.836 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 84.6 mmm -62.22 -38.17 88.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.239 -0.913 . . . . 0.0 109.208 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -57.91 138.18 56.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.456 -0.778 . . . . 0.0 109.554 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -108.03 -16.57 14.25 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -130.61 151.29 78.44 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.644 -0.66 . . . . 0.0 109.829 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.54 159.82 51.9 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.163 2.575 . . . . 0.0 112.881 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.462 ' NH2' ' O ' ' A' ' 68' ' ' LYS . 78.6 ttt-85 -66.82 132.53 48.23 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.786 0.803 . . . . 0.0 110.039 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -119.13 -72.43 0.69 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.39 158.44 9.87 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -62.57 -44.54 96.07 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.937 0.875 . . . . 0.0 109.636 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -73.55 -23.7 60.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.79 -45.47 67.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.523 -0.736 . . . . 0.0 109.673 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 91' ' ' LEU . 25.3 pt -66.79 -36.12 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.423 0.63 . . . . 0.0 109.563 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.42 ' N ' HG13 ' A' ' 90' ' ' ILE . 39.2 mt -63.63 -40.49 97.01 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.577 -0.702 . . . . 0.0 109.561 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.616 -0.678 . . . . 0.0 109.628 -179.692 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.407 0.623 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -64.81 -36.5 84.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.395 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -61.38 -40.73 95.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.441 -0.787 . . . . 0.0 109.187 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -65.59 -40.25 92.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.565 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 66' ' ' ASP . 99.4 mm-40 -64.71 -42.43 95.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.691 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -64.25 -40.45 96.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.664 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.81 -44.5 93.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.86 . . . . 0.0 109.636 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.51 -41.7 96.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 109.862 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.3 t -64.63 -42.88 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.862 . . . . 0.0 109.644 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -59.74 -45.27 92.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.212 -0.93 . . . . 0.0 108.87 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.5 -41.96 98.53 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.398 -0.813 . . . . 0.0 109.281 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.484 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 83.1 t80 -58.99 -46.34 88.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.509 -0.744 . . . . 0.0 109.312 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -75.2 -22.93 57.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.69 -0.631 . . . . 0.0 109.712 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -63.96 -48.34 76.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.796 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . 0.619 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 26.2 p80 -81.81 -35.83 29.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.051 -1.031 . . . . 0.0 109.755 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.619 ' ND2' ' CE1' ' A' ' 27' ' ' HIS . 36.6 m-80 -64.04 -41.03 97.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -122.69 88.26 49.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.632 -0.667 . . . . 0.0 109.604 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -54.22 -29.79 58.49 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.756 2.304 . . . . 0.0 111.622 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -80.37 5.1 15.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -55.64 131.73 47.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.493 -0.755 . . . . 0.0 110.284 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -103.0 -65.71 0.98 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 t -149.93 165.0 33.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.841 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.1 p -128.12 135.64 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.8 m -126.5 123.46 37.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.574 -0.704 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -95.55 144.13 26.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 109.429 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.463 ' O ' ' OG1' ' A' ' 38' ' ' THR . 0.2 OUTLIER -143.32 17.95 1.89 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.925 . . . . 0.0 108.643 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -155.48 116.27 3.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.372 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -138.26 91.47 2.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -118.18 147.3 43.49 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.703 0.763 . . . . 0.0 109.965 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 42' ' ' PHE . 48.8 p90 -97.35 120.94 38.64 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.692 -0.63 . . . . 0.0 109.396 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.448 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 73.8 m-20 -103.58 154.59 37.78 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.342 -0.849 . . . . 0.0 108.909 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.92 -40.64 49.01 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.966 1.777 . . . . 0.0 111.594 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 92.0 mt -67.57 -41.26 85.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.456 -0.777 . . . . 0.0 109.059 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.54 -125.89 0.96 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.0 pt -128.36 151.33 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.588 -0.948 . . . . 0.0 110.011 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.448 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 6.0 m -127.04 122.45 34.44 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.11 130.89 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -129.8 149.85 51.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.708 0.766 . . . . 0.0 109.466 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.9 -168.14 34.47 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -142.48 164.79 29.17 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.344 -1.092 . . . . 0.0 110.309 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 pt -121.0 159.36 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.603 0.716 . . . . 0.0 110.306 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 57.52 32.8 22.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.565 -0.71 . . . . 0.0 109.518 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 46.74 32.18 1.66 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.32 -0.862 . . . . 0.0 110.123 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -109.57 108.29 18.68 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.528 -0.733 . . . . 0.0 109.466 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.92 -34.98 72.33 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.394 0.616 . . . . 0.0 109.61 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -62.55 -38.63 90.77 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.123 -0.986 . . . . 0.0 109.175 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.2 mt -83.91 77.55 9.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.1 t -107.37 162.76 13.63 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.372 0.606 . . . . 0.0 109.824 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -153.15 159.75 42.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.322 -0.861 . . . . 0.0 109.287 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.7 m -129.31 133.8 47.62 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.3 142.64 50.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.745 . . . . 0.0 109.14 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.49 124.82 5.4 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt 54.13 93.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.755 -0.85 . . . . 0.0 110.646 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD1' ' NE2' ' A' ' 17' ' ' GLN . 95.1 m-20 52.79 -103.23 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.708 -0.62 . . . . 0.0 110.109 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.84 17.8 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.53 -44.84 96.33 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.413 -0.804 . . . . 0.0 109.222 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.0 mt -121.89 126.06 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CD2' ' NH1' ' A' ' 84' ' ' ARG . 66.0 t80 -138.46 131.77 30.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.512 -0.742 . . . . 0.0 109.191 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 p -139.06 143.46 38.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.366 -0.834 . . . . 0.0 109.06 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 p -153.97 170.29 21.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.988 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -77.17 171.59 14.59 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.634 0.731 . . . . 0.0 110.835 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.71 -35.39 80.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.602 -0.686 . . . . 0.0 109.546 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -58.34 -57.55 12.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.115 -0.99 . . . . 0.0 109.279 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.97 -38.65 86.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.194 -0.941 . . . . 0.0 109.282 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -51.7 -38.42 55.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.378 -0.826 . . . . 0.0 109.702 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -60.42 -31.05 70.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 0.0 110.228 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.6 mmm -64.22 -35.45 80.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.953 . . . . 0.0 110.02 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -55.06 132.88 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.014 -1.054 . . . . 0.0 109.714 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -95.08 -71.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.623 -0.673 . . . . 0.0 109.484 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.19 158.03 41.89 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 109.352 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -46.56 158.35 0.38 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.243 1.962 . . . . 0.0 112.817 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.479 ' NH1' ' CD2' ' A' ' 70' ' ' PHE . 96.3 mtt-85 -67.59 141.33 56.82 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.392 -0.817 . . . . 0.0 109.59 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -130.95 145.72 52.12 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.458 0.646 . . . . 0.0 109.904 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.2 155.89 26.55 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -60.53 -46.01 91.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.8 -0.824 . . . . 0.0 109.403 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 45.8 p-10 -68.75 -32.93 73.05 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.16 -0.962 . . . . 0.0 109.683 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 83.0 tt0 -66.41 -43.09 86.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 110.508 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.7 pt -66.71 -37.73 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.033 -1.042 . . . . 0.0 109.375 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.56 -42.0 99.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.011 -1.055 . . . . 0.0 109.152 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 C--N 1.302 -1.472 0 O-C-N 121.437 -0.789 . . . . 0.0 109.328 179.779 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.317 0.58 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -63.65 -40.69 97.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 109.827 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.63 -41.17 98.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.806 . . . . 0.0 110.149 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.45 -40.0 92.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 109.962 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.89 -40.1 94.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.824 . . . . 0.0 110.058 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.01 -40.86 97.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.177 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -65.58 -40.25 92.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.967 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -63.25 -42.17 99.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -0.867 . . . . 0.0 109.415 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.53 -43.36 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.562 -0.712 . . . . 0.0 109.902 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -61.55 -44.65 96.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.661 -0.649 . . . . 0.0 110.146 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.2 tp -63.01 -44.13 96.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 110.379 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.514 ' CZ ' ' OD1' ' A' ' 28' ' ' ASN . 90.9 t80 -62.74 -45.13 94.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.037 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.05 -40.33 96.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.478 -0.764 . . . . 0.0 110.01 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -58.91 -45.03 91.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 110.744 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -68.23 -37.21 80.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.051 . . . . 0.0 110.26 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.514 ' OD1' ' CZ ' ' A' ' 24' ' ' TYR . 17.2 m120 -87.64 -5.39 58.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 109.177 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.4 mt -138.29 99.0 8.98 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.568 -0.708 . . . . 0.0 109.684 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.34 -14.75 31.32 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.334 2.023 . . . . 0.0 111.589 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -90.9 4.66 51.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.638 -0.664 . . . . 0.0 109.284 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -54.72 129.66 37.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.387 -0.821 . . . . 0.0 110.135 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -125.45 -56.11 1.52 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -146.49 156.46 43.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.341 -0.849 . . . . 0.0 109.627 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.91 140.28 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.623 -0.673 . . . . 0.0 109.872 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.6 m -124.68 128.2 48.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -97.88 124.91 42.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.472 -0.767 . . . . 0.0 110.015 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 39' ' ' ASN . 60.4 p -99.62 -15.16 18.67 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 38' ' ' THR . 74.4 m-20 58.1 148.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.596 0.712 . . . . 0.0 110.535 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.42 -163.96 1.59 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.346 -0.846 . . . . 0.0 109.946 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.12 -160.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.693 -0.629 . . . . 0.0 110.845 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -107.75 130.61 54.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.391 -0.818 . . . . 0.0 110.064 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -90.39 155.61 46.29 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.423 -0.798 . . . . 0.0 109.822 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -49.63 -37.03 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.534 2.156 . . . . 0.0 111.645 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.4 tt -68.4 -38.6 79.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.538 -0.726 . . . . 0.0 109.428 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.92 -97.14 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.56 148.82 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.882 . . . . 0.0 110.007 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 t -100.21 125.04 46.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.396 -0.815 . . . . 0.0 109.427 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.03 129.47 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 61' ' ' PHE . 22.6 t0 -130.68 152.14 50.37 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -175.41 -177.39 44.44 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -143.75 162.75 35.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.539 -0.977 . . . . 0.0 109.968 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.9 pt -121.41 161.5 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.595 0.712 . . . . 0.0 110.871 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 56.78 32.62 21.6 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.692 0.758 . . . . 0.0 109.616 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.7 m120 46.6 32.3 1.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.514 -0.741 . . . . 0.0 109.81 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -113.08 111.28 21.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.66 -0.65 . . . . 0.0 109.357 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -59.79 -31.75 69.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.605 -0.685 . . . . 0.0 109.564 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.96 -39.06 90.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 109.204 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.8 mt -83.5 73.14 10.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 108.986 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 m -105.05 159.67 15.65 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.649 0.737 . . . . 0.0 110.355 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.43 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 53.3 p90 -147.99 149.3 31.9 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.631 -0.668 . . . . 0.0 109.284 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.2 m -128.11 131.92 49.0 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.83 139.96 49.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.41 -0.806 . . . . 0.0 109.764 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -99.78 112.52 4.47 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.2 tttm 37.87 -83.0 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.097 -0.649 . . . . 0.0 111.813 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 64' ' ' GLY . 99.8 m-20 -78.21 125.19 28.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -60.39 0.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 66' ' ' ASP . 65.8 tttm -61.74 -42.59 99.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 109.467 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.86 112.85 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.487 0.66 . . . . 0.0 109.386 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -141.39 158.53 43.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.591 -0.693 . . . . 0.0 109.926 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.0 t -125.51 155.9 39.85 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.477 0.655 . . . . 0.0 109.555 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 p -150.15 162.13 41.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.439 -0.788 . . . . 0.0 109.636 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -77.34 170.83 15.86 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.99 0.9 . . . . 0.0 110.838 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 74' ' ' GLU . 58.7 mp0 -66.09 -37.93 87.0 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.777 -0.577 . . . . 0.0 109.61 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.43 ' OE1' ' NZ ' ' A' ' 78' ' ' LYS . 80.5 mm-40 -64.95 -39.96 94.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.558 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.6 tp -82.61 -21.4 35.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.299 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -66.93 -48.0 69.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.43 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 26.3 pttm -64.69 -22.62 67.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.402 -0.811 . . . . 0.0 110.227 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.8 mtp -65.27 -33.68 76.55 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.535 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -53.78 141.72 25.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.872 . . . . 0.0 110.429 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -85.4 -75.81 0.35 Allowed 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.831 -0.543 . . . . 0.0 109.963 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' PRO . 25.9 mt-10 -99.93 154.54 37.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.731 . . . . 0.0 109.862 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 82' ' ' GLU . 85.1 Cg_exo -40.93 170.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.837 2.358 . . . . 0.0 113.282 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -64.98 130.95 45.27 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.705 0.764 . . . . 0.0 110.018 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -109.14 -78.01 0.59 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.29 145.86 4.21 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -60.44 -45.1 94.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.792 -0.828 . . . . 0.0 109.567 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.58 -26.99 62.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.162 -0.961 . . . . 0.0 109.327 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -69.16 -43.24 74.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.465 -0.772 . . . . 0.0 110.014 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.4 pt -68.3 -37.05 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.316 -0.865 . . . . 0.0 109.777 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.91 -42.14 99.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.036 . . . . 0.0 109.777 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 C--N 1.301 -1.523 0 O-C-N 121.192 -0.942 . . . . 0.0 109.211 179.6 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.481 0.658 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -60.38 -43.55 96.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.503 -0.748 . . . . 0.0 109.754 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -63.56 -40.84 98.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.245 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -62.71 -40.66 97.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.588 -0.695 . . . . 0.0 109.477 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.06 -41.14 97.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.759 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.0 -41.18 97.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 109.437 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -64.1 -42.05 97.04 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.01 -43.27 93.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.606 -0.683 . . . . 0.0 109.859 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.31 -44.3 92.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.431 -0.793 . . . . 0.0 109.801 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.5 t -64.5 -45.26 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 110.072 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.8 m -62.44 -48.04 81.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.267 -0.896 . . . . 0.0 109.538 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 tp -64.08 -41.92 97.15 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.775 0.798 . . . . 0.0 109.656 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.604 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 78.5 t80 -63.96 -40.57 96.72 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.922 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.08 -46.13 90.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.855 . . . . 0.0 110.472 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -68.89 -29.2 67.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 110.308 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -68.48 -39.74 81.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.269 -0.894 . . . . 0.0 109.897 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.604 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 71.6 m-80 -94.63 -3.69 49.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 108.65 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.6 mt -138.38 93.98 11.04 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.92 -16.53 36.92 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.071 1.848 . . . . 0.0 111.057 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -90.12 5.54 46.38 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -58.11 133.81 55.9 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.55 -0.719 . . . . 0.0 110.164 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -110.19 -58.08 2.12 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 t -153.45 160.5 42.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 109.97 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.3 134.69 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -123.49 125.83 45.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.01 144.61 26.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.608 -0.682 . . . . 0.0 109.338 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.1 t -161.91 61.06 0.25 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.183 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -161.53 -83.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 40' ' ' GLU . 4.1 tm-20 56.13 75.13 0.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.794 . . . . 0.0 109.375 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -120.3 150.58 40.5 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.622 0.725 . . . . 0.0 109.614 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -92.23 120.31 32.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.376 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -103.49 156.01 36.07 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.28 -37.97 25.29 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.399 2.066 . . . . 0.0 112.06 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.0 tt -68.72 -37.73 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.119 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.11 -98.44 0.13 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 pt -123.35 157.81 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.526 -0.985 . . . . 0.0 110.275 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.0 p -139.98 123.78 17.42 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.405 HD12 HG21 ' A' ' 49' ' ' ILE . 96.8 mt -118.58 133.06 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.681 -0.637 . . . . 0.0 109.427 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 50.1 t0 -131.18 147.1 52.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.613 -0.68 . . . . 0.0 109.449 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -172.43 -170.61 36.44 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -141.42 165.59 27.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.356 -1.085 . . . . 0.0 110.156 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.4 pt -121.75 162.84 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.531 0.682 . . . . 0.0 110.872 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 57.76 33.18 22.91 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.347 0.594 . . . . 0.0 110.126 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 48.31 26.73 1.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.4 -0.812 . . . . 0.0 110.246 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -108.57 108.59 19.55 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.375 -0.828 . . . . 0.0 109.644 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.15 -32.47 68.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.652 -0.655 . . . . 0.0 109.65 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -62.58 -39.73 94.65 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.45 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.8 mt -81.89 80.31 8.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.163 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.8 m -104.86 153.41 21.4 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.747 0.784 . . . . 0.0 110.417 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -139.61 150.98 45.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.779 -0.575 . . . . 0.0 109.635 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.2 m -133.67 136.23 44.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.544 -0.723 . . . . 0.0 109.917 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.26 155.21 40.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.232 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.44 -130.35 3.91 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' ASP . 54.9 mtpt -59.23 128.57 37.82 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.487 -1.008 . . . . 0.0 110.716 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 67' ' ' VAL . 43.2 t0 44.93 -173.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.505 0.669 . . . . 0.0 110.278 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.527 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 2.3 t -94.69 21.28 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.097 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -63.4 -41.84 98.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.219 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.413 HG22 HD11 ' A' ' 69' ' ' ILE . 96.9 mt -118.37 126.06 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -136.13 135.44 39.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.537 -0.727 . . . . 0.0 109.183 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 t -134.48 144.54 48.13 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.74 . . . . 0.0 109.413 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.1 p -152.71 164.08 38.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 110.516 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.1 p -68.06 167.44 13.95 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.611 0.72 . . . . 0.0 110.67 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -66.46 -36.61 83.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.313 -0.867 . . . . 0.0 109.447 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.83 -32.22 73.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.552 -0.717 . . . . 0.0 109.478 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.4 tp -90.52 -17.94 26.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 109.16 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -73.2 -42.27 62.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.67 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -63.77 -21.31 66.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.642 -0.661 . . . . 0.0 109.745 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 86.1 mmm -64.51 -35.36 80.7 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.341 -0.849 . . . . 0.0 109.15 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -64.31 132.79 51.23 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.32 -0.862 . . . . 0.0 109.86 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -113.21 -16.99 12.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -119.08 153.62 53.04 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.742 -0.598 . . . . 0.0 109.853 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.31 157.34 58.36 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 123.022 2.481 . . . . 0.0 113.012 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -67.4 141.65 56.98 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.726 0.774 . . . . 0.0 110.845 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -141.27 150.54 42.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.647 -0.658 . . . . 0.0 109.308 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.65 158.72 51.16 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -60.41 -44.08 96.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.715 -0.873 . . . . 0.0 109.58 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -66.26 -34.58 78.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 109.663 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -62.65 -49.5 74.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 109.689 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 pt -66.95 -37.46 79.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.472 -0.767 . . . . 0.0 109.427 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.3 tp -62.51 -44.23 96.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.899 . . . . 0.0 109.461 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.64 -38.17 73.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.394 -0.817 . . . . 0.0 109.525 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 93' ' ' HIS . 53.4 t-80 51.83 23.99 2.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.352 -0.842 . . . . 0.0 109.463 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 94' ' ' HIS . 84.1 t60 55.79 16.27 1.96 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.459 -0.776 . . . . 0.0 109.366 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -94.89 122.73 37.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.792 . . . . 0.0 109.764 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.496 ' CG ' ' N ' ' A' ' 97' ' ' HIS . 58.9 t-80 -155.42 168.4 27.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 0.0 109.533 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.496 ' N ' ' CG ' ' A' ' 96' ' ' HIS . 99.3 m-70 -78.94 147.41 33.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.552 -0.717 . . . . 0.0 110.385 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 99.7 m-70 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 117.853 -1.07 . . . . 0.0 108.994 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.889 0.852 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -63.35 -17.91 63.08 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.385 0.612 . . . . 0.0 109.784 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -64.39 -36.56 84.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 109.658 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -63.23 -41.35 99.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.499 -0.751 . . . . 0.0 110.026 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 54.8 mp0 -67.62 -40.41 84.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.606 -0.683 . . . . 0.0 109.91 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 56.2 tp60 -67.75 -36.72 81.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.402 -0.811 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.72 -42.69 99.3 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.623 0.725 . . . . 0.0 109.372 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.62 -39.88 91.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.737 -0.602 . . . . 0.0 109.94 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.74 -42.37 97.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.377 -0.827 . . . . 0.0 109.962 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.38 -42.3 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.1 m -60.51 -45.28 94.38 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.729 0.776 . . . . 0.0 109.078 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -63.83 -41.91 97.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.444 -0.785 . . . . 0.0 108.998 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.525 ' CE2' ' OD1' ' A' ' 28' ' ' ASN . 75.6 t80 -61.36 -47.36 86.21 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.63 -39.83 94.39 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.57 0.7 . . . . 0.0 109.571 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -58.52 -47.82 82.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.624 -0.673 . . . . 0.0 110.272 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.5 m-70 -74.29 -42.75 59.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.28 -0.887 . . . . 0.0 110.072 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.525 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 28.2 m120 -65.28 -39.81 93.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.761 . . . . 0.0 109.499 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.1 mt -105.18 109.32 63.08 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.709 -0.62 . . . . 0.0 109.607 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.94 -16.67 29.14 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.258 1.972 . . . . 0.0 111.15 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -97.33 13.64 28.89 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -58.16 129.54 42.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.485 -0.759 . . . . 0.0 110.036 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.83 -53.64 1.54 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -146.19 158.17 43.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.358 -0.839 . . . . 0.0 110.044 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.2 138.38 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.185 0.516 . . . . 0.0 109.874 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -130.51 124.06 31.07 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.516 0.674 . . . . 0.0 109.589 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -101.32 117.73 35.55 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.452 0.644 . . . . 0.0 109.583 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 t -154.76 30.04 0.42 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.601 -0.687 . . . . 0.0 109.237 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -147.51 16.16 1.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.487 -0.758 . . . . 0.0 109.006 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.75 141.11 45.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.592 0.711 . . . . 0.0 110.685 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -146.3 155.41 42.62 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.472 0.653 . . . . 0.0 109.751 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -75.76 140.82 42.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.637 -0.664 . . . . 0.0 109.789 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -112.01 140.32 23.33 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.22 -36.62 29.75 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.253 1.969 . . . . 0.0 111.422 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.3 tt -86.5 -6.4 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.395 -0.815 . . . . 0.0 109.217 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.92 -114.88 0.63 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 pt -127.21 157.09 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.786 -0.832 . . . . 0.0 110.289 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -128.23 131.48 48.8 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.54 0.686 . . . . 0.0 109.396 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 49' ' ' ILE . 36.1 mm -98.82 119.21 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.432 0.634 . . . . 0.0 109.457 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -123.58 141.93 51.53 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.45 0.643 . . . . 0.0 109.601 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.29 -168.27 38.01 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -145.9 164.93 30.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.88 -0.777 . . . . 0.0 109.955 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -122.75 164.82 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 121.844 0.831 . . . . 0.0 110.7 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 57.98 32.43 21.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.774 0.797 . . . . 0.0 109.783 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 46.56 30.52 1.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.852 -0.53 . . . . 0.0 110.164 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -112.82 111.62 22.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.553 -0.717 . . . . 0.0 109.569 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.04 -32.52 69.82 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.449 0.642 . . . . 0.0 109.493 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.82 -39.01 92.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.806 . . . . 0.0 109.424 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.35 76.13 9.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.456 -0.777 . . . . 0.0 109.442 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.1 m -100.34 159.65 14.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.459 0.647 . . . . 0.0 110.452 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -146.62 150.24 35.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.429 0.633 . . . . 0.0 109.812 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 52.3 m -131.29 135.59 47.43 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.23 145.94 51.01 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.591 0.71 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -93.99 111.59 4.17 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.578 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 13.0 ptmt 26.93 -107.3 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.527 0.679 . . . . 0.0 111.123 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.37 42.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.714 0.769 . . . . 0.0 109.666 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.52 ' H ' ' C ' ' A' ' 65' ' ' LYS . 2.3 t 51.13 37.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.939 0.876 . . . . 0.0 109.921 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -63.64 -41.96 98.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.655 -0.653 . . . . 0.0 109.362 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 11.1 tp -135.09 131.31 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.617 -0.677 . . . . 0.0 109.279 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -124.21 133.43 53.53 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.525 0.679 . . . . 0.0 110.168 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -128.76 152.32 48.58 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.0 m -130.21 152.44 49.63 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.803 0.811 . . . . 0.0 110.161 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 77' ' ' ASP . 17.0 p -78.58 172.3 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.811 0.815 . . . . 0.0 110.65 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -58.64 -44.11 89.97 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.55 0.691 . . . . 0.0 109.9 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.05 -36.81 75.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.447 -0.783 . . . . 0.0 109.567 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.7 tp -81.37 -15.99 53.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.752 0.787 . . . . 0.0 109.43 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' SER . 65.2 t0 -61.12 -47.29 86.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.22 -0.925 . . . . 0.0 110.589 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -59.98 -44.0 94.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.445 -0.784 . . . . 0.0 110.595 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 94.5 mtp -66.51 -38.99 88.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.66 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -75.17 108.31 7.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.48 -0.763 . . . . 0.0 109.983 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -145.24 7.47 1.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -122.52 83.23 47.49 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.5 118.71 2.23 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.776 2.318 . . . . 0.0 113.128 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -80.97 166.0 21.23 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.972 0.891 . . . . 0.0 110.594 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -87.74 -5.91 58.44 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.867 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.65 165.79 14.39 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.715 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.71 -22.23 66.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.907 -0.761 . . . . 0.0 109.154 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -81.3 -26.82 35.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.552 -0.718 . . . . 0.0 109.937 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -72.48 -40.86 66.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.428 -0.795 . . . . 0.0 110.184 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 17.5 pt -60.44 -23.93 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.453 -0.779 . . . . 0.0 110.356 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.2 mt -65.55 -33.58 76.25 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.242 -0.911 . . . . 0.0 109.896 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -54.13 -17.8 3.12 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.454 0.645 . . . . 0.0 110.024 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -57.35 -39.43 75.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.406 -0.809 . . . . 0.0 109.639 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -98.19 71.1 2.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 0.0 109.09 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -79.51 -4.85 53.22 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.638 0.732 . . . . 0.0 109.222 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -53.62 -76.28 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.594 0.711 . . . . 0.0 109.849 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.5 -43.86 98.11 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.578 0.704 . . . . 0.0 109.605 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.235 -179.767 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -61.98 -43.2 99.33 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.252 0.548 . . . . 0.0 109.812 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -85.56 -27.25 25.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.795 -0.566 . . . . 0.0 109.519 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -62.69 -44.83 95.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.789 -0.569 . . . . 0.0 109.947 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -65.79 -37.12 85.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.851 -0.531 . . . . 0.0 109.755 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.98 -43.08 99.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.8 -0.563 . . . . 0.0 110.033 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -64.78 -39.96 94.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.781 -0.574 . . . . 0.0 110.362 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.19 -39.48 94.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.712 -0.617 . . . . 0.0 109.561 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.33 -42.25 98.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.81 -0.556 . . . . 0.0 109.68 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.18 -43.3 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -61.88 -43.48 98.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.157 0.503 . . . . 0.0 109.782 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 51.8 tp -62.26 -41.26 98.3 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.324 0.583 . . . . 0.0 109.595 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.533 ' CD1' ' OD1' ' A' ' 28' ' ' ASN . 74.6 t80 -60.14 -46.28 90.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 29' ' ' ILE . 69.4 mt -63.77 -41.28 98.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.819 -0.551 . . . . 0.0 110.611 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -61.73 -40.51 95.33 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.869 -0.519 . . . . 0.0 110.148 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -86.72 -25.1 24.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.995 -0.441 . . . . 0.0 110.431 -178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' OD1' ' CD1' ' A' ' 24' ' ' TYR . 25.6 m120 -97.33 -11.41 24.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.427 -0.795 . . . . 0.0 109.228 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 25' ' ' LEU . 11.1 mt -148.16 88.67 5.39 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.31 -30.84 64.39 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.816 2.344 . . . . 0.0 112.051 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -78.94 6.17 9.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.54 130.67 47.08 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.782 0.801 . . . . 0.0 109.994 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -107.77 -56.06 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -161.46 165.95 27.96 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.503 0.668 . . . . 0.0 109.93 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.8 p -127.59 137.22 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.741 0.782 . . . . 0.0 109.804 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.9 m -119.08 122.84 43.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.525 0.678 . . . . 0.0 109.549 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' ' CG2' ' A' ' 49' ' ' ILE . 72.9 m-85 -106.4 119.77 40.13 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.717 0.77 . . . . 0.0 109.743 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -33.91 0.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' GLU . 8.9 m120 -69.51 -73.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.762 -0.586 . . . . 0.0 109.757 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 39' ' ' ASN . 81.7 tt0 55.5 151.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.924 0.869 . . . . 0.0 111.233 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -160.97 144.92 13.45 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.798 0.809 . . . . 0.0 109.806 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -92.83 140.54 29.4 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.532 0.682 . . . . 0.0 109.917 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -131.1 149.73 74.56 Favored Pre-proline 0 N--CA 1.486 1.352 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.77 -35.16 38.24 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.638 2.225 . . . . 0.0 112.021 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.8 pt -72.7 -4.94 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.53 -118.44 1.42 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 pt -126.55 154.73 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.797 -0.825 . . . . 0.0 110.103 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.2 p -135.87 131.46 35.33 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.759 0.79 . . . . 0.0 109.678 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.482 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 96.8 mt -94.48 127.64 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.538 0.685 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 65.9 t0 -127.58 137.13 52.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.615 0.721 . . . . 0.0 109.786 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -177.08 -151.66 9.25 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -146.09 160.69 41.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.816 -0.814 . . . . 0.0 110.26 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.0 pt -120.31 163.7 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.804 0.812 . . . . 0.0 110.95 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 58.09 33.54 23.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.837 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 45.92 29.26 0.71 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.436 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -111.74 109.57 19.48 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.773 0.797 . . . . 0.0 109.433 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -58.15 -34.21 70.04 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.846 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -62.26 -39.4 92.78 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.2 mt -81.69 86.8 6.36 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.562 0.696 . . . . 0.0 110.041 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.5 p -80.3 163.87 23.62 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.872 0.844 . . . . 0.0 110.846 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -149.66 131.03 14.69 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.585 0.707 . . . . 0.0 109.672 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.4 m -137.45 132.47 33.42 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.783 0.801 . . . . 0.0 110.058 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.41 142.62 37.48 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.789 0.804 . . . . 0.0 109.736 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -99.28 129.11 9.79 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' GLY . 17.9 tptm 35.36 -122.43 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.08 0.467 . . . . 0.0 110.649 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 68' ' ' LYS . 67.2 t0 -83.36 72.26 10.22 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.377 0.608 . . . . 0.0 109.745 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 66' ' ' ASP . 2.1 t 40.87 28.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.507 0.67 . . . . 0.0 109.345 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ASP . 49.1 mtpt -63.05 -41.94 99.6 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.69 126.17 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.639 0.733 . . . . 0.0 109.82 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -92.71 123.55 36.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.877 0.846 . . . . 0.0 109.718 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -141.29 119.75 12.34 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.809 0.814 . . . . 0.0 109.437 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 p -153.36 165.16 36.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.947 0.88 . . . . 0.0 110.489 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.2 p -75.19 164.35 26.57 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.838 0.828 . . . . 0.0 110.433 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.65 -36.99 83.87 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.6 -34.69 76.07 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 15.0 tp -91.97 -21.28 20.63 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -65.76 -35.43 80.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 109.754 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -75.03 -12.26 60.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.624 -0.672 . . . . 0.0 110.133 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 82.2 mtp -77.11 -5.18 47.96 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -89.7 120.62 31.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.764 0.792 . . . . 0.0 109.031 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.419 ' CD ' ' N ' ' A' ' 81' ' ' GLN . 23.7 mp0 -97.47 -11.99 23.17 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -133.03 149.95 74.23 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.692 -0.63 . . . . 0.0 109.702 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.62 149.57 10.04 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.503 2.135 . . . . 0.0 112.393 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -64.55 136.8 57.4 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.654 0.74 . . . . 0.0 110.285 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -128.65 143.89 51.04 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.053 0.93 . . . . 0.0 110.355 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.21 160.24 52.7 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -60.25 -45.33 93.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.234 -0.568 . . . . 0.0 109.938 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.68 -36.97 86.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.577 -0.702 . . . . 0.0 109.695 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -62.22 -48.4 80.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.824 -0.547 . . . . 0.0 110.0 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.9 pt -69.59 -32.49 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.767 -0.583 . . . . 0.0 109.518 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.24 -44.23 92.46 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.863 -0.523 . . . . 0.0 109.733 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.47 -36.14 73.71 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.682 ' CD2' ' HD1' ' A' ' 94' ' ' HIS . 80.8 t60 54.19 -95.68 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.269 0.557 . . . . 0.0 109.986 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.682 ' HD1' ' CD2' ' A' ' 93' ' ' HIS . 72.9 m80 -136.78 152.1 49.92 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.822 0.82 . . . . 0.0 110.229 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -149.63 164.24 35.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.679 0.752 . . . . 0.0 109.949 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 47.52 73.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.627 0.727 . . . . 0.0 109.434 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.436 ' H ' ' CD2' ' A' ' 97' ' ' HIS . 7.1 p80 -79.9 -16.62 54.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.405 ' OXT' ' O ' ' A' ' 97' ' ' HIS . 76.8 m80 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.845 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.496 0.665 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -63.6 -42.19 98.27 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -62.35 -43.81 97.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.85 -0.531 . . . . 0.0 110.37 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -62.52 -42.16 99.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.444 -0.785 . . . . 0.0 110.163 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.81 -39.15 87.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.797 -0.565 . . . . 0.0 110.272 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.405 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 20.1 mm100 -66.0 -39.71 90.51 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.716 . . . . 0.0 109.751 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -62.98 -43.16 99.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.604 -0.685 . . . . 0.0 109.923 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.59 -43.38 80.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.774 -0.579 . . . . 0.0 110.06 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -65.47 -42.52 92.16 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.0 109.915 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.5 t -64.56 -43.76 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.845 -0.535 . . . . 0.0 109.913 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -61.09 -48.53 81.28 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.93 -40.81 91.74 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.495 ' HH ' ' H ' ' A' ' 84' ' ' ARG . 36.6 t80 -61.07 -48.77 80.2 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.13 -41.87 94.41 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.315 0.579 . . . . 0.0 109.834 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.1 -44.0 91.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.884 -0.51 . . . . 0.0 110.68 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.4 m170 -68.86 -37.06 78.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.373 -0.83 . . . . 0.0 110.318 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.443 HD22 ' CG ' ' A' ' 84' ' ' ARG . 1.3 m-20 -87.2 -5.15 59.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -138.2 94.54 10.97 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.06 -18.51 27.4 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.321 2.014 . . . . 0.0 111.278 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.98 7.44 44.05 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CG ' ' N ' ' A' ' 33' ' ' ASN . 61.1 t80 -54.82 158.19 2.8 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.704 0.764 . . . . 0.0 110.143 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.451 ' N ' ' CG ' ' A' ' 32' ' ' PHE . 65.4 t30 -145.31 -52.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -149.8 151.35 33.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.818 . . . . 0.0 110.095 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.2 137.15 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.534 0.683 . . . . 0.0 109.834 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 87.4 m -116.96 112.23 20.71 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.621 0.724 . . . . 0.0 109.117 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -80.6 145.63 31.63 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.485 0.659 . . . . 0.0 110.303 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 50' ' ' ASP . 25.3 p -155.45 106.45 2.54 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.712 0.767 . . . . 0.0 109.655 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 38' ' ' THR . 9.3 m120 -49.99 -105.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.383 0.611 . . . . 0.0 109.989 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 41' ' ' GLU . 81.6 tt0 55.83 113.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.48 0.657 . . . . 0.0 110.336 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 42' ' ' PHE . 5.5 tm-20 79.23 141.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.466 0.65 . . . . 0.0 110.395 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.502 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 96.9 m-85 -135.06 151.92 51.21 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.835 0.826 . . . . 0.0 110.372 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.51 157.08 89.61 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -37.48 -66.74 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.904 2.403 . . . . 0.0 112.598 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 45' ' ' ILE . 27.9 mm -108.01 -26.71 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.72 -160.63 34.18 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.5 pt -120.44 146.27 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.694 0.759 . . . . 0.0 109.818 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.405 ' H ' ' HA ' ' A' ' 42' ' ' PHE . 10.1 t -111.47 128.46 56.01 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.551 0.691 . . . . 0.0 109.532 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -115.27 127.3 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.672 0.748 . . . . 0.0 109.767 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 59.4 t0 -113.89 154.14 28.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.846 0.831 . . . . 0.0 109.667 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -179.58 -175.23 46.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.1 p90 -149.91 166.22 30.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.874 -0.78 . . . . 0.0 110.436 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 pt -118.83 158.86 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 CA-C-O 121.89 0.852 . . . . 0.0 110.849 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 66.0 m-80 56.75 36.87 28.31 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.194 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 25.1 p30 45.04 23.28 0.09 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.084 0.469 . . . . 0.0 110.535 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -105.67 113.97 27.85 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.66 0.743 . . . . 0.0 109.836 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.23 -30.64 69.54 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -62.17 -38.7 90.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.549 -0.72 . . . . 0.0 109.381 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.4 mt -83.56 63.45 7.38 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.6 p -89.49 160.86 16.53 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.121 0.962 . . . . 0.0 110.961 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -151.9 150.91 30.59 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.468 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.7 m -134.86 134.1 40.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.598 0.713 . . . . 0.0 110.069 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.33 135.85 54.39 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.844 0.83 . . . . 0.0 109.564 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -100.22 89.06 0.81 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.405 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 65.6 tttm 57.89 -72.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 122.286 -0.538 . . . . 0.0 110.259 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 64' ' ' GLY . 98.1 m-20 -89.46 129.91 35.88 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.864 0.84 . . . . 0.0 110.21 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 46.2 t -62.6 -0.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 66' ' ' ASP . 66.0 tttm -62.92 -41.59 99.51 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.65 111.13 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.808 0.813 . . . . 0.0 108.897 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -140.8 126.93 19.58 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.733 0.778 . . . . 0.0 110.333 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 p -84.01 168.32 16.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.493 0.663 . . . . 0.0 109.535 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.6 p -152.75 155.91 38.1 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.855 0.836 . . . . 0.0 110.704 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.2 p -75.7 166.03 24.16 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.738 0.78 . . . . 0.0 110.46 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.92 -44.15 97.37 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.027 0.442 . . . . 0.0 109.813 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.5 mp0 -69.24 -39.14 78.67 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.47 0.653 . . . . 0.0 109.844 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.44 -34.9 77.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.749 -0.594 . . . . 0.0 109.513 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -61.93 -33.33 74.05 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -73.26 -38.25 66.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.532 -0.73 . . . . 0.0 109.863 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.4 mmm -66.22 -65.29 0.7 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.602 -0.687 . . . . 0.0 110.55 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -60.04 149.27 32.77 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.764 0.792 . . . . 0.0 110.38 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -80.39 -105.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.34 0.591 . . . . 0.0 110.503 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -104.44 147.3 34.16 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.773 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.6 145.89 53.51 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.36 2.04 . . . . 0.0 112.073 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.495 ' H ' ' HH ' ' A' ' 24' ' ' TYR . 74.4 mmt-85 -86.55 165.99 15.79 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.881 0.848 . . . . 0.0 110.671 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.66 -6.06 58.42 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.02 176.72 25.01 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -63.39 -37.14 86.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.922 -0.752 . . . . 0.0 109.25 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.69 -20.67 62.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.566 -0.709 . . . . 0.0 109.207 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -72.32 -48.67 40.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.634 -0.666 . . . . 0.0 109.741 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 14.3 pt -61.84 -41.18 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.623 -0.673 . . . . 0.0 109.869 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 12.0 mt -65.41 -40.28 93.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.577 -0.702 . . . . 0.0 109.721 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' OE1' ' O ' ' A' ' 93' ' ' HIS . 12.3 tm-20 -67.65 -38.95 84.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.795 -0.566 . . . . 0.0 109.813 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.413 ' O ' ' OE1' ' A' ' 92' ' ' GLU . 15.8 t-80 64.03 138.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.724 0.773 . . . . 0.0 109.969 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -59.12 -42.51 90.75 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -102.43 166.58 10.47 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.787 0.804 . . . . 0.0 110.053 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.43 ' ND1' ' O ' ' A' ' 96' ' ' HIS . 62.8 t-80 59.76 50.43 7.08 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.6 0.714 . . . . 0.0 109.314 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.672 ' CE1' ' HD1' ' A' ' 98' ' ' HIS . 51.9 p-80 -81.09 -12.54 59.25 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.672 ' HD1' ' CE1' ' A' ' 97' ' ' HIS . 53.7 p-80 . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.654 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.1 -46.58 89.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.783 . . . . 0.0 109.91 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -63.04 -43.48 98.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.528 -0.732 . . . . 0.0 109.62 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -64.3 -42.25 96.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.695 -0.628 . . . . 0.0 110.08 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.74 -37.91 85.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.458 -0.776 . . . . 0.0 110.195 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.554 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 48.9 tp60 -62.93 -42.59 99.85 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -63.71 -40.38 96.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.472 -0.768 . . . . 0.0 109.369 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -63.4 -41.51 98.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.537 -0.727 . . . . 0.0 110.085 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -61.38 -42.05 98.09 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.508 -0.745 . . . . 0.0 109.847 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.01 -40.89 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.433 -0.792 . . . . 0.0 109.267 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 m -59.69 -43.46 94.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.642 -0.661 . . . . 0.0 109.247 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.24 -41.43 98.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.509 -0.744 . . . . 0.0 109.831 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.524 ' OH ' ' CE1' ' A' ' 70' ' ' PHE . 90.1 t80 -60.28 -49.11 78.92 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.3 mt -68.18 -41.2 81.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.634 -0.666 . . . . 0.0 110.641 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -65.05 -43.33 92.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.405 -0.809 . . . . 0.0 110.442 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -80.28 -15.94 55.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.386 -0.821 . . . . 0.0 110.456 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.506 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 8.3 m120 -104.2 -10.24 18.06 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.258 -0.901 . . . . 0.0 108.88 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 mt -144.11 88.11 7.63 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.516 ' C ' ' H ' ' A' ' 32' ' ' PHE . 53.2 Cg_exo -53.63 -30.89 57.51 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.51 2.14 . . . . 0.0 111.271 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -72.66 13.09 0.4 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.516 ' H ' ' C ' ' A' ' 30' ' ' PRO . 29.1 t80 -61.22 130.38 45.95 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.689 0.757 . . . . 0.0 110.236 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -118.96 -61.52 1.63 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 t -146.12 164.54 31.85 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.515 0.674 . . . . 0.0 109.935 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.5 138.16 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.544 0.688 . . . . 0.0 109.624 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.2 m -126.76 115.24 19.07 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.66 0.743 . . . . 0.0 109.551 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -94.08 126.61 39.41 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.759 0.79 . . . . 0.0 109.563 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.34 86.1 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -177.43 -64.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 41.38 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.592 -0.693 . . . . 0.0 110.053 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -122.4 147.34 46.42 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.996 0.903 . . . . 0.0 110.034 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.528 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 53.0 p90 -88.81 120.24 30.03 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.503 0.668 . . . . 0.0 109.736 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -107.41 154.74 40.48 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -46.38 -40.76 22.77 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.504 2.136 . . . . 0.0 111.907 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.4 tt -70.02 -38.93 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.76 . . . . 0.0 109.615 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.25 -107.66 0.25 Allowed Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -121.23 143.81 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.626 -0.926 . . . . 0.0 110.17 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.0 t -119.26 134.91 54.95 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.653 0.739 . . . . 0.0 110.09 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.16 129.42 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.681 0.753 . . . . 0.0 109.359 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.5 t0 -133.49 142.4 48.23 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.831 0.824 . . . . 0.0 109.687 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -173.5 -165.16 29.89 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -142.39 165.09 28.38 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.678 -0.895 . . . . 0.0 110.274 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.5 pt -122.42 167.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.934 0.873 . . . . 0.0 110.725 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' ASP . 69.1 m-80 57.31 34.25 24.46 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.662 0.744 . . . . 0.0 109.441 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 44.56 24.44 0.1 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 54' ' ' ASN . 99.5 m-20 -108.17 111.1 22.93 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.668 0.747 . . . . 0.0 109.293 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.536 ' CB ' ' HZ2' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -59.22 -31.58 69.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.727 -0.608 . . . . 0.0 110.102 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -61.96 -38.77 89.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.45 -0.781 . . . . 0.0 109.495 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -82.74 75.26 9.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.474 -0.766 . . . . 0.0 109.534 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 m -95.85 156.13 16.46 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.922 0.867 . . . . 0.0 110.397 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -147.12 157.03 43.47 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.628 0.728 . . . . 0.0 109.923 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.1 m -141.29 138.87 33.49 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.692 -0.63 . . . . 0.0 109.873 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.94 144.62 31.16 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.649 0.737 . . . . 0.0 109.528 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -98.24 128.7 9.65 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.554 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 15.1 ptmt 24.76 -114.18 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.461 0.648 . . . . 0.0 111.238 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 68' ' ' LYS . 67.2 t0 -71.54 66.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.158 0.98 . . . . 0.0 109.955 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 50.43 12.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.545 0.688 . . . . 0.0 109.455 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 66' ' ' ASP . 68.7 mmtt -61.43 115.57 3.99 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 122.051 0.929 . . . . 0.0 109.82 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.6 mt 55.16 115.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.87 0.843 . . . . 0.0 109.883 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.524 ' CE1' ' OH ' ' A' ' 24' ' ' TYR . 47.2 p90 -139.26 153.9 47.88 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.877 0.846 . . . . 0.0 110.203 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 p -141.74 160.86 39.32 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.621 0.724 . . . . 0.0 109.47 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.2 m -145.68 155.21 42.85 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.977 0.894 . . . . 0.0 110.414 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -65.88 163.03 17.78 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.943 0.878 . . . . 0.0 110.371 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.1 mp0 -58.5 -48.9 79.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.545 -0.722 . . . . 0.0 109.743 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mp0 -64.54 -42.04 95.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.622 -0.674 . . . . 0.0 110.066 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.17 -38.76 85.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.595 -0.691 . . . . 0.0 110.034 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -63.32 -33.67 76.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.411 -0.806 . . . . 0.0 109.402 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.01 -12.32 60.88 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.38 -0.825 . . . . 0.0 109.973 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.7 mtp -85.09 -8.21 58.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.26 -0.9 . . . . 0.0 109.38 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -63.64 135.91 57.11 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.591 0.71 . . . . 0.0 110.006 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -111.9 -25.04 9.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -120.13 153.7 55.54 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.75 179.63 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.982 2.455 . . . . 0.0 113.094 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.46 ' NH1' ' CZ ' ' A' ' 70' ' ' PHE . 95.5 mtt-85 -63.86 126.72 28.54 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.067 0.937 . . . . 0.0 110.597 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -136.88 147.51 46.52 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.734 0.778 . . . . 0.0 109.911 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.88 164.44 44.67 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.8 t80 -61.5 -44.0 97.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.804 -0.821 . . . . 0.0 109.133 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -70.13 -31.11 68.49 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.476 -0.765 . . . . 0.0 109.803 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.86 -45.51 77.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.415 HD12 HG22 ' A' ' 90' ' ' ILE . 28.8 pt -66.16 -35.91 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.43 -0.794 . . . . 0.0 109.57 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.36 -42.41 98.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -79.38 -32.02 42.99 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.465 ' HD1' ' N ' ' A' ' 94' ' ' HIS . 56.5 t-80 60.2 -94.34 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.499 0.666 . . . . 0.0 110.684 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.465 ' N ' ' HD1' ' A' ' 93' ' ' HIS . 14.4 m-70 46.25 -167.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.888 0.852 . . . . 0.0 110.809 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -76.35 131.56 39.24 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.757 0.789 . . . . 0.0 110.359 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -64.04 -10.35 21.52 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -65.66 -40.37 92.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.529 -0.732 . . . . 0.0 109.354 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.503 ' O ' ' CG ' ' A' ' 98' ' ' HIS . 86.3 t60 . . . . . 0 N--CA 1.5 2.069 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.037 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.46 0.648 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.524 ' CZ ' ' NE2' ' A' ' 17' ' ' GLN . 91.3 t80 -62.51 -24.22 67.37 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.645 0.736 . . . . 0.0 109.242 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -65.31 -36.64 84.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.512 -0.742 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.53 -41.33 98.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.148 -0.97 . . . . 0.0 109.838 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.62 -39.97 88.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.58 -0.7 . . . . 0.0 110.445 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.524 ' NE2' ' CZ ' ' A' ' 13' ' ' PHE . 96.6 mm-40 -64.78 -40.72 95.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 109.897 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.04 -40.99 97.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.71 -41.83 98.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.861 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -64.1 -42.43 96.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.745 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.9 -43.08 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.444 -0.785 . . . . 0.0 109.619 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.8 m -61.29 -44.65 96.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.497 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.1 tp -62.88 -42.81 99.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.367 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.507 ' CE1' ' OD1' ' A' ' 28' ' ' ASN . 58.7 t80 -61.05 -47.85 84.46 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.492 0.663 . . . . 0.0 109.712 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.01 -39.6 93.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -0.791 . . . . 0.0 109.703 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -59.75 -45.51 92.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.877 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.419 ' O ' ' OE1' ' A' ' 82' ' ' GLU . 32.9 m-70 -74.47 -32.78 62.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.826 . . . . 0.0 109.757 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.507 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 32.1 m120 -87.19 -2.9 58.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.379 -0.826 . . . . 0.0 109.608 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.4 mt -146.76 89.85 5.63 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.229 -0.919 . . . . 0.0 109.034 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -55.38 -30.19 71.77 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.454 2.103 . . . . 0.0 111.34 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -84.98 16.15 3.59 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 21.8 t80 -57.57 128.99 39.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.493 -0.755 . . . . 0.0 110.463 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.456 ' ND2' ' OD1' ' A' ' 54' ' ' ASN . 99.9 m-20 -113.8 -64.96 1.24 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.562 0.696 . . . . 0.0 109.331 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -150.82 158.73 44.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.752 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.13 135.53 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.586 -0.696 . . . . 0.0 109.425 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -124.64 123.8 40.83 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.661 0.743 . . . . 0.0 109.368 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -96.31 137.54 35.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.647 -0.658 . . . . 0.0 109.241 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.6 p -147.12 -35.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 108.805 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -103.41 145.45 29.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.28 -0.887 . . . . 0.0 110.356 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -169.05 143.94 3.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.377 -0.827 . . . . 0.0 109.623 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -139.07 151.8 47.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.443 -0.786 . . . . 0.0 109.321 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -90.59 118.84 30.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.233 -0.917 . . . . 0.0 109.903 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.5 OUTLIER -90.43 158.07 43.77 Favored Pre-proline 0 C--N 1.306 -1.326 0 O-C-N 121.5 -0.75 . . . . 0.0 109.975 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.23 -27.12 41.48 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 123.099 2.532 . . . . 0.0 110.417 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -102.56 -8.23 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 171.06 -144.42 8.26 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.404 ' HA ' ' H ' ' A' ' 43' ' ' ASN . 42.0 pt -124.82 152.31 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.558 -0.966 . . . . 0.0 109.485 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.4 m -117.43 127.45 54.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.435 HD12 HG21 ' A' ' 49' ' ' ILE . 96.7 mt -111.74 130.36 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.619 0.723 . . . . 0.0 109.36 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -130.06 125.84 36.2 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.588 0.709 . . . . 0.0 109.225 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.31 -161.46 10.36 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -144.15 160.88 40.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.983 . . . . 0.0 109.874 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.6 pt -119.76 167.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-O 121.601 0.715 . . . . 0.0 110.728 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.456 ' OD1' ' ND2' ' A' ' 33' ' ' ASN . 66.4 m-80 59.11 32.92 22.56 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.629 0.728 . . . . 0.0 109.55 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 46.87 32.23 1.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.51 -0.744 . . . . 0.0 109.564 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -126.99 103.93 7.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.604 -0.685 . . . . 0.0 109.321 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -56.12 -17.13 6.32 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.416 0.627 . . . . 0.0 109.543 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -63.9 -38.32 90.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.35 -0.844 . . . . 0.0 108.889 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.5 mt -88.24 73.91 8.82 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.2 m -87.92 154.75 20.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.821 0.82 . . . . 0.0 110.771 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -147.62 158.82 44.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.722 -0.612 . . . . 0.0 109.587 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.2 m -134.11 136.53 43.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.771 . . . . 0.0 109.706 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.49 141.07 48.62 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 67' ' ' VAL . . . -97.93 115.71 5.34 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 64' ' ' GLY . 88.6 tttt 26.06 -95.17 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.389 0.614 . . . . 0.0 111.795 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -85.71 45.31 1.19 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.356 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 64' ' ' GLY . 2.1 t 51.93 35.3 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.164 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -62.83 -41.32 99.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.825 . . . . 0.0 109.008 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.0 tp -127.57 136.32 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -126.46 129.78 49.37 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.645 0.736 . . . . 0.0 109.835 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 t -137.3 149.06 46.81 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.2 p -138.89 157.04 46.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 0.0 110.357 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.0 p -76.02 171.12 15.0 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.866 0.841 . . . . 0.0 110.758 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -59.37 -41.01 88.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.681 -0.637 . . . . 0.0 109.947 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.45 -48.79 59.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.958 . . . . 0.0 109.886 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.69 -22.06 66.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.34 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -62.41 -36.18 81.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.559 -0.713 . . . . 0.0 110.077 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -62.68 -45.06 94.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 0.0 110.53 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 98.6 mtp -68.74 -38.03 79.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.09 -1.006 . . . . 0.0 109.482 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.512 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 72.4 t80 -75.68 119.39 19.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 110.03 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.401 ' NE2' ' O ' ' A' ' 80' ' ' PHE . 99.6 mm-40 -142.93 2.19 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 47.9 mt-10 -102.66 130.12 24.54 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.471 -0.768 . . . . 0.0 109.561 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -47.41 140.78 15.2 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.473 2.115 . . . . 0.0 113.151 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -76.97 140.07 40.32 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.6 0.714 . . . . 0.0 110.256 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -137.66 147.96 45.34 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.732 0.777 . . . . 0.0 109.698 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.47 161.15 12.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -62.46 -42.48 99.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.795 -0.827 . . . . 0.0 109.194 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 34.5 p-10 -68.54 -31.18 70.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.442 -0.786 . . . . 0.0 109.757 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 80.1 mm-40 -64.58 -48.6 74.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.451 -0.781 . . . . 0.0 109.848 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 91' ' ' LEU . 25.9 pt -68.18 -37.69 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.442 -0.786 . . . . 0.0 109.196 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.406 ' N ' HG13 ' A' ' 90' ' ' ILE . 57.9 tp -63.47 -41.94 98.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 94' ' ' HIS . 79.6 tt0 -82.82 -18.65 39.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.226 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 94' ' ' HIS . 46.1 m-70 67.89 -40.6 0.42 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.914 -0.491 . . . . 0.0 110.014 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.488 ' H ' ' C ' ' A' ' 92' ' ' GLU . 50.0 t-80 38.26 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.723 0.773 . . . . 0.0 110.58 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -149.44 7.86 0.69 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.414 ' O ' ' CG ' ' A' ' 96' ' ' HIS . 1.9 t60 42.56 44.44 3.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.542 -0.724 . . . . 0.0 110.203 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 55.46 172.01 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.674 0.749 . . . . 0.0 110.665 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.638 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.431 0.634 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.403 ' O ' ' OE1' ' A' ' 17' ' ' GLN . 79.2 t80 -61.0 -44.83 96.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.777 -0.577 . . . . 0.0 109.564 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -64.27 -40.1 95.3 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.351 0.596 . . . . 0.0 109.86 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -62.59 -40.72 97.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.676 -0.64 . . . . 0.0 109.931 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.6 -38.75 87.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.518 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 1.5 mp0 -64.09 -40.49 96.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.524 -0.735 . . . . 0.0 109.557 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -64.66 -40.21 95.03 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.249 0.547 . . . . 0.0 109.956 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -65.62 -41.01 93.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.705 -0.622 . . . . 0.0 110.052 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.517 ' NZ ' ' CE2' ' A' ' 87' ' ' TYR . 68.2 mttm -63.08 -44.29 96.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.605 -0.684 . . . . 0.0 110.101 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.48 -44.12 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.653 -0.654 . . . . 0.0 109.984 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.1 m -63.58 -43.8 95.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.574 -0.704 . . . . 0.0 109.841 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.7 -43.16 99.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.724 -0.61 . . . . 0.0 110.317 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.482 ' CE1' ' OD1' ' A' ' 28' ' ' ASN . 66.8 t80 -62.35 -47.83 82.5 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.335 0.588 . . . . 0.0 109.803 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.46 -41.45 96.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.616 -0.678 . . . . 0.0 109.895 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.17 -43.98 92.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.769 -0.582 . . . . 0.0 109.931 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -68.66 -37.88 79.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.751 -0.593 . . . . 0.0 110.236 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.482 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 9.3 m120 -90.79 -0.71 57.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.4 -0.812 . . . . 0.0 109.322 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.4 mt -143.81 83.6 10.37 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 109.035 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -54.88 -26.64 49.51 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.664 2.243 . . . . 0.0 111.284 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -78.38 0.36 25.96 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -59.0 129.14 40.75 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.723 0.773 . . . . 0.0 110.128 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -123.84 -57.82 1.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -147.49 155.58 42.03 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.73 0.776 . . . . 0.0 110.151 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.39 140.43 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.434 0.635 . . . . 0.0 109.41 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.9 m -128.67 125.9 39.02 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.898 0.856 . . . . 0.0 110.133 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -93.76 134.58 35.95 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 t -172.9 55.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.662 -0.649 . . . . 0.0 109.447 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' GLU . 24.3 t-20 -173.31 133.68 0.51 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.556 -0.715 . . . . 0.0 110.417 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' ASN . 96.9 mt-10 58.21 140.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.755 0.788 . . . . 0.0 110.683 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -144.54 -90.34 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.652 -0.655 . . . . 0.0 109.476 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -75.19 147.36 40.46 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.853 0.835 . . . . 0.0 110.243 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -173.96 168.1 2.26 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.529 ' C ' ' H ' ' A' ' 46' ' ' GLY . 52.3 Cg_exo -50.91 -39.43 58.88 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.436 2.091 . . . . 0.0 111.814 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.5 pt -76.51 28.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.518 0.675 . . . . 0.0 109.195 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 81.82 -99.42 2.0 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.9 pt -119.85 144.14 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.859 0.838 . . . . 0.0 109.948 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.7 m -119.66 122.44 41.51 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.695 0.759 . . . . 0.0 109.831 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.02 125.89 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.929 0.871 . . . . 0.0 109.382 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.6 t0 -142.9 139.85 30.95 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.01 0.91 . . . . 0.0 109.832 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -167.22 -162.62 19.37 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -140.46 161.72 37.05 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.908 -0.76 . . . . 0.0 110.628 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 pt -118.73 156.6 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 121.959 0.885 . . . . 0.0 110.689 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 56.3 33.89 23.09 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.048 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 47.95 32.68 2.94 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.17 0.51 . . . . 0.0 110.0 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -111.79 109.65 19.6 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.72 0.771 . . . . 0.0 109.317 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -57.28 -34.51 68.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.905 -0.497 . . . . 0.0 109.98 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.57 -39.25 93.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.599 -0.688 . . . . 0.0 109.742 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.8 76.95 9.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.511 -0.743 . . . . 0.0 109.583 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.8 p -112.5 156.59 22.35 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.817 0.818 . . . . 0.0 110.478 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.404 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 32.1 p90 -150.49 158.45 44.17 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.461 0.648 . . . . 0.0 109.595 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.9 m -136.08 132.15 35.78 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.683 0.754 . . . . 0.0 110.135 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.07 140.95 42.37 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.832 0.825 . . . . 0.0 109.617 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 65' ' ' LYS . . . -109.08 140.2 15.55 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 64' ' ' GLY . 53.6 mtpt 40.46 100.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.298 0.57 . . . . 0.0 110.598 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.504 ' OD1' ' NE2' ' A' ' 17' ' ' GLN . 99.0 m-20 57.93 -88.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.404 0.621 . . . . 0.0 109.712 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.79 13.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 69' ' ' ILE . 68.5 mttm -70.51 131.45 44.04 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.872 0.844 . . . . 0.0 109.859 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.4 mt 52.59 103.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.645 0.736 . . . . 0.0 109.41 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -138.25 153.86 49.09 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.891 0.853 . . . . 0.0 110.29 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.1 t -136.87 151.02 48.62 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.76 0.79 . . . . 0.0 109.614 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.446 ' HG ' ' N ' ' A' ' 73' ' ' SER . 38.2 t -134.66 150.18 50.61 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.822 0.82 . . . . 0.0 110.101 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.446 ' N ' ' HG ' ' A' ' 72' ' ' SER . 23.0 p -75.89 166.8 22.98 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.883 0.849 . . . . 0.0 110.221 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.66 -45.39 92.19 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.215 0.531 . . . . 0.0 109.639 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.432 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.5 mp0 -65.28 -45.71 83.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.644 -0.66 . . . . 0.0 109.657 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.6 tp -69.0 -28.94 67.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.83 -36.4 83.38 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 109.407 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -75.68 -7.54 54.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.449 -0.782 . . . . 0.0 109.914 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 77.0 mtp -82.42 -8.79 59.62 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -69.1 138.5 54.35 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.62 0.724 . . . . 0.0 109.464 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -128.04 -45.45 1.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.49 154.96 39.58 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.626 -0.671 . . . . 0.0 109.581 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -53.31 145.55 44.39 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.363 2.042 . . . . 0.0 112.649 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -77.36 138.01 39.07 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.781 0.8 . . . . 0.0 109.969 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.86 150.47 47.17 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.858 0.837 . . . . 0.0 110.116 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.1 163.4 25.68 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.517 ' CE2' ' NZ ' ' A' ' 20' ' ' LYS . 78.5 t80 -60.57 -44.7 95.9 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.6 0.714 . . . . 0.0 109.681 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 36.6 p-10 -68.43 -32.87 73.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.572 -0.705 . . . . 0.0 109.902 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 79.8 mm-40 -66.78 -45.34 78.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.664 -0.647 . . . . 0.0 110.447 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.6 pt -65.92 -35.52 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.512 -0.742 . . . . 0.0 109.631 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.522 ' O ' ' ND1' ' A' ' 93' ' ' HIS . 34.3 mt -63.02 -42.13 99.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.553 -0.717 . . . . 0.0 109.748 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.502 ' O ' ' CG ' ' A' ' 93' ' ' HIS . 80.3 mm-40 -69.82 -40.48 75.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' A' ' 91' ' ' LEU . 20.9 p-80 40.06 -163.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.386 0.612 . . . . 0.0 110.773 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 94' ' ' HIS . 56.4 p-80 -118.56 119.45 34.55 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.715 0.769 . . . . 0.0 109.801 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -127.87 121.35 29.81 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.692 0.758 . . . . 0.0 109.78 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -113.36 108.74 17.64 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.898 0.856 . . . . 0.0 109.58 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -67.74 -43.79 79.11 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.728 -179.423 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -62.8 -42.6 99.78 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.538 -0.726 . . . . 0.0 110.132 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -62.86 -42.2 99.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.643 -0.661 . . . . 0.0 109.931 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.21 -40.45 97.51 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.368 0.604 . . . . 0.0 109.696 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.41 -39.23 85.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.674 -0.641 . . . . 0.0 109.587 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -63.38 -39.71 95.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.383 -0.823 . . . . 0.0 108.946 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -62.66 -42.12 99.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.825 -0.547 . . . . 0.0 110.017 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -66.88 -39.74 87.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.628 -0.67 . . . . 0.0 109.546 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.8 -43.54 96.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.752 -0.592 . . . . 0.0 109.541 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.4 t -65.39 -42.83 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.841 -0.537 . . . . 0.0 109.577 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -59.74 -45.25 92.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.708 . . . . 0.0 109.263 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.94 -42.3 97.37 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.422 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 64.9 t80 -61.9 -46.92 87.27 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.46 ' CD2' ' CE2' ' A' ' 61' ' ' PHE . 92.6 mt -64.73 -39.3 93.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.564 -0.71 . . . . 0.0 109.883 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -60.72 -44.41 96.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.66 -0.65 . . . . 0.0 109.628 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.476 ' HD1' ' NH2' ' A' ' 84' ' ' ARG . 13.4 m170 -69.06 -41.98 76.87 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.658 -0.651 . . . . 0.0 110.186 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.422 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 44.2 m-80 -65.02 -41.36 95.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.432 -0.792 . . . . 0.0 109.338 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.7 mt -114.36 115.28 44.94 Favored Pre-proline 0 N--CA 1.485 1.307 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.5 -17.61 23.5 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.286 1.991 . . . . 0.0 110.652 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -95.87 8.87 42.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 34.9 t80 -51.65 126.85 18.8 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.82 0.819 . . . . 0.0 109.888 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -113.35 -65.88 1.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -147.17 160.56 42.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.591 -0.693 . . . . 0.0 110.319 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.9 p -140.16 139.73 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.4 0.619 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -129.21 125.66 37.44 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.558 0.694 . . . . 0.0 109.318 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 49' ' ' ILE . 59.2 m-85 -91.4 142.88 27.2 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.653 0.74 . . . . 0.0 109.732 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.461 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -173.28 123.12 0.39 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.721 -0.612 . . . . 0.0 109.647 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 38' ' ' THR . 1.1 m120 82.22 157.22 0.13 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.911 0.862 . . . . 0.0 110.983 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 69.53 101.38 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.58 0.705 . . . . 0.0 109.733 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -144.12 -22.08 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -115.85 133.69 55.77 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.77 0.795 . . . . 0.0 110.108 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -170.57 154.98 4.77 Favored Pre-proline 0 N--CA 1.487 1.404 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.48 ' C ' ' H ' ' A' ' 46' ' ' GLY . 71.4 Cg_exo -44.85 -36.55 11.01 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.37 2.047 . . . . 0.0 112.034 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 mt -78.93 34.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.811 0.815 . . . . 0.0 109.028 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 80.33 -106.42 2.49 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 46.3 pt -118.31 149.65 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.652 0.739 . . . . 0.0 109.675 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.9 m -127.96 155.25 44.55 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.799 0.809 . . . . 0.0 110.457 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 96.7 mt -122.92 125.51 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.555 0.693 . . . . 0.0 109.395 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -128.69 130.54 47.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.67 0.748 . . . . 0.0 109.598 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.01 -163.14 13.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -143.11 162.5 35.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.748 -0.854 . . . . 0.0 109.685 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 pt -122.54 162.43 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.805 0.812 . . . . 0.0 110.438 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.83 30.65 19.36 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.432 0.634 . . . . 0.0 109.736 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 48.89 33.02 4.1 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.39 0.614 . . . . 0.0 109.624 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -112.9 111.17 21.73 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.416 0.627 . . . . 0.0 109.501 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -59.09 -33.02 70.34 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -62.47 -39.29 92.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.9 mt -84.52 83.03 8.15 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.408 0.623 . . . . 0.0 109.764 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.2 p -95.9 148.32 22.74 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.433 0.635 . . . . 0.0 110.069 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.46 ' CE2' ' CD2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -131.75 136.9 47.95 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.48 0.657 . . . . 0.0 109.985 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.8 m -128.42 129.73 46.6 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.731 0.777 . . . . 0.0 110.061 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.29 149.22 40.97 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.674 0.75 . . . . 0.0 109.376 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -90.8 135.61 12.94 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 39.84 -109.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.402 0.62 . . . . 0.0 110.579 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' CG ' ' H ' ' A' ' 67' ' ' VAL . 20.1 p-10 -82.15 -67.15 0.81 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.682 -0.636 . . . . 0.0 109.682 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.569 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 2.7 t -146.19 11.83 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.732 . . . . 0.0 109.032 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 69' ' ' ILE . 88.8 tttt -65.77 117.93 8.9 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.291 -0.881 . . . . 0.0 110.414 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.0 mt 56.94 125.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.793 0.806 . . . . 0.0 110.016 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -139.07 129.83 26.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.419 -0.801 . . . . 0.0 110.387 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.7 m -126.83 154.57 44.15 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.582 0.706 . . . . 0.0 109.412 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.9 p -153.11 163.97 38.89 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.751 0.786 . . . . 0.0 110.46 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -67.98 163.87 21.24 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.817 0.817 . . . . 0.0 110.158 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -57.8 -48.82 78.61 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.759 -0.588 . . . . 0.0 109.584 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.25 -40.73 98.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.773 -0.579 . . . . 0.0 109.674 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.0 tp -76.42 -22.58 54.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.525 -0.734 . . . . 0.0 110.252 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -72.06 -36.66 69.64 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.443 -0.785 . . . . 0.0 109.402 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -79.1 -8.01 58.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.586 -0.696 . . . . 0.0 110.334 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.4 mmm -63.89 -42.31 97.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.352 -0.842 . . . . 0.0 109.691 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.497 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 31.0 p90 -102.33 125.66 49.11 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.756 0.789 . . . . 0.0 109.72 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -97.68 -6.72 32.48 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -133.66 83.97 46.43 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.485 -0.759 . . . . 0.0 109.445 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.81 138.13 76.26 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 123.04 2.494 . . . . 0.0 112.97 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.476 ' NH2' ' HD1' ' A' ' 27' ' ' HIS . 21.0 mmm180 -99.04 162.97 12.77 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.606 0.717 . . . . 0.0 110.358 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -91.04 -131.64 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.31 0.576 . . . . 0.0 111.281 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.42 170.27 50.36 Favored Glycine 0 N--CA 1.498 2.803 0 CA-C-O 122.061 0.812 . . . . 0.0 111.971 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -61.76 -43.12 99.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.945 -0.738 . . . . 0.0 110.436 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.56 -38.76 92.35 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.447 -0.783 . . . . 0.0 109.635 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -60.84 -50.04 75.04 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.811 -0.556 . . . . 0.0 109.91 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 27.7 pt -69.24 -30.06 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.331 -0.856 . . . . 0.0 109.398 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.5 tp -64.24 -42.52 96.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.14 -37.74 84.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -95.91 111.81 23.7 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.772 0.796 . . . . 0.0 109.891 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.618 ' HD1' ' N ' ' A' ' 96' ' ' HIS . 59.1 t-80 -148.68 143.02 26.21 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.613 0.72 . . . . 0.0 110.167 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.499 ' O ' ' NE2' ' A' ' 97' ' ' HIS . 75.5 m80 -98.62 45.07 1.01 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.356 0.598 . . . . 0.0 109.395 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.618 ' N ' ' HD1' ' A' ' 94' ' ' HIS . 53.6 t-80 -62.61 -84.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.56 -0.713 . . . . 0.0 109.518 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 96' ' ' HIS . 21.8 p80 41.48 -166.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.739 0.78 . . . . 0.0 110.745 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.4 t60 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.648 -179.215 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.719 0.771 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -62.86 -33.59 75.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.557 0.694 . . . . 0.0 109.328 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -61.79 -33.32 73.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.495 -0.753 . . . . 0.0 109.632 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.71 -40.75 98.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.497 -0.752 . . . . 0.0 109.576 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.71 -39.61 88.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.483 -0.761 . . . . 0.0 109.628 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.45 -39.03 93.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.433 -0.792 . . . . 0.0 109.578 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -63.42 -41.47 98.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.588 0.709 . . . . 0.0 109.49 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -65.81 -42.4 90.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.626 -0.671 . . . . 0.0 109.975 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -63.66 -44.57 93.4 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.793 0.806 . . . . 0.0 110.036 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.21 -41.33 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.579 -0.701 . . . . 0.0 109.848 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -55.78 -46.22 77.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.478 -0.764 . . . . 0.0 110.029 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.6 tp -64.29 -42.4 96.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.551 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.621 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 89.1 t80 -59.96 -44.18 94.6 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.728 0.775 . . . . 0.0 109.317 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.85 -43.05 99.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.586 -0.696 . . . . 0.0 110.349 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.41 -43.44 97.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 0.0 110.537 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.419 ' CG ' ' CD1' ' A' ' 90' ' ' ILE . 33.8 m-70 -75.34 -32.11 60.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 110.992 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.621 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 29.3 m-80 -89.25 -6.94 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.102 -0.998 . . . . 0.0 109.47 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.3 mt -137.41 105.51 8.5 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.585 -0.697 . . . . 0.0 109.15 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.99 -16.49 32.38 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.436 2.09 . . . . 0.0 111.782 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -95.96 11.42 34.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.519 -0.738 . . . . 0.0 109.419 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -56.67 132.68 52.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.3 -0.875 . . . . 0.0 109.818 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -133.46 -48.69 0.83 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -148.31 154.71 40.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.293 -0.879 . . . . 0.0 110.219 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.89 137.13 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.307 0.575 . . . . 0.0 109.557 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -128.41 121.86 30.03 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.588 0.708 . . . . 0.0 109.162 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -97.39 122.83 40.89 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.6 p -106.37 -22.39 12.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.709 -0.619 . . . . 0.0 109.68 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -110.49 145.76 37.14 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.296 -0.878 . . . . 0.0 110.561 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -166.02 80.49 0.28 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -153.5 -161.91 1.36 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.429 -0.795 . . . . 0.0 109.777 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.478 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 54.3 p90 -102.47 127.34 49.55 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.596 0.712 . . . . 0.0 109.953 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -96.97 164.63 17.49 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.719 -0.613 . . . . 0.0 109.457 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.3 -39.96 62.02 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.36 2.04 . . . . 0.0 111.584 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 45' ' ' ILE . 97.0 mt -81.73 -4.08 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.557 -0.714 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 137.92 -104.7 0.46 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.4 pt -127.37 133.78 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.876 . . . . 0.0 109.879 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.7 m -138.77 149.08 44.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.587 -0.695 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.417 HD11 HG21 ' A' ' 49' ' ' ILE . 96.7 mt -125.58 133.74 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 33.0 t0 -127.73 147.27 50.4 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.588 0.708 . . . . 0.0 109.9 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -175.76 -165.57 31.91 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -144.11 164.53 30.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.768 -0.842 . . . . 0.0 109.77 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.1 pt -124.6 164.67 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.862 0.839 . . . . 0.0 111.344 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 58.43 32.38 22.03 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.643 0.735 . . . . 0.0 110.191 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.0 m120 48.89 29.84 2.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.639 -0.663 . . . . 0.0 109.838 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.49 111.74 22.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.448 -0.783 . . . . 0.0 109.988 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -58.88 -32.26 69.33 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.56 0.695 . . . . 0.0 109.441 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.57 -39.38 93.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.461 -0.774 . . . . 0.0 109.621 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.1 mt -82.03 78.94 8.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.533 -0.73 . . . . 0.0 109.81 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.6 t -104.39 155.16 19.02 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.656 0.741 . . . . 0.0 110.011 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -150.2 158.37 44.09 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.56 0.695 . . . . 0.0 109.825 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.7 m -134.17 138.7 45.34 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.87 135.29 48.2 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.589 0.709 . . . . 0.0 109.596 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.5 137.95 14.62 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 67' ' ' VAL . 29.3 mmtp 40.37 -161.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.489 0.661 . . . . 0.0 111.12 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 68' ' ' LYS . 93.8 m-20 -59.2 77.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.935 0.874 . . . . 0.0 109.782 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 65' ' ' LYS . 2.0 t 41.68 24.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.659 0.742 . . . . 0.0 109.853 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 66' ' ' ASP . 28.6 tptp -64.06 -44.23 93.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.2 mt -121.13 128.46 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -132.74 129.84 39.2 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.492 0.663 . . . . 0.0 109.628 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.5 m -130.48 152.29 50.04 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 p -143.0 155.46 44.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.742 0.782 . . . . 0.0 110.509 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 77' ' ' ASP . 18.6 p -74.73 168.78 19.17 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.772 0.796 . . . . 0.0 110.719 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -59.93 -43.07 95.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.753 -0.592 . . . . 0.0 110.167 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -65.94 -36.18 82.64 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.71 0.767 . . . . 0.0 109.558 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.5 tp -85.01 -21.02 29.63 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.926 0.87 . . . . 0.0 109.035 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 73' ' ' SER . 29.9 t70 -66.86 -44.54 80.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.538 -0.726 . . . . 0.0 110.084 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -71.68 -18.4 62.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 110.033 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.75 -62.37 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.44 -0.788 . . . . 0.0 109.966 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -71.72 138.62 48.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.602 -0.686 . . . . 0.0 110.519 -178.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -137.52 40.26 2.42 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -115.39 150.83 45.2 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.333 -0.855 . . . . 0.0 109.412 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.46 156.22 66.4 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.695 2.264 . . . . 0.0 112.465 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -69.93 132.74 46.44 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.808 0.813 . . . . 0.0 110.033 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -155.21 145.68 22.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.591 0.71 . . . . 0.0 109.47 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.39 168.14 51.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -62.45 -45.24 93.97 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.676 0.75 . . . . 0.0 109.7 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 47.7 p-10 -64.96 -33.39 75.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 109.687 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.551 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 14.4 tm-20 -62.98 -51.87 65.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.627 -0.671 . . . . 0.0 109.953 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.419 ' CD1' ' CG ' ' A' ' 27' ' ' HIS . 9.9 tt -67.82 -29.6 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.92 -44.04 97.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.505 -0.747 . . . . 0.0 109.703 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' A' ' 93' ' ' HIS . 22.3 pt-20 -90.0 -33.21 16.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.959 0.885 . . . . 0.0 108.941 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.621 ' ND1' ' CE1' ' A' ' 95' ' ' HIS . 17.3 t-80 42.53 95.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.915 0.864 . . . . 0.0 110.12 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -66.25 -25.18 66.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.724 -0.61 . . . . 0.0 109.877 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.621 ' CE1' ' ND1' ' A' ' 93' ' ' HIS . 96.2 m-70 58.05 87.88 0.07 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.888 0.851 . . . . 0.0 109.975 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -66.88 -40.54 87.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.585 -0.697 . . . . 0.0 109.548 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -152.83 -33.51 0.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.827 -1.082 . . . . 0.0 109.989 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.354 0.597 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.471 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 91.3 m-85 -63.15 -28.77 70.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.516 -0.74 . . . . 0.0 109.882 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -58.67 -34.96 71.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.435 -0.79 . . . . 0.0 109.48 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -62.37 -40.34 96.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.53 -39.26 91.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.572 -0.705 . . . . 0.0 109.831 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -65.73 -39.83 91.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.582 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.85 -40.42 96.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.423 -0.798 . . . . 0.0 109.893 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.68 -41.95 98.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -0.839 . . . . 0.0 109.809 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.1 -41.97 97.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.389 -0.82 . . . . 0.0 110.159 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.03 -42.87 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.724 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.9 m -60.96 -44.49 97.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.872 . . . . 0.0 109.93 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.56 -42.94 99.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.663 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 57.2 t80 -61.0 -42.79 99.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.56 -0.712 . . . . 0.0 109.763 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' ILE . 86.3 mt -62.77 -41.93 99.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.9 -40.28 94.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.327 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -65.85 -40.32 91.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.408 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.577 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 99.3 m-20 -93.73 -4.75 49.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.56 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 25' ' ' LEU . 8.7 mt -143.45 91.23 6.93 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -71.16 -16.67 31.76 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.447 2.098 . . . . 0.0 111.812 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -92.46 4.22 53.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.536 -0.728 . . . . 0.0 109.183 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -50.08 137.84 16.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.063 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -111.59 -63.35 1.43 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.749 -0.594 . . . . 0.0 109.891 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.523 ' HG1' ' N ' ' A' ' 35' ' ' VAL . 4.4 t -149.52 156.77 42.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.054 -1.029 . . . . 0.0 110.02 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.523 ' N ' ' HG1' ' A' ' 34' ' ' THR . 7.2 p -127.23 133.46 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.668 -0.645 . . . . 0.0 109.337 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.8 m -118.83 119.96 35.93 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -93.39 121.96 35.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.597 -0.69 . . . . 0.0 109.547 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.0 p -109.03 0.22 19.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.6 t30 59.01 -96.2 0.06 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.798 -0.564 . . . . 0.0 109.677 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 10.0 tm-20 60.14 -88.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.393 0.616 . . . . 0.0 110.845 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 40' ' ' GLU . 78.1 tt0 -57.36 148.89 21.77 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.466 -0.772 . . . . 0.0 110.362 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -151.68 96.75 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.263 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 46' ' ' GLY . 36.1 m-20 -44.27 108.61 0.74 Allowed Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.564 -0.71 . . . . 0.0 109.835 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.05 -33.45 43.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.223 1.949 . . . . 0.0 111.664 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -85.88 -5.26 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 43' ' ' ASN . . . -166.69 -127.93 0.94 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 pt -135.29 149.46 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.432 -1.04 . . . . 0.0 109.749 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.6 t -142.79 141.67 31.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.134 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -124.87 122.09 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.567 0.699 . . . . 0.0 109.707 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 54.7 t0 -104.5 154.71 19.55 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.46 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -175.42 -170.31 38.18 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.609 -1.281 . . . . 0.0 109.936 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -145.25 162.82 36.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.484 -1.009 . . . . 0.0 109.675 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.37 162.81 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.457 0.646 . . . . 0.0 110.747 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 56.97 32.85 22.35 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.45 0.643 . . . . 0.0 109.85 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 47.97 29.62 1.76 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -111.68 108.37 17.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.491 -0.756 . . . . 0.0 109.525 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -58.59 -33.99 70.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.663 . . . . 0.0 109.599 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -62.48 -38.53 90.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.432 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.2 mt -82.76 82.63 8.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.191 -0.943 . . . . 0.0 109.095 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 m -100.6 160.83 14.03 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.598 0.713 . . . . 0.0 110.524 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -146.26 153.77 40.96 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.5 m -133.13 133.27 42.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.682 -0.636 . . . . 0.0 109.741 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.21 139.54 52.86 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -112.16 130.83 9.83 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' VAL . 45.8 tttt 43.57 -144.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.623 0.725 . . . . 0.0 110.869 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.2 62.31 0.13 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.533 0.682 . . . . 0.0 109.185 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LYS . 1.9 t 51.8 19.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.477 0.656 . . . . 0.0 109.639 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -64.09 -42.67 96.85 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.395 -0.815 . . . . 0.0 109.53 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 64' ' ' GLY . 96.7 mt -131.96 118.55 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.584 -0.698 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -139.73 152.08 46.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.7 t -139.83 148.28 41.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.438 -0.789 . . . . 0.0 109.555 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.0 t -131.81 147.44 52.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.451 -0.781 . . . . 0.0 109.639 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -76.61 170.04 17.16 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.788 0.804 . . . . 0.0 110.789 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -61.99 -42.98 99.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.571 -0.705 . . . . 0.0 109.664 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.57 -40.95 96.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.239 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.8 tp -79.55 -26.62 41.37 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.382 -0.824 . . . . 0.0 109.347 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -62.15 -38.25 88.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 110.247 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -59.11 -28.46 66.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.398 -0.814 . . . . 0.0 109.804 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 97.7 mmm -64.9 -35.29 80.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.658 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -63.9 135.95 56.97 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.301 -0.874 . . . . 0.0 109.841 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -112.39 -22.91 10.62 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -113.68 166.15 11.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.672 -0.643 . . . . 0.0 109.477 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.1 146.64 87.09 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.526 2.151 . . . . 0.0 112.677 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -67.59 124.04 22.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 109.428 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.479 ' O ' ' CE1' ' A' ' 24' ' ' TYR . 68.8 mmtt -134.97 154.95 51.53 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.771 0.796 . . . . 0.0 109.997 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.64 166.34 52.11 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -60.73 -42.29 96.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 122.014 -0.698 . . . . 0.0 109.507 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 9.5 p-10 -64.61 -34.74 78.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.429 -0.794 . . . . 0.0 110.45 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 50.3 mp0 -64.77 -47.51 77.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.262 -0.899 . . . . 0.0 110.053 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.418 HD11 HG21 ' A' ' 90' ' ' ILE . 35.2 pt -69.93 -35.45 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 110.083 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.27 -42.99 99.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.986 -1.071 . . . . 0.0 109.395 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.3 -37.64 83.71 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.346 -0.846 . . . . 0.0 109.547 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -82.84 121.57 27.1 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.389 -0.82 . . . . 0.0 109.791 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.523 ' C ' ' H ' ' A' ' 96' ' ' HIS . 62.4 t-80 -167.93 70.4 0.09 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.387 -0.821 . . . . 0.0 109.036 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 80.8 m80 52.48 7.04 0.06 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.728 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.523 ' H ' ' C ' ' A' ' 94' ' ' HIS . 86.6 t60 -66.52 -38.7 87.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -70.43 136.46 49.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.347 -0.846 . . . . 0.0 111.019 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.758 -1.115 . . . . 0.0 109.03 179.216 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.503 0.668 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -61.21 -27.78 68.68 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -59.64 -37.97 80.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.883 -0.511 . . . . 0.0 109.848 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.51 -40.85 98.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.748 -0.595 . . . . 0.0 109.488 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.61 -39.37 88.33 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 99.3 mm-40 -64.5 -40.42 95.62 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.15 -42.08 99.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.055 -0.403 . . . . 0.0 110.372 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.42 -46.44 79.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.889 -0.507 . . . . 0.0 109.857 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -65.67 -43.23 89.98 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.035 0.445 . . . . 0.0 110.199 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 53.7 t -65.41 -43.85 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.6 m -62.37 -45.55 92.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.8 tp -63.38 -43.92 96.2 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.812 -0.555 . . . . 0.0 109.72 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.602 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 71.7 t80 -62.21 -47.09 86.01 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.06 -40.56 96.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.936 -0.477 . . . . 0.0 109.929 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -59.66 -46.06 90.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 122.042 -0.411 . . . . 0.0 110.281 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 46.5 m-70 -72.29 -34.02 67.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 110.528 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.602 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 73.3 m-80 -86.58 -2.35 58.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.21 -0.932 . . . . 0.0 109.231 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 53.2 mt -136.56 104.86 9.17 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.613 . . . . 0.0 109.472 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.03 -16.99 25.34 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.779 2.319 . . . . 0.0 111.298 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -94.01 8.03 42.93 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -56.5 133.55 53.43 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.927 0.87 . . . . 0.0 110.48 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -135.9 -51.08 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -148.64 156.09 41.94 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.663 0.744 . . . . 0.0 110.207 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 p -139.82 140.83 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.539 0.685 . . . . 0.0 109.601 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.0 m -126.09 118.52 25.46 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.723 0.773 . . . . 0.0 109.486 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -95.67 126.49 40.98 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.556 0.694 . . . . 0.0 109.742 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.7 p -97.34 -17.2 19.89 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.5 m120 59.82 33.57 21.7 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.379 0.609 . . . . 0.0 109.557 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -92.74 179.74 5.39 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.684 0.754 . . . . 0.0 110.452 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 59.1 150.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.692 0.758 . . . . 0.0 110.362 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -155.33 114.85 3.66 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.826 0.822 . . . . 0.0 109.594 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.432 ' N ' ' ND2' ' A' ' 43' ' ' ASN . 2.6 m120 -91.92 146.71 33.42 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.29 -21.43 41.46 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.395 2.063 . . . . 0.0 111.62 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -76.61 -4.3 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.815 -0.553 . . . . 0.0 109.815 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.06 -123.51 1.19 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 pt -129.37 140.75 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.848 -0.795 . . . . 0.0 110.005 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.2 t -115.96 130.0 56.63 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.599 0.714 . . . . 0.0 109.926 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.9 127.23 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.749 0.785 . . . . 0.0 109.284 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -114.09 149.44 35.54 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.831 0.825 . . . . 0.0 110.0 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.02 179.88 45.09 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -143.23 166.02 25.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.76 -0.847 . . . . 0.0 110.609 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.6 pt -120.48 162.29 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.747 0.785 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 57.52 33.6 23.48 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 44.59 29.23 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.015 0.436 . . . . 0.0 109.864 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -109.13 112.4 24.55 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.66 0.743 . . . . 0.0 109.811 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -57.99 -34.11 69.63 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.963 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.08 -38.72 92.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.723 -0.611 . . . . 0.0 109.354 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.6 mt -82.46 75.84 9.36 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.1 m -102.49 160.39 14.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.964 0.888 . . . . 0.0 110.72 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.2 154.95 40.79 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.631 0.729 . . . . 0.0 109.716 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 96.9 m -134.66 133.85 40.53 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.66 0.743 . . . . 0.0 110.643 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.98 138.09 50.65 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.773 0.797 . . . . 0.0 109.376 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.66 133.77 11.81 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.433 ' O ' ' OE1' ' A' ' 17' ' ' GLN . 71.3 tttt 37.9 -133.75 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.212 0.529 . . . . 0.0 110.894 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -73.84 62.1 0.81 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 45.39 24.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -64.09 -42.36 96.97 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.74 127.41 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.694 0.759 . . . . 0.0 109.013 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.56 ' CZ ' ' NE ' ' A' ' 84' ' ' ARG . 28.3 p90 -139.95 153.44 46.91 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.971 0.891 . . . . 0.0 110.621 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 t -140.84 152.41 45.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.688 0.756 . . . . 0.0 109.423 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 p -138.47 153.9 48.82 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.896 0.855 . . . . 0.0 110.144 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.0 p -82.64 168.89 16.85 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.817 0.818 . . . . 0.0 110.546 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -65.44 -29.6 70.3 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -73.93 -50.4 20.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.756 -0.59 . . . . 0.0 109.583 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.27 -19.97 65.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.68 . . . . 0.0 109.484 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -64.0 -33.38 75.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.878 -0.514 . . . . 0.0 110.01 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.514 ' CG ' ' N ' ' A' ' 79' ' ' MET . 17.7 pttp -64.05 -43.83 94.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.617 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.514 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 59.8 mmm -68.41 -38.33 81.17 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.527 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 73.8 t80 -66.27 124.43 22.64 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.551 0.691 . . . . 0.0 109.138 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -142.97 -1.2 1.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.527 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 6.2 tp10 -102.43 113.4 65.89 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -48.87 149.01 8.28 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.407 2.071 . . . . 0.0 112.805 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.56 ' NE ' ' CZ ' ' A' ' 70' ' ' PHE . 15.9 mmm180 -67.77 143.6 55.78 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.735 0.779 . . . . 0.0 110.064 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -140.4 -76.64 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 159.32 160.89 10.73 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -62.71 -44.8 95.29 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.407 0.622 . . . . 0.0 109.632 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.96 -34.74 78.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.684 -0.635 . . . . 0.0 110.095 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.559 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 47.8 mp0 -65.66 -44.58 85.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.346 -0.846 . . . . 0.0 110.891 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.2 pt -66.2 -38.75 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.595 -0.691 . . . . 0.0 110.3 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 31.1 mt -63.64 -40.47 96.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.665 -0.647 . . . . 0.0 109.556 -179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.81 -37.01 81.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.828 -0.545 . . . . 0.0 109.614 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.411 ' O ' ' C ' ' A' ' 94' ' ' HIS . 86.6 t60 -70.32 87.78 0.62 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.491 0.662 . . . . 0.0 110.128 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.411 ' C ' ' O ' ' A' ' 93' ' ' HIS . 59.7 t-80 35.81 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.667 0.746 . . . . 0.0 110.725 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.485 ' CD2' ' H ' ' A' ' 95' ' ' HIS . 5.9 p80 -76.21 -54.83 6.23 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.518 ' C ' ' H ' ' A' ' 98' ' ' HIS . 85.1 t60 -161.83 -64.76 0.05 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.484 ' O ' ' ND1' ' A' ' 97' ' ' HIS . 60.4 t-80 49.8 10.97 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.518 ' H ' ' C ' ' A' ' 96' ' ' HIS . 85.9 t60 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.968 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -61.23 -45.92 92.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.497 -0.752 . . . . 0.0 109.244 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -65.79 -38.71 89.74 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.544 -0.722 . . . . 0.0 109.522 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -61.67 -41.44 97.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.769 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -64.53 -44.07 92.01 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.331 -0.856 . . . . 0.0 108.956 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -65.16 -39.06 92.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.574 -0.704 . . . . 0.0 109.363 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -63.76 -40.35 96.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.599 -0.688 . . . . 0.0 109.773 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -65.6 -38.35 89.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.444 -0.785 . . . . 0.0 109.597 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.29 -41.39 98.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.334 -0.853 . . . . 0.0 109.78 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.22 -43.67 97.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.0 m -61.43 -44.31 97.35 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.526 -0.734 . . . . 0.0 109.095 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.53 -42.54 99.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.502 -0.749 . . . . 0.0 109.101 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.55 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 62.8 t80 -61.01 -47.28 87.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.434 -0.791 . . . . 0.0 109.402 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 29' ' ' ILE . 86.2 mt -63.51 -41.97 98.5 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.419 -0.801 . . . . 0.0 109.696 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -61.86 -42.24 98.82 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.469 -0.77 . . . . 0.0 110.046 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -69.21 -39.17 78.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -0.836 . . . . 0.0 109.914 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.55 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 69.6 m-80 -86.26 -13.06 47.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.141 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 25' ' ' LEU . 11.1 mt -137.25 81.38 31.78 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.24 -28.24 70.37 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.481 2.121 . . . . 0.0 110.823 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.71 12.69 5.54 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -54.1 134.34 43.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.604 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -110.32 -63.17 1.42 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 t -150.42 157.95 43.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 0.0 109.95 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.13 133.19 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.599 -0.688 . . . . 0.0 109.318 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.5 m -121.02 120.22 34.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.62 -0.675 . . . . 0.0 109.242 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -94.26 140.62 29.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.593 -0.692 . . . . 0.0 109.402 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.0 p -116.41 -32.14 5.36 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -138.66 139.35 38.45 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.383 -0.823 . . . . 0.0 110.103 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -138.14 58.72 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -175.21 -170.17 0.42 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.629 -0.669 . . . . 0.0 109.791 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 t80 63.24 92.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.513 0.673 . . . . 0.0 109.94 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -171.37 119.99 0.47 Allowed Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.432 -0.793 . . . . 0.0 109.139 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.95 -42.97 25.11 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.283 1.989 . . . . 0.0 112.479 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 tp -70.5 -37.53 70.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.423 -0.798 . . . . 0.0 109.816 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -179.15 -87.91 0.07 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.9 pt -135.19 151.83 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.485 -1.009 . . . . 0.0 110.008 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.1 t -116.41 131.8 56.85 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.691 -0.631 . . . . 0.0 109.567 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.6 mt -106.83 116.49 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -119.73 139.32 52.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.44 36.48 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -145.42 166.13 26.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -1.073 . . . . 0.0 110.077 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.9 pt -120.84 162.85 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 121.576 0.703 . . . . 0.0 110.584 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 56.59 32.75 21.5 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.524 0.678 . . . . 0.0 109.547 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 m120 44.7 30.94 0.58 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.482 -0.761 . . . . 0.0 109.734 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -109.11 112.35 24.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.558 -0.714 . . . . 0.0 109.268 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -58.61 -33.35 69.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.669 -0.644 . . . . 0.0 109.807 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -62.86 -38.33 90.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.789 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.7 mt -83.76 79.92 9.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -0.89 . . . . 0.0 109.575 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.3 t -104.45 158.12 16.69 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.492 0.663 . . . . 0.0 110.063 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -144.56 145.87 32.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.479 -0.763 . . . . 0.0 109.513 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 52.1 m -130.24 131.3 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.05 138.17 48.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.632 -0.667 . . . . 0.0 109.277 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -96.53 99.51 2.33 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.7 tttp 43.86 -83.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.984 -0.715 . . . . 0.0 110.915 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 64' ' ' GLY . 99.2 m-20 -73.86 125.37 28.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 61.0 t -60.89 -1.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.531 -0.731 . . . . 0.0 109.453 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.502 ' H ' ' C ' ' A' ' 66' ' ' ASP . 54.6 mtpt -62.89 -41.22 99.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 69' ' ' ILE . 96.6 mt -116.2 116.21 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.473 -0.767 . . . . 0.0 109.346 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.532 ' CZ ' ' OH ' ' A' ' 24' ' ' TYR . 54.6 p90 -141.09 157.27 45.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.724 . . . . 0.0 110.021 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.3 t -120.4 137.27 54.4 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.2 t -137.56 146.46 44.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.443 -0.786 . . . . 0.0 109.958 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.8 m -80.68 172.83 13.25 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.675 0.75 . . . . 0.0 110.275 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -66.0 -35.57 80.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.638 -0.663 . . . . 0.0 109.959 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -65.1 -33.3 75.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.495 -0.753 . . . . 0.0 109.772 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.5 tp -91.3 -24.44 19.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 109.019 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -65.11 -38.03 89.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.818 . . . . 0.0 109.858 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.05 -12.8 61.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 110.283 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.7 mmm -79.37 -9.49 59.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.808 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.38 128.96 37.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.958 . . . . 0.0 109.828 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -109.4 -43.99 4.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.617 -0.677 . . . . 0.0 109.573 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -96.5 165.44 16.11 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.419 -0.8 . . . . 0.0 110.175 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.55 146.91 89.21 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.297 1.998 . . . . 0.0 112.006 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.42 124.1 20.92 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.462 -0.774 . . . . 0.0 110.462 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -138.43 140.91 39.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.718 -0.613 . . . . 0.0 109.429 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.8 174.14 49.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -60.9 -43.97 97.77 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.67 0.748 . . . . 0.0 109.767 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 48.4 p-10 -69.76 -32.98 71.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.124 -0.985 . . . . 0.0 110.166 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 78.5 mm-40 -66.25 -44.21 84.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.1 pt -65.57 -38.46 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.007 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 82.8 mt -62.5 -42.18 99.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.97 -1.081 . . . . 0.0 109.488 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.23 -37.96 84.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.13 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -83.99 101.69 11.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.49 -0.756 . . . . 0.0 109.348 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.441 ' CG ' ' N ' ' A' ' 95' ' ' HIS . 86.3 t60 -81.7 160.59 23.64 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.576 0.703 . . . . 0.0 110.334 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.441 ' N ' ' CG ' ' A' ' 94' ' ' HIS . 4.3 t-160 -80.09 126.42 31.05 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.489 -0.757 . . . . 0.0 110.34 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -66.25 -43.35 86.78 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.5 0.667 . . . . 0.0 109.359 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.579 ' HD1' ' CD2' ' A' ' 98' ' ' HIS . 66.3 t-80 -62.15 -42.78 99.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.616 -0.678 . . . . 0.0 109.615 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.579 ' CD2' ' HD1' ' A' ' 97' ' ' HIS . 93.4 m-70 . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.35 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.946 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.73 -43.02 99.67 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.87 0.843 . . . . 0.0 109.738 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CD1' ' OE2' ' A' ' 40' ' ' GLU . 85.0 m-85 -68.91 -35.23 76.58 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.484 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -62.54 -44.96 95.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.103 -0.998 . . . . 0.0 110.291 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -69.18 -36.03 76.91 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.155 -0.965 . . . . 0.0 109.758 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -63.16 -42.27 99.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -0.938 . . . . 0.0 109.599 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.83 -40.86 95.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 0.0 109.232 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.04 -43.95 98.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.562 -0.711 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.67 -43.32 97.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.412 -0.805 . . . . 0.0 109.942 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.3 -42.79 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 m -60.99 -46.12 92.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.392 -0.818 . . . . 0.0 109.383 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.6 tp -63.98 -42.01 97.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.526 ' CE2' ' OD1' ' A' ' 28' ' ' ASN . 77.4 t80 -61.42 -46.87 88.31 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.689 0.757 . . . . 0.0 109.87 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.15 -39.24 89.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.348 -0.845 . . . . 0.0 110.237 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -60.31 -45.67 92.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.289 -0.882 . . . . 0.0 110.521 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 37.0 m-70 -69.51 -38.67 77.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.203 -0.935 . . . . 0.0 110.37 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.526 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 25.2 m120 -64.17 -40.53 96.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.945 . . . . 0.0 109.81 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.4 mt -115.54 119.11 38.47 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.695 . . . . 0.0 109.908 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.61 -19.42 28.07 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.597 2.198 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -95.72 8.44 43.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 108.926 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -49.28 120.92 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.876 0.846 . . . . 0.0 110.032 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -102.27 -68.71 0.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.701 0.762 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.68 ' HG1' ' N ' ' A' ' 35' ' ' VAL . 2.8 t -148.06 163.92 35.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.193 -0.942 . . . . 0.0 109.711 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.68 ' N ' ' HG1' ' A' ' 34' ' ' THR . 3.8 p -133.25 137.08 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.585 -0.697 . . . . 0.0 109.493 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.9 m -125.21 123.51 39.73 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.681 0.753 . . . . 0.0 109.368 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -88.42 132.35 34.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.562 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -107.15 -53.94 2.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.48 -0.763 . . . . 0.0 109.756 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -100.65 142.43 32.13 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.073 -1.017 . . . . 0.0 110.427 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.427 ' OE2' ' CD1' ' A' ' 14' ' ' PHE . 76.5 tt0 -162.47 106.84 1.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.531 -0.731 . . . . 0.0 109.09 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -170.03 177.77 4.18 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.465 -0.772 . . . . 0.0 110.043 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -61.68 -178.37 0.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.988 0.899 . . . . 0.0 110.61 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -175.45 167.75 1.73 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.13 -40.54 76.65 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.295 1.997 . . . . 0.0 111.528 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.9 -4.09 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.752 . . . . 0.0 109.453 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 134.4 -94.31 0.26 Allowed Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.5 pt -126.9 149.14 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.626 -0.926 . . . . 0.0 110.04 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 t -127.28 130.89 50.39 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.666 0.746 . . . . 0.0 108.997 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -128.04 132.01 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 40.3 t0 -135.42 146.06 47.89 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.593 -0.692 . . . . 0.0 109.807 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -167.89 -164.9 24.38 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -144.28 161.5 38.76 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.492 -1.004 . . . . 0.0 110.028 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -121.05 159.63 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 122.09 0.948 . . . . 0.0 111.308 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.1 m-20 57.39 32.93 22.56 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.825 0.821 . . . . 0.0 109.902 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 49.42 30.86 3.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 0.0 109.536 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -112.6 108.15 17.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.401 -0.812 . . . . 0.0 109.528 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -59.7 -31.44 69.59 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.568 0.699 . . . . 0.0 109.518 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -62.76 -39.07 93.0 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.178 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.6 mt -83.09 77.52 9.73 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.226 -0.921 . . . . 0.0 109.684 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.4 p -104.08 161.74 13.75 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.803 0.811 . . . . 0.0 110.596 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -149.75 156.09 41.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.537 -0.727 . . . . 0.0 109.688 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.3 m -137.29 140.05 41.32 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.658 -0.652 . . . . 0.0 109.894 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.87 150.43 46.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.365 -0.835 . . . . 0.0 109.394 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 65' ' ' LYS . . . -126.86 94.64 0.42 Allowed Glycine 0 N--CA 1.503 3.15 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' GLY . 88.6 tttt 52.84 115.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.945 0.879 . . . . 0.0 111.133 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.59 ' C ' ' H ' ' A' ' 68' ' ' LYS . 65.6 t0 60.05 139.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.84 0.828 . . . . 0.0 110.591 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.566 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 26.3 t -58.48 0.63 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.558 0.694 . . . . 0.0 109.354 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.59 ' H ' ' C ' ' A' ' 66' ' ' ASP . 63.3 tttp -55.79 -40.05 72.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 108.788 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.45 119.03 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.483 -0.761 . . . . 0.0 109.084 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -138.63 125.91 21.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.413 -0.804 . . . . 0.0 109.365 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.8 m -107.71 150.57 26.78 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.609 0.719 . . . . 0.0 109.338 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.2 m -151.51 152.52 33.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.93 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.3 p -80.95 172.62 13.51 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.91 0.862 . . . . 0.0 110.874 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -58.77 -45.67 89.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.679 -0.638 . . . . 0.0 110.074 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.59 -48.96 78.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.15 -0.969 . . . . 0.0 110.22 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.59 -36.2 83.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.091 -1.006 . . . . 0.0 109.108 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.77 -41.45 97.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.343 -0.848 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -66.1 -35.06 79.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.153 -0.967 . . . . 0.0 109.714 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.5 mmm -62.26 -38.53 89.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.203 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -55.97 140.7 42.26 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.949 0.88 . . . . 0.0 110.104 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -106.45 -16.8 14.45 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -133.21 154.97 81.37 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.364 -0.835 . . . . 0.0 109.589 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.87 162.95 29.96 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 123.041 2.494 . . . . 0.0 112.69 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -63.77 135.76 56.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.921 0.867 . . . . 0.0 110.355 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -138.85 151.18 46.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.701 0.762 . . . . 0.0 109.641 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.98 152.81 45.97 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.07 -42.88 95.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.778 -0.836 . . . . 0.0 109.518 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.86 -37.97 88.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.777 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -60.7 -48.1 83.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.379 -0.825 . . . . 0.0 110.382 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.444 HG21 HD11 ' A' ' 90' ' ' ILE . 34.8 pt -71.01 -31.58 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.937 -1.102 . . . . 0.0 109.946 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.04 -43.29 95.99 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 109.452 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.81 -41.94 82.32 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.855 0.836 . . . . 0.0 109.32 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.536 ' CG ' ' N ' ' A' ' 94' ' ' HIS . 82.4 t60 52.96 -108.85 0.44 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.537 -0.727 . . . . 0.0 110.613 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.575 ' O ' ' CG ' ' A' ' 95' ' ' HIS . 74.1 t60 -84.83 -2.8 58.2 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.223 -0.923 . . . . 0.0 109.671 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 94' ' ' HIS . 44.2 p-80 54.0 104.42 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -75.6 135.33 40.52 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.375 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.671 ' CG ' ' H ' ' A' ' 98' ' ' HIS . 70.8 t60 -81.7 -177.43 6.55 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.776 0.798 . . . . 0.0 110.695 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.671 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 91.4 m-70 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.784 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.315 0.578 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.517 ' CE2' ' NE2' ' A' ' 17' ' ' GLN . 69.0 t80 -62.77 -44.87 95.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.431 -0.793 . . . . 0.0 109.504 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -65.3 -37.95 88.71 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.467 0.651 . . . . 0.0 109.465 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.47 -40.96 96.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.508 -0.745 . . . . 0.0 109.293 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.54 -49.52 76.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.455 -0.778 . . . . 0.0 109.423 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.517 ' NE2' ' CE2' ' A' ' 13' ' ' PHE . 97.8 mt-30 -68.18 -33.61 74.76 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.552 0.692 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.09 -44.83 95.8 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.494 0.664 . . . . 0.0 109.794 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.03 -39.53 87.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.668 -0.645 . . . . 0.0 110.133 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -63.47 -42.43 98.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.543 -0.723 . . . . 0.0 110.596 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.94 -42.01 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.812 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.5 m -60.5 -46.62 89.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.416 -0.803 . . . . 0.0 109.861 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 54.6 tp -64.73 -40.97 96.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.763 . . . . 0.0 109.665 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.558 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 80.0 t80 -60.08 -44.71 94.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.491 -0.756 . . . . 0.0 109.849 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.45 -42.19 98.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.478 -0.764 . . . . 0.0 110.434 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -40.45 96.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.495 -0.753 . . . . 0.0 110.334 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -67.56 -35.22 78.63 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.495 -0.753 . . . . 0.0 110.585 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.558 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 71.4 m-80 -95.04 -1.3 52.53 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.112 -0.992 . . . . 0.0 109.515 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.1 mt -140.91 84.44 13.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 109.484 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.4 -28.94 75.3 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.709 2.273 . . . . 0.0 111.17 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -88.59 15.8 7.55 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.535 0.683 . . . . 0.0 109.164 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -49.85 130.5 21.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.458 -0.776 . . . . 0.0 109.912 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -115.85 -68.6 0.91 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 t -143.28 161.07 39.27 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.598 0.713 . . . . 0.0 110.058 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.61 139.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 91.9 m -123.45 125.79 45.57 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -90.88 136.88 32.78 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.615 0.722 . . . . 0.0 110.095 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 39' ' ' ASN . 14.4 p -117.02 -33.48 4.71 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' ' 38' ' ' THR . 9.0 p30 38.24 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.0 0.905 . . . . 0.0 110.838 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -157.9 36.08 0.26 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 109.394 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -144.58 121.33 11.21 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.221 -0.924 . . . . 0.0 109.871 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -109.97 121.7 45.86 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.538 0.685 . . . . 0.0 109.288 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.434 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 2.0 m-20 -106.46 137.39 19.42 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -49.4 -31.36 23.05 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.569 2.179 . . . . 0.0 112.007 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.0 pt -80.08 -10.14 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.513 -0.742 . . . . 0.0 109.588 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 43' ' ' ASN . . . 154.52 -176.78 32.19 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.636 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.417 ' H ' ' HE2' ' A' ' 65' ' ' LYS . 34.0 pt -83.84 140.09 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.67 -0.9 . . . . 0.0 110.424 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.434 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 72.2 m -111.15 126.46 54.87 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.607 0.718 . . . . 0.0 109.525 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.56 126.15 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.625 -0.672 . . . . 0.0 109.516 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -115.48 149.09 38.65 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.839 0.828 . . . . 0.0 110.109 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.85 -177.83 46.12 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -142.67 163.07 33.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.761 -0.846 . . . . 0.0 109.959 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 pt -121.94 162.78 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 121.914 0.864 . . . . 0.0 110.825 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.5 m120 59.59 31.31 20.86 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.529 0.68 . . . . 0.0 110.298 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 48.32 30.71 2.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.587 -0.696 . . . . 0.0 109.573 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -113.67 109.74 19.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.761 0.791 . . . . 0.0 109.513 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.53 -32.69 70.55 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.345 0.593 . . . . 0.0 109.588 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.76 -38.63 91.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.333 -0.854 . . . . 0.0 109.075 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.5 mt -83.2 75.82 9.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.559 -0.713 . . . . 0.0 109.506 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 t -99.76 162.99 12.66 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.723 0.773 . . . . 0.0 110.427 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -149.08 155.23 40.42 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.626 0.727 . . . . 0.0 109.793 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.1 m -132.74 136.1 46.15 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.451 0.643 . . . . 0.0 110.11 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.77 136.96 47.97 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.724 0.773 . . . . 0.0 109.287 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -102.43 136.3 12.74 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' GLY . 60.9 mmtt 33.59 -121.72 0.09 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.434 0.635 . . . . 0.0 111.421 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 68' ' ' LYS . 99.2 m-20 -85.67 76.3 9.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 66' ' ' ASP . 2.1 t 38.26 28.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.778 0.799 . . . . 0.0 110.003 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 66' ' ' ASP . 18.3 mmmt -62.62 -42.83 99.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.51 -0.744 . . . . 0.0 109.346 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 69' ' ' ILE . 97.2 mt -129.32 125.92 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.603 -0.686 . . . . 0.0 109.293 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -123.5 131.7 53.71 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.529 0.681 . . . . 0.0 109.573 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.6 m -127.49 150.63 49.59 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 p -136.93 155.2 50.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.911 0.862 . . . . 0.0 110.396 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -81.69 174.42 11.39 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.535 0.683 . . . . 0.0 110.066 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.2 -41.58 99.19 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.463 0.649 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.3 mp0 -70.57 -44.32 67.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -0.859 . . . . 0.0 109.549 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.62 -37.48 86.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.708 -0.62 . . . . 0.0 109.596 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -54.86 -33.0 61.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.742 . . . . 0.0 109.518 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.75 -40.84 97.71 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.352 -0.843 . . . . 0.0 110.057 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.2 mmm -65.93 -37.82 87.04 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.154 -0.966 . . . . 0.0 109.068 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -64.98 133.57 52.01 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.66 0.743 . . . . 0.0 109.988 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -116.5 -22.28 8.8 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.481 ' N ' ' CD ' ' A' ' 82' ' ' GLU . 1.7 pm0 -114.82 153.35 46.94 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.692 -0.63 . . . . 0.0 109.495 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.88 173.5 8.1 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.679 2.253 . . . . 0.0 112.735 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.35 139.74 58.8 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.931 0.872 . . . . 0.0 110.181 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -139.67 145.51 38.52 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.763 0.792 . . . . 0.0 109.848 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -74.42 154.8 47.96 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -61.99 -43.37 98.97 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.66 0.743 . . . . 0.0 110.002 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.36 -36.23 83.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.433 -0.792 . . . . 0.0 109.787 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.557 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 41.5 mp0 -62.89 -51.67 66.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.41 -0.806 . . . . 0.0 110.452 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 pt -64.62 -37.37 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.23 -43.69 97.34 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.55 0.69 . . . . 0.0 110.077 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -71.77 -38.0 70.39 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.711 0.767 . . . . 0.0 108.97 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 89' ' ' GLU . 56.4 m-70 -67.57 -39.8 84.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.659 -0.651 . . . . 0.0 109.959 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -60.82 82.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.598 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 93' ' ' HIS . 71.2 m80 -87.24 -12.3 47.14 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.622 ' H ' ' HD1' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -151.13 164.96 35.3 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.331 -0.855 . . . . 0.0 109.714 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 98' ' ' HIS . 32.1 p-80 -66.35 -42.63 87.81 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.478 0.656 . . . . 0.0 109.749 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 75.9 m80 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.221 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.544 0.688 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.437 ' CZ ' ' CZ ' ' A' ' 14' ' ' PHE . 50.8 p90 -67.95 -14.84 63.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.437 ' CZ ' ' CZ ' ' A' ' 13' ' ' PHE . 86.5 m-85 -59.91 -29.33 68.28 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.487 0.661 . . . . 0.0 109.321 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -61.81 -37.82 85.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.479 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.56 -46.43 86.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.647 -0.658 . . . . 0.0 109.957 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.617 HE22 ' CG2' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -67.24 -37.12 83.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.5 -0.75 . . . . 0.0 109.218 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.51 -42.02 99.22 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.479 0.657 . . . . 0.0 109.453 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -65.0 -40.55 95.11 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -64.01 -40.67 96.87 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.313 0.578 . . . . 0.0 110.047 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.617 ' CG2' HE22 ' A' ' 17' ' ' GLN . 69.1 t -64.68 -41.57 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.543 -0.723 . . . . 0.0 109.412 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 m -59.73 -46.18 89.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.633 -0.667 . . . . 0.0 109.691 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.67 -40.14 96.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.692 -0.63 . . . . 0.0 109.732 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.644 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 59.0 t80 -58.84 -48.18 82.24 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.97 -40.56 96.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.601 -0.687 . . . . 0.0 110.068 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -49.81 -61.77 1.94 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.759 -0.588 . . . . 0.0 111.259 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.634 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 20.9 p80 -71.47 -36.01 71.03 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.269 0.557 . . . . 0.0 110.523 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.644 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 33.4 m-80 -64.52 -41.13 96.58 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.9 mt -127.12 114.1 21.74 Favored Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 120.56 -0.456 . . . . 0.0 109.921 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.91 -15.74 26.24 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.633 2.222 . . . . 0.0 111.087 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.81 4.56 52.57 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -55.98 129.01 37.99 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.872 0.844 . . . . 0.0 110.201 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -118.16 -59.64 1.88 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.432 ' HG1' ' N ' ' A' ' 35' ' ' VAL . 4.1 t -146.5 167.29 24.05 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.868 0.842 . . . . 0.0 110.171 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.432 ' N ' ' HG1' ' A' ' 34' ' ' THR . 2.7 p -132.52 134.41 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.61 0.719 . . . . 0.0 109.573 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.0 m -115.64 105.8 13.17 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.737 0.779 . . . . 0.0 109.19 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -80.76 140.22 35.64 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.514 0.674 . . . . 0.0 109.76 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.1 p -120.09 -34.16 3.76 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 53.63 81.94 0.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.518 -0.739 . . . . 0.0 109.843 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -144.36 28.83 1.32 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.435 ' OE1' ' OD2' ' A' ' 50' ' ' ASP . 82.7 tt0 -160.3 135.86 8.2 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.882 0.848 . . . . 0.0 109.987 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -123.83 144.54 49.67 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.707 0.765 . . . . 0.0 109.915 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -98.59 149.91 36.2 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.694 -0.629 . . . . 0.0 109.653 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.47 -20.97 41.01 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.889 2.392 . . . . 0.0 111.495 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.3 pt -98.63 -5.18 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.02 -168.93 40.63 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.688 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 pt -81.55 157.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.865 0.841 . . . . 0.0 109.922 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.6 t -138.67 141.96 39.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.595 0.712 . . . . 0.0 109.809 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.9 mt -112.78 127.88 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.876 0.846 . . . . 0.0 109.968 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.435 ' OD2' ' OE1' ' A' ' 41' ' ' GLU . 24.8 m-20 -117.46 151.11 37.74 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.839 0.828 . . . . 0.0 110.021 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.84 -156.76 28.9 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -150.28 166.77 28.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.456 -1.026 . . . . 0.0 110.645 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.1 pt -121.76 167.8 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.732 0.777 . . . . 0.0 110.354 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 57.99 33.7 23.48 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.459 0.647 . . . . 0.0 109.978 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 42.19 34.52 0.49 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.958 -0.464 . . . . 0.0 109.935 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -115.18 107.67 15.6 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.706 0.765 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -58.6 -36.66 74.36 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.916 -0.49 . . . . 0.0 110.252 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -62.5 -37.03 84.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.245 -0.909 . . . . 0.0 109.804 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.9 mt -82.34 83.55 7.42 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.338 -0.851 . . . . 0.0 109.705 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 t -79.9 145.33 32.73 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.062 0.934 . . . . 0.0 110.668 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -140.29 130.37 24.88 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.756 0.789 . . . . 0.0 109.674 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 41.8 m -134.69 136.5 42.81 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.838 0.828 . . . . 0.0 110.11 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -134.22 144.07 48.21 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.943 0.878 . . . . 0.0 110.0 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.09 175.84 38.47 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -53.75 133.71 42.15 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.611 0.72 . . . . 0.0 110.943 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 68' ' ' LYS . 93.3 m-20 57.57 34.14 24.17 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.177 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' ILE . 39.6 t 59.46 -78.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' ASP . 67.9 mttm 39.45 -89.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.524 0.678 . . . . 0.0 109.99 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' VAL . 96.9 mt -109.04 136.43 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.777 0.799 . . . . 0.0 109.304 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.527 ' CZ ' ' OH ' ' A' ' 24' ' ' TYR . 53.0 p90 -139.75 167.27 22.49 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.014 0.912 . . . . 0.0 109.868 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.3 t -133.67 150.86 51.55 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.975 0.893 . . . . 0.0 109.688 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.9 p -151.33 160.74 43.63 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.715 0.769 . . . . 0.0 110.156 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 p -75.72 164.98 25.72 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.951 0.882 . . . . 0.0 110.737 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -61.05 -43.18 99.27 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -66.0 -34.0 77.09 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.4 tp -81.99 -26.16 34.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.404 -0.81 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -66.5 -43.82 84.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.531 -0.73 . . . . 0.0 109.998 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -71.75 -9.87 58.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.558 -0.714 . . . . 0.0 110.713 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.9 mtp -82.27 -8.89 59.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.217 -0.927 . . . . 0.0 109.362 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -68.06 135.92 52.99 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -0.855 . . . . 0.0 109.604 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -92.12 -74.21 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.305 0.574 . . . . 0.0 109.816 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.03 155.54 49.62 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.471 -0.768 . . . . 0.0 109.754 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.02 165.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.598 2.199 . . . . 0.0 112.724 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.25 136.25 53.24 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.787 0.803 . . . . 0.0 110.281 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.94 140.36 45.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.817 0.818 . . . . 0.0 109.905 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.5 165.92 53.24 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -62.25 -42.86 99.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.987 -0.714 . . . . 0.0 109.402 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -63.89 -37.71 88.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.64 -0.663 . . . . 0.0 110.324 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -65.21 -44.38 88.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.416 -0.802 . . . . 0.0 110.416 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.4 pt -72.66 -32.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.278 -0.889 . . . . 0.0 110.392 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.82 -40.39 96.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.105 -0.997 . . . . 0.0 109.342 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -50.33 -27.48 6.3 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -104.85 124.68 49.87 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.868 0.842 . . . . 0.0 110.153 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -149.94 -52.36 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 96' ' ' HIS . 42.0 p-80 -67.35 -34.02 76.45 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.347 -0.846 . . . . 0.0 109.643 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 95' ' ' HIS . 58.5 t-80 57.27 157.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.83 0.824 . . . . 0.0 110.678 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -153.72 162.66 41.05 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.839 0.828 . . . . 0.0 109.767 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.6 m170 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.746 -179.5 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.466 0.651 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CZ ' ' CE2' ' A' ' 14' ' ' PHE . 22.4 p90 -65.27 -12.11 48.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.578 -0.701 . . . . 0.0 109.52 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.53 ' CE2' ' CZ ' ' A' ' 13' ' ' PHE . 90.2 m-85 -64.87 -37.52 87.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.175 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.88 -41.0 99.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -0.813 . . . . 0.0 109.466 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.67 -40.19 92.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.587 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.18 -41.5 94.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.77 -40.73 97.39 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.384 -0.822 . . . . 0.0 109.351 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.15 -43.3 99.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 0.0 109.618 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -63.53 -42.64 98.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.332 -0.855 . . . . 0.0 109.879 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.47 -42.94 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 0.0 109.417 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.526 ' CG2' ' NZ ' ' A' ' 26' ' ' LYS . 76.1 m -60.73 -44.33 96.76 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.38 -0.825 . . . . 0.0 109.688 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 tp -63.71 -42.14 98.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.246 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.616 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 75.0 t80 -60.82 -44.58 96.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.577 -0.702 . . . . 0.0 110.232 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 29' ' ' ILE . 88.9 mt -63.64 -41.81 98.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 110.305 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.526 ' NZ ' ' CG2' ' A' ' 22' ' ' THR . 62.2 mttp -61.12 -40.75 94.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.91 -1.119 . . . . 0.0 110.444 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -66.84 -38.84 87.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.969 -1.082 . . . . 0.0 110.178 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.616 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 97.5 m-20 -92.5 -7.29 47.78 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.086 -1.009 . . . . 0.0 109.358 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 25' ' ' LEU . 12.3 mt -142.15 81.83 13.84 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.576 -0.702 . . . . 0.0 109.427 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.73 -27.73 78.96 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.711 2.274 . . . . 0.0 111.093 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -82.81 10.07 8.49 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 22.7 t80 -56.08 130.39 43.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -100.52 -68.76 0.8 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.448 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.607 ' HG1' ' H ' ' A' ' 35' ' ' VAL . 3.6 t -152.33 168.22 26.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.722 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.607 ' H ' ' HG1' ' A' ' 34' ' ' THR . 3.5 p -129.03 138.22 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.4 m -125.12 124.67 42.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.606 -0.684 . . . . 0.0 109.27 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -104.43 118.47 36.7 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 t -141.26 18.64 2.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -151.09 106.67 3.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.113 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -130.82 140.6 50.28 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.323 -0.86 . . . . 0.0 109.473 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -135.82 156.35 48.93 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.453 -0.779 . . . . 0.0 109.577 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.49 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 48.9 p90 -97.69 123.35 41.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.931 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.515 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 1.3 m-80 -96.05 153.97 39.01 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.466 -0.771 . . . . 0.0 109.145 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.64 -22.6 50.39 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.667 2.245 . . . . 0.0 111.299 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.4 pt -102.13 -3.84 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.49 -133.88 3.2 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.9 pt -127.79 159.61 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.312 -1.111 . . . . 0.0 110.749 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.515 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 3.6 p -126.14 137.13 53.56 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.405 HG21 HD13 ' A' ' 49' ' ' ILE . 96.6 mt -124.88 130.66 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.536 -0.728 . . . . 0.0 109.344 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -130.6 137.51 49.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.621 -0.674 . . . . 0.0 109.382 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.75 -160.78 14.48 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -147.69 167.39 24.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.26 -1.141 . . . . 0.0 109.946 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.8 pt -121.2 160.44 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 121.953 0.882 . . . . 0.0 110.784 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 58.6 33.38 23.04 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.563 0.697 . . . . 0.0 109.873 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.8 m120 46.41 29.49 0.89 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.306 -0.871 . . . . 0.0 110.08 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -109.24 111.76 23.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 0.0 109.504 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -58.7 -34.29 71.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.529 -0.732 . . . . 0.0 109.495 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -61.76 -39.11 90.48 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.321 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.79 73.89 8.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.074 -1.016 . . . . 0.0 109.083 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -100.56 156.5 17.26 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.6 0.714 . . . . 0.0 110.109 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.0 154.52 37.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.567 -0.708 . . . . 0.0 109.614 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 93.2 m -131.59 132.66 44.27 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.95 144.59 45.51 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.408 -0.807 . . . . 0.0 109.662 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.89 179.37 36.78 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -51.67 132.46 30.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.645 -0.915 . . . . 0.0 110.836 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 t0 56.01 38.09 29.56 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.672 0.749 . . . . 0.0 109.698 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 69' ' ' ILE . 36.1 t 58.56 -103.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.562 -0.711 . . . . 0.0 110.315 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 62.09 -69.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.616 -0.678 . . . . 0.0 109.53 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 67' ' ' VAL . 87.6 mt -105.73 121.84 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 108.752 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -128.39 133.97 48.72 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.5 t -132.01 141.78 49.37 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.0 p -139.45 156.15 47.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.475 -0.766 . . . . 0.0 109.968 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.9 p -68.93 170.05 10.46 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.647 0.737 . . . . 0.0 110.805 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.62 -46.52 88.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.494 -0.754 . . . . 0.0 110.263 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 57.8 mp0 -65.36 -45.7 83.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 0.0 109.618 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.58 -38.74 90.39 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.314 -0.866 . . . . 0.0 109.678 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 84' ' ' ARG . 32.1 t70 -61.5 -36.02 79.31 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.128 -0.983 . . . . 0.0 109.59 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -68.86 -13.93 62.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.992 . . . . 0.0 110.207 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.2 mtp -82.2 -9.34 59.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.78 -1.2 . . . . 0.0 109.418 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -72.88 137.08 45.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.154 -0.966 . . . . 0.0 109.721 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -114.68 -11.39 12.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -127.1 153.43 76.65 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.71 -0.619 . . . . 0.0 109.917 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.86 152.13 59.8 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 122.323 2.015 . . . . 0.0 112.859 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.519 ' NH2' ' OD1' ' A' ' 77' ' ' ASP . 26.2 mmt85 -66.29 138.74 57.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 109.864 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -145.9 166.27 26.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.533 -0.729 . . . . 0.0 109.905 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.408 ' H ' ' CD ' ' A' ' 89' ' ' GLU . . . -82.31 167.8 47.56 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -62.01 -45.51 93.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.516 -0.99 . . . . 0.0 109.63 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -70.72 -29.14 65.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.839 -1.163 . . . . 0.0 109.005 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 86' ' ' GLY . 94.9 mt-10 -65.44 -45.33 84.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.395 -0.815 . . . . 0.0 109.936 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.6 pt -68.08 -33.42 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 109.749 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 41.4 mt -65.04 -41.23 95.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.384 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 94' ' ' HIS . 12.9 pt-20 -86.93 -13.14 45.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -0.994 . . . . 0.0 109.653 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.564 ' O ' ' N ' ' A' ' 95' ' ' HIS . 76.8 t60 -44.16 91.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.393 -0.817 . . . . 0.0 110.609 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 92' ' ' GLU . 79.8 m80 41.64 19.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.543 0.687 . . . . 0.0 109.979 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.564 ' N ' ' O ' ' A' ' 93' ' ' HIS . 85.2 t60 -66.22 -41.1 90.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.261 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.22 -45.1 95.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.314 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -66.73 -39.34 87.94 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 109.221 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.755 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.629 0.728 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.78 -43.7 97.72 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.771 0.796 . . . . 0.0 109.047 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -59.88 -43.09 94.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.631 . . . . 0.0 109.555 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -62.95 -41.6 99.55 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.688 0.756 . . . . 0.0 109.007 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.99 -38.53 88.75 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.547 0.689 . . . . 0.0 109.398 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 67.4 tp60 -61.98 -43.56 98.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.679 . . . . 0.0 110.148 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.16 -40.21 96.9 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.658 0.742 . . . . 0.0 109.273 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.67 -44.34 94.04 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.546 0.689 . . . . 0.0 109.56 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -63.73 -42.94 97.81 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.427 0.632 . . . . 0.0 110.269 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.38 -44.69 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.641 0.734 . . . . 0.0 109.707 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.9 m -62.16 -42.4 99.22 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.55 0.691 . . . . 0.0 109.875 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.2 tp -60.8 -44.36 96.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.489 -0.757 . . . . 0.0 109.597 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -62.46 -45.88 91.04 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.598 0.714 . . . . 0.0 110.186 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.33 -39.46 93.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.482 -0.761 . . . . 0.0 110.069 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -60.55 -42.0 95.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.521 -0.737 . . . . 0.0 109.804 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 51.8 m-70 -66.51 -39.08 88.48 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.519 0.676 . . . . 0.0 110.0 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -87.97 -2.98 58.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.462 -0.774 . . . . 0.0 109.435 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.3 mt -142.53 83.1 12.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.67 . . . . 0.0 109.215 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.63 -32.06 73.38 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.597 2.198 . . . . 0.0 111.159 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -83.87 16.05 3.0 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.587 0.708 . . . . 0.0 109.445 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.73 129.19 40.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.497 -0.752 . . . . 0.0 109.883 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -108.98 -58.4 2.02 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -153.91 164.32 38.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.246 -0.908 . . . . 0.0 110.447 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.09 135.84 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 100.0 m -128.82 125.36 37.58 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.701 0.762 . . . . 0.0 110.01 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -99.16 147.42 25.13 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 p -142.17 -76.21 0.28 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.489 0.661 . . . . 0.0 109.595 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -78.18 128.48 33.82 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.662 0.744 . . . . 0.0 110.571 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.97 69.6 1.36 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -81.24 162.76 23.41 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.87 0.843 . . . . 0.0 110.213 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -99.4 119.88 38.69 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.777 0.799 . . . . 0.0 110.168 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.679 ' ND2' ' H ' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -95.15 152.25 39.33 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.36 -38.89 27.44 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.671 2.247 . . . . 0.0 112.077 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.9 -41.17 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.58 -0.7 . . . . 0.0 109.961 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' A' ' 43' ' ' ASN . . . -179.41 -135.1 2.32 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.418 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.523 ' C ' HD22 ' A' ' 43' ' ' ASN . 15.8 pt -103.74 139.26 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.758 -0.848 . . . . 0.0 109.801 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.513 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 50.7 m -116.54 124.96 51.17 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.579 0.705 . . . . 0.0 109.591 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.15 125.48 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 61' ' ' PHE . 38.8 t70 -124.25 153.67 41.33 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.861 0.839 . . . . 0.0 109.932 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 178.54 -167.49 38.0 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.469 ' CE2' ' NZ ' ' A' ' 57' ' ' LYS . 19.7 p90 -142.17 163.73 32.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.831 -0.805 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -120.78 161.53 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.674 0.749 . . . . 0.0 110.027 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 58.89 32.16 21.98 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.623 0.725 . . . . 0.0 109.844 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 45.82 32.11 1.2 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.653 . . . . 0.0 109.595 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -115.57 109.51 17.89 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.416 0.627 . . . . 0.0 109.541 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' NZ ' ' CE2' ' A' ' 52' ' ' TYR . 69.6 mmtt -57.85 -33.36 68.57 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.408 0.623 . . . . 0.0 110.032 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -60.5 -39.26 87.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 109.0 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.44 68.77 9.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.445 -0.785 . . . . 0.0 109.373 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.6 p -91.93 161.39 14.84 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.615 0.722 . . . . 0.0 109.855 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.408 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 49.2 p90 -155.07 160.9 41.35 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.63 0.728 . . . . 0.0 109.725 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.6 m -140.68 144.57 35.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.611 -0.681 . . . . 0.0 109.7 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.47 140.69 26.42 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -105.13 147.84 16.38 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.538 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 63.8 mmtt 35.22 -122.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.439 0.637 . . . . 0.0 111.232 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 68' ' ' LYS . 97.7 m-20 -88.21 86.84 7.15 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.774 0.797 . . . . 0.0 109.921 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.497 ' H ' HE22 ' A' ' 17' ' ' GLN . 2.0 t 45.67 14.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.661 0.743 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 66' ' ' ASP . 25.5 tptt -78.44 136.46 37.63 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.878 0.847 . . . . 0.0 110.05 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 68' ' ' LYS . 9.4 mm 49.15 99.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.59 0.709 . . . . 0.0 109.513 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -135.79 153.97 51.36 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.687 0.756 . . . . 0.0 110.083 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 p -136.53 157.25 47.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 m -133.95 153.08 52.01 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.935 0.874 . . . . 0.0 110.135 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.2 p -65.13 168.55 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.765 0.793 . . . . 0.0 110.744 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.17 -51.81 68.17 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.467 0.651 . . . . 0.0 109.82 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.95 -43.36 92.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.526 -0.734 . . . . 0.0 109.715 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.6 tp -63.8 -39.1 93.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -61.02 -38.03 84.67 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.631 0.729 . . . . 0.0 109.371 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.97 -36.64 82.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.334 -0.854 . . . . 0.0 109.509 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 81' ' ' GLN . 79.1 mtp -63.32 -41.34 98.91 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.467 -0.771 . . . . 0.0 109.943 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -43.44 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.922 0.868 . . . . 0.0 110.238 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' MET . 57.7 tt0 -67.79 -36.34 80.28 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.194 -0.603 . . . . 0.0 109.642 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -105.89 152.66 40.29 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.499 -0.75 . . . . 0.0 109.921 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.54 167.62 20.34 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.81 2.34 . . . . 0.0 112.844 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -63.78 140.22 58.85 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.777 0.798 . . . . 0.0 110.212 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -144.52 -111.34 0.1 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.685 -0.634 . . . . 0.0 109.843 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -176.94 161.06 28.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.452 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.88 -44.39 97.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.385 0.612 . . . . 0.0 110.059 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -58.76 -39.79 82.01 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.534 0.683 . . . . 0.0 110.121 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -57.96 -56.36 22.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 109.667 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.403 HG21 HD12 ' A' ' 90' ' ' ILE . 38.8 pt -65.64 -26.14 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.436 -0.79 . . . . 0.0 110.029 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 tt -63.61 -35.85 81.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.503 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -51.71 -30.8 23.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.257 -0.902 . . . . 0.0 109.322 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -155.1 119.34 4.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.651 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -67.51 -40.82 85.16 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.655 0.741 . . . . 0.0 109.087 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -156.99 156.58 33.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.438 -0.789 . . . . 0.0 110.188 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -145.32 135.04 23.46 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.555 0.693 . . . . 0.0 109.362 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -94.36 122.52 37.0 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.522 0.677 . . . . 0.0 109.774 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.417 ' C ' ' ND1' ' A' ' 98' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.227 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.943 0.878 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -66.06 -18.2 65.19 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.606 0.717 . . . . 0.0 109.443 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -67.9 -33.95 75.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.445 -0.785 . . . . 0.0 109.842 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.415 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 90.9 m-20 -61.62 -46.76 88.45 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.462 -0.774 . . . . 0.0 110.062 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.31 -36.07 71.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 109.588 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.451 HE22 ' H ' ' A' ' 67' ' ' VAL . 68.4 tp60 -66.27 -41.13 90.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.578 -0.701 . . . . 0.0 109.521 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -64.85 -40.93 95.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.557 -0.714 . . . . 0.0 109.58 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -61.35 -42.37 98.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.575 -0.703 . . . . 0.0 109.583 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.3 -42.51 96.34 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.599 0.714 . . . . 0.0 109.175 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.4 t -65.43 -43.61 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.476 0.655 . . . . 0.0 109.659 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -61.74 -45.1 95.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.694 -0.629 . . . . 0.0 110.103 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 tp -63.31 -41.01 98.89 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.949 0.881 . . . . 0.0 109.976 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.623 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 62.9 t80 -66.43 -39.26 88.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.499 -0.75 . . . . 0.0 109.52 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.0 mt -61.82 -47.31 85.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.588 -0.695 . . . . 0.0 111.017 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.97 -34.56 78.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.503 -0.748 . . . . 0.0 110.314 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -72.46 -35.92 68.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 110.277 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.623 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 69.9 m-80 -94.72 -1.28 53.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.292 -0.88 . . . . 0.0 109.483 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 mt -140.93 86.79 11.41 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.389 -0.82 . . . . 0.0 109.346 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -55.98 -31.92 83.96 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.678 2.252 . . . . 0.0 111.303 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -82.25 13.46 3.5 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 25.1 t80 -57.2 130.68 47.24 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.758 0.79 . . . . 0.0 109.826 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -116.42 -66.82 1.04 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.524 ' HG1' ' H ' ' A' ' 35' ' ' VAL . 3.0 t -141.06 165.31 27.9 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.507 -0.746 . . . . 0.0 109.935 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.524 ' H ' ' HG1' ' A' ' 34' ' ' THR . 3.0 p -133.68 138.84 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.42 0.629 . . . . 0.0 109.357 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.8 m -124.91 115.75 21.11 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.689 0.757 . . . . 0.0 109.494 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -86.85 135.47 33.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -111.53 -35.79 5.7 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.74 32.38 19.32 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.507 0.67 . . . . 0.0 109.363 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.33 16.7 14.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.467 -0.771 . . . . 0.0 109.561 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -134.68 148.39 50.32 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.298 -0.876 . . . . 0.0 109.929 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.483 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 35.1 p90 -161.18 125.08 3.38 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.512 0.672 . . . . 0.0 109.313 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 4.3 p30 -91.02 150.99 42.76 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.527 -0.733 . . . . 0.0 109.847 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -65.06 -24.36 59.81 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.599 2.199 . . . . 0.0 111.766 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tp -70.39 -26.89 29.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.616 0.722 . . . . 0.0 109.382 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.38 -119.93 0.63 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.4 pt -126.2 158.98 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.691 -0.888 . . . . 0.0 110.533 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.4 m -141.67 139.75 33.05 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.2 127.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.55 0.691 . . . . 0.0 109.49 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.5 t0 -119.89 142.92 48.25 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.555 0.693 . . . . 0.0 109.571 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -173.09 -176.15 41.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -143.1 164.03 31.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.597 -0.943 . . . . 0.0 110.341 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 pt -119.03 164.47 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.793 0.806 . . . . 0.0 110.282 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' ASP . 68.7 m-80 58.11 34.35 24.1 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.543 0.687 . . . . 0.0 109.734 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 45.25 20.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.49 0.662 . . . . 0.0 109.657 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' ASN . 99.8 m-20 -102.14 109.65 21.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.494 -0.754 . . . . 0.0 109.232 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -57.37 -33.13 67.48 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.26 0.552 . . . . 0.0 109.933 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -61.99 -39.37 91.98 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.3 mt -81.24 71.28 8.22 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.293 -0.88 . . . . 0.0 109.59 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.3 p -90.67 161.69 15.26 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.676 0.75 . . . . 0.0 110.497 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -149.24 152.66 36.35 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.455 0.645 . . . . 0.0 109.665 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.8 m -131.06 135.21 47.35 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.583 0.706 . . . . 0.0 110.167 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.22 146.38 40.42 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.646 0.736 . . . . 0.0 109.309 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.09 -155.74 16.9 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.31 134.26 55.51 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.944 0.878 . . . . 0.0 110.571 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 50.93 29.88 4.81 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.474 0.654 . . . . 0.0 109.463 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.451 ' H ' HE22 ' A' ' 17' ' ' GLN . 2.0 t 48.49 30.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.659 0.743 . . . . 0.0 109.454 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' NH2' ' A' ' 84' ' ' ARG . 28.2 tptp -62.16 -45.19 94.51 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.622 -0.674 . . . . 0.0 109.237 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.18 128.26 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -134.5 138.49 44.73 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.664 0.745 . . . . 0.0 109.877 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 t -132.85 146.17 51.59 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.514 0.673 . . . . 0.0 109.25 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.1 t -135.01 147.12 49.6 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.817 0.818 . . . . 0.0 110.172 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.1 p -77.8 173.77 11.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.645 0.736 . . . . 0.0 110.284 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.39 -48.59 80.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.361 0.6 . . . . 0.0 110.16 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.457 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 59.5 mp0 -67.41 -45.01 77.4 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.441 -0.787 . . . . 0.0 109.819 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.16 -40.28 95.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.423 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -58.7 -41.26 85.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.595 -0.69 . . . . 0.0 109.191 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -65.21 -36.52 84.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.41 -0.807 . . . . 0.0 109.836 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 84.6 mmm -62.22 -38.17 88.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.239 -0.913 . . . . 0.0 109.208 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -57.91 138.18 56.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.456 -0.778 . . . . 0.0 109.554 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -108.03 -16.57 14.25 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -130.61 151.29 78.44 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.644 -0.66 . . . . 0.0 109.829 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.54 159.82 51.9 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.163 2.575 . . . . 0.0 112.881 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.462 ' NH2' ' O ' ' A' ' 68' ' ' LYS . 78.6 ttt-85 -66.82 132.53 48.23 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.786 0.803 . . . . 0.0 110.039 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -119.13 -72.43 0.69 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.39 158.44 9.87 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.4 t80 -62.57 -44.54 96.07 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.937 0.875 . . . . 0.0 109.636 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -73.55 -23.7 60.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.79 -45.47 67.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.523 -0.736 . . . . 0.0 109.673 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.42 HG13 ' N ' ' A' ' 91' ' ' LEU . 25.3 pt -66.79 -36.12 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.423 0.63 . . . . 0.0 109.563 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.42 ' N ' HG13 ' A' ' 90' ' ' ILE . 39.2 mt -63.63 -40.49 97.01 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.577 -0.702 . . . . 0.0 109.561 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -68.19 -41.97 80.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.616 -0.678 . . . . 0.0 109.628 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -68.03 -38.97 83.17 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.731 . . . . 0.0 109.852 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.59 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 14.2 t60 -60.56 -43.46 97.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.434 -0.791 . . . . 0.0 109.528 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.59 ' CD2' ' CD2' ' A' ' 94' ' ' HIS . 75.8 m-70 -155.48 -80.84 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.86 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.483 ' CG ' ' N ' ' A' ' 97' ' ' HIS . 19.6 p-80 -158.98 -142.6 0.09 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.448 -0.783 . . . . 0.0 110.308 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.549 ' N ' ' HD1' ' A' ' 97' ' ' HIS . 2.9 p-80 -152.4 153.2 33.1 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.738 0.78 . . . . 0.0 110.029 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 98' ' ' HIS . 58.1 t-80 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.106 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.324 0.583 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -62.33 -45.31 93.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.313 -0.867 . . . . 0.0 109.51 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -64.81 -36.5 84.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.395 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -61.38 -40.73 95.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.441 -0.787 . . . . 0.0 109.187 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -65.59 -40.25 92.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.565 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 66' ' ' ASP . 99.4 mm-40 -64.71 -42.43 95.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.691 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -64.25 -40.45 96.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.664 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.81 -44.5 93.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.86 . . . . 0.0 109.636 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.51 -41.7 96.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 109.862 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.3 t -64.63 -42.88 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.862 . . . . 0.0 109.644 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -59.74 -45.27 92.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.212 -0.93 . . . . 0.0 108.87 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.5 -41.96 98.53 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.398 -0.813 . . . . 0.0 109.281 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.484 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 83.1 t80 -58.99 -46.34 88.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.509 -0.744 . . . . 0.0 109.312 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -75.2 -22.93 57.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.69 -0.631 . . . . 0.0 109.712 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -63.96 -48.34 76.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.796 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . 0.619 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 26.2 p80 -81.81 -35.83 29.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.051 -1.031 . . . . 0.0 109.755 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.619 ' ND2' ' CE1' ' A' ' 27' ' ' HIS . 36.6 m-80 -64.04 -41.03 97.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -122.69 88.26 49.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.632 -0.667 . . . . 0.0 109.604 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -54.22 -29.79 58.49 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.756 2.304 . . . . 0.0 111.622 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -80.37 5.1 15.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -55.64 131.73 47.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.493 -0.755 . . . . 0.0 110.284 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -103.0 -65.71 0.98 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 t -149.93 165.0 33.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.841 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.1 p -128.12 135.64 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.8 m -126.5 123.46 37.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.574 -0.704 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -95.55 144.13 26.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 109.429 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.463 ' O ' ' OG1' ' A' ' 38' ' ' THR . 0.2 OUTLIER -143.32 17.95 1.89 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.925 . . . . 0.0 108.643 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -155.48 116.27 3.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.372 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -138.26 91.47 2.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -118.18 147.3 43.49 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.703 0.763 . . . . 0.0 109.965 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 42' ' ' PHE . 48.8 p90 -97.35 120.94 38.64 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.692 -0.63 . . . . 0.0 109.396 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.448 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 73.8 m-20 -103.58 154.59 37.78 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.342 -0.849 . . . . 0.0 108.909 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.92 -40.64 49.01 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.966 1.777 . . . . 0.0 111.594 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 92.0 mt -67.57 -41.26 85.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.456 -0.777 . . . . 0.0 109.059 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.54 -125.89 0.96 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.0 pt -128.36 151.33 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.588 -0.948 . . . . 0.0 110.011 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.448 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 6.0 m -127.04 122.45 34.44 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.11 130.89 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -129.8 149.85 51.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.708 0.766 . . . . 0.0 109.466 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.9 -168.14 34.47 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -142.48 164.79 29.17 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.344 -1.092 . . . . 0.0 110.309 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 pt -121.0 159.36 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.603 0.716 . . . . 0.0 110.306 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 57.52 32.8 22.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.565 -0.71 . . . . 0.0 109.518 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 46.74 32.18 1.66 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.32 -0.862 . . . . 0.0 110.123 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -109.57 108.29 18.68 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.528 -0.733 . . . . 0.0 109.466 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.92 -34.98 72.33 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.394 0.616 . . . . 0.0 109.61 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -62.55 -38.63 90.77 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.123 -0.986 . . . . 0.0 109.175 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.2 mt -83.91 77.55 9.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.1 t -107.37 162.76 13.63 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.372 0.606 . . . . 0.0 109.824 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -153.15 159.75 42.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.322 -0.861 . . . . 0.0 109.287 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.7 m -129.31 133.8 47.62 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.3 142.64 50.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.745 . . . . 0.0 109.14 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.49 124.82 5.4 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt 54.13 93.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.755 -0.85 . . . . 0.0 110.646 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD1' ' NE2' ' A' ' 17' ' ' GLN . 95.1 m-20 52.79 -103.23 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.708 -0.62 . . . . 0.0 110.109 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.84 17.8 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.53 -44.84 96.33 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.413 -0.804 . . . . 0.0 109.222 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.0 mt -121.89 126.06 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CD2' ' NH1' ' A' ' 84' ' ' ARG . 66.0 t80 -138.46 131.77 30.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.512 -0.742 . . . . 0.0 109.191 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 p -139.06 143.46 38.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.366 -0.834 . . . . 0.0 109.06 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 p -153.97 170.29 21.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.988 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -77.17 171.59 14.59 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.634 0.731 . . . . 0.0 110.835 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.71 -35.39 80.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.602 -0.686 . . . . 0.0 109.546 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -58.34 -57.55 12.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.115 -0.99 . . . . 0.0 109.279 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.97 -38.65 86.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.194 -0.941 . . . . 0.0 109.282 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -51.7 -38.42 55.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.378 -0.826 . . . . 0.0 109.702 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -60.42 -31.05 70.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 0.0 110.228 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.6 mmm -64.22 -35.45 80.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.953 . . . . 0.0 110.02 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -55.06 132.88 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.014 -1.054 . . . . 0.0 109.714 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -95.08 -71.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.623 -0.673 . . . . 0.0 109.484 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.19 158.03 41.89 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 109.352 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -46.56 158.35 0.38 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.243 1.962 . . . . 0.0 112.817 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.479 ' NH1' ' CD2' ' A' ' 70' ' ' PHE . 96.3 mtt-85 -67.59 141.33 56.82 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.392 -0.817 . . . . 0.0 109.59 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -130.95 145.72 52.12 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.458 0.646 . . . . 0.0 109.904 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.2 155.89 26.55 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -60.53 -46.01 91.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.8 -0.824 . . . . 0.0 109.403 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 45.8 p-10 -68.75 -32.93 73.05 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.16 -0.962 . . . . 0.0 109.683 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 83.0 tt0 -66.41 -43.09 86.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 110.508 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.7 pt -66.71 -37.73 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.033 -1.042 . . . . 0.0 109.375 -179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.56 -42.0 99.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.011 -1.055 . . . . 0.0 109.152 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 94' ' ' HIS . 96.8 mt-10 -66.6 -40.34 88.82 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.437 -0.789 . . . . 0.0 109.328 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 70.5 t60 58.5 -71.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.346 0.593 . . . . 0.0 110.453 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 92' ' ' GLU . 59.2 t-80 -60.99 153.19 25.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 110.567 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 95' ' ' HIS . 2.6 p80 -149.4 165.97 30.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 109.599 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.551 ' O ' ' N ' ' A' ' 98' ' ' HIS . 57.2 t-80 -85.13 79.08 9.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.348 -0.845 . . . . 0.0 109.226 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.2 t60 43.08 -90.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.606 -0.684 . . . . 0.0 110.365 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.551 ' N ' ' O ' ' A' ' 96' ' ' HIS . 84.7 t60 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.024 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.298 0.57 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -64.61 -45.04 88.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.489 -0.757 . . . . 0.0 110.266 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -63.65 -40.69 97.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 109.827 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.63 -41.17 98.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.806 . . . . 0.0 110.149 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.45 -40.0 92.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 109.962 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.89 -40.1 94.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.824 . . . . 0.0 110.058 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.01 -40.86 97.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.177 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -65.58 -40.25 92.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.967 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -63.25 -42.17 99.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -0.867 . . . . 0.0 109.415 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.53 -43.36 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.562 -0.712 . . . . 0.0 109.902 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -61.55 -44.65 96.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.661 -0.649 . . . . 0.0 110.146 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.2 tp -63.01 -44.13 96.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 110.379 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.514 ' CZ ' ' OD1' ' A' ' 28' ' ' ASN . 90.9 t80 -62.74 -45.13 94.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.037 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.05 -40.33 96.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.478 -0.764 . . . . 0.0 110.01 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -58.91 -45.03 91.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 110.744 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -68.23 -37.21 80.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.051 . . . . 0.0 110.26 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.514 ' OD1' ' CZ ' ' A' ' 24' ' ' TYR . 17.2 m120 -87.64 -5.39 58.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 109.177 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.4 mt -138.29 99.0 8.98 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.568 -0.708 . . . . 0.0 109.684 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.34 -14.75 31.32 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.334 2.023 . . . . 0.0 111.589 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -90.9 4.66 51.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.638 -0.664 . . . . 0.0 109.284 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -54.72 129.66 37.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.387 -0.821 . . . . 0.0 110.135 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -125.45 -56.11 1.52 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -146.49 156.46 43.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.341 -0.849 . . . . 0.0 109.627 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.91 140.28 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.623 -0.673 . . . . 0.0 109.872 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.6 m -124.68 128.2 48.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -97.88 124.91 42.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.472 -0.767 . . . . 0.0 110.015 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 39' ' ' ASN . 60.4 p -99.62 -15.16 18.67 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 38' ' ' THR . 74.4 m-20 58.1 148.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.596 0.712 . . . . 0.0 110.535 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.42 -163.96 1.59 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.346 -0.846 . . . . 0.0 109.946 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.12 -160.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.693 -0.629 . . . . 0.0 110.845 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -107.75 130.61 54.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.391 -0.818 . . . . 0.0 110.064 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -90.39 155.61 46.29 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.423 -0.798 . . . . 0.0 109.822 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -49.63 -37.03 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.534 2.156 . . . . 0.0 111.645 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.4 tt -68.4 -38.6 79.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.538 -0.726 . . . . 0.0 109.428 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 177.92 -97.14 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.56 148.82 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.882 . . . . 0.0 110.007 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 t -100.21 125.04 46.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.396 -0.815 . . . . 0.0 109.427 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.03 129.47 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 61' ' ' PHE . 22.6 t0 -130.68 152.14 50.37 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -175.41 -177.39 44.44 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -143.75 162.75 35.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.539 -0.977 . . . . 0.0 109.968 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.9 pt -121.41 161.5 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.595 0.712 . . . . 0.0 110.871 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 56.78 32.62 21.6 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.692 0.758 . . . . 0.0 109.616 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.7 m120 46.6 32.3 1.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.514 -0.741 . . . . 0.0 109.81 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -113.08 111.28 21.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.66 -0.65 . . . . 0.0 109.357 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -59.79 -31.75 69.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.605 -0.685 . . . . 0.0 109.564 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.96 -39.06 90.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 109.204 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.8 mt -83.5 73.14 10.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 108.986 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 m -105.05 159.67 15.65 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.649 0.737 . . . . 0.0 110.355 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.43 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 53.3 p90 -147.99 149.3 31.9 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.631 -0.668 . . . . 0.0 109.284 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.2 m -128.11 131.92 49.0 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.83 139.96 49.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.41 -0.806 . . . . 0.0 109.764 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -99.78 112.52 4.47 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.2 tttm 37.87 -83.0 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.097 -0.649 . . . . 0.0 111.813 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 64' ' ' GLY . 99.8 m-20 -78.21 125.19 28.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 37.2 t -60.39 0.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.548 ' H ' ' C ' ' A' ' 66' ' ' ASP . 65.8 tttm -61.74 -42.59 99.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 109.467 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.86 112.85 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.487 0.66 . . . . 0.0 109.386 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -141.39 158.53 43.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.591 -0.693 . . . . 0.0 109.926 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.0 t -125.51 155.9 39.85 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.477 0.655 . . . . 0.0 109.555 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 p -150.15 162.13 41.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.439 -0.788 . . . . 0.0 109.636 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -77.34 170.83 15.86 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.99 0.9 . . . . 0.0 110.838 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 74' ' ' GLU . 58.7 mp0 -66.09 -37.93 87.0 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.777 -0.577 . . . . 0.0 109.61 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.43 ' OE1' ' NZ ' ' A' ' 78' ' ' LYS . 80.5 mm-40 -64.95 -39.96 94.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.558 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.6 tp -82.61 -21.4 35.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.299 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -66.93 -48.0 69.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.43 ' NZ ' ' OE1' ' A' ' 75' ' ' GLU . 26.3 pttm -64.69 -22.62 67.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.402 -0.811 . . . . 0.0 110.227 -178.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.8 mtp -65.27 -33.68 76.55 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.535 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -53.78 141.72 25.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.872 . . . . 0.0 110.429 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -85.4 -75.81 0.35 Allowed 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.831 -0.543 . . . . 0.0 109.963 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' PRO . 25.9 mt-10 -99.93 154.54 37.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.731 . . . . 0.0 109.862 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 82' ' ' GLU . 85.1 Cg_exo -40.93 170.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.837 2.358 . . . . 0.0 113.282 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -64.98 130.95 45.27 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.705 0.764 . . . . 0.0 110.018 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -109.14 -78.01 0.59 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.29 145.86 4.21 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -60.44 -45.1 94.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.792 -0.828 . . . . 0.0 109.567 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.58 -26.99 62.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.162 -0.961 . . . . 0.0 109.327 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -69.16 -43.24 74.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.465 -0.772 . . . . 0.0 110.014 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.4 pt -68.3 -37.05 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.316 -0.865 . . . . 0.0 109.777 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 86.3 mt -62.91 -42.14 99.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.036 . . . . 0.0 109.777 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.06 -38.31 82.3 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.192 -0.942 . . . . 0.0 109.211 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.01 130.58 37.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.461 -0.774 . . . . 0.0 110.008 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -111.91 139.16 47.63 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.457 0.646 . . . . 0.0 109.674 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.439 ' NE2' ' NE2' ' A' ' 96' ' ' HIS . 27.0 p-80 -82.6 -11.8 58.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.586 -0.696 . . . . 0.0 109.168 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.439 ' NE2' ' NE2' ' A' ' 95' ' ' HIS . 99.5 m-70 -75.14 143.16 43.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -0.855 . . . . 0.0 110.289 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -153.73 163.86 39.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.698 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.601 ' CD2' ' H ' ' A' ' 98' ' ' HIS . 6.4 p80 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.831 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.375 0.607 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -63.56 -40.84 98.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.245 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -62.71 -40.66 97.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.588 -0.695 . . . . 0.0 109.477 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.06 -41.14 97.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.759 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.0 -41.18 97.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 109.437 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -64.1 -42.05 97.04 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.01 -43.27 93.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.606 -0.683 . . . . 0.0 109.859 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.31 -44.3 92.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.431 -0.793 . . . . 0.0 109.801 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.5 t -64.5 -45.26 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 110.072 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.8 m -62.44 -48.04 81.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.267 -0.896 . . . . 0.0 109.538 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 tp -64.08 -41.92 97.15 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.775 0.798 . . . . 0.0 109.656 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.454 ' CZ ' ' OD1' ' A' ' 28' ' ' ASN . 78.5 t80 -63.96 -40.57 96.72 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.922 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.08 -46.13 90.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.855 . . . . 0.0 110.472 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -68.89 -29.2 67.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 110.308 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -68.48 -39.74 81.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.269 -0.894 . . . . 0.0 109.897 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.454 ' OD1' ' CZ ' ' A' ' 24' ' ' TYR . 31.5 m120 -94.63 -3.69 49.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 108.65 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 80' ' ' PHE . 20.6 mt -138.38 93.98 11.04 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.92 -16.53 36.92 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.071 1.848 . . . . 0.0 111.057 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -90.12 5.54 46.38 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -58.11 133.81 55.9 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.55 -0.719 . . . . 0.0 110.164 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -110.19 -58.08 2.12 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 t -153.45 160.5 42.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 109.97 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.3 134.69 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -123.49 125.83 45.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.01 144.61 26.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.608 -0.682 . . . . 0.0 109.338 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.1 t -161.91 61.06 0.25 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.183 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -161.53 -83.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 40' ' ' GLU . 4.1 tm-20 56.13 75.13 0.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.794 . . . . 0.0 109.375 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -120.3 150.58 40.5 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.622 0.725 . . . . 0.0 109.614 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -92.23 120.31 32.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.376 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -103.49 156.01 36.07 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.28 -37.97 25.29 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.399 2.066 . . . . 0.0 112.06 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 46' ' ' GLY . 21.0 tt -68.72 -37.73 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.119 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.457 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 170.11 -98.44 0.13 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 pt -123.35 157.81 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.526 -0.985 . . . . 0.0 110.275 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.0 p -139.98 123.78 17.42 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.58 133.06 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.681 -0.637 . . . . 0.0 109.427 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 50.1 t0 -131.18 147.1 52.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.613 -0.68 . . . . 0.0 109.449 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -172.43 -170.61 36.44 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -141.42 165.59 27.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.356 -1.085 . . . . 0.0 110.156 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.4 pt -121.75 162.84 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.531 0.682 . . . . 0.0 110.872 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 57.76 33.18 22.91 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.347 0.594 . . . . 0.0 110.126 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 48.31 26.73 1.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.4 -0.812 . . . . 0.0 110.246 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -108.57 108.59 19.55 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.375 -0.828 . . . . 0.0 109.644 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.15 -32.47 68.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.652 -0.655 . . . . 0.0 109.65 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.58 -39.73 94.65 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.45 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.8 mt -81.89 80.31 8.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.163 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.8 m -104.86 153.41 21.4 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.747 0.784 . . . . 0.0 110.417 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -139.61 150.98 45.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.779 -0.575 . . . . 0.0 109.635 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.2 m -133.67 136.23 44.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.544 -0.723 . . . . 0.0 109.917 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.26 155.21 40.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.232 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.44 -130.35 3.91 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' ASP . 54.9 mtpt -59.23 128.57 37.82 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.487 -1.008 . . . . 0.0 110.716 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 67' ' ' VAL . 43.2 t0 44.93 -173.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.505 0.669 . . . . 0.0 110.278 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.506 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 2.3 t -94.69 21.28 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.097 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -63.4 -41.84 98.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.219 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.37 126.06 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -136.13 135.44 39.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.537 -0.727 . . . . 0.0 109.183 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 t -134.48 144.54 48.13 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.74 . . . . 0.0 109.413 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.1 p -152.71 164.08 38.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 110.516 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.1 p -68.06 167.44 13.95 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.611 0.72 . . . . 0.0 110.67 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -66.46 -36.61 83.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.313 -0.867 . . . . 0.0 109.447 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.83 -32.22 73.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.552 -0.717 . . . . 0.0 109.478 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.4 tp -90.52 -17.94 26.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 109.16 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -73.2 -42.27 62.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.67 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -63.77 -21.31 66.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.642 -0.661 . . . . 0.0 109.745 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 86.1 mmm -64.51 -35.36 80.7 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.341 -0.849 . . . . 0.0 109.15 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 29' ' ' ILE . 14.4 m-85 -64.31 132.79 51.23 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.32 -0.862 . . . . 0.0 109.86 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -113.21 -16.99 12.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -119.08 153.62 53.04 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.742 -0.598 . . . . 0.0 109.853 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.31 157.34 58.36 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 123.022 2.481 . . . . 0.0 113.012 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -67.4 141.65 56.98 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.726 0.774 . . . . 0.0 110.845 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -141.27 150.54 42.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.647 -0.658 . . . . 0.0 109.308 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.65 158.72 51.16 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -60.41 -44.08 96.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.715 -0.873 . . . . 0.0 109.58 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -66.26 -34.58 78.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 109.663 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -62.65 -49.5 74.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 109.689 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 pt -66.95 -37.46 79.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.472 -0.767 . . . . 0.0 109.427 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.3 tp -62.51 -44.23 96.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.899 . . . . 0.0 109.461 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.394 -0.817 . . . . 0.0 109.525 -179.472 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.0 t80 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.385 0.612 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -64.39 -36.56 84.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 109.658 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -63.23 -41.35 99.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.499 -0.751 . . . . 0.0 110.026 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 54.8 mp0 -67.62 -40.41 84.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.606 -0.683 . . . . 0.0 109.91 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.422 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 9.0 tp-100 -67.75 -36.72 81.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.402 -0.811 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.72 -42.69 99.3 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.623 0.725 . . . . 0.0 109.372 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.62 -39.88 91.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.737 -0.602 . . . . 0.0 109.94 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.74 -42.37 97.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.377 -0.827 . . . . 0.0 109.962 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.38 -42.3 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.1 m -60.51 -45.28 94.38 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.729 0.776 . . . . 0.0 109.078 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.404 HD11 ' NE2' ' A' ' 27' ' ' HIS . 41.8 tp -63.83 -41.91 97.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.444 -0.785 . . . . 0.0 108.998 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.675 ' CE2' ' ND2' ' A' ' 28' ' ' ASN . 75.6 t80 -61.36 -47.36 86.21 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.63 -39.83 94.39 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.57 0.7 . . . . 0.0 109.571 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -58.52 -47.82 82.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.624 -0.673 . . . . 0.0 110.272 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.404 ' NE2' HD11 ' A' ' 23' ' ' LEU . 59.5 m-70 -74.29 -42.75 59.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.28 -0.887 . . . . 0.0 110.072 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.675 ' ND2' ' CE2' ' A' ' 24' ' ' TYR . 68.9 m-80 -65.28 -39.81 93.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.761 . . . . 0.0 109.499 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.1 mt -105.18 109.32 63.08 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.709 -0.62 . . . . 0.0 109.607 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.94 -16.67 29.14 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.258 1.972 . . . . 0.0 111.15 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.525 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 54.4 t0 -97.33 13.64 28.89 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -58.16 129.54 42.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.485 -0.759 . . . . 0.0 110.036 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 31' ' ' ASP . 13.9 m-80 -125.83 -53.64 1.54 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -146.19 158.17 43.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.358 -0.839 . . . . 0.0 110.044 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.2 138.38 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.185 0.516 . . . . 0.0 109.874 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -130.51 124.06 31.07 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.516 0.674 . . . . 0.0 109.589 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -101.32 117.73 35.55 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.452 0.644 . . . . 0.0 109.583 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 t -154.76 30.04 0.42 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.601 -0.687 . . . . 0.0 109.237 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -147.51 16.16 1.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.487 -0.758 . . . . 0.0 109.006 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.75 141.11 45.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.592 0.711 . . . . 0.0 110.685 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -146.3 155.41 42.62 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.472 0.653 . . . . 0.0 109.751 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -75.76 140.82 42.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.637 -0.664 . . . . 0.0 109.789 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -112.01 140.32 23.33 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.22 -36.62 29.75 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.253 1.969 . . . . 0.0 111.422 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.3 tt -86.5 -6.4 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.395 -0.815 . . . . 0.0 109.217 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.92 -114.88 0.63 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 pt -127.21 157.09 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.786 -0.832 . . . . 0.0 110.289 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -128.23 131.48 48.8 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.54 0.686 . . . . 0.0 109.396 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mm -98.82 119.21 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.432 0.634 . . . . 0.0 109.457 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.432 ' OD1' HG23 ' A' ' 62' ' ' THR . 98.3 m-20 -123.58 141.93 51.53 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.45 0.643 . . . . 0.0 109.601 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.29 -168.27 38.01 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -145.9 164.93 30.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.88 -0.777 . . . . 0.0 109.955 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -122.75 164.82 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 121.844 0.831 . . . . 0.0 110.7 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 57.98 32.43 21.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.774 0.797 . . . . 0.0 109.783 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 46.56 30.52 1.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.852 -0.53 . . . . 0.0 110.164 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -112.82 111.62 22.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.553 -0.717 . . . . 0.0 109.569 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.04 -32.52 69.82 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.449 0.642 . . . . 0.0 109.493 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -62.82 -39.01 92.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.806 . . . . 0.0 109.424 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.35 76.13 9.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.456 -0.777 . . . . 0.0 109.442 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.1 m -100.34 159.65 14.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.459 0.647 . . . . 0.0 110.452 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -146.62 150.24 35.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.429 0.633 . . . . 0.0 109.812 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.432 HG23 ' OD1' ' A' ' 50' ' ' ASP . 52.3 m -131.29 135.59 47.43 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.23 145.94 51.01 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.591 0.71 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -93.99 111.59 4.17 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 67' ' ' VAL . 13.0 ptmt 26.93 -107.3 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.527 0.679 . . . . 0.0 111.123 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.37 42.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.714 0.769 . . . . 0.0 109.666 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 65' ' ' LYS . 2.3 t 51.13 37.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.939 0.876 . . . . 0.0 109.921 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -63.64 -41.96 98.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.655 -0.653 . . . . 0.0 109.362 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 69' ' ' ILE . 11.1 tp -135.09 131.31 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.617 -0.677 . . . . 0.0 109.279 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -124.21 133.43 53.53 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.525 0.679 . . . . 0.0 110.168 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -128.76 152.32 48.58 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.0 m -130.21 152.44 49.63 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.803 0.811 . . . . 0.0 110.161 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 77' ' ' ASP . 17.0 p -78.58 172.3 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.811 0.815 . . . . 0.0 110.65 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -58.64 -44.11 89.97 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.55 0.691 . . . . 0.0 109.9 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.05 -36.81 75.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.447 -0.783 . . . . 0.0 109.567 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.7 tp -81.37 -15.99 53.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.752 0.787 . . . . 0.0 109.43 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' SER . 65.2 t0 -61.12 -47.29 86.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.22 -0.925 . . . . 0.0 110.589 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -59.98 -44.0 94.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.445 -0.784 . . . . 0.0 110.595 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 94.5 mtp -66.51 -38.99 88.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.66 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -75.17 108.31 7.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.48 -0.763 . . . . 0.0 109.983 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -145.24 7.47 1.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -122.52 83.23 47.49 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.5 118.71 2.23 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.776 2.318 . . . . 0.0 113.128 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -80.97 166.0 21.23 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.972 0.891 . . . . 0.0 110.594 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -87.74 -5.91 58.44 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.867 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.65 165.79 14.39 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.715 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.421 ' CD2' HD11 ' A' ' 90' ' ' ILE . 52.9 t80 -62.71 -22.23 66.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.907 -0.761 . . . . 0.0 109.154 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -81.3 -26.82 35.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.552 -0.718 . . . . 0.0 109.937 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -72.48 -40.86 66.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.428 -0.795 . . . . 0.0 110.184 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 87' ' ' TYR . 17.5 pt -60.44 -23.93 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.453 -0.779 . . . . 0.0 110.356 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.2 mt -65.55 -33.58 76.25 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.242 -0.911 . . . . 0.0 109.896 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.454 0.645 . . . . 0.0 110.024 -179.325 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.8 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.252 0.548 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -85.56 -27.25 25.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.795 -0.566 . . . . 0.0 109.519 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -62.69 -44.83 95.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.789 -0.569 . . . . 0.0 109.947 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -65.79 -37.12 85.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.851 -0.531 . . . . 0.0 109.755 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.98 -43.08 99.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.8 -0.563 . . . . 0.0 110.033 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -64.78 -39.96 94.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.781 -0.574 . . . . 0.0 110.362 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.19 -39.48 94.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.712 -0.617 . . . . 0.0 109.561 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.33 -42.25 98.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.81 -0.556 . . . . 0.0 109.68 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.18 -43.3 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -61.88 -43.48 98.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.157 0.503 . . . . 0.0 109.782 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.427 HD11 ' NE2' ' A' ' 27' ' ' HIS . 51.8 tp -62.26 -41.26 98.3 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.324 0.583 . . . . 0.0 109.595 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.533 ' CD1' ' OD1' ' A' ' 28' ' ' ASN . 74.6 t80 -60.14 -46.28 90.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.668 HD21 ' CE2' ' A' ' 61' ' ' PHE . 69.4 mt -63.77 -41.28 98.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.819 -0.551 . . . . 0.0 110.611 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -61.73 -40.51 95.33 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.869 -0.519 . . . . 0.0 110.148 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.427 ' NE2' HD11 ' A' ' 23' ' ' LEU . 27.1 m-70 -86.72 -25.1 24.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.995 -0.441 . . . . 0.0 110.431 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' OD1' ' CD1' ' A' ' 24' ' ' TYR . 25.6 m120 -97.33 -11.41 24.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.427 -0.795 . . . . 0.0 109.228 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 25' ' ' LEU . 11.1 mt -148.16 88.67 5.39 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.31 -30.84 64.39 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.816 2.344 . . . . 0.0 112.051 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -78.94 6.17 9.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.54 130.67 47.08 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.782 0.801 . . . . 0.0 109.994 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -107.77 -56.06 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -161.46 165.95 27.96 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.503 0.668 . . . . 0.0 109.93 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.427 HG21 ' CZ ' ' A' ' 37' ' ' PHE . 14.8 p -127.59 137.22 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.741 0.782 . . . . 0.0 109.804 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.9 m -119.08 122.84 43.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.525 0.678 . . . . 0.0 109.549 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' ' CG2' ' A' ' 49' ' ' ILE . 72.9 m-85 -106.4 119.77 40.13 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.717 0.77 . . . . 0.0 109.743 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -33.91 0.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' GLU . 86.5 m-20 -69.51 -73.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.762 -0.586 . . . . 0.0 109.757 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 39' ' ' ASN . 81.7 tt0 55.5 151.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.924 0.869 . . . . 0.0 111.233 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -160.97 144.92 13.45 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.798 0.809 . . . . 0.0 109.806 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -92.83 140.54 29.4 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.532 0.682 . . . . 0.0 109.917 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -131.1 149.73 74.56 Favored Pre-proline 0 N--CA 1.486 1.352 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.77 -35.16 38.24 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.638 2.225 . . . . 0.0 112.021 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.8 pt -72.7 -4.94 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.53 -118.44 1.42 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 pt -126.55 154.73 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.797 -0.825 . . . . 0.0 110.103 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.2 p -135.87 131.46 35.33 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.759 0.79 . . . . 0.0 109.678 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.482 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 96.8 mt -94.48 127.64 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.538 0.685 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 65.9 t0 -127.58 137.13 52.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.615 0.721 . . . . 0.0 109.786 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -177.08 -151.66 9.25 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -146.09 160.69 41.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.816 -0.814 . . . . 0.0 110.26 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.02 HD11 HD11 ' A' ' 76' ' ' LEU . 51.0 pt -120.31 163.7 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.804 0.812 . . . . 0.0 110.95 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 58.09 33.54 23.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.837 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 45.92 29.26 0.71 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.436 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -111.74 109.57 19.48 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.773 0.797 . . . . 0.0 109.433 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -58.15 -34.21 70.04 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.846 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -62.26 -39.4 92.78 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.515 ' HB3' HD13 ' A' ' 76' ' ' LEU . 66.2 mt -81.69 86.8 6.36 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.562 0.696 . . . . 0.0 110.041 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.5 p -80.3 163.87 23.62 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.872 0.844 . . . . 0.0 110.846 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.668 ' CE2' HD21 ' A' ' 25' ' ' LEU . 52.7 t80 -149.66 131.03 14.69 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.585 0.707 . . . . 0.0 109.672 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.4 m -137.45 132.47 33.42 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.783 0.801 . . . . 0.0 110.058 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.41 142.62 37.48 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.789 0.804 . . . . 0.0 109.736 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -99.28 129.11 9.79 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' GLY . 17.9 tptm 35.36 -122.43 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.08 0.467 . . . . 0.0 110.649 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 68' ' ' LYS . 67.2 t0 -83.36 72.26 10.22 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.377 0.608 . . . . 0.0 109.745 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 66' ' ' ASP . 2.1 t 40.87 28.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.507 0.67 . . . . 0.0 109.345 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ASP . 49.1 mtpt -63.05 -41.94 99.6 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.69 126.17 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.639 0.733 . . . . 0.0 109.82 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -92.71 123.55 36.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.877 0.846 . . . . 0.0 109.718 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -141.29 119.75 12.34 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.809 0.814 . . . . 0.0 109.437 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 p -153.36 165.16 36.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.947 0.88 . . . . 0.0 110.489 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.2 p -75.19 164.35 26.57 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.838 0.828 . . . . 0.0 110.433 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.65 -36.99 83.87 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.6 -34.69 76.07 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.02 HD11 HD11 ' A' ' 53' ' ' ILE . 15.0 tp -91.97 -21.28 20.63 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -65.76 -35.43 80.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 109.754 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -75.03 -12.26 60.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.624 -0.672 . . . . 0.0 110.133 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.784 ' SD ' HD12 ' A' ' 76' ' ' LEU . 82.2 mtp -77.11 -5.18 47.96 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -89.7 120.62 31.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.764 0.792 . . . . 0.0 109.031 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 79' ' ' MET . 3.0 mp0 -97.47 -11.99 23.17 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -133.03 149.95 74.23 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.692 -0.63 . . . . 0.0 109.702 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.62 149.57 10.04 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.503 2.135 . . . . 0.0 112.393 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -64.55 136.8 57.4 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.654 0.74 . . . . 0.0 110.285 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -128.65 143.89 51.04 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.053 0.93 . . . . 0.0 110.355 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.21 160.24 52.7 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -60.25 -45.33 93.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.234 -0.568 . . . . 0.0 109.938 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.68 -36.97 86.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.577 -0.702 . . . . 0.0 109.695 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -62.22 -48.4 80.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.824 -0.547 . . . . 0.0 110.0 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.9 pt -69.59 -32.49 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.767 -0.583 . . . . 0.0 109.518 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.24 -44.23 92.46 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.863 -0.523 . . . . 0.0 109.733 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.323 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -62.35 -43.81 97.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.85 -0.531 . . . . 0.0 110.37 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -62.52 -42.16 99.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.444 -0.785 . . . . 0.0 110.163 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.81 -39.15 87.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.797 -0.565 . . . . 0.0 110.272 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 21' ' ' VAL . 89.6 mm-40 -66.0 -39.71 90.51 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.716 . . . . 0.0 109.751 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HZ2' ' CB ' ' A' ' 37' ' ' PHE . 68.4 mttm -62.98 -43.16 99.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.604 -0.685 . . . . 0.0 109.923 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.59 -43.38 80.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.774 -0.579 . . . . 0.0 110.06 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -65.47 -42.52 92.16 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.0 109.915 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 17' ' ' GLN . 55.5 t -64.56 -43.76 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.845 -0.535 . . . . 0.0 109.913 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -61.09 -48.53 81.28 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.579 HD11 ' NE2' ' A' ' 27' ' ' HIS . 58.5 tp -65.93 -40.81 91.74 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 90' ' ' ILE . 36.6 t80 -61.07 -48.77 80.2 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.13 -41.87 94.41 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.315 0.579 . . . . 0.0 109.834 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.1 -44.0 91.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.884 -0.51 . . . . 0.0 110.68 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.579 ' NE2' HD11 ' A' ' 23' ' ' LEU . 16.4 m170 -68.86 -37.06 78.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.373 -0.83 . . . . 0.0 110.318 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.461 HD21 ' CG ' ' A' ' 84' ' ' ARG . 1.3 m-20 -87.2 -5.15 59.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -138.2 94.54 10.97 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.06 -18.51 27.4 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.321 2.014 . . . . 0.0 111.278 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.98 7.44 44.05 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CG ' ' N ' ' A' ' 33' ' ' ASN . 61.1 t80 -54.82 158.19 2.8 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.704 0.764 . . . . 0.0 110.143 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.451 ' N ' ' CG ' ' A' ' 32' ' ' PHE . 65.4 t30 -145.31 -52.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -149.8 151.35 33.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.818 . . . . 0.0 110.095 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.2 137.15 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.534 0.683 . . . . 0.0 109.834 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.467 HG21 ' OH ' ' A' ' 52' ' ' TYR . 87.4 m -116.96 112.23 20.71 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.621 0.724 . . . . 0.0 109.117 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' O ' HG23 ' A' ' 38' ' ' THR . 74.1 m-85 -80.6 145.63 31.63 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.485 0.659 . . . . 0.0 110.303 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 50' ' ' ASP . 25.3 p -155.45 106.45 2.54 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.712 0.767 . . . . 0.0 109.655 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 38' ' ' THR . 90.9 m-20 -49.99 -105.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.383 0.611 . . . . 0.0 109.989 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 41' ' ' GLU . 81.6 tt0 55.83 113.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.48 0.657 . . . . 0.0 110.336 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 42' ' ' PHE . 5.5 tm-20 79.23 141.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.466 0.65 . . . . 0.0 110.395 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.502 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 96.9 m-85 -135.06 151.92 51.21 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.835 0.826 . . . . 0.0 110.372 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -72.51 157.08 89.61 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -37.48 -66.74 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.904 2.403 . . . . 0.0 112.598 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.9 mm -108.01 -26.71 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.72 -160.63 34.18 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.5 pt -120.44 146.27 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.694 0.759 . . . . 0.0 109.818 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.46 ' H ' ' HA ' ' A' ' 42' ' ' PHE . 10.1 t -111.47 128.46 56.01 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.551 0.691 . . . . 0.0 109.532 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -115.27 127.3 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.672 0.748 . . . . 0.0 109.767 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 59.4 t0 -113.89 154.14 28.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.846 0.831 . . . . 0.0 109.667 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -179.58 -175.23 46.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.1 p90 -149.91 166.22 30.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.874 -0.78 . . . . 0.0 110.436 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 pt -118.83 158.86 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 CA-C-O 121.89 0.852 . . . . 0.0 110.849 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 66.0 m-80 56.75 36.87 28.31 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.194 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 25.1 p30 45.04 23.28 0.09 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.084 0.469 . . . . 0.0 110.535 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -105.67 113.97 27.85 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.66 0.743 . . . . 0.0 109.836 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.23 -30.64 69.54 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -62.17 -38.7 90.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.549 -0.72 . . . . 0.0 109.381 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.4 mt -83.56 63.45 7.38 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.6 p -89.49 160.86 16.53 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.121 0.962 . . . . 0.0 110.961 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -151.9 150.91 30.59 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.468 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.7 m -134.86 134.1 40.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.598 0.713 . . . . 0.0 110.069 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.33 135.85 54.39 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.844 0.83 . . . . 0.0 109.564 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -100.22 89.06 0.81 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.6 tttm 57.89 -72.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 122.286 -0.538 . . . . 0.0 110.259 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 64' ' ' GLY . 98.1 m-20 -89.46 129.91 35.88 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.864 0.84 . . . . 0.0 110.21 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 67' ' ' VAL . 46.2 t -62.6 -0.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 66' ' ' ASP . 66.0 tttm -62.92 -41.59 99.51 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.65 111.13 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.808 0.813 . . . . 0.0 108.897 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -140.8 126.93 19.58 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.733 0.778 . . . . 0.0 110.333 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 p -84.01 168.32 16.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.493 0.663 . . . . 0.0 109.535 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.6 p -152.75 155.91 38.1 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.855 0.836 . . . . 0.0 110.704 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.2 p -75.7 166.03 24.16 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.738 0.78 . . . . 0.0 110.46 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.92 -44.15 97.37 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.027 0.442 . . . . 0.0 109.813 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.5 mp0 -69.24 -39.14 78.67 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.47 0.653 . . . . 0.0 109.844 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.44 -34.9 77.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.749 -0.594 . . . . 0.0 109.513 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -61.93 -33.33 74.05 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -73.26 -38.25 66.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.532 -0.73 . . . . 0.0 109.863 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.4 mmm -66.22 -65.29 0.7 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.602 -0.687 . . . . 0.0 110.55 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -60.04 149.27 32.77 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.764 0.792 . . . . 0.0 110.38 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -80.39 -105.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.34 0.591 . . . . 0.0 110.503 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -104.44 147.3 34.16 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.773 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.6 145.89 53.51 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.36 2.04 . . . . 0.0 112.073 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.461 ' CG ' HD21 ' A' ' 28' ' ' ASN . 74.4 mmt-85 -86.55 165.99 15.79 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.881 0.848 . . . . 0.0 110.671 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.66 -6.06 58.42 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.02 176.72 25.01 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.638 ' CD1' HD11 ' A' ' 90' ' ' ILE . 61.5 t80 -63.39 -37.14 86.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.922 -0.752 . . . . 0.0 109.25 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.69 -20.67 62.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.566 -0.709 . . . . 0.0 109.207 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -72.32 -48.67 40.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.634 -0.666 . . . . 0.0 109.741 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 87' ' ' TYR . 14.3 pt -61.84 -41.18 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.623 -0.673 . . . . 0.0 109.869 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.554 HD11 ' CE2' ' A' ' 87' ' ' TYR . 12.0 mt -65.41 -40.28 93.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.577 -0.702 . . . . 0.0 109.721 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.795 -0.566 . . . . 0.0 109.813 -179.286 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.6 t80 . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.119 0.485 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -63.04 -43.48 98.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.528 -0.732 . . . . 0.0 109.62 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -64.3 -42.25 96.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.695 -0.628 . . . . 0.0 110.08 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.74 -37.91 85.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.458 -0.776 . . . . 0.0 110.195 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.411 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 7.6 tp-100 -62.93 -42.59 99.85 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -63.71 -40.38 96.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.472 -0.768 . . . . 0.0 109.369 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -63.4 -41.51 98.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.537 -0.727 . . . . 0.0 110.085 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -61.38 -42.05 98.09 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.508 -0.745 . . . . 0.0 109.847 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.01 -40.89 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.433 -0.792 . . . . 0.0 109.267 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 m -59.69 -43.46 94.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.642 -0.661 . . . . 0.0 109.247 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.24 -41.43 98.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.509 -0.744 . . . . 0.0 109.831 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.655 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 90.1 t80 -60.28 -49.11 78.92 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.3 mt -68.18 -41.2 81.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.634 -0.666 . . . . 0.0 110.641 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -65.05 -43.33 92.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.405 -0.809 . . . . 0.0 110.442 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -80.28 -15.94 55.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.386 -0.821 . . . . 0.0 110.456 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.655 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 91.4 m-20 -104.2 -10.24 18.06 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.258 -0.901 . . . . 0.0 108.88 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 mt -144.11 88.11 7.63 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 32' ' ' PHE . 53.2 Cg_exo -53.63 -30.89 57.51 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.51 2.14 . . . . 0.0 111.271 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -72.66 13.09 0.4 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' PRO . 29.1 t80 -61.22 130.38 45.95 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.689 0.757 . . . . 0.0 110.236 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -118.96 -61.52 1.63 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 t -146.12 164.54 31.85 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.515 0.674 . . . . 0.0 109.935 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.5 138.16 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.544 0.688 . . . . 0.0 109.624 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.2 m -126.76 115.24 19.07 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.66 0.743 . . . . 0.0 109.551 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -94.08 126.61 39.41 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.759 0.79 . . . . 0.0 109.563 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.34 86.1 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -177.43 -64.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 41.38 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.592 -0.693 . . . . 0.0 110.053 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -122.4 147.34 46.42 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.996 0.903 . . . . 0.0 110.034 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.528 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 53.0 p90 -88.81 120.24 30.03 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.503 0.668 . . . . 0.0 109.736 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -107.41 154.74 40.48 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -46.38 -40.76 22.77 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.504 2.136 . . . . 0.0 111.907 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 46' ' ' GLY . 21.4 tt -70.02 -38.93 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.76 . . . . 0.0 109.615 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 173.25 -107.66 0.25 Allowed Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -121.23 143.81 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.626 -0.926 . . . . 0.0 110.17 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.0 t -119.26 134.91 54.95 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.653 0.739 . . . . 0.0 110.09 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.16 129.42 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.681 0.753 . . . . 0.0 109.359 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.5 t0 -133.49 142.4 48.23 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.831 0.824 . . . . 0.0 109.687 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -173.5 -165.16 29.89 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -142.39 165.09 28.38 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.678 -0.895 . . . . 0.0 110.274 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.5 pt -122.42 167.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.934 0.873 . . . . 0.0 110.725 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' ASP . 69.1 m-80 57.31 34.25 24.46 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.662 0.744 . . . . 0.0 109.441 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 44.56 24.44 0.1 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 54' ' ' ASN . 99.5 m-20 -108.17 111.1 22.93 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.668 0.747 . . . . 0.0 109.293 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.477 ' HB3' ' HZ3' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -59.22 -31.58 69.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.727 -0.608 . . . . 0.0 110.102 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -61.96 -38.77 89.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.45 -0.781 . . . . 0.0 109.495 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -82.74 75.26 9.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.474 -0.766 . . . . 0.0 109.534 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 m -95.85 156.13 16.46 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.922 0.867 . . . . 0.0 110.397 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -147.12 157.03 43.47 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.628 0.728 . . . . 0.0 109.923 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.1 m -141.29 138.87 33.49 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.692 -0.63 . . . . 0.0 109.873 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.94 144.62 31.16 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.649 0.737 . . . . 0.0 109.528 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -98.24 128.7 9.65 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 64' ' ' GLY . 15.1 ptmt 24.76 -114.18 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.461 0.648 . . . . 0.0 111.238 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.454 ' C ' ' N ' ' A' ' 68' ' ' LYS . 67.2 t0 -71.54 66.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.158 0.98 . . . . 0.0 109.955 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 50.43 12.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.545 0.688 . . . . 0.0 109.455 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 64' ' ' GLY . 68.7 mmtt -61.43 115.57 3.99 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 122.051 0.929 . . . . 0.0 109.82 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.6 mt 55.16 115.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.87 0.843 . . . . 0.0 109.883 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.508 ' CE1' ' OH ' ' A' ' 24' ' ' TYR . 47.2 p90 -139.26 153.9 47.88 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.877 0.846 . . . . 0.0 110.203 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 p -141.74 160.86 39.32 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.621 0.724 . . . . 0.0 109.47 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.2 m -145.68 155.21 42.85 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.977 0.894 . . . . 0.0 110.414 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -65.88 163.03 17.78 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.943 0.878 . . . . 0.0 110.371 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.1 mp0 -58.5 -48.9 79.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.545 -0.722 . . . . 0.0 109.743 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mp0 -64.54 -42.04 95.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.622 -0.674 . . . . 0.0 110.066 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.17 -38.76 85.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.595 -0.691 . . . . 0.0 110.034 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -63.32 -33.67 76.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.411 -0.806 . . . . 0.0 109.402 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.01 -12.32 60.88 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.38 -0.825 . . . . 0.0 109.973 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.7 mtp -85.09 -8.21 58.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.26 -0.9 . . . . 0.0 109.38 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -63.64 135.91 57.11 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.591 0.71 . . . . 0.0 110.006 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -111.9 -25.04 9.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -120.13 153.7 55.54 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.75 179.63 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.982 2.455 . . . . 0.0 113.094 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.46 ' NH1' ' CZ ' ' A' ' 70' ' ' PHE . 95.5 mtt-85 -63.86 126.72 28.54 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.067 0.937 . . . . 0.0 110.597 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -136.88 147.51 46.52 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.734 0.778 . . . . 0.0 109.911 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.88 164.44 44.67 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.567 ' CE2' HD11 ' A' ' 91' ' ' LEU . 71.8 t80 -61.5 -44.0 97.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.804 -0.821 . . . . 0.0 109.133 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -70.13 -31.11 68.49 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.476 -0.765 . . . . 0.0 109.803 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.86 -45.51 77.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 91' ' ' LEU . 28.8 pt -66.16 -35.91 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.43 -0.794 . . . . 0.0 109.57 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.567 HD11 ' CE2' ' A' ' 87' ' ' TYR . 35.7 mt -63.36 -42.41 98.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.524 ' CZ ' ' NE2' ' A' ' 17' ' ' GLN . 91.3 t80 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.645 0.736 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -65.31 -36.64 84.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.512 -0.742 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.53 -41.33 98.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.148 -0.97 . . . . 0.0 109.838 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.62 -39.97 88.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.58 -0.7 . . . . 0.0 110.445 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.524 ' NE2' ' CZ ' ' A' ' 13' ' ' PHE . 96.6 mm-40 -64.78 -40.72 95.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 109.897 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.04 -40.99 97.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.71 -41.83 98.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.861 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -64.1 -42.43 96.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.745 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.9 -43.08 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.444 -0.785 . . . . 0.0 109.619 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.8 m -61.29 -44.65 96.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.497 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.58 HD11 ' NE2' ' A' ' 27' ' ' HIS . 49.1 tp -62.88 -42.81 99.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.367 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.507 ' CE1' ' OD1' ' A' ' 28' ' ' ASN . 58.7 t80 -61.05 -47.85 84.46 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.492 0.663 . . . . 0.0 109.712 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.01 -39.6 93.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -0.791 . . . . 0.0 109.703 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -59.75 -45.51 92.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.877 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.58 ' NE2' HD11 ' A' ' 23' ' ' LEU . 32.9 m-70 -74.47 -32.78 62.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.826 . . . . 0.0 109.757 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.507 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 32.1 m120 -87.19 -2.9 58.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.379 -0.826 . . . . 0.0 109.608 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.4 mt -146.76 89.85 5.63 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.229 -0.919 . . . . 0.0 109.034 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -55.38 -30.19 71.77 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.454 2.103 . . . . 0.0 111.34 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -84.98 16.15 3.59 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 21.8 t80 -57.57 128.99 39.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.493 -0.755 . . . . 0.0 110.463 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.456 ' ND2' ' OD1' ' A' ' 54' ' ' ASN . 99.9 m-20 -113.8 -64.96 1.24 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.562 0.696 . . . . 0.0 109.331 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -150.82 158.73 44.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.752 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.13 135.53 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.586 -0.696 . . . . 0.0 109.425 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -124.64 123.8 40.83 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.661 0.743 . . . . 0.0 109.368 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -96.31 137.54 35.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.647 -0.658 . . . . 0.0 109.241 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.6 p -147.12 -35.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 108.805 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -103.41 145.45 29.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.28 -0.887 . . . . 0.0 110.356 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -169.05 143.94 3.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.377 -0.827 . . . . 0.0 109.623 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -139.07 151.8 47.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.443 -0.786 . . . . 0.0 109.321 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -90.59 118.84 30.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.233 -0.917 . . . . 0.0 109.903 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 46' ' ' GLY . 1.6 m-20 -90.43 158.07 43.77 Favored Pre-proline 0 C--N 1.306 -1.326 0 O-C-N 121.5 -0.75 . . . . 0.0 109.975 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.23 -27.12 41.48 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 123.099 2.532 . . . . 0.0 110.417 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -102.56 -8.23 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 171.06 -144.42 8.26 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.441 ' HA ' ' H ' ' A' ' 43' ' ' ASN . 42.0 pt -124.82 152.31 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.558 -0.966 . . . . 0.0 109.485 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.4 m -117.43 127.45 54.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.74 130.36 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.619 0.723 . . . . 0.0 109.36 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -130.06 125.84 36.2 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.588 0.709 . . . . 0.0 109.225 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.31 -161.46 10.36 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -144.15 160.88 40.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.983 . . . . 0.0 109.874 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.6 pt -119.76 167.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-O 121.601 0.715 . . . . 0.0 110.728 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.456 ' OD1' ' ND2' ' A' ' 33' ' ' ASN . 66.4 m-80 59.11 32.92 22.56 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.629 0.728 . . . . 0.0 109.55 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 46.87 32.23 1.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.51 -0.744 . . . . 0.0 109.564 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -126.99 103.93 7.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.604 -0.685 . . . . 0.0 109.321 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -56.12 -17.13 6.32 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.416 0.627 . . . . 0.0 109.543 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -63.9 -38.32 90.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.35 -0.844 . . . . 0.0 108.889 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.5 mt -88.24 73.91 8.82 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.2 m -87.92 154.75 20.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.821 0.82 . . . . 0.0 110.771 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -147.62 158.82 44.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.722 -0.612 . . . . 0.0 109.587 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.2 m -134.11 136.53 43.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.771 . . . . 0.0 109.706 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.49 141.07 48.62 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 67' ' ' VAL . . . -97.93 115.71 5.34 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 64' ' ' GLY . 88.6 tttt 26.06 -95.17 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.389 0.614 . . . . 0.0 111.795 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -85.71 45.31 1.19 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.356 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 64' ' ' GLY . 2.1 t 51.93 35.3 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.164 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -62.83 -41.32 99.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.825 . . . . 0.0 109.008 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.0 tp -127.57 136.32 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -126.46 129.78 49.37 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.645 0.736 . . . . 0.0 109.835 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 t -137.3 149.06 46.81 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.2 p -138.89 157.04 46.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 0.0 110.357 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.0 p -76.02 171.12 15.0 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.866 0.841 . . . . 0.0 110.758 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -59.37 -41.01 88.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.681 -0.637 . . . . 0.0 109.947 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.45 -48.79 59.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.958 . . . . 0.0 109.886 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.69 -22.06 66.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.34 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -62.41 -36.18 81.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.559 -0.713 . . . . 0.0 110.077 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -62.68 -45.06 94.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 0.0 110.53 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 98.6 mtp -68.74 -38.03 79.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.09 -1.006 . . . . 0.0 109.482 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.512 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 72.4 t80 -75.68 119.39 19.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 110.03 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -142.93 2.19 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.512 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 47.9 mt-10 -102.66 130.12 24.54 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.471 -0.768 . . . . 0.0 109.561 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -47.41 140.78 15.2 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.473 2.115 . . . . 0.0 113.151 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -76.97 140.07 40.32 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.6 0.714 . . . . 0.0 110.256 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -137.66 147.96 45.34 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.732 0.777 . . . . 0.0 109.698 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.47 161.15 12.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -62.46 -42.48 99.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.795 -0.827 . . . . 0.0 109.194 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 34.5 p-10 -68.54 -31.18 70.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.442 -0.786 . . . . 0.0 109.757 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 80.1 mm-40 -64.58 -48.6 74.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.451 -0.781 . . . . 0.0 109.848 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 91' ' ' LEU . 25.9 pt -68.18 -37.69 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.442 -0.786 . . . . 0.0 109.196 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.426 ' N ' HG13 ' A' ' 90' ' ' ILE . 57.9 tp -63.47 -41.94 98.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.226 -179.963 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.403 ' O ' ' OE1' ' A' ' 17' ' ' GLN . 79.2 t80 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.25 0.547 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -64.27 -40.1 95.3 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.351 0.596 . . . . 0.0 109.86 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -62.59 -40.72 97.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.676 -0.64 . . . . 0.0 109.931 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.6 -38.75 87.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.518 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 1.5 mp0 -64.09 -40.49 96.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.524 -0.735 . . . . 0.0 109.557 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -64.66 -40.21 95.03 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.249 0.547 . . . . 0.0 109.956 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -65.62 -41.01 93.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.705 -0.622 . . . . 0.0 110.052 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.495 ' NZ ' ' CE2' ' A' ' 87' ' ' TYR . 68.2 mttm -63.08 -44.29 96.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.605 -0.684 . . . . 0.0 110.101 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.48 -44.12 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.653 -0.654 . . . . 0.0 109.984 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.1 m -63.58 -43.8 95.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.574 -0.704 . . . . 0.0 109.841 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.7 -43.16 99.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.724 -0.61 . . . . 0.0 110.317 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.639 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 66.8 t80 -62.35 -47.83 82.5 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.335 0.588 . . . . 0.0 109.803 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.46 -41.45 96.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.616 -0.678 . . . . 0.0 109.895 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.17 -43.98 92.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.769 -0.582 . . . . 0.0 109.931 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -68.66 -37.88 79.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.751 -0.593 . . . . 0.0 110.236 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.639 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 85.0 m-20 -90.79 -0.71 57.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.4 -0.812 . . . . 0.0 109.322 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.4 mt -143.81 83.6 10.37 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 109.035 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -54.88 -26.64 49.51 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.664 2.243 . . . . 0.0 111.284 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -78.38 0.36 25.96 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -59.0 129.14 40.75 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.723 0.773 . . . . 0.0 110.128 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -123.84 -57.82 1.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -147.49 155.58 42.03 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.73 0.776 . . . . 0.0 110.151 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.39 140.43 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.434 0.635 . . . . 0.0 109.41 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.9 m -128.67 125.9 39.02 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.898 0.856 . . . . 0.0 110.133 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -93.76 134.58 35.95 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 t -172.9 55.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.662 -0.649 . . . . 0.0 109.447 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' GLU . 24.3 t-20 -173.31 133.68 0.51 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.556 -0.715 . . . . 0.0 110.417 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' ASN . 96.9 mt-10 58.21 140.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.755 0.788 . . . . 0.0 110.683 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -144.54 -90.34 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.652 -0.655 . . . . 0.0 109.476 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -75.19 147.36 40.46 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.853 0.835 . . . . 0.0 110.243 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.96 168.1 2.26 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 46' ' ' GLY . 52.3 Cg_exo -50.91 -39.43 58.88 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.436 2.091 . . . . 0.0 111.814 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.5 pt -76.51 28.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.518 0.675 . . . . 0.0 109.195 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 81.82 -99.42 2.0 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.9 pt -119.85 144.14 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.859 0.838 . . . . 0.0 109.948 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.7 m -119.66 122.44 41.51 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.695 0.759 . . . . 0.0 109.831 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.02 125.89 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.929 0.871 . . . . 0.0 109.382 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.6 t0 -142.9 139.85 30.95 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.01 0.91 . . . . 0.0 109.832 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -167.22 -162.62 19.37 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -140.46 161.72 37.05 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.908 -0.76 . . . . 0.0 110.628 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 pt -118.73 156.6 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 121.959 0.885 . . . . 0.0 110.689 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 56.3 33.89 23.09 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.048 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 47.95 32.68 2.94 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.17 0.51 . . . . 0.0 110.0 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -111.79 109.65 19.6 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.72 0.771 . . . . 0.0 109.317 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -57.28 -34.51 68.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.905 -0.497 . . . . 0.0 109.98 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.57 -39.25 93.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.599 -0.688 . . . . 0.0 109.742 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.8 76.95 9.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.511 -0.743 . . . . 0.0 109.583 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.8 p -112.5 156.59 22.35 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.817 0.818 . . . . 0.0 110.478 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.404 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 32.1 p90 -150.49 158.45 44.17 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.461 0.648 . . . . 0.0 109.595 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.9 m -136.08 132.15 35.78 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.683 0.754 . . . . 0.0 110.135 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.07 140.95 42.37 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.832 0.825 . . . . 0.0 109.617 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 65' ' ' LYS . . . -109.08 140.2 15.55 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 64' ' ' GLY . 53.6 mtpt 40.46 100.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.298 0.57 . . . . 0.0 110.598 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.504 ' OD1' ' NE2' ' A' ' 17' ' ' GLN . 99.0 m-20 57.93 -88.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.404 0.621 . . . . 0.0 109.712 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.79 13.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 69' ' ' ILE . 68.5 mttm -70.51 131.45 44.04 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.872 0.844 . . . . 0.0 109.859 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.4 mt 52.59 103.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.645 0.736 . . . . 0.0 109.41 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -138.25 153.86 49.09 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.891 0.853 . . . . 0.0 110.29 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.1 t -136.87 151.02 48.62 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.76 0.79 . . . . 0.0 109.614 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.2 t -134.66 150.18 50.61 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.822 0.82 . . . . 0.0 110.101 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 p -75.89 166.8 22.98 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.883 0.849 . . . . 0.0 110.221 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.66 -45.39 92.19 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.215 0.531 . . . . 0.0 109.639 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -65.28 -45.71 83.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.644 -0.66 . . . . 0.0 109.657 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.535 HD12 ' SD ' ' A' ' 79' ' ' MET . 58.6 tp -69.0 -28.94 67.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.83 -36.4 83.38 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 109.407 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -75.68 -7.54 54.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.449 -0.782 . . . . 0.0 109.914 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.535 ' SD ' HD12 ' A' ' 76' ' ' LEU . 77.0 mtp -82.42 -8.79 59.62 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -69.1 138.5 54.35 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.62 0.724 . . . . 0.0 109.464 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -128.04 -45.45 1.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.49 154.96 39.58 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.626 -0.671 . . . . 0.0 109.581 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -53.31 145.55 44.39 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.363 2.042 . . . . 0.0 112.649 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -77.36 138.01 39.07 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.781 0.8 . . . . 0.0 109.969 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.86 150.47 47.17 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.858 0.837 . . . . 0.0 110.116 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.1 163.4 25.68 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.643 ' CE2' HD11 ' A' ' 91' ' ' LEU . 78.5 t80 -60.57 -44.7 95.9 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.6 0.714 . . . . 0.0 109.681 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 36.6 p-10 -68.43 -32.87 73.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.572 -0.705 . . . . 0.0 109.902 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 79.8 mm-40 -66.78 -45.34 78.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.664 -0.647 . . . . 0.0 110.447 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.6 pt -65.92 -35.52 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.512 -0.742 . . . . 0.0 109.631 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.643 HD11 ' CE2' ' A' ' 87' ' ' TYR . 34.3 mt -63.02 -42.13 99.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.553 -0.717 . . . . 0.0 109.748 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.831 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.185 0.517 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -62.86 -42.2 99.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.643 -0.661 . . . . 0.0 109.931 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.21 -40.45 97.51 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.368 0.604 . . . . 0.0 109.696 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.41 -39.23 85.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.674 -0.641 . . . . 0.0 109.587 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.442 HE22 HD11 ' A' ' 47' ' ' ILE . 86.4 mt-30 -63.38 -39.71 95.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.383 -0.823 . . . . 0.0 108.946 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -62.66 -42.12 99.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.825 -0.547 . . . . 0.0 110.017 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -66.88 -39.74 87.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.628 -0.67 . . . . 0.0 109.546 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.8 -43.54 96.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.752 -0.592 . . . . 0.0 109.541 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.4 t -65.39 -42.83 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.841 -0.537 . . . . 0.0 109.577 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -59.74 -45.25 92.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.708 . . . . 0.0 109.263 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.94 -42.3 97.37 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.422 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 64.9 t80 -61.9 -46.92 87.27 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.46 ' CD2' ' CE2' ' A' ' 61' ' ' PHE . 92.6 mt -64.73 -39.3 93.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.564 -0.71 . . . . 0.0 109.883 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -60.72 -44.41 96.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.66 -0.65 . . . . 0.0 109.628 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -69.06 -41.98 76.87 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.658 -0.651 . . . . 0.0 110.186 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.422 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 44.2 m-80 -65.02 -41.36 95.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.432 -0.792 . . . . 0.0 109.338 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.7 mt -114.36 115.28 44.94 Favored Pre-proline 0 N--CA 1.485 1.307 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.5 -17.61 23.5 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.286 1.991 . . . . 0.0 110.652 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -95.87 8.87 42.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 34.9 t80 -51.65 126.85 18.8 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.82 0.819 . . . . 0.0 109.888 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -113.35 -65.88 1.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -147.17 160.56 42.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.591 -0.693 . . . . 0.0 110.319 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.9 p -140.16 139.73 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.4 0.619 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -129.21 125.66 37.44 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.558 0.694 . . . . 0.0 109.318 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 49' ' ' ILE . 59.2 m-85 -91.4 142.88 27.2 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.653 0.74 . . . . 0.0 109.732 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.461 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -173.28 123.12 0.39 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.721 -0.612 . . . . 0.0 109.647 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 38' ' ' THR . 2.3 m-20 82.22 157.22 0.13 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.911 0.862 . . . . 0.0 110.983 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 69.53 101.38 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.58 0.705 . . . . 0.0 109.733 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -144.12 -22.08 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -115.85 133.69 55.77 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.77 0.795 . . . . 0.0 110.108 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -170.57 154.98 4.77 Favored Pre-proline 0 N--CA 1.487 1.404 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 46' ' ' GLY . 71.4 Cg_exo -44.85 -36.55 11.01 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.37 2.047 . . . . 0.0 112.034 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 mt -78.93 34.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.811 0.815 . . . . 0.0 109.028 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 80.33 -106.42 2.49 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.442 HD11 HE22 ' A' ' 17' ' ' GLN . 46.3 pt -118.31 149.65 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.652 0.739 . . . . 0.0 109.675 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.9 m -127.96 155.25 44.55 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.799 0.809 . . . . 0.0 110.457 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 96.7 mt -122.92 125.51 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.555 0.693 . . . . 0.0 109.395 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -128.69 130.54 47.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.67 0.748 . . . . 0.0 109.598 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.01 -163.14 13.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -143.11 162.5 35.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.748 -0.854 . . . . 0.0 109.685 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 pt -122.54 162.43 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.805 0.812 . . . . 0.0 110.438 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.83 30.65 19.36 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.432 0.634 . . . . 0.0 109.736 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 48.89 33.02 4.1 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.39 0.614 . . . . 0.0 109.624 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -112.9 111.17 21.73 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.416 0.627 . . . . 0.0 109.501 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -59.09 -33.02 70.34 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.47 -39.29 92.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.9 mt -84.52 83.03 8.15 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.408 0.623 . . . . 0.0 109.764 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.632 ' O ' HD23 ' A' ' 76' ' ' LEU . 88.2 p -95.9 148.32 22.74 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.433 0.635 . . . . 0.0 110.069 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.728 ' CD2' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -131.75 136.9 47.95 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.48 0.657 . . . . 0.0 109.985 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.8 m -128.42 129.73 46.6 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.731 0.777 . . . . 0.0 110.061 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.29 149.22 40.97 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.674 0.75 . . . . 0.0 109.376 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -90.8 135.61 12.94 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 39.84 -109.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.402 0.62 . . . . 0.0 110.579 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 67' ' ' VAL . 20.1 p-10 -82.15 -67.15 0.81 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.682 -0.636 . . . . 0.0 109.682 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.528 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 2.7 t -146.19 11.83 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.732 . . . . 0.0 109.032 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 69' ' ' ILE . 88.8 tttt -65.77 117.93 8.9 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.291 -0.881 . . . . 0.0 110.414 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.0 mt 56.94 125.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.793 0.806 . . . . 0.0 110.016 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -139.07 129.83 26.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.419 -0.801 . . . . 0.0 110.387 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.7 m -126.83 154.57 44.15 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.582 0.706 . . . . 0.0 109.412 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.9 p -153.11 163.97 38.89 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.751 0.786 . . . . 0.0 110.46 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -67.98 163.87 21.24 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.817 0.817 . . . . 0.0 110.158 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -57.8 -48.82 78.61 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.759 -0.588 . . . . 0.0 109.584 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.25 -40.73 98.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.773 -0.579 . . . . 0.0 109.674 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.728 HD21 ' CD2' ' A' ' 61' ' ' PHE . 36.0 tp -76.42 -22.58 54.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.525 -0.734 . . . . 0.0 110.252 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -72.06 -36.66 69.64 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.443 -0.785 . . . . 0.0 109.402 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -79.1 -8.01 58.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.586 -0.696 . . . . 0.0 110.334 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.4 mmm -63.89 -42.31 97.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.352 -0.842 . . . . 0.0 109.691 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.497 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 31.0 p90 -102.33 125.66 49.11 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.756 0.789 . . . . 0.0 109.72 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -97.68 -6.72 32.48 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -133.66 83.97 46.43 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.485 -0.759 . . . . 0.0 109.445 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.81 138.13 76.26 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 123.04 2.494 . . . . 0.0 112.97 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.592 HH21 HG22 ' A' ' 90' ' ' ILE . 21.0 mmm180 -99.04 162.97 12.77 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.606 0.717 . . . . 0.0 110.358 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -91.04 -131.64 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.31 0.576 . . . . 0.0 111.281 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.42 170.27 50.36 Favored Glycine 0 N--CA 1.498 2.803 0 CA-C-O 122.061 0.812 . . . . 0.0 111.971 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -61.76 -43.12 99.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.945 -0.738 . . . . 0.0 110.436 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.56 -38.76 92.35 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.447 -0.783 . . . . 0.0 109.635 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -60.84 -50.04 75.04 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.811 -0.556 . . . . 0.0 109.91 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.592 HG22 HH21 ' A' ' 84' ' ' ARG . 27.7 pt -69.24 -30.06 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.331 -0.856 . . . . 0.0 109.398 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.5 tp -64.24 -42.52 96.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.557 0.694 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -61.79 -33.32 73.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.495 -0.753 . . . . 0.0 109.632 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.71 -40.75 98.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.497 -0.752 . . . . 0.0 109.576 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.71 -39.61 88.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.483 -0.761 . . . . 0.0 109.628 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.45 -39.03 93.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.433 -0.792 . . . . 0.0 109.578 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -63.42 -41.47 98.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.588 0.709 . . . . 0.0 109.49 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -65.81 -42.4 90.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.626 -0.671 . . . . 0.0 109.975 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -63.66 -44.57 93.4 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.793 0.806 . . . . 0.0 110.036 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.21 -41.33 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.579 -0.701 . . . . 0.0 109.848 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -55.78 -46.22 77.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.478 -0.764 . . . . 0.0 110.029 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.6 tp -64.29 -42.4 96.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.551 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.621 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 89.1 t80 -59.96 -44.18 94.6 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.728 0.775 . . . . 0.0 109.317 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.85 -43.05 99.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.586 -0.696 . . . . 0.0 110.349 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.41 -43.44 97.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 0.0 110.537 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.688 ' CG ' HD11 ' A' ' 90' ' ' ILE . 33.8 m-70 -75.34 -32.11 60.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 110.992 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.621 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 29.3 m-80 -89.25 -6.94 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.102 -0.998 . . . . 0.0 109.47 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.3 mt -137.41 105.51 8.5 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.585 -0.697 . . . . 0.0 109.15 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.99 -16.49 32.38 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.436 2.09 . . . . 0.0 111.782 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -95.96 11.42 34.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.519 -0.738 . . . . 0.0 109.419 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -56.67 132.68 52.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.3 -0.875 . . . . 0.0 109.818 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -133.46 -48.69 0.83 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -148.31 154.71 40.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.293 -0.879 . . . . 0.0 110.219 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.89 137.13 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.307 0.575 . . . . 0.0 109.557 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -128.41 121.86 30.03 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.588 0.708 . . . . 0.0 109.162 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -97.39 122.83 40.89 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.6 p -106.37 -22.39 12.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.709 -0.619 . . . . 0.0 109.68 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -110.49 145.76 37.14 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.296 -0.878 . . . . 0.0 110.561 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -166.02 80.49 0.28 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -153.5 -161.91 1.36 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.429 -0.795 . . . . 0.0 109.777 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 42' ' ' PHE . 54.3 p90 -102.47 127.34 49.55 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.596 0.712 . . . . 0.0 109.953 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -96.97 164.63 17.49 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.719 -0.613 . . . . 0.0 109.457 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.3 -39.96 62.02 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.36 2.04 . . . . 0.0 111.584 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.524 ' O ' HG22 ' A' ' 45' ' ' ILE . 97.0 mt -81.73 -4.08 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.557 -0.714 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 137.92 -104.7 0.46 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.4 pt -127.37 133.78 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.876 . . . . 0.0 109.879 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.7 m -138.77 149.08 44.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.587 -0.695 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.58 133.74 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 33.0 t0 -127.73 147.27 50.4 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.588 0.708 . . . . 0.0 109.9 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -175.76 -165.57 31.91 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -144.11 164.53 30.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.768 -0.842 . . . . 0.0 109.77 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.1 pt -124.6 164.67 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.862 0.839 . . . . 0.0 111.344 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 58.43 32.38 22.03 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.643 0.735 . . . . 0.0 110.191 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 48.89 29.84 2.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.639 -0.663 . . . . 0.0 109.838 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.49 111.74 22.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.448 -0.783 . . . . 0.0 109.988 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -58.88 -32.26 69.33 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.56 0.695 . . . . 0.0 109.441 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.57 -39.38 93.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.461 -0.774 . . . . 0.0 109.621 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.1 mt -82.03 78.94 8.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.533 -0.73 . . . . 0.0 109.81 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.6 t -104.39 155.16 19.02 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.656 0.741 . . . . 0.0 110.011 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -150.2 158.37 44.09 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.56 0.695 . . . . 0.0 109.825 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.7 m -134.17 138.7 45.34 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.87 135.29 48.2 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.589 0.709 . . . . 0.0 109.596 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.5 137.95 14.62 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 67' ' ' VAL . 29.3 mmtp 40.37 -161.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.489 0.661 . . . . 0.0 111.12 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 68' ' ' LYS . 93.8 m-20 -59.2 77.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.935 0.874 . . . . 0.0 109.782 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 65' ' ' LYS . 2.0 t 41.68 24.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.659 0.742 . . . . 0.0 109.853 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 66' ' ' ASP . 28.6 tptp -64.06 -44.23 93.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.2 mt -121.13 128.46 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -132.74 129.84 39.2 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.492 0.663 . . . . 0.0 109.628 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.5 m -130.48 152.29 50.04 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 p -143.0 155.46 44.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.742 0.782 . . . . 0.0 110.509 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 77' ' ' ASP . 18.6 p -74.73 168.78 19.17 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.772 0.796 . . . . 0.0 110.719 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -59.93 -43.07 95.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.753 -0.592 . . . . 0.0 110.167 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -65.94 -36.18 82.64 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.71 0.767 . . . . 0.0 109.558 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.5 tp -85.01 -21.02 29.63 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.926 0.87 . . . . 0.0 109.035 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 73' ' ' SER . 29.9 t70 -66.86 -44.54 80.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.538 -0.726 . . . . 0.0 110.084 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -71.68 -18.4 62.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 110.033 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.75 -62.37 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.44 -0.788 . . . . 0.0 109.966 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.439 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -71.72 138.62 48.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.602 -0.686 . . . . 0.0 110.519 -178.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -137.52 40.26 2.42 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -115.39 150.83 45.2 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.333 -0.855 . . . . 0.0 109.412 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.46 156.22 66.4 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.695 2.264 . . . . 0.0 112.465 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -69.93 132.74 46.44 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.808 0.813 . . . . 0.0 110.033 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.8 ' HZ3' HD12 ' A' ' 90' ' ' ILE . 20.2 pttp -155.21 145.68 22.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.591 0.71 . . . . 0.0 109.47 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.39 168.14 51.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -62.45 -45.24 93.97 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.676 0.75 . . . . 0.0 109.7 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 47.7 p-10 -64.96 -33.39 75.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 109.687 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.551 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 14.4 tm-20 -62.98 -51.87 65.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.627 -0.671 . . . . 0.0 109.953 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.8 HD12 ' HZ3' ' A' ' 85' ' ' LYS . 9.9 tt -67.82 -29.6 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.92 -44.04 97.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.505 -0.747 . . . . 0.0 109.703 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.959 0.885 . . . . 0.0 108.941 179.918 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.471 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 91.3 m-85 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.365 0.602 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -58.67 -34.96 71.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.435 -0.79 . . . . 0.0 109.48 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -62.37 -40.34 96.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.53 -39.26 91.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.572 -0.705 . . . . 0.0 109.831 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -65.73 -39.83 91.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.582 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.85 -40.42 96.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.423 -0.798 . . . . 0.0 109.893 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.68 -41.95 98.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -0.839 . . . . 0.0 109.809 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.1 -41.97 97.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.389 -0.82 . . . . 0.0 110.159 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.03 -42.87 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.724 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.9 m -60.96 -44.49 97.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.872 . . . . 0.0 109.93 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.56 -42.94 99.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.663 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 57.2 t80 -61.0 -42.79 99.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.56 -0.712 . . . . 0.0 109.763 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' ILE . 86.3 mt -62.77 -41.93 99.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.9 -40.28 94.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.327 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -65.85 -40.32 91.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.408 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.577 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 99.3 m-20 -93.73 -4.75 49.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.56 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 25' ' ' LEU . 8.7 mt -143.45 91.23 6.93 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -71.16 -16.67 31.76 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.447 2.098 . . . . 0.0 111.812 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -92.46 4.22 53.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.536 -0.728 . . . . 0.0 109.183 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -50.08 137.84 16.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.063 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -111.59 -63.35 1.43 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.749 -0.594 . . . . 0.0 109.891 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -149.52 156.77 42.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.054 -1.029 . . . . 0.0 110.02 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.23 133.46 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.668 -0.645 . . . . 0.0 109.337 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.8 m -118.83 119.96 35.93 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -93.39 121.96 35.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.597 -0.69 . . . . 0.0 109.547 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.0 p -109.03 0.22 19.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.6 t30 59.01 -96.2 0.06 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.798 -0.564 . . . . 0.0 109.677 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 10.0 tm-20 60.14 -88.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.393 0.616 . . . . 0.0 110.845 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 40' ' ' GLU . 78.1 tt0 -57.36 148.89 21.77 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.466 -0.772 . . . . 0.0 110.362 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -151.68 96.75 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.263 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 46' ' ' GLY . 36.1 m-20 -44.27 108.61 0.74 Allowed Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.564 -0.71 . . . . 0.0 109.835 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.05 -33.45 43.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.223 1.949 . . . . 0.0 111.664 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -85.88 -5.26 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 43' ' ' ASN . . . -166.69 -127.93 0.94 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 pt -135.29 149.46 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.432 -1.04 . . . . 0.0 109.749 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.409 ' HB2' ' H ' ' A' ' 43' ' ' ASN . 22.6 t -142.79 141.67 31.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.134 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -124.87 122.09 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.567 0.699 . . . . 0.0 109.707 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 54.7 t0 -104.5 154.71 19.55 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -175.42 -170.31 38.18 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.609 -1.281 . . . . 0.0 109.936 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -145.25 162.82 36.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.484 -1.009 . . . . 0.0 109.675 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.37 162.81 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.457 0.646 . . . . 0.0 110.747 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 56.97 32.85 22.35 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.45 0.643 . . . . 0.0 109.85 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 47.97 29.62 1.76 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -111.68 108.37 17.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.491 -0.756 . . . . 0.0 109.525 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -58.59 -33.99 70.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.663 . . . . 0.0 109.599 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.48 -38.53 90.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.432 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.2 mt -82.76 82.63 8.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.191 -0.943 . . . . 0.0 109.095 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 m -100.6 160.83 14.03 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.598 0.713 . . . . 0.0 110.524 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -146.26 153.77 40.96 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.5 m -133.13 133.27 42.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.682 -0.636 . . . . 0.0 109.741 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.21 139.54 52.86 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -112.16 130.83 9.83 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' VAL . 45.8 tttt 43.57 -144.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.623 0.725 . . . . 0.0 110.869 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.2 62.31 0.13 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.533 0.682 . . . . 0.0 109.185 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LYS . 1.9 t 51.8 19.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.477 0.656 . . . . 0.0 109.639 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -64.09 -42.67 96.85 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.395 -0.815 . . . . 0.0 109.53 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 64' ' ' GLY . 96.7 mt -131.96 118.55 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.584 -0.698 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -139.73 152.08 46.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.7 t -139.83 148.28 41.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.438 -0.789 . . . . 0.0 109.555 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.0 t -131.81 147.44 52.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.451 -0.781 . . . . 0.0 109.639 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -76.61 170.04 17.16 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.788 0.804 . . . . 0.0 110.789 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -61.99 -42.98 99.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.571 -0.705 . . . . 0.0 109.664 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.57 -40.95 96.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.239 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.8 tp -79.55 -26.62 41.37 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.382 -0.824 . . . . 0.0 109.347 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -62.15 -38.25 88.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 110.247 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -59.11 -28.46 66.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.398 -0.814 . . . . 0.0 109.804 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 97.7 mmm -64.9 -35.29 80.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.658 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -63.9 135.95 56.97 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.301 -0.874 . . . . 0.0 109.841 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -112.39 -22.91 10.62 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -113.68 166.15 11.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.672 -0.643 . . . . 0.0 109.477 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.1 146.64 87.09 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.526 2.151 . . . . 0.0 112.677 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -67.59 124.04 22.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 109.428 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.479 ' O ' ' CE1' ' A' ' 24' ' ' TYR . 68.8 mmtt -134.97 154.95 51.53 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.771 0.796 . . . . 0.0 109.997 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.64 166.34 52.11 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -60.73 -42.29 96.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 122.014 -0.698 . . . . 0.0 109.507 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 9.5 p-10 -64.61 -34.74 78.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.429 -0.794 . . . . 0.0 110.45 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 50.3 mp0 -64.77 -47.51 77.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.262 -0.899 . . . . 0.0 110.053 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.2 pt -69.93 -35.45 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 110.083 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.27 -42.99 99.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.986 -1.071 . . . . 0.0 109.395 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.487 1.389 0 O-C-N 121.346 -0.846 . . . . 0.0 109.547 -179.805 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -59.64 -37.97 80.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.883 -0.511 . . . . 0.0 109.848 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.51 -40.85 98.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.748 -0.595 . . . . 0.0 109.488 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.61 -39.37 88.33 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 99.3 mm-40 -64.5 -40.42 95.62 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.15 -42.08 99.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.055 -0.403 . . . . 0.0 110.372 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.42 -46.44 79.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.889 -0.507 . . . . 0.0 109.857 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -65.67 -43.23 89.98 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.035 0.445 . . . . 0.0 110.199 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 17' ' ' GLN . 53.7 t -65.41 -43.85 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.6 m -62.37 -45.55 92.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.549 HD11 ' NE2' ' A' ' 27' ' ' HIS . 41.8 tp -63.38 -43.92 96.2 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.812 -0.555 . . . . 0.0 109.72 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.602 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 71.7 t80 -62.21 -47.09 86.01 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.06 -40.56 96.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.936 -0.477 . . . . 0.0 109.929 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -59.66 -46.06 90.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 122.042 -0.411 . . . . 0.0 110.281 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.549 ' NE2' HD11 ' A' ' 23' ' ' LEU . 46.5 m-70 -72.29 -34.02 67.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 110.528 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.602 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 73.3 m-80 -86.58 -2.35 58.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.21 -0.932 . . . . 0.0 109.231 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 53.2 mt -136.56 104.86 9.17 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.613 . . . . 0.0 109.472 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.03 -16.99 25.34 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.779 2.319 . . . . 0.0 111.298 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -94.01 8.03 42.93 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -56.5 133.55 53.43 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.927 0.87 . . . . 0.0 110.48 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -135.9 -51.08 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -148.64 156.09 41.94 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.663 0.744 . . . . 0.0 110.207 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 p -139.82 140.83 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.539 0.685 . . . . 0.0 109.601 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.0 m -126.09 118.52 25.46 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.723 0.773 . . . . 0.0 109.486 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -95.67 126.49 40.98 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.556 0.694 . . . . 0.0 109.742 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.7 p -97.34 -17.2 19.89 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 59.82 33.57 21.7 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.379 0.609 . . . . 0.0 109.557 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -92.74 179.74 5.39 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.684 0.754 . . . . 0.0 110.452 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 59.1 150.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.692 0.758 . . . . 0.0 110.362 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -155.33 114.85 3.66 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.826 0.822 . . . . 0.0 109.594 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -91.92 146.71 33.42 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.29 -21.43 41.46 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.395 2.063 . . . . 0.0 111.62 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -76.61 -4.3 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.815 -0.553 . . . . 0.0 109.815 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.06 -123.51 1.19 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 pt -129.37 140.75 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.848 -0.795 . . . . 0.0 110.005 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.2 t -115.96 130.0 56.63 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.599 0.714 . . . . 0.0 109.926 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.9 127.23 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.749 0.785 . . . . 0.0 109.284 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -114.09 149.44 35.54 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.831 0.825 . . . . 0.0 110.0 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.02 179.88 45.09 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -143.23 166.02 25.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.76 -0.847 . . . . 0.0 110.609 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.6 pt -120.48 162.29 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.747 0.785 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 57.52 33.6 23.48 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 44.59 29.23 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.015 0.436 . . . . 0.0 109.864 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -109.13 112.4 24.55 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.66 0.743 . . . . 0.0 109.811 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -57.99 -34.11 69.63 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.963 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.08 -38.72 92.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.723 -0.611 . . . . 0.0 109.354 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.6 mt -82.46 75.84 9.36 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.1 m -102.49 160.39 14.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.964 0.888 . . . . 0.0 110.72 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.2 154.95 40.79 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.631 0.729 . . . . 0.0 109.716 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 96.9 m -134.66 133.85 40.53 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.66 0.743 . . . . 0.0 110.643 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.98 138.09 50.65 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.773 0.797 . . . . 0.0 109.376 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.66 133.77 11.81 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.433 ' O ' ' OE1' ' A' ' 17' ' ' GLN . 71.3 tttt 37.9 -133.75 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.212 0.529 . . . . 0.0 110.894 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -73.84 62.1 0.81 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 45.39 24.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -64.09 -42.36 96.97 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.74 127.41 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.694 0.759 . . . . 0.0 109.013 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.56 ' CZ ' ' NE ' ' A' ' 84' ' ' ARG . 28.3 p90 -139.95 153.44 46.91 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.971 0.891 . . . . 0.0 110.621 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 t -140.84 152.41 45.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.688 0.756 . . . . 0.0 109.423 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 p -138.47 153.9 48.82 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.896 0.855 . . . . 0.0 110.144 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.0 p -82.64 168.89 16.85 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.817 0.818 . . . . 0.0 110.546 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -65.44 -29.6 70.3 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -73.93 -50.4 20.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.756 -0.59 . . . . 0.0 109.583 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.27 -19.97 65.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.68 . . . . 0.0 109.484 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -64.0 -33.38 75.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.878 -0.514 . . . . 0.0 110.01 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.514 ' CG ' ' N ' ' A' ' 79' ' ' MET . 17.7 pttp -64.05 -43.83 94.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.617 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.514 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 59.8 mmm -68.41 -38.33 81.17 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.527 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 73.8 t80 -66.27 124.43 22.64 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.551 0.691 . . . . 0.0 109.138 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -142.97 -1.2 1.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.527 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 6.2 tp10 -102.43 113.4 65.89 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -48.87 149.01 8.28 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.407 2.071 . . . . 0.0 112.805 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.56 ' NE ' ' CZ ' ' A' ' 70' ' ' PHE . 15.9 mmm180 -67.77 143.6 55.78 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.735 0.779 . . . . 0.0 110.064 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -140.4 -76.64 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 159.32 160.89 10.73 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.568 ' CE2' HD11 ' A' ' 91' ' ' LEU . 77.3 t80 -62.71 -44.8 95.29 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.407 0.622 . . . . 0.0 109.632 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.96 -34.74 78.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.684 -0.635 . . . . 0.0 110.095 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 47.8 mp0 -65.66 -44.58 85.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.346 -0.846 . . . . 0.0 110.891 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.2 pt -66.2 -38.75 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.595 -0.691 . . . . 0.0 110.3 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.568 HD11 ' CE2' ' A' ' 87' ' ' TYR . 31.1 mt -63.64 -40.47 96.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.665 -0.647 . . . . 0.0 109.556 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.828 -0.545 . . . . 0.0 109.614 -179.907 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.4 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -65.79 -38.71 89.74 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.544 -0.722 . . . . 0.0 109.522 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -61.67 -41.44 97.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.769 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -64.53 -44.07 92.01 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.331 -0.856 . . . . 0.0 108.956 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -65.16 -39.06 92.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.574 -0.704 . . . . 0.0 109.363 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -63.76 -40.35 96.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.599 -0.688 . . . . 0.0 109.773 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -65.6 -38.35 89.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.444 -0.785 . . . . 0.0 109.597 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.29 -41.39 98.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.334 -0.853 . . . . 0.0 109.78 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.22 -43.67 97.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.0 m -61.43 -44.31 97.35 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.526 -0.734 . . . . 0.0 109.095 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.53 -42.54 99.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.502 -0.749 . . . . 0.0 109.101 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.473 ' OH ' ' CZ ' ' A' ' 70' ' ' PHE . 62.8 t80 -61.01 -47.28 87.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.434 -0.791 . . . . 0.0 109.402 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' ILE . 86.2 mt -63.51 -41.97 98.5 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.419 -0.801 . . . . 0.0 109.696 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -61.86 -42.24 98.82 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.469 -0.77 . . . . 0.0 110.046 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -69.21 -39.17 78.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -0.836 . . . . 0.0 109.914 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.401 ' OD1' ' CZ ' ' A' ' 24' ' ' TYR . 27.3 m120 -86.26 -13.06 47.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.141 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' LEU . 11.1 mt -137.25 81.38 31.78 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.24 -28.24 70.37 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.481 2.121 . . . . 0.0 110.823 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.71 12.69 5.54 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -54.1 134.34 43.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.604 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -110.32 -63.17 1.42 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 t -150.42 157.95 43.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 0.0 109.95 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.13 133.19 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.599 -0.688 . . . . 0.0 109.318 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.5 m -121.02 120.22 34.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.62 -0.675 . . . . 0.0 109.242 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -94.26 140.62 29.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.593 -0.692 . . . . 0.0 109.402 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.0 p -116.41 -32.14 5.36 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -138.66 139.35 38.45 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.383 -0.823 . . . . 0.0 110.103 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -138.14 58.72 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -175.21 -170.17 0.42 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.629 -0.669 . . . . 0.0 109.791 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 t80 63.24 92.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.513 0.673 . . . . 0.0 109.94 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -171.37 119.99 0.47 Allowed Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.432 -0.793 . . . . 0.0 109.139 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.95 -42.97 25.11 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.283 1.989 . . . . 0.0 112.479 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 46' ' ' GLY . 10.5 tp -70.5 -37.53 70.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.423 -0.798 . . . . 0.0 109.816 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 45' ' ' ILE . . . -179.15 -87.91 0.07 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.9 pt -135.19 151.83 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.485 -1.009 . . . . 0.0 110.008 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.1 t -116.41 131.8 56.85 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.691 -0.631 . . . . 0.0 109.567 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.6 mt -106.83 116.49 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.477 ' OD1' HG23 ' A' ' 62' ' ' THR . 64.8 m-20 -119.73 139.32 52.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.44 36.48 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -145.42 166.13 26.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -1.073 . . . . 0.0 110.077 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.9 pt -120.84 162.85 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 121.576 0.703 . . . . 0.0 110.584 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 56.59 32.75 21.5 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.524 0.678 . . . . 0.0 109.547 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 m120 44.7 30.94 0.58 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.482 -0.761 . . . . 0.0 109.734 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -109.11 112.35 24.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.558 -0.714 . . . . 0.0 109.268 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -58.61 -33.35 69.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.669 -0.644 . . . . 0.0 109.807 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -62.86 -38.33 90.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.789 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.7 mt -83.76 79.92 9.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -0.89 . . . . 0.0 109.575 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.3 t -104.45 158.12 16.69 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.492 0.663 . . . . 0.0 110.063 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -144.56 145.87 32.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.479 -0.763 . . . . 0.0 109.513 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.477 HG23 ' OD1' ' A' ' 50' ' ' ASP . 52.1 m -130.24 131.3 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.05 138.17 48.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.632 -0.667 . . . . 0.0 109.277 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -96.53 99.51 2.33 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.7 tttp 43.86 -83.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.984 -0.715 . . . . 0.0 110.915 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 64' ' ' GLY . 99.2 m-20 -73.86 125.37 28.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 67' ' ' VAL . 61.0 t -60.89 -1.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.531 -0.731 . . . . 0.0 109.453 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 66' ' ' ASP . 54.6 mtpt -62.89 -41.22 99.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.2 116.21 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.473 -0.767 . . . . 0.0 109.346 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CZ ' ' OH ' ' A' ' 24' ' ' TYR . 54.6 p90 -141.09 157.27 45.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.724 . . . . 0.0 110.021 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.3 t -120.4 137.27 54.4 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.2 t -137.56 146.46 44.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.443 -0.786 . . . . 0.0 109.958 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.8 m -80.68 172.83 13.25 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.675 0.75 . . . . 0.0 110.275 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -66.0 -35.57 80.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.638 -0.663 . . . . 0.0 109.959 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -65.1 -33.3 75.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.495 -0.753 . . . . 0.0 109.772 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.5 tp -91.3 -24.44 19.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 109.019 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -65.11 -38.03 89.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.818 . . . . 0.0 109.858 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.05 -12.8 61.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 110.283 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.7 mmm -79.37 -9.49 59.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.808 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.38 128.96 37.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.958 . . . . 0.0 109.828 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -109.4 -43.99 4.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.617 -0.677 . . . . 0.0 109.573 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -96.5 165.44 16.11 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.419 -0.8 . . . . 0.0 110.175 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.55 146.91 89.21 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.297 1.998 . . . . 0.0 112.006 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.42 124.1 20.92 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.462 -0.774 . . . . 0.0 110.462 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -138.43 140.91 39.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.718 -0.613 . . . . 0.0 109.429 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.8 174.14 49.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.589 ' CE2' HD11 ' A' ' 91' ' ' LEU . 83.4 t80 -60.9 -43.97 97.77 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.67 0.748 . . . . 0.0 109.767 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 48.4 p-10 -69.76 -32.98 71.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.124 -0.985 . . . . 0.0 110.166 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 78.5 mm-40 -66.25 -44.21 84.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.1 pt -65.57 -38.46 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.007 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.589 HD11 ' CE2' ' A' ' 87' ' ' TYR . 82.8 mt -62.5 -42.18 99.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.97 -1.081 . . . . 0.0 109.488 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.13 179.577 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.9 t80 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.87 0.843 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CD1' ' OE2' ' A' ' 40' ' ' GLU . 85.0 m-85 -68.91 -35.23 76.58 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.484 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -62.54 -44.96 95.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.103 -0.998 . . . . 0.0 110.291 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -69.18 -36.03 76.91 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.155 -0.965 . . . . 0.0 109.758 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -63.16 -42.27 99.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -0.938 . . . . 0.0 109.599 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.83 -40.86 95.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 0.0 109.232 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.04 -43.95 98.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.562 -0.711 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.67 -43.32 97.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.412 -0.805 . . . . 0.0 109.942 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.3 -42.79 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 m -60.99 -46.12 92.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.392 -0.818 . . . . 0.0 109.383 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.622 HD11 ' NE2' ' A' ' 27' ' ' HIS . 48.6 tp -63.98 -42.01 97.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.526 ' CE2' ' OD1' ' A' ' 28' ' ' ASN . 77.4 t80 -61.42 -46.87 88.31 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.689 0.757 . . . . 0.0 109.87 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.15 -39.24 89.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.348 -0.845 . . . . 0.0 110.237 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -60.31 -45.67 92.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.289 -0.882 . . . . 0.0 110.521 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.622 ' NE2' HD11 ' A' ' 23' ' ' LEU . 37.0 m-70 -69.51 -38.67 77.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.203 -0.935 . . . . 0.0 110.37 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.526 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 25.2 m120 -64.17 -40.53 96.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.945 . . . . 0.0 109.81 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.4 mt -115.54 119.11 38.47 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.695 . . . . 0.0 109.908 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.61 -19.42 28.07 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.597 2.198 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -95.72 8.44 43.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 108.926 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -49.28 120.92 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.876 0.846 . . . . 0.0 110.032 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -102.27 -68.71 0.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.701 0.762 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 t -148.06 163.92 35.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.193 -0.942 . . . . 0.0 109.711 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.25 137.08 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.585 -0.697 . . . . 0.0 109.493 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.9 m -125.21 123.51 39.73 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.681 0.753 . . . . 0.0 109.368 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -88.42 132.35 34.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.562 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -107.15 -53.94 2.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.48 -0.763 . . . . 0.0 109.756 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -100.65 142.43 32.13 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.073 -1.017 . . . . 0.0 110.427 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.427 ' OE2' ' CD1' ' A' ' 14' ' ' PHE . 76.5 tt0 -162.47 106.84 1.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.531 -0.731 . . . . 0.0 109.09 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -170.03 177.77 4.18 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.465 -0.772 . . . . 0.0 110.043 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -61.68 -178.37 0.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.988 0.899 . . . . 0.0 110.61 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -175.45 167.75 1.73 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.13 -40.54 76.65 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.295 1.997 . . . . 0.0 111.528 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.9 -4.09 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.752 . . . . 0.0 109.453 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 134.4 -94.31 0.26 Allowed Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.5 pt -126.9 149.14 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.626 -0.926 . . . . 0.0 110.04 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 t -127.28 130.89 50.39 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.666 0.746 . . . . 0.0 108.997 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -128.04 132.01 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 40.3 t0 -135.42 146.06 47.89 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.593 -0.692 . . . . 0.0 109.807 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -167.89 -164.9 24.38 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -144.28 161.5 38.76 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.492 -1.004 . . . . 0.0 110.028 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -121.05 159.63 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 122.09 0.948 . . . . 0.0 111.308 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.1 m-20 57.39 32.93 22.56 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.825 0.821 . . . . 0.0 109.902 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 49.42 30.86 3.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 0.0 109.536 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -112.6 108.15 17.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.401 -0.812 . . . . 0.0 109.528 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -59.7 -31.44 69.59 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.568 0.699 . . . . 0.0 109.518 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -62.76 -39.07 93.0 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.178 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.6 mt -83.09 77.52 9.73 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.226 -0.921 . . . . 0.0 109.684 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.4 p -104.08 161.74 13.75 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.803 0.811 . . . . 0.0 110.596 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -149.75 156.09 41.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.537 -0.727 . . . . 0.0 109.688 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.3 m -137.29 140.05 41.32 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.658 -0.652 . . . . 0.0 109.894 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.87 150.43 46.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.365 -0.835 . . . . 0.0 109.394 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 65' ' ' LYS . . . -126.86 94.64 0.42 Allowed Glycine 0 N--CA 1.503 3.15 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' GLY . 88.6 tttt 52.84 115.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.945 0.879 . . . . 0.0 111.133 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 67' ' ' VAL . 65.6 t0 60.05 139.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.84 0.828 . . . . 0.0 110.591 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.566 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 26.3 t -58.48 0.63 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.558 0.694 . . . . 0.0 109.354 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.552 ' H ' ' C ' ' A' ' 66' ' ' ASP . 63.3 tttp -55.79 -40.05 72.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 108.788 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.45 119.03 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.483 -0.761 . . . . 0.0 109.084 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -138.63 125.91 21.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.413 -0.804 . . . . 0.0 109.365 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.8 m -107.71 150.57 26.78 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.609 0.719 . . . . 0.0 109.338 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.2 m -151.51 152.52 33.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.93 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.3 p -80.95 172.62 13.51 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.91 0.862 . . . . 0.0 110.874 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -58.77 -45.67 89.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.679 -0.638 . . . . 0.0 110.074 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.59 -48.96 78.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.15 -0.969 . . . . 0.0 110.22 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.59 -36.2 83.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.091 -1.006 . . . . 0.0 109.108 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.77 -41.45 97.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.343 -0.848 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -66.1 -35.06 79.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.153 -0.967 . . . . 0.0 109.714 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.5 mmm -62.26 -38.53 89.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.203 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -55.97 140.7 42.26 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.949 0.88 . . . . 0.0 110.104 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -106.45 -16.8 14.45 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -133.21 154.97 81.37 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.364 -0.835 . . . . 0.0 109.589 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.87 162.95 29.96 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 123.041 2.494 . . . . 0.0 112.69 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -63.77 135.76 56.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.921 0.867 . . . . 0.0 110.355 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -138.85 151.18 46.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.701 0.762 . . . . 0.0 109.641 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.98 152.81 45.97 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.07 -42.88 95.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.778 -0.836 . . . . 0.0 109.518 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.86 -37.97 88.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.777 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -60.7 -48.1 83.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.379 -0.825 . . . . 0.0 110.382 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.01 -31.58 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.937 -1.102 . . . . 0.0 109.946 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.04 -43.29 95.99 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 109.452 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.855 0.836 . . . . 0.0 109.32 -179.799 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.517 ' CE2' ' NE2' ' A' ' 17' ' ' GLN . 69.0 t80 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.643 0.735 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -65.3 -37.95 88.71 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.467 0.651 . . . . 0.0 109.465 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.47 -40.96 96.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.508 -0.745 . . . . 0.0 109.293 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.54 -49.52 76.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.455 -0.778 . . . . 0.0 109.423 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.517 ' NE2' ' CE2' ' A' ' 13' ' ' PHE . 97.8 mt-30 -68.18 -33.61 74.76 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.552 0.692 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.09 -44.83 95.8 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.494 0.664 . . . . 0.0 109.794 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.03 -39.53 87.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.668 -0.645 . . . . 0.0 110.133 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -63.47 -42.43 98.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.543 -0.723 . . . . 0.0 110.596 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.94 -42.01 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.812 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.5 m -60.5 -46.62 89.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.416 -0.803 . . . . 0.0 109.861 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.407 HD11 ' NE2' ' A' ' 27' ' ' HIS . 54.6 tp -64.73 -40.97 96.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.763 . . . . 0.0 109.665 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.558 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 80.0 t80 -60.08 -44.71 94.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.491 -0.756 . . . . 0.0 109.849 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.45 -42.19 98.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.478 -0.764 . . . . 0.0 110.434 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -40.45 96.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.495 -0.753 . . . . 0.0 110.334 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.407 ' NE2' HD11 ' A' ' 23' ' ' LEU . 11.3 m-70 -67.56 -35.22 78.63 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.495 -0.753 . . . . 0.0 110.585 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.558 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 71.4 m-80 -95.04 -1.3 52.53 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.112 -0.992 . . . . 0.0 109.515 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.1 mt -140.91 84.44 13.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 109.484 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.4 -28.94 75.3 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.709 2.273 . . . . 0.0 111.17 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -88.59 15.8 7.55 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.535 0.683 . . . . 0.0 109.164 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -49.85 130.5 21.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.458 -0.776 . . . . 0.0 109.912 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -115.85 -68.6 0.91 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 t -143.28 161.07 39.27 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.598 0.713 . . . . 0.0 110.058 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.61 139.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.445 HG21 ' OH ' ' A' ' 52' ' ' TYR . 91.9 m -123.45 125.79 45.57 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -90.88 136.88 32.78 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.615 0.722 . . . . 0.0 110.095 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 39' ' ' ASN . 14.4 p -117.02 -33.48 4.71 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' ' 38' ' ' THR . 9.0 p30 38.24 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.0 0.905 . . . . 0.0 110.838 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -157.9 36.08 0.26 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 109.394 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -144.58 121.33 11.21 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.221 -0.924 . . . . 0.0 109.871 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -109.97 121.7 45.86 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.538 0.685 . . . . 0.0 109.288 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.434 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 2.0 m-20 -106.46 137.39 19.42 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -49.4 -31.36 23.05 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.569 2.179 . . . . 0.0 112.007 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.0 pt -80.08 -10.14 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.513 -0.742 . . . . 0.0 109.588 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 43' ' ' ASN . . . 154.52 -176.78 32.19 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.636 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.416 ' H ' ' HE2' ' A' ' 65' ' ' LYS . 34.0 pt -83.84 140.09 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.67 -0.9 . . . . 0.0 110.424 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.434 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 72.2 m -111.15 126.46 54.87 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.607 0.718 . . . . 0.0 109.525 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.56 126.15 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.625 -0.672 . . . . 0.0 109.516 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -115.48 149.09 38.65 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.839 0.828 . . . . 0.0 110.109 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.85 -177.83 46.12 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.445 ' OH ' HG21 ' A' ' 36' ' ' THR . 23.0 p90 -142.67 163.07 33.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.761 -0.846 . . . . 0.0 109.959 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 pt -121.94 162.78 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 121.914 0.864 . . . . 0.0 110.825 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.5 m120 59.59 31.31 20.86 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.529 0.68 . . . . 0.0 110.298 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 48.32 30.71 2.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.587 -0.696 . . . . 0.0 109.573 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -113.67 109.74 19.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.761 0.791 . . . . 0.0 109.513 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.53 -32.69 70.55 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.345 0.593 . . . . 0.0 109.588 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.76 -38.63 91.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.333 -0.854 . . . . 0.0 109.075 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.5 mt -83.2 75.82 9.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.559 -0.713 . . . . 0.0 109.506 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 t -99.76 162.99 12.66 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.723 0.773 . . . . 0.0 110.427 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -149.08 155.23 40.42 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.626 0.727 . . . . 0.0 109.793 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.1 m -132.74 136.1 46.15 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.451 0.643 . . . . 0.0 110.11 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.77 136.96 47.97 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.724 0.773 . . . . 0.0 109.287 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -102.43 136.3 12.74 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' GLY . 60.9 mmtt 33.59 -121.72 0.09 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.434 0.635 . . . . 0.0 111.421 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 68' ' ' LYS . 99.2 m-20 -85.67 76.3 9.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 66' ' ' ASP . 2.1 t 38.26 28.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.778 0.799 . . . . 0.0 110.003 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 66' ' ' ASP . 18.3 mmmt -62.62 -42.83 99.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.51 -0.744 . . . . 0.0 109.346 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.2 mt -129.32 125.92 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.603 -0.686 . . . . 0.0 109.293 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -123.5 131.7 53.71 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.529 0.681 . . . . 0.0 109.573 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.6 m -127.49 150.63 49.59 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 p -136.93 155.2 50.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.911 0.862 . . . . 0.0 110.396 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -81.69 174.42 11.39 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.535 0.683 . . . . 0.0 110.066 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.2 -41.58 99.19 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.463 0.649 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.3 mp0 -70.57 -44.32 67.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -0.859 . . . . 0.0 109.549 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.62 -37.48 86.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.708 -0.62 . . . . 0.0 109.596 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -54.86 -33.0 61.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.742 . . . . 0.0 109.518 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.75 -40.84 97.71 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.352 -0.843 . . . . 0.0 110.057 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.2 mmm -65.93 -37.82 87.04 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.154 -0.966 . . . . 0.0 109.068 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -64.98 133.57 52.01 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.66 0.743 . . . . 0.0 109.988 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -116.5 -22.28 8.8 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' A' ' 82' ' ' GLU . 1.7 pm0 -114.82 153.35 46.94 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.692 -0.63 . . . . 0.0 109.495 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.88 173.5 8.1 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.679 2.253 . . . . 0.0 112.735 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.35 139.74 58.8 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.931 0.872 . . . . 0.0 110.181 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -139.67 145.51 38.52 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.763 0.792 . . . . 0.0 109.848 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -74.42 154.8 47.96 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -61.99 -43.37 98.97 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.66 0.743 . . . . 0.0 110.002 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.36 -36.23 83.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.433 -0.792 . . . . 0.0 109.787 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 41.5 mp0 -62.89 -51.67 66.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.41 -0.806 . . . . 0.0 110.452 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 pt -64.62 -37.37 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.23 -43.69 97.34 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.55 0.69 . . . . 0.0 110.077 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--N 1.3 -1.552 0 CA-C-O 121.711 0.767 . . . . 0.0 108.97 -179.557 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.437 ' CZ ' ' CZ ' ' A' ' 14' ' ' PHE . 50.8 p90 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.437 ' CZ ' ' CZ ' ' A' ' 13' ' ' PHE . 86.5 m-85 -59.91 -29.33 68.28 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.487 0.661 . . . . 0.0 109.321 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -61.81 -37.82 85.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.479 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.56 -46.43 86.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.647 -0.658 . . . . 0.0 109.957 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.516 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -67.24 -37.12 83.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.5 -0.75 . . . . 0.0 109.218 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.51 -42.02 99.22 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.479 0.657 . . . . 0.0 109.453 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -65.0 -40.55 95.11 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -64.01 -40.67 96.87 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.313 0.578 . . . . 0.0 110.047 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.68 -41.57 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.543 -0.723 . . . . 0.0 109.412 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 m -59.73 -46.18 89.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.633 -0.667 . . . . 0.0 109.691 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.67 -40.14 96.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.692 -0.63 . . . . 0.0 109.732 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.522 ' OH ' ' CZ ' ' A' ' 70' ' ' PHE . 59.0 t80 -58.84 -48.18 82.24 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.451 HD21 ' CZ ' ' A' ' 61' ' ' PHE . 82.1 mt -63.97 -40.56 96.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.601 -0.687 . . . . 0.0 110.068 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -49.81 -61.77 1.94 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.759 -0.588 . . . . 0.0 111.259 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.489 ' CE1' ' CG ' ' A' ' 28' ' ' ASN . 20.9 p80 -71.47 -36.01 71.03 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.269 0.557 . . . . 0.0 110.523 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.498 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 9.6 m120 -64.52 -41.13 96.58 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.9 mt -127.12 114.1 21.74 Favored Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 120.56 -0.456 . . . . 0.0 109.921 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.91 -15.74 26.24 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.633 2.222 . . . . 0.0 111.087 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.81 4.56 52.57 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -55.98 129.01 37.99 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.872 0.844 . . . . 0.0 110.201 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -118.16 -59.64 1.88 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -146.5 167.29 24.05 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.868 0.842 . . . . 0.0 110.171 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.52 134.41 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.61 0.719 . . . . 0.0 109.573 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.0 m -115.64 105.8 13.17 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.737 0.779 . . . . 0.0 109.19 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -80.76 140.22 35.64 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.514 0.674 . . . . 0.0 109.76 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.1 p -120.09 -34.16 3.76 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 53.63 81.94 0.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.518 -0.739 . . . . 0.0 109.843 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -144.36 28.83 1.32 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.435 ' OE1' ' OD2' ' A' ' 50' ' ' ASP . 82.7 tt0 -160.3 135.86 8.2 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.882 0.848 . . . . 0.0 109.987 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -123.83 144.54 49.67 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.707 0.765 . . . . 0.0 109.915 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -98.59 149.91 36.2 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.694 -0.629 . . . . 0.0 109.653 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.47 -20.97 41.01 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.889 2.392 . . . . 0.0 111.495 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.3 pt -98.63 -5.18 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.02 -168.93 40.63 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.688 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 pt -81.55 157.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.865 0.841 . . . . 0.0 109.922 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.6 t -138.67 141.96 39.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.595 0.712 . . . . 0.0 109.809 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.9 mt -112.78 127.88 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.876 0.846 . . . . 0.0 109.968 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.611 ' OD1' HG23 ' A' ' 62' ' ' THR . 24.8 m-20 -117.46 151.11 37.74 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.839 0.828 . . . . 0.0 110.021 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.84 -156.76 28.9 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -150.28 166.77 28.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.456 -1.026 . . . . 0.0 110.645 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.1 pt -121.76 167.8 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.732 0.777 . . . . 0.0 110.354 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 57.99 33.7 23.48 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.459 0.647 . . . . 0.0 109.978 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 42.19 34.52 0.49 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.958 -0.464 . . . . 0.0 109.935 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -115.18 107.67 15.6 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.706 0.765 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -58.6 -36.66 74.36 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.916 -0.49 . . . . 0.0 110.252 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -62.5 -37.03 84.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.245 -0.909 . . . . 0.0 109.804 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.9 mt -82.34 83.55 7.42 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.338 -0.851 . . . . 0.0 109.705 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 t -79.9 145.33 32.73 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.062 0.934 . . . . 0.0 110.668 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.451 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 33.2 t80 -140.29 130.37 24.88 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.756 0.789 . . . . 0.0 109.674 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.611 HG23 ' OD1' ' A' ' 50' ' ' ASP . 41.8 m -134.69 136.5 42.81 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.838 0.828 . . . . 0.0 110.11 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -134.22 144.07 48.21 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.943 0.878 . . . . 0.0 110.0 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.09 175.84 38.47 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -53.75 133.71 42.15 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.611 0.72 . . . . 0.0 110.943 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 68' ' ' LYS . 93.3 m-20 57.57 34.14 24.17 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.177 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' ILE . 39.6 t 59.46 -78.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' ASP . 67.9 mttm 39.45 -89.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.524 0.678 . . . . 0.0 109.99 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' VAL . 96.9 mt -109.04 136.43 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.777 0.799 . . . . 0.0 109.304 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.522 ' CZ ' ' OH ' ' A' ' 24' ' ' TYR . 53.0 p90 -139.75 167.27 22.49 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.014 0.912 . . . . 0.0 109.868 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.3 t -133.67 150.86 51.55 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.975 0.893 . . . . 0.0 109.688 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.9 p -151.33 160.74 43.63 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.715 0.769 . . . . 0.0 110.156 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 p -75.72 164.98 25.72 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.951 0.882 . . . . 0.0 110.737 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -61.05 -43.18 99.27 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -66.0 -34.0 77.09 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.4 tp -81.99 -26.16 34.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.404 -0.81 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -66.5 -43.82 84.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.531 -0.73 . . . . 0.0 109.998 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -71.75 -9.87 58.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.558 -0.714 . . . . 0.0 110.713 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.9 mtp -82.27 -8.89 59.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.217 -0.927 . . . . 0.0 109.362 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -68.06 135.92 52.99 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -0.855 . . . . 0.0 109.604 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -92.12 -74.21 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.305 0.574 . . . . 0.0 109.816 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.03 155.54 49.62 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.471 -0.768 . . . . 0.0 109.754 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.02 165.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.598 2.199 . . . . 0.0 112.724 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.25 136.25 53.24 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.787 0.803 . . . . 0.0 110.281 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.94 140.36 45.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.817 0.818 . . . . 0.0 109.905 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.5 165.92 53.24 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -62.25 -42.86 99.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.987 -0.714 . . . . 0.0 109.402 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -63.89 -37.71 88.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.64 -0.663 . . . . 0.0 110.324 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -65.21 -44.38 88.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.416 -0.802 . . . . 0.0 110.416 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.4 pt -72.66 -32.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.278 -0.889 . . . . 0.0 110.392 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.82 -40.39 96.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.105 -0.997 . . . . 0.0 109.342 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.234 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CZ ' ' CE2' ' A' ' 14' ' ' PHE . 22.4 p90 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.399 0.618 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.53 ' CE2' ' CZ ' ' A' ' 13' ' ' PHE . 90.2 m-85 -64.87 -37.52 87.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.175 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.88 -41.0 99.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -0.813 . . . . 0.0 109.466 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.67 -40.19 92.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.587 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.18 -41.5 94.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.77 -40.73 97.39 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.384 -0.822 . . . . 0.0 109.351 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.15 -43.3 99.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 0.0 109.618 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -63.53 -42.64 98.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.332 -0.855 . . . . 0.0 109.879 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.47 -42.94 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 0.0 109.417 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.526 ' CG2' ' NZ ' ' A' ' 26' ' ' LYS . 76.1 m -60.73 -44.33 96.76 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.38 -0.825 . . . . 0.0 109.688 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 tp -63.71 -42.14 98.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.246 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.616 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 75.0 t80 -60.82 -44.58 96.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.577 -0.702 . . . . 0.0 110.232 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 29' ' ' ILE . 88.9 mt -63.64 -41.81 98.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 110.305 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.526 ' NZ ' ' CG2' ' A' ' 22' ' ' THR . 62.2 mttp -61.12 -40.75 94.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.91 -1.119 . . . . 0.0 110.444 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -66.84 -38.84 87.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.969 -1.082 . . . . 0.0 110.178 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.616 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 97.5 m-20 -92.5 -7.29 47.78 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.086 -1.009 . . . . 0.0 109.358 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 25' ' ' LEU . 12.3 mt -142.15 81.83 13.84 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.576 -0.702 . . . . 0.0 109.427 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.73 -27.73 78.96 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.711 2.274 . . . . 0.0 111.093 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -82.81 10.07 8.49 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 22.7 t80 -56.08 130.39 43.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -100.52 -68.76 0.8 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.448 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.6 t -152.33 168.22 26.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.722 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.03 138.22 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.4 m -125.12 124.67 42.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.606 -0.684 . . . . 0.0 109.27 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -104.43 118.47 36.7 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 t -141.26 18.64 2.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -151.09 106.67 3.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.113 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -130.82 140.6 50.28 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.323 -0.86 . . . . 0.0 109.473 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -135.82 156.35 48.93 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.453 -0.779 . . . . 0.0 109.577 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.49 ' CD2' ' O ' ' A' ' 42' ' ' PHE . 48.9 p90 -97.69 123.35 41.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.931 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -96.05 153.97 39.01 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.466 -0.771 . . . . 0.0 109.145 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.64 -22.6 50.39 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.667 2.245 . . . . 0.0 111.299 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.4 pt -102.13 -3.84 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.49 -133.88 3.2 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.402 ' H ' ' HB2' ' A' ' 65' ' ' LYS . 39.9 pt -127.79 159.61 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.312 -1.111 . . . . 0.0 110.749 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 p -126.14 137.13 53.56 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.88 130.66 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.536 -0.728 . . . . 0.0 109.344 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -130.6 137.51 49.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.621 -0.674 . . . . 0.0 109.382 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.75 -160.78 14.48 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -147.69 167.39 24.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.26 -1.141 . . . . 0.0 109.946 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.8 pt -121.2 160.44 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 121.953 0.882 . . . . 0.0 110.784 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 58.6 33.38 23.04 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.563 0.697 . . . . 0.0 109.873 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 46.41 29.49 0.89 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.306 -0.871 . . . . 0.0 110.08 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -109.24 111.76 23.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 0.0 109.504 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -58.7 -34.29 71.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.529 -0.732 . . . . 0.0 109.495 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -61.76 -39.11 90.48 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.321 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.79 73.89 8.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.074 -1.016 . . . . 0.0 109.083 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -100.56 156.5 17.26 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.6 0.714 . . . . 0.0 110.109 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.0 154.52 37.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.567 -0.708 . . . . 0.0 109.614 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 93.2 m -131.59 132.66 44.27 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.95 144.59 45.51 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.408 -0.807 . . . . 0.0 109.662 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.89 179.37 36.78 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HB2' ' H ' ' A' ' 47' ' ' ILE . 86.5 tttt -51.67 132.46 30.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.645 -0.915 . . . . 0.0 110.836 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 t0 56.01 38.09 29.56 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.672 0.749 . . . . 0.0 109.698 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 69' ' ' ILE . 36.1 t 58.56 -103.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.562 -0.711 . . . . 0.0 110.315 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 62.09 -69.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.616 -0.678 . . . . 0.0 109.53 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 67' ' ' VAL . 87.6 mt -105.73 121.84 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 108.752 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -128.39 133.97 48.72 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.5 t -132.01 141.78 49.37 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.0 p -139.45 156.15 47.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.475 -0.766 . . . . 0.0 109.968 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.9 p -68.93 170.05 10.46 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.647 0.737 . . . . 0.0 110.805 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.62 -46.52 88.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.494 -0.754 . . . . 0.0 110.263 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -65.36 -45.7 83.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 0.0 109.618 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.58 -38.74 90.39 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.314 -0.866 . . . . 0.0 109.678 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 84' ' ' ARG . 32.1 t70 -61.5 -36.02 79.31 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.128 -0.983 . . . . 0.0 109.59 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -68.86 -13.93 62.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.992 . . . . 0.0 110.207 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.2 mtp -82.2 -9.34 59.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.78 -1.2 . . . . 0.0 109.418 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -72.88 137.08 45.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.154 -0.966 . . . . 0.0 109.721 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -114.68 -11.39 12.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -127.1 153.43 76.65 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.71 -0.619 . . . . 0.0 109.917 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.86 152.13 59.8 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 122.323 2.015 . . . . 0.0 112.859 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.519 ' NH2' ' OD1' ' A' ' 77' ' ' ASP . 26.2 mmt85 -66.29 138.74 57.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 109.864 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -145.9 166.27 26.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.533 -0.729 . . . . 0.0 109.905 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.461 ' H ' ' CD ' ' A' ' 89' ' ' GLU . . . -82.31 167.8 47.56 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.578 ' CE2' HD11 ' A' ' 91' ' ' LEU . 71.6 t80 -62.01 -45.51 93.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.516 -0.99 . . . . 0.0 109.63 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -70.72 -29.14 65.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.839 -1.163 . . . . 0.0 109.005 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 86' ' ' GLY . 94.9 mt-10 -65.44 -45.33 84.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.395 -0.815 . . . . 0.0 109.936 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.6 pt -68.08 -33.42 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 109.749 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.578 HD11 ' CE2' ' A' ' 87' ' ' TYR . 41.4 mt -65.04 -41.23 95.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.384 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.11 -0.994 . . . . 0.0 109.653 -179.062 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 77.0 t80 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.771 0.796 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -59.88 -43.09 94.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.631 . . . . 0.0 109.555 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -62.95 -41.6 99.55 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.688 0.756 . . . . 0.0 109.007 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.99 -38.53 88.75 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.547 0.689 . . . . 0.0 109.398 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.596 HE22 ' HA ' ' A' ' 66' ' ' ASP . 10.3 tp-100 -61.98 -43.56 98.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.679 . . . . 0.0 110.148 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.16 -40.21 96.9 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.658 0.742 . . . . 0.0 109.273 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.67 -44.34 94.04 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.546 0.689 . . . . 0.0 109.56 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -63.73 -42.94 97.81 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.427 0.632 . . . . 0.0 110.269 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.38 -44.69 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.641 0.734 . . . . 0.0 109.707 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.9 m -62.16 -42.4 99.22 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.55 0.691 . . . . 0.0 109.875 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.518 HD11 ' NE2' ' A' ' 27' ' ' HIS . 49.2 tp -60.8 -44.36 96.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.489 -0.757 . . . . 0.0 109.597 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -62.46 -45.88 91.04 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.598 0.714 . . . . 0.0 110.186 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.33 -39.46 93.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.482 -0.761 . . . . 0.0 110.069 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -60.55 -42.0 95.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.521 -0.737 . . . . 0.0 109.804 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.518 ' NE2' HD11 ' A' ' 23' ' ' LEU . 51.8 m-70 -66.51 -39.08 88.48 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.519 0.676 . . . . 0.0 110.0 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -87.97 -2.98 58.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.462 -0.774 . . . . 0.0 109.435 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.413 HD11 HD11 ' A' ' 76' ' ' LEU . 24.3 mt -142.53 83.1 12.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.67 . . . . 0.0 109.215 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.63 -32.06 73.38 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.597 2.198 . . . . 0.0 111.159 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -83.87 16.05 3.0 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.587 0.708 . . . . 0.0 109.445 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.73 129.19 40.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.497 -0.752 . . . . 0.0 109.883 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -108.98 -58.4 2.02 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -153.91 164.32 38.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.246 -0.908 . . . . 0.0 110.447 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.09 135.84 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 100.0 m -128.82 125.36 37.58 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.701 0.762 . . . . 0.0 110.01 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -99.16 147.42 25.13 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 p -142.17 -76.21 0.28 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.489 0.661 . . . . 0.0 109.595 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -78.18 128.48 33.82 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.662 0.744 . . . . 0.0 110.571 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.97 69.6 1.36 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -81.24 162.76 23.41 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.87 0.843 . . . . 0.0 110.213 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -99.4 119.88 38.69 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.777 0.799 . . . . 0.0 110.168 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 46' ' ' GLY . 7.0 p-10 -95.15 152.25 39.33 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.36 -38.89 27.44 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.671 2.247 . . . . 0.0 112.077 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.9 -41.17 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.58 -0.7 . . . . 0.0 109.961 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' H ' ' ND2' ' A' ' 43' ' ' ASN . . . -179.41 -135.1 2.32 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.418 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 pt -103.74 139.26 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.758 -0.848 . . . . 0.0 109.801 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.7 m -116.54 124.96 51.17 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.579 0.705 . . . . 0.0 109.591 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.15 125.48 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 61' ' ' PHE . 38.8 t70 -124.25 153.67 41.33 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.861 0.839 . . . . 0.0 109.932 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 178.54 -167.49 38.0 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.469 ' CE2' ' NZ ' ' A' ' 57' ' ' LYS . 19.7 p90 -142.17 163.73 32.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.831 -0.805 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -120.78 161.53 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.674 0.749 . . . . 0.0 110.027 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 58.89 32.16 21.98 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.623 0.725 . . . . 0.0 109.844 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 45.82 32.11 1.2 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.653 . . . . 0.0 109.595 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -115.57 109.51 17.89 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.416 0.627 . . . . 0.0 109.541 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' NZ ' ' CE2' ' A' ' 52' ' ' TYR . 69.6 mmtt -57.85 -33.36 68.57 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.408 0.623 . . . . 0.0 110.032 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -60.5 -39.26 87.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 109.0 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.44 68.77 9.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.445 -0.785 . . . . 0.0 109.373 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.6 p -91.93 161.39 14.84 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.615 0.722 . . . . 0.0 109.855 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.408 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 49.2 p90 -155.07 160.9 41.35 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.63 0.728 . . . . 0.0 109.725 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.6 m -140.68 144.57 35.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.611 -0.681 . . . . 0.0 109.7 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.47 140.69 26.42 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -105.13 147.84 16.38 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 64' ' ' GLY . 63.8 mmtt 35.22 -122.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.439 0.637 . . . . 0.0 111.232 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.596 ' HA ' HE22 ' A' ' 17' ' ' GLN . 97.7 m-20 -88.21 86.84 7.15 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.774 0.797 . . . . 0.0 109.921 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 45.67 14.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.661 0.743 . . . . 0.0 109.668 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 66' ' ' ASP . 25.5 tptt -78.44 136.46 37.63 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.878 0.847 . . . . 0.0 110.05 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 68' ' ' LYS . 9.4 mm 49.15 99.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.59 0.709 . . . . 0.0 109.513 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -135.79 153.97 51.36 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.687 0.756 . . . . 0.0 110.083 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 p -136.53 157.25 47.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 m -133.95 153.08 52.01 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.935 0.874 . . . . 0.0 110.135 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.2 p -65.13 168.55 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.765 0.793 . . . . 0.0 110.744 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.17 -51.81 68.17 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.467 0.651 . . . . 0.0 109.82 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.95 -43.36 92.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.526 -0.734 . . . . 0.0 109.715 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.413 HD11 HD11 ' A' ' 29' ' ' ILE . 56.6 tp -63.8 -39.1 93.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -61.02 -38.03 84.67 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.631 0.729 . . . . 0.0 109.371 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.97 -36.64 82.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.334 -0.854 . . . . 0.0 109.509 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 81' ' ' GLN . 79.1 mtp -63.32 -41.34 98.91 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.467 -0.771 . . . . 0.0 109.943 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -43.44 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.922 0.868 . . . . 0.0 110.238 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' MET . 57.7 tt0 -67.79 -36.34 80.28 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.194 -0.603 . . . . 0.0 109.642 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -105.89 152.66 40.29 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.499 -0.75 . . . . 0.0 109.921 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.54 167.62 20.34 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.81 2.34 . . . . 0.0 112.844 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -63.78 140.22 58.85 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.777 0.798 . . . . 0.0 110.212 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -144.52 -111.34 0.1 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.685 -0.634 . . . . 0.0 109.843 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -176.94 161.06 28.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.452 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.88 -44.39 97.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.385 0.612 . . . . 0.0 110.059 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -58.76 -39.79 82.01 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.534 0.683 . . . . 0.0 110.121 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -57.96 -56.36 22.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 109.667 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.8 pt -65.64 -26.14 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.436 -0.79 . . . . 0.0 110.029 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.58 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.2 tt -63.61 -35.85 81.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.503 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.257 -0.902 . . . . 0.0 109.322 -179.111 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.606 0.717 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -67.9 -33.95 75.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.445 -0.785 . . . . 0.0 109.842 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.415 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 90.9 m-20 -61.62 -46.76 88.45 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.462 -0.774 . . . . 0.0 110.062 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.31 -36.07 71.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 109.588 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.458 HE22 ' H ' ' A' ' 67' ' ' VAL . 68.4 tp60 -66.27 -41.13 90.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.578 -0.701 . . . . 0.0 109.521 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -64.85 -40.93 95.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.557 -0.714 . . . . 0.0 109.58 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -61.35 -42.37 98.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.575 -0.703 . . . . 0.0 109.583 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.3 -42.51 96.34 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.599 0.714 . . . . 0.0 109.175 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.4 t -65.43 -43.61 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.476 0.655 . . . . 0.0 109.659 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -61.74 -45.1 95.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.694 -0.629 . . . . 0.0 110.103 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 tp -63.31 -41.01 98.89 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.949 0.881 . . . . 0.0 109.976 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.623 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 62.9 t80 -66.43 -39.26 88.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.499 -0.75 . . . . 0.0 109.52 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.0 mt -61.82 -47.31 85.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.588 -0.695 . . . . 0.0 111.017 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.97 -34.56 78.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.503 -0.748 . . . . 0.0 110.314 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -72.46 -35.92 68.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 110.277 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.623 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 69.9 m-80 -94.72 -1.28 53.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.292 -0.88 . . . . 0.0 109.483 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 mt -140.93 86.79 11.41 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.389 -0.82 . . . . 0.0 109.346 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -55.98 -31.92 83.96 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.678 2.252 . . . . 0.0 111.303 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -82.25 13.46 3.5 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 25.1 t80 -57.2 130.68 47.24 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.758 0.79 . . . . 0.0 109.826 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -116.42 -66.82 1.04 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -141.06 165.31 27.9 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.507 -0.746 . . . . 0.0 109.935 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.68 138.84 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.42 0.629 . . . . 0.0 109.357 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.526 HG21 ' OH ' ' A' ' 52' ' ' TYR . 97.8 m -124.91 115.75 21.11 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.689 0.757 . . . . 0.0 109.494 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -86.85 135.47 33.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -111.53 -35.79 5.7 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.74 32.38 19.32 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.507 0.67 . . . . 0.0 109.363 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.33 16.7 14.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.467 -0.771 . . . . 0.0 109.561 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -134.68 148.39 50.32 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.298 -0.876 . . . . 0.0 109.929 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 42' ' ' PHE . 35.1 p90 -161.18 125.08 3.38 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.512 0.672 . . . . 0.0 109.313 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 4.3 p30 -91.02 150.99 42.76 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.527 -0.733 . . . . 0.0 109.847 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -65.06 -24.36 59.81 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.599 2.199 . . . . 0.0 111.766 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tp -70.39 -26.89 29.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.616 0.722 . . . . 0.0 109.382 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.38 -119.93 0.63 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.4 pt -126.2 158.98 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.691 -0.888 . . . . 0.0 110.533 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.4 m -141.67 139.75 33.05 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.2 127.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.55 0.691 . . . . 0.0 109.49 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.5 t0 -119.89 142.92 48.25 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.555 0.693 . . . . 0.0 109.571 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -173.09 -176.15 41.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.526 ' OH ' HG21 ' A' ' 36' ' ' THR . 13.3 p90 -143.1 164.03 31.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.597 -0.943 . . . . 0.0 110.341 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 pt -119.03 164.47 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.793 0.806 . . . . 0.0 110.282 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' ASP . 68.7 m-80 58.11 34.35 24.1 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.543 0.687 . . . . 0.0 109.734 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 45.25 20.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.49 0.662 . . . . 0.0 109.657 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' ASN . 99.8 m-20 -102.14 109.65 21.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.494 -0.754 . . . . 0.0 109.232 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -57.37 -33.13 67.48 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.26 0.552 . . . . 0.0 109.933 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -61.99 -39.37 91.98 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.3 mt -81.24 71.28 8.22 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.293 -0.88 . . . . 0.0 109.59 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.416 ' O ' HD22 ' A' ' 76' ' ' LEU . 18.3 p -90.67 161.69 15.26 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.676 0.75 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -149.24 152.66 36.35 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.455 0.645 . . . . 0.0 109.665 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.8 m -131.06 135.21 47.35 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.583 0.706 . . . . 0.0 110.167 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.22 146.38 40.42 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.646 0.736 . . . . 0.0 109.309 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.09 -155.74 16.9 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.31 134.26 55.51 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.944 0.878 . . . . 0.0 110.571 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 50.93 29.88 4.81 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.474 0.654 . . . . 0.0 109.463 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' H ' HE22 ' A' ' 17' ' ' GLN . 2.0 t 48.49 30.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.659 0.743 . . . . 0.0 109.454 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' NH2' ' A' ' 84' ' ' ARG . 28.2 tptp -62.16 -45.19 94.51 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.622 -0.674 . . . . 0.0 109.237 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.18 128.26 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -134.5 138.49 44.73 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.664 0.745 . . . . 0.0 109.877 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 t -132.85 146.17 51.59 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.514 0.673 . . . . 0.0 109.25 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.1 t -135.01 147.12 49.6 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.817 0.818 . . . . 0.0 110.172 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.1 p -77.8 173.77 11.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.645 0.736 . . . . 0.0 110.284 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.39 -48.59 80.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.361 0.6 . . . . 0.0 110.16 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.457 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 59.5 mp0 -67.41 -45.01 77.4 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.441 -0.787 . . . . 0.0 109.819 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 60' ' ' SER . 52.9 tp -64.16 -40.28 95.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.423 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -58.7 -41.26 85.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.595 -0.69 . . . . 0.0 109.191 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -65.21 -36.52 84.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.41 -0.807 . . . . 0.0 109.836 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 84.6 mmm -62.22 -38.17 88.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.239 -0.913 . . . . 0.0 109.208 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -57.91 138.18 56.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.456 -0.778 . . . . 0.0 109.554 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -108.03 -16.57 14.25 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -130.61 151.29 78.44 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.644 -0.66 . . . . 0.0 109.829 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.54 159.82 51.9 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.163 2.575 . . . . 0.0 112.881 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.462 ' NH2' ' O ' ' A' ' 68' ' ' LYS . 78.6 ttt-85 -66.82 132.53 48.23 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.786 0.803 . . . . 0.0 110.039 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -119.13 -72.43 0.69 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.39 158.44 9.87 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.534 ' CE2' HD11 ' A' ' 91' ' ' LEU . 81.4 t80 -62.57 -44.54 96.07 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.937 0.875 . . . . 0.0 109.636 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -73.55 -23.7 60.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.79 -45.47 67.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.523 -0.736 . . . . 0.0 109.673 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 91' ' ' LEU . 25.3 pt -66.79 -36.12 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.423 0.63 . . . . 0.0 109.563 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.534 HD11 ' CE2' ' A' ' 87' ' ' TYR . 39.2 mt -63.63 -40.49 97.01 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.577 -0.702 . . . . 0.0 109.561 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.616 -0.678 . . . . 0.0 109.628 -179.692 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.407 0.623 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -64.81 -36.5 84.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.395 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -61.38 -40.73 95.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.441 -0.787 . . . . 0.0 109.187 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -65.59 -40.25 92.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.565 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 66' ' ' ASP . 99.4 mm-40 -64.71 -42.43 95.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.691 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -64.25 -40.45 96.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.664 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.81 -44.5 93.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.86 . . . . 0.0 109.636 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.51 -41.7 96.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 109.862 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.3 t -64.63 -42.88 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.862 . . . . 0.0 109.644 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -59.74 -45.27 92.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.212 -0.93 . . . . 0.0 108.87 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.5 -41.96 98.53 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.398 -0.813 . . . . 0.0 109.281 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.484 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 83.1 t80 -58.99 -46.34 88.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.509 -0.744 . . . . 0.0 109.312 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -75.2 -22.93 57.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.69 -0.631 . . . . 0.0 109.712 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -63.96 -48.34 76.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.796 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.619 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 26.2 p80 -81.81 -35.83 29.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.051 -1.031 . . . . 0.0 109.755 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.619 ' ND2' ' CE1' ' A' ' 27' ' ' HIS . 36.6 m-80 -64.04 -41.03 97.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -122.69 88.26 49.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.632 -0.667 . . . . 0.0 109.604 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -54.22 -29.79 58.49 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.756 2.304 . . . . 0.0 111.622 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -80.37 5.1 15.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -55.64 131.73 47.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.493 -0.755 . . . . 0.0 110.284 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -103.0 -65.71 0.98 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 t -149.93 165.0 33.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.841 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.1 p -128.12 135.64 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.8 m -126.5 123.46 37.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.574 -0.704 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -95.55 144.13 26.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 109.429 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.463 ' O ' ' OG1' ' A' ' 38' ' ' THR . 0.2 OUTLIER -143.32 17.95 1.89 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.925 . . . . 0.0 108.643 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -155.48 116.27 3.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.372 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -138.26 91.47 2.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -118.18 147.3 43.49 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.703 0.763 . . . . 0.0 109.965 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 42' ' ' PHE . 48.8 p90 -97.35 120.94 38.64 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.692 -0.63 . . . . 0.0 109.396 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.45 HD21 ' HA ' ' A' ' 43' ' ' ASN . 5.1 m120 -103.58 154.59 37.78 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.342 -0.849 . . . . 0.0 108.909 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.92 -40.64 49.01 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.966 1.777 . . . . 0.0 111.594 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 92.0 mt -67.57 -41.26 85.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.456 -0.777 . . . . 0.0 109.059 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.54 -125.89 0.96 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.0 pt -128.36 151.33 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.588 -0.948 . . . . 0.0 110.011 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 m -127.04 122.45 34.44 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.11 130.89 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -129.8 149.85 51.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.708 0.766 . . . . 0.0 109.466 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.9 -168.14 34.47 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -142.48 164.79 29.17 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.344 -1.092 . . . . 0.0 110.309 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 pt -121.0 159.36 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.603 0.716 . . . . 0.0 110.306 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 57.52 32.8 22.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.565 -0.71 . . . . 0.0 109.518 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 46.74 32.18 1.66 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.32 -0.862 . . . . 0.0 110.123 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -109.57 108.29 18.68 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.528 -0.733 . . . . 0.0 109.466 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.92 -34.98 72.33 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.394 0.616 . . . . 0.0 109.61 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -62.55 -38.63 90.77 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.123 -0.986 . . . . 0.0 109.175 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.2 mt -83.91 77.55 9.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.1 t -107.37 162.76 13.63 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.372 0.606 . . . . 0.0 109.824 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -153.15 159.75 42.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.322 -0.861 . . . . 0.0 109.287 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.7 m -129.31 133.8 47.62 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.3 142.64 50.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.745 . . . . 0.0 109.14 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.49 124.82 5.4 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt 54.13 93.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.755 -0.85 . . . . 0.0 110.646 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD1' ' NE2' ' A' ' 17' ' ' GLN . 95.1 m-20 52.79 -103.23 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.708 -0.62 . . . . 0.0 110.109 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.84 17.8 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.53 -44.84 96.33 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.413 -0.804 . . . . 0.0 109.222 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.0 mt -121.89 126.06 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CD2' ' NH1' ' A' ' 84' ' ' ARG . 66.0 t80 -138.46 131.77 30.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.512 -0.742 . . . . 0.0 109.191 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 p -139.06 143.46 38.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.366 -0.834 . . . . 0.0 109.06 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 p -153.97 170.29 21.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.988 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -77.17 171.59 14.59 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.634 0.731 . . . . 0.0 110.835 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.71 -35.39 80.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.602 -0.686 . . . . 0.0 109.546 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -58.34 -57.55 12.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.115 -0.99 . . . . 0.0 109.279 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.97 -38.65 86.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.194 -0.941 . . . . 0.0 109.282 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -51.7 -38.42 55.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.378 -0.826 . . . . 0.0 109.702 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -60.42 -31.05 70.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 0.0 110.228 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.6 mmm -64.22 -35.45 80.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.953 . . . . 0.0 110.02 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -55.06 132.88 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.014 -1.054 . . . . 0.0 109.714 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -95.08 -71.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.623 -0.673 . . . . 0.0 109.484 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.19 158.03 41.89 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 109.352 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -46.56 158.35 0.38 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.243 1.962 . . . . 0.0 112.817 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.479 ' NH1' ' CD2' ' A' ' 70' ' ' PHE . 96.3 mtt-85 -67.59 141.33 56.82 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.392 -0.817 . . . . 0.0 109.59 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -130.95 145.72 52.12 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.458 0.646 . . . . 0.0 109.904 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.2 155.89 26.55 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.522 ' CE2' HD11 ' A' ' 91' ' ' LEU . 85.5 t80 -60.53 -46.01 91.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.8 -0.824 . . . . 0.0 109.403 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 45.8 p-10 -68.75 -32.93 73.05 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.16 -0.962 . . . . 0.0 109.683 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 83.0 tt0 -66.41 -43.09 86.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 110.508 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 91' ' ' LEU . 29.7 pt -66.71 -37.73 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.033 -1.042 . . . . 0.0 109.375 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.522 HD11 ' CE2' ' A' ' 87' ' ' TYR . 89.1 mt -62.56 -42.0 99.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.011 -1.055 . . . . 0.0 109.152 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 C--N 1.302 -1.472 0 O-C-N 121.437 -0.789 . . . . 0.0 109.328 179.779 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.317 0.58 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -63.65 -40.69 97.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 109.827 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.63 -41.17 98.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.806 . . . . 0.0 110.149 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.45 -40.0 92.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 109.962 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.89 -40.1 94.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.824 . . . . 0.0 110.058 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.01 -40.86 97.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.177 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -65.58 -40.25 92.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.967 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -63.25 -42.17 99.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -0.867 . . . . 0.0 109.415 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.53 -43.36 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.562 -0.712 . . . . 0.0 109.902 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -61.55 -44.65 96.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.661 -0.649 . . . . 0.0 110.146 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.489 HD11 ' NE2' ' A' ' 27' ' ' HIS . 38.2 tp -63.01 -44.13 96.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 110.379 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.671 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 90.9 t80 -62.74 -45.13 94.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.037 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.05 -40.33 96.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.478 -0.764 . . . . 0.0 110.01 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -58.91 -45.03 91.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 110.744 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.489 ' NE2' HD11 ' A' ' 23' ' ' LEU . 84.4 m-70 -68.23 -37.21 80.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.051 . . . . 0.0 110.26 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.671 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 72.4 m-20 -87.64 -5.39 58.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 109.177 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.4 mt -138.29 99.0 8.98 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.568 -0.708 . . . . 0.0 109.684 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.34 -14.75 31.32 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.334 2.023 . . . . 0.0 111.589 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -90.9 4.66 51.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.638 -0.664 . . . . 0.0 109.284 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -54.72 129.66 37.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.387 -0.821 . . . . 0.0 110.135 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -125.45 -56.11 1.52 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -146.49 156.46 43.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.341 -0.849 . . . . 0.0 109.627 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.91 140.28 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.623 -0.673 . . . . 0.0 109.872 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.6 m -124.68 128.2 48.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -97.88 124.91 42.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.472 -0.767 . . . . 0.0 110.015 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 39' ' ' ASN . 60.4 p -99.62 -15.16 18.67 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 38' ' ' THR . 74.4 m-20 58.1 148.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.596 0.712 . . . . 0.0 110.535 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.42 -163.96 1.59 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.346 -0.846 . . . . 0.0 109.946 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.12 -160.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.693 -0.629 . . . . 0.0 110.845 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -107.75 130.61 54.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.391 -0.818 . . . . 0.0 110.064 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -90.39 155.61 46.29 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.423 -0.798 . . . . 0.0 109.822 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -49.63 -37.03 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.534 2.156 . . . . 0.0 111.645 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 46' ' ' GLY . 21.4 tt -68.4 -38.6 79.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.538 -0.726 . . . . 0.0 109.428 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 177.92 -97.14 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.56 148.82 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.882 . . . . 0.0 110.007 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 t -100.21 125.04 46.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.396 -0.815 . . . . 0.0 109.427 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.03 129.47 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 61' ' ' PHE . 22.6 t0 -130.68 152.14 50.37 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -175.41 -177.39 44.44 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -143.75 162.75 35.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.539 -0.977 . . . . 0.0 109.968 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.9 pt -121.41 161.5 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.595 0.712 . . . . 0.0 110.871 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 56.78 32.62 21.6 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.692 0.758 . . . . 0.0 109.616 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 46.6 32.3 1.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.514 -0.741 . . . . 0.0 109.81 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -113.08 111.28 21.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.66 -0.65 . . . . 0.0 109.357 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -59.79 -31.75 69.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.605 -0.685 . . . . 0.0 109.564 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.96 -39.06 90.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 109.204 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.8 mt -83.5 73.14 10.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 108.986 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 m -105.05 159.67 15.65 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.649 0.737 . . . . 0.0 110.355 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.43 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 53.3 p90 -147.99 149.3 31.9 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.631 -0.668 . . . . 0.0 109.284 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.2 m -128.11 131.92 49.0 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.83 139.96 49.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.41 -0.806 . . . . 0.0 109.764 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -99.78 112.52 4.47 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.2 tttm 37.87 -83.0 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.097 -0.649 . . . . 0.0 111.813 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 64' ' ' GLY . 99.8 m-20 -78.21 125.19 28.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 67' ' ' VAL . 37.2 t -60.39 0.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 66' ' ' ASP . 65.8 tttm -61.74 -42.59 99.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 109.467 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.86 112.85 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.487 0.66 . . . . 0.0 109.386 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -141.39 158.53 43.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.591 -0.693 . . . . 0.0 109.926 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.0 t -125.51 155.9 39.85 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.477 0.655 . . . . 0.0 109.555 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 p -150.15 162.13 41.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.439 -0.788 . . . . 0.0 109.636 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -77.34 170.83 15.86 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.99 0.9 . . . . 0.0 110.838 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 74' ' ' GLU . 58.7 mp0 -66.09 -37.93 87.0 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.777 -0.577 . . . . 0.0 109.61 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.95 -39.96 94.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.558 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.467 HD12 ' SD ' ' A' ' 79' ' ' MET . 58.6 tp -82.61 -21.4 35.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.299 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -66.93 -48.0 69.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -64.69 -22.62 67.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.402 -0.811 . . . . 0.0 110.227 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.467 ' SD ' HD12 ' A' ' 76' ' ' LEU . 90.8 mtp -65.27 -33.68 76.55 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.535 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -53.78 141.72 25.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.872 . . . . 0.0 110.429 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -85.4 -75.81 0.35 Allowed 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.831 -0.543 . . . . 0.0 109.963 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' PRO . 25.9 mt-10 -99.93 154.54 37.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.731 . . . . 0.0 109.862 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 82' ' ' GLU . 85.1 Cg_exo -40.93 170.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.837 2.358 . . . . 0.0 113.282 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -64.98 130.95 45.27 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.705 0.764 . . . . 0.0 110.018 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -109.14 -78.01 0.59 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.29 145.86 4.21 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.526 ' CE2' HD11 ' A' ' 91' ' ' LEU . 81.9 t80 -60.44 -45.1 94.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.792 -0.828 . . . . 0.0 109.567 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.58 -26.99 62.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.162 -0.961 . . . . 0.0 109.327 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -69.16 -43.24 74.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.465 -0.772 . . . . 0.0 110.014 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.4 pt -68.3 -37.05 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.316 -0.865 . . . . 0.0 109.777 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 87' ' ' TYR . 86.3 mt -62.91 -42.14 99.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.036 . . . . 0.0 109.777 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 C--N 1.301 -1.523 0 O-C-N 121.192 -0.942 . . . . 0.0 109.211 179.6 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.481 0.658 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -60.38 -43.55 96.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.503 -0.748 . . . . 0.0 109.754 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -63.56 -40.84 98.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.245 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -62.71 -40.66 97.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.588 -0.695 . . . . 0.0 109.477 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.06 -41.14 97.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.759 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.0 -41.18 97.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 109.437 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -64.1 -42.05 97.04 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.01 -43.27 93.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.606 -0.683 . . . . 0.0 109.859 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.31 -44.3 92.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.431 -0.793 . . . . 0.0 109.801 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.5 t -64.5 -45.26 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 110.072 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.8 m -62.44 -48.04 81.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.267 -0.896 . . . . 0.0 109.538 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 tp -64.08 -41.92 97.15 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.775 0.798 . . . . 0.0 109.656 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.454 ' CZ ' ' OD1' ' A' ' 28' ' ' ASN . 78.5 t80 -63.96 -40.57 96.72 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.922 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.08 -46.13 90.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.855 . . . . 0.0 110.472 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -68.89 -29.2 67.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 110.308 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -68.48 -39.74 81.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.269 -0.894 . . . . 0.0 109.897 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.454 ' OD1' ' CZ ' ' A' ' 24' ' ' TYR . 31.5 m120 -94.63 -3.69 49.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 108.65 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 80' ' ' PHE . 20.6 mt -138.38 93.98 11.04 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.92 -16.53 36.92 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.071 1.848 . . . . 0.0 111.057 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -90.12 5.54 46.38 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -58.11 133.81 55.9 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.55 -0.719 . . . . 0.0 110.164 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -110.19 -58.08 2.12 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 t -153.45 160.5 42.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 109.97 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.3 134.69 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -123.49 125.83 45.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.01 144.61 26.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.608 -0.682 . . . . 0.0 109.338 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.1 t -161.91 61.06 0.25 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.183 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -161.53 -83.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 40' ' ' GLU . 4.1 tm-20 56.13 75.13 0.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.794 . . . . 0.0 109.375 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -120.3 150.58 40.5 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.622 0.725 . . . . 0.0 109.614 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -92.23 120.31 32.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.376 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -103.49 156.01 36.07 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.28 -37.97 25.29 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.399 2.066 . . . . 0.0 112.06 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 46' ' ' GLY . 21.0 tt -68.72 -37.73 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.119 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 170.11 -98.44 0.13 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 pt -123.35 157.81 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.526 -0.985 . . . . 0.0 110.275 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.0 p -139.98 123.78 17.42 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.58 133.06 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.681 -0.637 . . . . 0.0 109.427 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 50.1 t0 -131.18 147.1 52.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.613 -0.68 . . . . 0.0 109.449 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -172.43 -170.61 36.44 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -141.42 165.59 27.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.356 -1.085 . . . . 0.0 110.156 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.4 pt -121.75 162.84 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.531 0.682 . . . . 0.0 110.872 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 57.76 33.18 22.91 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.347 0.594 . . . . 0.0 110.126 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 48.31 26.73 1.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.4 -0.812 . . . . 0.0 110.246 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -108.57 108.59 19.55 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.375 -0.828 . . . . 0.0 109.644 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.15 -32.47 68.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.652 -0.655 . . . . 0.0 109.65 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -62.58 -39.73 94.65 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.45 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.8 mt -81.89 80.31 8.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.163 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.8 m -104.86 153.41 21.4 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.747 0.784 . . . . 0.0 110.417 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -139.61 150.98 45.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.779 -0.575 . . . . 0.0 109.635 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.2 m -133.67 136.23 44.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.544 -0.723 . . . . 0.0 109.917 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.26 155.21 40.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.232 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.44 -130.35 3.91 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' ASP . 54.9 mtpt -59.23 128.57 37.82 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.487 -1.008 . . . . 0.0 110.716 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 67' ' ' VAL . 43.2 t0 44.93 -173.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.505 0.669 . . . . 0.0 110.278 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.506 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 2.3 t -94.69 21.28 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.097 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -63.4 -41.84 98.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.219 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.37 126.06 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -136.13 135.44 39.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.537 -0.727 . . . . 0.0 109.183 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 t -134.48 144.54 48.13 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.74 . . . . 0.0 109.413 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.1 p -152.71 164.08 38.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 110.516 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.1 p -68.06 167.44 13.95 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.611 0.72 . . . . 0.0 110.67 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -66.46 -36.61 83.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.313 -0.867 . . . . 0.0 109.447 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.83 -32.22 73.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.552 -0.717 . . . . 0.0 109.478 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.4 tp -90.52 -17.94 26.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 109.16 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -73.2 -42.27 62.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.67 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -63.77 -21.31 66.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.642 -0.661 . . . . 0.0 109.745 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 86.1 mmm -64.51 -35.36 80.7 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.341 -0.849 . . . . 0.0 109.15 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 29' ' ' ILE . 14.4 m-85 -64.31 132.79 51.23 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.32 -0.862 . . . . 0.0 109.86 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -113.21 -16.99 12.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -119.08 153.62 53.04 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.742 -0.598 . . . . 0.0 109.853 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.31 157.34 58.36 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 123.022 2.481 . . . . 0.0 113.012 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -67.4 141.65 56.98 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.726 0.774 . . . . 0.0 110.845 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -141.27 150.54 42.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.647 -0.658 . . . . 0.0 109.308 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.65 158.72 51.16 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -60.41 -44.08 96.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.715 -0.873 . . . . 0.0 109.58 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -66.26 -34.58 78.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 109.663 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -62.65 -49.5 74.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 109.689 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 pt -66.95 -37.46 79.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.472 -0.767 . . . . 0.0 109.427 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.3 tp -62.51 -44.23 96.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.899 . . . . 0.0 109.461 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.64 -38.17 73.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.394 -0.817 . . . . 0.0 109.525 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 93' ' ' HIS . 53.4 t-80 51.83 23.99 2.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.352 -0.842 . . . . 0.0 109.463 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 94' ' ' HIS . 84.1 t60 55.79 16.27 1.96 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.459 -0.776 . . . . 0.0 109.366 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -94.89 122.73 37.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.792 . . . . 0.0 109.764 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.496 ' CG ' ' N ' ' A' ' 97' ' ' HIS . 58.9 t-80 -155.42 168.4 27.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 0.0 109.533 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.496 ' N ' ' CG ' ' A' ' 96' ' ' HIS . 99.3 m-70 -78.94 147.41 33.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.552 -0.717 . . . . 0.0 110.385 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 99.7 m-70 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 117.853 -1.07 . . . . 0.0 108.994 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.889 0.852 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -63.35 -17.91 63.08 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.385 0.612 . . . . 0.0 109.784 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -64.39 -36.56 84.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 109.658 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -63.23 -41.35 99.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.499 -0.751 . . . . 0.0 110.026 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 54.8 mp0 -67.62 -40.41 84.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.606 -0.683 . . . . 0.0 109.91 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.422 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 9.0 tp-100 -67.75 -36.72 81.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.402 -0.811 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.72 -42.69 99.3 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.623 0.725 . . . . 0.0 109.372 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.62 -39.88 91.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.737 -0.602 . . . . 0.0 109.94 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.74 -42.37 97.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.377 -0.827 . . . . 0.0 109.962 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.38 -42.3 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.1 m -60.51 -45.28 94.38 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.729 0.776 . . . . 0.0 109.078 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.404 HD11 ' NE2' ' A' ' 27' ' ' HIS . 41.8 tp -63.83 -41.91 97.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.444 -0.785 . . . . 0.0 108.998 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.675 ' CE2' ' ND2' ' A' ' 28' ' ' ASN . 75.6 t80 -61.36 -47.36 86.21 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.63 -39.83 94.39 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.57 0.7 . . . . 0.0 109.571 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -58.52 -47.82 82.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.624 -0.673 . . . . 0.0 110.272 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.404 ' NE2' HD11 ' A' ' 23' ' ' LEU . 59.5 m-70 -74.29 -42.75 59.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.28 -0.887 . . . . 0.0 110.072 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.675 ' ND2' ' CE2' ' A' ' 24' ' ' TYR . 68.9 m-80 -65.28 -39.81 93.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.761 . . . . 0.0 109.499 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.1 mt -105.18 109.32 63.08 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.709 -0.62 . . . . 0.0 109.607 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.94 -16.67 29.14 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.258 1.972 . . . . 0.0 111.15 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.525 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 54.4 t0 -97.33 13.64 28.89 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -58.16 129.54 42.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.485 -0.759 . . . . 0.0 110.036 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 31' ' ' ASP . 13.9 m-80 -125.83 -53.64 1.54 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -146.19 158.17 43.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.358 -0.839 . . . . 0.0 110.044 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.2 138.38 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.185 0.516 . . . . 0.0 109.874 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -130.51 124.06 31.07 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.516 0.674 . . . . 0.0 109.589 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -101.32 117.73 35.55 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.452 0.644 . . . . 0.0 109.583 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 t -154.76 30.04 0.42 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.601 -0.687 . . . . 0.0 109.237 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -147.51 16.16 1.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.487 -0.758 . . . . 0.0 109.006 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.75 141.11 45.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.592 0.711 . . . . 0.0 110.685 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -146.3 155.41 42.62 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.472 0.653 . . . . 0.0 109.751 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -75.76 140.82 42.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.637 -0.664 . . . . 0.0 109.789 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -112.01 140.32 23.33 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.22 -36.62 29.75 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.253 1.969 . . . . 0.0 111.422 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.3 tt -86.5 -6.4 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.395 -0.815 . . . . 0.0 109.217 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.92 -114.88 0.63 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 pt -127.21 157.09 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.786 -0.832 . . . . 0.0 110.289 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -128.23 131.48 48.8 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.54 0.686 . . . . 0.0 109.396 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mm -98.82 119.21 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.432 0.634 . . . . 0.0 109.457 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.432 ' OD1' HG23 ' A' ' 62' ' ' THR . 98.3 m-20 -123.58 141.93 51.53 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.45 0.643 . . . . 0.0 109.601 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.29 -168.27 38.01 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -145.9 164.93 30.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.88 -0.777 . . . . 0.0 109.955 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -122.75 164.82 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 121.844 0.831 . . . . 0.0 110.7 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 57.98 32.43 21.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.774 0.797 . . . . 0.0 109.783 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 46.56 30.52 1.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.852 -0.53 . . . . 0.0 110.164 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -112.82 111.62 22.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.553 -0.717 . . . . 0.0 109.569 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.04 -32.52 69.82 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.449 0.642 . . . . 0.0 109.493 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -62.82 -39.01 92.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.806 . . . . 0.0 109.424 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.35 76.13 9.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.456 -0.777 . . . . 0.0 109.442 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.1 m -100.34 159.65 14.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.459 0.647 . . . . 0.0 110.452 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -146.62 150.24 35.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.429 0.633 . . . . 0.0 109.812 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.432 HG23 ' OD1' ' A' ' 50' ' ' ASP . 52.3 m -131.29 135.59 47.43 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.23 145.94 51.01 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.591 0.71 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -93.99 111.59 4.17 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' A' ' 67' ' ' VAL . 13.0 ptmt 26.93 -107.3 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.527 0.679 . . . . 0.0 111.123 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -69.37 42.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.714 0.769 . . . . 0.0 109.666 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 65' ' ' LYS . 2.3 t 51.13 37.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.939 0.876 . . . . 0.0 109.921 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -63.64 -41.96 98.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.655 -0.653 . . . . 0.0 109.362 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 69' ' ' ILE . 11.1 tp -135.09 131.31 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.617 -0.677 . . . . 0.0 109.279 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -124.21 133.43 53.53 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.525 0.679 . . . . 0.0 110.168 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -128.76 152.32 48.58 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.0 m -130.21 152.44 49.63 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.803 0.811 . . . . 0.0 110.161 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 77' ' ' ASP . 17.0 p -78.58 172.3 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.811 0.815 . . . . 0.0 110.65 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -58.64 -44.11 89.97 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.55 0.691 . . . . 0.0 109.9 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.05 -36.81 75.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.447 -0.783 . . . . 0.0 109.567 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.7 tp -81.37 -15.99 53.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.752 0.787 . . . . 0.0 109.43 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' SER . 65.2 t0 -61.12 -47.29 86.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.22 -0.925 . . . . 0.0 110.589 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -59.98 -44.0 94.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.445 -0.784 . . . . 0.0 110.595 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 94.5 mtp -66.51 -38.99 88.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.66 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -75.17 108.31 7.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.48 -0.763 . . . . 0.0 109.983 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -145.24 7.47 1.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -122.52 83.23 47.49 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.5 118.71 2.23 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.776 2.318 . . . . 0.0 113.128 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -80.97 166.0 21.23 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.972 0.891 . . . . 0.0 110.594 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -87.74 -5.91 58.44 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.867 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.65 165.79 14.39 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.715 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.421 ' CD2' HD11 ' A' ' 90' ' ' ILE . 52.9 t80 -62.71 -22.23 66.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.907 -0.761 . . . . 0.0 109.154 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -81.3 -26.82 35.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.552 -0.718 . . . . 0.0 109.937 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -72.48 -40.86 66.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.428 -0.795 . . . . 0.0 110.184 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 87' ' ' TYR . 17.5 pt -60.44 -23.93 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.453 -0.779 . . . . 0.0 110.356 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.2 mt -65.55 -33.58 76.25 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.242 -0.911 . . . . 0.0 109.896 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -54.13 -17.8 3.12 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.454 0.645 . . . . 0.0 110.024 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -57.35 -39.43 75.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.406 -0.809 . . . . 0.0 109.639 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -98.19 71.1 2.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 0.0 109.09 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -79.51 -4.85 53.22 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.638 0.732 . . . . 0.0 109.222 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -53.62 -76.28 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.594 0.711 . . . . 0.0 109.849 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.5 -43.86 98.11 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.578 0.704 . . . . 0.0 109.605 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.235 -179.767 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -61.98 -43.2 99.33 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.252 0.548 . . . . 0.0 109.812 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -85.56 -27.25 25.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.795 -0.566 . . . . 0.0 109.519 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -62.69 -44.83 95.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.789 -0.569 . . . . 0.0 109.947 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -65.79 -37.12 85.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.851 -0.531 . . . . 0.0 109.755 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.98 -43.08 99.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.8 -0.563 . . . . 0.0 110.033 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -64.78 -39.96 94.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.781 -0.574 . . . . 0.0 110.362 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.19 -39.48 94.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.712 -0.617 . . . . 0.0 109.561 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.33 -42.25 98.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.81 -0.556 . . . . 0.0 109.68 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.18 -43.3 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -61.88 -43.48 98.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.157 0.503 . . . . 0.0 109.782 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.427 HD11 ' NE2' ' A' ' 27' ' ' HIS . 51.8 tp -62.26 -41.26 98.3 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.324 0.583 . . . . 0.0 109.595 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.533 ' CD1' ' OD1' ' A' ' 28' ' ' ASN . 74.6 t80 -60.14 -46.28 90.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.668 HD21 ' CE2' ' A' ' 61' ' ' PHE . 69.4 mt -63.77 -41.28 98.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.819 -0.551 . . . . 0.0 110.611 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -61.73 -40.51 95.33 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.869 -0.519 . . . . 0.0 110.148 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.427 ' NE2' HD11 ' A' ' 23' ' ' LEU . 27.1 m-70 -86.72 -25.1 24.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.995 -0.441 . . . . 0.0 110.431 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' OD1' ' CD1' ' A' ' 24' ' ' TYR . 25.6 m120 -97.33 -11.41 24.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.427 -0.795 . . . . 0.0 109.228 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 25' ' ' LEU . 11.1 mt -148.16 88.67 5.39 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.31 -30.84 64.39 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.816 2.344 . . . . 0.0 112.051 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -78.94 6.17 9.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.54 130.67 47.08 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.782 0.801 . . . . 0.0 109.994 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -107.77 -56.06 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -161.46 165.95 27.96 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.503 0.668 . . . . 0.0 109.93 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.427 HG21 ' CZ ' ' A' ' 37' ' ' PHE . 14.8 p -127.59 137.22 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.741 0.782 . . . . 0.0 109.804 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.9 m -119.08 122.84 43.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.525 0.678 . . . . 0.0 109.549 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' ' CG2' ' A' ' 49' ' ' ILE . 72.9 m-85 -106.4 119.77 40.13 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.717 0.77 . . . . 0.0 109.743 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -33.91 0.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' GLU . 86.5 m-20 -69.51 -73.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.762 -0.586 . . . . 0.0 109.757 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 39' ' ' ASN . 81.7 tt0 55.5 151.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.924 0.869 . . . . 0.0 111.233 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -160.97 144.92 13.45 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.798 0.809 . . . . 0.0 109.806 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -92.83 140.54 29.4 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.532 0.682 . . . . 0.0 109.917 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -131.1 149.73 74.56 Favored Pre-proline 0 N--CA 1.486 1.352 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.77 -35.16 38.24 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.638 2.225 . . . . 0.0 112.021 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.8 pt -72.7 -4.94 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.53 -118.44 1.42 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 pt -126.55 154.73 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.797 -0.825 . . . . 0.0 110.103 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.2 p -135.87 131.46 35.33 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.759 0.79 . . . . 0.0 109.678 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.482 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 96.8 mt -94.48 127.64 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.538 0.685 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 65.9 t0 -127.58 137.13 52.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.615 0.721 . . . . 0.0 109.786 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -177.08 -151.66 9.25 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -146.09 160.69 41.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.816 -0.814 . . . . 0.0 110.26 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.02 HD11 HD11 ' A' ' 76' ' ' LEU . 51.0 pt -120.31 163.7 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.804 0.812 . . . . 0.0 110.95 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 58.09 33.54 23.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.837 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 45.92 29.26 0.71 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.436 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -111.74 109.57 19.48 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.773 0.797 . . . . 0.0 109.433 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -58.15 -34.21 70.04 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.846 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -62.26 -39.4 92.78 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.515 ' HB3' HD13 ' A' ' 76' ' ' LEU . 66.2 mt -81.69 86.8 6.36 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.562 0.696 . . . . 0.0 110.041 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.5 p -80.3 163.87 23.62 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.872 0.844 . . . . 0.0 110.846 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.668 ' CE2' HD21 ' A' ' 25' ' ' LEU . 52.7 t80 -149.66 131.03 14.69 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.585 0.707 . . . . 0.0 109.672 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.4 m -137.45 132.47 33.42 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.783 0.801 . . . . 0.0 110.058 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.41 142.62 37.48 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.789 0.804 . . . . 0.0 109.736 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -99.28 129.11 9.79 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' GLY . 17.9 tptm 35.36 -122.43 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.08 0.467 . . . . 0.0 110.649 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 68' ' ' LYS . 67.2 t0 -83.36 72.26 10.22 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.377 0.608 . . . . 0.0 109.745 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 66' ' ' ASP . 2.1 t 40.87 28.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.507 0.67 . . . . 0.0 109.345 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ASP . 49.1 mtpt -63.05 -41.94 99.6 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.69 126.17 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.639 0.733 . . . . 0.0 109.82 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -92.71 123.55 36.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.877 0.846 . . . . 0.0 109.718 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -141.29 119.75 12.34 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.809 0.814 . . . . 0.0 109.437 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 p -153.36 165.16 36.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.947 0.88 . . . . 0.0 110.489 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.2 p -75.19 164.35 26.57 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.838 0.828 . . . . 0.0 110.433 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.65 -36.99 83.87 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.6 -34.69 76.07 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.02 HD11 HD11 ' A' ' 53' ' ' ILE . 15.0 tp -91.97 -21.28 20.63 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -65.76 -35.43 80.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 109.754 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -75.03 -12.26 60.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.624 -0.672 . . . . 0.0 110.133 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.784 ' SD ' HD12 ' A' ' 76' ' ' LEU . 82.2 mtp -77.11 -5.18 47.96 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -89.7 120.62 31.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.764 0.792 . . . . 0.0 109.031 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.495 ' NE2' ' O ' ' A' ' 79' ' ' MET . 3.0 mp0 -97.47 -11.99 23.17 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -133.03 149.95 74.23 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.692 -0.63 . . . . 0.0 109.702 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.62 149.57 10.04 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.503 2.135 . . . . 0.0 112.393 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -64.55 136.8 57.4 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.654 0.74 . . . . 0.0 110.285 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -128.65 143.89 51.04 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.053 0.93 . . . . 0.0 110.355 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.21 160.24 52.7 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -60.25 -45.33 93.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.234 -0.568 . . . . 0.0 109.938 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.68 -36.97 86.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.577 -0.702 . . . . 0.0 109.695 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -62.22 -48.4 80.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.824 -0.547 . . . . 0.0 110.0 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.9 pt -69.59 -32.49 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.767 -0.583 . . . . 0.0 109.518 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.24 -44.23 92.46 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.863 -0.523 . . . . 0.0 109.733 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.47 -36.14 73.71 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.538 ' CE1' ' ND1' ' A' ' 94' ' ' HIS . 28.0 t-80 54.19 -95.68 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.269 0.557 . . . . 0.0 109.986 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.538 ' ND1' ' CE1' ' A' ' 93' ' ' HIS . 72.9 m80 -136.78 152.1 49.92 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.822 0.82 . . . . 0.0 110.229 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -149.63 164.24 35.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.679 0.752 . . . . 0.0 109.949 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 47.52 73.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.627 0.727 . . . . 0.0 109.434 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.405 ' O ' ' OXT' ' A' ' 98' ' ' HIS . 12.4 p-80 -79.9 -16.62 54.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.405 ' OXT' ' O ' ' A' ' 97' ' ' HIS . 76.8 m80 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.845 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.496 0.665 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -63.6 -42.19 98.27 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -62.35 -43.81 97.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.85 -0.531 . . . . 0.0 110.37 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -62.52 -42.16 99.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.444 -0.785 . . . . 0.0 110.163 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.81 -39.15 87.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.797 -0.565 . . . . 0.0 110.272 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 21' ' ' VAL . 89.6 mm-40 -66.0 -39.71 90.51 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.716 . . . . 0.0 109.751 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HZ2' ' CB ' ' A' ' 37' ' ' PHE . 68.4 mttm -62.98 -43.16 99.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.604 -0.685 . . . . 0.0 109.923 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.59 -43.38 80.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.774 -0.579 . . . . 0.0 110.06 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -65.47 -42.52 92.16 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.0 109.915 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 17' ' ' GLN . 55.5 t -64.56 -43.76 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.845 -0.535 . . . . 0.0 109.913 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -61.09 -48.53 81.28 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.579 HD11 ' NE2' ' A' ' 27' ' ' HIS . 58.5 tp -65.93 -40.81 91.74 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 90' ' ' ILE . 36.6 t80 -61.07 -48.77 80.2 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.13 -41.87 94.41 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.315 0.579 . . . . 0.0 109.834 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.1 -44.0 91.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.884 -0.51 . . . . 0.0 110.68 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.579 ' NE2' HD11 ' A' ' 23' ' ' LEU . 16.4 m170 -68.86 -37.06 78.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.373 -0.83 . . . . 0.0 110.318 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.461 HD21 ' CG ' ' A' ' 84' ' ' ARG . 1.3 m-20 -87.2 -5.15 59.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -138.2 94.54 10.97 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.06 -18.51 27.4 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.321 2.014 . . . . 0.0 111.278 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.98 7.44 44.05 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CG ' ' N ' ' A' ' 33' ' ' ASN . 61.1 t80 -54.82 158.19 2.8 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.704 0.764 . . . . 0.0 110.143 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.451 ' N ' ' CG ' ' A' ' 32' ' ' PHE . 65.4 t30 -145.31 -52.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -149.8 151.35 33.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.818 . . . . 0.0 110.095 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.2 137.15 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.534 0.683 . . . . 0.0 109.834 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.467 HG21 ' OH ' ' A' ' 52' ' ' TYR . 87.4 m -116.96 112.23 20.71 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.621 0.724 . . . . 0.0 109.117 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' O ' HG23 ' A' ' 38' ' ' THR . 74.1 m-85 -80.6 145.63 31.63 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.485 0.659 . . . . 0.0 110.303 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 50' ' ' ASP . 25.3 p -155.45 106.45 2.54 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.712 0.767 . . . . 0.0 109.655 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 38' ' ' THR . 90.9 m-20 -49.99 -105.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.383 0.611 . . . . 0.0 109.989 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 41' ' ' GLU . 81.6 tt0 55.83 113.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.48 0.657 . . . . 0.0 110.336 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 42' ' ' PHE . 5.5 tm-20 79.23 141.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.466 0.65 . . . . 0.0 110.395 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.502 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 96.9 m-85 -135.06 151.92 51.21 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.835 0.826 . . . . 0.0 110.372 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -72.51 157.08 89.61 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -37.48 -66.74 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.904 2.403 . . . . 0.0 112.598 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.9 mm -108.01 -26.71 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.72 -160.63 34.18 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.5 pt -120.44 146.27 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.694 0.759 . . . . 0.0 109.818 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.46 ' H ' ' HA ' ' A' ' 42' ' ' PHE . 10.1 t -111.47 128.46 56.01 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.551 0.691 . . . . 0.0 109.532 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -115.27 127.3 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.672 0.748 . . . . 0.0 109.767 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 59.4 t0 -113.89 154.14 28.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.846 0.831 . . . . 0.0 109.667 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -179.58 -175.23 46.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.1 p90 -149.91 166.22 30.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.874 -0.78 . . . . 0.0 110.436 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 pt -118.83 158.86 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 CA-C-O 121.89 0.852 . . . . 0.0 110.849 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 66.0 m-80 56.75 36.87 28.31 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.194 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 25.1 p30 45.04 23.28 0.09 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.084 0.469 . . . . 0.0 110.535 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -105.67 113.97 27.85 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.66 0.743 . . . . 0.0 109.836 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.23 -30.64 69.54 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -62.17 -38.7 90.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.549 -0.72 . . . . 0.0 109.381 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.4 mt -83.56 63.45 7.38 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.6 p -89.49 160.86 16.53 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.121 0.962 . . . . 0.0 110.961 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -151.9 150.91 30.59 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.468 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.7 m -134.86 134.1 40.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.598 0.713 . . . . 0.0 110.069 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.33 135.85 54.39 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.844 0.83 . . . . 0.0 109.564 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -100.22 89.06 0.81 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.6 tttm 57.89 -72.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 122.286 -0.538 . . . . 0.0 110.259 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 64' ' ' GLY . 98.1 m-20 -89.46 129.91 35.88 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.864 0.84 . . . . 0.0 110.21 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 67' ' ' VAL . 46.2 t -62.6 -0.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 66' ' ' ASP . 66.0 tttm -62.92 -41.59 99.51 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.65 111.13 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.808 0.813 . . . . 0.0 108.897 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -140.8 126.93 19.58 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.733 0.778 . . . . 0.0 110.333 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 p -84.01 168.32 16.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.493 0.663 . . . . 0.0 109.535 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.6 p -152.75 155.91 38.1 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.855 0.836 . . . . 0.0 110.704 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.2 p -75.7 166.03 24.16 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.738 0.78 . . . . 0.0 110.46 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.92 -44.15 97.37 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.027 0.442 . . . . 0.0 109.813 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.5 mp0 -69.24 -39.14 78.67 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.47 0.653 . . . . 0.0 109.844 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.44 -34.9 77.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.749 -0.594 . . . . 0.0 109.513 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -61.93 -33.33 74.05 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -73.26 -38.25 66.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.532 -0.73 . . . . 0.0 109.863 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.4 mmm -66.22 -65.29 0.7 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.602 -0.687 . . . . 0.0 110.55 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -60.04 149.27 32.77 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.764 0.792 . . . . 0.0 110.38 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -80.39 -105.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.34 0.591 . . . . 0.0 110.503 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -104.44 147.3 34.16 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.773 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.6 145.89 53.51 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.36 2.04 . . . . 0.0 112.073 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.461 ' CG ' HD21 ' A' ' 28' ' ' ASN . 74.4 mmt-85 -86.55 165.99 15.79 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.881 0.848 . . . . 0.0 110.671 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.66 -6.06 58.42 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.02 176.72 25.01 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.638 ' CD1' HD11 ' A' ' 90' ' ' ILE . 61.5 t80 -63.39 -37.14 86.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.922 -0.752 . . . . 0.0 109.25 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.69 -20.67 62.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.566 -0.709 . . . . 0.0 109.207 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -72.32 -48.67 40.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.634 -0.666 . . . . 0.0 109.741 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 87' ' ' TYR . 14.3 pt -61.84 -41.18 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.623 -0.673 . . . . 0.0 109.869 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.554 HD11 ' CE2' ' A' ' 87' ' ' TYR . 12.0 mt -65.41 -40.28 93.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.577 -0.702 . . . . 0.0 109.721 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' OE1' ' O ' ' A' ' 93' ' ' HIS . 12.3 tm-20 -67.65 -38.95 84.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.795 -0.566 . . . . 0.0 109.813 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.413 ' O ' ' OE1' ' A' ' 92' ' ' GLU . 15.8 t-80 64.03 138.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.724 0.773 . . . . 0.0 109.969 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -59.12 -42.51 90.75 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -102.43 166.58 10.47 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.787 0.804 . . . . 0.0 110.053 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.43 ' ND1' ' O ' ' A' ' 96' ' ' HIS . 62.8 t-80 59.76 50.43 7.08 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.6 0.714 . . . . 0.0 109.314 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.555 ' NE2' ' ND1' ' A' ' 98' ' ' HIS . 51.9 p-80 -81.09 -12.54 59.25 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.555 ' ND1' ' NE2' ' A' ' 97' ' ' HIS . 53.7 p-80 . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.654 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.1 -46.58 89.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.783 . . . . 0.0 109.91 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -63.04 -43.48 98.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.528 -0.732 . . . . 0.0 109.62 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -64.3 -42.25 96.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.695 -0.628 . . . . 0.0 110.08 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.74 -37.91 85.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.458 -0.776 . . . . 0.0 110.195 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.411 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 7.6 tp-100 -62.93 -42.59 99.85 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -63.71 -40.38 96.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.472 -0.768 . . . . 0.0 109.369 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -63.4 -41.51 98.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.537 -0.727 . . . . 0.0 110.085 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -61.38 -42.05 98.09 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.508 -0.745 . . . . 0.0 109.847 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.01 -40.89 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.433 -0.792 . . . . 0.0 109.267 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 m -59.69 -43.46 94.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.642 -0.661 . . . . 0.0 109.247 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.24 -41.43 98.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.509 -0.744 . . . . 0.0 109.831 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.655 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 90.1 t80 -60.28 -49.11 78.92 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.3 mt -68.18 -41.2 81.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.634 -0.666 . . . . 0.0 110.641 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -65.05 -43.33 92.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.405 -0.809 . . . . 0.0 110.442 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -80.28 -15.94 55.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.386 -0.821 . . . . 0.0 110.456 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.655 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 91.4 m-20 -104.2 -10.24 18.06 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.258 -0.901 . . . . 0.0 108.88 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 mt -144.11 88.11 7.63 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 32' ' ' PHE . 53.2 Cg_exo -53.63 -30.89 57.51 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.51 2.14 . . . . 0.0 111.271 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -72.66 13.09 0.4 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' PRO . 29.1 t80 -61.22 130.38 45.95 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.689 0.757 . . . . 0.0 110.236 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -118.96 -61.52 1.63 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 t -146.12 164.54 31.85 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.515 0.674 . . . . 0.0 109.935 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.5 138.16 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.544 0.688 . . . . 0.0 109.624 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.2 m -126.76 115.24 19.07 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.66 0.743 . . . . 0.0 109.551 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -94.08 126.61 39.41 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.759 0.79 . . . . 0.0 109.563 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.34 86.1 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -177.43 -64.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 41.38 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.592 -0.693 . . . . 0.0 110.053 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -122.4 147.34 46.42 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.996 0.903 . . . . 0.0 110.034 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.528 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 53.0 p90 -88.81 120.24 30.03 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.503 0.668 . . . . 0.0 109.736 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -107.41 154.74 40.48 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -46.38 -40.76 22.77 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.504 2.136 . . . . 0.0 111.907 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 46' ' ' GLY . 21.4 tt -70.02 -38.93 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.76 . . . . 0.0 109.615 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 173.25 -107.66 0.25 Allowed Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -121.23 143.81 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.626 -0.926 . . . . 0.0 110.17 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.0 t -119.26 134.91 54.95 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.653 0.739 . . . . 0.0 110.09 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.16 129.42 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.681 0.753 . . . . 0.0 109.359 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.5 t0 -133.49 142.4 48.23 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.831 0.824 . . . . 0.0 109.687 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -173.5 -165.16 29.89 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -142.39 165.09 28.38 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.678 -0.895 . . . . 0.0 110.274 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.5 pt -122.42 167.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.934 0.873 . . . . 0.0 110.725 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' ASP . 69.1 m-80 57.31 34.25 24.46 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.662 0.744 . . . . 0.0 109.441 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 44.56 24.44 0.1 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 54' ' ' ASN . 99.5 m-20 -108.17 111.1 22.93 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.668 0.747 . . . . 0.0 109.293 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' HB3' ' HZ3' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -59.22 -31.58 69.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.727 -0.608 . . . . 0.0 110.102 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -61.96 -38.77 89.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.45 -0.781 . . . . 0.0 109.495 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -82.74 75.26 9.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.474 -0.766 . . . . 0.0 109.534 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 m -95.85 156.13 16.46 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.922 0.867 . . . . 0.0 110.397 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -147.12 157.03 43.47 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.628 0.728 . . . . 0.0 109.923 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.1 m -141.29 138.87 33.49 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.692 -0.63 . . . . 0.0 109.873 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.94 144.62 31.16 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.649 0.737 . . . . 0.0 109.528 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -98.24 128.7 9.65 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 64' ' ' GLY . 15.1 ptmt 24.76 -114.18 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.461 0.648 . . . . 0.0 111.238 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.454 ' C ' ' N ' ' A' ' 68' ' ' LYS . 67.2 t0 -71.54 66.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.158 0.98 . . . . 0.0 109.955 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 50.43 12.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.545 0.688 . . . . 0.0 109.455 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 64' ' ' GLY . 68.7 mmtt -61.43 115.57 3.99 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 122.051 0.929 . . . . 0.0 109.82 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.6 mt 55.16 115.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.87 0.843 . . . . 0.0 109.883 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.508 ' CE1' ' OH ' ' A' ' 24' ' ' TYR . 47.2 p90 -139.26 153.9 47.88 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.877 0.846 . . . . 0.0 110.203 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 p -141.74 160.86 39.32 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.621 0.724 . . . . 0.0 109.47 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.2 m -145.68 155.21 42.85 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.977 0.894 . . . . 0.0 110.414 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -65.88 163.03 17.78 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.943 0.878 . . . . 0.0 110.371 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.1 mp0 -58.5 -48.9 79.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.545 -0.722 . . . . 0.0 109.743 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mp0 -64.54 -42.04 95.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.622 -0.674 . . . . 0.0 110.066 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.17 -38.76 85.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.595 -0.691 . . . . 0.0 110.034 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -63.32 -33.67 76.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.411 -0.806 . . . . 0.0 109.402 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.01 -12.32 60.88 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.38 -0.825 . . . . 0.0 109.973 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.7 mtp -85.09 -8.21 58.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.26 -0.9 . . . . 0.0 109.38 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -63.64 135.91 57.11 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.591 0.71 . . . . 0.0 110.006 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -111.9 -25.04 9.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -120.13 153.7 55.54 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.75 179.63 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.982 2.455 . . . . 0.0 113.094 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.46 ' NH1' ' CZ ' ' A' ' 70' ' ' PHE . 95.5 mtt-85 -63.86 126.72 28.54 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.067 0.937 . . . . 0.0 110.597 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -136.88 147.51 46.52 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.734 0.778 . . . . 0.0 109.911 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.88 164.44 44.67 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.567 ' CE2' HD11 ' A' ' 91' ' ' LEU . 71.8 t80 -61.5 -44.0 97.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.804 -0.821 . . . . 0.0 109.133 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -70.13 -31.11 68.49 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.476 -0.765 . . . . 0.0 109.803 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.86 -45.51 77.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 91' ' ' LEU . 28.8 pt -66.16 -35.91 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.43 -0.794 . . . . 0.0 109.57 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.567 HD11 ' CE2' ' A' ' 87' ' ' TYR . 35.7 mt -63.36 -42.41 98.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -79.38 -32.02 42.99 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 94' ' ' HIS . 56.5 t-80 60.2 -94.34 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.499 0.666 . . . . 0.0 110.684 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.454 ' N ' ' ND1' ' A' ' 93' ' ' HIS . 14.4 m-70 46.25 -167.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.888 0.852 . . . . 0.0 110.809 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -76.35 131.56 39.24 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.757 0.789 . . . . 0.0 110.359 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -64.04 -10.35 21.52 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -65.66 -40.37 92.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.529 -0.732 . . . . 0.0 109.354 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.503 ' O ' ' CG ' ' A' ' 98' ' ' HIS . 86.3 t60 . . . . . 0 N--CA 1.5 2.069 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.037 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.46 0.648 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.524 ' CZ ' ' NE2' ' A' ' 17' ' ' GLN . 91.3 t80 -62.51 -24.22 67.37 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.645 0.736 . . . . 0.0 109.242 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -65.31 -36.64 84.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.512 -0.742 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.53 -41.33 98.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.148 -0.97 . . . . 0.0 109.838 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.62 -39.97 88.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.58 -0.7 . . . . 0.0 110.445 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.524 ' NE2' ' CZ ' ' A' ' 13' ' ' PHE . 96.6 mm-40 -64.78 -40.72 95.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 109.897 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.04 -40.99 97.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.71 -41.83 98.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.861 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -64.1 -42.43 96.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.745 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.9 -43.08 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.444 -0.785 . . . . 0.0 109.619 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.8 m -61.29 -44.65 96.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.497 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.58 HD11 ' NE2' ' A' ' 27' ' ' HIS . 49.1 tp -62.88 -42.81 99.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.367 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.507 ' CE1' ' OD1' ' A' ' 28' ' ' ASN . 58.7 t80 -61.05 -47.85 84.46 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.492 0.663 . . . . 0.0 109.712 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.01 -39.6 93.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -0.791 . . . . 0.0 109.703 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -59.75 -45.51 92.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.877 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.58 ' NE2' HD11 ' A' ' 23' ' ' LEU . 32.9 m-70 -74.47 -32.78 62.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.826 . . . . 0.0 109.757 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.507 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 32.1 m120 -87.19 -2.9 58.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.379 -0.826 . . . . 0.0 109.608 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.4 mt -146.76 89.85 5.63 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.229 -0.919 . . . . 0.0 109.034 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -55.38 -30.19 71.77 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.454 2.103 . . . . 0.0 111.34 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -84.98 16.15 3.59 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 21.8 t80 -57.57 128.99 39.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.493 -0.755 . . . . 0.0 110.463 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.456 ' ND2' ' OD1' ' A' ' 54' ' ' ASN . 99.9 m-20 -113.8 -64.96 1.24 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.562 0.696 . . . . 0.0 109.331 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -150.82 158.73 44.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.752 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.13 135.53 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.586 -0.696 . . . . 0.0 109.425 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -124.64 123.8 40.83 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.661 0.743 . . . . 0.0 109.368 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -96.31 137.54 35.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.647 -0.658 . . . . 0.0 109.241 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.6 p -147.12 -35.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 108.805 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -103.41 145.45 29.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.28 -0.887 . . . . 0.0 110.356 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -169.05 143.94 3.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.377 -0.827 . . . . 0.0 109.623 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -139.07 151.8 47.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.443 -0.786 . . . . 0.0 109.321 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -90.59 118.84 30.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.233 -0.917 . . . . 0.0 109.903 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 46' ' ' GLY . 1.6 m-20 -90.43 158.07 43.77 Favored Pre-proline 0 C--N 1.306 -1.326 0 O-C-N 121.5 -0.75 . . . . 0.0 109.975 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.23 -27.12 41.48 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 123.099 2.532 . . . . 0.0 110.417 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -102.56 -8.23 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 171.06 -144.42 8.26 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.441 ' HA ' ' H ' ' A' ' 43' ' ' ASN . 42.0 pt -124.82 152.31 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.558 -0.966 . . . . 0.0 109.485 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.4 m -117.43 127.45 54.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.74 130.36 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.619 0.723 . . . . 0.0 109.36 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -130.06 125.84 36.2 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.588 0.709 . . . . 0.0 109.225 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.31 -161.46 10.36 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -144.15 160.88 40.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.983 . . . . 0.0 109.874 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.6 pt -119.76 167.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-O 121.601 0.715 . . . . 0.0 110.728 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.456 ' OD1' ' ND2' ' A' ' 33' ' ' ASN . 66.4 m-80 59.11 32.92 22.56 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.629 0.728 . . . . 0.0 109.55 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 46.87 32.23 1.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.51 -0.744 . . . . 0.0 109.564 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -126.99 103.93 7.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.604 -0.685 . . . . 0.0 109.321 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -56.12 -17.13 6.32 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.416 0.627 . . . . 0.0 109.543 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -63.9 -38.32 90.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.35 -0.844 . . . . 0.0 108.889 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.5 mt -88.24 73.91 8.82 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.2 m -87.92 154.75 20.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.821 0.82 . . . . 0.0 110.771 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -147.62 158.82 44.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.722 -0.612 . . . . 0.0 109.587 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.2 m -134.11 136.53 43.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.771 . . . . 0.0 109.706 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.49 141.07 48.62 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 67' ' ' VAL . . . -97.93 115.71 5.34 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 64' ' ' GLY . 88.6 tttt 26.06 -95.17 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.389 0.614 . . . . 0.0 111.795 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -85.71 45.31 1.19 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.356 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 64' ' ' GLY . 2.1 t 51.93 35.3 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.164 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -62.83 -41.32 99.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.825 . . . . 0.0 109.008 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.0 tp -127.57 136.32 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -126.46 129.78 49.37 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.645 0.736 . . . . 0.0 109.835 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 t -137.3 149.06 46.81 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.2 p -138.89 157.04 46.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 0.0 110.357 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.0 p -76.02 171.12 15.0 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.866 0.841 . . . . 0.0 110.758 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -59.37 -41.01 88.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.681 -0.637 . . . . 0.0 109.947 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.45 -48.79 59.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.958 . . . . 0.0 109.886 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.69 -22.06 66.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.34 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -62.41 -36.18 81.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.559 -0.713 . . . . 0.0 110.077 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -62.68 -45.06 94.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 0.0 110.53 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 98.6 mtp -68.74 -38.03 79.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.09 -1.006 . . . . 0.0 109.482 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.512 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 72.4 t80 -75.68 119.39 19.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 110.03 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -142.93 2.19 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 47.9 mt-10 -102.66 130.12 24.54 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.471 -0.768 . . . . 0.0 109.561 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -47.41 140.78 15.2 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.473 2.115 . . . . 0.0 113.151 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -76.97 140.07 40.32 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.6 0.714 . . . . 0.0 110.256 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -137.66 147.96 45.34 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.732 0.777 . . . . 0.0 109.698 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.47 161.15 12.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -62.46 -42.48 99.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.795 -0.827 . . . . 0.0 109.194 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 34.5 p-10 -68.54 -31.18 70.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.442 -0.786 . . . . 0.0 109.757 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 80.1 mm-40 -64.58 -48.6 74.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.451 -0.781 . . . . 0.0 109.848 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 91' ' ' LEU . 25.9 pt -68.18 -37.69 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.442 -0.786 . . . . 0.0 109.196 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.426 ' N ' HG13 ' A' ' 90' ' ' ILE . 57.9 tp -63.47 -41.94 98.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.46 ' C ' ' H ' ' A' ' 94' ' ' HIS . 79.6 tt0 -82.82 -18.65 39.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.226 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 94' ' ' HIS . 46.1 m-70 67.89 -40.6 0.42 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.914 -0.491 . . . . 0.0 110.014 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.46 ' H ' ' C ' ' A' ' 92' ' ' GLU . 50.0 t-80 38.26 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.723 0.773 . . . . 0.0 110.58 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -149.44 7.86 0.69 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.414 ' O ' ' CG ' ' A' ' 96' ' ' HIS . 1.9 t60 42.56 44.44 3.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.542 -0.724 . . . . 0.0 110.203 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 55.46 172.01 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.674 0.749 . . . . 0.0 110.665 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.638 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.431 0.634 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.403 ' O ' ' OE1' ' A' ' 17' ' ' GLN . 79.2 t80 -61.0 -44.83 96.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.777 -0.577 . . . . 0.0 109.564 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -64.27 -40.1 95.3 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.351 0.596 . . . . 0.0 109.86 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -62.59 -40.72 97.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.676 -0.64 . . . . 0.0 109.931 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.6 -38.75 87.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.518 ' N ' ' OE1' ' A' ' 17' ' ' GLN . 1.5 mp0 -64.09 -40.49 96.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.524 -0.735 . . . . 0.0 109.557 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -64.66 -40.21 95.03 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.249 0.547 . . . . 0.0 109.956 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -65.62 -41.01 93.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.705 -0.622 . . . . 0.0 110.052 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.495 ' NZ ' ' CE2' ' A' ' 87' ' ' TYR . 68.2 mttm -63.08 -44.29 96.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.605 -0.684 . . . . 0.0 110.101 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.48 -44.12 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.653 -0.654 . . . . 0.0 109.984 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.1 m -63.58 -43.8 95.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.574 -0.704 . . . . 0.0 109.841 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.7 -43.16 99.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.724 -0.61 . . . . 0.0 110.317 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.639 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 66.8 t80 -62.35 -47.83 82.5 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.335 0.588 . . . . 0.0 109.803 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.46 -41.45 96.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.616 -0.678 . . . . 0.0 109.895 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.17 -43.98 92.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.769 -0.582 . . . . 0.0 109.931 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -68.66 -37.88 79.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.751 -0.593 . . . . 0.0 110.236 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.639 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 85.0 m-20 -90.79 -0.71 57.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.4 -0.812 . . . . 0.0 109.322 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.4 mt -143.81 83.6 10.37 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 109.035 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -54.88 -26.64 49.51 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.664 2.243 . . . . 0.0 111.284 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -78.38 0.36 25.96 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -59.0 129.14 40.75 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.723 0.773 . . . . 0.0 110.128 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -123.84 -57.82 1.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -147.49 155.58 42.03 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.73 0.776 . . . . 0.0 110.151 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.39 140.43 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.434 0.635 . . . . 0.0 109.41 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.9 m -128.67 125.9 39.02 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.898 0.856 . . . . 0.0 110.133 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -93.76 134.58 35.95 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 t -172.9 55.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.662 -0.649 . . . . 0.0 109.447 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' GLU . 24.3 t-20 -173.31 133.68 0.51 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.556 -0.715 . . . . 0.0 110.417 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' ASN . 96.9 mt-10 58.21 140.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.755 0.788 . . . . 0.0 110.683 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -144.54 -90.34 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.652 -0.655 . . . . 0.0 109.476 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -75.19 147.36 40.46 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.853 0.835 . . . . 0.0 110.243 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -173.96 168.1 2.26 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 46' ' ' GLY . 52.3 Cg_exo -50.91 -39.43 58.88 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.436 2.091 . . . . 0.0 111.814 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.5 pt -76.51 28.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.518 0.675 . . . . 0.0 109.195 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 81.82 -99.42 2.0 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.9 pt -119.85 144.14 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.859 0.838 . . . . 0.0 109.948 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.7 m -119.66 122.44 41.51 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.695 0.759 . . . . 0.0 109.831 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.02 125.89 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.929 0.871 . . . . 0.0 109.382 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.6 t0 -142.9 139.85 30.95 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.01 0.91 . . . . 0.0 109.832 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -167.22 -162.62 19.37 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -140.46 161.72 37.05 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.908 -0.76 . . . . 0.0 110.628 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 pt -118.73 156.6 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 121.959 0.885 . . . . 0.0 110.689 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 56.3 33.89 23.09 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.048 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 47.95 32.68 2.94 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.17 0.51 . . . . 0.0 110.0 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -111.79 109.65 19.6 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.72 0.771 . . . . 0.0 109.317 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -57.28 -34.51 68.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.905 -0.497 . . . . 0.0 109.98 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.57 -39.25 93.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.599 -0.688 . . . . 0.0 109.742 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.8 76.95 9.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.511 -0.743 . . . . 0.0 109.583 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.8 p -112.5 156.59 22.35 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.817 0.818 . . . . 0.0 110.478 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.404 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 32.1 p90 -150.49 158.45 44.17 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.461 0.648 . . . . 0.0 109.595 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.9 m -136.08 132.15 35.78 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.683 0.754 . . . . 0.0 110.135 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.07 140.95 42.37 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.832 0.825 . . . . 0.0 109.617 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 65' ' ' LYS . . . -109.08 140.2 15.55 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 64' ' ' GLY . 53.6 mtpt 40.46 100.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.298 0.57 . . . . 0.0 110.598 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.504 ' OD1' ' NE2' ' A' ' 17' ' ' GLN . 99.0 m-20 57.93 -88.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.404 0.621 . . . . 0.0 109.712 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.79 13.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 69' ' ' ILE . 68.5 mttm -70.51 131.45 44.04 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.872 0.844 . . . . 0.0 109.859 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.4 mt 52.59 103.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.645 0.736 . . . . 0.0 109.41 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -138.25 153.86 49.09 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.891 0.853 . . . . 0.0 110.29 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.1 t -136.87 151.02 48.62 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.76 0.79 . . . . 0.0 109.614 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.2 t -134.66 150.18 50.61 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.822 0.82 . . . . 0.0 110.101 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 p -75.89 166.8 22.98 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.883 0.849 . . . . 0.0 110.221 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.66 -45.39 92.19 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.215 0.531 . . . . 0.0 109.639 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -65.28 -45.71 83.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.644 -0.66 . . . . 0.0 109.657 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.535 HD12 ' SD ' ' A' ' 79' ' ' MET . 58.6 tp -69.0 -28.94 67.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.83 -36.4 83.38 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 109.407 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -75.68 -7.54 54.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.449 -0.782 . . . . 0.0 109.914 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.535 ' SD ' HD12 ' A' ' 76' ' ' LEU . 77.0 mtp -82.42 -8.79 59.62 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -69.1 138.5 54.35 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.62 0.724 . . . . 0.0 109.464 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -128.04 -45.45 1.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.49 154.96 39.58 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.626 -0.671 . . . . 0.0 109.581 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -53.31 145.55 44.39 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.363 2.042 . . . . 0.0 112.649 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -77.36 138.01 39.07 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.781 0.8 . . . . 0.0 109.969 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.86 150.47 47.17 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.858 0.837 . . . . 0.0 110.116 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.1 163.4 25.68 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.643 ' CE2' HD11 ' A' ' 91' ' ' LEU . 78.5 t80 -60.57 -44.7 95.9 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.6 0.714 . . . . 0.0 109.681 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 36.6 p-10 -68.43 -32.87 73.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.572 -0.705 . . . . 0.0 109.902 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 79.8 mm-40 -66.78 -45.34 78.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.664 -0.647 . . . . 0.0 110.447 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.6 pt -65.92 -35.52 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.512 -0.742 . . . . 0.0 109.631 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.643 HD11 ' CE2' ' A' ' 87' ' ' TYR . 34.3 mt -63.02 -42.13 99.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.553 -0.717 . . . . 0.0 109.748 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.502 ' O ' ' CG ' ' A' ' 93' ' ' HIS . 80.3 mm-40 -69.82 -40.48 75.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' A' ' 91' ' ' LEU . 20.9 p-80 40.06 -163.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.386 0.612 . . . . 0.0 110.773 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 94' ' ' HIS . 56.4 p-80 -118.56 119.45 34.55 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.715 0.769 . . . . 0.0 109.801 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -127.87 121.35 29.81 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.692 0.758 . . . . 0.0 109.78 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -113.36 108.74 17.64 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.898 0.856 . . . . 0.0 109.58 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -67.74 -43.79 79.11 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.728 -179.423 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -62.8 -42.6 99.78 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.538 -0.726 . . . . 0.0 110.132 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -62.86 -42.2 99.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.643 -0.661 . . . . 0.0 109.931 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.21 -40.45 97.51 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.368 0.604 . . . . 0.0 109.696 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.41 -39.23 85.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.674 -0.641 . . . . 0.0 109.587 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.442 HE22 HD11 ' A' ' 47' ' ' ILE . 86.4 mt-30 -63.38 -39.71 95.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.383 -0.823 . . . . 0.0 108.946 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -62.66 -42.12 99.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.825 -0.547 . . . . 0.0 110.017 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -66.88 -39.74 87.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.628 -0.67 . . . . 0.0 109.546 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.8 -43.54 96.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.752 -0.592 . . . . 0.0 109.541 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.4 t -65.39 -42.83 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.841 -0.537 . . . . 0.0 109.577 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -59.74 -45.25 92.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.708 . . . . 0.0 109.263 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.94 -42.3 97.37 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.422 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 64.9 t80 -61.9 -46.92 87.27 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.46 ' CD2' ' CE2' ' A' ' 61' ' ' PHE . 92.6 mt -64.73 -39.3 93.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.564 -0.71 . . . . 0.0 109.883 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -60.72 -44.41 96.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.66 -0.65 . . . . 0.0 109.628 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -69.06 -41.98 76.87 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.658 -0.651 . . . . 0.0 110.186 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.422 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 44.2 m-80 -65.02 -41.36 95.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.432 -0.792 . . . . 0.0 109.338 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.7 mt -114.36 115.28 44.94 Favored Pre-proline 0 N--CA 1.485 1.307 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.5 -17.61 23.5 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.286 1.991 . . . . 0.0 110.652 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -95.87 8.87 42.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 34.9 t80 -51.65 126.85 18.8 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.82 0.819 . . . . 0.0 109.888 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -113.35 -65.88 1.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -147.17 160.56 42.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.591 -0.693 . . . . 0.0 110.319 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.9 p -140.16 139.73 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.4 0.619 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -129.21 125.66 37.44 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.558 0.694 . . . . 0.0 109.318 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 49' ' ' ILE . 59.2 m-85 -91.4 142.88 27.2 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.653 0.74 . . . . 0.0 109.732 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.461 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -173.28 123.12 0.39 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.721 -0.612 . . . . 0.0 109.647 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 38' ' ' THR . 2.3 m-20 82.22 157.22 0.13 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.911 0.862 . . . . 0.0 110.983 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 69.53 101.38 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.58 0.705 . . . . 0.0 109.733 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -144.12 -22.08 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -115.85 133.69 55.77 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.77 0.795 . . . . 0.0 110.108 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -170.57 154.98 4.77 Favored Pre-proline 0 N--CA 1.487 1.404 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 46' ' ' GLY . 71.4 Cg_exo -44.85 -36.55 11.01 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.37 2.047 . . . . 0.0 112.034 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 mt -78.93 34.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.811 0.815 . . . . 0.0 109.028 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 80.33 -106.42 2.49 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.442 HD11 HE22 ' A' ' 17' ' ' GLN . 46.3 pt -118.31 149.65 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.652 0.739 . . . . 0.0 109.675 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.9 m -127.96 155.25 44.55 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.799 0.809 . . . . 0.0 110.457 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 96.7 mt -122.92 125.51 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.555 0.693 . . . . 0.0 109.395 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -128.69 130.54 47.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.67 0.748 . . . . 0.0 109.598 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.01 -163.14 13.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -143.11 162.5 35.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.748 -0.854 . . . . 0.0 109.685 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 pt -122.54 162.43 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.805 0.812 . . . . 0.0 110.438 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.83 30.65 19.36 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.432 0.634 . . . . 0.0 109.736 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 48.89 33.02 4.1 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.39 0.614 . . . . 0.0 109.624 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -112.9 111.17 21.73 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.416 0.627 . . . . 0.0 109.501 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -59.09 -33.02 70.34 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -62.47 -39.29 92.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.9 mt -84.52 83.03 8.15 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.408 0.623 . . . . 0.0 109.764 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.632 ' O ' HD23 ' A' ' 76' ' ' LEU . 88.2 p -95.9 148.32 22.74 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.433 0.635 . . . . 0.0 110.069 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.728 ' CD2' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -131.75 136.9 47.95 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.48 0.657 . . . . 0.0 109.985 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.8 m -128.42 129.73 46.6 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.731 0.777 . . . . 0.0 110.061 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.29 149.22 40.97 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.674 0.75 . . . . 0.0 109.376 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -90.8 135.61 12.94 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 39.84 -109.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.402 0.62 . . . . 0.0 110.579 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 67' ' ' VAL . 20.1 p-10 -82.15 -67.15 0.81 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.682 -0.636 . . . . 0.0 109.682 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.528 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 2.7 t -146.19 11.83 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.732 . . . . 0.0 109.032 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 69' ' ' ILE . 88.8 tttt -65.77 117.93 8.9 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.291 -0.881 . . . . 0.0 110.414 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.0 mt 56.94 125.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.793 0.806 . . . . 0.0 110.016 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -139.07 129.83 26.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.419 -0.801 . . . . 0.0 110.387 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.7 m -126.83 154.57 44.15 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.582 0.706 . . . . 0.0 109.412 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.9 p -153.11 163.97 38.89 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.751 0.786 . . . . 0.0 110.46 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -67.98 163.87 21.24 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.817 0.817 . . . . 0.0 110.158 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -57.8 -48.82 78.61 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.759 -0.588 . . . . 0.0 109.584 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.25 -40.73 98.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.773 -0.579 . . . . 0.0 109.674 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.728 HD21 ' CD2' ' A' ' 61' ' ' PHE . 36.0 tp -76.42 -22.58 54.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.525 -0.734 . . . . 0.0 110.252 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -72.06 -36.66 69.64 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.443 -0.785 . . . . 0.0 109.402 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -79.1 -8.01 58.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.586 -0.696 . . . . 0.0 110.334 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.4 mmm -63.89 -42.31 97.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.352 -0.842 . . . . 0.0 109.691 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 80' ' ' PHE . 31.0 p90 -102.33 125.66 49.11 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.756 0.789 . . . . 0.0 109.72 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -97.68 -6.72 32.48 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -133.66 83.97 46.43 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.485 -0.759 . . . . 0.0 109.445 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.81 138.13 76.26 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 123.04 2.494 . . . . 0.0 112.97 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.592 HH21 HG22 ' A' ' 90' ' ' ILE . 21.0 mmm180 -99.04 162.97 12.77 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.606 0.717 . . . . 0.0 110.358 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -91.04 -131.64 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.31 0.576 . . . . 0.0 111.281 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.42 170.27 50.36 Favored Glycine 0 N--CA 1.498 2.803 0 CA-C-O 122.061 0.812 . . . . 0.0 111.971 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -61.76 -43.12 99.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.945 -0.738 . . . . 0.0 110.436 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.56 -38.76 92.35 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.447 -0.783 . . . . 0.0 109.635 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -60.84 -50.04 75.04 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.811 -0.556 . . . . 0.0 109.91 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.592 HG22 HH21 ' A' ' 84' ' ' ARG . 27.7 pt -69.24 -30.06 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.331 -0.856 . . . . 0.0 109.398 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.5 tp -64.24 -42.52 96.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.14 -37.74 84.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -95.91 111.81 23.7 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.772 0.796 . . . . 0.0 109.891 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -148.68 143.02 26.21 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.613 0.72 . . . . 0.0 110.167 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.499 ' O ' ' NE2' ' A' ' 97' ' ' HIS . 75.5 m80 -98.62 45.07 1.01 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.356 0.598 . . . . 0.0 109.395 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.534 ' O ' ' CG ' ' A' ' 97' ' ' HIS . 53.6 t-80 -62.61 -84.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.56 -0.713 . . . . 0.0 109.518 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 96' ' ' HIS . 21.8 p80 41.48 -166.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.739 0.78 . . . . 0.0 110.745 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.4 t60 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.648 -179.215 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.719 0.771 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -62.86 -33.59 75.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.557 0.694 . . . . 0.0 109.328 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -61.79 -33.32 73.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.495 -0.753 . . . . 0.0 109.632 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.71 -40.75 98.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.497 -0.752 . . . . 0.0 109.576 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.71 -39.61 88.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.483 -0.761 . . . . 0.0 109.628 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.45 -39.03 93.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.433 -0.792 . . . . 0.0 109.578 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -63.42 -41.47 98.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.588 0.709 . . . . 0.0 109.49 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -65.81 -42.4 90.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.626 -0.671 . . . . 0.0 109.975 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -63.66 -44.57 93.4 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.793 0.806 . . . . 0.0 110.036 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.21 -41.33 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.579 -0.701 . . . . 0.0 109.848 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -55.78 -46.22 77.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.478 -0.764 . . . . 0.0 110.029 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.6 tp -64.29 -42.4 96.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.551 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.621 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 89.1 t80 -59.96 -44.18 94.6 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.728 0.775 . . . . 0.0 109.317 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.85 -43.05 99.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.586 -0.696 . . . . 0.0 110.349 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.41 -43.44 97.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 0.0 110.537 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.688 ' CG ' HD11 ' A' ' 90' ' ' ILE . 33.8 m-70 -75.34 -32.11 60.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 110.992 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.621 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 29.3 m-80 -89.25 -6.94 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.102 -0.998 . . . . 0.0 109.47 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.3 mt -137.41 105.51 8.5 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.585 -0.697 . . . . 0.0 109.15 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.99 -16.49 32.38 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.436 2.09 . . . . 0.0 111.782 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -95.96 11.42 34.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.519 -0.738 . . . . 0.0 109.419 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -56.67 132.68 52.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.3 -0.875 . . . . 0.0 109.818 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -133.46 -48.69 0.83 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -148.31 154.71 40.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.293 -0.879 . . . . 0.0 110.219 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.89 137.13 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.307 0.575 . . . . 0.0 109.557 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -128.41 121.86 30.03 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.588 0.708 . . . . 0.0 109.162 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -97.39 122.83 40.89 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.6 p -106.37 -22.39 12.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.709 -0.619 . . . . 0.0 109.68 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -110.49 145.76 37.14 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.296 -0.878 . . . . 0.0 110.561 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -166.02 80.49 0.28 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -153.5 -161.91 1.36 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.429 -0.795 . . . . 0.0 109.777 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.478 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 54.3 p90 -102.47 127.34 49.55 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.596 0.712 . . . . 0.0 109.953 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -96.97 164.63 17.49 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.719 -0.613 . . . . 0.0 109.457 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.3 -39.96 62.02 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.36 2.04 . . . . 0.0 111.584 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 45' ' ' ILE . 97.0 mt -81.73 -4.08 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.557 -0.714 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 137.92 -104.7 0.46 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.4 pt -127.37 133.78 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.876 . . . . 0.0 109.879 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.7 m -138.77 149.08 44.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.587 -0.695 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.58 133.74 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 33.0 t0 -127.73 147.27 50.4 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.588 0.708 . . . . 0.0 109.9 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -175.76 -165.57 31.91 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -144.11 164.53 30.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.768 -0.842 . . . . 0.0 109.77 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.1 pt -124.6 164.67 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.862 0.839 . . . . 0.0 111.344 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 58.43 32.38 22.03 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.643 0.735 . . . . 0.0 110.191 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 48.89 29.84 2.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.639 -0.663 . . . . 0.0 109.838 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.49 111.74 22.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.448 -0.783 . . . . 0.0 109.988 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -58.88 -32.26 69.33 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.56 0.695 . . . . 0.0 109.441 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.57 -39.38 93.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.461 -0.774 . . . . 0.0 109.621 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.1 mt -82.03 78.94 8.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.533 -0.73 . . . . 0.0 109.81 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.6 t -104.39 155.16 19.02 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.656 0.741 . . . . 0.0 110.011 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -150.2 158.37 44.09 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.56 0.695 . . . . 0.0 109.825 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.7 m -134.17 138.7 45.34 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.87 135.29 48.2 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.589 0.709 . . . . 0.0 109.596 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.5 137.95 14.62 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 67' ' ' VAL . 29.3 mmtp 40.37 -161.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.489 0.661 . . . . 0.0 111.12 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 68' ' ' LYS . 93.8 m-20 -59.2 77.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.935 0.874 . . . . 0.0 109.782 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 65' ' ' LYS . 2.0 t 41.68 24.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.659 0.742 . . . . 0.0 109.853 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 66' ' ' ASP . 28.6 tptp -64.06 -44.23 93.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.2 mt -121.13 128.46 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -132.74 129.84 39.2 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.492 0.663 . . . . 0.0 109.628 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.5 m -130.48 152.29 50.04 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 p -143.0 155.46 44.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.742 0.782 . . . . 0.0 110.509 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 77' ' ' ASP . 18.6 p -74.73 168.78 19.17 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.772 0.796 . . . . 0.0 110.719 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -59.93 -43.07 95.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.753 -0.592 . . . . 0.0 110.167 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -65.94 -36.18 82.64 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.71 0.767 . . . . 0.0 109.558 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.5 tp -85.01 -21.02 29.63 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.926 0.87 . . . . 0.0 109.035 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 73' ' ' SER . 29.9 t70 -66.86 -44.54 80.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.538 -0.726 . . . . 0.0 110.084 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -71.68 -18.4 62.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 110.033 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.75 -62.37 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.44 -0.788 . . . . 0.0 109.966 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -71.72 138.62 48.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.602 -0.686 . . . . 0.0 110.519 -178.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -137.52 40.26 2.42 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -115.39 150.83 45.2 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.333 -0.855 . . . . 0.0 109.412 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.46 156.22 66.4 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.695 2.264 . . . . 0.0 112.465 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -69.93 132.74 46.44 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.808 0.813 . . . . 0.0 110.033 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.8 ' HZ3' HD12 ' A' ' 90' ' ' ILE . 20.2 pttp -155.21 145.68 22.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.591 0.71 . . . . 0.0 109.47 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.39 168.14 51.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -62.45 -45.24 93.97 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.676 0.75 . . . . 0.0 109.7 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 47.7 p-10 -64.96 -33.39 75.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 109.687 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.551 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 14.4 tm-20 -62.98 -51.87 65.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.627 -0.671 . . . . 0.0 109.953 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.8 HD12 ' HZ3' ' A' ' 85' ' ' LYS . 9.9 tt -67.82 -29.6 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.92 -44.04 97.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.505 -0.747 . . . . 0.0 109.703 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' A' ' 93' ' ' HIS . 22.3 pt-20 -90.0 -33.21 16.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.959 0.885 . . . . 0.0 108.941 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.621 ' ND1' ' CE1' ' A' ' 95' ' ' HIS . 17.3 t-80 42.53 95.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.915 0.864 . . . . 0.0 110.12 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -66.25 -25.18 66.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.724 -0.61 . . . . 0.0 109.877 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.621 ' CE1' ' ND1' ' A' ' 93' ' ' HIS . 96.2 m-70 58.05 87.88 0.07 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.888 0.851 . . . . 0.0 109.975 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -66.88 -40.54 87.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.585 -0.697 . . . . 0.0 109.548 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -152.83 -33.51 0.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.827 -1.082 . . . . 0.0 109.989 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.354 0.597 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.471 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 91.3 m-85 -63.15 -28.77 70.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.516 -0.74 . . . . 0.0 109.882 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -58.67 -34.96 71.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.435 -0.79 . . . . 0.0 109.48 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -62.37 -40.34 96.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.53 -39.26 91.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.572 -0.705 . . . . 0.0 109.831 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -65.73 -39.83 91.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.582 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.85 -40.42 96.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.423 -0.798 . . . . 0.0 109.893 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.68 -41.95 98.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -0.839 . . . . 0.0 109.809 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.1 -41.97 97.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.389 -0.82 . . . . 0.0 110.159 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.03 -42.87 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.724 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.9 m -60.96 -44.49 97.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.872 . . . . 0.0 109.93 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.56 -42.94 99.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.663 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 57.2 t80 -61.0 -42.79 99.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.56 -0.712 . . . . 0.0 109.763 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' ILE . 86.3 mt -62.77 -41.93 99.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.9 -40.28 94.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.327 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -65.85 -40.32 91.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.408 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.577 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 99.3 m-20 -93.73 -4.75 49.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.56 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 25' ' ' LEU . 8.7 mt -143.45 91.23 6.93 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -71.16 -16.67 31.76 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.447 2.098 . . . . 0.0 111.812 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -92.46 4.22 53.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.536 -0.728 . . . . 0.0 109.183 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -50.08 137.84 16.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.063 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -111.59 -63.35 1.43 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.749 -0.594 . . . . 0.0 109.891 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -149.52 156.77 42.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.054 -1.029 . . . . 0.0 110.02 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.23 133.46 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.668 -0.645 . . . . 0.0 109.337 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.8 m -118.83 119.96 35.93 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -93.39 121.96 35.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.597 -0.69 . . . . 0.0 109.547 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.0 p -109.03 0.22 19.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.6 t30 59.01 -96.2 0.06 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.798 -0.564 . . . . 0.0 109.677 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 10.0 tm-20 60.14 -88.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.393 0.616 . . . . 0.0 110.845 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 40' ' ' GLU . 78.1 tt0 -57.36 148.89 21.77 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.466 -0.772 . . . . 0.0 110.362 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -151.68 96.75 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.263 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 46' ' ' GLY . 36.1 m-20 -44.27 108.61 0.74 Allowed Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.564 -0.71 . . . . 0.0 109.835 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.05 -33.45 43.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.223 1.949 . . . . 0.0 111.664 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -85.88 -5.26 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 43' ' ' ASN . . . -166.69 -127.93 0.94 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 pt -135.29 149.46 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.432 -1.04 . . . . 0.0 109.749 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.409 ' HB2' ' H ' ' A' ' 43' ' ' ASN . 22.6 t -142.79 141.67 31.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.134 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -124.87 122.09 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.567 0.699 . . . . 0.0 109.707 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 54.7 t0 -104.5 154.71 19.55 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -175.42 -170.31 38.18 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.609 -1.281 . . . . 0.0 109.936 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -145.25 162.82 36.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.484 -1.009 . . . . 0.0 109.675 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.37 162.81 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.457 0.646 . . . . 0.0 110.747 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 56.97 32.85 22.35 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.45 0.643 . . . . 0.0 109.85 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 47.97 29.62 1.76 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -111.68 108.37 17.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.491 -0.756 . . . . 0.0 109.525 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -58.59 -33.99 70.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.663 . . . . 0.0 109.599 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -62.48 -38.53 90.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.432 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.2 mt -82.76 82.63 8.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.191 -0.943 . . . . 0.0 109.095 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 m -100.6 160.83 14.03 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.598 0.713 . . . . 0.0 110.524 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -146.26 153.77 40.96 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.5 m -133.13 133.27 42.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.682 -0.636 . . . . 0.0 109.741 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.21 139.54 52.86 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -112.16 130.83 9.83 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' VAL . 45.8 tttt 43.57 -144.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.623 0.725 . . . . 0.0 110.869 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.2 62.31 0.13 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.533 0.682 . . . . 0.0 109.185 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LYS . 1.9 t 51.8 19.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.477 0.656 . . . . 0.0 109.639 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -64.09 -42.67 96.85 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.395 -0.815 . . . . 0.0 109.53 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 64' ' ' GLY . 96.7 mt -131.96 118.55 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.584 -0.698 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -139.73 152.08 46.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.7 t -139.83 148.28 41.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.438 -0.789 . . . . 0.0 109.555 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.0 t -131.81 147.44 52.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.451 -0.781 . . . . 0.0 109.639 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -76.61 170.04 17.16 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.788 0.804 . . . . 0.0 110.789 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -61.99 -42.98 99.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.571 -0.705 . . . . 0.0 109.664 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.57 -40.95 96.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.239 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.8 tp -79.55 -26.62 41.37 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.382 -0.824 . . . . 0.0 109.347 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -62.15 -38.25 88.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 110.247 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -59.11 -28.46 66.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.398 -0.814 . . . . 0.0 109.804 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 97.7 mmm -64.9 -35.29 80.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.658 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -63.9 135.95 56.97 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.301 -0.874 . . . . 0.0 109.841 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -112.39 -22.91 10.62 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -113.68 166.15 11.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.672 -0.643 . . . . 0.0 109.477 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.1 146.64 87.09 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.526 2.151 . . . . 0.0 112.677 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -67.59 124.04 22.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 109.428 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.479 ' O ' ' CE1' ' A' ' 24' ' ' TYR . 68.8 mmtt -134.97 154.95 51.53 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.771 0.796 . . . . 0.0 109.997 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.64 166.34 52.11 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -60.73 -42.29 96.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 122.014 -0.698 . . . . 0.0 109.507 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 9.5 p-10 -64.61 -34.74 78.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.429 -0.794 . . . . 0.0 110.45 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 50.3 mp0 -64.77 -47.51 77.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.262 -0.899 . . . . 0.0 110.053 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.2 pt -69.93 -35.45 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 110.083 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.27 -42.99 99.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.986 -1.071 . . . . 0.0 109.395 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.3 -37.64 83.71 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.346 -0.846 . . . . 0.0 109.547 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -82.84 121.57 27.1 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.389 -0.82 . . . . 0.0 109.791 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.504 ' C ' ' H ' ' A' ' 96' ' ' HIS . 62.4 t-80 -167.93 70.4 0.09 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.387 -0.821 . . . . 0.0 109.036 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 80.8 m80 52.48 7.04 0.06 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.728 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.504 ' H ' ' C ' ' A' ' 94' ' ' HIS . 86.6 t60 -66.52 -38.7 87.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -70.43 136.46 49.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.347 -0.846 . . . . 0.0 111.019 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.758 -1.115 . . . . 0.0 109.03 179.216 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.503 0.668 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -61.21 -27.78 68.68 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -59.64 -37.97 80.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.883 -0.511 . . . . 0.0 109.848 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.51 -40.85 98.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.748 -0.595 . . . . 0.0 109.488 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.61 -39.37 88.33 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 99.3 mm-40 -64.5 -40.42 95.62 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.15 -42.08 99.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.055 -0.403 . . . . 0.0 110.372 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.42 -46.44 79.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.889 -0.507 . . . . 0.0 109.857 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -65.67 -43.23 89.98 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.035 0.445 . . . . 0.0 110.199 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 17' ' ' GLN . 53.7 t -65.41 -43.85 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.6 m -62.37 -45.55 92.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.549 HD11 ' NE2' ' A' ' 27' ' ' HIS . 41.8 tp -63.38 -43.92 96.2 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.812 -0.555 . . . . 0.0 109.72 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.602 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 71.7 t80 -62.21 -47.09 86.01 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.06 -40.56 96.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.936 -0.477 . . . . 0.0 109.929 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -59.66 -46.06 90.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 122.042 -0.411 . . . . 0.0 110.281 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.549 ' NE2' HD11 ' A' ' 23' ' ' LEU . 46.5 m-70 -72.29 -34.02 67.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 110.528 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.602 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 73.3 m-80 -86.58 -2.35 58.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.21 -0.932 . . . . 0.0 109.231 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 53.2 mt -136.56 104.86 9.17 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.613 . . . . 0.0 109.472 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.03 -16.99 25.34 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.779 2.319 . . . . 0.0 111.298 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -94.01 8.03 42.93 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -56.5 133.55 53.43 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.927 0.87 . . . . 0.0 110.48 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -135.9 -51.08 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -148.64 156.09 41.94 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.663 0.744 . . . . 0.0 110.207 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 p -139.82 140.83 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.539 0.685 . . . . 0.0 109.601 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.0 m -126.09 118.52 25.46 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.723 0.773 . . . . 0.0 109.486 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -95.67 126.49 40.98 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.556 0.694 . . . . 0.0 109.742 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.7 p -97.34 -17.2 19.89 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 34.0 m-20 59.82 33.57 21.7 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.379 0.609 . . . . 0.0 109.557 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -92.74 179.74 5.39 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.684 0.754 . . . . 0.0 110.452 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 59.1 150.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.692 0.758 . . . . 0.0 110.362 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -155.33 114.85 3.66 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.826 0.822 . . . . 0.0 109.594 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -91.92 146.71 33.42 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.29 -21.43 41.46 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.395 2.063 . . . . 0.0 111.62 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -76.61 -4.3 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.815 -0.553 . . . . 0.0 109.815 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.06 -123.51 1.19 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 pt -129.37 140.75 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.848 -0.795 . . . . 0.0 110.005 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.2 t -115.96 130.0 56.63 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.599 0.714 . . . . 0.0 109.926 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.9 127.23 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.749 0.785 . . . . 0.0 109.284 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -114.09 149.44 35.54 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.831 0.825 . . . . 0.0 110.0 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.02 179.88 45.09 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -143.23 166.02 25.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.76 -0.847 . . . . 0.0 110.609 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.6 pt -120.48 162.29 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.747 0.785 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 57.52 33.6 23.48 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 44.59 29.23 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.015 0.436 . . . . 0.0 109.864 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -109.13 112.4 24.55 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.66 0.743 . . . . 0.0 109.811 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -57.99 -34.11 69.63 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.963 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.08 -38.72 92.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.723 -0.611 . . . . 0.0 109.354 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.6 mt -82.46 75.84 9.36 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.1 m -102.49 160.39 14.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.964 0.888 . . . . 0.0 110.72 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.2 154.95 40.79 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.631 0.729 . . . . 0.0 109.716 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 96.9 m -134.66 133.85 40.53 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.66 0.743 . . . . 0.0 110.643 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.98 138.09 50.65 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.773 0.797 . . . . 0.0 109.376 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.66 133.77 11.81 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.433 ' O ' ' OE1' ' A' ' 17' ' ' GLN . 71.3 tttt 37.9 -133.75 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.212 0.529 . . . . 0.0 110.894 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -73.84 62.1 0.81 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 45.39 24.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -64.09 -42.36 96.97 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.74 127.41 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.694 0.759 . . . . 0.0 109.013 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.56 ' CZ ' ' NE ' ' A' ' 84' ' ' ARG . 28.3 p90 -139.95 153.44 46.91 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.971 0.891 . . . . 0.0 110.621 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 t -140.84 152.41 45.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.688 0.756 . . . . 0.0 109.423 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 p -138.47 153.9 48.82 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.896 0.855 . . . . 0.0 110.144 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.0 p -82.64 168.89 16.85 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.817 0.818 . . . . 0.0 110.546 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -65.44 -29.6 70.3 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -73.93 -50.4 20.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.756 -0.59 . . . . 0.0 109.583 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.27 -19.97 65.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.68 . . . . 0.0 109.484 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -64.0 -33.38 75.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.878 -0.514 . . . . 0.0 110.01 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.514 ' CG ' ' N ' ' A' ' 79' ' ' MET . 17.7 pttp -64.05 -43.83 94.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.617 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.514 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 59.8 mmm -68.41 -38.33 81.17 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.527 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 73.8 t80 -66.27 124.43 22.64 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.551 0.691 . . . . 0.0 109.138 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -142.97 -1.2 1.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.527 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 6.2 tp10 -102.43 113.4 65.89 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -48.87 149.01 8.28 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.407 2.071 . . . . 0.0 112.805 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.56 ' NE ' ' CZ ' ' A' ' 70' ' ' PHE . 15.9 mmm180 -67.77 143.6 55.78 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.735 0.779 . . . . 0.0 110.064 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -140.4 -76.64 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 159.32 160.89 10.73 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.568 ' CE2' HD11 ' A' ' 91' ' ' LEU . 77.3 t80 -62.71 -44.8 95.29 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.407 0.622 . . . . 0.0 109.632 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.96 -34.74 78.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.684 -0.635 . . . . 0.0 110.095 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.559 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 47.8 mp0 -65.66 -44.58 85.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.346 -0.846 . . . . 0.0 110.891 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.2 pt -66.2 -38.75 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.595 -0.691 . . . . 0.0 110.3 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.568 HD11 ' CE2' ' A' ' 87' ' ' TYR . 31.1 mt -63.64 -40.47 96.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.665 -0.647 . . . . 0.0 109.556 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.81 -37.01 81.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.828 -0.545 . . . . 0.0 109.614 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.411 ' O ' ' C ' ' A' ' 94' ' ' HIS . 86.6 t60 -70.32 87.78 0.62 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.491 0.662 . . . . 0.0 110.128 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.411 ' C ' ' O ' ' A' ' 93' ' ' HIS . 59.7 t-80 35.81 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.667 0.746 . . . . 0.0 110.725 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.574 ' CD2' ' H ' ' A' ' 95' ' ' HIS . 5.9 p80 -76.21 -54.83 6.23 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.501 ' C ' ' H ' ' A' ' 98' ' ' HIS . 42.3 t-80 -161.83 -64.76 0.05 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.484 ' O ' ' ND1' ' A' ' 97' ' ' HIS . 60.4 t-80 49.8 10.97 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' A' ' 96' ' ' HIS . 85.9 t60 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.968 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -61.23 -45.92 92.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.497 -0.752 . . . . 0.0 109.244 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -65.79 -38.71 89.74 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.544 -0.722 . . . . 0.0 109.522 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -61.67 -41.44 97.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.769 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -64.53 -44.07 92.01 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.331 -0.856 . . . . 0.0 108.956 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -65.16 -39.06 92.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.574 -0.704 . . . . 0.0 109.363 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -63.76 -40.35 96.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.599 -0.688 . . . . 0.0 109.773 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -65.6 -38.35 89.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.444 -0.785 . . . . 0.0 109.597 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.29 -41.39 98.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.334 -0.853 . . . . 0.0 109.78 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.22 -43.67 97.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.0 m -61.43 -44.31 97.35 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.526 -0.734 . . . . 0.0 109.095 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.53 -42.54 99.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.502 -0.749 . . . . 0.0 109.101 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.473 ' OH ' ' CZ ' ' A' ' 70' ' ' PHE . 62.8 t80 -61.01 -47.28 87.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.434 -0.791 . . . . 0.0 109.402 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' ILE . 86.2 mt -63.51 -41.97 98.5 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.419 -0.801 . . . . 0.0 109.696 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -61.86 -42.24 98.82 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.469 -0.77 . . . . 0.0 110.046 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -69.21 -39.17 78.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -0.836 . . . . 0.0 109.914 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.401 ' OD1' ' CZ ' ' A' ' 24' ' ' TYR . 27.3 m120 -86.26 -13.06 47.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.141 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' LEU . 11.1 mt -137.25 81.38 31.78 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.24 -28.24 70.37 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.481 2.121 . . . . 0.0 110.823 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.71 12.69 5.54 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -54.1 134.34 43.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.604 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -110.32 -63.17 1.42 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 t -150.42 157.95 43.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 0.0 109.95 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.13 133.19 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.599 -0.688 . . . . 0.0 109.318 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.5 m -121.02 120.22 34.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.62 -0.675 . . . . 0.0 109.242 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -94.26 140.62 29.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.593 -0.692 . . . . 0.0 109.402 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.0 p -116.41 -32.14 5.36 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -138.66 139.35 38.45 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.383 -0.823 . . . . 0.0 110.103 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -138.14 58.72 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -175.21 -170.17 0.42 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.629 -0.669 . . . . 0.0 109.791 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 t80 63.24 92.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.513 0.673 . . . . 0.0 109.94 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -171.37 119.99 0.47 Allowed Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.432 -0.793 . . . . 0.0 109.139 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.95 -42.97 25.11 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.283 1.989 . . . . 0.0 112.479 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 46' ' ' GLY . 10.5 tp -70.5 -37.53 70.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.423 -0.798 . . . . 0.0 109.816 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 45' ' ' ILE . . . -179.15 -87.91 0.07 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.9 pt -135.19 151.83 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.485 -1.009 . . . . 0.0 110.008 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.1 t -116.41 131.8 56.85 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.691 -0.631 . . . . 0.0 109.567 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.6 mt -106.83 116.49 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.477 ' OD1' HG23 ' A' ' 62' ' ' THR . 64.8 m-20 -119.73 139.32 52.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.44 36.48 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -145.42 166.13 26.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -1.073 . . . . 0.0 110.077 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.9 pt -120.84 162.85 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 121.576 0.703 . . . . 0.0 110.584 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 56.59 32.75 21.5 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.524 0.678 . . . . 0.0 109.547 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 m120 44.7 30.94 0.58 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.482 -0.761 . . . . 0.0 109.734 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -109.11 112.35 24.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.558 -0.714 . . . . 0.0 109.268 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -58.61 -33.35 69.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.669 -0.644 . . . . 0.0 109.807 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -62.86 -38.33 90.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.789 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.7 mt -83.76 79.92 9.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -0.89 . . . . 0.0 109.575 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.3 t -104.45 158.12 16.69 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.492 0.663 . . . . 0.0 110.063 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -144.56 145.87 32.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.479 -0.763 . . . . 0.0 109.513 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.477 HG23 ' OD1' ' A' ' 50' ' ' ASP . 52.1 m -130.24 131.3 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.05 138.17 48.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.632 -0.667 . . . . 0.0 109.277 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -96.53 99.51 2.33 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.7 tttp 43.86 -83.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.984 -0.715 . . . . 0.0 110.915 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 64' ' ' GLY . 99.2 m-20 -73.86 125.37 28.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 67' ' ' VAL . 61.0 t -60.89 -1.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.531 -0.731 . . . . 0.0 109.453 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 66' ' ' ASP . 54.6 mtpt -62.89 -41.22 99.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.2 116.21 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.473 -0.767 . . . . 0.0 109.346 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CZ ' ' OH ' ' A' ' 24' ' ' TYR . 54.6 p90 -141.09 157.27 45.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.724 . . . . 0.0 110.021 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.3 t -120.4 137.27 54.4 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.2 t -137.56 146.46 44.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.443 -0.786 . . . . 0.0 109.958 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.8 m -80.68 172.83 13.25 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.675 0.75 . . . . 0.0 110.275 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -66.0 -35.57 80.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.638 -0.663 . . . . 0.0 109.959 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -65.1 -33.3 75.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.495 -0.753 . . . . 0.0 109.772 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.5 tp -91.3 -24.44 19.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 109.019 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -65.11 -38.03 89.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.818 . . . . 0.0 109.858 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.05 -12.8 61.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 110.283 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.7 mmm -79.37 -9.49 59.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.808 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.38 128.96 37.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.958 . . . . 0.0 109.828 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -109.4 -43.99 4.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.617 -0.677 . . . . 0.0 109.573 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -96.5 165.44 16.11 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.419 -0.8 . . . . 0.0 110.175 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.55 146.91 89.21 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.297 1.998 . . . . 0.0 112.006 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.42 124.1 20.92 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.462 -0.774 . . . . 0.0 110.462 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -138.43 140.91 39.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.718 -0.613 . . . . 0.0 109.429 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.8 174.14 49.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.589 ' CE2' HD11 ' A' ' 91' ' ' LEU . 83.4 t80 -60.9 -43.97 97.77 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.67 0.748 . . . . 0.0 109.767 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 48.4 p-10 -69.76 -32.98 71.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.124 -0.985 . . . . 0.0 110.166 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 78.5 mm-40 -66.25 -44.21 84.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.1 pt -65.57 -38.46 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.007 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.589 HD11 ' CE2' ' A' ' 87' ' ' TYR . 82.8 mt -62.5 -42.18 99.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.97 -1.081 . . . . 0.0 109.488 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.23 -37.96 84.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.13 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -83.99 101.69 11.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.49 -0.756 . . . . 0.0 109.348 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.441 ' CG ' ' N ' ' A' ' 95' ' ' HIS . 86.3 t60 -81.7 160.59 23.64 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.576 0.703 . . . . 0.0 110.334 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.441 ' N ' ' CG ' ' A' ' 94' ' ' HIS . 4.3 t-160 -80.09 126.42 31.05 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.489 -0.757 . . . . 0.0 110.34 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -66.25 -43.35 86.78 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.5 0.667 . . . . 0.0 109.359 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.436 ' ND1' ' NE2' ' A' ' 98' ' ' HIS . 66.3 t-80 -62.15 -42.78 99.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.616 -0.678 . . . . 0.0 109.615 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.436 ' NE2' ' ND1' ' A' ' 97' ' ' HIS . 93.4 m-70 . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.35 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.946 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.73 -43.02 99.67 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.87 0.843 . . . . 0.0 109.738 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CD1' ' OE2' ' A' ' 40' ' ' GLU . 85.0 m-85 -68.91 -35.23 76.58 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.484 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -62.54 -44.96 95.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.103 -0.998 . . . . 0.0 110.291 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -69.18 -36.03 76.91 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.155 -0.965 . . . . 0.0 109.758 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -63.16 -42.27 99.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -0.938 . . . . 0.0 109.599 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.83 -40.86 95.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 0.0 109.232 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.04 -43.95 98.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.562 -0.711 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.67 -43.32 97.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.412 -0.805 . . . . 0.0 109.942 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.3 -42.79 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 m -60.99 -46.12 92.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.392 -0.818 . . . . 0.0 109.383 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.622 HD11 ' NE2' ' A' ' 27' ' ' HIS . 48.6 tp -63.98 -42.01 97.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.526 ' CE2' ' OD1' ' A' ' 28' ' ' ASN . 77.4 t80 -61.42 -46.87 88.31 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.689 0.757 . . . . 0.0 109.87 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.15 -39.24 89.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.348 -0.845 . . . . 0.0 110.237 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -60.31 -45.67 92.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.289 -0.882 . . . . 0.0 110.521 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.622 ' NE2' HD11 ' A' ' 23' ' ' LEU . 37.0 m-70 -69.51 -38.67 77.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.203 -0.935 . . . . 0.0 110.37 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.526 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 25.2 m120 -64.17 -40.53 96.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.945 . . . . 0.0 109.81 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.4 mt -115.54 119.11 38.47 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.695 . . . . 0.0 109.908 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.61 -19.42 28.07 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.597 2.198 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -95.72 8.44 43.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 108.926 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -49.28 120.92 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.876 0.846 . . . . 0.0 110.032 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -102.27 -68.71 0.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.701 0.762 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 t -148.06 163.92 35.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.193 -0.942 . . . . 0.0 109.711 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.25 137.08 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.585 -0.697 . . . . 0.0 109.493 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.9 m -125.21 123.51 39.73 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.681 0.753 . . . . 0.0 109.368 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -88.42 132.35 34.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.562 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -107.15 -53.94 2.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.48 -0.763 . . . . 0.0 109.756 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -100.65 142.43 32.13 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.073 -1.017 . . . . 0.0 110.427 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.427 ' OE2' ' CD1' ' A' ' 14' ' ' PHE . 76.5 tt0 -162.47 106.84 1.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.531 -0.731 . . . . 0.0 109.09 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -170.03 177.77 4.18 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.465 -0.772 . . . . 0.0 110.043 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -61.68 -178.37 0.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.988 0.899 . . . . 0.0 110.61 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -175.45 167.75 1.73 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.13 -40.54 76.65 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.295 1.997 . . . . 0.0 111.528 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.9 -4.09 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.752 . . . . 0.0 109.453 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 134.4 -94.31 0.26 Allowed Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.5 pt -126.9 149.14 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.626 -0.926 . . . . 0.0 110.04 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 t -127.28 130.89 50.39 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.666 0.746 . . . . 0.0 108.997 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -128.04 132.01 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 40.3 t0 -135.42 146.06 47.89 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.593 -0.692 . . . . 0.0 109.807 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -167.89 -164.9 24.38 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -144.28 161.5 38.76 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.492 -1.004 . . . . 0.0 110.028 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -121.05 159.63 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 122.09 0.948 . . . . 0.0 111.308 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.1 m-20 57.39 32.93 22.56 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.825 0.821 . . . . 0.0 109.902 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 49.42 30.86 3.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 0.0 109.536 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -112.6 108.15 17.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.401 -0.812 . . . . 0.0 109.528 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -59.7 -31.44 69.59 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.568 0.699 . . . . 0.0 109.518 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -62.76 -39.07 93.0 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.178 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.6 mt -83.09 77.52 9.73 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.226 -0.921 . . . . 0.0 109.684 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.4 p -104.08 161.74 13.75 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.803 0.811 . . . . 0.0 110.596 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -149.75 156.09 41.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.537 -0.727 . . . . 0.0 109.688 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.3 m -137.29 140.05 41.32 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.658 -0.652 . . . . 0.0 109.894 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.87 150.43 46.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.365 -0.835 . . . . 0.0 109.394 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 65' ' ' LYS . . . -126.86 94.64 0.42 Allowed Glycine 0 N--CA 1.503 3.15 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' GLY . 88.6 tttt 52.84 115.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.945 0.879 . . . . 0.0 111.133 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 67' ' ' VAL . 65.6 t0 60.05 139.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.84 0.828 . . . . 0.0 110.591 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.566 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 26.3 t -58.48 0.63 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.558 0.694 . . . . 0.0 109.354 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.552 ' H ' ' C ' ' A' ' 66' ' ' ASP . 63.3 tttp -55.79 -40.05 72.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 108.788 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.45 119.03 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.483 -0.761 . . . . 0.0 109.084 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -138.63 125.91 21.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.413 -0.804 . . . . 0.0 109.365 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.8 m -107.71 150.57 26.78 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.609 0.719 . . . . 0.0 109.338 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.2 m -151.51 152.52 33.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.93 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.3 p -80.95 172.62 13.51 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.91 0.862 . . . . 0.0 110.874 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -58.77 -45.67 89.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.679 -0.638 . . . . 0.0 110.074 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.59 -48.96 78.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.15 -0.969 . . . . 0.0 110.22 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.59 -36.2 83.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.091 -1.006 . . . . 0.0 109.108 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.77 -41.45 97.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.343 -0.848 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -66.1 -35.06 79.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.153 -0.967 . . . . 0.0 109.714 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.5 mmm -62.26 -38.53 89.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.203 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -55.97 140.7 42.26 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.949 0.88 . . . . 0.0 110.104 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -106.45 -16.8 14.45 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -133.21 154.97 81.37 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.364 -0.835 . . . . 0.0 109.589 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.87 162.95 29.96 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 123.041 2.494 . . . . 0.0 112.69 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -63.77 135.76 56.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.921 0.867 . . . . 0.0 110.355 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -138.85 151.18 46.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.701 0.762 . . . . 0.0 109.641 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.98 152.81 45.97 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.07 -42.88 95.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.778 -0.836 . . . . 0.0 109.518 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.86 -37.97 88.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.777 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -60.7 -48.1 83.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.379 -0.825 . . . . 0.0 110.382 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.01 -31.58 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.937 -1.102 . . . . 0.0 109.946 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.04 -43.29 95.99 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 109.452 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.81 -41.94 82.32 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.855 0.836 . . . . 0.0 109.32 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.536 ' CG ' ' N ' ' A' ' 94' ' ' HIS . 29.8 t-80 52.96 -108.85 0.44 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.537 -0.727 . . . . 0.0 110.613 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.575 ' O ' ' CG ' ' A' ' 95' ' ' HIS . 74.1 t60 -84.83 -2.8 58.2 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.223 -0.923 . . . . 0.0 109.671 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 94' ' ' HIS . 44.2 p-80 54.0 104.42 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -75.6 135.33 40.52 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.375 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.638 ' CG ' ' H ' ' A' ' 98' ' ' HIS . 20.6 t-80 -81.7 -177.43 6.55 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.776 0.798 . . . . 0.0 110.695 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.638 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 91.4 m-70 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.784 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.315 0.578 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.517 ' CE2' ' NE2' ' A' ' 17' ' ' GLN . 69.0 t80 -62.77 -44.87 95.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.431 -0.793 . . . . 0.0 109.504 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -65.3 -37.95 88.71 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.467 0.651 . . . . 0.0 109.465 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.47 -40.96 96.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.508 -0.745 . . . . 0.0 109.293 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.54 -49.52 76.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.455 -0.778 . . . . 0.0 109.423 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.517 ' NE2' ' CE2' ' A' ' 13' ' ' PHE . 97.8 mt-30 -68.18 -33.61 74.76 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.552 0.692 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.09 -44.83 95.8 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.494 0.664 . . . . 0.0 109.794 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.03 -39.53 87.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.668 -0.645 . . . . 0.0 110.133 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -63.47 -42.43 98.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.543 -0.723 . . . . 0.0 110.596 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.94 -42.01 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.812 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.5 m -60.5 -46.62 89.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.416 -0.803 . . . . 0.0 109.861 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.407 HD11 ' NE2' ' A' ' 27' ' ' HIS . 54.6 tp -64.73 -40.97 96.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.763 . . . . 0.0 109.665 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.558 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 80.0 t80 -60.08 -44.71 94.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.491 -0.756 . . . . 0.0 109.849 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.45 -42.19 98.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.478 -0.764 . . . . 0.0 110.434 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -40.45 96.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.495 -0.753 . . . . 0.0 110.334 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.407 ' NE2' HD11 ' A' ' 23' ' ' LEU . 11.3 m-70 -67.56 -35.22 78.63 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.495 -0.753 . . . . 0.0 110.585 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.558 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 71.4 m-80 -95.04 -1.3 52.53 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.112 -0.992 . . . . 0.0 109.515 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.1 mt -140.91 84.44 13.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 109.484 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.4 -28.94 75.3 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.709 2.273 . . . . 0.0 111.17 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -88.59 15.8 7.55 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.535 0.683 . . . . 0.0 109.164 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -49.85 130.5 21.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.458 -0.776 . . . . 0.0 109.912 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -115.85 -68.6 0.91 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 t -143.28 161.07 39.27 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.598 0.713 . . . . 0.0 110.058 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.61 139.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.445 HG21 ' OH ' ' A' ' 52' ' ' TYR . 91.9 m -123.45 125.79 45.57 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -90.88 136.88 32.78 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.615 0.722 . . . . 0.0 110.095 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 39' ' ' ASN . 14.4 p -117.02 -33.48 4.71 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' ' 38' ' ' THR . 9.0 p30 38.24 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.0 0.905 . . . . 0.0 110.838 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -157.9 36.08 0.26 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 109.394 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -144.58 121.33 11.21 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.221 -0.924 . . . . 0.0 109.871 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -109.97 121.7 45.86 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.538 0.685 . . . . 0.0 109.288 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.434 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 2.0 m-20 -106.46 137.39 19.42 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -49.4 -31.36 23.05 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.569 2.179 . . . . 0.0 112.007 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.0 pt -80.08 -10.14 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.513 -0.742 . . . . 0.0 109.588 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 43' ' ' ASN . . . 154.52 -176.78 32.19 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.636 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.416 ' H ' ' HE2' ' A' ' 65' ' ' LYS . 34.0 pt -83.84 140.09 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.67 -0.9 . . . . 0.0 110.424 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.434 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 72.2 m -111.15 126.46 54.87 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.607 0.718 . . . . 0.0 109.525 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.56 126.15 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.625 -0.672 . . . . 0.0 109.516 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -115.48 149.09 38.65 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.839 0.828 . . . . 0.0 110.109 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.85 -177.83 46.12 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.445 ' OH ' HG21 ' A' ' 36' ' ' THR . 23.0 p90 -142.67 163.07 33.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.761 -0.846 . . . . 0.0 109.959 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 pt -121.94 162.78 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 121.914 0.864 . . . . 0.0 110.825 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.5 m120 59.59 31.31 20.86 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.529 0.68 . . . . 0.0 110.298 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 48.32 30.71 2.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.587 -0.696 . . . . 0.0 109.573 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -113.67 109.74 19.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.761 0.791 . . . . 0.0 109.513 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.53 -32.69 70.55 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.345 0.593 . . . . 0.0 109.588 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.76 -38.63 91.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.333 -0.854 . . . . 0.0 109.075 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.5 mt -83.2 75.82 9.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.559 -0.713 . . . . 0.0 109.506 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 t -99.76 162.99 12.66 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.723 0.773 . . . . 0.0 110.427 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -149.08 155.23 40.42 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.626 0.727 . . . . 0.0 109.793 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.1 m -132.74 136.1 46.15 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.451 0.643 . . . . 0.0 110.11 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.77 136.96 47.97 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.724 0.773 . . . . 0.0 109.287 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -102.43 136.3 12.74 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' GLY . 60.9 mmtt 33.59 -121.72 0.09 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.434 0.635 . . . . 0.0 111.421 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 68' ' ' LYS . 99.2 m-20 -85.67 76.3 9.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 66' ' ' ASP . 2.1 t 38.26 28.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.778 0.799 . . . . 0.0 110.003 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 66' ' ' ASP . 18.3 mmmt -62.62 -42.83 99.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.51 -0.744 . . . . 0.0 109.346 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.2 mt -129.32 125.92 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.603 -0.686 . . . . 0.0 109.293 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -123.5 131.7 53.71 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.529 0.681 . . . . 0.0 109.573 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.6 m -127.49 150.63 49.59 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 p -136.93 155.2 50.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.911 0.862 . . . . 0.0 110.396 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -81.69 174.42 11.39 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.535 0.683 . . . . 0.0 110.066 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.2 -41.58 99.19 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.463 0.649 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.3 mp0 -70.57 -44.32 67.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -0.859 . . . . 0.0 109.549 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.62 -37.48 86.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.708 -0.62 . . . . 0.0 109.596 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -54.86 -33.0 61.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.742 . . . . 0.0 109.518 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.75 -40.84 97.71 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.352 -0.843 . . . . 0.0 110.057 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.2 mmm -65.93 -37.82 87.04 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.154 -0.966 . . . . 0.0 109.068 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -64.98 133.57 52.01 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.66 0.743 . . . . 0.0 109.988 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -116.5 -22.28 8.8 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.481 ' N ' ' CD ' ' A' ' 82' ' ' GLU . 1.7 pm0 -114.82 153.35 46.94 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.692 -0.63 . . . . 0.0 109.495 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.88 173.5 8.1 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.679 2.253 . . . . 0.0 112.735 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.35 139.74 58.8 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.931 0.872 . . . . 0.0 110.181 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -139.67 145.51 38.52 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.763 0.792 . . . . 0.0 109.848 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -74.42 154.8 47.96 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -61.99 -43.37 98.97 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.66 0.743 . . . . 0.0 110.002 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.36 -36.23 83.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.433 -0.792 . . . . 0.0 109.787 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 41.5 mp0 -62.89 -51.67 66.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.41 -0.806 . . . . 0.0 110.452 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 pt -64.62 -37.37 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.23 -43.69 97.34 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.55 0.69 . . . . 0.0 110.077 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -71.77 -38.0 70.39 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.711 0.767 . . . . 0.0 108.97 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.462 ' O ' ' N ' ' A' ' 95' ' ' HIS . 30.2 m170 -67.57 -39.8 84.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.659 -0.651 . . . . 0.0 109.959 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -60.82 82.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.598 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 93' ' ' HIS . 71.2 m80 -87.24 -12.3 47.14 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.479 ' N ' ' ND1' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -151.13 164.96 35.3 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.331 -0.855 . . . . 0.0 109.714 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 98' ' ' HIS . 32.1 p-80 -66.35 -42.63 87.81 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.478 0.656 . . . . 0.0 109.749 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 75.9 m80 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.221 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.544 0.688 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.437 ' CZ ' ' CZ ' ' A' ' 14' ' ' PHE . 50.8 p90 -67.95 -14.84 63.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.437 ' CZ ' ' CZ ' ' A' ' 13' ' ' PHE . 86.5 m-85 -59.91 -29.33 68.28 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.487 0.661 . . . . 0.0 109.321 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -61.81 -37.82 85.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.479 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.56 -46.43 86.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.647 -0.658 . . . . 0.0 109.957 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.516 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 0.0 OUTLIER -67.24 -37.12 83.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.5 -0.75 . . . . 0.0 109.218 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.51 -42.02 99.22 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.479 0.657 . . . . 0.0 109.453 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -65.0 -40.55 95.11 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -64.01 -40.67 96.87 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.313 0.578 . . . . 0.0 110.047 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.68 -41.57 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.543 -0.723 . . . . 0.0 109.412 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 m -59.73 -46.18 89.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.633 -0.667 . . . . 0.0 109.691 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.67 -40.14 96.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.692 -0.63 . . . . 0.0 109.732 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.522 ' OH ' ' CZ ' ' A' ' 70' ' ' PHE . 59.0 t80 -58.84 -48.18 82.24 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.451 HD21 ' CZ ' ' A' ' 61' ' ' PHE . 82.1 mt -63.97 -40.56 96.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.601 -0.687 . . . . 0.0 110.068 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -49.81 -61.77 1.94 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.759 -0.588 . . . . 0.0 111.259 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.489 ' CE1' ' CG ' ' A' ' 28' ' ' ASN . 20.9 p80 -71.47 -36.01 71.03 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.269 0.557 . . . . 0.0 110.523 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.498 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 9.6 m120 -64.52 -41.13 96.58 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.9 mt -127.12 114.1 21.74 Favored Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 120.56 -0.456 . . . . 0.0 109.921 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.91 -15.74 26.24 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.633 2.222 . . . . 0.0 111.087 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.81 4.56 52.57 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -55.98 129.01 37.99 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.872 0.844 . . . . 0.0 110.201 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -118.16 -59.64 1.88 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -146.5 167.29 24.05 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.868 0.842 . . . . 0.0 110.171 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.52 134.41 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.61 0.719 . . . . 0.0 109.573 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.0 m -115.64 105.8 13.17 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.737 0.779 . . . . 0.0 109.19 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -80.76 140.22 35.64 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.514 0.674 . . . . 0.0 109.76 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.1 p -120.09 -34.16 3.76 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 53.63 81.94 0.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.518 -0.739 . . . . 0.0 109.843 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -144.36 28.83 1.32 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.435 ' OE1' ' OD2' ' A' ' 50' ' ' ASP . 82.7 tt0 -160.3 135.86 8.2 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.882 0.848 . . . . 0.0 109.987 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -123.83 144.54 49.67 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.707 0.765 . . . . 0.0 109.915 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -98.59 149.91 36.2 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.694 -0.629 . . . . 0.0 109.653 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.47 -20.97 41.01 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.889 2.392 . . . . 0.0 111.495 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.3 pt -98.63 -5.18 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.02 -168.93 40.63 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.688 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 pt -81.55 157.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.865 0.841 . . . . 0.0 109.922 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.6 t -138.67 141.96 39.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.595 0.712 . . . . 0.0 109.809 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.9 mt -112.78 127.88 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.876 0.846 . . . . 0.0 109.968 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.611 ' OD1' HG23 ' A' ' 62' ' ' THR . 24.8 m-20 -117.46 151.11 37.74 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.839 0.828 . . . . 0.0 110.021 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.84 -156.76 28.9 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -150.28 166.77 28.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.456 -1.026 . . . . 0.0 110.645 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.1 pt -121.76 167.8 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.732 0.777 . . . . 0.0 110.354 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 57.99 33.7 23.48 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.459 0.647 . . . . 0.0 109.978 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 42.19 34.52 0.49 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.958 -0.464 . . . . 0.0 109.935 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -115.18 107.67 15.6 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.706 0.765 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -58.6 -36.66 74.36 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.916 -0.49 . . . . 0.0 110.252 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -62.5 -37.03 84.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.245 -0.909 . . . . 0.0 109.804 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.9 mt -82.34 83.55 7.42 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.338 -0.851 . . . . 0.0 109.705 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 t -79.9 145.33 32.73 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.062 0.934 . . . . 0.0 110.668 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.451 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 33.2 t80 -140.29 130.37 24.88 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.756 0.789 . . . . 0.0 109.674 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.611 HG23 ' OD1' ' A' ' 50' ' ' ASP . 41.8 m -134.69 136.5 42.81 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.838 0.828 . . . . 0.0 110.11 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -134.22 144.07 48.21 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.943 0.878 . . . . 0.0 110.0 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.09 175.84 38.47 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -53.75 133.71 42.15 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.611 0.72 . . . . 0.0 110.943 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 68' ' ' LYS . 93.3 m-20 57.57 34.14 24.17 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.177 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' ILE . 39.6 t 59.46 -78.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' ASP . 67.9 mttm 39.45 -89.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.524 0.678 . . . . 0.0 109.99 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' VAL . 96.9 mt -109.04 136.43 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.777 0.799 . . . . 0.0 109.304 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.522 ' CZ ' ' OH ' ' A' ' 24' ' ' TYR . 53.0 p90 -139.75 167.27 22.49 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.014 0.912 . . . . 0.0 109.868 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.3 t -133.67 150.86 51.55 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.975 0.893 . . . . 0.0 109.688 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.9 p -151.33 160.74 43.63 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.715 0.769 . . . . 0.0 110.156 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 p -75.72 164.98 25.72 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.951 0.882 . . . . 0.0 110.737 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -61.05 -43.18 99.27 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -66.0 -34.0 77.09 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.4 tp -81.99 -26.16 34.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.404 -0.81 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -66.5 -43.82 84.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.531 -0.73 . . . . 0.0 109.998 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -71.75 -9.87 58.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.558 -0.714 . . . . 0.0 110.713 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.9 mtp -82.27 -8.89 59.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.217 -0.927 . . . . 0.0 109.362 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -68.06 135.92 52.99 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -0.855 . . . . 0.0 109.604 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -92.12 -74.21 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.305 0.574 . . . . 0.0 109.816 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.03 155.54 49.62 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.471 -0.768 . . . . 0.0 109.754 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.02 165.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.598 2.199 . . . . 0.0 112.724 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.25 136.25 53.24 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.787 0.803 . . . . 0.0 110.281 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.94 140.36 45.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.817 0.818 . . . . 0.0 109.905 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.5 165.92 53.24 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -62.25 -42.86 99.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.987 -0.714 . . . . 0.0 109.402 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -63.89 -37.71 88.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.64 -0.663 . . . . 0.0 110.324 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -65.21 -44.38 88.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.416 -0.802 . . . . 0.0 110.416 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.4 pt -72.66 -32.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.278 -0.889 . . . . 0.0 110.392 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.82 -40.39 96.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.105 -0.997 . . . . 0.0 109.342 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -50.33 -27.48 6.3 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -104.85 124.68 49.87 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.868 0.842 . . . . 0.0 110.153 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -149.94 -52.36 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 96' ' ' HIS . 42.0 p-80 -67.35 -34.02 76.45 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.347 -0.846 . . . . 0.0 109.643 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 95' ' ' HIS . 58.5 t-80 57.27 157.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.83 0.824 . . . . 0.0 110.678 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -153.72 162.66 41.05 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.839 0.828 . . . . 0.0 109.767 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.6 m170 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.746 -179.5 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.466 0.651 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CZ ' ' CE2' ' A' ' 14' ' ' PHE . 22.4 p90 -65.27 -12.11 48.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.578 -0.701 . . . . 0.0 109.52 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.53 ' CE2' ' CZ ' ' A' ' 13' ' ' PHE . 90.2 m-85 -64.87 -37.52 87.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.175 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.88 -41.0 99.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -0.813 . . . . 0.0 109.466 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.67 -40.19 92.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.587 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.18 -41.5 94.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.77 -40.73 97.39 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.384 -0.822 . . . . 0.0 109.351 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.15 -43.3 99.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 0.0 109.618 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -63.53 -42.64 98.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.332 -0.855 . . . . 0.0 109.879 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.47 -42.94 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 0.0 109.417 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.526 ' CG2' ' NZ ' ' A' ' 26' ' ' LYS . 76.1 m -60.73 -44.33 96.76 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.38 -0.825 . . . . 0.0 109.688 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 tp -63.71 -42.14 98.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.246 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.616 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 75.0 t80 -60.82 -44.58 96.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.577 -0.702 . . . . 0.0 110.232 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 29' ' ' ILE . 88.9 mt -63.64 -41.81 98.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 110.305 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.526 ' NZ ' ' CG2' ' A' ' 22' ' ' THR . 62.2 mttp -61.12 -40.75 94.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.91 -1.119 . . . . 0.0 110.444 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -66.84 -38.84 87.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.969 -1.082 . . . . 0.0 110.178 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.616 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 97.5 m-20 -92.5 -7.29 47.78 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.086 -1.009 . . . . 0.0 109.358 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 25' ' ' LEU . 12.3 mt -142.15 81.83 13.84 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.576 -0.702 . . . . 0.0 109.427 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.73 -27.73 78.96 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.711 2.274 . . . . 0.0 111.093 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -82.81 10.07 8.49 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 22.7 t80 -56.08 130.39 43.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -100.52 -68.76 0.8 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.448 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.6 t -152.33 168.22 26.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.722 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.03 138.22 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.4 m -125.12 124.67 42.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.606 -0.684 . . . . 0.0 109.27 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -104.43 118.47 36.7 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 t -141.26 18.64 2.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -151.09 106.67 3.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.113 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -130.82 140.6 50.28 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.323 -0.86 . . . . 0.0 109.473 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -135.82 156.35 48.93 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.453 -0.779 . . . . 0.0 109.577 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.49 ' CD2' ' O ' ' A' ' 42' ' ' PHE . 48.9 p90 -97.69 123.35 41.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.931 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -96.05 153.97 39.01 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.466 -0.771 . . . . 0.0 109.145 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.64 -22.6 50.39 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.667 2.245 . . . . 0.0 111.299 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.4 pt -102.13 -3.84 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.49 -133.88 3.2 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.402 ' H ' ' HB2' ' A' ' 65' ' ' LYS . 39.9 pt -127.79 159.61 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.312 -1.111 . . . . 0.0 110.749 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.6 p -126.14 137.13 53.56 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.88 130.66 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.536 -0.728 . . . . 0.0 109.344 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -130.6 137.51 49.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.621 -0.674 . . . . 0.0 109.382 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.75 -160.78 14.48 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -147.69 167.39 24.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.26 -1.141 . . . . 0.0 109.946 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.8 pt -121.2 160.44 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 121.953 0.882 . . . . 0.0 110.784 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 58.6 33.38 23.04 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.563 0.697 . . . . 0.0 109.873 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 46.41 29.49 0.89 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.306 -0.871 . . . . 0.0 110.08 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -109.24 111.76 23.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 0.0 109.504 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -58.7 -34.29 71.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.529 -0.732 . . . . 0.0 109.495 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -61.76 -39.11 90.48 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.321 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.79 73.89 8.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.074 -1.016 . . . . 0.0 109.083 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -100.56 156.5 17.26 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.6 0.714 . . . . 0.0 110.109 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.0 154.52 37.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.567 -0.708 . . . . 0.0 109.614 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 93.2 m -131.59 132.66 44.27 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.95 144.59 45.51 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.408 -0.807 . . . . 0.0 109.662 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.89 179.37 36.78 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HB2' ' H ' ' A' ' 47' ' ' ILE . 86.5 tttt -51.67 132.46 30.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.645 -0.915 . . . . 0.0 110.836 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 t0 56.01 38.09 29.56 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.672 0.749 . . . . 0.0 109.698 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 69' ' ' ILE . 36.1 t 58.56 -103.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.562 -0.711 . . . . 0.0 110.315 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 62.09 -69.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.616 -0.678 . . . . 0.0 109.53 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 67' ' ' VAL . 87.6 mt -105.73 121.84 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 108.752 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -128.39 133.97 48.72 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.5 t -132.01 141.78 49.37 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.0 p -139.45 156.15 47.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.475 -0.766 . . . . 0.0 109.968 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.9 p -68.93 170.05 10.46 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.647 0.737 . . . . 0.0 110.805 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.62 -46.52 88.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.494 -0.754 . . . . 0.0 110.263 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -65.36 -45.7 83.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 0.0 109.618 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.58 -38.74 90.39 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.314 -0.866 . . . . 0.0 109.678 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 84' ' ' ARG . 32.1 t70 -61.5 -36.02 79.31 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.128 -0.983 . . . . 0.0 109.59 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -68.86 -13.93 62.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.992 . . . . 0.0 110.207 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.2 mtp -82.2 -9.34 59.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.78 -1.2 . . . . 0.0 109.418 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -72.88 137.08 45.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.154 -0.966 . . . . 0.0 109.721 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -114.68 -11.39 12.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -127.1 153.43 76.65 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.71 -0.619 . . . . 0.0 109.917 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.86 152.13 59.8 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 122.323 2.015 . . . . 0.0 112.859 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.519 ' NH2' ' OD1' ' A' ' 77' ' ' ASP . 26.2 mmt85 -66.29 138.74 57.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 109.864 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -145.9 166.27 26.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.533 -0.729 . . . . 0.0 109.905 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.461 ' H ' ' CD ' ' A' ' 89' ' ' GLU . . . -82.31 167.8 47.56 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.578 ' CE2' HD11 ' A' ' 91' ' ' LEU . 71.6 t80 -62.01 -45.51 93.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.516 -0.99 . . . . 0.0 109.63 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -70.72 -29.14 65.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.839 -1.163 . . . . 0.0 109.005 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 86' ' ' GLY . 94.9 mt-10 -65.44 -45.33 84.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.395 -0.815 . . . . 0.0 109.936 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.6 pt -68.08 -33.42 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 109.749 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.578 HD11 ' CE2' ' A' ' 87' ' ' TYR . 41.4 mt -65.04 -41.23 95.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.384 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 94' ' ' HIS . 12.9 pt-20 -86.93 -13.14 45.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -0.994 . . . . 0.0 109.653 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.564 ' O ' ' N ' ' A' ' 95' ' ' HIS . 76.8 t60 -44.16 91.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.393 -0.817 . . . . 0.0 110.609 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 92' ' ' GLU . 79.8 m80 41.64 19.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.543 0.687 . . . . 0.0 109.979 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.564 ' N ' ' O ' ' A' ' 93' ' ' HIS . 85.2 t60 -66.22 -41.1 90.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.261 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.22 -45.1 95.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.314 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -66.73 -39.34 87.94 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 109.221 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.755 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.629 0.728 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.78 -43.7 97.72 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.771 0.796 . . . . 0.0 109.047 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -59.88 -43.09 94.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.631 . . . . 0.0 109.555 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -62.95 -41.6 99.55 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.688 0.756 . . . . 0.0 109.007 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.99 -38.53 88.75 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.547 0.689 . . . . 0.0 109.398 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.596 HE22 ' HA ' ' A' ' 66' ' ' ASP . 10.3 tp-100 -61.98 -43.56 98.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.679 . . . . 0.0 110.148 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.16 -40.21 96.9 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.658 0.742 . . . . 0.0 109.273 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.67 -44.34 94.04 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.546 0.689 . . . . 0.0 109.56 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -63.73 -42.94 97.81 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.427 0.632 . . . . 0.0 110.269 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.38 -44.69 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.641 0.734 . . . . 0.0 109.707 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.9 m -62.16 -42.4 99.22 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.55 0.691 . . . . 0.0 109.875 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.518 HD11 ' NE2' ' A' ' 27' ' ' HIS . 49.2 tp -60.8 -44.36 96.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.489 -0.757 . . . . 0.0 109.597 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -62.46 -45.88 91.04 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.598 0.714 . . . . 0.0 110.186 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.33 -39.46 93.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.482 -0.761 . . . . 0.0 110.069 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -60.55 -42.0 95.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.521 -0.737 . . . . 0.0 109.804 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.518 ' NE2' HD11 ' A' ' 23' ' ' LEU . 51.8 m-70 -66.51 -39.08 88.48 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.519 0.676 . . . . 0.0 110.0 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -87.97 -2.98 58.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.462 -0.774 . . . . 0.0 109.435 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.413 HD11 HD11 ' A' ' 76' ' ' LEU . 24.3 mt -142.53 83.1 12.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.67 . . . . 0.0 109.215 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.63 -32.06 73.38 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.597 2.198 . . . . 0.0 111.159 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -83.87 16.05 3.0 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.587 0.708 . . . . 0.0 109.445 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.73 129.19 40.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.497 -0.752 . . . . 0.0 109.883 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -108.98 -58.4 2.02 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -153.91 164.32 38.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.246 -0.908 . . . . 0.0 110.447 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.09 135.84 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 100.0 m -128.82 125.36 37.58 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.701 0.762 . . . . 0.0 110.01 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -99.16 147.42 25.13 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 p -142.17 -76.21 0.28 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.489 0.661 . . . . 0.0 109.595 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -78.18 128.48 33.82 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.662 0.744 . . . . 0.0 110.571 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.97 69.6 1.36 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -81.24 162.76 23.41 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.87 0.843 . . . . 0.0 110.213 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -99.4 119.88 38.69 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.777 0.799 . . . . 0.0 110.168 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.466 ' ND2' ' H ' ' A' ' 46' ' ' GLY . 7.0 p-10 -95.15 152.25 39.33 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.36 -38.89 27.44 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.671 2.247 . . . . 0.0 112.077 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.9 -41.17 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.58 -0.7 . . . . 0.0 109.961 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' H ' ' ND2' ' A' ' 43' ' ' ASN . . . -179.41 -135.1 2.32 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.418 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.8 pt -103.74 139.26 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.758 -0.848 . . . . 0.0 109.801 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.7 m -116.54 124.96 51.17 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.579 0.705 . . . . 0.0 109.591 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.15 125.48 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 61' ' ' PHE . 38.8 t70 -124.25 153.67 41.33 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.861 0.839 . . . . 0.0 109.932 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 178.54 -167.49 38.0 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.469 ' CE2' ' NZ ' ' A' ' 57' ' ' LYS . 19.7 p90 -142.17 163.73 32.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.831 -0.805 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -120.78 161.53 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.674 0.749 . . . . 0.0 110.027 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 58.89 32.16 21.98 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.623 0.725 . . . . 0.0 109.844 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 45.82 32.11 1.2 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.653 . . . . 0.0 109.595 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -115.57 109.51 17.89 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.416 0.627 . . . . 0.0 109.541 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' NZ ' ' CE2' ' A' ' 52' ' ' TYR . 69.6 mmtt -57.85 -33.36 68.57 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.408 0.623 . . . . 0.0 110.032 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -60.5 -39.26 87.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 109.0 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.44 68.77 9.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.445 -0.785 . . . . 0.0 109.373 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.6 p -91.93 161.39 14.84 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.615 0.722 . . . . 0.0 109.855 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.408 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 49.2 p90 -155.07 160.9 41.35 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.63 0.728 . . . . 0.0 109.725 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.6 m -140.68 144.57 35.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.611 -0.681 . . . . 0.0 109.7 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.47 140.69 26.42 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -105.13 147.84 16.38 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.414 ' C ' ' O ' ' A' ' 64' ' ' GLY . 63.8 mmtt 35.22 -122.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.439 0.637 . . . . 0.0 111.232 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.596 ' HA ' HE22 ' A' ' 17' ' ' GLN . 97.7 m-20 -88.21 86.84 7.15 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.774 0.797 . . . . 0.0 109.921 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 45.67 14.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.661 0.743 . . . . 0.0 109.668 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 66' ' ' ASP . 25.5 tptt -78.44 136.46 37.63 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.878 0.847 . . . . 0.0 110.05 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 68' ' ' LYS . 9.4 mm 49.15 99.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.59 0.709 . . . . 0.0 109.513 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -135.79 153.97 51.36 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.687 0.756 . . . . 0.0 110.083 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 p -136.53 157.25 47.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 m -133.95 153.08 52.01 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.935 0.874 . . . . 0.0 110.135 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.2 p -65.13 168.55 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.765 0.793 . . . . 0.0 110.744 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.17 -51.81 68.17 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.467 0.651 . . . . 0.0 109.82 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.95 -43.36 92.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.526 -0.734 . . . . 0.0 109.715 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.413 HD11 HD11 ' A' ' 29' ' ' ILE . 56.6 tp -63.8 -39.1 93.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -61.02 -38.03 84.67 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.631 0.729 . . . . 0.0 109.371 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.97 -36.64 82.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.334 -0.854 . . . . 0.0 109.509 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 81' ' ' GLN . 79.1 mtp -63.32 -41.34 98.91 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.467 -0.771 . . . . 0.0 109.943 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -43.44 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.922 0.868 . . . . 0.0 110.238 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' MET . 57.7 tt0 -67.79 -36.34 80.28 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.194 -0.603 . . . . 0.0 109.642 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -105.89 152.66 40.29 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.499 -0.75 . . . . 0.0 109.921 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.54 167.62 20.34 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.81 2.34 . . . . 0.0 112.844 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -63.78 140.22 58.85 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.777 0.798 . . . . 0.0 110.212 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -144.52 -111.34 0.1 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.685 -0.634 . . . . 0.0 109.843 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -176.94 161.06 28.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.452 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.88 -44.39 97.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.385 0.612 . . . . 0.0 110.059 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -58.76 -39.79 82.01 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.534 0.683 . . . . 0.0 110.121 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -57.96 -56.36 22.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 109.667 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.8 pt -65.64 -26.14 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.436 -0.79 . . . . 0.0 110.029 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.58 ' O ' HD23 ' A' ' 91' ' ' LEU . 1.2 tt -63.61 -35.85 81.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.503 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -51.71 -30.8 23.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.257 -0.902 . . . . 0.0 109.322 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -155.1 119.34 4.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.651 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -67.51 -40.82 85.16 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.655 0.741 . . . . 0.0 109.087 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -156.99 156.58 33.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.438 -0.789 . . . . 0.0 110.188 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -145.32 135.04 23.46 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.555 0.693 . . . . 0.0 109.362 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -94.36 122.52 37.0 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.522 0.677 . . . . 0.0 109.774 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.417 ' ND1' ' C ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.227 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.943 0.878 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -66.06 -18.2 65.19 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.606 0.717 . . . . 0.0 109.443 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -67.9 -33.95 75.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.445 -0.785 . . . . 0.0 109.842 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.415 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 90.9 m-20 -61.62 -46.76 88.45 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.462 -0.774 . . . . 0.0 110.062 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.31 -36.07 71.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 109.588 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.458 HE22 ' H ' ' A' ' 67' ' ' VAL . 68.4 tp60 -66.27 -41.13 90.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.578 -0.701 . . . . 0.0 109.521 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -64.85 -40.93 95.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.557 -0.714 . . . . 0.0 109.58 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -61.35 -42.37 98.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.575 -0.703 . . . . 0.0 109.583 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.3 -42.51 96.34 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.599 0.714 . . . . 0.0 109.175 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.4 t -65.43 -43.61 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.476 0.655 . . . . 0.0 109.659 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -61.74 -45.1 95.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.694 -0.629 . . . . 0.0 110.103 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 tp -63.31 -41.01 98.89 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.949 0.881 . . . . 0.0 109.976 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.623 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 62.9 t80 -66.43 -39.26 88.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.499 -0.75 . . . . 0.0 109.52 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.0 mt -61.82 -47.31 85.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.588 -0.695 . . . . 0.0 111.017 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.97 -34.56 78.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.503 -0.748 . . . . 0.0 110.314 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -72.46 -35.92 68.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 110.277 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.623 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 69.9 m-80 -94.72 -1.28 53.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.292 -0.88 . . . . 0.0 109.483 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 mt -140.93 86.79 11.41 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.389 -0.82 . . . . 0.0 109.346 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -55.98 -31.92 83.96 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.678 2.252 . . . . 0.0 111.303 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -82.25 13.46 3.5 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 25.1 t80 -57.2 130.68 47.24 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.758 0.79 . . . . 0.0 109.826 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -116.42 -66.82 1.04 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -141.06 165.31 27.9 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.507 -0.746 . . . . 0.0 109.935 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.68 138.84 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.42 0.629 . . . . 0.0 109.357 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.526 HG21 ' OH ' ' A' ' 52' ' ' TYR . 97.8 m -124.91 115.75 21.11 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.689 0.757 . . . . 0.0 109.494 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -86.85 135.47 33.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -111.53 -35.79 5.7 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.74 32.38 19.32 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.507 0.67 . . . . 0.0 109.363 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.33 16.7 14.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.467 -0.771 . . . . 0.0 109.561 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -134.68 148.39 50.32 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.298 -0.876 . . . . 0.0 109.929 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.483 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 35.1 p90 -161.18 125.08 3.38 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.512 0.672 . . . . 0.0 109.313 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 4.3 p30 -91.02 150.99 42.76 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.527 -0.733 . . . . 0.0 109.847 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -65.06 -24.36 59.81 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.599 2.199 . . . . 0.0 111.766 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tp -70.39 -26.89 29.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.616 0.722 . . . . 0.0 109.382 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.38 -119.93 0.63 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.4 pt -126.2 158.98 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.691 -0.888 . . . . 0.0 110.533 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.4 m -141.67 139.75 33.05 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.2 127.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.55 0.691 . . . . 0.0 109.49 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.5 t0 -119.89 142.92 48.25 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.555 0.693 . . . . 0.0 109.571 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -173.09 -176.15 41.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' OH ' HG21 ' A' ' 36' ' ' THR . 13.3 p90 -143.1 164.03 31.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.597 -0.943 . . . . 0.0 110.341 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 pt -119.03 164.47 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.793 0.806 . . . . 0.0 110.282 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' ASP . 68.7 m-80 58.11 34.35 24.1 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.543 0.687 . . . . 0.0 109.734 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 45.25 20.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.49 0.662 . . . . 0.0 109.657 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' ASN . 99.8 m-20 -102.14 109.65 21.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.494 -0.754 . . . . 0.0 109.232 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -57.37 -33.13 67.48 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.26 0.552 . . . . 0.0 109.933 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -61.99 -39.37 91.98 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.3 mt -81.24 71.28 8.22 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.293 -0.88 . . . . 0.0 109.59 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.416 ' O ' HD22 ' A' ' 76' ' ' LEU . 18.3 p -90.67 161.69 15.26 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.676 0.75 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -149.24 152.66 36.35 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.455 0.645 . . . . 0.0 109.665 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.8 m -131.06 135.21 47.35 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.583 0.706 . . . . 0.0 110.167 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.22 146.38 40.42 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.646 0.736 . . . . 0.0 109.309 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.09 -155.74 16.9 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.31 134.26 55.51 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.944 0.878 . . . . 0.0 110.571 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 50.93 29.88 4.81 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.474 0.654 . . . . 0.0 109.463 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' H ' HE22 ' A' ' 17' ' ' GLN . 2.0 t 48.49 30.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.659 0.743 . . . . 0.0 109.454 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' NH2' ' A' ' 84' ' ' ARG . 28.2 tptp -62.16 -45.19 94.51 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.622 -0.674 . . . . 0.0 109.237 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.18 128.26 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -134.5 138.49 44.73 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.664 0.745 . . . . 0.0 109.877 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 t -132.85 146.17 51.59 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.514 0.673 . . . . 0.0 109.25 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.1 t -135.01 147.12 49.6 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.817 0.818 . . . . 0.0 110.172 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.1 p -77.8 173.77 11.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.645 0.736 . . . . 0.0 110.284 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.39 -48.59 80.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.361 0.6 . . . . 0.0 110.16 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.457 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 59.5 mp0 -67.41 -45.01 77.4 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.441 -0.787 . . . . 0.0 109.819 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 60' ' ' SER . 52.9 tp -64.16 -40.28 95.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.423 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -58.7 -41.26 85.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.595 -0.69 . . . . 0.0 109.191 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -65.21 -36.52 84.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.41 -0.807 . . . . 0.0 109.836 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 84.6 mmm -62.22 -38.17 88.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.239 -0.913 . . . . 0.0 109.208 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -57.91 138.18 56.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.456 -0.778 . . . . 0.0 109.554 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -108.03 -16.57 14.25 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -130.61 151.29 78.44 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.644 -0.66 . . . . 0.0 109.829 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.54 159.82 51.9 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.163 2.575 . . . . 0.0 112.881 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.462 ' NH2' ' O ' ' A' ' 68' ' ' LYS . 78.6 ttt-85 -66.82 132.53 48.23 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.786 0.803 . . . . 0.0 110.039 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -119.13 -72.43 0.69 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.39 158.44 9.87 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.534 ' CE2' HD11 ' A' ' 91' ' ' LEU . 81.4 t80 -62.57 -44.54 96.07 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.937 0.875 . . . . 0.0 109.636 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -73.55 -23.7 60.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.79 -45.47 67.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.523 -0.736 . . . . 0.0 109.673 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 91' ' ' LEU . 25.3 pt -66.79 -36.12 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.423 0.63 . . . . 0.0 109.563 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.534 HD11 ' CE2' ' A' ' 87' ' ' TYR . 39.2 mt -63.63 -40.49 97.01 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.577 -0.702 . . . . 0.0 109.561 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -68.19 -41.97 80.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.616 -0.678 . . . . 0.0 109.628 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -68.03 -38.97 83.17 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.731 . . . . 0.0 109.852 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.59 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 14.2 t60 -60.56 -43.46 97.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.434 -0.791 . . . . 0.0 109.528 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.59 ' CD2' ' CD2' ' A' ' 94' ' ' HIS . 75.8 m-70 -155.48 -80.84 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.86 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.483 ' CG ' ' N ' ' A' ' 97' ' ' HIS . 19.6 p-80 -158.98 -142.6 0.09 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.448 -0.783 . . . . 0.0 110.308 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.483 ' N ' ' CG ' ' A' ' 96' ' ' HIS . 2.9 p-80 -152.4 153.2 33.1 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.738 0.78 . . . . 0.0 110.029 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 98' ' ' HIS . 58.1 t-80 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.106 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.324 0.583 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -62.33 -45.31 93.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.313 -0.867 . . . . 0.0 109.51 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -64.81 -36.5 84.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.395 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -61.38 -40.73 95.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.441 -0.787 . . . . 0.0 109.187 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -65.59 -40.25 92.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.565 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 66' ' ' ASP . 99.4 mm-40 -64.71 -42.43 95.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.691 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -64.25 -40.45 96.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.664 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.81 -44.5 93.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.86 . . . . 0.0 109.636 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.51 -41.7 96.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 109.862 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.3 t -64.63 -42.88 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.862 . . . . 0.0 109.644 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -59.74 -45.27 92.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.212 -0.93 . . . . 0.0 108.87 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.5 -41.96 98.53 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.398 -0.813 . . . . 0.0 109.281 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.484 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 83.1 t80 -58.99 -46.34 88.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.509 -0.744 . . . . 0.0 109.312 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -75.2 -22.93 57.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.69 -0.631 . . . . 0.0 109.712 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -63.96 -48.34 76.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.796 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.619 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 26.2 p80 -81.81 -35.83 29.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.051 -1.031 . . . . 0.0 109.755 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.619 ' ND2' ' CE1' ' A' ' 27' ' ' HIS . 36.6 m-80 -64.04 -41.03 97.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -122.69 88.26 49.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.632 -0.667 . . . . 0.0 109.604 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -54.22 -29.79 58.49 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.756 2.304 . . . . 0.0 111.622 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -80.37 5.1 15.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -55.64 131.73 47.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.493 -0.755 . . . . 0.0 110.284 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -103.0 -65.71 0.98 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 t -149.93 165.0 33.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.841 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.1 p -128.12 135.64 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.8 m -126.5 123.46 37.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.574 -0.704 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -95.55 144.13 26.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 109.429 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.463 ' O ' ' OG1' ' A' ' 38' ' ' THR . 0.2 OUTLIER -143.32 17.95 1.89 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.925 . . . . 0.0 108.643 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -155.48 116.27 3.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.372 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -138.26 91.47 2.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -118.18 147.3 43.49 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.703 0.763 . . . . 0.0 109.965 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 42' ' ' PHE . 48.8 p90 -97.35 120.94 38.64 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.692 -0.63 . . . . 0.0 109.396 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.45 HD21 ' HA ' ' A' ' 43' ' ' ASN . 5.1 m120 -103.58 154.59 37.78 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.342 -0.849 . . . . 0.0 108.909 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.92 -40.64 49.01 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.966 1.777 . . . . 0.0 111.594 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 92.0 mt -67.57 -41.26 85.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.456 -0.777 . . . . 0.0 109.059 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.54 -125.89 0.96 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.0 pt -128.36 151.33 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.588 -0.948 . . . . 0.0 110.011 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.0 m -127.04 122.45 34.44 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.11 130.89 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -129.8 149.85 51.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.708 0.766 . . . . 0.0 109.466 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.9 -168.14 34.47 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -142.48 164.79 29.17 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.344 -1.092 . . . . 0.0 110.309 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 pt -121.0 159.36 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.603 0.716 . . . . 0.0 110.306 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 57.52 32.8 22.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.565 -0.71 . . . . 0.0 109.518 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 46.74 32.18 1.66 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.32 -0.862 . . . . 0.0 110.123 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -109.57 108.29 18.68 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.528 -0.733 . . . . 0.0 109.466 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.92 -34.98 72.33 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.394 0.616 . . . . 0.0 109.61 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -62.55 -38.63 90.77 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.123 -0.986 . . . . 0.0 109.175 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.2 mt -83.91 77.55 9.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.1 t -107.37 162.76 13.63 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.372 0.606 . . . . 0.0 109.824 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -153.15 159.75 42.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.322 -0.861 . . . . 0.0 109.287 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.7 m -129.31 133.8 47.62 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.3 142.64 50.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.745 . . . . 0.0 109.14 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.49 124.82 5.4 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt 54.13 93.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.755 -0.85 . . . . 0.0 110.646 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD1' ' NE2' ' A' ' 17' ' ' GLN . 95.1 m-20 52.79 -103.23 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.708 -0.62 . . . . 0.0 110.109 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.84 17.8 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.53 -44.84 96.33 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.413 -0.804 . . . . 0.0 109.222 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.0 mt -121.89 126.06 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CD2' ' NH1' ' A' ' 84' ' ' ARG . 66.0 t80 -138.46 131.77 30.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.512 -0.742 . . . . 0.0 109.191 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 p -139.06 143.46 38.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.366 -0.834 . . . . 0.0 109.06 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 p -153.97 170.29 21.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.988 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -77.17 171.59 14.59 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.634 0.731 . . . . 0.0 110.835 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.71 -35.39 80.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.602 -0.686 . . . . 0.0 109.546 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -58.34 -57.55 12.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.115 -0.99 . . . . 0.0 109.279 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.97 -38.65 86.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.194 -0.941 . . . . 0.0 109.282 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -51.7 -38.42 55.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.378 -0.826 . . . . 0.0 109.702 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -60.42 -31.05 70.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 0.0 110.228 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.6 mmm -64.22 -35.45 80.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.953 . . . . 0.0 110.02 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -55.06 132.88 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.014 -1.054 . . . . 0.0 109.714 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -95.08 -71.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.623 -0.673 . . . . 0.0 109.484 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.19 158.03 41.89 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 109.352 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -46.56 158.35 0.38 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.243 1.962 . . . . 0.0 112.817 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.479 ' NH1' ' CD2' ' A' ' 70' ' ' PHE . 96.3 mtt-85 -67.59 141.33 56.82 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.392 -0.817 . . . . 0.0 109.59 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -130.95 145.72 52.12 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.458 0.646 . . . . 0.0 109.904 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.2 155.89 26.55 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.522 ' CE2' HD11 ' A' ' 91' ' ' LEU . 85.5 t80 -60.53 -46.01 91.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.8 -0.824 . . . . 0.0 109.403 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 45.8 p-10 -68.75 -32.93 73.05 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.16 -0.962 . . . . 0.0 109.683 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 83.0 tt0 -66.41 -43.09 86.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 110.508 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 91' ' ' LEU . 29.7 pt -66.71 -37.73 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.033 -1.042 . . . . 0.0 109.375 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.522 HD11 ' CE2' ' A' ' 87' ' ' TYR . 89.1 mt -62.56 -42.0 99.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.011 -1.055 . . . . 0.0 109.152 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 94' ' ' HIS . 96.8 mt-10 -66.6 -40.34 88.82 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.437 -0.789 . . . . 0.0 109.328 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 70.5 t60 58.5 -71.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.346 0.593 . . . . 0.0 110.453 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 92' ' ' GLU . 59.2 t-80 -60.99 153.19 25.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 110.567 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -149.4 165.97 30.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 109.599 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.551 ' O ' ' N ' ' A' ' 98' ' ' HIS . 57.2 t-80 -85.13 79.08 9.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.348 -0.845 . . . . 0.0 109.226 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 43.08 -90.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.606 -0.684 . . . . 0.0 110.365 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.551 ' N ' ' O ' ' A' ' 96' ' ' HIS . 84.7 t60 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.024 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.298 0.57 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -64.61 -45.04 88.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.489 -0.757 . . . . 0.0 110.266 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -63.65 -40.69 97.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 109.827 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.63 -41.17 98.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.806 . . . . 0.0 110.149 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.45 -40.0 92.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 109.962 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.89 -40.1 94.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.824 . . . . 0.0 110.058 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.01 -40.86 97.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.177 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -65.58 -40.25 92.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.967 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -63.25 -42.17 99.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -0.867 . . . . 0.0 109.415 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.53 -43.36 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.562 -0.712 . . . . 0.0 109.902 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -61.55 -44.65 96.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.661 -0.649 . . . . 0.0 110.146 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.489 HD11 ' NE2' ' A' ' 27' ' ' HIS . 38.2 tp -63.01 -44.13 96.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 110.379 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.671 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 90.9 t80 -62.74 -45.13 94.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.037 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.05 -40.33 96.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.478 -0.764 . . . . 0.0 110.01 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -58.91 -45.03 91.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 110.744 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.489 ' NE2' HD11 ' A' ' 23' ' ' LEU . 84.4 m-70 -68.23 -37.21 80.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.051 . . . . 0.0 110.26 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.671 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 72.4 m-20 -87.64 -5.39 58.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 109.177 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.4 mt -138.29 99.0 8.98 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.568 -0.708 . . . . 0.0 109.684 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.34 -14.75 31.32 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.334 2.023 . . . . 0.0 111.589 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -90.9 4.66 51.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.638 -0.664 . . . . 0.0 109.284 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -54.72 129.66 37.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.387 -0.821 . . . . 0.0 110.135 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -125.45 -56.11 1.52 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -146.49 156.46 43.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.341 -0.849 . . . . 0.0 109.627 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.91 140.28 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.623 -0.673 . . . . 0.0 109.872 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.6 m -124.68 128.2 48.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -97.88 124.91 42.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.472 -0.767 . . . . 0.0 110.015 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 39' ' ' ASN . 60.4 p -99.62 -15.16 18.67 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 38' ' ' THR . 74.4 m-20 58.1 148.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.596 0.712 . . . . 0.0 110.535 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.42 -163.96 1.59 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.346 -0.846 . . . . 0.0 109.946 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.12 -160.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.693 -0.629 . . . . 0.0 110.845 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -107.75 130.61 54.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.391 -0.818 . . . . 0.0 110.064 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -90.39 155.61 46.29 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.423 -0.798 . . . . 0.0 109.822 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -49.63 -37.03 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.534 2.156 . . . . 0.0 111.645 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 46' ' ' GLY . 21.4 tt -68.4 -38.6 79.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.538 -0.726 . . . . 0.0 109.428 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 177.92 -97.14 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.56 148.82 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.882 . . . . 0.0 110.007 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 t -100.21 125.04 46.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.396 -0.815 . . . . 0.0 109.427 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.03 129.47 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 61' ' ' PHE . 22.6 t0 -130.68 152.14 50.37 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -175.41 -177.39 44.44 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -143.75 162.75 35.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.539 -0.977 . . . . 0.0 109.968 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.9 pt -121.41 161.5 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.595 0.712 . . . . 0.0 110.871 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 56.78 32.62 21.6 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.692 0.758 . . . . 0.0 109.616 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 46.6 32.3 1.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.514 -0.741 . . . . 0.0 109.81 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -113.08 111.28 21.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.66 -0.65 . . . . 0.0 109.357 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -59.79 -31.75 69.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.605 -0.685 . . . . 0.0 109.564 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.96 -39.06 90.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 109.204 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.8 mt -83.5 73.14 10.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 108.986 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 m -105.05 159.67 15.65 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.649 0.737 . . . . 0.0 110.355 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.43 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 53.3 p90 -147.99 149.3 31.9 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.631 -0.668 . . . . 0.0 109.284 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.2 m -128.11 131.92 49.0 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.83 139.96 49.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.41 -0.806 . . . . 0.0 109.764 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -99.78 112.52 4.47 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.2 tttm 37.87 -83.0 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.097 -0.649 . . . . 0.0 111.813 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 64' ' ' GLY . 99.8 m-20 -78.21 125.19 28.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 67' ' ' VAL . 37.2 t -60.39 0.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 66' ' ' ASP . 65.8 tttm -61.74 -42.59 99.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 109.467 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.86 112.85 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.487 0.66 . . . . 0.0 109.386 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -141.39 158.53 43.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.591 -0.693 . . . . 0.0 109.926 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.0 t -125.51 155.9 39.85 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.477 0.655 . . . . 0.0 109.555 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 p -150.15 162.13 41.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.439 -0.788 . . . . 0.0 109.636 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -77.34 170.83 15.86 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.99 0.9 . . . . 0.0 110.838 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 74' ' ' GLU . 58.7 mp0 -66.09 -37.93 87.0 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.777 -0.577 . . . . 0.0 109.61 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.95 -39.96 94.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.558 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.467 HD12 ' SD ' ' A' ' 79' ' ' MET . 58.6 tp -82.61 -21.4 35.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.299 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -66.93 -48.0 69.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -64.69 -22.62 67.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.402 -0.811 . . . . 0.0 110.227 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.467 ' SD ' HD12 ' A' ' 76' ' ' LEU . 90.8 mtp -65.27 -33.68 76.55 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.535 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -53.78 141.72 25.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.872 . . . . 0.0 110.429 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -85.4 -75.81 0.35 Allowed 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.831 -0.543 . . . . 0.0 109.963 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' PRO . 25.9 mt-10 -99.93 154.54 37.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.731 . . . . 0.0 109.862 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 82' ' ' GLU . 85.1 Cg_exo -40.93 170.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.837 2.358 . . . . 0.0 113.282 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -64.98 130.95 45.27 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.705 0.764 . . . . 0.0 110.018 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -109.14 -78.01 0.59 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.29 145.86 4.21 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.526 ' CE2' HD11 ' A' ' 91' ' ' LEU . 81.9 t80 -60.44 -45.1 94.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.792 -0.828 . . . . 0.0 109.567 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.58 -26.99 62.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.162 -0.961 . . . . 0.0 109.327 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -69.16 -43.24 74.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.465 -0.772 . . . . 0.0 110.014 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.4 pt -68.3 -37.05 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.316 -0.865 . . . . 0.0 109.777 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 87' ' ' TYR . 86.3 mt -62.91 -42.14 99.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.036 . . . . 0.0 109.777 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.06 -38.31 82.3 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.192 -0.942 . . . . 0.0 109.211 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.01 130.58 37.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.461 -0.774 . . . . 0.0 110.008 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -111.91 139.16 47.63 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.457 0.646 . . . . 0.0 109.674 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.439 ' NE2' ' NE2' ' A' ' 96' ' ' HIS . 27.0 p-80 -82.6 -11.8 58.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.586 -0.696 . . . . 0.0 109.168 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.439 ' NE2' ' NE2' ' A' ' 95' ' ' HIS . 99.5 m-70 -75.14 143.16 43.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -0.855 . . . . 0.0 110.289 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -153.73 163.86 39.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.698 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.831 -179.881 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.375 0.607 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -63.56 -40.84 98.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.245 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -62.71 -40.66 97.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.588 -0.695 . . . . 0.0 109.477 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.06 -41.14 97.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.759 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.0 -41.18 97.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 109.437 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -64.1 -42.05 97.04 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.01 -43.27 93.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.606 -0.683 . . . . 0.0 109.859 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.31 -44.3 92.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.431 -0.793 . . . . 0.0 109.801 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.5 t -64.5 -45.26 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 110.072 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.8 m -62.44 -48.04 81.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.267 -0.896 . . . . 0.0 109.538 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 tp -64.08 -41.92 97.15 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.775 0.798 . . . . 0.0 109.656 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.604 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 78.5 t80 -63.96 -40.57 96.72 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.922 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.08 -46.13 90.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.855 . . . . 0.0 110.472 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -68.89 -29.2 67.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 110.308 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -68.48 -39.74 81.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.269 -0.894 . . . . 0.0 109.897 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.604 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 71.6 m-80 -94.63 -3.69 49.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 108.65 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 80' ' ' PHE . 20.6 mt -138.38 93.98 11.04 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.92 -16.53 36.92 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.071 1.848 . . . . 0.0 111.057 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -90.12 5.54 46.38 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -58.11 133.81 55.9 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.55 -0.719 . . . . 0.0 110.164 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -110.19 -58.08 2.12 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 t -153.45 160.5 42.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 109.97 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.3 134.69 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -123.49 125.83 45.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.01 144.61 26.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.608 -0.682 . . . . 0.0 109.338 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.1 t -161.91 61.06 0.25 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.183 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -161.53 -83.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 40' ' ' GLU . 4.1 tm-20 56.13 75.13 0.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.794 . . . . 0.0 109.375 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -120.3 150.58 40.5 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.622 0.725 . . . . 0.0 109.614 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -92.23 120.31 32.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.376 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -103.49 156.01 36.07 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.28 -37.97 25.29 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.399 2.066 . . . . 0.0 112.06 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 46' ' ' GLY . 21.0 tt -68.72 -37.73 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.119 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.457 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 170.11 -98.44 0.13 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 pt -123.35 157.81 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.526 -0.985 . . . . 0.0 110.275 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.0 p -139.98 123.78 17.42 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.58 133.06 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.681 -0.637 . . . . 0.0 109.427 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 50.1 t0 -131.18 147.1 52.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.613 -0.68 . . . . 0.0 109.449 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -172.43 -170.61 36.44 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -141.42 165.59 27.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.356 -1.085 . . . . 0.0 110.156 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.4 pt -121.75 162.84 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.531 0.682 . . . . 0.0 110.872 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 57.76 33.18 22.91 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.347 0.594 . . . . 0.0 110.126 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 48.31 26.73 1.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.4 -0.812 . . . . 0.0 110.246 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -108.57 108.59 19.55 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.375 -0.828 . . . . 0.0 109.644 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.15 -32.47 68.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.652 -0.655 . . . . 0.0 109.65 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -62.58 -39.73 94.65 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.45 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.8 mt -81.89 80.31 8.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.163 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.8 m -104.86 153.41 21.4 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.747 0.784 . . . . 0.0 110.417 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -139.61 150.98 45.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.779 -0.575 . . . . 0.0 109.635 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.2 m -133.67 136.23 44.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.544 -0.723 . . . . 0.0 109.917 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.26 155.21 40.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.232 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.44 -130.35 3.91 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' ASP . 54.9 mtpt -59.23 128.57 37.82 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.487 -1.008 . . . . 0.0 110.716 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 67' ' ' VAL . 43.2 t0 44.93 -173.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.505 0.669 . . . . 0.0 110.278 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.506 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 2.3 t -94.69 21.28 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.097 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -63.4 -41.84 98.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.219 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.37 126.06 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -136.13 135.44 39.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.537 -0.727 . . . . 0.0 109.183 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 t -134.48 144.54 48.13 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.74 . . . . 0.0 109.413 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.1 p -152.71 164.08 38.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 110.516 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.1 p -68.06 167.44 13.95 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.611 0.72 . . . . 0.0 110.67 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -66.46 -36.61 83.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.313 -0.867 . . . . 0.0 109.447 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.83 -32.22 73.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.552 -0.717 . . . . 0.0 109.478 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.4 tp -90.52 -17.94 26.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 109.16 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -73.2 -42.27 62.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.67 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -63.77 -21.31 66.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.642 -0.661 . . . . 0.0 109.745 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 86.1 mmm -64.51 -35.36 80.7 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.341 -0.849 . . . . 0.0 109.15 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 29' ' ' ILE . 14.4 m-85 -64.31 132.79 51.23 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.32 -0.862 . . . . 0.0 109.86 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -113.21 -16.99 12.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -119.08 153.62 53.04 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.742 -0.598 . . . . 0.0 109.853 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.31 157.34 58.36 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 123.022 2.481 . . . . 0.0 113.012 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -67.4 141.65 56.98 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.726 0.774 . . . . 0.0 110.845 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -141.27 150.54 42.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.647 -0.658 . . . . 0.0 109.308 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.65 158.72 51.16 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -60.41 -44.08 96.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.715 -0.873 . . . . 0.0 109.58 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -66.26 -34.58 78.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 109.663 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -62.65 -49.5 74.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 109.689 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 pt -66.95 -37.46 79.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.472 -0.767 . . . . 0.0 109.427 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.3 tp -62.51 -44.23 96.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.899 . . . . 0.0 109.461 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.394 -0.817 . . . . 0.0 109.525 -179.472 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.0 t80 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.385 0.612 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -64.39 -36.56 84.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 109.658 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -63.23 -41.35 99.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.499 -0.751 . . . . 0.0 110.026 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 54.8 mp0 -67.62 -40.41 84.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.606 -0.683 . . . . 0.0 109.91 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 56.2 tp60 -67.75 -36.72 81.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.402 -0.811 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.72 -42.69 99.3 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.623 0.725 . . . . 0.0 109.372 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.62 -39.88 91.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.737 -0.602 . . . . 0.0 109.94 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.74 -42.37 97.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.377 -0.827 . . . . 0.0 109.962 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.38 -42.3 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.1 m -60.51 -45.28 94.38 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.729 0.776 . . . . 0.0 109.078 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.404 HD11 ' NE2' ' A' ' 27' ' ' HIS . 41.8 tp -63.83 -41.91 97.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.444 -0.785 . . . . 0.0 108.998 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.525 ' CE2' ' OD1' ' A' ' 28' ' ' ASN . 75.6 t80 -61.36 -47.36 86.21 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.63 -39.83 94.39 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.57 0.7 . . . . 0.0 109.571 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -58.52 -47.82 82.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.624 -0.673 . . . . 0.0 110.272 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.404 ' NE2' HD11 ' A' ' 23' ' ' LEU . 59.5 m-70 -74.29 -42.75 59.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.28 -0.887 . . . . 0.0 110.072 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.525 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 28.2 m120 -65.28 -39.81 93.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.761 . . . . 0.0 109.499 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.1 mt -105.18 109.32 63.08 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.709 -0.62 . . . . 0.0 109.607 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.94 -16.67 29.14 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.258 1.972 . . . . 0.0 111.15 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -97.33 13.64 28.89 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -58.16 129.54 42.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.485 -0.759 . . . . 0.0 110.036 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.83 -53.64 1.54 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -146.19 158.17 43.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.358 -0.839 . . . . 0.0 110.044 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.2 138.38 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.185 0.516 . . . . 0.0 109.874 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -130.51 124.06 31.07 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.516 0.674 . . . . 0.0 109.589 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -101.32 117.73 35.55 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.452 0.644 . . . . 0.0 109.583 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 t -154.76 30.04 0.42 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.601 -0.687 . . . . 0.0 109.237 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -147.51 16.16 1.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.487 -0.758 . . . . 0.0 109.006 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.75 141.11 45.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.592 0.711 . . . . 0.0 110.685 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -146.3 155.41 42.62 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.472 0.653 . . . . 0.0 109.751 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -75.76 140.82 42.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.637 -0.664 . . . . 0.0 109.789 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -112.01 140.32 23.33 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.22 -36.62 29.75 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.253 1.969 . . . . 0.0 111.422 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.3 tt -86.5 -6.4 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.395 -0.815 . . . . 0.0 109.217 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.92 -114.88 0.63 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 pt -127.21 157.09 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.786 -0.832 . . . . 0.0 110.289 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -128.23 131.48 48.8 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.54 0.686 . . . . 0.0 109.396 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mm -98.82 119.21 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.432 0.634 . . . . 0.0 109.457 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.432 ' OD1' HG23 ' A' ' 62' ' ' THR . 98.3 m-20 -123.58 141.93 51.53 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.45 0.643 . . . . 0.0 109.601 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.29 -168.27 38.01 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -145.9 164.93 30.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.88 -0.777 . . . . 0.0 109.955 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -122.75 164.82 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 121.844 0.831 . . . . 0.0 110.7 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 57.98 32.43 21.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.774 0.797 . . . . 0.0 109.783 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 46.56 30.52 1.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.852 -0.53 . . . . 0.0 110.164 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -112.82 111.62 22.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.553 -0.717 . . . . 0.0 109.569 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.04 -32.52 69.82 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.449 0.642 . . . . 0.0 109.493 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.82 -39.01 92.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.806 . . . . 0.0 109.424 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.35 76.13 9.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.456 -0.777 . . . . 0.0 109.442 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.1 m -100.34 159.65 14.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.459 0.647 . . . . 0.0 110.452 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -146.62 150.24 35.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.429 0.633 . . . . 0.0 109.812 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.432 HG23 ' OD1' ' A' ' 50' ' ' ASP . 52.3 m -131.29 135.59 47.43 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.23 145.94 51.01 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.591 0.71 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -93.99 111.59 4.17 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.578 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 13.0 ptmt 26.93 -107.3 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.527 0.679 . . . . 0.0 111.123 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.402 ' HA ' HE22 ' A' ' 17' ' ' GLN . 99.5 m-20 -69.37 42.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.714 0.769 . . . . 0.0 109.666 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 65' ' ' LYS . 2.3 t 51.13 37.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.939 0.876 . . . . 0.0 109.921 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -63.64 -41.96 98.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.655 -0.653 . . . . 0.0 109.362 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 69' ' ' ILE . 11.1 tp -135.09 131.31 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.617 -0.677 . . . . 0.0 109.279 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -124.21 133.43 53.53 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.525 0.679 . . . . 0.0 110.168 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -128.76 152.32 48.58 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.0 m -130.21 152.44 49.63 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.803 0.811 . . . . 0.0 110.161 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 77' ' ' ASP . 17.0 p -78.58 172.3 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.811 0.815 . . . . 0.0 110.65 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -58.64 -44.11 89.97 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.55 0.691 . . . . 0.0 109.9 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.05 -36.81 75.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.447 -0.783 . . . . 0.0 109.567 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.7 tp -81.37 -15.99 53.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.752 0.787 . . . . 0.0 109.43 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' SER . 65.2 t0 -61.12 -47.29 86.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.22 -0.925 . . . . 0.0 110.589 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -59.98 -44.0 94.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.445 -0.784 . . . . 0.0 110.595 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 94.5 mtp -66.51 -38.99 88.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.66 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -75.17 108.31 7.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.48 -0.763 . . . . 0.0 109.983 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -145.24 7.47 1.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -122.52 83.23 47.49 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.5 118.71 2.23 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.776 2.318 . . . . 0.0 113.128 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -80.97 166.0 21.23 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.972 0.891 . . . . 0.0 110.594 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -87.74 -5.91 58.44 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.867 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.65 165.79 14.39 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.715 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.421 ' CD2' HD11 ' A' ' 90' ' ' ILE . 52.9 t80 -62.71 -22.23 66.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.907 -0.761 . . . . 0.0 109.154 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -81.3 -26.82 35.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.552 -0.718 . . . . 0.0 109.937 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -72.48 -40.86 66.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.428 -0.795 . . . . 0.0 110.184 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 87' ' ' TYR . 17.5 pt -60.44 -23.93 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.453 -0.779 . . . . 0.0 110.356 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.2 mt -65.55 -33.58 76.25 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.242 -0.911 . . . . 0.0 109.896 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.454 0.645 . . . . 0.0 110.024 -179.325 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.8 t80 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.252 0.548 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -85.56 -27.25 25.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.795 -0.566 . . . . 0.0 109.519 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -62.69 -44.83 95.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.789 -0.569 . . . . 0.0 109.947 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -65.79 -37.12 85.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.851 -0.531 . . . . 0.0 109.755 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.98 -43.08 99.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.8 -0.563 . . . . 0.0 110.033 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -64.78 -39.96 94.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.781 -0.574 . . . . 0.0 110.362 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.19 -39.48 94.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.712 -0.617 . . . . 0.0 109.561 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.33 -42.25 98.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.81 -0.556 . . . . 0.0 109.68 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.18 -43.3 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -61.88 -43.48 98.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.157 0.503 . . . . 0.0 109.782 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.427 HD11 ' NE2' ' A' ' 27' ' ' HIS . 51.8 tp -62.26 -41.26 98.3 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.324 0.583 . . . . 0.0 109.595 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.533 ' CD1' ' OD1' ' A' ' 28' ' ' ASN . 74.6 t80 -60.14 -46.28 90.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.668 HD21 ' CE2' ' A' ' 61' ' ' PHE . 69.4 mt -63.77 -41.28 98.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.819 -0.551 . . . . 0.0 110.611 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -61.73 -40.51 95.33 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.869 -0.519 . . . . 0.0 110.148 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.427 ' NE2' HD11 ' A' ' 23' ' ' LEU . 27.1 m-70 -86.72 -25.1 24.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.995 -0.441 . . . . 0.0 110.431 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.533 ' OD1' ' CD1' ' A' ' 24' ' ' TYR . 25.6 m120 -97.33 -11.41 24.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.427 -0.795 . . . . 0.0 109.228 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 25' ' ' LEU . 11.1 mt -148.16 88.67 5.39 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.31 -30.84 64.39 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.816 2.344 . . . . 0.0 112.051 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -78.94 6.17 9.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.54 130.67 47.08 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.782 0.801 . . . . 0.0 109.994 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -107.77 -56.06 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -161.46 165.95 27.96 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.503 0.668 . . . . 0.0 109.93 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.427 HG21 ' CZ ' ' A' ' 37' ' ' PHE . 14.8 p -127.59 137.22 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.741 0.782 . . . . 0.0 109.804 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.9 m -119.08 122.84 43.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.525 0.678 . . . . 0.0 109.549 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' ' CG2' ' A' ' 49' ' ' ILE . 72.9 m-85 -106.4 119.77 40.13 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.717 0.77 . . . . 0.0 109.743 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -33.91 0.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' GLU . 8.9 m120 -69.51 -73.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.762 -0.586 . . . . 0.0 109.757 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 39' ' ' ASN . 81.7 tt0 55.5 151.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.924 0.869 . . . . 0.0 111.233 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -160.97 144.92 13.45 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.798 0.809 . . . . 0.0 109.806 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -92.83 140.54 29.4 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.532 0.682 . . . . 0.0 109.917 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -131.1 149.73 74.56 Favored Pre-proline 0 N--CA 1.486 1.352 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.77 -35.16 38.24 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.638 2.225 . . . . 0.0 112.021 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.8 pt -72.7 -4.94 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.53 -118.44 1.42 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 pt -126.55 154.73 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.797 -0.825 . . . . 0.0 110.103 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.2 p -135.87 131.46 35.33 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.759 0.79 . . . . 0.0 109.678 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.482 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 96.8 mt -94.48 127.64 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.538 0.685 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 65.9 t0 -127.58 137.13 52.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.615 0.721 . . . . 0.0 109.786 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -177.08 -151.66 9.25 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -146.09 160.69 41.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.816 -0.814 . . . . 0.0 110.26 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.02 HD11 HD11 ' A' ' 76' ' ' LEU . 51.0 pt -120.31 163.7 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.804 0.812 . . . . 0.0 110.95 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 58.09 33.54 23.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.837 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 45.92 29.26 0.71 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.436 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -111.74 109.57 19.48 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.773 0.797 . . . . 0.0 109.433 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -58.15 -34.21 70.04 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.846 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -62.26 -39.4 92.78 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.515 ' HB3' HD13 ' A' ' 76' ' ' LEU . 66.2 mt -81.69 86.8 6.36 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.562 0.696 . . . . 0.0 110.041 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.5 p -80.3 163.87 23.62 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.872 0.844 . . . . 0.0 110.846 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.668 ' CE2' HD21 ' A' ' 25' ' ' LEU . 52.7 t80 -149.66 131.03 14.69 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.585 0.707 . . . . 0.0 109.672 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.4 m -137.45 132.47 33.42 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.783 0.801 . . . . 0.0 110.058 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.41 142.62 37.48 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.789 0.804 . . . . 0.0 109.736 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -99.28 129.11 9.79 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' GLY . 17.9 tptm 35.36 -122.43 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.08 0.467 . . . . 0.0 110.649 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 68' ' ' LYS . 67.2 t0 -83.36 72.26 10.22 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.377 0.608 . . . . 0.0 109.745 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 66' ' ' ASP . 2.1 t 40.87 28.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.507 0.67 . . . . 0.0 109.345 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ASP . 49.1 mtpt -63.05 -41.94 99.6 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.69 126.17 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.639 0.733 . . . . 0.0 109.82 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -92.71 123.55 36.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.877 0.846 . . . . 0.0 109.718 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -141.29 119.75 12.34 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.809 0.814 . . . . 0.0 109.437 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 p -153.36 165.16 36.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.947 0.88 . . . . 0.0 110.489 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.2 p -75.19 164.35 26.57 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.838 0.828 . . . . 0.0 110.433 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.65 -36.99 83.87 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.6 -34.69 76.07 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.02 HD11 HD11 ' A' ' 53' ' ' ILE . 15.0 tp -91.97 -21.28 20.63 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -65.76 -35.43 80.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 109.754 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -75.03 -12.26 60.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.624 -0.672 . . . . 0.0 110.133 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.784 ' SD ' HD12 ' A' ' 76' ' ' LEU . 82.2 mtp -77.11 -5.18 47.96 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -89.7 120.62 31.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.764 0.792 . . . . 0.0 109.031 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.419 ' CD ' ' N ' ' A' ' 81' ' ' GLN . 23.7 mp0 -97.47 -11.99 23.17 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -133.03 149.95 74.23 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.692 -0.63 . . . . 0.0 109.702 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.62 149.57 10.04 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.503 2.135 . . . . 0.0 112.393 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -64.55 136.8 57.4 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.654 0.74 . . . . 0.0 110.285 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -128.65 143.89 51.04 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.053 0.93 . . . . 0.0 110.355 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.21 160.24 52.7 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -60.25 -45.33 93.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.234 -0.568 . . . . 0.0 109.938 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.68 -36.97 86.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.577 -0.702 . . . . 0.0 109.695 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -62.22 -48.4 80.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.824 -0.547 . . . . 0.0 110.0 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.9 pt -69.59 -32.49 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.767 -0.583 . . . . 0.0 109.518 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.24 -44.23 92.46 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.863 -0.523 . . . . 0.0 109.733 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.323 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -62.35 -43.81 97.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.85 -0.531 . . . . 0.0 110.37 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -62.52 -42.16 99.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.444 -0.785 . . . . 0.0 110.163 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.81 -39.15 87.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.797 -0.565 . . . . 0.0 110.272 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 21' ' ' VAL . 20.1 mm100 -66.0 -39.71 90.51 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.716 . . . . 0.0 109.751 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HZ2' ' CB ' ' A' ' 37' ' ' PHE . 68.4 mttm -62.98 -43.16 99.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.604 -0.685 . . . . 0.0 109.923 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.59 -43.38 80.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.774 -0.579 . . . . 0.0 110.06 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -65.47 -42.52 92.16 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.0 109.915 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 17' ' ' GLN . 55.5 t -64.56 -43.76 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.845 -0.535 . . . . 0.0 109.913 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -61.09 -48.53 81.28 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.579 HD11 ' NE2' ' A' ' 27' ' ' HIS . 58.5 tp -65.93 -40.81 91.74 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 90' ' ' ILE . 36.6 t80 -61.07 -48.77 80.2 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.13 -41.87 94.41 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.315 0.579 . . . . 0.0 109.834 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.1 -44.0 91.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.884 -0.51 . . . . 0.0 110.68 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.579 ' NE2' HD11 ' A' ' 23' ' ' LEU . 16.4 m170 -68.86 -37.06 78.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.373 -0.83 . . . . 0.0 110.318 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.461 HD21 ' CG ' ' A' ' 84' ' ' ARG . 1.3 m-20 -87.2 -5.15 59.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -138.2 94.54 10.97 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.06 -18.51 27.4 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.321 2.014 . . . . 0.0 111.278 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.98 7.44 44.05 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CG ' ' N ' ' A' ' 33' ' ' ASN . 61.1 t80 -54.82 158.19 2.8 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.704 0.764 . . . . 0.0 110.143 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.451 ' N ' ' CG ' ' A' ' 32' ' ' PHE . 65.4 t30 -145.31 -52.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -149.8 151.35 33.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.818 . . . . 0.0 110.095 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.2 137.15 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.534 0.683 . . . . 0.0 109.834 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.467 HG21 ' OH ' ' A' ' 52' ' ' TYR . 87.4 m -116.96 112.23 20.71 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.621 0.724 . . . . 0.0 109.117 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' O ' HG23 ' A' ' 38' ' ' THR . 74.1 m-85 -80.6 145.63 31.63 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.485 0.659 . . . . 0.0 110.303 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 50' ' ' ASP . 25.3 p -155.45 106.45 2.54 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.712 0.767 . . . . 0.0 109.655 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 38' ' ' THR . 9.3 m120 -49.99 -105.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.383 0.611 . . . . 0.0 109.989 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 41' ' ' GLU . 81.6 tt0 55.83 113.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.48 0.657 . . . . 0.0 110.336 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 42' ' ' PHE . 5.5 tm-20 79.23 141.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.466 0.65 . . . . 0.0 110.395 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.502 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 96.9 m-85 -135.06 151.92 51.21 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.835 0.826 . . . . 0.0 110.372 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.51 157.08 89.61 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -37.48 -66.74 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.904 2.403 . . . . 0.0 112.598 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.9 mm -108.01 -26.71 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.72 -160.63 34.18 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.5 pt -120.44 146.27 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.694 0.759 . . . . 0.0 109.818 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.46 ' H ' ' HA ' ' A' ' 42' ' ' PHE . 10.1 t -111.47 128.46 56.01 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.551 0.691 . . . . 0.0 109.532 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -115.27 127.3 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.672 0.748 . . . . 0.0 109.767 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 59.4 t0 -113.89 154.14 28.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.846 0.831 . . . . 0.0 109.667 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -179.58 -175.23 46.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.1 p90 -149.91 166.22 30.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.874 -0.78 . . . . 0.0 110.436 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 pt -118.83 158.86 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 CA-C-O 121.89 0.852 . . . . 0.0 110.849 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 66.0 m-80 56.75 36.87 28.31 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.194 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 25.1 p30 45.04 23.28 0.09 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.084 0.469 . . . . 0.0 110.535 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -105.67 113.97 27.85 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.66 0.743 . . . . 0.0 109.836 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.23 -30.64 69.54 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -62.17 -38.7 90.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.549 -0.72 . . . . 0.0 109.381 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.4 mt -83.56 63.45 7.38 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.6 p -89.49 160.86 16.53 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.121 0.962 . . . . 0.0 110.961 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -151.9 150.91 30.59 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.468 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.7 m -134.86 134.1 40.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.598 0.713 . . . . 0.0 110.069 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.33 135.85 54.39 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.844 0.83 . . . . 0.0 109.564 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -100.22 89.06 0.81 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.405 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 65.6 tttm 57.89 -72.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 122.286 -0.538 . . . . 0.0 110.259 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 64' ' ' GLY . 98.1 m-20 -89.46 129.91 35.88 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.864 0.84 . . . . 0.0 110.21 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 67' ' ' VAL . 46.2 t -62.6 -0.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 66' ' ' ASP . 66.0 tttm -62.92 -41.59 99.51 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.65 111.13 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.808 0.813 . . . . 0.0 108.897 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -140.8 126.93 19.58 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.733 0.778 . . . . 0.0 110.333 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 p -84.01 168.32 16.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.493 0.663 . . . . 0.0 109.535 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.6 p -152.75 155.91 38.1 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.855 0.836 . . . . 0.0 110.704 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.2 p -75.7 166.03 24.16 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.738 0.78 . . . . 0.0 110.46 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.92 -44.15 97.37 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.027 0.442 . . . . 0.0 109.813 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.435 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.5 mp0 -69.24 -39.14 78.67 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.47 0.653 . . . . 0.0 109.844 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.44 -34.9 77.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.749 -0.594 . . . . 0.0 109.513 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -61.93 -33.33 74.05 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -73.26 -38.25 66.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.532 -0.73 . . . . 0.0 109.863 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.4 mmm -66.22 -65.29 0.7 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.602 -0.687 . . . . 0.0 110.55 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -60.04 149.27 32.77 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.764 0.792 . . . . 0.0 110.38 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -80.39 -105.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.34 0.591 . . . . 0.0 110.503 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -104.44 147.3 34.16 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.773 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.6 145.89 53.51 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.36 2.04 . . . . 0.0 112.073 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.461 ' CG ' HD21 ' A' ' 28' ' ' ASN . 74.4 mmt-85 -86.55 165.99 15.79 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.881 0.848 . . . . 0.0 110.671 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.66 -6.06 58.42 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.02 176.72 25.01 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.638 ' CD1' HD11 ' A' ' 90' ' ' ILE . 61.5 t80 -63.39 -37.14 86.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.922 -0.752 . . . . 0.0 109.25 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.69 -20.67 62.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.566 -0.709 . . . . 0.0 109.207 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -72.32 -48.67 40.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.634 -0.666 . . . . 0.0 109.741 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 87' ' ' TYR . 14.3 pt -61.84 -41.18 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.623 -0.673 . . . . 0.0 109.869 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.554 HD11 ' CE2' ' A' ' 87' ' ' TYR . 12.0 mt -65.41 -40.28 93.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.577 -0.702 . . . . 0.0 109.721 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.795 -0.566 . . . . 0.0 109.813 -179.286 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.6 t80 . . . . . 0 N--CA 1.498 1.952 0 CA-C-O 121.119 0.485 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -63.04 -43.48 98.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.528 -0.732 . . . . 0.0 109.62 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -64.3 -42.25 96.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.695 -0.628 . . . . 0.0 110.08 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.74 -37.91 85.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.458 -0.776 . . . . 0.0 110.195 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.554 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 48.9 tp60 -62.93 -42.59 99.85 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -63.71 -40.38 96.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.472 -0.768 . . . . 0.0 109.369 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -63.4 -41.51 98.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.537 -0.727 . . . . 0.0 110.085 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -61.38 -42.05 98.09 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.508 -0.745 . . . . 0.0 109.847 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.01 -40.89 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.433 -0.792 . . . . 0.0 109.267 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 m -59.69 -43.46 94.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.642 -0.661 . . . . 0.0 109.247 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.24 -41.43 98.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.509 -0.744 . . . . 0.0 109.831 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.508 ' OH ' ' CE1' ' A' ' 70' ' ' PHE . 90.1 t80 -60.28 -49.11 78.92 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.3 mt -68.18 -41.2 81.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.634 -0.666 . . . . 0.0 110.641 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -65.05 -43.33 92.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.405 -0.809 . . . . 0.0 110.442 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -80.28 -15.94 55.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.386 -0.821 . . . . 0.0 110.456 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.506 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 8.3 m120 -104.2 -10.24 18.06 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.258 -0.901 . . . . 0.0 108.88 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 mt -144.11 88.11 7.63 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 32' ' ' PHE . 53.2 Cg_exo -53.63 -30.89 57.51 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.51 2.14 . . . . 0.0 111.271 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -72.66 13.09 0.4 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' PRO . 29.1 t80 -61.22 130.38 45.95 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.689 0.757 . . . . 0.0 110.236 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -118.96 -61.52 1.63 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 t -146.12 164.54 31.85 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.515 0.674 . . . . 0.0 109.935 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.5 138.16 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.544 0.688 . . . . 0.0 109.624 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.2 m -126.76 115.24 19.07 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.66 0.743 . . . . 0.0 109.551 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -94.08 126.61 39.41 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.759 0.79 . . . . 0.0 109.563 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.34 86.1 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -177.43 -64.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 41.38 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.592 -0.693 . . . . 0.0 110.053 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -122.4 147.34 46.42 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.996 0.903 . . . . 0.0 110.034 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.528 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 53.0 p90 -88.81 120.24 30.03 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.503 0.668 . . . . 0.0 109.736 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -107.41 154.74 40.48 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -46.38 -40.76 22.77 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.504 2.136 . . . . 0.0 111.907 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 46' ' ' GLY . 21.4 tt -70.02 -38.93 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.76 . . . . 0.0 109.615 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 173.25 -107.66 0.25 Allowed Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -121.23 143.81 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.626 -0.926 . . . . 0.0 110.17 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.0 t -119.26 134.91 54.95 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.653 0.739 . . . . 0.0 110.09 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.16 129.42 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.681 0.753 . . . . 0.0 109.359 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.5 t0 -133.49 142.4 48.23 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.831 0.824 . . . . 0.0 109.687 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -173.5 -165.16 29.89 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -142.39 165.09 28.38 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.678 -0.895 . . . . 0.0 110.274 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.5 pt -122.42 167.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.934 0.873 . . . . 0.0 110.725 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' ASP . 69.1 m-80 57.31 34.25 24.46 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.662 0.744 . . . . 0.0 109.441 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 44.56 24.44 0.1 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 54' ' ' ASN . 99.5 m-20 -108.17 111.1 22.93 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.668 0.747 . . . . 0.0 109.293 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.477 ' HB3' ' HZ3' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -59.22 -31.58 69.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.727 -0.608 . . . . 0.0 110.102 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -61.96 -38.77 89.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.45 -0.781 . . . . 0.0 109.495 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -82.74 75.26 9.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.474 -0.766 . . . . 0.0 109.534 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 m -95.85 156.13 16.46 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.922 0.867 . . . . 0.0 110.397 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -147.12 157.03 43.47 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.628 0.728 . . . . 0.0 109.923 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.1 m -141.29 138.87 33.49 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.692 -0.63 . . . . 0.0 109.873 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.94 144.62 31.16 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.649 0.737 . . . . 0.0 109.528 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -98.24 128.7 9.65 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.554 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 15.1 ptmt 24.76 -114.18 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.461 0.648 . . . . 0.0 111.238 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.454 ' C ' ' N ' ' A' ' 68' ' ' LYS . 67.2 t0 -71.54 66.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.158 0.98 . . . . 0.0 109.955 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 50.43 12.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.545 0.688 . . . . 0.0 109.455 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 64' ' ' GLY . 68.7 mmtt -61.43 115.57 3.99 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 122.051 0.929 . . . . 0.0 109.82 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.6 mt 55.16 115.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.87 0.843 . . . . 0.0 109.883 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.508 ' CE1' ' OH ' ' A' ' 24' ' ' TYR . 47.2 p90 -139.26 153.9 47.88 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.877 0.846 . . . . 0.0 110.203 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 p -141.74 160.86 39.32 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.621 0.724 . . . . 0.0 109.47 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.2 m -145.68 155.21 42.85 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.977 0.894 . . . . 0.0 110.414 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -65.88 163.03 17.78 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.943 0.878 . . . . 0.0 110.371 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.1 mp0 -58.5 -48.9 79.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.545 -0.722 . . . . 0.0 109.743 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mp0 -64.54 -42.04 95.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.622 -0.674 . . . . 0.0 110.066 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.17 -38.76 85.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.595 -0.691 . . . . 0.0 110.034 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -63.32 -33.67 76.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.411 -0.806 . . . . 0.0 109.402 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.01 -12.32 60.88 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.38 -0.825 . . . . 0.0 109.973 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.7 mtp -85.09 -8.21 58.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.26 -0.9 . . . . 0.0 109.38 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -63.64 135.91 57.11 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.591 0.71 . . . . 0.0 110.006 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -111.9 -25.04 9.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -120.13 153.7 55.54 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.75 179.63 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.982 2.455 . . . . 0.0 113.094 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.46 ' NH1' ' CZ ' ' A' ' 70' ' ' PHE . 95.5 mtt-85 -63.86 126.72 28.54 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.067 0.937 . . . . 0.0 110.597 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -136.88 147.51 46.52 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.734 0.778 . . . . 0.0 109.911 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.88 164.44 44.67 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.567 ' CE2' HD11 ' A' ' 91' ' ' LEU . 71.8 t80 -61.5 -44.0 97.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.804 -0.821 . . . . 0.0 109.133 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -70.13 -31.11 68.49 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.476 -0.765 . . . . 0.0 109.803 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.86 -45.51 77.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 91' ' ' LEU . 28.8 pt -66.16 -35.91 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.43 -0.794 . . . . 0.0 109.57 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.567 HD11 ' CE2' ' A' ' 87' ' ' TYR . 35.7 mt -63.36 -42.41 98.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.524 ' CZ ' ' NE2' ' A' ' 17' ' ' GLN . 91.3 t80 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.645 0.736 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -65.31 -36.64 84.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.512 -0.742 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.53 -41.33 98.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.148 -0.97 . . . . 0.0 109.838 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.62 -39.97 88.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.58 -0.7 . . . . 0.0 110.445 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.524 ' NE2' ' CZ ' ' A' ' 13' ' ' PHE . 96.6 mm-40 -64.78 -40.72 95.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 109.897 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.04 -40.99 97.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.71 -41.83 98.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.861 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -64.1 -42.43 96.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.745 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.9 -43.08 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.444 -0.785 . . . . 0.0 109.619 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.8 m -61.29 -44.65 96.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.497 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.58 HD11 ' NE2' ' A' ' 27' ' ' HIS . 49.1 tp -62.88 -42.81 99.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.367 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.507 ' CE1' ' OD1' ' A' ' 28' ' ' ASN . 58.7 t80 -61.05 -47.85 84.46 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.492 0.663 . . . . 0.0 109.712 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.01 -39.6 93.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -0.791 . . . . 0.0 109.703 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -59.75 -45.51 92.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.877 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.58 ' NE2' HD11 ' A' ' 23' ' ' LEU . 32.9 m-70 -74.47 -32.78 62.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.826 . . . . 0.0 109.757 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.507 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 32.1 m120 -87.19 -2.9 58.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.379 -0.826 . . . . 0.0 109.608 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.4 mt -146.76 89.85 5.63 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.229 -0.919 . . . . 0.0 109.034 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -55.38 -30.19 71.77 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.454 2.103 . . . . 0.0 111.34 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -84.98 16.15 3.59 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 21.8 t80 -57.57 128.99 39.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.493 -0.755 . . . . 0.0 110.463 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.456 ' ND2' ' OD1' ' A' ' 54' ' ' ASN . 99.9 m-20 -113.8 -64.96 1.24 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.562 0.696 . . . . 0.0 109.331 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -150.82 158.73 44.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.752 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.13 135.53 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.586 -0.696 . . . . 0.0 109.425 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -124.64 123.8 40.83 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.661 0.743 . . . . 0.0 109.368 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -96.31 137.54 35.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.647 -0.658 . . . . 0.0 109.241 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.6 p -147.12 -35.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 108.805 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -103.41 145.45 29.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.28 -0.887 . . . . 0.0 110.356 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -169.05 143.94 3.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.377 -0.827 . . . . 0.0 109.623 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -139.07 151.8 47.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.443 -0.786 . . . . 0.0 109.321 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -90.59 118.84 30.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.233 -0.917 . . . . 0.0 109.903 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.5 OUTLIER -90.43 158.07 43.77 Favored Pre-proline 0 C--N 1.306 -1.326 0 O-C-N 121.5 -0.75 . . . . 0.0 109.975 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.23 -27.12 41.48 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 123.099 2.532 . . . . 0.0 110.417 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -102.56 -8.23 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 171.06 -144.42 8.26 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.441 ' HA ' ' H ' ' A' ' 43' ' ' ASN . 42.0 pt -124.82 152.31 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.558 -0.966 . . . . 0.0 109.485 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.4 m -117.43 127.45 54.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.74 130.36 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.619 0.723 . . . . 0.0 109.36 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -130.06 125.84 36.2 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.588 0.709 . . . . 0.0 109.225 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.31 -161.46 10.36 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -144.15 160.88 40.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.983 . . . . 0.0 109.874 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.6 pt -119.76 167.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-O 121.601 0.715 . . . . 0.0 110.728 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.456 ' OD1' ' ND2' ' A' ' 33' ' ' ASN . 66.4 m-80 59.11 32.92 22.56 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.629 0.728 . . . . 0.0 109.55 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 46.87 32.23 1.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.51 -0.744 . . . . 0.0 109.564 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -126.99 103.93 7.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.604 -0.685 . . . . 0.0 109.321 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -56.12 -17.13 6.32 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.416 0.627 . . . . 0.0 109.543 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -63.9 -38.32 90.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.35 -0.844 . . . . 0.0 108.889 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.5 mt -88.24 73.91 8.82 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.2 m -87.92 154.75 20.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.821 0.82 . . . . 0.0 110.771 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -147.62 158.82 44.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.722 -0.612 . . . . 0.0 109.587 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.2 m -134.11 136.53 43.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.771 . . . . 0.0 109.706 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.49 141.07 48.62 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 67' ' ' VAL . . . -97.93 115.71 5.34 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 64' ' ' GLY . 88.6 tttt 26.06 -95.17 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.389 0.614 . . . . 0.0 111.795 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -85.71 45.31 1.19 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.356 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 64' ' ' GLY . 2.1 t 51.93 35.3 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.164 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -62.83 -41.32 99.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.825 . . . . 0.0 109.008 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.0 tp -127.57 136.32 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -126.46 129.78 49.37 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.645 0.736 . . . . 0.0 109.835 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 t -137.3 149.06 46.81 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.2 p -138.89 157.04 46.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 0.0 110.357 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.0 p -76.02 171.12 15.0 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.866 0.841 . . . . 0.0 110.758 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -59.37 -41.01 88.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.681 -0.637 . . . . 0.0 109.947 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.45 -48.79 59.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.958 . . . . 0.0 109.886 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.69 -22.06 66.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.34 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -62.41 -36.18 81.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.559 -0.713 . . . . 0.0 110.077 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -62.68 -45.06 94.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 0.0 110.53 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 98.6 mtp -68.74 -38.03 79.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.09 -1.006 . . . . 0.0 109.482 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.512 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 72.4 t80 -75.68 119.39 19.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 110.03 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.401 ' NE2' ' O ' ' A' ' 80' ' ' PHE . 99.6 mm-40 -142.93 2.19 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.512 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 47.9 mt-10 -102.66 130.12 24.54 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.471 -0.768 . . . . 0.0 109.561 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -47.41 140.78 15.2 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.473 2.115 . . . . 0.0 113.151 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -76.97 140.07 40.32 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.6 0.714 . . . . 0.0 110.256 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -137.66 147.96 45.34 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.732 0.777 . . . . 0.0 109.698 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.47 161.15 12.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -62.46 -42.48 99.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.795 -0.827 . . . . 0.0 109.194 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 34.5 p-10 -68.54 -31.18 70.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.442 -0.786 . . . . 0.0 109.757 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 80.1 mm-40 -64.58 -48.6 74.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.451 -0.781 . . . . 0.0 109.848 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 91' ' ' LEU . 25.9 pt -68.18 -37.69 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.442 -0.786 . . . . 0.0 109.196 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.426 ' N ' HG13 ' A' ' 90' ' ' ILE . 57.9 tp -63.47 -41.94 98.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.226 -179.963 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.403 ' O ' ' OE1' ' A' ' 17' ' ' GLN . 79.2 t80 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.25 0.547 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -64.27 -40.1 95.3 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.351 0.596 . . . . 0.0 109.86 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -62.59 -40.72 97.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.676 -0.64 . . . . 0.0 109.931 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.6 -38.75 87.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.518 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 1.5 mp0 -64.09 -40.49 96.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.524 -0.735 . . . . 0.0 109.557 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -64.66 -40.21 95.03 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.249 0.547 . . . . 0.0 109.956 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -65.62 -41.01 93.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.705 -0.622 . . . . 0.0 110.052 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.495 ' NZ ' ' CE2' ' A' ' 87' ' ' TYR . 68.2 mttm -63.08 -44.29 96.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.605 -0.684 . . . . 0.0 110.101 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.48 -44.12 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.653 -0.654 . . . . 0.0 109.984 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.1 m -63.58 -43.8 95.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.574 -0.704 . . . . 0.0 109.841 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.7 -43.16 99.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.724 -0.61 . . . . 0.0 110.317 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.482 ' CE1' ' OD1' ' A' ' 28' ' ' ASN . 66.8 t80 -62.35 -47.83 82.5 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.335 0.588 . . . . 0.0 109.803 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.46 -41.45 96.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.616 -0.678 . . . . 0.0 109.895 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.17 -43.98 92.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.769 -0.582 . . . . 0.0 109.931 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -68.66 -37.88 79.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.751 -0.593 . . . . 0.0 110.236 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.482 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 9.3 m120 -90.79 -0.71 57.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.4 -0.812 . . . . 0.0 109.322 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.4 mt -143.81 83.6 10.37 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 109.035 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -54.88 -26.64 49.51 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.664 2.243 . . . . 0.0 111.284 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -78.38 0.36 25.96 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -59.0 129.14 40.75 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.723 0.773 . . . . 0.0 110.128 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -123.84 -57.82 1.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -147.49 155.58 42.03 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.73 0.776 . . . . 0.0 110.151 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.39 140.43 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.434 0.635 . . . . 0.0 109.41 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.9 m -128.67 125.9 39.02 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.898 0.856 . . . . 0.0 110.133 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -93.76 134.58 35.95 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 t -172.9 55.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.662 -0.649 . . . . 0.0 109.447 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' GLU . 24.3 t-20 -173.31 133.68 0.51 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.556 -0.715 . . . . 0.0 110.417 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' ASN . 96.9 mt-10 58.21 140.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.755 0.788 . . . . 0.0 110.683 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -144.54 -90.34 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.652 -0.655 . . . . 0.0 109.476 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -75.19 147.36 40.46 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.853 0.835 . . . . 0.0 110.243 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -173.96 168.1 2.26 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 46' ' ' GLY . 52.3 Cg_exo -50.91 -39.43 58.88 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.436 2.091 . . . . 0.0 111.814 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.5 pt -76.51 28.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.518 0.675 . . . . 0.0 109.195 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 81.82 -99.42 2.0 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.9 pt -119.85 144.14 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.859 0.838 . . . . 0.0 109.948 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.7 m -119.66 122.44 41.51 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.695 0.759 . . . . 0.0 109.831 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.02 125.89 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.929 0.871 . . . . 0.0 109.382 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.6 t0 -142.9 139.85 30.95 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.01 0.91 . . . . 0.0 109.832 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -167.22 -162.62 19.37 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -140.46 161.72 37.05 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.908 -0.76 . . . . 0.0 110.628 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 pt -118.73 156.6 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 121.959 0.885 . . . . 0.0 110.689 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 56.3 33.89 23.09 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.048 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 47.95 32.68 2.94 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.17 0.51 . . . . 0.0 110.0 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -111.79 109.65 19.6 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.72 0.771 . . . . 0.0 109.317 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -57.28 -34.51 68.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.905 -0.497 . . . . 0.0 109.98 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.57 -39.25 93.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.599 -0.688 . . . . 0.0 109.742 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.8 76.95 9.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.511 -0.743 . . . . 0.0 109.583 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.8 p -112.5 156.59 22.35 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.817 0.818 . . . . 0.0 110.478 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.404 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 32.1 p90 -150.49 158.45 44.17 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.461 0.648 . . . . 0.0 109.595 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.9 m -136.08 132.15 35.78 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.683 0.754 . . . . 0.0 110.135 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.07 140.95 42.37 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.832 0.825 . . . . 0.0 109.617 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 65' ' ' LYS . . . -109.08 140.2 15.55 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 64' ' ' GLY . 53.6 mtpt 40.46 100.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.298 0.57 . . . . 0.0 110.598 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.504 ' OD1' ' NE2' ' A' ' 17' ' ' GLN . 99.0 m-20 57.93 -88.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.404 0.621 . . . . 0.0 109.712 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.79 13.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 69' ' ' ILE . 68.5 mttm -70.51 131.45 44.04 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.872 0.844 . . . . 0.0 109.859 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.4 mt 52.59 103.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.645 0.736 . . . . 0.0 109.41 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -138.25 153.86 49.09 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.891 0.853 . . . . 0.0 110.29 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.1 t -136.87 151.02 48.62 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.76 0.79 . . . . 0.0 109.614 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.2 t -134.66 150.18 50.61 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.822 0.82 . . . . 0.0 110.101 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 p -75.89 166.8 22.98 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.883 0.849 . . . . 0.0 110.221 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.66 -45.39 92.19 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.215 0.531 . . . . 0.0 109.639 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -65.28 -45.71 83.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.644 -0.66 . . . . 0.0 109.657 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.535 HD12 ' SD ' ' A' ' 79' ' ' MET . 58.6 tp -69.0 -28.94 67.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.83 -36.4 83.38 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 109.407 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -75.68 -7.54 54.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.449 -0.782 . . . . 0.0 109.914 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.535 ' SD ' HD12 ' A' ' 76' ' ' LEU . 77.0 mtp -82.42 -8.79 59.62 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -69.1 138.5 54.35 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.62 0.724 . . . . 0.0 109.464 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -128.04 -45.45 1.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.49 154.96 39.58 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.626 -0.671 . . . . 0.0 109.581 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -53.31 145.55 44.39 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.363 2.042 . . . . 0.0 112.649 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -77.36 138.01 39.07 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.781 0.8 . . . . 0.0 109.969 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.86 150.47 47.17 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.858 0.837 . . . . 0.0 110.116 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.1 163.4 25.68 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.643 ' CE2' HD11 ' A' ' 91' ' ' LEU . 78.5 t80 -60.57 -44.7 95.9 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.6 0.714 . . . . 0.0 109.681 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 36.6 p-10 -68.43 -32.87 73.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.572 -0.705 . . . . 0.0 109.902 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 79.8 mm-40 -66.78 -45.34 78.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.664 -0.647 . . . . 0.0 110.447 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.6 pt -65.92 -35.52 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.512 -0.742 . . . . 0.0 109.631 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.643 HD11 ' CE2' ' A' ' 87' ' ' TYR . 34.3 mt -63.02 -42.13 99.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.553 -0.717 . . . . 0.0 109.748 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.831 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.185 0.517 . . . . 0.0 110.132 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -62.86 -42.2 99.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.643 -0.661 . . . . 0.0 109.931 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.21 -40.45 97.51 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.368 0.604 . . . . 0.0 109.696 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.41 -39.23 85.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.674 -0.641 . . . . 0.0 109.587 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.442 HE22 HD11 ' A' ' 47' ' ' ILE . 86.4 mt-30 -63.38 -39.71 95.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.383 -0.823 . . . . 0.0 108.946 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -62.66 -42.12 99.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.825 -0.547 . . . . 0.0 110.017 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -66.88 -39.74 87.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.628 -0.67 . . . . 0.0 109.546 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.8 -43.54 96.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.752 -0.592 . . . . 0.0 109.541 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.4 t -65.39 -42.83 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.841 -0.537 . . . . 0.0 109.577 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -59.74 -45.25 92.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.708 . . . . 0.0 109.263 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.94 -42.3 97.37 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.422 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 64.9 t80 -61.9 -46.92 87.27 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.46 ' CD2' ' CE2' ' A' ' 61' ' ' PHE . 92.6 mt -64.73 -39.3 93.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.564 -0.71 . . . . 0.0 109.883 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -60.72 -44.41 96.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.66 -0.65 . . . . 0.0 109.628 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -69.06 -41.98 76.87 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.658 -0.651 . . . . 0.0 110.186 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.422 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 44.2 m-80 -65.02 -41.36 95.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.432 -0.792 . . . . 0.0 109.338 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.7 mt -114.36 115.28 44.94 Favored Pre-proline 0 N--CA 1.485 1.307 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.5 -17.61 23.5 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.286 1.991 . . . . 0.0 110.652 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -95.87 8.87 42.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 34.9 t80 -51.65 126.85 18.8 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.82 0.819 . . . . 0.0 109.888 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -113.35 -65.88 1.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -147.17 160.56 42.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.591 -0.693 . . . . 0.0 110.319 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.9 p -140.16 139.73 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.4 0.619 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -129.21 125.66 37.44 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.558 0.694 . . . . 0.0 109.318 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 49' ' ' ILE . 59.2 m-85 -91.4 142.88 27.2 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.653 0.74 . . . . 0.0 109.732 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.461 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -173.28 123.12 0.39 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.721 -0.612 . . . . 0.0 109.647 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 38' ' ' THR . 1.1 m120 82.22 157.22 0.13 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.911 0.862 . . . . 0.0 110.983 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 69.53 101.38 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.58 0.705 . . . . 0.0 109.733 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -144.12 -22.08 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -115.85 133.69 55.77 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.77 0.795 . . . . 0.0 110.108 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -170.57 154.98 4.77 Favored Pre-proline 0 N--CA 1.487 1.404 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 46' ' ' GLY . 71.4 Cg_exo -44.85 -36.55 11.01 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.37 2.047 . . . . 0.0 112.034 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 mt -78.93 34.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.811 0.815 . . . . 0.0 109.028 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 80.33 -106.42 2.49 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.442 HD11 HE22 ' A' ' 17' ' ' GLN . 46.3 pt -118.31 149.65 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.652 0.739 . . . . 0.0 109.675 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.9 m -127.96 155.25 44.55 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.799 0.809 . . . . 0.0 110.457 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 96.7 mt -122.92 125.51 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.555 0.693 . . . . 0.0 109.395 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -128.69 130.54 47.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.67 0.748 . . . . 0.0 109.598 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.01 -163.14 13.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -143.11 162.5 35.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.748 -0.854 . . . . 0.0 109.685 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 pt -122.54 162.43 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.805 0.812 . . . . 0.0 110.438 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.83 30.65 19.36 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.432 0.634 . . . . 0.0 109.736 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 48.89 33.02 4.1 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.39 0.614 . . . . 0.0 109.624 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -112.9 111.17 21.73 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.416 0.627 . . . . 0.0 109.501 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -59.09 -33.02 70.34 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -62.47 -39.29 92.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.9 mt -84.52 83.03 8.15 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.408 0.623 . . . . 0.0 109.764 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.632 ' O ' HD23 ' A' ' 76' ' ' LEU . 88.2 p -95.9 148.32 22.74 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.433 0.635 . . . . 0.0 110.069 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.728 ' CD2' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -131.75 136.9 47.95 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.48 0.657 . . . . 0.0 109.985 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.8 m -128.42 129.73 46.6 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.731 0.777 . . . . 0.0 110.061 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.29 149.22 40.97 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.674 0.75 . . . . 0.0 109.376 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -90.8 135.61 12.94 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 39.84 -109.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.402 0.62 . . . . 0.0 110.579 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 67' ' ' VAL . 20.1 p-10 -82.15 -67.15 0.81 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.682 -0.636 . . . . 0.0 109.682 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.528 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 2.7 t -146.19 11.83 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.732 . . . . 0.0 109.032 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 69' ' ' ILE . 88.8 tttt -65.77 117.93 8.9 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.291 -0.881 . . . . 0.0 110.414 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.0 mt 56.94 125.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.793 0.806 . . . . 0.0 110.016 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -139.07 129.83 26.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.419 -0.801 . . . . 0.0 110.387 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.7 m -126.83 154.57 44.15 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.582 0.706 . . . . 0.0 109.412 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.9 p -153.11 163.97 38.89 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.751 0.786 . . . . 0.0 110.46 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -67.98 163.87 21.24 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.817 0.817 . . . . 0.0 110.158 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -57.8 -48.82 78.61 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.759 -0.588 . . . . 0.0 109.584 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.25 -40.73 98.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.773 -0.579 . . . . 0.0 109.674 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.728 HD21 ' CD2' ' A' ' 61' ' ' PHE . 36.0 tp -76.42 -22.58 54.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.525 -0.734 . . . . 0.0 110.252 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -72.06 -36.66 69.64 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.443 -0.785 . . . . 0.0 109.402 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -79.1 -8.01 58.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.586 -0.696 . . . . 0.0 110.334 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.4 mmm -63.89 -42.31 97.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.352 -0.842 . . . . 0.0 109.691 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.497 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 31.0 p90 -102.33 125.66 49.11 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.756 0.789 . . . . 0.0 109.72 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -97.68 -6.72 32.48 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -133.66 83.97 46.43 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.485 -0.759 . . . . 0.0 109.445 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.81 138.13 76.26 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 123.04 2.494 . . . . 0.0 112.97 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.592 HH21 HG22 ' A' ' 90' ' ' ILE . 21.0 mmm180 -99.04 162.97 12.77 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.606 0.717 . . . . 0.0 110.358 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -91.04 -131.64 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.31 0.576 . . . . 0.0 111.281 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.42 170.27 50.36 Favored Glycine 0 N--CA 1.498 2.803 0 CA-C-O 122.061 0.812 . . . . 0.0 111.971 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -61.76 -43.12 99.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.945 -0.738 . . . . 0.0 110.436 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.56 -38.76 92.35 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.447 -0.783 . . . . 0.0 109.635 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -60.84 -50.04 75.04 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.811 -0.556 . . . . 0.0 109.91 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.592 HG22 HH21 ' A' ' 84' ' ' ARG . 27.7 pt -69.24 -30.06 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.331 -0.856 . . . . 0.0 109.398 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.5 tp -64.24 -42.52 96.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.557 0.694 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -61.79 -33.32 73.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.495 -0.753 . . . . 0.0 109.632 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.71 -40.75 98.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.497 -0.752 . . . . 0.0 109.576 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.71 -39.61 88.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.483 -0.761 . . . . 0.0 109.628 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.45 -39.03 93.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.433 -0.792 . . . . 0.0 109.578 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -63.42 -41.47 98.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.588 0.709 . . . . 0.0 109.49 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -65.81 -42.4 90.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.626 -0.671 . . . . 0.0 109.975 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -63.66 -44.57 93.4 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.793 0.806 . . . . 0.0 110.036 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.21 -41.33 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.579 -0.701 . . . . 0.0 109.848 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -55.78 -46.22 77.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.478 -0.764 . . . . 0.0 110.029 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.6 tp -64.29 -42.4 96.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.551 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.621 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 89.1 t80 -59.96 -44.18 94.6 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.728 0.775 . . . . 0.0 109.317 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.85 -43.05 99.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.586 -0.696 . . . . 0.0 110.349 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.41 -43.44 97.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 0.0 110.537 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.688 ' CG ' HD11 ' A' ' 90' ' ' ILE . 33.8 m-70 -75.34 -32.11 60.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 110.992 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.621 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 29.3 m-80 -89.25 -6.94 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.102 -0.998 . . . . 0.0 109.47 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.3 mt -137.41 105.51 8.5 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.585 -0.697 . . . . 0.0 109.15 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.99 -16.49 32.38 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.436 2.09 . . . . 0.0 111.782 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -95.96 11.42 34.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.519 -0.738 . . . . 0.0 109.419 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -56.67 132.68 52.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.3 -0.875 . . . . 0.0 109.818 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -133.46 -48.69 0.83 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -148.31 154.71 40.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.293 -0.879 . . . . 0.0 110.219 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.89 137.13 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.307 0.575 . . . . 0.0 109.557 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -128.41 121.86 30.03 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.588 0.708 . . . . 0.0 109.162 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -97.39 122.83 40.89 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.6 p -106.37 -22.39 12.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.709 -0.619 . . . . 0.0 109.68 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -110.49 145.76 37.14 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.296 -0.878 . . . . 0.0 110.561 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -166.02 80.49 0.28 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -153.5 -161.91 1.36 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.429 -0.795 . . . . 0.0 109.777 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 42' ' ' PHE . 54.3 p90 -102.47 127.34 49.55 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.596 0.712 . . . . 0.0 109.953 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -96.97 164.63 17.49 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.719 -0.613 . . . . 0.0 109.457 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.3 -39.96 62.02 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.36 2.04 . . . . 0.0 111.584 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.524 ' O ' HG22 ' A' ' 45' ' ' ILE . 97.0 mt -81.73 -4.08 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.557 -0.714 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 137.92 -104.7 0.46 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.4 pt -127.37 133.78 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.876 . . . . 0.0 109.879 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.7 m -138.77 149.08 44.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.587 -0.695 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.58 133.74 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 33.0 t0 -127.73 147.27 50.4 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.588 0.708 . . . . 0.0 109.9 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -175.76 -165.57 31.91 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -144.11 164.53 30.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.768 -0.842 . . . . 0.0 109.77 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.1 pt -124.6 164.67 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.862 0.839 . . . . 0.0 111.344 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 58.43 32.38 22.03 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.643 0.735 . . . . 0.0 110.191 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.0 m120 48.89 29.84 2.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.639 -0.663 . . . . 0.0 109.838 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.49 111.74 22.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.448 -0.783 . . . . 0.0 109.988 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -58.88 -32.26 69.33 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.56 0.695 . . . . 0.0 109.441 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.57 -39.38 93.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.461 -0.774 . . . . 0.0 109.621 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.1 mt -82.03 78.94 8.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.533 -0.73 . . . . 0.0 109.81 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.6 t -104.39 155.16 19.02 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.656 0.741 . . . . 0.0 110.011 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -150.2 158.37 44.09 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.56 0.695 . . . . 0.0 109.825 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.7 m -134.17 138.7 45.34 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.87 135.29 48.2 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.589 0.709 . . . . 0.0 109.596 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.5 137.95 14.62 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 67' ' ' VAL . 29.3 mmtp 40.37 -161.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.489 0.661 . . . . 0.0 111.12 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 68' ' ' LYS . 93.8 m-20 -59.2 77.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.935 0.874 . . . . 0.0 109.782 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 65' ' ' LYS . 2.0 t 41.68 24.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.659 0.742 . . . . 0.0 109.853 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 66' ' ' ASP . 28.6 tptp -64.06 -44.23 93.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.2 mt -121.13 128.46 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -132.74 129.84 39.2 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.492 0.663 . . . . 0.0 109.628 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.5 m -130.48 152.29 50.04 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 p -143.0 155.46 44.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.742 0.782 . . . . 0.0 110.509 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 77' ' ' ASP . 18.6 p -74.73 168.78 19.17 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.772 0.796 . . . . 0.0 110.719 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -59.93 -43.07 95.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.753 -0.592 . . . . 0.0 110.167 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -65.94 -36.18 82.64 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.71 0.767 . . . . 0.0 109.558 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.5 tp -85.01 -21.02 29.63 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.926 0.87 . . . . 0.0 109.035 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 73' ' ' SER . 29.9 t70 -66.86 -44.54 80.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.538 -0.726 . . . . 0.0 110.084 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -71.68 -18.4 62.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 110.033 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.75 -62.37 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.44 -0.788 . . . . 0.0 109.966 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.439 ' O ' ' CD1' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -71.72 138.62 48.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.602 -0.686 . . . . 0.0 110.519 -178.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -137.52 40.26 2.42 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -115.39 150.83 45.2 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.333 -0.855 . . . . 0.0 109.412 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.46 156.22 66.4 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.695 2.264 . . . . 0.0 112.465 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -69.93 132.74 46.44 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.808 0.813 . . . . 0.0 110.033 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.8 ' HZ3' HD12 ' A' ' 90' ' ' ILE . 20.2 pttp -155.21 145.68 22.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.591 0.71 . . . . 0.0 109.47 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.39 168.14 51.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -62.45 -45.24 93.97 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.676 0.75 . . . . 0.0 109.7 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 47.7 p-10 -64.96 -33.39 75.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 109.687 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.551 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 14.4 tm-20 -62.98 -51.87 65.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.627 -0.671 . . . . 0.0 109.953 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.8 HD12 ' HZ3' ' A' ' 85' ' ' LYS . 9.9 tt -67.82 -29.6 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.92 -44.04 97.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.505 -0.747 . . . . 0.0 109.703 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.959 0.885 . . . . 0.0 108.941 179.918 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.471 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 91.3 m-85 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.365 0.602 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -58.67 -34.96 71.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.435 -0.79 . . . . 0.0 109.48 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -62.37 -40.34 96.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.53 -39.26 91.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.572 -0.705 . . . . 0.0 109.831 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -65.73 -39.83 91.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.582 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.85 -40.42 96.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.423 -0.798 . . . . 0.0 109.893 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.68 -41.95 98.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -0.839 . . . . 0.0 109.809 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.1 -41.97 97.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.389 -0.82 . . . . 0.0 110.159 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.03 -42.87 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.724 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.9 m -60.96 -44.49 97.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.872 . . . . 0.0 109.93 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.56 -42.94 99.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.663 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 57.2 t80 -61.0 -42.79 99.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.56 -0.712 . . . . 0.0 109.763 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' ILE . 86.3 mt -62.77 -41.93 99.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.9 -40.28 94.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.327 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -65.85 -40.32 91.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.408 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.577 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 99.3 m-20 -93.73 -4.75 49.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.56 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 25' ' ' LEU . 8.7 mt -143.45 91.23 6.93 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -71.16 -16.67 31.76 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.447 2.098 . . . . 0.0 111.812 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -92.46 4.22 53.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.536 -0.728 . . . . 0.0 109.183 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -50.08 137.84 16.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.063 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -111.59 -63.35 1.43 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.749 -0.594 . . . . 0.0 109.891 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -149.52 156.77 42.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.054 -1.029 . . . . 0.0 110.02 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.23 133.46 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.668 -0.645 . . . . 0.0 109.337 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.8 m -118.83 119.96 35.93 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -93.39 121.96 35.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.597 -0.69 . . . . 0.0 109.547 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.0 p -109.03 0.22 19.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.6 t30 59.01 -96.2 0.06 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.798 -0.564 . . . . 0.0 109.677 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 10.0 tm-20 60.14 -88.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.393 0.616 . . . . 0.0 110.845 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 40' ' ' GLU . 78.1 tt0 -57.36 148.89 21.77 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.466 -0.772 . . . . 0.0 110.362 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -151.68 96.75 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.263 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 46' ' ' GLY . 36.1 m-20 -44.27 108.61 0.74 Allowed Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.564 -0.71 . . . . 0.0 109.835 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.05 -33.45 43.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.223 1.949 . . . . 0.0 111.664 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -85.88 -5.26 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 43' ' ' ASN . . . -166.69 -127.93 0.94 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 pt -135.29 149.46 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.432 -1.04 . . . . 0.0 109.749 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.409 ' HB2' ' H ' ' A' ' 43' ' ' ASN . 22.6 t -142.79 141.67 31.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.134 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -124.87 122.09 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.567 0.699 . . . . 0.0 109.707 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 54.7 t0 -104.5 154.71 19.55 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -175.42 -170.31 38.18 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.609 -1.281 . . . . 0.0 109.936 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -145.25 162.82 36.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.484 -1.009 . . . . 0.0 109.675 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.37 162.81 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.457 0.646 . . . . 0.0 110.747 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 56.97 32.85 22.35 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.45 0.643 . . . . 0.0 109.85 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 47.97 29.62 1.76 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -111.68 108.37 17.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.491 -0.756 . . . . 0.0 109.525 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -58.59 -33.99 70.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.663 . . . . 0.0 109.599 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -62.48 -38.53 90.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.432 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.2 mt -82.76 82.63 8.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.191 -0.943 . . . . 0.0 109.095 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 m -100.6 160.83 14.03 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.598 0.713 . . . . 0.0 110.524 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -146.26 153.77 40.96 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.5 m -133.13 133.27 42.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.682 -0.636 . . . . 0.0 109.741 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.21 139.54 52.86 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -112.16 130.83 9.83 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' VAL . 45.8 tttt 43.57 -144.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.623 0.725 . . . . 0.0 110.869 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.2 62.31 0.13 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.533 0.682 . . . . 0.0 109.185 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LYS . 1.9 t 51.8 19.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.477 0.656 . . . . 0.0 109.639 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -64.09 -42.67 96.85 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.395 -0.815 . . . . 0.0 109.53 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 64' ' ' GLY . 96.7 mt -131.96 118.55 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.584 -0.698 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -139.73 152.08 46.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.7 t -139.83 148.28 41.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.438 -0.789 . . . . 0.0 109.555 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.0 t -131.81 147.44 52.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.451 -0.781 . . . . 0.0 109.639 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -76.61 170.04 17.16 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.788 0.804 . . . . 0.0 110.789 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -61.99 -42.98 99.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.571 -0.705 . . . . 0.0 109.664 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.57 -40.95 96.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.239 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.8 tp -79.55 -26.62 41.37 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.382 -0.824 . . . . 0.0 109.347 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -62.15 -38.25 88.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 110.247 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -59.11 -28.46 66.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.398 -0.814 . . . . 0.0 109.804 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 97.7 mmm -64.9 -35.29 80.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.658 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -63.9 135.95 56.97 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.301 -0.874 . . . . 0.0 109.841 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -112.39 -22.91 10.62 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -113.68 166.15 11.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.672 -0.643 . . . . 0.0 109.477 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.1 146.64 87.09 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.526 2.151 . . . . 0.0 112.677 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -67.59 124.04 22.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 109.428 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.479 ' O ' ' CE1' ' A' ' 24' ' ' TYR . 68.8 mmtt -134.97 154.95 51.53 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.771 0.796 . . . . 0.0 109.997 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.64 166.34 52.11 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -60.73 -42.29 96.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 122.014 -0.698 . . . . 0.0 109.507 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 9.5 p-10 -64.61 -34.74 78.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.429 -0.794 . . . . 0.0 110.45 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 50.3 mp0 -64.77 -47.51 77.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.262 -0.899 . . . . 0.0 110.053 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.2 pt -69.93 -35.45 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 110.083 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.27 -42.99 99.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.986 -1.071 . . . . 0.0 109.395 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.487 1.389 0 O-C-N 121.346 -0.846 . . . . 0.0 109.547 -179.805 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -59.64 -37.97 80.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.883 -0.511 . . . . 0.0 109.848 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.51 -40.85 98.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.748 -0.595 . . . . 0.0 109.488 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.61 -39.37 88.33 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 99.3 mm-40 -64.5 -40.42 95.62 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HE2' HD21 ' A' ' 39' ' ' ASN . 97.5 mttt -63.15 -42.08 99.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.055 -0.403 . . . . 0.0 110.372 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.42 -46.44 79.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.889 -0.507 . . . . 0.0 109.857 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -65.67 -43.23 89.98 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.035 0.445 . . . . 0.0 110.199 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 17' ' ' GLN . 53.7 t -65.41 -43.85 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.6 m -62.37 -45.55 92.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.549 HD11 ' NE2' ' A' ' 27' ' ' HIS . 41.8 tp -63.38 -43.92 96.2 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.812 -0.555 . . . . 0.0 109.72 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.602 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 71.7 t80 -62.21 -47.09 86.01 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.06 -40.56 96.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.936 -0.477 . . . . 0.0 109.929 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -59.66 -46.06 90.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 122.042 -0.411 . . . . 0.0 110.281 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.549 ' NE2' HD11 ' A' ' 23' ' ' LEU . 46.5 m-70 -72.29 -34.02 67.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 110.528 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.602 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 73.3 m-80 -86.58 -2.35 58.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.21 -0.932 . . . . 0.0 109.231 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 53.2 mt -136.56 104.86 9.17 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.613 . . . . 0.0 109.472 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.03 -16.99 25.34 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.779 2.319 . . . . 0.0 111.298 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -94.01 8.03 42.93 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -56.5 133.55 53.43 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.927 0.87 . . . . 0.0 110.48 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -135.9 -51.08 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -148.64 156.09 41.94 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.663 0.744 . . . . 0.0 110.207 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 p -139.82 140.83 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.539 0.685 . . . . 0.0 109.601 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.0 m -126.09 118.52 25.46 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.723 0.773 . . . . 0.0 109.486 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -95.67 126.49 40.98 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.556 0.694 . . . . 0.0 109.742 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.7 p -97.34 -17.2 19.89 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.411 HD21 ' HE2' ' A' ' 18' ' ' LYS . 7.5 m120 59.82 33.57 21.7 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.379 0.609 . . . . 0.0 109.557 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -92.74 179.74 5.39 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.684 0.754 . . . . 0.0 110.452 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 59.1 150.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.692 0.758 . . . . 0.0 110.362 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -155.33 114.85 3.66 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.826 0.822 . . . . 0.0 109.594 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.432 ' N ' ' ND2' ' A' ' 43' ' ' ASN . 2.6 m120 -91.92 146.71 33.42 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.29 -21.43 41.46 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.395 2.063 . . . . 0.0 111.62 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -76.61 -4.3 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.815 -0.553 . . . . 0.0 109.815 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.06 -123.51 1.19 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 pt -129.37 140.75 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.848 -0.795 . . . . 0.0 110.005 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.2 t -115.96 130.0 56.63 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.599 0.714 . . . . 0.0 109.926 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.9 127.23 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.749 0.785 . . . . 0.0 109.284 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -114.09 149.44 35.54 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.831 0.825 . . . . 0.0 110.0 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.02 179.88 45.09 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -143.23 166.02 25.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.76 -0.847 . . . . 0.0 110.609 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.6 pt -120.48 162.29 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.747 0.785 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 57.52 33.6 23.48 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 44.59 29.23 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.015 0.436 . . . . 0.0 109.864 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -109.13 112.4 24.55 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.66 0.743 . . . . 0.0 109.811 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -57.99 -34.11 69.63 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.963 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.08 -38.72 92.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.723 -0.611 . . . . 0.0 109.354 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.6 mt -82.46 75.84 9.36 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.1 m -102.49 160.39 14.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.964 0.888 . . . . 0.0 110.72 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.2 154.95 40.79 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.631 0.729 . . . . 0.0 109.716 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 96.9 m -134.66 133.85 40.53 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.66 0.743 . . . . 0.0 110.643 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.98 138.09 50.65 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.773 0.797 . . . . 0.0 109.376 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.66 133.77 11.81 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.433 ' O ' ' OE1' ' A' ' 17' ' ' GLN . 71.3 tttt 37.9 -133.75 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.212 0.529 . . . . 0.0 110.894 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -73.84 62.1 0.81 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 45.39 24.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -64.09 -42.36 96.97 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.74 127.41 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.694 0.759 . . . . 0.0 109.013 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.56 ' CZ ' ' NE ' ' A' ' 84' ' ' ARG . 28.3 p90 -139.95 153.44 46.91 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.971 0.891 . . . . 0.0 110.621 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 t -140.84 152.41 45.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.688 0.756 . . . . 0.0 109.423 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 p -138.47 153.9 48.82 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.896 0.855 . . . . 0.0 110.144 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.0 p -82.64 168.89 16.85 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.817 0.818 . . . . 0.0 110.546 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -65.44 -29.6 70.3 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -73.93 -50.4 20.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.756 -0.59 . . . . 0.0 109.583 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.27 -19.97 65.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.68 . . . . 0.0 109.484 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -64.0 -33.38 75.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.878 -0.514 . . . . 0.0 110.01 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.514 ' CG ' ' N ' ' A' ' 79' ' ' MET . 17.7 pttp -64.05 -43.83 94.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.617 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.514 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 59.8 mmm -68.41 -38.33 81.17 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.527 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 73.8 t80 -66.27 124.43 22.64 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.551 0.691 . . . . 0.0 109.138 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -142.97 -1.2 1.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.527 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 6.2 tp10 -102.43 113.4 65.89 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -48.87 149.01 8.28 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.407 2.071 . . . . 0.0 112.805 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.56 ' NE ' ' CZ ' ' A' ' 70' ' ' PHE . 15.9 mmm180 -67.77 143.6 55.78 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.735 0.779 . . . . 0.0 110.064 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -140.4 -76.64 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 159.32 160.89 10.73 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.568 ' CE2' HD11 ' A' ' 91' ' ' LEU . 77.3 t80 -62.71 -44.8 95.29 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.407 0.622 . . . . 0.0 109.632 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.96 -34.74 78.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.684 -0.635 . . . . 0.0 110.095 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 47.8 mp0 -65.66 -44.58 85.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.346 -0.846 . . . . 0.0 110.891 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.2 pt -66.2 -38.75 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.595 -0.691 . . . . 0.0 110.3 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.568 HD11 ' CE2' ' A' ' 87' ' ' TYR . 31.1 mt -63.64 -40.47 96.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.665 -0.647 . . . . 0.0 109.556 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.828 -0.545 . . . . 0.0 109.614 -179.907 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.4 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -65.79 -38.71 89.74 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.544 -0.722 . . . . 0.0 109.522 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -61.67 -41.44 97.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.769 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -64.53 -44.07 92.01 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.331 -0.856 . . . . 0.0 108.956 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -65.16 -39.06 92.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.574 -0.704 . . . . 0.0 109.363 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -63.76 -40.35 96.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.599 -0.688 . . . . 0.0 109.773 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -65.6 -38.35 89.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.444 -0.785 . . . . 0.0 109.597 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.29 -41.39 98.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.334 -0.853 . . . . 0.0 109.78 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.22 -43.67 97.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.0 m -61.43 -44.31 97.35 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.526 -0.734 . . . . 0.0 109.095 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.53 -42.54 99.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.502 -0.749 . . . . 0.0 109.101 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.55 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 62.8 t80 -61.01 -47.28 87.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.434 -0.791 . . . . 0.0 109.402 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' ILE . 86.2 mt -63.51 -41.97 98.5 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.419 -0.801 . . . . 0.0 109.696 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -61.86 -42.24 98.82 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.469 -0.77 . . . . 0.0 110.046 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -69.21 -39.17 78.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -0.836 . . . . 0.0 109.914 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.55 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 69.6 m-80 -86.26 -13.06 47.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.141 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' LEU . 11.1 mt -137.25 81.38 31.78 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.24 -28.24 70.37 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.481 2.121 . . . . 0.0 110.823 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.71 12.69 5.54 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -54.1 134.34 43.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.604 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -110.32 -63.17 1.42 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 t -150.42 157.95 43.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 0.0 109.95 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.13 133.19 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.599 -0.688 . . . . 0.0 109.318 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.5 m -121.02 120.22 34.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.62 -0.675 . . . . 0.0 109.242 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -94.26 140.62 29.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.593 -0.692 . . . . 0.0 109.402 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.0 p -116.41 -32.14 5.36 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -138.66 139.35 38.45 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.383 -0.823 . . . . 0.0 110.103 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -138.14 58.72 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -175.21 -170.17 0.42 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.629 -0.669 . . . . 0.0 109.791 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 t80 63.24 92.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.513 0.673 . . . . 0.0 109.94 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -171.37 119.99 0.47 Allowed Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.432 -0.793 . . . . 0.0 109.139 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.95 -42.97 25.11 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.283 1.989 . . . . 0.0 112.479 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 46' ' ' GLY . 10.5 tp -70.5 -37.53 70.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.423 -0.798 . . . . 0.0 109.816 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 45' ' ' ILE . . . -179.15 -87.91 0.07 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.9 pt -135.19 151.83 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.485 -1.009 . . . . 0.0 110.008 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.1 t -116.41 131.8 56.85 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.691 -0.631 . . . . 0.0 109.567 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.6 mt -106.83 116.49 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.477 ' OD1' HG23 ' A' ' 62' ' ' THR . 64.8 m-20 -119.73 139.32 52.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.44 36.48 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -145.42 166.13 26.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -1.073 . . . . 0.0 110.077 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.9 pt -120.84 162.85 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 121.576 0.703 . . . . 0.0 110.584 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 56.59 32.75 21.5 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.524 0.678 . . . . 0.0 109.547 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 m120 44.7 30.94 0.58 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.482 -0.761 . . . . 0.0 109.734 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -109.11 112.35 24.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.558 -0.714 . . . . 0.0 109.268 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -58.61 -33.35 69.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.669 -0.644 . . . . 0.0 109.807 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -62.86 -38.33 90.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.789 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.7 mt -83.76 79.92 9.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -0.89 . . . . 0.0 109.575 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.3 t -104.45 158.12 16.69 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.492 0.663 . . . . 0.0 110.063 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -144.56 145.87 32.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.479 -0.763 . . . . 0.0 109.513 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.477 HG23 ' OD1' ' A' ' 50' ' ' ASP . 52.1 m -130.24 131.3 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.05 138.17 48.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.632 -0.667 . . . . 0.0 109.277 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -96.53 99.51 2.33 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.7 tttp 43.86 -83.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.984 -0.715 . . . . 0.0 110.915 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 64' ' ' GLY . 99.2 m-20 -73.86 125.37 28.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 67' ' ' VAL . 61.0 t -60.89 -1.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.531 -0.731 . . . . 0.0 109.453 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 66' ' ' ASP . 54.6 mtpt -62.89 -41.22 99.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.2 116.21 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.473 -0.767 . . . . 0.0 109.346 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CZ ' ' OH ' ' A' ' 24' ' ' TYR . 54.6 p90 -141.09 157.27 45.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.724 . . . . 0.0 110.021 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.3 t -120.4 137.27 54.4 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.2 t -137.56 146.46 44.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.443 -0.786 . . . . 0.0 109.958 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.8 m -80.68 172.83 13.25 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.675 0.75 . . . . 0.0 110.275 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -66.0 -35.57 80.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.638 -0.663 . . . . 0.0 109.959 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -65.1 -33.3 75.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.495 -0.753 . . . . 0.0 109.772 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.5 tp -91.3 -24.44 19.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 109.019 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -65.11 -38.03 89.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.818 . . . . 0.0 109.858 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.05 -12.8 61.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 110.283 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.7 mmm -79.37 -9.49 59.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.808 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.38 128.96 37.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.958 . . . . 0.0 109.828 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -109.4 -43.99 4.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.617 -0.677 . . . . 0.0 109.573 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -96.5 165.44 16.11 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.419 -0.8 . . . . 0.0 110.175 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.55 146.91 89.21 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.297 1.998 . . . . 0.0 112.006 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.42 124.1 20.92 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.462 -0.774 . . . . 0.0 110.462 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -138.43 140.91 39.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.718 -0.613 . . . . 0.0 109.429 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.8 174.14 49.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.589 ' CE2' HD11 ' A' ' 91' ' ' LEU . 83.4 t80 -60.9 -43.97 97.77 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.67 0.748 . . . . 0.0 109.767 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 48.4 p-10 -69.76 -32.98 71.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.124 -0.985 . . . . 0.0 110.166 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 78.5 mm-40 -66.25 -44.21 84.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.1 pt -65.57 -38.46 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.007 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.589 HD11 ' CE2' ' A' ' 87' ' ' TYR . 82.8 mt -62.5 -42.18 99.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.97 -1.081 . . . . 0.0 109.488 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.13 179.577 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.9 t80 . . . . . 0 N--CA 1.497 1.888 0 CA-C-O 121.87 0.843 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CD1' ' OE2' ' A' ' 40' ' ' GLU . 85.0 m-85 -68.91 -35.23 76.58 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.484 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -62.54 -44.96 95.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.103 -0.998 . . . . 0.0 110.291 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -69.18 -36.03 76.91 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.155 -0.965 . . . . 0.0 109.758 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -63.16 -42.27 99.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -0.938 . . . . 0.0 109.599 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.83 -40.86 95.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 0.0 109.232 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.04 -43.95 98.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.562 -0.711 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.67 -43.32 97.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.412 -0.805 . . . . 0.0 109.942 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.3 -42.79 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 m -60.99 -46.12 92.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.392 -0.818 . . . . 0.0 109.383 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.622 HD11 ' NE2' ' A' ' 27' ' ' HIS . 48.6 tp -63.98 -42.01 97.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.526 ' CE2' ' OD1' ' A' ' 28' ' ' ASN . 77.4 t80 -61.42 -46.87 88.31 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.689 0.757 . . . . 0.0 109.87 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.15 -39.24 89.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.348 -0.845 . . . . 0.0 110.237 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -60.31 -45.67 92.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.289 -0.882 . . . . 0.0 110.521 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.622 ' NE2' HD11 ' A' ' 23' ' ' LEU . 37.0 m-70 -69.51 -38.67 77.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.203 -0.935 . . . . 0.0 110.37 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.526 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 25.2 m120 -64.17 -40.53 96.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.945 . . . . 0.0 109.81 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.4 mt -115.54 119.11 38.47 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.695 . . . . 0.0 109.908 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.61 -19.42 28.07 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.597 2.198 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -95.72 8.44 43.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 108.926 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -49.28 120.92 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.876 0.846 . . . . 0.0 110.032 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -102.27 -68.71 0.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.701 0.762 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 t -148.06 163.92 35.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.193 -0.942 . . . . 0.0 109.711 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.25 137.08 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.585 -0.697 . . . . 0.0 109.493 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.9 m -125.21 123.51 39.73 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.681 0.753 . . . . 0.0 109.368 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -88.42 132.35 34.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.562 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -107.15 -53.94 2.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.48 -0.763 . . . . 0.0 109.756 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -100.65 142.43 32.13 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.073 -1.017 . . . . 0.0 110.427 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.427 ' OE2' ' CD1' ' A' ' 14' ' ' PHE . 76.5 tt0 -162.47 106.84 1.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.531 -0.731 . . . . 0.0 109.09 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -170.03 177.77 4.18 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.465 -0.772 . . . . 0.0 110.043 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -61.68 -178.37 0.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.988 0.899 . . . . 0.0 110.61 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -175.45 167.75 1.73 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.13 -40.54 76.65 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.295 1.997 . . . . 0.0 111.528 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.9 -4.09 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.752 . . . . 0.0 109.453 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 134.4 -94.31 0.26 Allowed Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.5 pt -126.9 149.14 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.626 -0.926 . . . . 0.0 110.04 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 t -127.28 130.89 50.39 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.666 0.746 . . . . 0.0 108.997 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -128.04 132.01 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 40.3 t0 -135.42 146.06 47.89 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.593 -0.692 . . . . 0.0 109.807 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -167.89 -164.9 24.38 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -144.28 161.5 38.76 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.492 -1.004 . . . . 0.0 110.028 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -121.05 159.63 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 122.09 0.948 . . . . 0.0 111.308 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.1 m-20 57.39 32.93 22.56 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.825 0.821 . . . . 0.0 109.902 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 49.42 30.86 3.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 0.0 109.536 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -112.6 108.15 17.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.401 -0.812 . . . . 0.0 109.528 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -59.7 -31.44 69.59 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.568 0.699 . . . . 0.0 109.518 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -62.76 -39.07 93.0 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.178 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.6 mt -83.09 77.52 9.73 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.226 -0.921 . . . . 0.0 109.684 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.4 p -104.08 161.74 13.75 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.803 0.811 . . . . 0.0 110.596 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -149.75 156.09 41.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.537 -0.727 . . . . 0.0 109.688 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.3 m -137.29 140.05 41.32 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.658 -0.652 . . . . 0.0 109.894 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.87 150.43 46.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.365 -0.835 . . . . 0.0 109.394 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 65' ' ' LYS . . . -126.86 94.64 0.42 Allowed Glycine 0 N--CA 1.503 3.15 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' GLY . 88.6 tttt 52.84 115.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.945 0.879 . . . . 0.0 111.133 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 67' ' ' VAL . 65.6 t0 60.05 139.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.84 0.828 . . . . 0.0 110.591 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.566 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 26.3 t -58.48 0.63 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.558 0.694 . . . . 0.0 109.354 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.552 ' H ' ' C ' ' A' ' 66' ' ' ASP . 63.3 tttp -55.79 -40.05 72.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 108.788 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.45 119.03 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.483 -0.761 . . . . 0.0 109.084 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -138.63 125.91 21.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.413 -0.804 . . . . 0.0 109.365 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.8 m -107.71 150.57 26.78 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.609 0.719 . . . . 0.0 109.338 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.2 m -151.51 152.52 33.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.93 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.3 p -80.95 172.62 13.51 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.91 0.862 . . . . 0.0 110.874 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -58.77 -45.67 89.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.679 -0.638 . . . . 0.0 110.074 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.59 -48.96 78.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.15 -0.969 . . . . 0.0 110.22 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.59 -36.2 83.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.091 -1.006 . . . . 0.0 109.108 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.77 -41.45 97.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.343 -0.848 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -66.1 -35.06 79.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.153 -0.967 . . . . 0.0 109.714 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.5 mmm -62.26 -38.53 89.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.203 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -55.97 140.7 42.26 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.949 0.88 . . . . 0.0 110.104 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -106.45 -16.8 14.45 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -133.21 154.97 81.37 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.364 -0.835 . . . . 0.0 109.589 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.87 162.95 29.96 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 123.041 2.494 . . . . 0.0 112.69 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -63.77 135.76 56.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.921 0.867 . . . . 0.0 110.355 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -138.85 151.18 46.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.701 0.762 . . . . 0.0 109.641 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.98 152.81 45.97 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.07 -42.88 95.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.778 -0.836 . . . . 0.0 109.518 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.86 -37.97 88.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.777 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -60.7 -48.1 83.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.379 -0.825 . . . . 0.0 110.382 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.01 -31.58 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.937 -1.102 . . . . 0.0 109.946 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.04 -43.29 95.99 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 109.452 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.855 0.836 . . . . 0.0 109.32 -179.799 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.517 ' CE2' ' NE2' ' A' ' 17' ' ' GLN . 69.0 t80 . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.643 0.735 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -65.3 -37.95 88.71 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.467 0.651 . . . . 0.0 109.465 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.47 -40.96 96.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.508 -0.745 . . . . 0.0 109.293 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.54 -49.52 76.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.455 -0.778 . . . . 0.0 109.423 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.517 ' NE2' ' CE2' ' A' ' 13' ' ' PHE . 97.8 mt-30 -68.18 -33.61 74.76 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.552 0.692 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.09 -44.83 95.8 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.494 0.664 . . . . 0.0 109.794 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.03 -39.53 87.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.668 -0.645 . . . . 0.0 110.133 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -63.47 -42.43 98.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.543 -0.723 . . . . 0.0 110.596 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.94 -42.01 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.812 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.5 m -60.5 -46.62 89.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.416 -0.803 . . . . 0.0 109.861 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.407 HD11 ' NE2' ' A' ' 27' ' ' HIS . 54.6 tp -64.73 -40.97 96.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.763 . . . . 0.0 109.665 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.558 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 80.0 t80 -60.08 -44.71 94.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.491 -0.756 . . . . 0.0 109.849 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.45 -42.19 98.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.478 -0.764 . . . . 0.0 110.434 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -40.45 96.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.495 -0.753 . . . . 0.0 110.334 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.407 ' NE2' HD11 ' A' ' 23' ' ' LEU . 11.3 m-70 -67.56 -35.22 78.63 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.495 -0.753 . . . . 0.0 110.585 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.558 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 71.4 m-80 -95.04 -1.3 52.53 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.112 -0.992 . . . . 0.0 109.515 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.1 mt -140.91 84.44 13.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 109.484 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.4 -28.94 75.3 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.709 2.273 . . . . 0.0 111.17 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -88.59 15.8 7.55 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.535 0.683 . . . . 0.0 109.164 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -49.85 130.5 21.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.458 -0.776 . . . . 0.0 109.912 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -115.85 -68.6 0.91 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 t -143.28 161.07 39.27 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.598 0.713 . . . . 0.0 110.058 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.61 139.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.445 HG21 ' OH ' ' A' ' 52' ' ' TYR . 91.9 m -123.45 125.79 45.57 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -90.88 136.88 32.78 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.615 0.722 . . . . 0.0 110.095 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 39' ' ' ASN . 14.4 p -117.02 -33.48 4.71 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' ' 38' ' ' THR . 9.0 p30 38.24 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.0 0.905 . . . . 0.0 110.838 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -157.9 36.08 0.26 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 109.394 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -144.58 121.33 11.21 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.221 -0.924 . . . . 0.0 109.871 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -109.97 121.7 45.86 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.538 0.685 . . . . 0.0 109.288 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.434 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 2.0 m-20 -106.46 137.39 19.42 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -49.4 -31.36 23.05 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.569 2.179 . . . . 0.0 112.007 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.0 pt -80.08 -10.14 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.513 -0.742 . . . . 0.0 109.588 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 43' ' ' ASN . . . 154.52 -176.78 32.19 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.636 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.416 ' H ' ' HE2' ' A' ' 65' ' ' LYS . 34.0 pt -83.84 140.09 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.67 -0.9 . . . . 0.0 110.424 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.434 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 72.2 m -111.15 126.46 54.87 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.607 0.718 . . . . 0.0 109.525 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.56 126.15 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.625 -0.672 . . . . 0.0 109.516 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -115.48 149.09 38.65 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.839 0.828 . . . . 0.0 110.109 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.85 -177.83 46.12 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.445 ' OH ' HG21 ' A' ' 36' ' ' THR . 23.0 p90 -142.67 163.07 33.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.761 -0.846 . . . . 0.0 109.959 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 pt -121.94 162.78 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 121.914 0.864 . . . . 0.0 110.825 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.5 m120 59.59 31.31 20.86 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.529 0.68 . . . . 0.0 110.298 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 48.32 30.71 2.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.587 -0.696 . . . . 0.0 109.573 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -113.67 109.74 19.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.761 0.791 . . . . 0.0 109.513 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.53 -32.69 70.55 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.345 0.593 . . . . 0.0 109.588 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.76 -38.63 91.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.333 -0.854 . . . . 0.0 109.075 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.5 mt -83.2 75.82 9.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.559 -0.713 . . . . 0.0 109.506 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 t -99.76 162.99 12.66 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.723 0.773 . . . . 0.0 110.427 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -149.08 155.23 40.42 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.626 0.727 . . . . 0.0 109.793 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.1 m -132.74 136.1 46.15 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.451 0.643 . . . . 0.0 110.11 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.77 136.96 47.97 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.724 0.773 . . . . 0.0 109.287 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -102.43 136.3 12.74 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' GLY . 60.9 mmtt 33.59 -121.72 0.09 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.434 0.635 . . . . 0.0 111.421 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 68' ' ' LYS . 99.2 m-20 -85.67 76.3 9.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 66' ' ' ASP . 2.1 t 38.26 28.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.778 0.799 . . . . 0.0 110.003 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 66' ' ' ASP . 18.3 mmmt -62.62 -42.83 99.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.51 -0.744 . . . . 0.0 109.346 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.2 mt -129.32 125.92 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.603 -0.686 . . . . 0.0 109.293 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -123.5 131.7 53.71 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.529 0.681 . . . . 0.0 109.573 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.6 m -127.49 150.63 49.59 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 p -136.93 155.2 50.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.911 0.862 . . . . 0.0 110.396 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -81.69 174.42 11.39 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.535 0.683 . . . . 0.0 110.066 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.2 -41.58 99.19 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.463 0.649 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.3 mp0 -70.57 -44.32 67.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -0.859 . . . . 0.0 109.549 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.62 -37.48 86.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.708 -0.62 . . . . 0.0 109.596 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -54.86 -33.0 61.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.742 . . . . 0.0 109.518 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.75 -40.84 97.71 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.352 -0.843 . . . . 0.0 110.057 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.2 mmm -65.93 -37.82 87.04 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.154 -0.966 . . . . 0.0 109.068 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -64.98 133.57 52.01 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.66 0.743 . . . . 0.0 109.988 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -116.5 -22.28 8.8 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' A' ' 82' ' ' GLU . 1.7 pm0 -114.82 153.35 46.94 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.692 -0.63 . . . . 0.0 109.495 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.88 173.5 8.1 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.679 2.253 . . . . 0.0 112.735 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.35 139.74 58.8 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.931 0.872 . . . . 0.0 110.181 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -139.67 145.51 38.52 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.763 0.792 . . . . 0.0 109.848 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -74.42 154.8 47.96 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -61.99 -43.37 98.97 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.66 0.743 . . . . 0.0 110.002 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.36 -36.23 83.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.433 -0.792 . . . . 0.0 109.787 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 41.5 mp0 -62.89 -51.67 66.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.41 -0.806 . . . . 0.0 110.452 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 pt -64.62 -37.37 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.23 -43.69 97.34 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.55 0.69 . . . . 0.0 110.077 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--N 1.3 -1.552 0 CA-C-O 121.711 0.767 . . . . 0.0 108.97 -179.557 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.437 ' CZ ' ' CZ ' ' A' ' 14' ' ' PHE . 50.8 p90 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.437 ' CZ ' ' CZ ' ' A' ' 13' ' ' PHE . 86.5 m-85 -59.91 -29.33 68.28 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.487 0.661 . . . . 0.0 109.321 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -61.81 -37.82 85.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.479 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.56 -46.43 86.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.647 -0.658 . . . . 0.0 109.957 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.651 HE22 ' CG2' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -67.24 -37.12 83.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.5 -0.75 . . . . 0.0 109.218 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.51 -42.02 99.22 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.479 0.657 . . . . 0.0 109.453 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -65.0 -40.55 95.11 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -64.01 -40.67 96.87 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.313 0.578 . . . . 0.0 110.047 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.651 ' CG2' HE22 ' A' ' 17' ' ' GLN . 69.1 t -64.68 -41.57 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.543 -0.723 . . . . 0.0 109.412 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 m -59.73 -46.18 89.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.633 -0.667 . . . . 0.0 109.691 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.67 -40.14 96.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.692 -0.63 . . . . 0.0 109.732 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.644 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 59.0 t80 -58.84 -48.18 82.24 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.451 HD21 ' CZ ' ' A' ' 61' ' ' PHE . 82.1 mt -63.97 -40.56 96.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.601 -0.687 . . . . 0.0 110.068 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -49.81 -61.77 1.94 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.759 -0.588 . . . . 0.0 111.259 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.634 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 20.9 p80 -71.47 -36.01 71.03 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.269 0.557 . . . . 0.0 110.523 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.644 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 33.4 m-80 -64.52 -41.13 96.58 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.9 mt -127.12 114.1 21.74 Favored Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 120.56 -0.456 . . . . 0.0 109.921 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.91 -15.74 26.24 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.633 2.222 . . . . 0.0 111.087 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.81 4.56 52.57 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -55.98 129.01 37.99 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.872 0.844 . . . . 0.0 110.201 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -118.16 -59.64 1.88 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -146.5 167.29 24.05 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.868 0.842 . . . . 0.0 110.171 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.52 134.41 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.61 0.719 . . . . 0.0 109.573 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.0 m -115.64 105.8 13.17 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.737 0.779 . . . . 0.0 109.19 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -80.76 140.22 35.64 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.514 0.674 . . . . 0.0 109.76 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.1 p -120.09 -34.16 3.76 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 53.63 81.94 0.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.518 -0.739 . . . . 0.0 109.843 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -144.36 28.83 1.32 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.435 ' OE1' ' OD2' ' A' ' 50' ' ' ASP . 82.7 tt0 -160.3 135.86 8.2 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.882 0.848 . . . . 0.0 109.987 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -123.83 144.54 49.67 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.707 0.765 . . . . 0.0 109.915 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -98.59 149.91 36.2 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.694 -0.629 . . . . 0.0 109.653 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.47 -20.97 41.01 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.889 2.392 . . . . 0.0 111.495 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.3 pt -98.63 -5.18 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.02 -168.93 40.63 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.688 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 pt -81.55 157.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.865 0.841 . . . . 0.0 109.922 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.6 t -138.67 141.96 39.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.595 0.712 . . . . 0.0 109.809 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.9 mt -112.78 127.88 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.876 0.846 . . . . 0.0 109.968 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.611 ' OD1' HG23 ' A' ' 62' ' ' THR . 24.8 m-20 -117.46 151.11 37.74 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.839 0.828 . . . . 0.0 110.021 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.84 -156.76 28.9 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -150.28 166.77 28.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.456 -1.026 . . . . 0.0 110.645 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.1 pt -121.76 167.8 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.732 0.777 . . . . 0.0 110.354 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 57.99 33.7 23.48 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.459 0.647 . . . . 0.0 109.978 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 42.19 34.52 0.49 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.958 -0.464 . . . . 0.0 109.935 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -115.18 107.67 15.6 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.706 0.765 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -58.6 -36.66 74.36 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.916 -0.49 . . . . 0.0 110.252 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -62.5 -37.03 84.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.245 -0.909 . . . . 0.0 109.804 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.9 mt -82.34 83.55 7.42 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.338 -0.851 . . . . 0.0 109.705 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 t -79.9 145.33 32.73 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.062 0.934 . . . . 0.0 110.668 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.451 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 33.2 t80 -140.29 130.37 24.88 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.756 0.789 . . . . 0.0 109.674 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.611 HG23 ' OD1' ' A' ' 50' ' ' ASP . 41.8 m -134.69 136.5 42.81 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.838 0.828 . . . . 0.0 110.11 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -134.22 144.07 48.21 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.943 0.878 . . . . 0.0 110.0 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.09 175.84 38.47 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -53.75 133.71 42.15 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.611 0.72 . . . . 0.0 110.943 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 68' ' ' LYS . 93.3 m-20 57.57 34.14 24.17 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.177 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' ILE . 39.6 t 59.46 -78.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' ASP . 67.9 mttm 39.45 -89.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.524 0.678 . . . . 0.0 109.99 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' VAL . 96.9 mt -109.04 136.43 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.777 0.799 . . . . 0.0 109.304 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.522 ' CZ ' ' OH ' ' A' ' 24' ' ' TYR . 53.0 p90 -139.75 167.27 22.49 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.014 0.912 . . . . 0.0 109.868 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.3 t -133.67 150.86 51.55 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.975 0.893 . . . . 0.0 109.688 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.9 p -151.33 160.74 43.63 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.715 0.769 . . . . 0.0 110.156 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 p -75.72 164.98 25.72 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.951 0.882 . . . . 0.0 110.737 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -61.05 -43.18 99.27 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -66.0 -34.0 77.09 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.4 tp -81.99 -26.16 34.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.404 -0.81 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -66.5 -43.82 84.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.531 -0.73 . . . . 0.0 109.998 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -71.75 -9.87 58.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.558 -0.714 . . . . 0.0 110.713 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.9 mtp -82.27 -8.89 59.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.217 -0.927 . . . . 0.0 109.362 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -68.06 135.92 52.99 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -0.855 . . . . 0.0 109.604 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -92.12 -74.21 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.305 0.574 . . . . 0.0 109.816 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.03 155.54 49.62 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.471 -0.768 . . . . 0.0 109.754 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.02 165.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.598 2.199 . . . . 0.0 112.724 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.25 136.25 53.24 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.787 0.803 . . . . 0.0 110.281 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.94 140.36 45.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.817 0.818 . . . . 0.0 109.905 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.5 165.92 53.24 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -62.25 -42.86 99.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.987 -0.714 . . . . 0.0 109.402 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -63.89 -37.71 88.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.64 -0.663 . . . . 0.0 110.324 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -65.21 -44.38 88.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.416 -0.802 . . . . 0.0 110.416 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.4 pt -72.66 -32.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.278 -0.889 . . . . 0.0 110.392 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.82 -40.39 96.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.105 -0.997 . . . . 0.0 109.342 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.234 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CZ ' ' CE2' ' A' ' 14' ' ' PHE . 22.4 p90 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.399 0.618 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.53 ' CE2' ' CZ ' ' A' ' 13' ' ' PHE . 90.2 m-85 -64.87 -37.52 87.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.175 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.88 -41.0 99.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -0.813 . . . . 0.0 109.466 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.67 -40.19 92.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.587 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.18 -41.5 94.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.77 -40.73 97.39 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.384 -0.822 . . . . 0.0 109.351 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.15 -43.3 99.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 0.0 109.618 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -63.53 -42.64 98.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.332 -0.855 . . . . 0.0 109.879 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.47 -42.94 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 0.0 109.417 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.526 ' CG2' ' NZ ' ' A' ' 26' ' ' LYS . 76.1 m -60.73 -44.33 96.76 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.38 -0.825 . . . . 0.0 109.688 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 tp -63.71 -42.14 98.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.246 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.616 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 75.0 t80 -60.82 -44.58 96.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.577 -0.702 . . . . 0.0 110.232 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 29' ' ' ILE . 88.9 mt -63.64 -41.81 98.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 110.305 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.526 ' NZ ' ' CG2' ' A' ' 22' ' ' THR . 62.2 mttp -61.12 -40.75 94.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.91 -1.119 . . . . 0.0 110.444 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -66.84 -38.84 87.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.969 -1.082 . . . . 0.0 110.178 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.616 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 97.5 m-20 -92.5 -7.29 47.78 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.086 -1.009 . . . . 0.0 109.358 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 25' ' ' LEU . 12.3 mt -142.15 81.83 13.84 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.576 -0.702 . . . . 0.0 109.427 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.73 -27.73 78.96 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.711 2.274 . . . . 0.0 111.093 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -82.81 10.07 8.49 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 22.7 t80 -56.08 130.39 43.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -100.52 -68.76 0.8 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.448 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.6 t -152.33 168.22 26.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.722 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.03 138.22 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.4 m -125.12 124.67 42.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.606 -0.684 . . . . 0.0 109.27 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -104.43 118.47 36.7 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 t -141.26 18.64 2.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -151.09 106.67 3.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.113 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -130.82 140.6 50.28 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.323 -0.86 . . . . 0.0 109.473 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -135.82 156.35 48.93 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.453 -0.779 . . . . 0.0 109.577 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.49 ' CD2' ' O ' ' A' ' 42' ' ' PHE . 48.9 p90 -97.69 123.35 41.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.931 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.515 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 1.3 m-80 -96.05 153.97 39.01 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.466 -0.771 . . . . 0.0 109.145 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.64 -22.6 50.39 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.667 2.245 . . . . 0.0 111.299 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.4 pt -102.13 -3.84 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.49 -133.88 3.2 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.402 ' H ' ' HB2' ' A' ' 65' ' ' LYS . 39.9 pt -127.79 159.61 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.312 -1.111 . . . . 0.0 110.749 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.515 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 3.6 p -126.14 137.13 53.56 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.88 130.66 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.536 -0.728 . . . . 0.0 109.344 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -130.6 137.51 49.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.621 -0.674 . . . . 0.0 109.382 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.75 -160.78 14.48 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -147.69 167.39 24.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.26 -1.141 . . . . 0.0 109.946 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.8 pt -121.2 160.44 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 121.953 0.882 . . . . 0.0 110.784 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 58.6 33.38 23.04 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.563 0.697 . . . . 0.0 109.873 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.8 m120 46.41 29.49 0.89 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.306 -0.871 . . . . 0.0 110.08 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -109.24 111.76 23.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 0.0 109.504 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -58.7 -34.29 71.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.529 -0.732 . . . . 0.0 109.495 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -61.76 -39.11 90.48 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.321 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.79 73.89 8.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.074 -1.016 . . . . 0.0 109.083 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -100.56 156.5 17.26 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.6 0.714 . . . . 0.0 110.109 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.0 154.52 37.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.567 -0.708 . . . . 0.0 109.614 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 93.2 m -131.59 132.66 44.27 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.95 144.59 45.51 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.408 -0.807 . . . . 0.0 109.662 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.89 179.37 36.78 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HB2' ' H ' ' A' ' 47' ' ' ILE . 86.5 tttt -51.67 132.46 30.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.645 -0.915 . . . . 0.0 110.836 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 t0 56.01 38.09 29.56 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.672 0.749 . . . . 0.0 109.698 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 69' ' ' ILE . 36.1 t 58.56 -103.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.562 -0.711 . . . . 0.0 110.315 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 62.09 -69.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.616 -0.678 . . . . 0.0 109.53 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 67' ' ' VAL . 87.6 mt -105.73 121.84 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 108.752 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -128.39 133.97 48.72 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.5 t -132.01 141.78 49.37 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.0 p -139.45 156.15 47.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.475 -0.766 . . . . 0.0 109.968 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.9 p -68.93 170.05 10.46 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.647 0.737 . . . . 0.0 110.805 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.62 -46.52 88.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.494 -0.754 . . . . 0.0 110.263 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -65.36 -45.7 83.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 0.0 109.618 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.58 -38.74 90.39 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.314 -0.866 . . . . 0.0 109.678 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 84' ' ' ARG . 32.1 t70 -61.5 -36.02 79.31 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.128 -0.983 . . . . 0.0 109.59 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -68.86 -13.93 62.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.992 . . . . 0.0 110.207 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.2 mtp -82.2 -9.34 59.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.78 -1.2 . . . . 0.0 109.418 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -72.88 137.08 45.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.154 -0.966 . . . . 0.0 109.721 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -114.68 -11.39 12.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -127.1 153.43 76.65 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.71 -0.619 . . . . 0.0 109.917 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.86 152.13 59.8 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 122.323 2.015 . . . . 0.0 112.859 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.519 ' NH2' ' OD1' ' A' ' 77' ' ' ASP . 26.2 mmt85 -66.29 138.74 57.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 109.864 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -145.9 166.27 26.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.533 -0.729 . . . . 0.0 109.905 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.461 ' H ' ' CD ' ' A' ' 89' ' ' GLU . . . -82.31 167.8 47.56 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.578 ' CE2' HD11 ' A' ' 91' ' ' LEU . 71.6 t80 -62.01 -45.51 93.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.516 -0.99 . . . . 0.0 109.63 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -70.72 -29.14 65.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.839 -1.163 . . . . 0.0 109.005 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 86' ' ' GLY . 94.9 mt-10 -65.44 -45.33 84.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.395 -0.815 . . . . 0.0 109.936 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.6 pt -68.08 -33.42 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 109.749 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.578 HD11 ' CE2' ' A' ' 87' ' ' TYR . 41.4 mt -65.04 -41.23 95.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.384 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 N--CA 1.494 1.731 0 O-C-N 121.11 -0.994 . . . . 0.0 109.653 -179.062 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 77.0 t80 . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.771 0.796 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -59.88 -43.09 94.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.631 . . . . 0.0 109.555 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -62.95 -41.6 99.55 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.688 0.756 . . . . 0.0 109.007 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.99 -38.53 88.75 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.547 0.689 . . . . 0.0 109.398 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 67.4 tp60 -61.98 -43.56 98.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.679 . . . . 0.0 110.148 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.16 -40.21 96.9 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.658 0.742 . . . . 0.0 109.273 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.67 -44.34 94.04 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.546 0.689 . . . . 0.0 109.56 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -63.73 -42.94 97.81 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.427 0.632 . . . . 0.0 110.269 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.38 -44.69 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.641 0.734 . . . . 0.0 109.707 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.9 m -62.16 -42.4 99.22 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.55 0.691 . . . . 0.0 109.875 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.518 HD11 ' NE2' ' A' ' 27' ' ' HIS . 49.2 tp -60.8 -44.36 96.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.489 -0.757 . . . . 0.0 109.597 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -62.46 -45.88 91.04 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.598 0.714 . . . . 0.0 110.186 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.33 -39.46 93.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.482 -0.761 . . . . 0.0 110.069 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -60.55 -42.0 95.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.521 -0.737 . . . . 0.0 109.804 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.518 ' NE2' HD11 ' A' ' 23' ' ' LEU . 51.8 m-70 -66.51 -39.08 88.48 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.519 0.676 . . . . 0.0 110.0 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -87.97 -2.98 58.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.462 -0.774 . . . . 0.0 109.435 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.413 HD11 HD11 ' A' ' 76' ' ' LEU . 24.3 mt -142.53 83.1 12.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.67 . . . . 0.0 109.215 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.63 -32.06 73.38 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.597 2.198 . . . . 0.0 111.159 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -83.87 16.05 3.0 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.587 0.708 . . . . 0.0 109.445 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.73 129.19 40.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.497 -0.752 . . . . 0.0 109.883 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -108.98 -58.4 2.02 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -153.91 164.32 38.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.246 -0.908 . . . . 0.0 110.447 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.09 135.84 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 100.0 m -128.82 125.36 37.58 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.701 0.762 . . . . 0.0 110.01 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -99.16 147.42 25.13 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 p -142.17 -76.21 0.28 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.489 0.661 . . . . 0.0 109.595 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -78.18 128.48 33.82 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.662 0.744 . . . . 0.0 110.571 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.97 69.6 1.36 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -81.24 162.76 23.41 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.87 0.843 . . . . 0.0 110.213 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -99.4 119.88 38.69 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.777 0.799 . . . . 0.0 110.168 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.73 ' ND2' ' H ' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -95.15 152.25 39.33 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.36 -38.89 27.44 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.671 2.247 . . . . 0.0 112.077 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.9 -41.17 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.58 -0.7 . . . . 0.0 109.961 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' A' ' 43' ' ' ASN . . . -179.41 -135.1 2.32 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.418 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.554 ' C ' HD21 ' A' ' 43' ' ' ASN . 15.8 pt -103.74 139.26 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.758 -0.848 . . . . 0.0 109.801 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.513 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 50.7 m -116.54 124.96 51.17 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.579 0.705 . . . . 0.0 109.591 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.15 125.48 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 61' ' ' PHE . 38.8 t70 -124.25 153.67 41.33 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.861 0.839 . . . . 0.0 109.932 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 178.54 -167.49 38.0 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.469 ' CE2' ' NZ ' ' A' ' 57' ' ' LYS . 19.7 p90 -142.17 163.73 32.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.831 -0.805 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -120.78 161.53 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.674 0.749 . . . . 0.0 110.027 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 58.89 32.16 21.98 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.623 0.725 . . . . 0.0 109.844 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 45.82 32.11 1.2 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.653 . . . . 0.0 109.595 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -115.57 109.51 17.89 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.416 0.627 . . . . 0.0 109.541 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' NZ ' ' CE2' ' A' ' 52' ' ' TYR . 69.6 mmtt -57.85 -33.36 68.57 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.408 0.623 . . . . 0.0 110.032 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -60.5 -39.26 87.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 109.0 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.44 68.77 9.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.445 -0.785 . . . . 0.0 109.373 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.6 p -91.93 161.39 14.84 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.615 0.722 . . . . 0.0 109.855 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.408 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 49.2 p90 -155.07 160.9 41.35 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.63 0.728 . . . . 0.0 109.725 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.6 m -140.68 144.57 35.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.611 -0.681 . . . . 0.0 109.7 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.47 140.69 26.42 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -105.13 147.84 16.38 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.538 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 63.8 mmtt 35.22 -122.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.439 0.637 . . . . 0.0 111.232 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 68' ' ' LYS . 97.7 m-20 -88.21 86.84 7.15 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.774 0.797 . . . . 0.0 109.921 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.505 ' H ' HE22 ' A' ' 17' ' ' GLN . 2.0 t 45.67 14.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.661 0.743 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 66' ' ' ASP . 25.5 tptt -78.44 136.46 37.63 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.878 0.847 . . . . 0.0 110.05 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 68' ' ' LYS . 9.4 mm 49.15 99.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.59 0.709 . . . . 0.0 109.513 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -135.79 153.97 51.36 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.687 0.756 . . . . 0.0 110.083 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 p -136.53 157.25 47.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 m -133.95 153.08 52.01 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.935 0.874 . . . . 0.0 110.135 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.2 p -65.13 168.55 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.765 0.793 . . . . 0.0 110.744 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.17 -51.81 68.17 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.467 0.651 . . . . 0.0 109.82 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.95 -43.36 92.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.526 -0.734 . . . . 0.0 109.715 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.413 HD11 HD11 ' A' ' 29' ' ' ILE . 56.6 tp -63.8 -39.1 93.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -61.02 -38.03 84.67 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.631 0.729 . . . . 0.0 109.371 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.97 -36.64 82.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.334 -0.854 . . . . 0.0 109.509 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 81' ' ' GLN . 79.1 mtp -63.32 -41.34 98.91 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.467 -0.771 . . . . 0.0 109.943 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -43.44 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.922 0.868 . . . . 0.0 110.238 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' MET . 57.7 tt0 -67.79 -36.34 80.28 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.194 -0.603 . . . . 0.0 109.642 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -105.89 152.66 40.29 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.499 -0.75 . . . . 0.0 109.921 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.54 167.62 20.34 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.81 2.34 . . . . 0.0 112.844 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -63.78 140.22 58.85 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.777 0.798 . . . . 0.0 110.212 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -144.52 -111.34 0.1 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.685 -0.634 . . . . 0.0 109.843 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -176.94 161.06 28.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.452 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.88 -44.39 97.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.385 0.612 . . . . 0.0 110.059 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -58.76 -39.79 82.01 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.534 0.683 . . . . 0.0 110.121 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -57.96 -56.36 22.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 109.667 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.8 pt -65.64 -26.14 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.436 -0.79 . . . . 0.0 110.029 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.2 tt -63.61 -35.85 81.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.503 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.257 -0.902 . . . . 0.0 109.322 -179.111 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.606 0.717 . . . . 0.0 109.443 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -67.9 -33.95 75.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.445 -0.785 . . . . 0.0 109.842 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.415 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 90.9 m-20 -61.62 -46.76 88.45 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.462 -0.774 . . . . 0.0 110.062 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.31 -36.07 71.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 109.588 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.458 HE22 ' H ' ' A' ' 67' ' ' VAL . 68.4 tp60 -66.27 -41.13 90.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.578 -0.701 . . . . 0.0 109.521 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -64.85 -40.93 95.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.557 -0.714 . . . . 0.0 109.58 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -61.35 -42.37 98.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.575 -0.703 . . . . 0.0 109.583 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.3 -42.51 96.34 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.599 0.714 . . . . 0.0 109.175 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.4 t -65.43 -43.61 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.476 0.655 . . . . 0.0 109.659 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -61.74 -45.1 95.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.694 -0.629 . . . . 0.0 110.103 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 tp -63.31 -41.01 98.89 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.949 0.881 . . . . 0.0 109.976 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.623 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 62.9 t80 -66.43 -39.26 88.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.499 -0.75 . . . . 0.0 109.52 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.0 mt -61.82 -47.31 85.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.588 -0.695 . . . . 0.0 111.017 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.97 -34.56 78.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.503 -0.748 . . . . 0.0 110.314 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -72.46 -35.92 68.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 110.277 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.623 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 69.9 m-80 -94.72 -1.28 53.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.292 -0.88 . . . . 0.0 109.483 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 mt -140.93 86.79 11.41 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.389 -0.82 . . . . 0.0 109.346 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -55.98 -31.92 83.96 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.678 2.252 . . . . 0.0 111.303 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -82.25 13.46 3.5 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 25.1 t80 -57.2 130.68 47.24 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.758 0.79 . . . . 0.0 109.826 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -116.42 -66.82 1.04 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -141.06 165.31 27.9 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.507 -0.746 . . . . 0.0 109.935 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.68 138.84 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.42 0.629 . . . . 0.0 109.357 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.526 HG21 ' OH ' ' A' ' 52' ' ' TYR . 97.8 m -124.91 115.75 21.11 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.689 0.757 . . . . 0.0 109.494 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -86.85 135.47 33.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -111.53 -35.79 5.7 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.74 32.38 19.32 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.507 0.67 . . . . 0.0 109.363 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.33 16.7 14.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.467 -0.771 . . . . 0.0 109.561 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -134.68 148.39 50.32 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.298 -0.876 . . . . 0.0 109.929 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.483 ' CD1' ' O ' ' A' ' 42' ' ' PHE . 35.1 p90 -161.18 125.08 3.38 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.512 0.672 . . . . 0.0 109.313 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 4.3 p30 -91.02 150.99 42.76 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.527 -0.733 . . . . 0.0 109.847 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -65.06 -24.36 59.81 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.599 2.199 . . . . 0.0 111.766 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tp -70.39 -26.89 29.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.616 0.722 . . . . 0.0 109.382 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.38 -119.93 0.63 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.4 pt -126.2 158.98 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.691 -0.888 . . . . 0.0 110.533 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.4 m -141.67 139.75 33.05 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.2 127.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.55 0.691 . . . . 0.0 109.49 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.5 t0 -119.89 142.92 48.25 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.555 0.693 . . . . 0.0 109.571 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -173.09 -176.15 41.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.526 ' OH ' HG21 ' A' ' 36' ' ' THR . 13.3 p90 -143.1 164.03 31.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.597 -0.943 . . . . 0.0 110.341 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 pt -119.03 164.47 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.793 0.806 . . . . 0.0 110.282 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' ASP . 68.7 m-80 58.11 34.35 24.1 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.543 0.687 . . . . 0.0 109.734 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 45.25 20.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.49 0.662 . . . . 0.0 109.657 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' ASN . 99.8 m-20 -102.14 109.65 21.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.494 -0.754 . . . . 0.0 109.232 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -57.37 -33.13 67.48 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.26 0.552 . . . . 0.0 109.933 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -61.99 -39.37 91.98 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.3 mt -81.24 71.28 8.22 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.293 -0.88 . . . . 0.0 109.59 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.416 ' O ' HD22 ' A' ' 76' ' ' LEU . 18.3 p -90.67 161.69 15.26 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.676 0.75 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -149.24 152.66 36.35 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.455 0.645 . . . . 0.0 109.665 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.8 m -131.06 135.21 47.35 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.583 0.706 . . . . 0.0 110.167 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.22 146.38 40.42 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.646 0.736 . . . . 0.0 109.309 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.09 -155.74 16.9 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.31 134.26 55.51 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.944 0.878 . . . . 0.0 110.571 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 50.93 29.88 4.81 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.474 0.654 . . . . 0.0 109.463 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.458 ' H ' HE22 ' A' ' 17' ' ' GLN . 2.0 t 48.49 30.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.659 0.743 . . . . 0.0 109.454 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' NH2' ' A' ' 84' ' ' ARG . 28.2 tptp -62.16 -45.19 94.51 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.622 -0.674 . . . . 0.0 109.237 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.18 128.26 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -134.5 138.49 44.73 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.664 0.745 . . . . 0.0 109.877 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 t -132.85 146.17 51.59 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.514 0.673 . . . . 0.0 109.25 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.1 t -135.01 147.12 49.6 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.817 0.818 . . . . 0.0 110.172 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.1 p -77.8 173.77 11.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.645 0.736 . . . . 0.0 110.284 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.39 -48.59 80.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.361 0.6 . . . . 0.0 110.16 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.457 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 59.5 mp0 -67.41 -45.01 77.4 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.441 -0.787 . . . . 0.0 109.819 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 60' ' ' SER . 52.9 tp -64.16 -40.28 95.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.423 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -58.7 -41.26 85.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.595 -0.69 . . . . 0.0 109.191 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -65.21 -36.52 84.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.41 -0.807 . . . . 0.0 109.836 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 84.6 mmm -62.22 -38.17 88.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.239 -0.913 . . . . 0.0 109.208 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -57.91 138.18 56.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.456 -0.778 . . . . 0.0 109.554 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -108.03 -16.57 14.25 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -130.61 151.29 78.44 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.644 -0.66 . . . . 0.0 109.829 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.54 159.82 51.9 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.163 2.575 . . . . 0.0 112.881 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.462 ' NH2' ' O ' ' A' ' 68' ' ' LYS . 78.6 ttt-85 -66.82 132.53 48.23 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.786 0.803 . . . . 0.0 110.039 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -119.13 -72.43 0.69 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.39 158.44 9.87 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.534 ' CE2' HD11 ' A' ' 91' ' ' LEU . 81.4 t80 -62.57 -44.54 96.07 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.937 0.875 . . . . 0.0 109.636 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -73.55 -23.7 60.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.79 -45.47 67.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.523 -0.736 . . . . 0.0 109.673 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 91' ' ' LEU . 25.3 pt -66.79 -36.12 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.423 0.63 . . . . 0.0 109.563 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.534 HD11 ' CE2' ' A' ' 87' ' ' TYR . 39.2 mt -63.63 -40.49 97.01 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.577 -0.702 . . . . 0.0 109.561 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.616 -0.678 . . . . 0.0 109.628 -179.692 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 121.407 0.623 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -64.81 -36.5 84.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.395 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -61.38 -40.73 95.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.441 -0.787 . . . . 0.0 109.187 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -65.59 -40.25 92.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.565 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 66' ' ' ASP . 99.4 mm-40 -64.71 -42.43 95.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.691 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -64.25 -40.45 96.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.664 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.81 -44.5 93.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.86 . . . . 0.0 109.636 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.51 -41.7 96.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 109.862 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.3 t -64.63 -42.88 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.862 . . . . 0.0 109.644 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -59.74 -45.27 92.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.212 -0.93 . . . . 0.0 108.87 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.5 -41.96 98.53 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.398 -0.813 . . . . 0.0 109.281 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.484 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 83.1 t80 -58.99 -46.34 88.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.509 -0.744 . . . . 0.0 109.312 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -75.2 -22.93 57.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.69 -0.631 . . . . 0.0 109.712 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -63.96 -48.34 76.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.796 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.619 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 26.2 p80 -81.81 -35.83 29.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.051 -1.031 . . . . 0.0 109.755 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.619 ' ND2' ' CE1' ' A' ' 27' ' ' HIS . 36.6 m-80 -64.04 -41.03 97.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -122.69 88.26 49.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.632 -0.667 . . . . 0.0 109.604 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -54.22 -29.79 58.49 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.756 2.304 . . . . 0.0 111.622 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -80.37 5.1 15.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -55.64 131.73 47.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.493 -0.755 . . . . 0.0 110.284 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -103.0 -65.71 0.98 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 t -149.93 165.0 33.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.841 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.1 p -128.12 135.64 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.8 m -126.5 123.46 37.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.574 -0.704 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -95.55 144.13 26.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 109.429 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.463 ' O ' ' OG1' ' A' ' 38' ' ' THR . 0.2 OUTLIER -143.32 17.95 1.89 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.925 . . . . 0.0 108.643 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -155.48 116.27 3.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.372 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -138.26 91.47 2.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -118.18 147.3 43.49 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.703 0.763 . . . . 0.0 109.965 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 42' ' ' PHE . 48.8 p90 -97.35 120.94 38.64 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.692 -0.63 . . . . 0.0 109.396 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.448 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 73.8 m-20 -103.58 154.59 37.78 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.342 -0.849 . . . . 0.0 108.909 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.92 -40.64 49.01 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.966 1.777 . . . . 0.0 111.594 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 92.0 mt -67.57 -41.26 85.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.456 -0.777 . . . . 0.0 109.059 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.54 -125.89 0.96 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.0 pt -128.36 151.33 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.588 -0.948 . . . . 0.0 110.011 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.448 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 6.0 m -127.04 122.45 34.44 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.11 130.89 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -129.8 149.85 51.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.708 0.766 . . . . 0.0 109.466 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.9 -168.14 34.47 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -142.48 164.79 29.17 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.344 -1.092 . . . . 0.0 110.309 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 pt -121.0 159.36 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.603 0.716 . . . . 0.0 110.306 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 57.52 32.8 22.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.565 -0.71 . . . . 0.0 109.518 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 46.74 32.18 1.66 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.32 -0.862 . . . . 0.0 110.123 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -109.57 108.29 18.68 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.528 -0.733 . . . . 0.0 109.466 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.92 -34.98 72.33 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.394 0.616 . . . . 0.0 109.61 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -62.55 -38.63 90.77 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.123 -0.986 . . . . 0.0 109.175 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.2 mt -83.91 77.55 9.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.1 t -107.37 162.76 13.63 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.372 0.606 . . . . 0.0 109.824 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -153.15 159.75 42.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.322 -0.861 . . . . 0.0 109.287 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.7 m -129.31 133.8 47.62 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.3 142.64 50.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.745 . . . . 0.0 109.14 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.49 124.82 5.4 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt 54.13 93.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.755 -0.85 . . . . 0.0 110.646 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD1' ' NE2' ' A' ' 17' ' ' GLN . 95.1 m-20 52.79 -103.23 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.708 -0.62 . . . . 0.0 110.109 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.84 17.8 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.53 -44.84 96.33 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.413 -0.804 . . . . 0.0 109.222 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.0 mt -121.89 126.06 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CD2' ' NH1' ' A' ' 84' ' ' ARG . 66.0 t80 -138.46 131.77 30.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.512 -0.742 . . . . 0.0 109.191 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 p -139.06 143.46 38.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.366 -0.834 . . . . 0.0 109.06 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 p -153.97 170.29 21.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.988 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -77.17 171.59 14.59 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.634 0.731 . . . . 0.0 110.835 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.71 -35.39 80.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.602 -0.686 . . . . 0.0 109.546 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -58.34 -57.55 12.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.115 -0.99 . . . . 0.0 109.279 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.97 -38.65 86.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.194 -0.941 . . . . 0.0 109.282 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -51.7 -38.42 55.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.378 -0.826 . . . . 0.0 109.702 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -60.42 -31.05 70.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 0.0 110.228 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.6 mmm -64.22 -35.45 80.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.953 . . . . 0.0 110.02 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -55.06 132.88 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.014 -1.054 . . . . 0.0 109.714 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -95.08 -71.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.623 -0.673 . . . . 0.0 109.484 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.19 158.03 41.89 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 109.352 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -46.56 158.35 0.38 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.243 1.962 . . . . 0.0 112.817 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.479 ' NH1' ' CD2' ' A' ' 70' ' ' PHE . 96.3 mtt-85 -67.59 141.33 56.82 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.392 -0.817 . . . . 0.0 109.59 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -130.95 145.72 52.12 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.458 0.646 . . . . 0.0 109.904 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.2 155.89 26.55 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.522 ' CE2' HD11 ' A' ' 91' ' ' LEU . 85.5 t80 -60.53 -46.01 91.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.8 -0.824 . . . . 0.0 109.403 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 45.8 p-10 -68.75 -32.93 73.05 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.16 -0.962 . . . . 0.0 109.683 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 83.0 tt0 -66.41 -43.09 86.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 110.508 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 91' ' ' LEU . 29.7 pt -66.71 -37.73 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.033 -1.042 . . . . 0.0 109.375 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.522 HD11 ' CE2' ' A' ' 87' ' ' TYR . 89.1 mt -62.56 -42.0 99.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.011 -1.055 . . . . 0.0 109.152 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 C--N 1.302 -1.472 0 O-C-N 121.437 -0.789 . . . . 0.0 109.328 179.779 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 121.317 0.58 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -63.65 -40.69 97.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 109.827 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.63 -41.17 98.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.806 . . . . 0.0 110.149 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.45 -40.0 92.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 109.962 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.89 -40.1 94.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.824 . . . . 0.0 110.058 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.01 -40.86 97.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.177 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -65.58 -40.25 92.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.967 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -63.25 -42.17 99.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -0.867 . . . . 0.0 109.415 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.53 -43.36 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.562 -0.712 . . . . 0.0 109.902 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -61.55 -44.65 96.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.661 -0.649 . . . . 0.0 110.146 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.489 HD11 ' NE2' ' A' ' 27' ' ' HIS . 38.2 tp -63.01 -44.13 96.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 110.379 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.514 ' CZ ' ' OD1' ' A' ' 28' ' ' ASN . 90.9 t80 -62.74 -45.13 94.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.037 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.05 -40.33 96.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.478 -0.764 . . . . 0.0 110.01 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -58.91 -45.03 91.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 110.744 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.489 ' NE2' HD11 ' A' ' 23' ' ' LEU . 84.4 m-70 -68.23 -37.21 80.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.051 . . . . 0.0 110.26 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.514 ' OD1' ' CZ ' ' A' ' 24' ' ' TYR . 17.2 m120 -87.64 -5.39 58.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 109.177 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.4 mt -138.29 99.0 8.98 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.568 -0.708 . . . . 0.0 109.684 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.34 -14.75 31.32 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.334 2.023 . . . . 0.0 111.589 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -90.9 4.66 51.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.638 -0.664 . . . . 0.0 109.284 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -54.72 129.66 37.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.387 -0.821 . . . . 0.0 110.135 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -125.45 -56.11 1.52 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -146.49 156.46 43.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.341 -0.849 . . . . 0.0 109.627 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.91 140.28 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.623 -0.673 . . . . 0.0 109.872 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.6 m -124.68 128.2 48.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -97.88 124.91 42.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.472 -0.767 . . . . 0.0 110.015 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 39' ' ' ASN . 60.4 p -99.62 -15.16 18.67 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 38' ' ' THR . 74.4 m-20 58.1 148.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.596 0.712 . . . . 0.0 110.535 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.42 -163.96 1.59 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.346 -0.846 . . . . 0.0 109.946 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.12 -160.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.693 -0.629 . . . . 0.0 110.845 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -107.75 130.61 54.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.391 -0.818 . . . . 0.0 110.064 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -90.39 155.61 46.29 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.423 -0.798 . . . . 0.0 109.822 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -49.63 -37.03 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.534 2.156 . . . . 0.0 111.645 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 46' ' ' GLY . 21.4 tt -68.4 -38.6 79.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.538 -0.726 . . . . 0.0 109.428 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 177.92 -97.14 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.56 148.82 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.882 . . . . 0.0 110.007 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 t -100.21 125.04 46.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.396 -0.815 . . . . 0.0 109.427 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.03 129.47 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 61' ' ' PHE . 22.6 t0 -130.68 152.14 50.37 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -175.41 -177.39 44.44 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -143.75 162.75 35.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.539 -0.977 . . . . 0.0 109.968 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.9 pt -121.41 161.5 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.595 0.712 . . . . 0.0 110.871 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 56.78 32.62 21.6 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.692 0.758 . . . . 0.0 109.616 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.7 m120 46.6 32.3 1.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.514 -0.741 . . . . 0.0 109.81 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -113.08 111.28 21.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.66 -0.65 . . . . 0.0 109.357 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -59.79 -31.75 69.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.605 -0.685 . . . . 0.0 109.564 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.96 -39.06 90.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 109.204 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.8 mt -83.5 73.14 10.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 108.986 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 m -105.05 159.67 15.65 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.649 0.737 . . . . 0.0 110.355 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.43 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 53.3 p90 -147.99 149.3 31.9 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.631 -0.668 . . . . 0.0 109.284 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.2 m -128.11 131.92 49.0 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.83 139.96 49.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.41 -0.806 . . . . 0.0 109.764 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -99.78 112.52 4.47 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.2 tttm 37.87 -83.0 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.097 -0.649 . . . . 0.0 111.813 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 64' ' ' GLY . 99.8 m-20 -78.21 125.19 28.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 67' ' ' VAL . 37.2 t -60.39 0.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 66' ' ' ASP . 65.8 tttm -61.74 -42.59 99.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 109.467 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.86 112.85 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.487 0.66 . . . . 0.0 109.386 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -141.39 158.53 43.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.591 -0.693 . . . . 0.0 109.926 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.0 t -125.51 155.9 39.85 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.477 0.655 . . . . 0.0 109.555 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 p -150.15 162.13 41.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.439 -0.788 . . . . 0.0 109.636 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -77.34 170.83 15.86 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.99 0.9 . . . . 0.0 110.838 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 74' ' ' GLU . 58.7 mp0 -66.09 -37.93 87.0 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.777 -0.577 . . . . 0.0 109.61 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.95 -39.96 94.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.558 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.467 HD12 ' SD ' ' A' ' 79' ' ' MET . 58.6 tp -82.61 -21.4 35.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.299 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -66.93 -48.0 69.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -64.69 -22.62 67.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.402 -0.811 . . . . 0.0 110.227 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.467 ' SD ' HD12 ' A' ' 76' ' ' LEU . 90.8 mtp -65.27 -33.68 76.55 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.535 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -53.78 141.72 25.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.872 . . . . 0.0 110.429 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -85.4 -75.81 0.35 Allowed 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.831 -0.543 . . . . 0.0 109.963 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' PRO . 25.9 mt-10 -99.93 154.54 37.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.731 . . . . 0.0 109.862 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 82' ' ' GLU . 85.1 Cg_exo -40.93 170.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.837 2.358 . . . . 0.0 113.282 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -64.98 130.95 45.27 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.705 0.764 . . . . 0.0 110.018 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -109.14 -78.01 0.59 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.29 145.86 4.21 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.526 ' CE2' HD11 ' A' ' 91' ' ' LEU . 81.9 t80 -60.44 -45.1 94.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.792 -0.828 . . . . 0.0 109.567 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.58 -26.99 62.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.162 -0.961 . . . . 0.0 109.327 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -69.16 -43.24 74.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.465 -0.772 . . . . 0.0 110.014 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.4 pt -68.3 -37.05 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.316 -0.865 . . . . 0.0 109.777 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 87' ' ' TYR . 86.3 mt -62.91 -42.14 99.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.036 . . . . 0.0 109.777 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 C--N 1.301 -1.523 0 O-C-N 121.192 -0.942 . . . . 0.0 109.211 179.6 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.481 0.658 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -60.38 -43.55 96.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.503 -0.748 . . . . 0.0 109.754 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -63.56 -40.84 98.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.245 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -62.71 -40.66 97.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.588 -0.695 . . . . 0.0 109.477 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.06 -41.14 97.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.759 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -62.0 -41.18 97.78 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 109.437 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -64.1 -42.05 97.04 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.503 -0.748 . . . . 0.0 109.289 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.01 -43.27 93.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.606 -0.683 . . . . 0.0 109.859 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.31 -44.3 92.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.431 -0.793 . . . . 0.0 109.801 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 69.5 t -64.5 -45.26 96.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.349 -0.844 . . . . 0.0 110.072 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.8 m -62.44 -48.04 81.41 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.267 -0.896 . . . . 0.0 109.538 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.4 tp -64.08 -41.92 97.15 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.775 0.798 . . . . 0.0 109.656 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.604 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 78.5 t80 -63.96 -40.57 96.72 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.922 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.0 mt -62.08 -46.13 90.47 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.855 . . . . 0.0 110.472 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -68.89 -29.2 67.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.022 -1.049 . . . . 0.0 110.308 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.5 m-70 -68.48 -39.74 81.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.269 -0.894 . . . . 0.0 109.897 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.604 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 71.6 m-80 -94.63 -3.69 49.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.928 . . . . 0.0 108.65 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.415 HD11 ' CE1' ' A' ' 80' ' ' PHE . 20.6 mt -138.38 93.98 11.04 Favored Pre-proline 0 N--CA 1.492 1.642 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.92 -16.53 36.92 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 122.071 1.848 . . . . 0.0 111.057 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 83.5 m-20 -90.12 5.54 46.38 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -58.11 133.81 55.9 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.55 -0.719 . . . . 0.0 110.164 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -110.19 -58.08 2.12 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.6 t -153.45 160.5 42.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.079 -1.013 . . . . 0.0 109.97 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.3 134.69 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -123.49 125.83 45.62 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.538 -0.726 . . . . 0.0 109.557 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -97.01 144.61 26.73 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.608 -0.682 . . . . 0.0 109.338 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.1 t -161.91 61.06 0.25 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.318 -0.864 . . . . 0.0 109.183 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -161.53 -83.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.418 ' O ' ' OE1' ' A' ' 40' ' ' GLU . 4.1 tm-20 56.13 75.13 0.35 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.429 -0.794 . . . . 0.0 109.375 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -120.3 150.58 40.5 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 121.622 0.725 . . . . 0.0 109.614 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -92.23 120.31 32.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.376 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -103.49 156.01 36.07 Favored Pre-proline 0 N--CA 1.491 1.591 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -47.28 -37.97 25.29 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.399 2.066 . . . . 0.0 112.06 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 46' ' ' GLY . 21.0 tt -68.72 -37.73 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.119 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 170.11 -98.44 0.13 Allowed Glycine 0 N--CA 1.485 1.943 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.6 pt -123.35 157.81 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.526 -0.985 . . . . 0.0 110.275 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.0 p -139.98 123.78 17.42 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -118.58 133.06 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.681 -0.637 . . . . 0.0 109.427 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 50.1 t0 -131.18 147.1 52.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.613 -0.68 . . . . 0.0 109.449 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.517 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -172.43 -170.61 36.44 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -141.42 165.59 27.09 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.356 -1.085 . . . . 0.0 110.156 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 48.4 pt -121.75 162.84 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.531 0.682 . . . . 0.0 110.872 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 57.76 33.18 22.91 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.347 0.594 . . . . 0.0 110.126 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 48.31 26.73 1.16 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.4 -0.812 . . . . 0.0 110.246 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -108.57 108.59 19.55 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.375 -0.828 . . . . 0.0 109.644 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -58.15 -32.47 68.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.652 -0.655 . . . . 0.0 109.65 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -62.58 -39.73 94.65 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.298 -0.876 . . . . 0.0 109.45 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.8 mt -81.89 80.31 8.2 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.163 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 72.8 m -104.86 153.41 21.4 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.747 0.784 . . . . 0.0 110.417 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -139.61 150.98 45.64 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.779 -0.575 . . . . 0.0 109.635 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.2 m -133.67 136.23 44.62 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.544 -0.723 . . . . 0.0 109.917 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -149.26 155.21 40.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.232 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.44 -130.35 3.91 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 66' ' ' ASP . 54.9 mtpt -59.23 128.57 37.82 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.487 -1.008 . . . . 0.0 110.716 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.506 ' CG ' ' H ' ' A' ' 67' ' ' VAL . 43.2 t0 44.93 -173.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.505 0.669 . . . . 0.0 110.278 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.506 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 2.3 t -94.69 21.28 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.097 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -63.4 -41.84 98.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.219 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -118.37 126.06 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -136.13 135.44 39.25 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.537 -0.727 . . . . 0.0 109.183 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 t -134.48 144.54 48.13 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.517 -0.74 . . . . 0.0 109.413 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.1 p -152.71 164.08 38.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.333 -0.854 . . . . 0.0 110.516 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 93.1 p -68.06 167.44 13.95 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.611 0.72 . . . . 0.0 110.67 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -66.46 -36.61 83.2 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.313 -0.867 . . . . 0.0 109.447 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.83 -32.22 73.35 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.552 -0.717 . . . . 0.0 109.478 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.4 tp -90.52 -17.94 26.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 109.16 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -73.2 -42.27 62.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.188 -0.945 . . . . 0.0 109.67 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -63.77 -21.31 66.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.642 -0.661 . . . . 0.0 109.745 -178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 86.1 mmm -64.51 -35.36 80.7 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.341 -0.849 . . . . 0.0 109.15 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.415 ' CE1' HD11 ' A' ' 29' ' ' ILE . 14.4 m-85 -64.31 132.79 51.23 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.32 -0.862 . . . . 0.0 109.86 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -113.21 -16.99 12.46 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -119.08 153.62 53.04 Favored Pre-proline 0 N--CA 1.496 1.844 0 O-C-N 121.742 -0.598 . . . . 0.0 109.853 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.31 157.34 58.36 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 123.022 2.481 . . . . 0.0 113.012 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -67.4 141.65 56.98 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.726 0.774 . . . . 0.0 110.845 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -141.27 150.54 42.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.647 -0.658 . . . . 0.0 109.308 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.65 158.72 51.16 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -60.41 -44.08 96.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.715 -0.873 . . . . 0.0 109.58 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -66.26 -34.58 78.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 109.663 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.4 tp10 -62.65 -49.5 74.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.303 -0.873 . . . . 0.0 109.689 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 pt -66.95 -37.46 79.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.472 -0.767 . . . . 0.0 109.427 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.3 tp -62.51 -44.23 96.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.261 -0.899 . . . . 0.0 109.461 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.64 -38.17 73.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.394 -0.817 . . . . 0.0 109.525 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.44 ' ND1' ' O ' ' A' ' 93' ' ' HIS . 53.4 t-80 51.83 23.99 2.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.352 -0.842 . . . . 0.0 109.463 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 94' ' ' HIS . 84.1 t60 55.79 16.27 1.96 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.459 -0.776 . . . . 0.0 109.366 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -94.89 122.73 37.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.432 -0.792 . . . . 0.0 109.764 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.496 ' CG ' ' N ' ' A' ' 97' ' ' HIS . 58.9 t-80 -155.42 168.4 27.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.398 -0.814 . . . . 0.0 109.533 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.496 ' N ' ' CG ' ' A' ' 96' ' ' HIS . 99.3 m-70 -78.94 147.41 33.02 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.552 -0.717 . . . . 0.0 110.385 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.424 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 99.7 m-70 . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 117.853 -1.07 . . . . 0.0 108.994 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.889 0.852 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -63.35 -17.91 63.08 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.385 0.612 . . . . 0.0 109.784 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -64.39 -36.56 84.56 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.48 -0.762 . . . . 0.0 109.658 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -63.23 -41.35 99.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.499 -0.751 . . . . 0.0 110.026 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' A' ' 16' ' ' GLU . 54.8 mp0 -67.62 -40.41 84.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.606 -0.683 . . . . 0.0 109.91 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.578 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 56.2 tp60 -67.75 -36.72 81.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.402 -0.811 . . . . 0.0 109.336 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -61.72 -42.69 99.3 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.623 0.725 . . . . 0.0 109.372 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.62 -39.88 91.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.737 -0.602 . . . . 0.0 109.94 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.74 -42.37 97.88 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.377 -0.827 . . . . 0.0 109.962 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.2 t -65.38 -42.3 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.33 -0.856 . . . . 0.0 109.098 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.1 m -60.51 -45.28 94.38 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.729 0.776 . . . . 0.0 109.078 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.404 HD11 ' NE2' ' A' ' 27' ' ' HIS . 41.8 tp -63.83 -41.91 97.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.444 -0.785 . . . . 0.0 108.998 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.525 ' CE2' ' OD1' ' A' ' 28' ' ' ASN . 75.6 t80 -61.36 -47.36 86.21 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.2 mt -64.63 -39.83 94.39 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.57 0.7 . . . . 0.0 109.571 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -58.52 -47.82 82.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.624 -0.673 . . . . 0.0 110.272 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.404 ' NE2' HD11 ' A' ' 23' ' ' LEU . 59.5 m-70 -74.29 -42.75 59.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.28 -0.887 . . . . 0.0 110.072 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.525 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 28.2 m120 -65.28 -39.81 93.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.483 -0.761 . . . . 0.0 109.499 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 57.1 mt -105.18 109.32 63.08 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.709 -0.62 . . . . 0.0 109.607 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -71.94 -16.67 29.14 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 122.258 1.972 . . . . 0.0 111.15 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -97.33 13.64 28.89 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -58.16 129.54 42.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.485 -0.759 . . . . 0.0 110.036 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.83 -53.64 1.54 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -146.19 158.17 43.86 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.358 -0.839 . . . . 0.0 110.044 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.7 p -138.2 138.38 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 CA-C-O 121.185 0.516 . . . . 0.0 109.874 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.7 m -130.51 124.06 31.07 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.516 0.674 . . . . 0.0 109.589 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -101.32 117.73 35.55 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.452 0.644 . . . . 0.0 109.583 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 t -154.76 30.04 0.42 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.601 -0.687 . . . . 0.0 109.237 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -147.51 16.16 1.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.487 -0.758 . . . . 0.0 109.006 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.75 141.11 45.38 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.592 0.711 . . . . 0.0 110.685 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -146.3 155.41 42.62 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.472 0.653 . . . . 0.0 109.751 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -75.76 140.82 42.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.637 -0.664 . . . . 0.0 109.789 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -112.01 140.32 23.33 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.22 -36.62 29.75 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.253 1.969 . . . . 0.0 111.422 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.3 tt -86.5 -6.4 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.395 -0.815 . . . . 0.0 109.217 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.92 -114.88 0.63 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.0 pt -127.21 157.09 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.786 -0.832 . . . . 0.0 110.289 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 43.6 t -128.23 131.48 48.8 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.54 0.686 . . . . 0.0 109.396 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.1 mm -98.82 119.21 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 121.432 0.634 . . . . 0.0 109.457 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.432 ' OD1' HG23 ' A' ' 62' ' ' THR . 98.3 m-20 -123.58 141.93 51.53 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.45 0.643 . . . . 0.0 109.601 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -179.29 -168.27 38.01 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -145.9 164.93 30.43 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.88 -0.777 . . . . 0.0 109.955 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.8 pt -122.75 164.82 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-O 121.844 0.831 . . . . 0.0 110.7 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 57.98 32.43 21.95 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.774 0.797 . . . . 0.0 109.783 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 46.56 30.52 1.13 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.852 -0.53 . . . . 0.0 110.164 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -112.82 111.62 22.52 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.553 -0.717 . . . . 0.0 109.569 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -59.04 -32.52 69.82 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.449 0.642 . . . . 0.0 109.493 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.82 -39.01 92.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.41 -0.806 . . . . 0.0 109.424 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.35 76.13 9.24 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.456 -0.777 . . . . 0.0 109.442 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.1 m -100.34 159.65 14.96 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.459 0.647 . . . . 0.0 110.452 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -146.62 150.24 35.08 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.429 0.633 . . . . 0.0 109.812 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.432 HG23 ' OD1' ' A' ' 50' ' ' ASP . 52.3 m -131.29 135.59 47.43 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -133.23 145.94 51.01 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.591 0.71 . . . . 0.0 109.479 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.485 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -93.99 111.59 4.17 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.578 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 13.0 ptmt 26.93 -107.3 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.527 0.679 . . . . 0.0 111.123 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.402 ' HA ' HE22 ' A' ' 17' ' ' GLN . 99.5 m-20 -69.37 42.11 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.714 0.769 . . . . 0.0 109.666 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' A' ' 65' ' ' LYS . 2.3 t 51.13 37.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 CA-C-O 121.939 0.876 . . . . 0.0 109.921 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.3 mmtm -63.64 -41.96 98.18 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.655 -0.653 . . . . 0.0 109.362 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 69' ' ' ILE . 11.1 tp -135.09 131.31 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.617 -0.677 . . . . 0.0 109.279 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -124.21 133.43 53.53 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.525 0.679 . . . . 0.0 110.168 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 m -128.76 152.32 48.58 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.0 m -130.21 152.44 49.63 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.803 0.811 . . . . 0.0 110.161 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 77' ' ' ASP . 17.0 p -78.58 172.3 13.88 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.811 0.815 . . . . 0.0 110.65 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -58.64 -44.11 89.97 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.55 0.691 . . . . 0.0 109.9 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.05 -36.81 75.28 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.447 -0.783 . . . . 0.0 109.567 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 35.7 tp -81.37 -15.99 53.61 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.752 0.787 . . . . 0.0 109.43 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' SER . 65.2 t0 -61.12 -47.29 86.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.22 -0.925 . . . . 0.0 110.589 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -59.98 -44.0 94.78 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.445 -0.784 . . . . 0.0 110.595 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 94.5 mtp -66.51 -38.99 88.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.66 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -75.17 108.31 7.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.48 -0.763 . . . . 0.0 109.983 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -145.24 7.47 1.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -122.52 83.23 47.49 Favored Pre-proline 0 N--CA 1.493 1.68 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -84.5 118.71 2.23 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.776 2.318 . . . . 0.0 113.128 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -80.97 166.0 21.23 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.972 0.891 . . . . 0.0 110.594 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -87.74 -5.91 58.44 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.867 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 154.65 165.79 14.39 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.94 -1.124 . . . . 0.0 110.715 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.421 ' CD2' HD11 ' A' ' 90' ' ' ILE . 52.9 t80 -62.71 -22.23 66.35 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.907 -0.761 . . . . 0.0 109.154 179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -81.3 -26.82 35.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.552 -0.718 . . . . 0.0 109.937 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -72.48 -40.86 66.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.428 -0.795 . . . . 0.0 110.184 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.421 HD11 ' CD2' ' A' ' 87' ' ' TYR . 17.5 pt -60.44 -23.93 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.453 -0.779 . . . . 0.0 110.356 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.2 mt -65.55 -33.58 76.25 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.242 -0.911 . . . . 0.0 109.896 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -54.13 -17.8 3.12 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.454 0.645 . . . . 0.0 110.024 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -57.35 -39.43 75.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.406 -0.809 . . . . 0.0 109.639 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -98.19 71.1 2.09 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 0.0 109.09 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 61.4 t-80 -79.51 -4.85 53.22 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.638 0.732 . . . . 0.0 109.222 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -53.62 -76.28 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.594 0.711 . . . . 0.0 109.849 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.5 -43.86 98.11 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.578 0.704 . . . . 0.0 109.605 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.235 -179.767 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -61.98 -43.2 99.33 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.252 0.548 . . . . 0.0 109.812 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -85.56 -27.25 25.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.795 -0.566 . . . . 0.0 109.519 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -62.69 -44.83 95.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.789 -0.569 . . . . 0.0 109.947 -178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -65.79 -37.12 85.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.851 -0.531 . . . . 0.0 109.755 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -62.98 -43.08 99.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.8 -0.563 . . . . 0.0 110.033 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -64.78 -39.96 94.46 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.781 -0.574 . . . . 0.0 110.362 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.19 -39.48 94.78 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.712 -0.617 . . . . 0.0 109.561 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.33 -42.25 98.95 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.81 -0.556 . . . . 0.0 109.68 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 87.3 t -64.18 -43.3 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.4 m -61.88 -43.48 98.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.157 0.503 . . . . 0.0 109.782 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.427 HD11 ' NE2' ' A' ' 27' ' ' HIS . 51.8 tp -62.26 -41.26 98.3 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.324 0.583 . . . . 0.0 109.595 -179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.533 ' CD1' ' OD1' ' A' ' 28' ' ' ASN . 74.6 t80 -60.14 -46.28 90.18 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.668 HD21 ' CE2' ' A' ' 61' ' ' PHE . 69.4 mt -63.77 -41.28 98.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.819 -0.551 . . . . 0.0 110.611 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -61.73 -40.51 95.33 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.869 -0.519 . . . . 0.0 110.148 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.427 ' NE2' HD11 ' A' ' 23' ' ' LEU . 27.1 m-70 -86.72 -25.1 24.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.995 -0.441 . . . . 0.0 110.431 -178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.533 ' OD1' ' CD1' ' A' ' 24' ' ' TYR . 25.6 m120 -97.33 -11.41 24.06 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.427 -0.795 . . . . 0.0 109.228 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.452 ' N ' ' O ' ' A' ' 25' ' ' LEU . 11.1 mt -148.16 88.67 5.39 Favored Pre-proline 0 N--CA 1.493 1.684 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.31 -30.84 64.39 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.816 2.344 . . . . 0.0 112.051 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -78.94 6.17 9.86 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -61.54 130.67 47.08 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.782 0.801 . . . . 0.0 109.994 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -107.77 -56.06 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -161.46 165.95 27.96 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.503 0.668 . . . . 0.0 109.93 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.427 HG21 ' CZ ' ' A' ' 37' ' ' PHE . 14.8 p -127.59 137.22 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-O 121.741 0.782 . . . . 0.0 109.804 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.9 m -119.08 122.84 43.02 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.525 0.678 . . . . 0.0 109.549 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' CD1' ' CG2' ' A' ' 49' ' ' ILE . 72.9 m-85 -106.4 119.77 40.13 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.717 0.77 . . . . 0.0 109.743 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.04 -33.91 0.36 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.444 ' O ' ' O ' ' A' ' 40' ' ' GLU . 8.9 m120 -69.51 -73.91 0.15 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.762 -0.586 . . . . 0.0 109.757 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 39' ' ' ASN . 81.7 tt0 55.5 151.08 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.924 0.869 . . . . 0.0 111.233 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -160.97 144.92 13.45 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 121.798 0.809 . . . . 0.0 109.806 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -92.83 140.54 29.4 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.532 0.682 . . . . 0.0 109.917 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -131.1 149.73 74.56 Favored Pre-proline 0 N--CA 1.486 1.352 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -49.77 -35.16 38.24 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.638 2.225 . . . . 0.0 112.021 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.8 pt -72.7 -4.94 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 140.53 -118.44 1.42 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.6 pt -126.55 154.73 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.797 -0.825 . . . . 0.0 110.103 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 83.2 p -135.87 131.46 35.33 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.759 0.79 . . . . 0.0 109.678 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.482 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 96.8 mt -94.48 127.64 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 121.538 0.685 . . . . 0.0 109.59 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 65.9 t0 -127.58 137.13 52.5 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.615 0.721 . . . . 0.0 109.786 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -177.08 -151.66 9.25 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -146.09 160.69 41.56 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.816 -0.814 . . . . 0.0 110.26 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.02 HD11 HD11 ' A' ' 76' ' ' LEU . 51.0 pt -120.31 163.7 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 121.804 0.812 . . . . 0.0 110.95 -178.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 58.09 33.54 23.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.837 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 45.92 29.26 0.71 Allowed 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.436 179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -111.74 109.57 19.48 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.773 0.797 . . . . 0.0 109.433 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -58.15 -34.21 70.04 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.846 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -62.26 -39.4 92.78 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.515 ' HB3' HD13 ' A' ' 76' ' ' LEU . 66.2 mt -81.69 86.8 6.36 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.562 0.696 . . . . 0.0 110.041 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.5 p -80.3 163.87 23.62 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.872 0.844 . . . . 0.0 110.846 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.668 ' CE2' HD21 ' A' ' 25' ' ' LEU . 52.7 t80 -149.66 131.03 14.69 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.585 0.707 . . . . 0.0 109.672 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 81.4 m -137.45 132.47 33.42 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.783 0.801 . . . . 0.0 110.058 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.41 142.62 37.48 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.789 0.804 . . . . 0.0 109.736 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -99.28 129.11 9.79 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 64' ' ' GLY . 17.9 tptm 35.36 -122.43 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 121.08 0.467 . . . . 0.0 110.649 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 68' ' ' LYS . 67.2 t0 -83.36 72.26 10.22 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.377 0.608 . . . . 0.0 109.745 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.402 ' C ' ' O ' ' A' ' 66' ' ' ASP . 2.1 t 40.87 28.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.507 0.67 . . . . 0.0 109.345 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ASP . 49.1 mtpt -63.05 -41.94 99.6 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.69 126.17 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 CA-C-O 121.639 0.733 . . . . 0.0 109.82 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -92.71 123.55 36.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.877 0.846 . . . . 0.0 109.718 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -141.29 119.75 12.34 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.809 0.814 . . . . 0.0 109.437 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 p -153.36 165.16 36.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.947 0.88 . . . . 0.0 110.489 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.2 p -75.19 164.35 26.57 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.838 0.828 . . . . 0.0 110.433 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.65 -36.99 83.87 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.6 -34.69 76.07 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.02 HD11 HD11 ' A' ' 53' ' ' ILE . 15.0 tp -91.97 -21.28 20.63 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -65.76 -35.43 80.68 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.571 -0.706 . . . . 0.0 109.754 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -75.03 -12.26 60.29 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.624 -0.672 . . . . 0.0 110.133 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.784 ' SD ' HD12 ' A' ' 76' ' ' LEU . 82.2 mtp -77.11 -5.18 47.96 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -89.7 120.62 31.13 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.764 0.792 . . . . 0.0 109.031 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.419 ' CD ' ' N ' ' A' ' 81' ' ' GLN . 23.7 mp0 -97.47 -11.99 23.17 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -133.03 149.95 74.23 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.692 -0.63 . . . . 0.0 109.702 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.62 149.57 10.04 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.503 2.135 . . . . 0.0 112.393 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 39.0 ptt180 -64.55 136.8 57.4 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.654 0.74 . . . . 0.0 110.285 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -128.65 143.89 51.04 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.053 0.93 . . . . 0.0 110.355 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.21 160.24 52.7 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -60.25 -45.33 93.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 122.234 -0.568 . . . . 0.0 109.938 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -64.68 -36.97 86.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.577 -0.702 . . . . 0.0 109.695 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -62.22 -48.4 80.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.824 -0.547 . . . . 0.0 110.0 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.9 pt -69.59 -32.49 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.767 -0.583 . . . . 0.0 109.518 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.24 -44.23 92.46 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.863 -0.523 . . . . 0.0 109.733 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -70.47 -36.14 73.71 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.526 ' CE1' ' ND1' ' A' ' 94' ' ' HIS . 80.8 t60 54.19 -95.68 0.05 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.269 0.557 . . . . 0.0 109.986 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.526 ' ND1' ' CE1' ' A' ' 93' ' ' HIS . 72.9 m80 -136.78 152.1 49.92 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.822 0.82 . . . . 0.0 110.229 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -149.63 164.24 35.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.679 0.752 . . . . 0.0 109.949 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 47.52 73.75 0.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.627 0.727 . . . . 0.0 109.434 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.522 ' CD2' ' H ' ' A' ' 97' ' ' HIS . 7.1 p80 -79.9 -16.62 54.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.405 ' OXT' ' O ' ' A' ' 97' ' ' HIS . 76.8 m80 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.845 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.496 0.665 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -63.6 -42.19 98.27 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -62.35 -43.81 97.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.85 -0.531 . . . . 0.0 110.37 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -62.52 -42.16 99.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.444 -0.785 . . . . 0.0 110.163 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.81 -39.15 87.62 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.797 -0.565 . . . . 0.0 110.272 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 21' ' ' VAL . 20.1 mm100 -66.0 -39.71 90.51 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.555 -0.716 . . . . 0.0 109.751 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HZ2' ' CB ' ' A' ' 37' ' ' PHE . 68.4 mttm -62.98 -43.16 99.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.604 -0.685 . . . . 0.0 109.923 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -67.59 -43.38 80.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.774 -0.579 . . . . 0.0 110.06 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -65.47 -42.52 92.16 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.257 0.551 . . . . 0.0 109.915 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 17' ' ' GLN . 55.5 t -64.56 -43.76 96.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.845 -0.535 . . . . 0.0 109.913 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.2 m -61.09 -48.53 81.28 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.579 HD11 ' NE2' ' A' ' 27' ' ' HIS . 58.5 tp -65.93 -40.81 91.74 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 90' ' ' ILE . 36.6 t80 -61.07 -48.77 80.2 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.13 -41.87 94.41 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.315 0.579 . . . . 0.0 109.834 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.1 -44.0 91.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.884 -0.51 . . . . 0.0 110.68 -178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.579 ' NE2' HD11 ' A' ' 23' ' ' LEU . 16.4 m170 -68.86 -37.06 78.84 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.373 -0.83 . . . . 0.0 110.318 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.461 HD21 ' CG ' ' A' ' 84' ' ' ARG . 1.3 m-20 -87.2 -5.15 59.07 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 42.5 mt -138.2 94.54 10.97 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.06 -18.51 27.4 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.321 2.014 . . . . 0.0 111.278 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -92.98 7.44 44.05 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.451 ' CG ' ' N ' ' A' ' 33' ' ' ASN . 61.1 t80 -54.82 158.19 2.8 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.704 0.764 . . . . 0.0 110.143 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.451 ' N ' ' CG ' ' A' ' 32' ' ' PHE . 65.4 t30 -145.31 -52.58 0.27 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -149.8 151.35 33.41 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.392 -0.818 . . . . 0.0 110.095 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -128.2 137.15 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.534 0.683 . . . . 0.0 109.834 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.467 HG21 ' OH ' ' A' ' 52' ' ' TYR . 87.4 m -116.96 112.23 20.71 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 121.621 0.724 . . . . 0.0 109.117 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' O ' HG23 ' A' ' 38' ' ' THR . 74.1 m-85 -80.6 145.63 31.63 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.485 0.659 . . . . 0.0 110.303 -179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.517 ' N ' ' O ' ' A' ' 50' ' ' ASP . 25.3 p -155.45 106.45 2.54 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.712 0.767 . . . . 0.0 109.655 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 38' ' ' THR . 9.3 m120 -49.99 -105.01 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.383 0.611 . . . . 0.0 109.989 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' O ' ' CB ' ' A' ' 41' ' ' GLU . 81.6 tt0 55.83 113.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 121.48 0.657 . . . . 0.0 110.336 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.502 ' OE1' ' N ' ' A' ' 42' ' ' PHE . 5.5 tm-20 79.23 141.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.466 0.65 . . . . 0.0 110.395 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.502 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 96.9 m-85 -135.06 151.92 51.21 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.835 0.826 . . . . 0.0 110.372 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -72.51 157.08 89.61 Favored Pre-proline 0 C--N 1.305 -1.347 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -37.48 -66.74 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.904 2.403 . . . . 0.0 112.598 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.9 mm -108.01 -26.71 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.72 -160.63 34.18 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.5 pt -120.44 146.27 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.694 0.759 . . . . 0.0 109.818 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.46 ' H ' ' HA ' ' A' ' 42' ' ' PHE . 10.1 t -111.47 128.46 56.01 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.551 0.691 . . . . 0.0 109.532 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -115.27 127.3 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.672 0.748 . . . . 0.0 109.767 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 59.4 t0 -113.89 154.14 28.02 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.846 0.831 . . . . 0.0 109.667 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.538 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -179.58 -175.23 46.23 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.481 ' N ' ' CD1' ' A' ' 52' ' ' TYR . 5.1 p90 -149.91 166.22 30.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.874 -0.78 . . . . 0.0 110.436 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.3 pt -118.83 158.86 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 CA-C-O 121.89 0.852 . . . . 0.0 110.849 -179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.475 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 66.0 m-80 56.75 36.87 28.31 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.194 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.475 ' OD1' ' O ' ' A' ' 54' ' ' ASN . 25.1 p30 45.04 23.28 0.09 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.084 0.469 . . . . 0.0 110.535 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -105.67 113.97 27.85 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.66 0.743 . . . . 0.0 109.836 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.23 -30.64 69.54 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -62.17 -38.7 90.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.549 -0.72 . . . . 0.0 109.381 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.4 mt -83.56 63.45 7.38 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.6 p -89.49 160.86 16.53 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.121 0.962 . . . . 0.0 110.961 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -151.9 150.91 30.59 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.468 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.7 m -134.86 134.1 40.41 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.598 0.713 . . . . 0.0 110.069 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -123.33 135.85 54.39 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.844 0.83 . . . . 0.0 109.564 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.559 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -100.22 89.06 0.81 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.405 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 65.6 tttm 57.89 -72.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 122.286 -0.538 . . . . 0.0 110.259 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.559 ' N ' ' O ' ' A' ' 64' ' ' GLY . 98.1 m-20 -89.46 129.91 35.88 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-O 121.864 0.84 . . . . 0.0 110.21 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 67' ' ' VAL . 46.2 t -62.6 -0.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' A' ' 66' ' ' ASP . 66.0 tttm -62.92 -41.59 99.51 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.65 111.13 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 CA-C-O 121.808 0.813 . . . . 0.0 108.897 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -140.8 126.93 19.58 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.733 0.778 . . . . 0.0 110.333 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 p -84.01 168.32 16.05 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.493 0.663 . . . . 0.0 109.535 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.6 p -152.75 155.91 38.1 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.855 0.836 . . . . 0.0 110.704 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.2 p -75.7 166.03 24.16 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.738 0.78 . . . . 0.0 110.46 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.92 -44.15 97.37 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.027 0.442 . . . . 0.0 109.813 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.435 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.5 mp0 -69.24 -39.14 78.67 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.47 0.653 . . . . 0.0 109.844 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 40.2 tp -62.44 -34.9 77.71 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.749 -0.594 . . . . 0.0 109.513 -179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -61.93 -33.33 74.05 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -73.26 -38.25 66.03 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.532 -0.73 . . . . 0.0 109.863 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.4 mmm -66.22 -65.29 0.7 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.602 -0.687 . . . . 0.0 110.55 -178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.495 ' CD1' ' O ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -60.04 149.27 32.77 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.764 0.792 . . . . 0.0 110.38 -178.417 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -80.39 -105.02 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.34 0.591 . . . . 0.0 110.503 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -104.44 147.3 34.16 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.608 -0.683 . . . . 0.0 109.773 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.6 145.89 53.51 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 122.36 2.04 . . . . 0.0 112.073 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.461 ' CG ' HD21 ' A' ' 28' ' ' ASN . 74.4 mmt-85 -86.55 165.99 15.79 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.881 0.848 . . . . 0.0 110.671 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -87.66 -6.06 58.42 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 152.02 176.72 25.01 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.638 ' CD1' HD11 ' A' ' 90' ' ' ILE . 61.5 t80 -63.39 -37.14 86.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.922 -0.752 . . . . 0.0 109.25 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -70.69 -20.67 62.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.566 -0.709 . . . . 0.0 109.207 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -72.32 -48.67 40.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.634 -0.666 . . . . 0.0 109.741 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.638 HD11 ' CD1' ' A' ' 87' ' ' TYR . 14.3 pt -61.84 -41.18 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.623 -0.673 . . . . 0.0 109.869 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.554 HD11 ' CE2' ' A' ' 87' ' ' TYR . 12.0 mt -65.41 -40.28 93.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.577 -0.702 . . . . 0.0 109.721 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' OE1' ' O ' ' A' ' 93' ' ' HIS . 12.3 tm-20 -67.65 -38.95 84.54 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.795 -0.566 . . . . 0.0 109.813 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.413 ' O ' ' OE1' ' A' ' 92' ' ' GLU . 15.8 t-80 64.03 138.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.724 0.773 . . . . 0.0 109.969 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -59.12 -42.51 90.75 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -102.43 166.58 10.47 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.787 0.804 . . . . 0.0 110.053 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.43 ' ND1' ' O ' ' A' ' 96' ' ' HIS . 62.8 t-80 59.76 50.43 7.08 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-O 121.6 0.714 . . . . 0.0 109.314 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.555 ' NE2' ' ND1' ' A' ' 98' ' ' HIS . 51.9 p-80 -81.09 -12.54 59.25 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.555 ' ND1' ' NE2' ' A' ' 97' ' ' HIS . 53.7 p-80 . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 118.283 -0.865 . . . . 0.0 109.654 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.1 -46.58 89.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.448 -0.783 . . . . 0.0 109.91 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -63.04 -43.48 98.55 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.528 -0.732 . . . . 0.0 109.62 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -64.3 -42.25 96.46 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.695 -0.628 . . . . 0.0 110.08 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.74 -37.91 85.6 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.458 -0.776 . . . . 0.0 110.195 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.554 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 48.9 tp60 -62.93 -42.59 99.85 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.243 -0.911 . . . . 0.0 109.636 -179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -63.71 -40.38 96.63 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.472 -0.768 . . . . 0.0 109.369 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -63.4 -41.51 98.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.537 -0.727 . . . . 0.0 110.085 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -61.38 -42.05 98.09 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.508 -0.745 . . . . 0.0 109.847 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.01 -40.89 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.433 -0.792 . . . . 0.0 109.267 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.1 m -59.69 -43.46 94.05 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.642 -0.661 . . . . 0.0 109.247 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.24 -41.43 98.42 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.509 -0.744 . . . . 0.0 109.831 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.508 ' OH ' ' CE1' ' A' ' 70' ' ' PHE . 90.1 t80 -60.28 -49.11 78.92 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 95.3 mt -68.18 -41.2 81.83 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.634 -0.666 . . . . 0.0 110.641 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -65.05 -43.33 92.69 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.405 -0.809 . . . . 0.0 110.442 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -80.28 -15.94 55.81 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.386 -0.821 . . . . 0.0 110.456 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.506 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 8.3 m120 -104.2 -10.24 18.06 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.258 -0.901 . . . . 0.0 108.88 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 mt -144.11 88.11 7.63 Favored Pre-proline 0 N--CA 1.495 1.79 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 32' ' ' PHE . 53.2 Cg_exo -53.63 -30.89 57.51 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.51 2.14 . . . . 0.0 111.271 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -72.66 13.09 0.4 Allowed 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' PRO . 29.1 t80 -61.22 130.38 45.95 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.689 0.757 . . . . 0.0 110.236 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -118.96 -61.52 1.63 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 t -146.12 164.54 31.85 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 121.515 0.674 . . . . 0.0 109.935 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 9.4 p -133.5 138.16 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 CA-C-O 121.544 0.688 . . . . 0.0 109.624 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.2 m -126.76 115.24 19.07 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.66 0.743 . . . . 0.0 109.551 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -94.08 126.61 39.41 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.759 0.79 . . . . 0.0 109.563 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -156.34 86.1 1.01 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -177.43 -64.34 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 41.38 84.94 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.592 -0.693 . . . . 0.0 110.053 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -122.4 147.34 46.42 Favored 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.996 0.903 . . . . 0.0 110.034 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.528 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 53.0 p90 -88.81 120.24 30.03 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.503 0.668 . . . . 0.0 109.736 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -107.41 154.74 40.48 Favored Pre-proline 0 N--CA 1.494 1.757 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -46.38 -40.76 22.77 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.504 2.136 . . . . 0.0 111.907 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 46' ' ' GLY . 21.4 tt -70.02 -38.93 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.76 . . . . 0.0 109.615 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 173.25 -107.66 0.25 Allowed Glycine 0 N--CA 1.5 2.913 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.2 pt -121.23 143.81 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.626 -0.926 . . . . 0.0 110.17 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.0 t -119.26 134.91 54.95 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.653 0.739 . . . . 0.0 110.09 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -115.16 129.42 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.681 0.753 . . . . 0.0 109.359 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.5 t0 -133.49 142.4 48.23 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.831 0.824 . . . . 0.0 109.687 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -173.5 -165.16 29.89 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.8 p90 -142.39 165.09 28.38 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.678 -0.895 . . . . 0.0 110.274 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.5 pt -122.42 167.43 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 CA-C-O 121.934 0.873 . . . . 0.0 110.725 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 56' ' ' ASP . 69.1 m-80 57.31 34.25 24.46 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.662 0.744 . . . . 0.0 109.441 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 44.56 24.44 0.1 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 54' ' ' ASN . 99.5 m-20 -108.17 111.1 22.93 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.668 0.747 . . . . 0.0 109.293 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' HB3' ' HZ3' ' A' ' 57' ' ' LYS . 0.3 OUTLIER -59.22 -31.58 69.18 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.727 -0.608 . . . . 0.0 110.102 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -61.96 -38.77 89.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.45 -0.781 . . . . 0.0 109.495 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -82.74 75.26 9.65 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.474 -0.766 . . . . 0.0 109.534 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.2 m -95.85 156.13 16.46 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.922 0.867 . . . . 0.0 110.397 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -147.12 157.03 43.47 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.628 0.728 . . . . 0.0 109.923 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.1 m -141.29 138.87 33.49 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.692 -0.63 . . . . 0.0 109.873 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -144.94 144.62 31.16 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.649 0.737 . . . . 0.0 109.528 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.498 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -98.24 128.7 9.65 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.311 -1.115 . . . . 0.0 110.311 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.554 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 15.1 ptmt 24.76 -114.18 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 121.461 0.648 . . . . 0.0 111.238 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.454 ' C ' ' N ' ' A' ' 68' ' ' LYS . 67.2 t0 -71.54 66.58 0.5 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.158 0.98 . . . . 0.0 109.955 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 50.43 12.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 121.545 0.688 . . . . 0.0 109.455 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 64' ' ' GLY . 68.7 mmtt -61.43 115.57 3.99 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 122.051 0.929 . . . . 0.0 109.82 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.6 mt 55.16 115.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.87 0.843 . . . . 0.0 109.883 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.508 ' CE1' ' OH ' ' A' ' 24' ' ' TYR . 47.2 p90 -139.26 153.9 47.88 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.877 0.846 . . . . 0.0 110.203 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 p -141.74 160.86 39.32 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.621 0.724 . . . . 0.0 109.47 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 52.2 m -145.68 155.21 42.85 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 121.977 0.894 . . . . 0.0 110.414 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -65.88 163.03 17.78 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.943 0.878 . . . . 0.0 110.371 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.1 mp0 -58.5 -48.9 79.29 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.545 -0.722 . . . . 0.0 109.743 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.8 mp0 -64.54 -42.04 95.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.622 -0.674 . . . . 0.0 110.066 -179.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.17 -38.76 85.96 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.595 -0.691 . . . . 0.0 110.034 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -63.32 -33.67 76.03 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.411 -0.806 . . . . 0.0 109.402 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -73.01 -12.32 60.88 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.38 -0.825 . . . . 0.0 109.973 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.7 mtp -85.09 -8.21 58.76 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.26 -0.9 . . . . 0.0 109.38 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -63.64 135.91 57.11 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.591 0.71 . . . . 0.0 110.006 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -111.9 -25.04 9.63 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -120.13 153.7 55.54 Favored Pre-proline 0 N--CA 1.5 2.069 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.75 179.63 2.09 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.982 2.455 . . . . 0.0 113.094 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.46 ' NH1' ' CZ ' ' A' ' 70' ' ' PHE . 95.5 mtt-85 -63.86 126.72 28.54 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.067 0.937 . . . . 0.0 110.597 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -136.88 147.51 46.52 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.734 0.778 . . . . 0.0 109.911 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.88 164.44 44.67 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.567 ' CE2' HD11 ' A' ' 91' ' ' LEU . 71.8 t80 -61.5 -44.0 97.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.804 -0.821 . . . . 0.0 109.133 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -70.13 -31.11 68.49 Favored 'General case' 0 C--N 1.298 -1.63 0 O-C-N 121.476 -0.765 . . . . 0.0 109.803 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.86 -45.51 77.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.516 -0.74 . . . . 0.0 110.16 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 91' ' ' LEU . 28.8 pt -66.16 -35.91 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.43 -0.794 . . . . 0.0 109.57 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.567 HD11 ' CE2' ' A' ' 87' ' ' TYR . 35.7 mt -63.36 -42.41 98.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.558 -0.714 . . . . 0.0 109.682 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 92' ' ' GLU . 0.5 OUTLIER -79.38 -32.02 42.99 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.454 ' ND1' ' N ' ' A' ' 94' ' ' HIS . 56.5 t-80 60.2 -94.34 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.499 0.666 . . . . 0.0 110.684 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.454 ' N ' ' ND1' ' A' ' 93' ' ' HIS . 14.4 m-70 46.25 -167.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.888 0.852 . . . . 0.0 110.809 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -76.35 131.56 39.24 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.757 0.789 . . . . 0.0 110.359 -179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -64.04 -10.35 21.52 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -65.66 -40.37 92.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.529 -0.732 . . . . 0.0 109.354 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.503 ' O ' ' CG ' ' A' ' 98' ' ' HIS . 86.3 t60 . . . . . 0 N--CA 1.5 2.069 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.037 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 121.46 0.648 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.524 ' CZ ' ' NE2' ' A' ' 17' ' ' GLN . 91.3 t80 -62.51 -24.22 67.37 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.645 0.736 . . . . 0.0 109.242 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -65.31 -36.64 84.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.512 -0.742 . . . . 0.0 110.314 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -62.53 -41.33 98.8 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.148 -0.97 . . . . 0.0 109.838 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.62 -39.97 88.55 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.58 -0.7 . . . . 0.0 110.445 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.524 ' NE2' ' CZ ' ' A' ' 13' ' ' PHE . 96.6 mm-40 -64.78 -40.72 95.71 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.375 -0.828 . . . . 0.0 109.897 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -64.04 -40.99 97.54 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.31 -0.869 . . . . 0.0 110.23 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.71 -41.83 98.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.332 -0.855 . . . . 0.0 109.861 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -64.1 -42.43 96.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.407 -0.808 . . . . 0.0 109.745 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.7 t -64.9 -43.08 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.444 -0.785 . . . . 0.0 109.619 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.8 m -61.29 -44.65 96.87 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.497 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.58 HD11 ' NE2' ' A' ' 27' ' ' HIS . 49.1 tp -62.88 -42.81 99.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.367 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.507 ' CE1' ' OD1' ' A' ' 28' ' ' ASN . 58.7 t80 -61.05 -47.85 84.46 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.492 0.663 . . . . 0.0 109.712 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.0 mt -65.01 -39.6 93.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.435 -0.791 . . . . 0.0 109.703 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -59.75 -45.51 92.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.877 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.58 ' NE2' HD11 ' A' ' 23' ' ' LEU . 32.9 m-70 -74.47 -32.78 62.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -0.826 . . . . 0.0 109.757 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.507 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 32.1 m120 -87.19 -2.9 58.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.379 -0.826 . . . . 0.0 109.608 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 15.4 mt -146.76 89.85 5.63 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.229 -0.919 . . . . 0.0 109.034 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_exo -55.38 -30.19 71.77 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.454 2.103 . . . . 0.0 111.34 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -84.98 16.15 3.59 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 21.8 t80 -57.57 128.99 39.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.493 -0.755 . . . . 0.0 110.463 -179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.456 ' ND2' ' OD1' ' A' ' 54' ' ' ASN . 99.9 m-20 -113.8 -64.96 1.24 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.562 0.696 . . . . 0.0 109.331 179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -150.82 158.73 44.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.752 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.1 p -130.13 135.53 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.586 -0.696 . . . . 0.0 109.425 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.8 m -124.64 123.8 40.83 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.661 0.743 . . . . 0.0 109.368 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -96.31 137.54 35.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.647 -0.658 . . . . 0.0 109.241 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.6 p -147.12 -35.94 0.24 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.325 -0.859 . . . . 0.0 108.805 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -103.41 145.45 29.96 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.28 -0.887 . . . . 0.0 110.356 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -169.05 143.94 3.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.377 -0.827 . . . . 0.0 109.623 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -139.07 151.8 47.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.443 -0.786 . . . . 0.0 109.321 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -90.59 118.84 30.35 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.233 -0.917 . . . . 0.0 109.903 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.5 OUTLIER -90.43 158.07 43.77 Favored Pre-proline 0 C--N 1.306 -1.326 0 O-C-N 121.5 -0.75 . . . . 0.0 109.975 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -67.23 -27.12 41.48 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 123.099 2.532 . . . . 0.0 110.417 178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 tt -102.56 -8.23 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 171.06 -144.42 8.26 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.744 -1.343 . . . . 0.0 109.744 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.441 ' HA ' ' H ' ' A' ' 43' ' ' ASN . 42.0 pt -124.82 152.31 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.558 -0.966 . . . . 0.0 109.485 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.4 m -117.43 127.45 54.04 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.74 130.36 65.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.619 0.723 . . . . 0.0 109.36 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -130.06 125.84 36.2 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.588 0.709 . . . . 0.0 109.225 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -153.31 -161.46 10.36 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.4 p90 -144.15 160.88 40.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.529 -0.983 . . . . 0.0 109.874 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.6 pt -119.76 167.61 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-O 121.601 0.715 . . . . 0.0 110.728 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.456 ' OD1' ' ND2' ' A' ' 33' ' ' ASN . 66.4 m-80 59.11 32.92 22.56 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.629 0.728 . . . . 0.0 109.55 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 46.87 32.23 1.74 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.51 -0.744 . . . . 0.0 109.564 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -126.99 103.93 7.73 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.604 -0.685 . . . . 0.0 109.321 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -56.12 -17.13 6.32 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.416 0.627 . . . . 0.0 109.543 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -63.9 -38.32 90.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.35 -0.844 . . . . 0.0 108.889 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 31.5 mt -88.24 73.91 8.82 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 67.2 m -87.92 154.75 20.26 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.821 0.82 . . . . 0.0 110.771 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -147.62 158.82 44.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.722 -0.612 . . . . 0.0 109.587 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 87.2 m -134.11 136.53 43.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.467 -0.771 . . . . 0.0 109.706 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.49 141.07 48.62 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 67' ' ' VAL . . . -97.93 115.71 5.34 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 64' ' ' GLY . 88.6 tttt 26.06 -95.17 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.389 0.614 . . . . 0.0 111.795 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 48.0 p-10 -85.71 45.31 1.19 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.444 -0.785 . . . . 0.0 109.356 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 64' ' ' GLY . 2.1 t 51.93 35.3 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.164 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -62.83 -41.32 99.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.825 . . . . 0.0 109.008 179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 10.0 tp -127.57 136.32 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -126.46 129.78 49.37 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.645 0.736 . . . . 0.0 109.835 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.0 t -137.3 149.06 46.81 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.2 p -138.89 157.04 46.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 0.0 110.357 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.0 p -76.02 171.12 15.0 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.866 0.841 . . . . 0.0 110.758 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -59.37 -41.01 88.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.681 -0.637 . . . . 0.0 109.947 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.45 -48.79 59.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.168 -0.958 . . . . 0.0 109.886 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.69 -22.06 66.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.519 -0.738 . . . . 0.0 109.34 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -62.41 -36.18 81.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.559 -0.713 . . . . 0.0 110.077 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -62.68 -45.06 94.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 0.0 110.53 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 98.6 mtp -68.74 -38.03 79.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.09 -1.006 . . . . 0.0 109.482 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.512 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 72.4 t80 -75.68 119.39 19.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.319 -0.863 . . . . 0.0 110.03 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.401 ' NE2' ' O ' ' A' ' 80' ' ' PHE . 99.6 mm-40 -142.93 2.19 1.33 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.512 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 47.9 mt-10 -102.66 130.12 24.54 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.471 -0.768 . . . . 0.0 109.561 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -47.41 140.78 15.2 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.473 2.115 . . . . 0.0 113.151 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -76.97 140.07 40.32 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 121.6 0.714 . . . . 0.0 110.256 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -137.66 147.96 45.34 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.732 0.777 . . . . 0.0 109.698 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -58.47 161.15 12.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -62.46 -42.48 99.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.795 -0.827 . . . . 0.0 109.194 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 34.5 p-10 -68.54 -31.18 70.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.442 -0.786 . . . . 0.0 109.757 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 80.1 mm-40 -64.58 -48.6 74.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.451 -0.781 . . . . 0.0 109.848 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.426 HG13 ' N ' ' A' ' 91' ' ' LEU . 25.9 pt -68.18 -37.69 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.442 -0.786 . . . . 0.0 109.196 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.426 ' N ' HG13 ' A' ' 90' ' ' ILE . 57.9 tp -63.47 -41.94 98.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.46 ' C ' ' H ' ' A' ' 94' ' ' HIS . 79.6 tt0 -82.82 -18.65 39.72 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.379 -0.826 . . . . 0.0 109.226 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.404 ' O ' ' C ' ' A' ' 94' ' ' HIS . 46.1 m-70 67.89 -40.6 0.42 Allowed 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.914 -0.491 . . . . 0.0 110.014 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.46 ' H ' ' C ' ' A' ' 92' ' ' GLU . 50.0 t-80 38.26 84.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.723 0.773 . . . . 0.0 110.58 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -149.44 7.86 0.69 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.414 ' O ' ' CG ' ' A' ' 96' ' ' HIS . 1.9 t60 42.56 44.44 3.6 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.542 -0.724 . . . . 0.0 110.203 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 55.46 172.01 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.674 0.749 . . . . 0.0 110.665 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.638 179.943 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.431 0.634 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.403 ' O ' ' OE1' ' A' ' 17' ' ' GLN . 79.2 t80 -61.0 -44.83 96.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.777 -0.577 . . . . 0.0 109.564 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -64.27 -40.1 95.3 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.351 0.596 . . . . 0.0 109.86 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -62.59 -40.72 97.8 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.676 -0.64 . . . . 0.0 109.931 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.6 -38.75 87.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.66 -0.65 . . . . 0.0 110.237 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.518 ' N ' ' OE1' ' A' ' 17' ' ' GLN . 1.5 mp0 -64.09 -40.49 96.34 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.524 -0.735 . . . . 0.0 109.557 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -64.66 -40.21 95.03 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.249 0.547 . . . . 0.0 109.956 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -65.62 -41.01 93.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.705 -0.622 . . . . 0.0 110.052 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.495 ' NZ ' ' CE2' ' A' ' 87' ' ' TYR . 68.2 mttm -63.08 -44.29 96.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.605 -0.684 . . . . 0.0 110.101 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -67.48 -44.12 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.653 -0.654 . . . . 0.0 109.984 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.1 m -63.58 -43.8 95.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.574 -0.704 . . . . 0.0 109.841 -179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 tp -62.7 -43.16 99.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.724 -0.61 . . . . 0.0 110.317 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.482 ' CE1' ' OD1' ' A' ' 28' ' ' ASN . 66.8 t80 -62.35 -47.83 82.5 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.335 0.588 . . . . 0.0 109.803 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.46 -41.45 96.5 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.616 -0.678 . . . . 0.0 109.895 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -59.17 -43.98 92.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.769 -0.582 . . . . 0.0 109.931 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -68.66 -37.88 79.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.751 -0.593 . . . . 0.0 110.236 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.482 ' OD1' ' CE1' ' A' ' 24' ' ' TYR . 9.3 m120 -90.79 -0.71 57.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.4 -0.812 . . . . 0.0 109.322 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.4 mt -143.81 83.6 10.37 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 109.035 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_exo -54.88 -26.64 49.51 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.664 2.243 . . . . 0.0 111.284 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -78.38 0.36 25.96 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -59.0 129.14 40.75 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.723 0.773 . . . . 0.0 110.128 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -123.84 -57.82 1.6 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -147.49 155.58 42.03 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.73 0.776 . . . . 0.0 110.151 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.9 p -140.39 140.43 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.434 0.635 . . . . 0.0 109.41 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.9 m -128.67 125.9 39.02 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.898 0.856 . . . . 0.0 110.133 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -93.76 134.58 35.95 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.1 t -172.9 55.19 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.662 -0.649 . . . . 0.0 109.447 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' GLU . 24.3 t-20 -173.31 133.68 0.51 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.556 -0.715 . . . . 0.0 110.417 179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' A' ' 39' ' ' ASN . 96.9 mt-10 58.21 140.75 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 121.755 0.788 . . . . 0.0 110.683 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -144.54 -90.34 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.652 -0.655 . . . . 0.0 109.476 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -75.19 147.36 40.46 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.853 0.835 . . . . 0.0 110.243 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -173.96 168.1 2.26 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 46' ' ' GLY . 52.3 Cg_exo -50.91 -39.43 58.88 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.436 2.091 . . . . 0.0 111.814 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.5 pt -76.51 28.51 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 CA-C-O 121.518 0.675 . . . . 0.0 109.195 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 81.82 -99.42 2.0 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.9 pt -119.85 144.14 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.859 0.838 . . . . 0.0 109.948 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 67.7 m -119.66 122.44 41.51 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.695 0.759 . . . . 0.0 109.831 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.1 mt -110.02 125.89 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 CA-C-O 121.929 0.871 . . . . 0.0 109.382 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.6 t0 -142.9 139.85 30.95 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.01 0.91 . . . . 0.0 109.832 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -167.22 -162.62 19.37 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 20.6 p90 -140.46 161.72 37.05 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.908 -0.76 . . . . 0.0 110.628 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.1 pt -118.73 156.6 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 121.959 0.885 . . . . 0.0 110.689 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 56.3 33.89 23.09 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.048 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 62.2 m-20 47.95 32.68 2.94 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 121.17 0.51 . . . . 0.0 110.0 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -111.79 109.65 19.6 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.72 0.771 . . . . 0.0 109.317 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -57.28 -34.51 68.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.905 -0.497 . . . . 0.0 109.98 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -62.57 -39.25 93.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.599 -0.688 . . . . 0.0 109.742 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.7 mt -82.8 76.95 9.61 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.511 -0.743 . . . . 0.0 109.583 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 88.8 p -112.5 156.59 22.35 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.817 0.818 . . . . 0.0 110.478 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.404 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 32.1 p90 -150.49 158.45 44.17 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.461 0.648 . . . . 0.0 109.595 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 95.9 m -136.08 132.15 35.78 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.683 0.754 . . . . 0.0 110.135 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -137.07 140.95 42.37 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.832 0.825 . . . . 0.0 109.617 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 65' ' ' LYS . . . -109.08 140.2 15.55 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' O ' ' O ' ' A' ' 64' ' ' GLY . 53.6 mtpt 40.46 100.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.298 0.57 . . . . 0.0 110.598 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.504 ' OD1' ' NE2' ' A' ' 17' ' ' GLN . 99.0 m-20 57.93 -88.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.404 0.621 . . . . 0.0 109.712 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t -143.79 13.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 69' ' ' ILE . 68.5 mttm -70.51 131.45 44.04 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.872 0.844 . . . . 0.0 109.859 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.4 mt 52.59 103.82 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.683 0 CA-C-O 121.645 0.736 . . . . 0.0 109.41 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -138.25 153.86 49.09 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.891 0.853 . . . . 0.0 110.29 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 48.1 t -136.87 151.02 48.62 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.76 0.79 . . . . 0.0 109.614 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.2 t -134.66 150.18 50.61 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.822 0.82 . . . . 0.0 110.101 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 p -75.89 166.8 22.98 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.883 0.849 . . . . 0.0 110.221 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -59.66 -45.39 92.19 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.215 0.531 . . . . 0.0 109.639 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -65.28 -45.71 83.35 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.644 -0.66 . . . . 0.0 109.657 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.535 HD12 ' SD ' ' A' ' 79' ' ' MET . 58.6 tp -69.0 -28.94 67.05 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -65.83 -36.4 83.38 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.378 -0.826 . . . . 0.0 109.407 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -75.68 -7.54 54.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.449 -0.782 . . . . 0.0 109.914 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.535 ' SD ' HD12 ' A' ' 76' ' ' LEU . 77.0 mtp -82.42 -8.79 59.62 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -69.1 138.5 54.35 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.62 0.724 . . . . 0.0 109.464 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -128.04 -45.45 1.41 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -106.49 154.96 39.58 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.626 -0.671 . . . . 0.0 109.581 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -53.31 145.55 44.39 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.363 2.042 . . . . 0.0 112.649 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.9 mtm-85 -77.36 138.01 39.07 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 121.781 0.8 . . . . 0.0 109.969 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.86 150.47 47.17 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.858 0.837 . . . . 0.0 110.116 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.1 163.4 25.68 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.643 ' CE2' HD11 ' A' ' 91' ' ' LEU . 78.5 t80 -60.57 -44.7 95.9 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.6 0.714 . . . . 0.0 109.681 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 36.6 p-10 -68.43 -32.87 73.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.572 -0.705 . . . . 0.0 109.902 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 79.8 mm-40 -66.78 -45.34 78.75 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.664 -0.647 . . . . 0.0 110.447 -178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.6 pt -65.92 -35.52 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.512 -0.742 . . . . 0.0 109.631 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.643 HD11 ' CE2' ' A' ' 87' ' ' TYR . 34.3 mt -63.02 -42.13 99.72 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.553 -0.717 . . . . 0.0 109.748 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.502 ' O ' ' CG ' ' A' ' 93' ' ' HIS . 80.3 mm-40 -69.82 -40.48 75.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' A' ' 91' ' ' LEU . 20.9 p-80 40.06 -163.55 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.386 0.612 . . . . 0.0 110.773 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 94' ' ' HIS . 56.4 p-80 -118.56 119.45 34.55 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-O 121.715 0.769 . . . . 0.0 109.801 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -127.87 121.35 29.81 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.692 0.758 . . . . 0.0 109.78 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -113.36 108.74 17.64 Favored 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.898 0.856 . . . . 0.0 109.58 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -67.74 -43.79 79.11 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 118.231 -0.89 . . . . 0.0 109.728 -179.423 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -62.8 -42.6 99.78 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.538 -0.726 . . . . 0.0 110.132 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -62.86 -42.2 99.66 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.643 -0.661 . . . . 0.0 109.931 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -63.21 -40.45 97.51 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.368 0.604 . . . . 0.0 109.696 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -67.41 -39.23 85.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.674 -0.641 . . . . 0.0 109.587 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.442 HE22 HD11 ' A' ' 47' ' ' ILE . 86.4 mt-30 -63.38 -39.71 95.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.383 -0.823 . . . . 0.0 108.946 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.4 mttp -62.66 -42.12 99.43 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.825 -0.547 . . . . 0.0 110.017 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -66.88 -39.74 87.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.628 -0.67 . . . . 0.0 109.546 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.8 -43.54 96.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.752 -0.592 . . . . 0.0 109.541 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.4 t -65.39 -42.83 94.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.841 -0.537 . . . . 0.0 109.577 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.6 m -59.74 -45.25 92.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.568 -0.708 . . . . 0.0 109.263 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.94 -42.3 97.37 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.422 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 64.9 t80 -61.9 -46.92 87.27 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.46 ' CD2' ' CE2' ' A' ' 61' ' ' PHE . 92.6 mt -64.73 -39.3 93.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.564 -0.71 . . . . 0.0 109.883 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -60.72 -44.41 96.66 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.66 -0.65 . . . . 0.0 109.628 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 13.4 m170 -69.06 -41.98 76.87 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.658 -0.651 . . . . 0.0 110.186 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.422 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 44.2 m-80 -65.02 -41.36 95.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.432 -0.792 . . . . 0.0 109.338 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.7 mt -114.36 115.28 44.94 Favored Pre-proline 0 N--CA 1.485 1.307 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.5 -17.61 23.5 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 122.286 1.991 . . . . 0.0 110.652 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -95.87 8.87 42.4 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 34.9 t80 -51.65 126.85 18.8 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.82 0.819 . . . . 0.0 109.888 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -113.35 -65.88 1.14 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -147.17 160.56 42.3 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.591 -0.693 . . . . 0.0 110.319 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.9 p -140.16 139.73 36.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.4 0.619 . . . . 0.0 109.744 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.1 m -129.21 125.66 37.44 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 121.558 0.694 . . . . 0.0 109.318 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 49' ' ' ILE . 59.2 m-85 -91.4 142.88 27.2 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.653 0.74 . . . . 0.0 109.732 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.461 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -173.28 123.12 0.39 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.721 -0.612 . . . . 0.0 109.647 -179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 38' ' ' THR . 1.1 m120 82.22 157.22 0.13 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.911 0.862 . . . . 0.0 110.983 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 69.53 101.38 0.06 Allowed 'General case' 0 N--CA 1.487 1.38 0 CA-C-O 121.58 0.705 . . . . 0.0 109.733 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -144.12 -22.08 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -115.85 133.69 55.77 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.77 0.795 . . . . 0.0 110.108 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -170.57 154.98 4.77 Favored Pre-proline 0 N--CA 1.487 1.404 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 46' ' ' GLY . 71.4 Cg_exo -44.85 -36.55 11.01 Favored 'Trans proline' 0 N--CA 1.492 1.405 0 C-N-CA 122.37 2.047 . . . . 0.0 112.034 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 mt -78.93 34.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.811 0.815 . . . . 0.0 109.028 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 44' ' ' PRO . . . 80.33 -106.42 2.49 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.442 HD11 HE22 ' A' ' 17' ' ' GLN . 46.3 pt -118.31 149.65 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.652 0.739 . . . . 0.0 109.675 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.9 m -127.96 155.25 44.55 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.799 0.809 . . . . 0.0 110.457 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 37' ' ' PHE . 96.7 mt -122.92 125.51 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 CA-C-O 121.555 0.693 . . . . 0.0 109.395 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -128.69 130.54 47.3 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.67 0.748 . . . . 0.0 109.598 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -161.01 -163.14 13.5 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -143.11 162.5 35.37 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.748 -0.854 . . . . 0.0 109.685 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 pt -122.54 162.43 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-O 121.805 0.812 . . . . 0.0 110.438 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.1 m120 57.83 30.65 19.36 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.432 0.634 . . . . 0.0 109.736 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 48.89 33.02 4.1 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.39 0.614 . . . . 0.0 109.624 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -112.9 111.17 21.73 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.416 0.627 . . . . 0.0 109.501 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmmm -59.09 -33.02 70.34 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -62.47 -39.29 92.93 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.9 mt -84.52 83.03 8.15 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.408 0.623 . . . . 0.0 109.764 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.632 ' O ' HD23 ' A' ' 76' ' ' LEU . 88.2 p -95.9 148.32 22.74 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.433 0.635 . . . . 0.0 110.069 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.728 ' CD2' HD21 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -131.75 136.9 47.95 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 121.48 0.657 . . . . 0.0 109.985 -179.934 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 71.8 m -128.42 129.73 46.6 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.731 0.777 . . . . 0.0 110.061 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -141.29 149.22 40.97 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.674 0.75 . . . . 0.0 109.376 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -90.8 135.61 12.94 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 39.84 -109.26 0.09 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.402 0.62 . . . . 0.0 110.579 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 67' ' ' VAL . 20.1 p-10 -82.15 -67.15 0.81 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.682 -0.636 . . . . 0.0 109.682 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.528 ' H ' ' CG ' ' A' ' 66' ' ' ASP . 2.7 t -146.19 11.83 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.528 -0.732 . . . . 0.0 109.032 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 69' ' ' ILE . 88.8 tttt -65.77 117.93 8.9 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.291 -0.881 . . . . 0.0 110.414 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 68' ' ' LYS . 96.0 mt 56.94 125.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 CA-C-O 121.793 0.806 . . . . 0.0 110.016 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -139.07 129.83 26.14 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.419 -0.801 . . . . 0.0 110.387 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.7 m -126.83 154.57 44.15 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.582 0.706 . . . . 0.0 109.412 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.9 p -153.11 163.97 38.89 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.751 0.786 . . . . 0.0 110.46 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.5 p -67.98 163.87 21.24 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.817 0.817 . . . . 0.0 110.158 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -57.8 -48.82 78.61 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.759 -0.588 . . . . 0.0 109.584 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.25 -40.73 98.25 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.773 -0.579 . . . . 0.0 109.674 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.728 HD21 ' CD2' ' A' ' 61' ' ' PHE . 36.0 tp -76.42 -22.58 54.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.525 -0.734 . . . . 0.0 110.252 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -72.06 -36.66 69.64 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.443 -0.785 . . . . 0.0 109.402 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -79.1 -8.01 58.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.586 -0.696 . . . . 0.0 110.334 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.4 mmm -63.89 -42.31 97.49 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.352 -0.842 . . . . 0.0 109.691 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.497 ' CD1' ' O ' ' A' ' 80' ' ' PHE . 31.0 p90 -102.33 125.66 49.11 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.756 0.789 . . . . 0.0 109.72 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -97.68 -6.72 32.48 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.5 mt-10 -133.66 83.97 46.43 Favored Pre-proline 0 N--CA 1.501 2.081 0 O-C-N 121.485 -0.759 . . . . 0.0 109.445 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.81 138.13 76.26 Favored 'Trans proline' 0 N--CA 1.499 1.843 0 C-N-CA 123.04 2.494 . . . . 0.0 112.97 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.592 HH21 HG22 ' A' ' 90' ' ' ILE . 21.0 mmm180 -99.04 162.97 12.77 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 121.606 0.717 . . . . 0.0 110.358 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -91.04 -131.64 0.11 Allowed 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.31 0.576 . . . . 0.0 111.281 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -82.42 170.27 50.36 Favored Glycine 0 N--CA 1.498 2.803 0 CA-C-O 122.061 0.812 . . . . 0.0 111.971 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -61.76 -43.12 99.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.945 -0.738 . . . . 0.0 110.436 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.56 -38.76 92.35 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.447 -0.783 . . . . 0.0 109.635 -178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -60.84 -50.04 75.04 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.811 -0.556 . . . . 0.0 109.91 -179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.592 HG22 HH21 ' A' ' 84' ' ' ARG . 27.7 pt -69.24 -30.06 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.331 -0.856 . . . . 0.0 109.398 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.5 tp -64.24 -42.52 96.5 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.14 -37.74 84.32 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -95.91 111.81 23.7 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 121.772 0.796 . . . . 0.0 109.891 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -148.68 143.02 26.21 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.613 0.72 . . . . 0.0 110.167 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.499 ' O ' ' NE2' ' A' ' 97' ' ' HIS . 75.5 m80 -98.62 45.07 1.01 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.356 0.598 . . . . 0.0 109.395 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.534 ' O ' ' CG ' ' A' ' 97' ' ' HIS . 53.6 t-80 -62.61 -84.33 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.56 -0.713 . . . . 0.0 109.518 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 96' ' ' HIS . 21.8 p80 41.48 -166.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.739 0.78 . . . . 0.0 110.745 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.4 t60 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.221 -0.895 . . . . 0.0 109.648 -179.215 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.719 0.771 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -62.86 -33.59 75.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.557 0.694 . . . . 0.0 109.328 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -61.79 -33.32 73.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.495 -0.753 . . . . 0.0 109.632 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -62.71 -40.75 98.13 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.497 -0.752 . . . . 0.0 109.576 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.71 -39.61 88.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.483 -0.761 . . . . 0.0 109.628 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -63.45 -39.03 93.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.433 -0.792 . . . . 0.0 109.578 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -63.42 -41.47 98.71 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.588 0.709 . . . . 0.0 109.49 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -65.81 -42.4 90.7 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.626 -0.671 . . . . 0.0 109.975 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -63.66 -44.57 93.4 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 121.793 0.806 . . . . 0.0 110.036 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.21 -41.33 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.579 -0.701 . . . . 0.0 109.848 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -55.78 -46.22 77.99 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.478 -0.764 . . . . 0.0 110.029 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 29.6 tp -64.29 -42.4 96.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.551 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.621 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 89.1 t80 -59.96 -44.18 94.6 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.728 0.775 . . . . 0.0 109.317 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.85 -43.05 99.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.586 -0.696 . . . . 0.0 110.349 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.41 -43.44 97.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.373 -0.829 . . . . 0.0 110.537 -179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.688 ' CG ' HD11 ' A' ' 90' ' ' ILE . 33.8 m-70 -75.34 -32.11 60.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.472 -0.767 . . . . 0.0 110.992 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.621 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 29.3 m-80 -89.25 -6.94 56.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.102 -0.998 . . . . 0.0 109.47 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 29.3 mt -137.41 105.51 8.5 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.585 -0.697 . . . . 0.0 109.15 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.99 -16.49 32.38 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.436 2.09 . . . . 0.0 111.782 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -95.96 11.42 34.0 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.519 -0.738 . . . . 0.0 109.419 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -56.67 132.68 52.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.3 -0.875 . . . . 0.0 109.818 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -133.46 -48.69 0.83 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 t -148.31 154.71 40.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.293 -0.879 . . . . 0.0 110.219 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.3 p -134.89 137.13 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 CA-C-O 121.307 0.575 . . . . 0.0 109.557 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.6 m -128.41 121.86 30.03 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.588 0.708 . . . . 0.0 109.162 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -97.39 122.83 40.89 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.6 p -106.37 -22.39 12.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.709 -0.619 . . . . 0.0 109.68 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -110.49 145.76 37.14 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.296 -0.878 . . . . 0.0 110.561 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -166.02 80.49 0.28 Allowed 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -153.5 -161.91 1.36 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.429 -0.795 . . . . 0.0 109.777 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.478 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 54.3 p90 -102.47 127.34 49.55 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.596 0.712 . . . . 0.0 109.953 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.7 OUTLIER -96.97 164.63 17.49 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.719 -0.613 . . . . 0.0 109.457 -179.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -51.3 -39.96 62.02 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.36 2.04 . . . . 0.0 111.584 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 45' ' ' ILE . 97.0 mt -81.73 -4.08 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.557 -0.714 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.522 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 137.92 -104.7 0.46 Allowed Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 15.4 pt -127.37 133.78 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.711 -0.876 . . . . 0.0 109.879 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 69.7 m -138.77 149.08 44.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.587 -0.695 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.58 133.74 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 33.0 t0 -127.73 147.27 50.4 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.588 0.708 . . . . 0.0 109.9 -178.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.415 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -175.76 -165.57 31.91 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -144.11 164.53 30.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.768 -0.842 . . . . 0.0 109.77 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.1 pt -124.6 164.67 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-O 121.862 0.839 . . . . 0.0 111.344 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 58.43 32.38 22.03 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.643 0.735 . . . . 0.0 110.191 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.0 m120 48.89 29.84 2.48 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.639 -0.663 . . . . 0.0 109.838 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.49 111.74 22.43 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.448 -0.783 . . . . 0.0 109.988 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -58.88 -32.26 69.33 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.56 0.695 . . . . 0.0 109.441 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -62.57 -39.38 93.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.461 -0.774 . . . . 0.0 109.621 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.1 mt -82.03 78.94 8.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.533 -0.73 . . . . 0.0 109.81 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.6 t -104.39 155.16 19.02 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.656 0.741 . . . . 0.0 110.011 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -150.2 158.37 44.09 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.56 0.695 . . . . 0.0 109.825 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 91.7 m -134.17 138.7 45.34 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.87 135.29 48.2 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 121.589 0.709 . . . . 0.0 109.596 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.5 137.95 14.62 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.56 ' O ' ' N ' ' A' ' 67' ' ' VAL . 29.3 mmtp 40.37 -161.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.489 0.661 . . . . 0.0 111.12 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 68' ' ' LYS . 93.8 m-20 -59.2 77.95 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.935 0.874 . . . . 0.0 109.782 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 65' ' ' LYS . 2.0 t 41.68 24.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.659 0.742 . . . . 0.0 109.853 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 66' ' ' ASP . 28.6 tptp -64.06 -44.23 93.08 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.2 mt -121.13 128.46 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -132.74 129.84 39.2 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.492 0.663 . . . . 0.0 109.628 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 62.5 m -130.48 152.29 50.04 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.3 p -143.0 155.46 44.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.742 0.782 . . . . 0.0 110.509 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 77' ' ' ASP . 18.6 p -74.73 168.78 19.17 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.772 0.796 . . . . 0.0 110.719 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -59.93 -43.07 95.16 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.753 -0.592 . . . . 0.0 110.167 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -65.94 -36.18 82.64 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.71 0.767 . . . . 0.0 109.558 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 58.5 tp -85.01 -21.02 29.63 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.926 0.87 . . . . 0.0 109.035 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 73' ' ' SER . 29.9 t70 -66.86 -44.54 80.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.538 -0.726 . . . . 0.0 110.084 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -71.68 -18.4 62.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.507 -0.746 . . . . 0.0 110.033 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.75 -62.37 1.56 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.44 -0.788 . . . . 0.0 109.966 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 80' ' ' PHE . 0.5 OUTLIER -71.72 138.62 48.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.602 -0.686 . . . . 0.0 110.519 -178.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -137.52 40.26 2.42 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -115.39 150.83 45.2 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.333 -0.855 . . . . 0.0 109.412 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.46 156.22 66.4 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.695 2.264 . . . . 0.0 112.465 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.0 mtm-85 -69.93 132.74 46.44 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.808 0.813 . . . . 0.0 110.033 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.8 ' HZ3' HD12 ' A' ' 90' ' ' ILE . 20.2 pttp -155.21 145.68 22.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.591 0.71 . . . . 0.0 109.47 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -80.39 168.14 51.34 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -62.45 -45.24 93.97 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.676 0.75 . . . . 0.0 109.7 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 47.7 p-10 -64.96 -33.39 75.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.38 -0.825 . . . . 0.0 109.687 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.551 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 14.4 tm-20 -62.98 -51.87 65.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.627 -0.671 . . . . 0.0 109.953 -179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.8 HD12 ' HZ3' ' A' ' 85' ' ' LYS . 9.9 tt -67.82 -29.6 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.238 -0.914 . . . . 0.0 109.565 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.0 tp -61.92 -44.04 97.59 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.505 -0.747 . . . . 0.0 109.703 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.416 ' O ' ' O ' ' A' ' 93' ' ' HIS . 22.3 pt-20 -90.0 -33.21 16.44 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.959 0.885 . . . . 0.0 108.941 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.621 ' ND1' ' CE1' ' A' ' 95' ' ' HIS . 17.3 t-80 42.53 95.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.915 0.864 . . . . 0.0 110.12 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -66.25 -25.18 66.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.724 -0.61 . . . . 0.0 109.877 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.621 ' CE1' ' ND1' ' A' ' 93' ' ' HIS . 96.2 m-70 58.05 87.88 0.07 Allowed 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.888 0.851 . . . . 0.0 109.975 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -66.88 -40.54 87.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.585 -0.697 . . . . 0.0 109.548 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -152.83 -33.51 0.12 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 117.827 -1.082 . . . . 0.0 109.989 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.354 0.597 . . . . 0.0 109.712 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.471 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 91.3 m-85 -63.15 -28.77 70.29 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.516 -0.74 . . . . 0.0 109.882 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -58.67 -34.96 71.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.435 -0.79 . . . . 0.0 109.48 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -62.37 -40.34 96.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.53 -39.26 91.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.572 -0.705 . . . . 0.0 109.831 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -65.73 -39.83 91.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.383 -0.823 . . . . 0.0 109.582 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -63.85 -40.42 96.54 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.423 -0.798 . . . . 0.0 109.893 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.68 -41.95 98.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -0.839 . . . . 0.0 109.809 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -64.1 -41.97 97.08 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.389 -0.82 . . . . 0.0 110.159 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.03 -42.87 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.318 -0.864 . . . . 0.0 109.724 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.9 m -60.96 -44.49 97.23 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.872 . . . . 0.0 109.93 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.5 tp -62.56 -42.94 99.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.321 -0.862 . . . . 0.0 109.663 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.577 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 57.2 t80 -61.0 -42.79 99.14 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.56 -0.712 . . . . 0.0 109.763 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 29' ' ' ILE . 86.3 mt -62.77 -41.93 99.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.445 -0.784 . . . . 0.0 110.46 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.9 -40.28 94.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.067 -1.021 . . . . 0.0 110.327 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 -65.85 -40.32 91.62 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.408 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.577 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 99.3 m-20 -93.73 -4.75 49.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.246 -0.909 . . . . 0.0 109.56 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.41 ' N ' ' O ' ' A' ' 25' ' ' LEU . 8.7 mt -143.45 91.23 6.93 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -71.16 -16.67 31.76 Favored 'Trans proline' 0 N--CA 1.498 1.755 0 C-N-CA 122.447 2.098 . . . . 0.0 111.812 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -92.46 4.22 53.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.536 -0.728 . . . . 0.0 109.183 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -50.08 137.84 16.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.392 -0.817 . . . . 0.0 110.063 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.6 t-20 -111.59 -63.35 1.43 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.749 -0.594 . . . . 0.0 109.891 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.4 t -149.52 156.77 42.51 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.054 -1.029 . . . . 0.0 110.02 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.2 p -127.23 133.46 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.668 -0.645 . . . . 0.0 109.337 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.8 m -118.83 119.96 35.93 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -93.39 121.96 35.31 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.597 -0.69 . . . . 0.0 109.547 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 13.0 p -109.03 0.22 19.84 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 48.6 t30 59.01 -96.2 0.06 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.798 -0.564 . . . . 0.0 109.677 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.529 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 10.0 tm-20 60.14 -88.03 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.393 0.616 . . . . 0.0 110.845 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.529 ' N ' ' OE1' ' A' ' 40' ' ' GLU . 78.1 tt0 -57.36 148.89 21.77 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.466 -0.772 . . . . 0.0 110.362 -178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -151.68 96.75 2.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.263 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.423 ' O ' ' O ' ' A' ' 46' ' ' GLY . 36.1 m-20 -44.27 108.61 0.74 Allowed Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.564 -0.71 . . . . 0.0 109.835 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -51.05 -33.45 43.0 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.223 1.949 . . . . 0.0 111.664 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.4 mm -85.88 -5.26 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 43' ' ' ASN . . . -166.69 -127.93 0.94 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 20.6 pt -135.29 149.46 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.432 -1.04 . . . . 0.0 109.749 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.409 ' HB2' ' H ' ' A' ' 43' ' ' ASN . 22.6 t -142.79 141.67 31.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.134 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.0 mt -124.87 122.09 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.567 0.699 . . . . 0.0 109.707 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 54.7 t0 -104.5 154.71 19.55 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.468 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -175.42 -170.31 38.18 Favored Glycine 0 N--CA 1.487 2.038 0 C-N-CA 119.609 -1.281 . . . . 0.0 109.936 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -145.25 162.82 36.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.484 -1.009 . . . . 0.0 109.675 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.8 pt -123.37 162.81 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.457 0.646 . . . . 0.0 110.747 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 56.97 32.85 22.35 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.45 0.643 . . . . 0.0 109.85 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 47.97 29.62 1.76 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.0 109.989 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -111.68 108.37 17.8 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.491 -0.756 . . . . 0.0 109.525 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -58.59 -33.99 70.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.663 . . . . 0.0 109.599 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -62.48 -38.53 90.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.432 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.2 mt -82.76 82.63 8.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.191 -0.943 . . . . 0.0 109.095 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 6.5 m -100.6 160.83 14.03 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.598 0.713 . . . . 0.0 110.524 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -146.26 153.77 40.96 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.5 m -133.13 133.27 42.67 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.682 -0.636 . . . . 0.0 109.741 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -127.21 139.54 52.86 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 69' ' ' ILE . . . -112.16 130.83 9.83 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.314 -1.114 . . . . 0.0 110.314 -179.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 67' ' ' VAL . 45.8 tttt 43.57 -144.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.623 0.725 . . . . 0.0 110.869 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.2 62.31 0.13 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.533 0.682 . . . . 0.0 109.185 -179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' LYS . 1.9 t 51.8 19.67 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 CA-C-O 121.477 0.656 . . . . 0.0 109.639 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -64.09 -42.67 96.85 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.395 -0.815 . . . . 0.0 109.53 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' A' ' 64' ' ' GLY . 96.7 mt -131.96 118.55 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.584 -0.698 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -139.73 152.08 46.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.0 109.576 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 38.7 t -139.83 148.28 41.91 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.438 -0.789 . . . . 0.0 109.555 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.0 t -131.81 147.44 52.49 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.451 -0.781 . . . . 0.0 109.639 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -76.61 170.04 17.16 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.788 0.804 . . . . 0.0 110.789 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -61.99 -42.98 99.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.571 -0.705 . . . . 0.0 109.664 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -61.57 -40.95 96.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.4 -0.813 . . . . 0.0 109.239 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 45.8 tp -79.55 -26.62 41.37 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.382 -0.824 . . . . 0.0 109.347 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -62.15 -38.25 88.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.407 -0.808 . . . . 0.0 110.247 -178.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.6 pttt -59.11 -28.46 66.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.398 -0.814 . . . . 0.0 109.804 -178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 97.7 mmm -64.9 -35.29 80.65 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.432 -0.792 . . . . 0.0 109.658 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -63.9 135.95 56.97 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.301 -0.874 . . . . 0.0 109.841 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -112.39 -22.91 10.62 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -113.68 166.15 11.94 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.672 -0.643 . . . . 0.0 109.477 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -58.1 146.64 87.09 Favored 'Trans proline' 0 N--CA 1.499 1.819 0 C-N-CA 122.526 2.151 . . . . 0.0 112.677 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -67.59 124.04 22.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 109.428 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.479 ' O ' ' CE1' ' A' ' 24' ' ' TYR . 68.8 mmtt -134.97 154.95 51.53 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.771 0.796 . . . . 0.0 109.997 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.64 166.34 52.11 Favored Glycine 0 N--CA 1.481 1.693 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -60.73 -42.29 96.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 122.014 -0.698 . . . . 0.0 109.507 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.443 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 9.5 p-10 -64.61 -34.74 78.98 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.429 -0.794 . . . . 0.0 110.45 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' A' ' 89' ' ' GLU . 50.3 mp0 -64.77 -47.51 77.91 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.262 -0.899 . . . . 0.0 110.053 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.2 pt -69.93 -35.45 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 110.083 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 56.2 tp -63.27 -42.99 99.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.986 -1.071 . . . . 0.0 109.395 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.3 -37.64 83.71 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.346 -0.846 . . . . 0.0 109.547 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -82.84 121.57 27.1 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.389 -0.82 . . . . 0.0 109.791 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.504 ' C ' ' H ' ' A' ' 96' ' ' HIS . 62.4 t-80 -167.93 70.4 0.09 Allowed 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.387 -0.821 . . . . 0.0 109.036 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 80.8 m80 52.48 7.04 0.06 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.362 -0.836 . . . . 0.0 109.728 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.504 ' H ' ' C ' ' A' ' 94' ' ' HIS . 86.6 t60 -66.52 -38.7 87.75 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.741 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -70.43 136.46 49.56 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.347 -0.846 . . . . 0.0 111.019 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.758 -1.115 . . . . 0.0 109.03 179.216 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.503 0.668 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -61.21 -27.78 68.68 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -59.64 -37.97 80.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.883 -0.511 . . . . 0.0 109.848 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -62.51 -40.85 98.07 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.748 -0.595 . . . . 0.0 109.488 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.61 -39.37 88.33 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.433 ' OE1' ' O ' ' A' ' 65' ' ' LYS . 99.3 mm-40 -64.5 -40.42 95.62 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.411 ' HE2' HD21 ' A' ' 39' ' ' ASN . 97.5 mttt -63.15 -42.08 99.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.055 -0.403 . . . . 0.0 110.372 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -65.42 -46.44 79.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.889 -0.507 . . . . 0.0 109.857 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -65.67 -43.23 89.98 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.035 0.445 . . . . 0.0 110.199 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 17' ' ' GLN . 53.7 t -65.41 -43.85 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.6 m -62.37 -45.55 92.64 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.549 HD11 ' NE2' ' A' ' 27' ' ' HIS . 41.8 tp -63.38 -43.92 96.2 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.812 -0.555 . . . . 0.0 109.72 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.602 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 71.7 t80 -62.21 -47.09 86.01 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.06 -40.56 96.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.936 -0.477 . . . . 0.0 109.929 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -59.66 -46.06 90.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 122.042 -0.411 . . . . 0.0 110.281 -178.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.549 ' NE2' HD11 ' A' ' 23' ' ' LEU . 46.5 m-70 -72.29 -34.02 67.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.605 -0.685 . . . . 0.0 110.528 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.602 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 73.3 m-80 -86.58 -2.35 58.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.21 -0.932 . . . . 0.0 109.231 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 53.2 mt -136.56 104.86 9.17 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.72 -0.613 . . . . 0.0 109.472 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -73.03 -16.99 25.34 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 122.779 2.319 . . . . 0.0 111.298 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -94.01 8.03 42.93 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -56.5 133.55 53.43 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.927 0.87 . . . . 0.0 110.48 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -135.9 -51.08 0.72 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.2 t -148.64 156.09 41.94 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.663 0.744 . . . . 0.0 110.207 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.5 p -139.82 140.83 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 121.539 0.685 . . . . 0.0 109.601 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.0 m -126.09 118.52 25.46 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.723 0.773 . . . . 0.0 109.486 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -95.67 126.49 40.98 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.556 0.694 . . . . 0.0 109.742 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.7 p -97.34 -17.2 19.89 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.411 HD21 ' HE2' ' A' ' 18' ' ' LYS . 7.5 m120 59.82 33.57 21.7 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.379 0.609 . . . . 0.0 109.557 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -92.74 179.74 5.39 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.684 0.754 . . . . 0.0 110.452 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 59.1 150.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.692 0.758 . . . . 0.0 110.362 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -155.33 114.85 3.66 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.826 0.822 . . . . 0.0 109.594 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.432 ' N ' ' ND2' ' A' ' 43' ' ' ASN . 2.6 m120 -91.92 146.71 33.42 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.29 -21.43 41.46 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.395 2.063 . . . . 0.0 111.62 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.2 tt -76.61 -4.3 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.815 -0.553 . . . . 0.0 109.815 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.06 -123.51 1.19 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.6 pt -129.37 140.75 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.848 -0.795 . . . . 0.0 110.005 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 41.2 t -115.96 130.0 56.63 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.599 0.714 . . . . 0.0 109.926 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -114.9 127.23 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 CA-C-O 121.749 0.785 . . . . 0.0 109.284 179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -114.09 149.44 35.54 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.831 0.825 . . . . 0.0 110.0 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -174.02 179.88 45.09 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -143.23 166.02 25.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.76 -0.847 . . . . 0.0 110.609 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.6 pt -120.48 162.29 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 121.747 0.785 . . . . 0.0 110.439 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 57.52 33.6 23.48 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.609 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 44.59 29.23 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.015 0.436 . . . . 0.0 109.864 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -109.13 112.4 24.55 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-O 121.66 0.743 . . . . 0.0 109.811 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -57.99 -34.11 69.63 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.963 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.08 -38.72 92.29 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.723 -0.611 . . . . 0.0 109.354 -179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 73.6 mt -82.46 75.84 9.36 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.1 m -102.49 160.39 14.6 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.964 0.888 . . . . 0.0 110.72 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.2 154.95 40.79 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.631 0.729 . . . . 0.0 109.716 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 96.9 m -134.66 133.85 40.53 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.66 0.743 . . . . 0.0 110.643 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -129.98 138.09 50.65 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.773 0.797 . . . . 0.0 109.376 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.66 133.77 11.81 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.433 ' O ' ' OE1' ' A' ' 17' ' ' GLN . 71.3 tttt 37.9 -133.75 0.11 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.212 0.529 . . . . 0.0 110.894 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -73.84 62.1 0.81 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.0 t 45.39 24.42 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -64.09 -42.36 96.97 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -128.74 127.41 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.694 0.759 . . . . 0.0 109.013 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.56 ' CZ ' ' NE ' ' A' ' 84' ' ' ARG . 28.3 p90 -139.95 153.44 46.91 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.971 0.891 . . . . 0.0 110.621 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.9 t -140.84 152.41 45.11 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-O 121.688 0.756 . . . . 0.0 109.423 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 p -138.47 153.9 48.82 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.896 0.855 . . . . 0.0 110.144 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 89.0 p -82.64 168.89 16.85 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.817 0.818 . . . . 0.0 110.546 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.5 mp0 -65.44 -29.6 70.3 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -73.93 -50.4 20.25 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.756 -0.59 . . . . 0.0 109.583 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.0 tp -66.27 -19.97 65.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.613 -0.68 . . . . 0.0 109.484 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -64.0 -33.38 75.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.878 -0.514 . . . . 0.0 110.01 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.514 ' CG ' ' N ' ' A' ' 79' ' ' MET . 17.7 pttp -64.05 -43.83 94.33 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.611 -0.681 . . . . 0.0 109.617 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.514 ' N ' ' CG ' ' A' ' 78' ' ' LYS . 59.8 mmm -68.41 -38.33 81.17 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.527 ' CZ ' ' O ' ' A' ' 82' ' ' GLU . 73.8 t80 -66.27 124.43 22.64 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 121.551 0.691 . . . . 0.0 109.138 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -142.97 -1.2 1.1 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.527 ' O ' ' CZ ' ' A' ' 80' ' ' PHE . 6.2 tp10 -102.43 113.4 65.89 Favored Pre-proline 0 N--CA 1.487 1.4 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -48.87 149.01 8.28 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 C-N-CA 122.407 2.071 . . . . 0.0 112.805 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.56 ' NE ' ' CZ ' ' A' ' 70' ' ' PHE . 15.9 mmm180 -67.77 143.6 55.78 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.735 0.779 . . . . 0.0 110.064 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -140.4 -76.64 0.32 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 159.32 160.89 10.73 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.568 ' CE2' HD11 ' A' ' 91' ' ' LEU . 77.3 t80 -62.71 -44.8 95.29 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.407 0.622 . . . . 0.0 109.632 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -66.96 -34.74 78.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.684 -0.635 . . . . 0.0 110.095 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.559 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 47.8 mp0 -65.66 -44.58 85.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.346 -0.846 . . . . 0.0 110.891 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.2 pt -66.2 -38.75 82.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.595 -0.691 . . . . 0.0 110.3 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.568 HD11 ' CE2' ' A' ' 87' ' ' TYR . 31.1 mt -63.64 -40.47 96.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.665 -0.647 . . . . 0.0 109.556 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.81 -37.01 81.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.828 -0.545 . . . . 0.0 109.614 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.411 ' O ' ' C ' ' A' ' 94' ' ' HIS . 86.6 t60 -70.32 87.78 0.62 Allowed 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.491 0.662 . . . . 0.0 110.128 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.411 ' C ' ' O ' ' A' ' 93' ' ' HIS . 59.7 t-80 35.81 88.79 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.667 0.746 . . . . 0.0 110.725 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.574 ' CD2' ' H ' ' A' ' 95' ' ' HIS . 5.9 p80 -76.21 -54.83 6.23 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.57 ' CD2' ' H ' ' A' ' 98' ' ' HIS . 85.1 t60 -161.83 -64.76 0.05 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.484 ' O ' ' ND1' ' A' ' 97' ' ' HIS . 60.4 t-80 49.8 10.97 0.05 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.57 ' H ' ' CD2' ' A' ' 96' ' ' HIS . 85.9 t60 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.968 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -61.23 -45.92 92.57 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.497 -0.752 . . . . 0.0 109.244 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -65.79 -38.71 89.74 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.544 -0.722 . . . . 0.0 109.522 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -61.67 -41.44 97.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.407 -0.808 . . . . 0.0 109.769 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -64.53 -44.07 92.01 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.331 -0.856 . . . . 0.0 108.956 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -65.16 -39.06 92.43 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.574 -0.704 . . . . 0.0 109.363 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -63.76 -40.35 96.5 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.599 -0.688 . . . . 0.0 109.773 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -65.6 -38.35 89.21 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.444 -0.785 . . . . 0.0 109.597 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.29 -41.39 98.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.334 -0.853 . . . . 0.0 109.78 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.22 -43.67 97.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 109.302 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 93.0 m -61.43 -44.31 97.35 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.526 -0.734 . . . . 0.0 109.095 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 48.1 tp -62.53 -42.54 99.59 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.502 -0.749 . . . . 0.0 109.101 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.55 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 62.8 t80 -61.01 -47.28 87.17 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.434 -0.791 . . . . 0.0 109.402 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' ILE . 86.2 mt -63.51 -41.97 98.5 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.419 -0.801 . . . . 0.0 109.696 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -61.86 -42.24 98.82 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.469 -0.77 . . . . 0.0 110.046 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -69.21 -39.17 78.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.363 -0.836 . . . . 0.0 109.914 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.55 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 69.6 m-80 -86.26 -13.06 47.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 109.141 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.431 ' N ' ' O ' ' A' ' 25' ' ' LEU . 11.1 mt -137.25 81.38 31.78 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_exo -56.24 -28.24 70.37 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.481 2.121 . . . . 0.0 110.823 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -83.71 12.69 5.54 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -54.1 134.34 43.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.543 -0.723 . . . . 0.0 110.604 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -110.32 -63.17 1.42 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.2 t -150.42 157.95 43.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.215 -0.928 . . . . 0.0 109.95 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.3 p -126.13 133.19 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.599 -0.688 . . . . 0.0 109.318 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 52.5 m -121.02 120.22 34.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.62 -0.675 . . . . 0.0 109.242 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -94.26 140.62 29.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.593 -0.692 . . . . 0.0 109.402 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 45.0 p -116.41 -32.14 5.36 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -138.66 139.35 38.45 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.383 -0.823 . . . . 0.0 110.103 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -138.14 58.72 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -175.21 -170.17 0.42 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.629 -0.669 . . . . 0.0 109.791 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 t80 63.24 92.99 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.513 0.673 . . . . 0.0 109.94 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -171.37 119.99 0.47 Allowed Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.432 -0.793 . . . . 0.0 109.139 178.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -46.95 -42.97 25.11 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.283 1.989 . . . . 0.0 112.479 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.427 HG23 ' N ' ' A' ' 46' ' ' GLY . 10.5 tp -70.5 -37.53 70.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.423 -0.798 . . . . 0.0 109.816 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 45' ' ' ILE . . . -179.15 -87.91 0.07 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.9 pt -135.19 151.83 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.485 -1.009 . . . . 0.0 110.008 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 14.1 t -116.41 131.8 56.85 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.691 -0.631 . . . . 0.0 109.567 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 97.6 mt -106.83 116.49 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.477 ' OD1' HG23 ' A' ' 62' ' ' THR . 64.8 m-20 -119.73 139.32 52.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.34 -168.44 36.48 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -145.42 166.13 26.51 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.376 -1.073 . . . . 0.0 110.077 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.9 pt -120.84 162.85 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 121.576 0.703 . . . . 0.0 110.584 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 56.59 32.75 21.5 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.524 0.678 . . . . 0.0 109.547 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.0 m120 44.7 30.94 0.58 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.482 -0.761 . . . . 0.0 109.734 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -109.11 112.35 24.47 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.558 -0.714 . . . . 0.0 109.268 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -58.61 -33.35 69.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.669 -0.644 . . . . 0.0 109.807 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -62.86 -38.33 90.39 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.305 -0.872 . . . . 0.0 109.789 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 63.7 mt -83.76 79.92 9.31 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -0.89 . . . . 0.0 109.575 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.3 t -104.45 158.12 16.69 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.492 0.663 . . . . 0.0 110.063 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -144.56 145.87 32.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.479 -0.763 . . . . 0.0 109.513 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.477 HG23 ' OD1' ' A' ' 50' ' ' ASP . 52.1 m -130.24 131.3 45.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.05 138.17 48.08 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.632 -0.667 . . . . 0.0 109.277 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.606 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -96.53 99.51 2.33 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.7 tttp 43.86 -83.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.984 -0.715 . . . . 0.0 110.915 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.606 ' N ' ' O ' ' A' ' 64' ' ' GLY . 99.2 m-20 -73.86 125.37 28.02 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.263 -0.898 . . . . 0.0 110.009 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 67' ' ' VAL . 61.0 t -60.89 -1.01 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.531 -0.731 . . . . 0.0 109.453 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.463 ' H ' ' C ' ' A' ' 66' ' ' ASP . 54.6 mtpt -62.89 -41.22 99.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.263 -0.898 . . . . 0.0 109.408 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.2 116.21 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.473 -0.767 . . . . 0.0 109.346 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.473 ' CZ ' ' OH ' ' A' ' 24' ' ' TYR . 54.6 p90 -141.09 157.27 45.52 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.541 -0.724 . . . . 0.0 110.021 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 28.3 t -120.4 137.27 54.4 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 38.2 t -137.56 146.46 44.11 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.443 -0.786 . . . . 0.0 109.958 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.8 m -80.68 172.83 13.25 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.675 0.75 . . . . 0.0 110.275 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -66.0 -35.57 80.92 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.638 -0.663 . . . . 0.0 109.959 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -65.1 -33.3 75.71 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.495 -0.753 . . . . 0.0 109.772 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 62.5 tp -91.3 -24.44 19.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.212 -0.93 . . . . 0.0 109.019 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -65.11 -38.03 89.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.39 -0.818 . . . . 0.0 109.858 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -70.05 -12.8 61.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.221 -0.924 . . . . 0.0 110.283 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.7 mmm -79.37 -9.49 59.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.808 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -70.38 128.96 37.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.958 . . . . 0.0 109.828 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -109.4 -43.99 4.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.617 -0.677 . . . . 0.0 109.573 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -96.5 165.44 16.11 Favored Pre-proline 0 N--CA 1.497 1.898 0 O-C-N 121.419 -0.8 . . . . 0.0 110.175 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.55 146.91 89.21 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.297 1.998 . . . . 0.0 112.006 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.42 124.1 20.92 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.462 -0.774 . . . . 0.0 110.462 -179.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -138.43 140.91 39.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.718 -0.613 . . . . 0.0 109.429 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.8 174.14 49.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.589 ' CE2' HD11 ' A' ' 91' ' ' LEU . 83.4 t80 -60.9 -43.97 97.77 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.67 0.748 . . . . 0.0 109.767 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 48.4 p-10 -69.76 -32.98 71.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.124 -0.985 . . . . 0.0 110.166 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 78.5 mm-40 -66.25 -44.21 84.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.265 -0.897 . . . . 0.0 110.319 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 26.1 pt -65.57 -38.46 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 0.0 110.007 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.589 HD11 ' CE2' ' A' ' 87' ' ' TYR . 82.8 mt -62.5 -42.18 99.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.97 -1.081 . . . . 0.0 109.488 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.23 -37.96 84.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.343 -0.848 . . . . 0.0 109.13 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -83.99 101.69 11.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.49 -0.756 . . . . 0.0 109.348 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.441 ' CG ' ' N ' ' A' ' 95' ' ' HIS . 86.3 t60 -81.7 160.59 23.64 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.576 0.703 . . . . 0.0 110.334 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.441 ' N ' ' CG ' ' A' ' 94' ' ' HIS . 4.3 t-160 -80.09 126.42 31.05 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.489 -0.757 . . . . 0.0 110.34 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -66.25 -43.35 86.78 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.5 0.667 . . . . 0.0 109.359 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.436 ' ND1' ' NE2' ' A' ' 98' ' ' HIS . 66.3 t-80 -62.15 -42.78 99.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.616 -0.678 . . . . 0.0 109.615 -179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.436 ' NE2' ' ND1' ' A' ' 97' ' ' HIS . 93.4 m-70 . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.35 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.946 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -61.73 -43.02 99.67 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.87 0.843 . . . . 0.0 109.738 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CD1' ' OE2' ' A' ' 40' ' ' GLU . 85.0 m-85 -68.91 -35.23 76.58 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.01 -1.056 . . . . 0.0 110.484 -179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -62.54 -44.96 95.07 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.103 -0.998 . . . . 0.0 110.291 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -69.18 -36.03 76.91 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.155 -0.965 . . . . 0.0 109.758 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -63.16 -42.27 99.4 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.2 -0.938 . . . . 0.0 109.599 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -64.83 -40.86 95.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 0.0 109.232 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.04 -43.95 98.12 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.562 -0.711 . . . . 0.0 109.965 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -63.67 -43.32 97.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.412 -0.805 . . . . 0.0 109.942 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.3 -42.79 94.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.245 -0.909 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 m -60.99 -46.12 92.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.392 -0.818 . . . . 0.0 109.383 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.622 HD11 ' NE2' ' A' ' 27' ' ' HIS . 48.6 tp -63.98 -42.01 97.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.412 179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.526 ' CE2' ' OD1' ' A' ' 28' ' ' ASN . 77.4 t80 -61.42 -46.87 88.31 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.689 0.757 . . . . 0.0 109.87 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 99.1 mt -66.15 -39.24 89.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.348 -0.845 . . . . 0.0 110.237 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -60.31 -45.67 92.58 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.289 -0.882 . . . . 0.0 110.521 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.622 ' NE2' HD11 ' A' ' 23' ' ' LEU . 37.0 m-70 -69.51 -38.67 77.7 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.203 -0.935 . . . . 0.0 110.37 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.526 ' OD1' ' CE2' ' A' ' 24' ' ' TYR . 25.2 m120 -64.17 -40.53 96.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.187 -0.945 . . . . 0.0 109.81 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 49.4 mt -115.54 119.11 38.47 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.587 -0.695 . . . . 0.0 109.908 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -71.61 -19.42 28.07 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.597 2.198 . . . . 0.0 111.563 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -95.72 8.44 43.46 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.34 -0.85 . . . . 0.0 108.926 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -49.28 120.92 4.4 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.876 0.846 . . . . 0.0 110.032 -179.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -102.27 -68.71 0.81 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 121.701 0.762 . . . . 0.0 109.506 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.8 t -148.06 163.92 35.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.193 -0.942 . . . . 0.0 109.711 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.8 p -133.25 137.08 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.585 -0.697 . . . . 0.0 109.493 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.9 m -125.21 123.51 39.73 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.681 0.753 . . . . 0.0 109.368 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -88.42 132.35 34.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.667 -0.646 . . . . 0.0 109.562 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 81.8 p -107.15 -53.94 2.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.48 -0.763 . . . . 0.0 109.756 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -100.65 142.43 32.13 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.073 -1.017 . . . . 0.0 110.427 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.427 ' OE2' ' CD1' ' A' ' 14' ' ' PHE . 76.5 tt0 -162.47 106.84 1.15 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.531 -0.731 . . . . 0.0 109.09 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -170.03 177.77 4.18 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.465 -0.772 . . . . 0.0 110.043 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -61.68 -178.37 0.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.988 0.899 . . . . 0.0 110.61 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.536 ' N ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -175.45 167.75 1.73 Allowed Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.13 -40.54 76.65 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.295 1.997 . . . . 0.0 111.528 178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.9 -4.09 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.496 -0.752 . . . . 0.0 109.453 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' A' ' 43' ' ' ASN . . . 134.4 -94.31 0.26 Allowed Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 40.5 pt -126.9 149.14 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.626 -0.926 . . . . 0.0 110.04 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.6 t -127.28 130.89 50.39 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.666 0.746 . . . . 0.0 108.997 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -128.04 132.01 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 40.3 t0 -135.42 146.06 47.89 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.593 -0.692 . . . . 0.0 109.807 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -167.89 -164.9 24.38 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -144.28 161.5 38.76 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.492 -1.004 . . . . 0.0 110.028 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -121.05 159.63 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-O 122.09 0.948 . . . . 0.0 111.308 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.487 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.1 m-20 57.39 32.93 22.56 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.825 0.821 . . . . 0.0 109.902 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 49.42 30.86 3.55 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 0.0 109.536 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -112.6 108.15 17.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.401 -0.812 . . . . 0.0 109.528 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -59.7 -31.44 69.59 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.568 0.699 . . . . 0.0 109.518 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -62.76 -39.07 93.0 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.178 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.6 mt -83.09 77.52 9.73 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.226 -0.921 . . . . 0.0 109.684 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.4 p -104.08 161.74 13.75 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.803 0.811 . . . . 0.0 110.596 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -149.75 156.09 41.26 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.537 -0.727 . . . . 0.0 109.688 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.3 m -137.29 140.05 41.32 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.658 -0.652 . . . . 0.0 109.894 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -124.87 150.43 46.48 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.365 -0.835 . . . . 0.0 109.394 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 65' ' ' LYS . . . -126.86 94.64 0.42 Allowed Glycine 0 N--CA 1.503 3.15 0 N-CA-C 110.226 -1.15 . . . . 0.0 110.226 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 64' ' ' GLY . 88.6 tttt 52.84 115.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.945 0.879 . . . . 0.0 111.133 179.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 67' ' ' VAL . 65.6 t0 60.05 139.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.84 0.828 . . . . 0.0 110.591 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.566 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 26.3 t -58.48 0.63 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.558 0.694 . . . . 0.0 109.354 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.552 ' H ' ' C ' ' A' ' 66' ' ' ASP . 63.3 tttp -55.79 -40.05 72.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -0.883 . . . . 0.0 108.788 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.1 mt -113.45 119.03 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.483 -0.761 . . . . 0.0 109.084 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -138.63 125.91 21.62 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.413 -0.804 . . . . 0.0 109.365 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.8 m -107.71 150.57 26.78 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.609 0.719 . . . . 0.0 109.338 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.2 m -151.51 152.52 33.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.93 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.3 p -80.95 172.62 13.51 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.91 0.862 . . . . 0.0 110.874 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -58.77 -45.67 89.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.679 -0.638 . . . . 0.0 110.074 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -61.59 -48.96 78.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.15 -0.969 . . . . 0.0 110.22 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.59 -36.2 83.48 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.091 -1.006 . . . . 0.0 109.108 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -61.77 -41.45 97.73 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.343 -0.848 . . . . 0.0 109.38 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -66.1 -35.06 79.5 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.153 -0.967 . . . . 0.0 109.714 179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 87.5 mmm -62.26 -38.53 89.63 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.316 -0.865 . . . . 0.0 109.203 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -55.97 140.7 42.26 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.949 0.88 . . . . 0.0 110.104 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -106.45 -16.8 14.45 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -133.21 154.97 81.37 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 121.364 -0.835 . . . . 0.0 109.589 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.87 162.95 29.96 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 123.041 2.494 . . . . 0.0 112.69 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -63.77 135.76 56.9 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.921 0.867 . . . . 0.0 110.355 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 53.9 mttp -138.85 151.18 46.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.701 0.762 . . . . 0.0 109.641 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -62.98 152.81 45.97 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -60.07 -42.88 95.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.778 -0.836 . . . . 0.0 109.518 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -62.86 -37.97 88.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.329 -0.857 . . . . 0.0 109.777 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -60.7 -48.1 83.32 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.379 -0.825 . . . . 0.0 110.382 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.8 pt -71.01 -31.58 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.937 -1.102 . . . . 0.0 109.946 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.7 tp -64.04 -43.29 95.99 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.125 -0.984 . . . . 0.0 109.452 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.81 -41.94 82.32 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.855 0.836 . . . . 0.0 109.32 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.536 ' CG ' ' N ' ' A' ' 94' ' ' HIS . 82.4 t60 52.96 -108.85 0.44 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.537 -0.727 . . . . 0.0 110.613 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.575 ' O ' ' CG ' ' A' ' 95' ' ' HIS . 74.1 t60 -84.83 -2.8 58.2 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.223 -0.923 . . . . 0.0 109.671 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 94' ' ' HIS . 44.2 p-80 54.0 104.42 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.796 0 N-CA-C 114.544 1.313 . . . . 0.0 114.544 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -75.6 135.33 40.52 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.375 178.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.638 ' CG ' ' H ' ' A' ' 98' ' ' HIS . 70.8 t60 -81.7 -177.43 6.55 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.776 0.798 . . . . 0.0 110.695 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.638 ' H ' ' CG ' ' A' ' 97' ' ' HIS . 91.4 m-70 . . . . . 0 N--CA 1.493 1.717 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.784 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.315 0.578 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.517 ' CE2' ' NE2' ' A' ' 17' ' ' GLN . 69.0 t80 -62.77 -44.87 95.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.431 -0.793 . . . . 0.0 109.504 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -65.3 -37.95 88.71 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.467 0.651 . . . . 0.0 109.465 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -61.47 -40.96 96.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.508 -0.745 . . . . 0.0 109.293 -179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.54 -49.52 76.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.455 -0.778 . . . . 0.0 109.423 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.517 ' NE2' ' CE2' ' A' ' 13' ' ' PHE . 97.8 mt-30 -68.18 -33.61 74.76 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.552 0.692 . . . . 0.0 109.487 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.09 -44.83 95.8 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 121.494 0.664 . . . . 0.0 109.794 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.03 -39.53 87.03 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.668 -0.645 . . . . 0.0 110.133 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -63.47 -42.43 98.6 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.543 -0.723 . . . . 0.0 110.596 -179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.0 t -65.94 -42.01 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.402 -0.812 . . . . 0.0 109.735 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.5 m -60.5 -46.62 89.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.416 -0.803 . . . . 0.0 109.861 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.407 HD11 ' NE2' ' A' ' 27' ' ' HIS . 54.6 tp -64.73 -40.97 96.22 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.48 -0.763 . . . . 0.0 109.665 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.558 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 80.0 t80 -60.08 -44.71 94.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.491 -0.756 . . . . 0.0 109.849 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.45 -42.19 98.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.478 -0.764 . . . . 0.0 110.434 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -62.49 -40.45 96.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.495 -0.753 . . . . 0.0 110.334 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.407 ' NE2' HD11 ' A' ' 23' ' ' LEU . 11.3 m-70 -67.56 -35.22 78.63 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.495 -0.753 . . . . 0.0 110.585 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.558 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 71.4 m-80 -95.04 -1.3 52.53 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.112 -0.992 . . . . 0.0 109.515 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.1 mt -140.91 84.44 13.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.334 -0.854 . . . . 0.0 109.484 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -56.4 -28.94 75.3 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.709 2.273 . . . . 0.0 111.17 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -88.59 15.8 7.55 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.535 0.683 . . . . 0.0 109.164 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -49.85 130.5 21.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.458 -0.776 . . . . 0.0 109.912 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -115.85 -68.6 0.91 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.6 t -143.28 161.07 39.27 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.598 0.713 . . . . 0.0 110.058 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.6 p -136.61 139.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.445 HG21 ' OH ' ' A' ' 52' ' ' TYR . 91.9 m -123.45 125.79 45.57 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -90.88 136.88 32.78 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.615 0.722 . . . . 0.0 110.095 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' O ' ' A' ' 39' ' ' ASN . 14.4 p -117.02 -33.48 4.71 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' ' 38' ' ' THR . 9.0 p30 38.24 97.06 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 122.0 0.905 . . . . 0.0 110.838 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -157.9 36.08 0.26 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.545 -0.722 . . . . 0.0 109.394 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -144.58 121.33 11.21 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.221 -0.924 . . . . 0.0 109.871 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -109.97 121.7 45.86 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.538 0.685 . . . . 0.0 109.288 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.434 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 2.0 m-20 -106.46 137.39 19.42 Favored Pre-proline 0 C--N 1.303 -1.424 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -49.4 -31.36 23.05 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.569 2.179 . . . . 0.0 112.007 178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 37.0 pt -80.08 -10.14 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.513 -0.742 . . . . 0.0 109.588 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 43' ' ' ASN . . . 154.52 -176.78 32.19 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 120.179 -1.01 . . . . 0.0 110.636 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.416 ' H ' ' HE2' ' A' ' 65' ' ' LYS . 34.0 pt -83.84 140.09 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.67 -0.9 . . . . 0.0 110.424 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.434 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 72.2 m -111.15 126.46 54.87 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.607 0.718 . . . . 0.0 109.525 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.5 mt -94.56 126.15 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.625 -0.672 . . . . 0.0 109.516 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -115.48 149.09 38.65 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.839 0.828 . . . . 0.0 110.109 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.85 -177.83 46.12 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.445 ' OH ' HG21 ' A' ' 36' ' ' THR . 23.0 p90 -142.67 163.07 33.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.761 -0.846 . . . . 0.0 109.959 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 pt -121.94 162.78 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 CA-C-O 121.914 0.864 . . . . 0.0 110.825 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.5 m120 59.59 31.31 20.86 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.529 0.68 . . . . 0.0 110.298 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 48.32 30.71 2.38 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.587 -0.696 . . . . 0.0 109.573 179.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -113.67 109.74 19.08 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.761 0.791 . . . . 0.0 109.513 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -59.53 -32.69 70.55 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.345 0.593 . . . . 0.0 109.588 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -62.76 -38.63 91.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.333 -0.854 . . . . 0.0 109.075 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.5 mt -83.2 75.82 9.91 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.559 -0.713 . . . . 0.0 109.506 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.0 t -99.76 162.99 12.66 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.723 0.773 . . . . 0.0 110.427 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -149.08 155.23 40.42 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.626 0.727 . . . . 0.0 109.793 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 98.1 m -132.74 136.1 46.15 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-O 121.451 0.643 . . . . 0.0 110.11 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.77 136.96 47.97 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.724 0.773 . . . . 0.0 109.287 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.436 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -102.43 136.3 12.74 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.549 -1.021 . . . . 0.0 110.549 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' GLY . 60.9 mmtt 33.59 -121.72 0.09 Allowed 'General case' 0 N--CA 1.498 1.926 0 CA-C-O 121.434 0.635 . . . . 0.0 111.421 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 68' ' ' LYS . 99.2 m-20 -85.67 76.3 9.99 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 66' ' ' ASP . 2.1 t 38.26 28.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 CA-C-O 121.778 0.799 . . . . 0.0 110.003 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.498 ' N ' ' O ' ' A' ' 66' ' ' ASP . 18.3 mmmt -62.62 -42.83 99.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.51 -0.744 . . . . 0.0 109.346 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.2 mt -129.32 125.92 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.603 -0.686 . . . . 0.0 109.293 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -123.5 131.7 53.71 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.529 0.681 . . . . 0.0 109.573 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.6 m -127.49 150.63 49.59 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.5 p -136.93 155.2 50.05 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.911 0.862 . . . . 0.0 110.396 -179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.8 t -81.69 174.42 11.39 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.535 0.683 . . . . 0.0 110.066 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.2 -41.58 99.19 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.463 0.649 . . . . 0.0 109.822 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.499 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 58.3 mp0 -70.57 -44.32 67.63 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.326 -0.859 . . . . 0.0 109.549 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 55.2 tp -62.62 -37.48 86.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.708 -0.62 . . . . 0.0 109.596 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -54.86 -33.0 61.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.512 -0.742 . . . . 0.0 109.518 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -63.75 -40.84 97.71 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.352 -0.843 . . . . 0.0 110.057 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 85.2 mmm -65.93 -37.82 87.04 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.154 -0.966 . . . . 0.0 109.068 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -64.98 133.57 52.01 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.66 0.743 . . . . 0.0 109.988 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -116.5 -22.28 8.8 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.481 ' N ' ' CD ' ' A' ' 82' ' ' GLU . 1.7 pm0 -114.82 153.35 46.94 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.692 -0.63 . . . . 0.0 109.495 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.88 173.5 8.1 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.679 2.253 . . . . 0.0 112.735 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -64.35 139.74 58.8 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.931 0.872 . . . . 0.0 110.181 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -139.67 145.51 38.52 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.763 0.792 . . . . 0.0 109.848 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -74.42 154.8 47.96 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -61.99 -43.37 98.97 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.66 0.743 . . . . 0.0 110.002 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.36 -36.23 83.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.433 -0.792 . . . . 0.0 109.787 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.532 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 41.5 mp0 -62.89 -51.67 66.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.41 -0.806 . . . . 0.0 110.452 -179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 18.0 pt -64.62 -37.37 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.5 tp -63.23 -43.69 97.34 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.55 0.69 . . . . 0.0 110.077 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -71.77 -38.0 70.39 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 121.711 0.767 . . . . 0.0 108.97 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.52 ' CD2' ' O ' ' A' ' 89' ' ' GLU . 56.4 m-70 -67.57 -39.8 84.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.659 -0.651 . . . . 0.0 109.959 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -60.82 82.42 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.393 -0.817 . . . . 0.0 109.598 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.462 ' N ' ' O ' ' A' ' 93' ' ' HIS . 71.2 m80 -87.24 -12.3 47.14 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.479 ' N ' ' ND1' ' A' ' 96' ' ' HIS . 0.1 OUTLIER -151.13 164.96 35.3 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.331 -0.855 . . . . 0.0 109.714 179.749 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.526 ' O ' ' CG ' ' A' ' 98' ' ' HIS . 32.1 p-80 -66.35 -42.63 87.81 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-O 121.478 0.656 . . . . 0.0 109.749 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.526 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 75.9 m80 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.221 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.846 0 CA-C-O 121.544 0.688 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.437 ' CZ ' ' CZ ' ' A' ' 14' ' ' PHE . 50.8 p90 -67.95 -14.84 63.28 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.437 ' CZ ' ' CZ ' ' A' ' 13' ' ' PHE . 86.5 m-85 -59.91 -29.33 68.28 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.487 0.661 . . . . 0.0 109.321 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 56.0 t-20 -61.81 -37.82 85.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.519 -0.738 . . . . 0.0 109.479 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.56 -46.43 86.91 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.647 -0.658 . . . . 0.0 109.957 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.651 HE22 ' CG2' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -67.24 -37.12 83.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.5 -0.75 . . . . 0.0 109.218 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.51 -42.02 99.22 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.479 0.657 . . . . 0.0 109.453 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -65.0 -40.55 95.11 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -64.01 -40.67 96.87 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.313 0.578 . . . . 0.0 110.047 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.651 ' CG2' HE22 ' A' ' 17' ' ' GLN . 69.1 t -64.68 -41.57 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.543 -0.723 . . . . 0.0 109.412 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 m -59.73 -46.18 89.9 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.633 -0.667 . . . . 0.0 109.691 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.67 -40.14 96.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.692 -0.63 . . . . 0.0 109.732 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.644 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 59.0 t80 -58.84 -48.18 82.24 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.451 HD21 ' CZ ' ' A' ' 61' ' ' PHE . 82.1 mt -63.97 -40.56 96.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.601 -0.687 . . . . 0.0 110.068 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -49.81 -61.77 1.94 Allowed 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.759 -0.588 . . . . 0.0 111.259 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.634 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 20.9 p80 -71.47 -36.01 71.03 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.269 0.557 . . . . 0.0 110.523 -177.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.644 ' ND2' ' CE1' ' A' ' 24' ' ' TYR . 33.4 m-80 -64.52 -41.13 96.58 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.9 mt -127.12 114.1 21.74 Favored Pre-proline 0 N--CA 1.487 1.424 0 C-N-CA 120.56 -0.456 . . . . 0.0 109.921 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.91 -15.74 26.24 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.633 2.222 . . . . 0.0 111.087 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -91.81 4.56 52.57 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -55.98 129.01 37.99 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.872 0.844 . . . . 0.0 110.201 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -118.16 -59.64 1.88 Allowed 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -146.5 167.29 24.05 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.868 0.842 . . . . 0.0 110.171 -179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.52 134.41 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 CA-C-O 121.61 0.719 . . . . 0.0 109.573 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 53.0 m -115.64 105.8 13.17 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 121.737 0.779 . . . . 0.0 109.19 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -80.76 140.22 35.64 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.514 0.674 . . . . 0.0 109.76 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 76.1 p -120.09 -34.16 3.76 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 53.63 81.94 0.09 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.518 -0.739 . . . . 0.0 109.843 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -144.36 28.83 1.32 Allowed 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.435 ' OE1' ' OD2' ' A' ' 50' ' ' ASP . 82.7 tt0 -160.3 135.86 8.2 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.882 0.848 . . . . 0.0 109.987 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -123.83 144.54 49.67 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.707 0.765 . . . . 0.0 109.915 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -98.59 149.91 36.2 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.694 -0.629 . . . . 0.0 109.653 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -68.47 -20.97 41.01 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.889 2.392 . . . . 0.0 111.495 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.3 pt -98.63 -5.18 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.02 -168.93 40.63 Favored Glycine 0 N--CA 1.494 2.56 0 C-N-CA 120.074 -1.06 . . . . 0.0 110.688 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 39.8 pt -81.55 157.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 121.865 0.841 . . . . 0.0 109.922 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.6 t -138.67 141.96 39.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.595 0.712 . . . . 0.0 109.809 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 95.9 mt -112.78 127.88 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-O 121.876 0.846 . . . . 0.0 109.968 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.611 ' OD1' HG23 ' A' ' 62' ' ' THR . 24.8 m-20 -117.46 151.11 37.74 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.839 0.828 . . . . 0.0 110.021 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.84 -156.76 28.9 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -150.28 166.77 28.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.456 -1.026 . . . . 0.0 110.645 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 45.1 pt -121.76 167.8 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 CA-C-O 121.732 0.777 . . . . 0.0 110.354 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 57.99 33.7 23.48 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.459 0.647 . . . . 0.0 109.978 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 42.19 34.52 0.49 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.958 -0.464 . . . . 0.0 109.935 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -115.18 107.67 15.6 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.706 0.765 . . . . 0.0 109.659 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -58.6 -36.66 74.36 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.916 -0.49 . . . . 0.0 110.252 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -62.5 -37.03 84.43 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.245 -0.909 . . . . 0.0 109.804 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 61.9 mt -82.34 83.55 7.42 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.338 -0.851 . . . . 0.0 109.705 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 39.5 t -79.9 145.33 32.73 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 122.062 0.934 . . . . 0.0 110.668 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.451 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 33.2 t80 -140.29 130.37 24.88 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.756 0.789 . . . . 0.0 109.674 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.611 HG23 ' OD1' ' A' ' 50' ' ' ASP . 41.8 m -134.69 136.5 42.81 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.838 0.828 . . . . 0.0 110.11 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -134.22 144.07 48.21 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-O 121.943 0.878 . . . . 0.0 110.0 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -92.09 175.84 38.47 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -53.75 133.71 42.15 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.611 0.72 . . . . 0.0 110.943 -179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 68' ' ' LYS . 93.3 m-20 57.57 34.14 24.17 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.177 179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 69' ' ' ILE . 39.6 t 59.46 -78.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 66' ' ' ASP . 67.9 mttm 39.45 -89.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.524 0.678 . . . . 0.0 109.99 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' VAL . 96.9 mt -109.04 136.43 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.777 0.799 . . . . 0.0 109.304 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.522 ' CZ ' ' OH ' ' A' ' 24' ' ' TYR . 53.0 p90 -139.75 167.27 22.49 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 122.014 0.912 . . . . 0.0 109.868 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 27.3 t -133.67 150.86 51.55 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.975 0.893 . . . . 0.0 109.688 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.9 p -151.33 160.74 43.63 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.715 0.769 . . . . 0.0 110.156 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.0 p -75.72 164.98 25.72 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.951 0.882 . . . . 0.0 110.737 -179.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -61.05 -43.18 99.27 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -66.0 -34.0 77.09 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 42.4 tp -81.99 -26.16 34.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.404 -0.81 . . . . 0.0 109.5 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -66.5 -43.82 84.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.531 -0.73 . . . . 0.0 109.998 -178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -71.75 -9.87 58.92 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.558 -0.714 . . . . 0.0 110.713 -178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 92.9 mtp -82.27 -8.89 59.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.217 -0.927 . . . . 0.0 109.362 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -68.06 135.92 52.99 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.331 -0.855 . . . . 0.0 109.604 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -92.12 -74.21 0.52 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.305 0.574 . . . . 0.0 109.816 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.03 155.54 49.62 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.471 -0.768 . . . . 0.0 109.754 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.02 165.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.598 2.199 . . . . 0.0 112.724 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -68.25 136.25 53.24 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.787 0.803 . . . . 0.0 110.281 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.94 140.36 45.67 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.817 0.818 . . . . 0.0 109.905 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -71.5 165.92 53.24 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -62.25 -42.86 99.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.987 -0.714 . . . . 0.0 109.402 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -63.89 -37.71 88.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.64 -0.663 . . . . 0.0 110.324 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -65.21 -44.38 88.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.416 -0.802 . . . . 0.0 110.416 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.4 pt -72.66 -32.4 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.278 -0.889 . . . . 0.0 110.392 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.82 -40.39 96.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.105 -0.997 . . . . 0.0 109.342 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -50.33 -27.48 6.3 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -104.85 124.68 49.87 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.868 0.842 . . . . 0.0 110.153 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -149.94 -52.36 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 96' ' ' HIS . 42.0 p-80 -67.35 -34.02 76.45 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.347 -0.846 . . . . 0.0 109.643 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.403 ' O ' ' O ' ' A' ' 95' ' ' HIS . 58.5 t-80 57.27 157.45 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.83 0.824 . . . . 0.0 110.678 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.3 p-80 -153.72 162.66 41.05 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.839 0.828 . . . . 0.0 109.767 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.6 m170 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.124 -0.941 . . . . 0.0 109.746 -179.5 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.466 0.651 . . . . 0.0 109.67 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CZ ' ' CE2' ' A' ' 14' ' ' PHE . 22.4 p90 -65.27 -12.11 48.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.578 -0.701 . . . . 0.0 109.52 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.53 ' CE2' ' CZ ' ' A' ' 13' ' ' PHE . 90.2 m-85 -64.87 -37.52 87.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.175 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -62.88 -41.0 99.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.4 -0.813 . . . . 0.0 109.466 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.67 -40.19 92.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.333 -0.854 . . . . 0.0 109.587 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -65.18 -41.5 94.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.304 -0.873 . . . . 0.0 109.47 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.77 -40.73 97.39 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.384 -0.822 . . . . 0.0 109.351 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.15 -43.3 99.1 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 0.0 109.618 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -63.53 -42.64 98.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.332 -0.855 . . . . 0.0 109.879 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.47 -42.94 94.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 0.0 109.417 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.526 ' CG2' ' NZ ' ' A' ' 26' ' ' LYS . 76.1 m -60.73 -44.33 96.76 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.38 -0.825 . . . . 0.0 109.688 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.9 tp -63.71 -42.14 98.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.217 -0.927 . . . . 0.0 109.246 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.616 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 75.0 t80 -60.82 -44.58 96.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.577 -0.702 . . . . 0.0 110.232 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 29' ' ' ILE . 88.9 mt -63.64 -41.81 98.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.177 -0.952 . . . . 0.0 110.305 -178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.526 ' NZ ' ' CG2' ' A' ' 22' ' ' THR . 62.2 mttp -61.12 -40.75 94.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.91 -1.119 . . . . 0.0 110.444 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 69.0 m-70 -66.84 -38.84 87.18 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.969 -1.082 . . . . 0.0 110.178 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.616 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 97.5 m-20 -92.5 -7.29 47.78 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.086 -1.009 . . . . 0.0 109.358 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 25' ' ' LEU . 12.3 mt -142.15 81.83 13.84 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.576 -0.702 . . . . 0.0 109.427 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -57.73 -27.73 78.96 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.711 2.274 . . . . 0.0 111.093 179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -82.81 10.07 8.49 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.42 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 22.7 t80 -56.08 130.39 43.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 110.19 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -100.52 -68.76 0.8 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.539 -0.726 . . . . 0.0 109.448 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.6 t -152.33 168.22 26.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.197 -0.939 . . . . 0.0 109.722 -179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.5 p -129.03 138.22 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.4 m -125.12 124.67 42.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.606 -0.684 . . . . 0.0 109.27 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -104.43 118.47 36.7 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 t -141.26 18.64 2.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -151.09 106.67 3.37 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.557 -0.714 . . . . 0.0 109.113 179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -130.82 140.6 50.28 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.323 -0.86 . . . . 0.0 109.473 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -135.82 156.35 48.93 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.453 -0.779 . . . . 0.0 109.577 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.49 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 48.9 p90 -97.69 123.35 41.57 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 0.0 109.931 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.515 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 1.3 m-80 -96.05 153.97 39.01 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.466 -0.771 . . . . 0.0 109.145 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -66.64 -22.6 50.39 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.667 2.245 . . . . 0.0 111.299 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.4 pt -102.13 -3.84 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.49 -133.88 3.2 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.402 ' H ' ' HB2' ' A' ' 65' ' ' LYS . 39.9 pt -127.79 159.61 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.312 -1.111 . . . . 0.0 110.749 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.515 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 3.6 p -126.14 137.13 53.56 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.6 mt -124.88 130.66 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.536 -0.728 . . . . 0.0 109.344 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -130.6 137.51 49.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.621 -0.674 . . . . 0.0 109.382 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -166.75 -160.78 14.48 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.4 p90 -147.69 167.39 24.76 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.26 -1.141 . . . . 0.0 109.946 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.8 pt -121.2 160.44 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 121.953 0.882 . . . . 0.0 110.784 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 58.6 33.38 23.04 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 121.563 0.697 . . . . 0.0 109.873 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.8 m120 46.41 29.49 0.89 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.306 -0.871 . . . . 0.0 110.08 179.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -109.24 111.76 23.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.47 -0.769 . . . . 0.0 109.504 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -58.7 -34.29 71.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.529 -0.732 . . . . 0.0 109.495 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -61.76 -39.11 90.48 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.321 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.8 mt -81.79 73.89 8.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.074 -1.016 . . . . 0.0 109.083 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 18.7 m -100.56 156.5 17.26 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.6 0.714 . . . . 0.0 110.109 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.0 154.52 37.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.567 -0.708 . . . . 0.0 109.614 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 93.2 m -131.59 132.66 44.27 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -135.95 144.59 45.51 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.408 -0.807 . . . . 0.0 109.662 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -94.89 179.37 36.78 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HB2' ' H ' ' A' ' 47' ' ' ILE . 86.5 tttt -51.67 132.46 30.83 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.645 -0.915 . . . . 0.0 110.836 -179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 55.1 t0 56.01 38.09 29.56 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.672 0.749 . . . . 0.0 109.698 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 69' ' ' ILE . 36.1 t 58.56 -103.23 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.562 -0.711 . . . . 0.0 110.315 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? 62.09 -69.14 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.616 -0.678 . . . . 0.0 109.53 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.544 ' N ' ' O ' ' A' ' 67' ' ' VAL . 87.6 mt -105.73 121.84 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.855 . . . . 0.0 108.752 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -128.39 133.97 48.72 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 44.5 t -132.01 141.78 49.37 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.0 p -139.45 156.15 47.14 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.475 -0.766 . . . . 0.0 109.968 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 86.9 p -68.93 170.05 10.46 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.647 0.737 . . . . 0.0 110.805 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.62 -46.52 88.72 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.494 -0.754 . . . . 0.0 110.263 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -65.36 -45.7 83.09 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 0.0 109.618 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.58 -38.74 90.39 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.314 -0.866 . . . . 0.0 109.678 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.519 ' OD1' ' NH2' ' A' ' 84' ' ' ARG . 32.1 t70 -61.5 -36.02 79.31 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.128 -0.983 . . . . 0.0 109.59 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -68.86 -13.93 62.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.992 . . . . 0.0 110.207 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.2 mtp -82.2 -9.34 59.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.78 -1.2 . . . . 0.0 109.418 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -72.88 137.08 45.42 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.154 -0.966 . . . . 0.0 109.721 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -114.68 -11.39 12.34 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -127.1 153.43 76.65 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.71 -0.619 . . . . 0.0 109.917 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -58.86 152.13 59.8 Favored 'Trans proline' 0 N--CA 1.501 1.94 0 C-N-CA 122.323 2.015 . . . . 0.0 112.859 178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.519 ' NH2' ' OD1' ' A' ' 77' ' ' ASP . 26.2 mmt85 -66.29 138.74 57.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.907 . . . . 0.0 109.864 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -145.9 166.27 26.47 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.533 -0.729 . . . . 0.0 109.905 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.461 ' H ' ' CD ' ' A' ' 89' ' ' GLU . . . -82.31 167.8 47.56 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.158 -1.177 . . . . 0.0 110.158 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.578 ' CE2' HD11 ' A' ' 91' ' ' LEU . 71.6 t80 -62.01 -45.51 93.28 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.516 -0.99 . . . . 0.0 109.63 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -70.72 -29.14 65.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.839 -1.163 . . . . 0.0 109.005 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 86' ' ' GLY . 94.9 mt-10 -65.44 -45.33 84.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.395 -0.815 . . . . 0.0 109.936 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.6 pt -68.08 -33.42 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.171 -0.956 . . . . 0.0 109.749 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.578 HD11 ' CE2' ' A' ' 87' ' ' TYR . 41.4 mt -65.04 -41.23 95.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.126 -0.984 . . . . 0.0 110.384 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 94' ' ' HIS . 12.9 pt-20 -86.93 -13.14 45.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.11 -0.994 . . . . 0.0 109.653 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.564 ' O ' ' N ' ' A' ' 95' ' ' HIS . 76.8 t60 -44.16 91.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.393 -0.817 . . . . 0.0 110.609 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.525 ' N ' ' O ' ' A' ' 92' ' ' GLU . 79.8 m80 41.64 19.21 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.543 0.687 . . . . 0.0 109.979 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.564 ' N ' ' O ' ' A' ' 93' ' ' HIS . 85.2 t60 -66.22 -41.1 90.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 0.0 109.261 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.22 -45.1 95.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.854 . . . . 0.0 109.314 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -66.73 -39.34 87.94 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.292 -0.88 . . . . 0.0 109.221 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 83.0 t60 . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.755 179.998 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 121.629 0.728 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -60.78 -43.7 97.72 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.771 0.796 . . . . 0.0 109.047 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -59.88 -43.09 94.95 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.631 . . . . 0.0 109.555 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -62.95 -41.6 99.55 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.688 0.756 . . . . 0.0 109.007 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.99 -38.53 88.75 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.547 0.689 . . . . 0.0 109.398 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 65' ' ' LYS . 67.4 tp60 -61.98 -43.56 98.58 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.614 -0.679 . . . . 0.0 110.148 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -63.16 -40.21 96.9 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 121.658 0.742 . . . . 0.0 109.273 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -63.67 -44.34 94.04 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.546 0.689 . . . . 0.0 109.56 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -63.73 -42.94 97.81 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.427 0.632 . . . . 0.0 110.269 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 77.9 t -64.38 -44.69 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 121.641 0.734 . . . . 0.0 109.707 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.9 m -62.16 -42.4 99.22 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.55 0.691 . . . . 0.0 109.875 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.518 HD11 ' NE2' ' A' ' 27' ' ' HIS . 49.2 tp -60.8 -44.36 96.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.489 -0.757 . . . . 0.0 109.597 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -62.46 -45.88 91.04 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.598 0.714 . . . . 0.0 110.186 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.2 mt -64.33 -39.46 93.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.482 -0.761 . . . . 0.0 110.069 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -60.55 -42.0 95.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.521 -0.737 . . . . 0.0 109.804 -179.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.518 ' NE2' HD11 ' A' ' 23' ' ' LEU . 51.8 m-70 -66.51 -39.08 88.48 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.519 0.676 . . . . 0.0 110.0 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -87.97 -2.98 58.95 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.462 -0.774 . . . . 0.0 109.435 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.413 HD11 HD11 ' A' ' 76' ' ' LEU . 24.3 mt -142.53 83.1 12.15 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.67 . . . . 0.0 109.215 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.63 -32.06 73.38 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.597 2.198 . . . . 0.0 111.159 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -83.87 16.05 3.0 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.587 0.708 . . . . 0.0 109.445 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -58.73 129.19 40.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.497 -0.752 . . . . 0.0 109.883 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -108.98 -58.4 2.02 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.1 t -153.91 164.32 38.6 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.246 -0.908 . . . . 0.0 110.447 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.6 p -129.09 135.84 61.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 100.0 m -128.82 125.36 37.58 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.701 0.762 . . . . 0.0 110.01 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -99.16 147.42 25.13 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 p -142.17 -76.21 0.28 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.489 0.661 . . . . 0.0 109.595 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -78.18 128.48 33.82 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.662 0.744 . . . . 0.0 110.571 -179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -139.97 69.6 1.36 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -81.24 162.76 23.41 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.87 0.843 . . . . 0.0 110.213 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -99.4 119.88 38.69 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.777 0.799 . . . . 0.0 110.168 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.73 ' ND2' ' H ' ' A' ' 43' ' ' ASN . 0.1 OUTLIER -95.15 152.25 39.33 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -47.36 -38.89 27.44 Favored 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.671 2.247 . . . . 0.0 112.077 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 68.2 mt -69.9 -41.17 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.58 -0.7 . . . . 0.0 109.961 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.409 ' O ' ' ND2' ' A' ' 43' ' ' ASN . . . -179.41 -135.1 2.32 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.418 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.554 ' C ' HD21 ' A' ' 43' ' ' ASN . 15.8 pt -103.74 139.26 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.758 -0.848 . . . . 0.0 109.801 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.513 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 50.7 m -116.54 124.96 51.17 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.579 0.705 . . . . 0.0 109.591 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -112.15 125.48 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.408 ' OD1' ' O ' ' A' ' 61' ' ' PHE . 38.8 t70 -124.25 153.67 41.33 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.861 0.839 . . . . 0.0 109.932 -178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 178.54 -167.49 38.0 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.469 ' CE2' ' NZ ' ' A' ' 57' ' ' LYS . 19.7 p90 -142.17 163.73 32.06 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.831 -0.805 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.7 pt -120.78 161.53 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 121.674 0.749 . . . . 0.0 110.027 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.494 ' N ' ' OD1' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 58.89 32.16 21.98 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.623 0.725 . . . . 0.0 109.844 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 45.82 32.11 1.2 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.656 -0.653 . . . . 0.0 109.595 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -115.57 109.51 17.89 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 121.416 0.627 . . . . 0.0 109.541 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' NZ ' ' CE2' ' A' ' 52' ' ' TYR . 69.6 mmtt -57.85 -33.36 68.57 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.408 0.623 . . . . 0.0 110.032 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -60.5 -39.26 87.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.306 -0.871 . . . . 0.0 109.0 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.3 mt -82.44 68.77 9.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.445 -0.785 . . . . 0.0 109.373 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 85.6 p -91.93 161.39 14.84 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.615 0.722 . . . . 0.0 109.855 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.408 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 49.2 p90 -155.07 160.9 41.35 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.63 0.728 . . . . 0.0 109.725 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 99.6 m -140.68 144.57 35.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.611 -0.681 . . . . 0.0 109.7 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.47 140.69 26.42 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 65' ' ' LYS . . . -105.13 147.84 16.38 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.538 ' O ' ' NE2' ' A' ' 17' ' ' GLN . 63.8 mmtt 35.22 -122.9 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.439 0.637 . . . . 0.0 111.232 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 68' ' ' LYS . 97.7 m-20 -88.21 86.84 7.15 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 121.774 0.797 . . . . 0.0 109.921 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.505 ' H ' HE22 ' A' ' 17' ' ' GLN . 2.0 t 45.67 14.61 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 121.661 0.743 . . . . 0.0 109.668 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 66' ' ' ASP . 25.5 tptt -78.44 136.46 37.63 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.878 0.847 . . . . 0.0 110.05 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' A' ' 68' ' ' LYS . 9.4 mm 49.15 99.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.59 0.709 . . . . 0.0 109.513 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -135.79 153.97 51.36 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.687 0.756 . . . . 0.0 110.083 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.3 p -136.53 157.25 47.22 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 26.6 m -133.95 153.08 52.01 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.935 0.874 . . . . 0.0 110.135 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.2 p -65.13 168.55 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.765 0.793 . . . . 0.0 110.744 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.17 -51.81 68.17 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.467 0.651 . . . . 0.0 109.82 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.95 -43.36 92.96 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.526 -0.734 . . . . 0.0 109.715 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.413 HD11 HD11 ' A' ' 29' ' ' ILE . 56.6 tp -63.8 -39.1 93.43 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -61.02 -38.03 84.67 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 121.631 0.729 . . . . 0.0 109.371 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -66.97 -36.64 82.66 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.334 -0.854 . . . . 0.0 109.509 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 81' ' ' GLN . 79.1 mtp -63.32 -41.34 98.91 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.467 -0.771 . . . . 0.0 109.943 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -43.44 99.34 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.922 0.868 . . . . 0.0 110.238 -179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 79' ' ' MET . 57.7 tt0 -67.79 -36.34 80.28 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 120.194 -0.603 . . . . 0.0 109.642 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -105.89 152.66 40.29 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.499 -0.75 . . . . 0.0 109.921 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.54 167.62 20.34 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.81 2.34 . . . . 0.0 112.844 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -63.78 140.22 58.85 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.777 0.798 . . . . 0.0 110.212 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -144.52 -111.34 0.1 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.685 -0.634 . . . . 0.0 109.843 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -176.94 161.06 28.61 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.971 -1.109 . . . . 0.0 110.452 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -60.88 -44.39 97.16 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 121.385 0.612 . . . . 0.0 110.059 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -58.76 -39.79 82.01 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.534 0.683 . . . . 0.0 110.121 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -57.96 -56.36 22.94 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.247 -0.908 . . . . 0.0 109.667 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.8 pt -65.64 -26.14 38.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.436 -0.79 . . . . 0.0 110.029 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.58 HD23 ' O ' ' A' ' 91' ' ' LEU . 1.2 tt -63.61 -35.85 81.87 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.473 -0.767 . . . . 0.0 109.503 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -51.71 -30.8 23.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.257 -0.902 . . . . 0.0 109.322 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 40.5 p-80 -155.1 119.34 4.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.335 -0.853 . . . . 0.0 109.651 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -67.51 -40.82 85.16 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.655 0.741 . . . . 0.0 109.087 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 38.3 p-80 -156.99 156.58 33.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.438 -0.789 . . . . 0.0 110.188 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -145.32 135.04 23.46 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.555 0.693 . . . . 0.0 109.362 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -94.36 122.52 37.0 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.522 0.677 . . . . 0.0 109.774 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.417 ' C ' ' ND1' ' A' ' 98' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.227 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.943 0.878 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -66.06 -18.2 65.19 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.606 0.717 . . . . 0.0 109.443 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -67.9 -33.95 75.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.445 -0.785 . . . . 0.0 109.842 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.415 ' O ' ' OE1' ' A' ' 19' ' ' GLU . 90.9 m-20 -61.62 -46.76 88.45 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.462 -0.774 . . . . 0.0 110.062 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.31 -36.07 71.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.443 -0.786 . . . . 0.0 109.588 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.458 HE22 ' H ' ' A' ' 67' ' ' VAL . 68.4 tp60 -66.27 -41.13 90.33 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.578 -0.701 . . . . 0.0 109.521 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -64.85 -40.93 95.96 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.557 -0.714 . . . . 0.0 109.58 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.53 ' OE1' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -61.35 -42.37 98.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.575 -0.703 . . . . 0.0 109.583 -179.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.3 -42.51 96.34 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.599 0.714 . . . . 0.0 109.175 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 81.4 t -65.43 -43.61 94.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.476 0.655 . . . . 0.0 109.659 -179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.8 m -61.74 -45.1 95.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.694 -0.629 . . . . 0.0 110.103 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 tp -63.31 -41.01 98.89 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.949 0.881 . . . . 0.0 109.976 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.623 ' CZ ' ' ND2' ' A' ' 28' ' ' ASN . 62.9 t80 -66.43 -39.26 88.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.499 -0.75 . . . . 0.0 109.52 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 41.0 mt -61.82 -47.31 85.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.588 -0.695 . . . . 0.0 111.017 -178.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.97 -34.56 78.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.503 -0.748 . . . . 0.0 110.314 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -72.46 -35.92 68.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.541 -0.725 . . . . 0.0 110.277 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.623 ' ND2' ' CZ ' ' A' ' 24' ' ' TYR . 69.9 m-80 -94.72 -1.28 53.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.292 -0.88 . . . . 0.0 109.483 -179.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 mt -140.93 86.79 11.41 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.389 -0.82 . . . . 0.0 109.346 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -55.98 -31.92 83.96 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.678 2.252 . . . . 0.0 111.303 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -82.25 13.46 3.5 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 32' ' ' PHE . 25.1 t80 -57.2 130.68 47.24 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.758 0.79 . . . . 0.0 109.826 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -116.42 -66.82 1.04 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -141.06 165.31 27.9 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.507 -0.746 . . . . 0.0 109.935 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -133.68 138.84 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-O 121.42 0.629 . . . . 0.0 109.357 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.526 HG21 ' OH ' ' A' ' 52' ' ' TYR . 97.8 m -124.91 115.75 21.11 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.689 0.757 . . . . 0.0 109.494 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -86.85 135.47 33.32 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.3 p -111.53 -35.79 5.7 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 55.74 32.38 19.32 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.507 0.67 . . . . 0.0 109.363 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -94.33 16.7 14.4 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.467 -0.771 . . . . 0.0 109.561 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -134.68 148.39 50.32 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.298 -0.876 . . . . 0.0 109.929 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.483 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 35.1 p90 -161.18 125.08 3.38 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.512 0.672 . . . . 0.0 109.313 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 43' ' ' ASN . 4.3 p30 -91.02 150.99 42.76 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.527 -0.733 . . . . 0.0 109.847 -179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -65.06 -24.36 59.81 Favored 'Trans proline' 0 N--CA 1.495 1.594 0 C-N-CA 122.599 2.199 . . . . 0.0 111.766 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.6 tp -70.39 -26.89 29.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 121.616 0.722 . . . . 0.0 109.382 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.38 -119.93 0.63 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.4 pt -126.2 158.98 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.691 -0.888 . . . . 0.0 110.533 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.4 m -141.67 139.75 33.05 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.2 127.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 CA-C-O 121.55 0.691 . . . . 0.0 109.49 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 51' ' ' GLY . 67.5 t0 -119.89 142.92 48.25 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.555 0.693 . . . . 0.0 109.571 -179.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 50' ' ' ASP . . . -173.09 -176.15 41.41 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' OH ' HG21 ' A' ' 36' ' ' THR . 13.3 p90 -143.1 164.03 31.25 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.597 -0.943 . . . . 0.0 110.341 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.4 pt -119.03 164.47 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.793 0.806 . . . . 0.0 110.282 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 56' ' ' ASP . 68.7 m-80 58.11 34.35 24.1 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.543 0.687 . . . . 0.0 109.734 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 45.25 20.47 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.49 0.662 . . . . 0.0 109.657 179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 54' ' ' ASN . 99.8 m-20 -102.14 109.65 21.4 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.494 -0.754 . . . . 0.0 109.232 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -57.37 -33.13 67.48 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.26 0.552 . . . . 0.0 109.933 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -61.99 -39.37 91.98 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.33 -0.856 . . . . 0.0 109.978 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.3 mt -81.24 71.28 8.22 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.293 -0.88 . . . . 0.0 109.59 -179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.416 ' O ' HD22 ' A' ' 76' ' ' LEU . 18.3 p -90.67 161.69 15.26 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.676 0.75 . . . . 0.0 110.497 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -149.24 152.66 36.35 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.455 0.645 . . . . 0.0 109.665 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.8 m -131.06 135.21 47.35 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.583 0.706 . . . . 0.0 110.167 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -139.22 146.38 40.42 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.646 0.736 . . . . 0.0 109.309 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -109.09 -155.74 16.9 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -63.31 134.26 55.51 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.944 0.878 . . . . 0.0 110.571 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 50.93 29.88 4.81 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.474 0.654 . . . . 0.0 109.463 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.458 ' H ' HE22 ' A' ' 17' ' ' GLN . 2.0 t 48.49 30.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-O 121.659 0.743 . . . . 0.0 109.454 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' O ' ' NH2' ' A' ' 84' ' ' ARG . 28.2 tptp -62.16 -45.19 94.51 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.622 -0.674 . . . . 0.0 109.237 179.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.9 mt -112.18 128.26 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -134.5 138.49 44.73 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.664 0.745 . . . . 0.0 109.877 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.9 t -132.85 146.17 51.59 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 121.514 0.673 . . . . 0.0 109.25 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.1 t -135.01 147.12 49.6 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.817 0.818 . . . . 0.0 110.172 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.1 p -77.8 173.77 11.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.645 0.736 . . . . 0.0 110.284 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -58.39 -48.59 80.14 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.361 0.6 . . . . 0.0 110.16 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.457 ' OE1' ' N ' ' A' ' 75' ' ' GLU . 59.5 mp0 -67.41 -45.01 77.4 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.441 -0.787 . . . . 0.0 109.819 -179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 60' ' ' SER . 52.9 tp -64.16 -40.28 95.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.441 -0.787 . . . . 0.0 109.423 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -58.7 -41.26 85.86 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.595 -0.69 . . . . 0.0 109.191 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -65.21 -36.52 84.44 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.41 -0.807 . . . . 0.0 109.836 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 84.6 mmm -62.22 -38.17 88.17 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.239 -0.913 . . . . 0.0 109.208 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -57.91 138.18 56.03 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.456 -0.778 . . . . 0.0 109.554 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -108.03 -16.57 14.25 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -130.61 151.29 78.44 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.644 -0.66 . . . . 0.0 109.829 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.54 159.82 51.9 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 123.163 2.575 . . . . 0.0 112.881 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.462 ' NH2' ' O ' ' A' ' 68' ' ' LYS . 78.6 ttt-85 -66.82 132.53 48.23 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.786 0.803 . . . . 0.0 110.039 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -119.13 -72.43 0.69 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 163.39 158.44 9.87 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.534 ' CE2' HD11 ' A' ' 91' ' ' LEU . 81.4 t80 -62.57 -44.54 96.07 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.937 0.875 . . . . 0.0 109.636 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -73.55 -23.7 60.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.79 -45.47 67.9 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.523 -0.736 . . . . 0.0 109.673 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.44 HG13 ' N ' ' A' ' 91' ' ' LEU . 25.3 pt -66.79 -36.12 76.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 121.423 0.63 . . . . 0.0 109.563 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.534 HD11 ' CE2' ' A' ' 87' ' ' TYR . 39.2 mt -63.63 -40.49 97.01 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.577 -0.702 . . . . 0.0 109.561 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -68.19 -41.97 80.64 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.616 -0.678 . . . . 0.0 109.628 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -68.03 -38.97 83.17 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.531 -0.731 . . . . 0.0 109.852 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.59 ' CD2' ' CD2' ' A' ' 95' ' ' HIS . 14.2 t60 -60.56 -43.46 97.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.434 -0.791 . . . . 0.0 109.528 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.59 ' CD2' ' CD2' ' A' ' 94' ' ' HIS . 75.8 m-70 -155.48 -80.84 0.08 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.323 -0.86 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.483 ' CG ' ' N ' ' A' ' 97' ' ' HIS . 19.6 p-80 -158.98 -142.6 0.09 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.448 -0.783 . . . . 0.0 110.308 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.483 ' N ' ' CG ' ' A' ' 96' ' ' HIS . 2.9 p-80 -152.4 153.2 33.1 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.738 0.78 . . . . 0.0 110.029 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.466 ' O ' ' ND1' ' A' ' 98' ' ' HIS . 58.1 t-80 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 118.055 -0.974 . . . . 0.0 109.106 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.324 0.583 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -62.33 -45.31 93.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.313 -0.867 . . . . 0.0 109.51 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -64.81 -36.5 84.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.237 -0.914 . . . . 0.0 109.395 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -61.38 -40.73 95.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.441 -0.787 . . . . 0.0 109.187 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -65.59 -40.25 92.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.282 -0.886 . . . . 0.0 109.565 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.524 ' NE2' ' OD1' ' A' ' 66' ' ' ASP . 99.4 mm-40 -64.71 -42.43 95.26 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.691 -179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -64.25 -40.45 96.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.664 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.81 -44.5 93.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.323 -0.86 . . . . 0.0 109.636 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -64.51 -41.7 96.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.366 -0.834 . . . . 0.0 109.862 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 83.3 t -64.63 -42.88 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.322 -0.862 . . . . 0.0 109.644 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -59.74 -45.27 92.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.212 -0.93 . . . . 0.0 108.87 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.8 tp -63.5 -41.96 98.53 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.398 -0.813 . . . . 0.0 109.281 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.484 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 83.1 t80 -58.99 -46.34 88.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.509 -0.744 . . . . 0.0 109.312 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 90.7 mt -75.2 -22.93 57.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.69 -0.631 . . . . 0.0 109.712 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -63.96 -48.34 76.84 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 0.0 110.796 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.619 ' CE1' ' ND2' ' A' ' 28' ' ' ASN . 26.2 p80 -81.81 -35.83 29.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.051 -1.031 . . . . 0.0 109.755 -179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.619 ' ND2' ' CE1' ' A' ' 27' ' ' HIS . 36.6 m-80 -64.04 -41.03 97.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 109.91 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.2 mt -122.69 88.26 49.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.632 -0.667 . . . . 0.0 109.604 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -54.22 -29.79 58.49 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 122.756 2.304 . . . . 0.0 111.622 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -80.37 5.1 15.86 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 54.6 t80 -55.64 131.73 47.15 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.493 -0.755 . . . . 0.0 110.284 -179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -103.0 -65.71 0.98 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.1 t -149.93 165.0 33.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.202 -0.936 . . . . 0.0 109.841 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.1 p -128.12 135.64 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.8 m -126.5 123.46 37.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.574 -0.704 . . . . 0.0 109.478 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -95.55 144.13 26.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.0 109.429 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.463 ' O ' ' OG1' ' A' ' 38' ' ' THR . 0.2 OUTLIER -143.32 17.95 1.89 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.925 . . . . 0.0 108.643 179.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -155.48 116.27 3.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.372 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -138.26 91.47 2.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -118.18 147.3 43.49 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.703 0.763 . . . . 0.0 109.965 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 42' ' ' PHE . 48.8 p90 -97.35 120.94 38.64 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.692 -0.63 . . . . 0.0 109.396 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.448 ' ND2' ' OG ' ' A' ' 48' ' ' SER . 73.8 m-20 -103.58 154.59 37.78 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.342 -0.849 . . . . 0.0 108.909 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -49.92 -40.64 49.01 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 121.966 1.777 . . . . 0.0 111.594 179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 92.0 mt -67.57 -41.26 85.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.456 -0.777 . . . . 0.0 109.059 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -178.54 -125.89 0.96 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 37.0 pt -128.36 151.33 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.588 -0.948 . . . . 0.0 110.011 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.448 ' OG ' ' ND2' ' A' ' 43' ' ' ASN . 6.0 m -127.04 122.45 34.44 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.8 mt -123.11 130.89 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -129.8 149.85 51.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.708 0.766 . . . . 0.0 109.466 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.9 -168.14 34.47 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.218 -1.553 . . . . 0.0 109.218 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -142.48 164.79 29.17 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.344 -1.092 . . . . 0.0 110.309 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 pt -121.0 159.36 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 CA-C-O 121.603 0.716 . . . . 0.0 110.306 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 54' ' ' ASN . 1.0 OUTLIER 57.52 32.8 22.38 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.565 -0.71 . . . . 0.0 109.518 -179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 46.74 32.18 1.66 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.32 -0.862 . . . . 0.0 110.123 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -109.57 108.29 18.68 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.528 -0.733 . . . . 0.0 109.466 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -58.92 -34.98 72.33 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.394 0.616 . . . . 0.0 109.61 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -62.55 -38.63 90.77 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.123 -0.986 . . . . 0.0 109.175 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.2 mt -83.91 77.55 9.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.535 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.1 t -107.37 162.76 13.63 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.372 0.606 . . . . 0.0 109.824 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -153.15 159.75 42.76 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.322 -0.861 . . . . 0.0 109.287 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 86.7 m -129.31 133.8 47.62 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -130.3 142.64 50.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.507 -0.745 . . . . 0.0 109.14 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.49 124.82 5.4 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt 54.13 93.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.755 -0.85 . . . . 0.0 110.646 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD1' ' NE2' ' A' ' 17' ' ' GLN . 95.1 m-20 52.79 -103.23 0.15 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.708 -0.62 . . . . 0.0 110.109 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.84 17.8 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.53 -44.84 96.33 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.413 -0.804 . . . . 0.0 109.222 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 97.0 mt -121.89 126.06 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.479 ' CD2' ' NH1' ' A' ' 84' ' ' ARG . 66.0 t80 -138.46 131.77 30.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.512 -0.742 . . . . 0.0 109.191 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.2 p -139.06 143.46 38.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.366 -0.834 . . . . 0.0 109.06 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.0 p -153.97 170.29 21.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.988 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.0 p -77.17 171.59 14.59 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.634 0.731 . . . . 0.0 110.835 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -66.71 -35.39 80.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.602 -0.686 . . . . 0.0 109.546 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -58.34 -57.55 12.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.115 -0.99 . . . . 0.0 109.279 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 56.9 tp -60.97 -38.65 86.68 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.194 -0.941 . . . . 0.0 109.282 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -51.7 -38.42 55.09 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.378 -0.826 . . . . 0.0 109.702 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -60.42 -31.05 70.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.268 -0.895 . . . . 0.0 110.228 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 95.6 mmm -64.22 -35.45 80.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.176 -0.953 . . . . 0.0 110.02 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -55.06 132.88 48.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.014 -1.054 . . . . 0.0 109.714 -178.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -95.08 -71.58 0.66 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.623 -0.673 . . . . 0.0 109.484 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.19 158.03 41.89 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.301 -0.874 . . . . 0.0 109.352 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -46.56 158.35 0.38 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.243 1.962 . . . . 0.0 112.817 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.479 ' NH1' ' CD2' ' A' ' 70' ' ' PHE . 96.3 mtt-85 -67.59 141.33 56.82 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.392 -0.817 . . . . 0.0 109.59 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -130.95 145.72 52.12 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.458 0.646 . . . . 0.0 109.904 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.2 155.89 26.55 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 110.031 -1.227 . . . . 0.0 110.031 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.522 ' CE2' HD11 ' A' ' 91' ' ' LEU . 85.5 t80 -60.53 -46.01 91.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.8 -0.824 . . . . 0.0 109.403 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 89' ' ' GLU . 45.8 p-10 -68.75 -32.93 73.05 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.16 -0.962 . . . . 0.0 109.683 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.545 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 83.0 tt0 -66.41 -43.09 86.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.326 -0.859 . . . . 0.0 110.508 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.41 HG13 ' N ' ' A' ' 91' ' ' LEU . 29.7 pt -66.71 -37.73 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.033 -1.042 . . . . 0.0 109.375 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.522 HD11 ' CE2' ' A' ' 87' ' ' TYR . 89.1 mt -62.56 -42.0 99.27 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.011 -1.055 . . . . 0.0 109.152 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 94' ' ' HIS . 96.8 mt-10 -66.6 -40.34 88.82 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.437 -0.789 . . . . 0.0 109.328 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 70.5 t60 58.5 -71.6 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.346 0.593 . . . . 0.0 110.453 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.575 ' N ' ' O ' ' A' ' 92' ' ' GLU . 59.2 t-80 -60.99 153.19 25.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.132 -0.98 . . . . 0.0 110.567 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.4 ' CD2' ' N ' ' A' ' 95' ' ' HIS . 2.6 p80 -149.4 165.97 30.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.0 109.599 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.551 ' O ' ' N ' ' A' ' 98' ' ' HIS . 57.2 t-80 -85.13 79.08 9.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.348 -0.845 . . . . 0.0 109.226 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 85.2 t60 43.08 -90.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.606 -0.684 . . . . 0.0 110.365 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.551 ' N ' ' O ' ' A' ' 96' ' ' HIS . 84.7 t60 . . . . . 0 C--N 1.302 -1.476 0 CA-C-O 117.922 -1.037 . . . . 0.0 109.024 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.298 0.57 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -64.61 -45.04 88.63 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.489 -0.757 . . . . 0.0 110.266 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -63.65 -40.69 97.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -0.911 . . . . 0.0 109.827 -179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -62.63 -41.17 98.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.411 -0.806 . . . . 0.0 110.149 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.45 -40.0 92.73 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.211 -0.931 . . . . 0.0 109.962 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.89 -40.1 94.57 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.381 -0.824 . . . . 0.0 110.058 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.01 -40.86 97.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.326 -0.859 . . . . 0.0 110.177 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -65.58 -40.25 92.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.311 -0.868 . . . . 0.0 109.967 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -63.25 -42.17 99.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.312 -0.867 . . . . 0.0 109.415 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.53 -43.36 96.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.562 -0.712 . . . . 0.0 109.902 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 m -61.55 -44.65 96.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.661 -0.649 . . . . 0.0 110.146 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.489 HD11 ' NE2' ' A' ' 27' ' ' HIS . 38.2 tp -63.01 -44.13 96.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 110.379 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.514 ' CZ ' ' OD1' ' A' ' 28' ' ' ASN . 90.9 t80 -62.74 -45.13 94.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.447 -0.783 . . . . 0.0 110.037 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.05 -40.33 96.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.478 -0.764 . . . . 0.0 110.01 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.8 ttpp -58.91 -45.03 91.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.162 -0.961 . . . . 0.0 110.744 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.489 ' NE2' HD11 ' A' ' 23' ' ' LEU . 84.4 m-70 -68.23 -37.21 80.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.019 -1.051 . . . . 0.0 110.26 -179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.514 ' OD1' ' CZ ' ' A' ' 24' ' ' TYR . 17.2 m120 -87.64 -5.39 58.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.167 -0.958 . . . . 0.0 109.177 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.4 mt -138.29 99.0 8.98 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.568 -0.708 . . . . 0.0 109.684 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.34 -14.75 31.32 Favored 'Trans proline' 0 N--CA 1.497 1.71 0 C-N-CA 122.334 2.023 . . . . 0.0 111.589 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -90.9 4.66 51.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.638 -0.664 . . . . 0.0 109.284 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.9 t80 -54.72 129.66 37.7 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.387 -0.821 . . . . 0.0 110.135 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -125.45 -56.11 1.52 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.0 t -146.49 156.46 43.29 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.341 -0.849 . . . . 0.0 109.627 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.5 p -138.91 140.28 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.623 -0.673 . . . . 0.0 109.872 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.6 m -124.68 128.2 48.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -97.88 124.91 42.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.472 -0.767 . . . . 0.0 110.015 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 39' ' ' ASN . 60.4 p -99.62 -15.16 18.67 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.451 ' O ' ' O ' ' A' ' 38' ' ' THR . 74.4 m-20 58.1 148.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.596 0.712 . . . . 0.0 110.535 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -139.42 -163.96 1.59 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.346 -0.846 . . . . 0.0 109.946 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.12 -160.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.693 -0.629 . . . . 0.0 110.845 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -107.75 130.61 54.94 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.391 -0.818 . . . . 0.0 110.064 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -90.39 155.61 46.29 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.423 -0.798 . . . . 0.0 109.822 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -49.63 -37.03 42.59 Favored 'Trans proline' 0 N--CA 1.496 1.651 0 C-N-CA 122.534 2.156 . . . . 0.0 111.645 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 46' ' ' GLY . 21.4 tt -68.4 -38.6 79.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.538 -0.726 . . . . 0.0 109.428 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 45' ' ' ILE . . . 177.92 -97.14 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 41.1 pt -120.56 148.82 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.701 -0.882 . . . . 0.0 110.007 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.2 t -100.21 125.04 46.31 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.396 -0.815 . . . . 0.0 109.427 -179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.03 129.47 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 61' ' ' PHE . 22.6 t0 -130.68 152.14 50.37 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -175.41 -177.39 44.44 Favored Glycine 0 N--CA 1.487 2.082 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -143.75 162.75 35.21 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.539 -0.977 . . . . 0.0 109.968 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.9 pt -121.41 161.5 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 CA-C-O 121.595 0.712 . . . . 0.0 110.871 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 56.78 32.62 21.6 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.692 0.758 . . . . 0.0 109.616 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.7 m120 46.6 32.3 1.63 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.514 -0.741 . . . . 0.0 109.81 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -113.08 111.28 21.87 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.66 -0.65 . . . . 0.0 109.357 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -59.79 -31.75 69.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.605 -0.685 . . . . 0.0 109.564 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.96 -39.06 90.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.833 . . . . 0.0 109.204 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.8 mt -83.5 73.14 10.23 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 0.0 108.986 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 m -105.05 159.67 15.65 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-O 121.649 0.737 . . . . 0.0 110.355 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.43 ' O ' ' OD1' ' A' ' 50' ' ' ASP . 53.3 p90 -147.99 149.3 31.9 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.631 -0.668 . . . . 0.0 109.284 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 94.2 m -128.11 131.92 49.0 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.83 139.96 49.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.41 -0.806 . . . . 0.0 109.764 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' A' ' 66' ' ' ASP . . . -99.78 112.52 4.47 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 65.2 tttm 37.87 -83.0 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 122.097 -0.649 . . . . 0.0 111.813 178.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.594 ' N ' ' O ' ' A' ' 64' ' ' GLY . 99.8 m-20 -78.21 125.19 28.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.25 -0.906 . . . . 0.0 110.182 -178.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 67' ' ' VAL . 37.2 t -60.39 0.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.508 ' H ' ' C ' ' A' ' 66' ' ' ASP . 65.8 tttm -61.74 -42.59 99.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.404 -0.81 . . . . 0.0 109.467 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.86 112.85 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 121.487 0.66 . . . . 0.0 109.386 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -141.39 158.53 43.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.591 -0.693 . . . . 0.0 109.926 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.0 t -125.51 155.9 39.85 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.477 0.655 . . . . 0.0 109.555 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.5 p -150.15 162.13 41.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.439 -0.788 . . . . 0.0 109.636 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 92.4 p -77.34 170.83 15.86 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.99 0.9 . . . . 0.0 110.838 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.46 ' OE1' ' N ' ' A' ' 74' ' ' GLU . 58.7 mp0 -66.09 -37.93 87.0 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.777 -0.577 . . . . 0.0 109.61 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.95 -39.96 94.28 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.422 -0.799 . . . . 0.0 109.558 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.467 HD12 ' SD ' ' A' ' 79' ' ' MET . 58.6 tp -82.61 -21.4 35.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.281 -0.887 . . . . 0.0 109.299 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -66.93 -48.0 69.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 110.459 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -64.69 -22.62 67.02 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.402 -0.811 . . . . 0.0 110.227 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.467 ' SD ' HD12 ' A' ' 76' ' ' LEU . 90.8 mtp -65.27 -33.68 76.55 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.245 -0.909 . . . . 0.0 109.535 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -53.78 141.72 25.96 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.304 -0.872 . . . . 0.0 110.429 -178.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -85.4 -75.81 0.35 Allowed 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.831 -0.543 . . . . 0.0 109.963 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' PRO . 25.9 mt-10 -99.93 154.54 37.18 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.53 -0.731 . . . . 0.0 109.862 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 82' ' ' GLU . 85.1 Cg_exo -40.93 170.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.837 2.358 . . . . 0.0 113.282 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 91.3 mtm-85 -64.98 130.95 45.27 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.705 0.764 . . . . 0.0 110.018 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -109.14 -78.01 0.59 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 149.29 145.86 4.21 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.526 ' CE2' HD11 ' A' ' 91' ' ' LEU . 81.9 t80 -60.44 -45.1 94.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.792 -0.828 . . . . 0.0 109.567 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -71.58 -26.99 62.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.162 -0.961 . . . . 0.0 109.327 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -69.16 -43.24 74.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.465 -0.772 . . . . 0.0 110.014 -179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.4 pt -68.3 -37.05 77.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.316 -0.865 . . . . 0.0 109.777 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.526 HD11 ' CE2' ' A' ' 87' ' ' TYR . 86.3 mt -62.91 -42.14 99.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.043 -1.036 . . . . 0.0 109.777 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.06 -38.31 82.3 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.192 -0.942 . . . . 0.0 109.211 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.01 130.58 37.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.461 -0.774 . . . . 0.0 110.008 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -111.91 139.16 47.63 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.457 0.646 . . . . 0.0 109.674 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.439 ' NE2' ' NE2' ' A' ' 96' ' ' HIS . 27.0 p-80 -82.6 -11.8 58.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.586 -0.696 . . . . 0.0 109.168 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.439 ' NE2' ' NE2' ' A' ' 95' ' ' HIS . 99.5 m-70 -75.14 143.16 43.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.332 -0.855 . . . . 0.0 110.289 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.0 p-80 -153.73 163.86 39.3 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.303 -0.873 . . . . 0.0 109.698 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.686 ' CD2' ' H ' ' A' ' 98' ' ' HIS . 6.4 p80 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.831 -179.881 . . . . . . . . 1 1 . 1 stop_ save_